data_5k6p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5k6p _Structure_validation_residue.Date_analyzed 2016-11-04 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 9.0 p -45.93 -29.35 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.185 0 C-N-CA 125.957 1.703 . . . . 0.0 113.769 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -62.62 -56.38 18.37 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.807 0.843 . . . . 0.0 110.878 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.49 -31.12 66.74 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.255 0.55 . . . . 0.0 110.052 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.51 -50.58 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.364 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.67 -35.97 82.74 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.064 0.459 . . . . 0.0 110.497 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -57.61 -33.9 68.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.33 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -109.42 6.63 24.45 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.288 -175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -89.59 155.78 48.12 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -62.91 136.56 57.71 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.34 2.027 . . . . 0.0 110.508 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.527 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 9.7 Cg_endo -54.23 -34.37 79.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.731 2.954 . . . . 0.0 115.496 -172.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 37.4 t -78.74 -13.98 59.52 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.399 -0.521 . . . . 0.0 112.252 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -98.67 -0.26 43.3 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.98 -174.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.527 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 20.8 m-30 -52.36 -45.21 65.66 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.2 -37.96 78.37 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.521 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 38.8 ttm-85 -63.21 -49.41 74.32 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 339' ' ' GLN . 41.6 mt -71.12 -37.01 65.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.539 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.95 -54.75 41.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.44 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -65.13 -24.31 67.38 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 336' ' ' ILE . 35.2 tt0 -61.88 -36.63 81.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.305 0.574 . . . . 0.0 109.577 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -98.52 -1.37 41.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.028 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 102.03 -5.73 53.4 Favored Glycine 0 C--O 1.244 0.738 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.333 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.64 134.12 27.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 121.369 0.604 . . . . 0.0 109.838 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 -10.82 12.05 Favored 'General case' 0 C--N 1.266 -3.045 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.362 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -100.95 45.53 0.97 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 49.9 p . . . . . 0 N--CA 1.431 -1.417 0 CA-C-O 121.252 0.549 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.402 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -85.61 -11.75 53.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.135 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.505 ' CD2' ' HB3' ' A' ' 441' ' ' GLU . 0.7 OUTLIER -94.84 145.64 24.76 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.204 175.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -108.33 -21.19 12.86 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -156.88 121.22 4.39 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.458 ' HG2' ' CD2' ' A' ' 365' ' ' PHE . 27.9 mtpp -101.3 163.12 12.43 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 54.0 mt -66.26 154.39 40.02 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 123.659 0.599 . . . . 0.0 111.118 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -68.09 161.62 66.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.093 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -55.39 -41.53 77.2 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.196 1.93 . . . . 0.0 111.362 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -154.72 162.43 41.12 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.152 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -136.2 141.46 44.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.6 132.32 55.2 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.51 153.67 37.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 379' ' ' HIS . 14.5 m -85.19 145.32 27.65 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.65 121.26 19.47 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.08 13.94 40.99 Favored Glycine 0 CA--C 1.494 -1.259 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 376' ' ' SER . 35.6 t60 -118.9 150.34 40.05 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -91.0 127.01 36.25 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.317 0.647 . . . . 0.0 111.03 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.653 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.4 tt -124.26 163.7 23.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 0.8 OUTLIER -143.58 137.37 28.34 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.941 0.401 . . . . 0.0 110.037 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -100.37 151.33 21.64 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 38.8 m -133.01 121.94 23.47 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.024 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 12.6 m -127.05 143.85 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.08 135.71 55.13 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.29 161.89 13.36 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -83.62 1.94 39.85 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.131 0.491 . . . . 0.0 110.599 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -138.85 146.37 41.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -80.73 -28.52 36.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -104.85 4.5 32.17 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.481 0.657 . . . . 0.0 111.074 -171.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -88.32 153.13 21.45 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.27 166.14 15.77 Favored 'General case' 0 C--N 1.268 -2.96 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.938 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 3.7 m -113.76 159.99 13.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.118 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 436' ' ' CYS . 31.7 mmmt -106.12 139.18 41.04 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.411 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 11.8 m-90 -113.46 111.51 22.05 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.3 mp -124.38 137.63 54.45 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.008 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -113.51 118.5 34.65 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.2 p30 50.4 18.61 0.45 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 126.104 1.762 . . . . 0.0 113.742 -175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.87 1.44 27.13 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.736 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -113.69 132.35 55.83 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 48.8 mt-10 -61.66 118.18 6.76 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 57.8 mt -71.16 108.96 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -100.41 150.72 22.33 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' MET . . . . . 0.459 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 86.7 mtp -67.63 96.88 0.57 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.101 0.477 . . . . 0.0 110.87 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.9 m -91.25 101.24 13.95 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 58.35 -130.73 51.44 Favored Glycine 0 N--CA 1.446 -0.646 0 O-C-N 123.704 0.627 . . . . 0.0 112.092 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 15.6 m -102.7 13.02 35.49 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.671 0.748 . . . . 0.0 109.307 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -82.6 -41.75 19.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.207 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . 0.459 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 72.7 m-85 -113.25 111.43 22.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 64.2 mt -122.49 117.69 52.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.05 0.452 . . . . 0.0 110.92 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.495 ' CD2' HD13 ' A' ' 421' ' ' LEU . 21.4 m-85 -87.37 109.14 19.34 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.72 108.41 19.87 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.9 p -102.19 105.55 16.25 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.743 0.782 . . . . 0.0 111.64 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.9 mm -100.37 87.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.21 -111.58 3.65 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.331 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -98.1 -6.04 32.46 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.617 0.723 . . . . 0.0 109.813 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -91.39 111.27 22.7 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.55 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -98.54 113.36 25.36 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.4 m -111.41 119.18 37.96 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.495 HD13 ' CD2' ' A' ' 412' ' ' PHE . 19.1 tp -97.09 107.47 20.0 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 96.2 m -94.26 123.05 37.41 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.409 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 59.7 mt -111.67 116.44 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 9.8 m -86.45 130.54 34.46 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.372 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 56.05 74.32 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.595 1.184 . . . . 0.0 111.697 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . 0.653 ' SG ' HG22 ' A' ' 381' ' ' ILE . 68.1 m -69.14 125.38 26.49 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.226 0.536 . . . . 0.0 111.25 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.5 p -109.28 -177.08 3.2 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 90.2 mt -72.63 -14.93 61.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.19 -20.58 48.02 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.694 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.58 -19.67 27.49 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.474 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.19 99.11 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -163.48 171.51 15.8 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.085 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -87.74 127.75 35.31 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -104.96 134.98 47.16 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.593 ' N ' HE21 ' A' ' 435' ' ' GLN . 0.0 OUTLIER -124.34 118.38 26.62 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 395' ' ' LYS . 83.0 m -96.45 108.02 20.5 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 171.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 26.3 t -105.92 117.25 51.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.977 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.75 155.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.58 112.13 4.56 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 117.758 -2.163 . . . . 0.0 111.001 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 105.51 -17.81 42.46 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.505 ' HB3' ' CD2' ' A' ' 365' ' ' PHE . 64.8 mm-40 -141.38 112.31 7.24 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -134.23 159.6 40.42 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 435' ' ' GLN . 47.8 t -142.48 134.47 27.21 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.1 m -108.92 110.6 21.96 Favored 'General case' 0 N--CA 1.426 -1.648 0 O-C-N 124.197 0.935 . . . . 0.0 109.267 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.3 t -102.04 150.11 23.57 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -114.6 116.4 28.69 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.455 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 49.3 tp -84.66 134.22 34.37 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -112.46 109.85 19.69 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.32 112.43 26.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.306 0.574 . . . . 0.0 109.59 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.95 116.05 28.47 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.427 -1.593 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.127 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 13.3 p -61.43 -23.19 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 124.068 0.947 . . . . 0.0 112.66 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -68.62 -41.78 79.02 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.167 0.508 . . . . 0.0 109.939 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.9 -28.33 27.98 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.217 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 76.2 mt -69.39 -47.12 74.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.536 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.89 -34.22 77.64 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.058 0.456 . . . . 0.0 111.257 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -59.27 -41.56 89.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -99.46 -0.41 40.83 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.515 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -71.15 155.5 93.07 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.463 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.68 134.21 46.17 Favored 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.346 2.031 . . . . 0.0 110.549 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 11.7 Cg_endo -53.66 -28.68 47.65 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 124.115 3.21 . . . . 0.0 115.172 -172.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 11.7 m -86.05 -15.02 42.65 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -101.26 3.49 40.9 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.148 -172.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 22.0 m-30 -50.94 -44.73 60.4 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.545 0.528 . . . . 0.0 112.264 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -59.92 -53.64 55.48 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 123.394 0.434 . . . . 0.0 112.14 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 53.4 ttp85 -61.73 -39.34 91.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.435 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 56.4 mt -73.01 -38.96 56.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.127 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.67 -56.83 16.64 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.061 0.545 . . . . 0.0 111.027 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -67.4 -23.54 65.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -65.99 -47.28 75.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.137 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -83.88 -19.29 35.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.162 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 100.77 40.56 2.88 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.086 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.97 128.24 63.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 19.1 p -104.3 -14.48 15.77 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 121.24 0.543 . . . . 0.0 110.44 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -79.28 44.75 0.6 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.331 0.586 . . . . 0.0 111.26 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 46.3 tp . . . . . 0 C--N 1.297 -1.696 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.301 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.417 HG21 ' OE2' ' A' ' 441' ' ' GLU . 7.3 t . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.556 0.217 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.467 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -92.55 -10.47 37.49 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.924 0.392 . . . . 0.0 111.069 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.21 110.07 20.12 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.903 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -74.26 -29.3 61.61 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.527 0.679 . . . . 0.0 109.655 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 367' ' ' LYS . 34.3 ttmt -149.38 119.21 7.07 Favored 'General case' 0 N--CA 1.398 -3.026 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -176.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.658 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 57.9 mtpt -100.04 166.21 11.14 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.758 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 71.4 mt -69.12 136.42 52.19 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.541 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -59.36 150.66 63.27 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -46.66 -39.27 23.19 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 123.095 2.53 . . . . 0.0 113.115 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -147.46 165.37 30.48 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.471 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -142.45 144.39 33.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.38 140.42 52.97 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.6 p -145.93 152.74 13.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 379' ' ' HIS . 25.1 m -91.14 150.85 21.21 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.32 128.79 37.73 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.871 0.367 . . . . 0.0 110.486 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 88.34 6.77 73.78 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.6 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 376' ' ' SER . 10.1 m-70 -102.75 -178.52 3.7 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.764 0.316 . . . . 0.0 110.21 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -119.65 141.24 49.52 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.457 HG23 ' SG ' ' A' ' 426' ' ' CYS . 16.1 tt -141.4 155.42 20.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 2.6 ptm180 -141.18 134.85 30.15 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.347 0.594 . . . . 0.0 110.598 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.57 125.21 48.19 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.817 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 54.1 m -106.28 121.28 43.9 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.702 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.44 144.12 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -124.41 131.44 53.5 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.86 159.86 16.77 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.8 -25.55 56.48 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.3 0.571 . . . . 0.0 110.261 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -131.2 159.41 37.81 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.124 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -80.8 -25.33 37.92 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.261 0.553 . . . . 0.0 109.895 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.08 3.19 40.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.051 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -99.93 118.02 35.46 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -103.01 163.73 12.03 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.167 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 3.7 m -117.81 141.09 38.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.484 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -109.46 122.9 48.42 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.406 ' O ' HD13 ' A' ' 397' ' ' LEU . 3.6 m-90 -93.37 114.0 26.31 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.665 -170.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 396' ' ' TRP . 7.8 mp -127.3 137.67 52.88 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 175.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 433' ' ' ALA . 60.4 pttt -117.34 119.45 35.17 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.8 p30 50.95 20.72 0.84 Allowed 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 125.415 1.486 . . . . 0.0 113.236 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.02 2.28 48.72 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.985 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -108.58 123.43 48.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -53.01 121.13 6.79 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.515 0.509 . . . . 0.0 110.603 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 53.1 mt -79.19 102.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -100.3 145.58 27.96 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 87.8 mtp -60.63 100.74 0.11 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.301 0.572 . . . . 0.0 111.617 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.7 m -102.6 103.1 13.38 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.115 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.99 -134.41 50.83 Favored Glycine 0 N--CA 1.442 -0.95 0 O-C-N 124.008 0.817 . . . . 0.0 113.307 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.3 t -99.98 7.72 44.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 26.2 ttmt -75.7 -54.43 6.97 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.708 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -102.33 107.66 18.76 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.121 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.05 110.15 30.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.365 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.546 ' CE1' HD13 ' A' ' 421' ' ' LEU . 22.4 m-85 -87.27 106.13 17.7 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.45 108.04 19.92 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.433 0.635 . . . . 0.0 110.464 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.86 107.19 19.03 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.53 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.41 84.27 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.74 -111.3 3.4 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.84 -6.86 26.15 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.256 0.55 . . . . 0.0 110.029 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -82.44 113.01 19.9 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.721 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -108.8 107.45 17.88 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.7 m -109.36 116.92 32.76 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.128 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.546 HD13 ' CE1' ' A' ' 412' ' ' PHE . 21.0 tp -91.17 106.39 18.48 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.3 m -93.84 119.99 33.51 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 54.5 mt -107.34 115.37 48.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.5 m -99.99 131.76 45.75 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 68.52 61.65 0.36 Allowed 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.355 1.062 . . . . 0.0 111.494 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . 0.457 ' SG ' HG23 ' A' ' 381' ' ' ILE . 59.7 m -62.95 121.74 14.29 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.561 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.3 p -113.82 -175.0 2.58 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.72 -18.77 62.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.261 0.553 . . . . 0.0 110.39 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -78.92 -11.17 59.99 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.752 0.787 . . . . 0.0 110.101 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . 0.425 ' OD1' ' HD3' ' A' ' 409' ' ' LYS . 23.2 m-20 -96.49 -19.48 19.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.976 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.04 103.15 0.9 Allowed 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -165.05 167.59 18.19 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 398' ' ' LYS . . . -85.76 124.15 31.93 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -104.67 139.46 39.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.409 ' HB3' ' CB ' ' A' ' 444' ' ' SER . 0.0 OUTLIER -142.97 138.76 30.31 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 121.173 0.511 . . . . 0.0 110.767 177.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 62.2 m -101.96 112.05 24.54 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.115 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.95 110.13 23.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.708 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 57.9 t -112.41 157.07 13.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.25 113.3 5.46 Favored Glycine 0 N--CA 1.428 -1.873 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.829 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 102.6 -33.47 6.53 Favored Glycine 0 N--CA 1.425 -2.033 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.158 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 24.7 mm-40 -132.44 131.37 41.67 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.365 0.602 . . . . 0.0 111.582 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.516 ' HG2' ' N ' ' A' ' 443' ' ' CYS . 33.5 ttmt -126.36 158.03 36.95 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.658 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 49.3 t -148.39 134.0 18.78 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' SER . . . . . 0.409 ' CB ' ' HB3' ' A' ' 435' ' ' GLN . 34.0 t -123.79 139.27 54.15 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.8 t -125.62 150.48 47.51 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -106.85 110.87 23.15 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.395 0.616 . . . . 0.0 110.593 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -89.6 139.67 30.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.001 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -121.69 117.02 25.62 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 123.609 0.763 . . . . 0.0 110.891 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 56.5 t -97.51 119.47 45.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.67 137.52 48.24 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.227 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.701 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.501 -0.922 0 CA-C-O 120.642 0.258 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.29 -35.52 36.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.745 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . 0.458 ' O ' ' HB2' ' A' ' 326' ' ' ARG . 17.7 m95 -56.6 -60.4 3.59 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 124.024 0.93 . . . . 0.0 110.913 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.85 -41.32 95.79 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.488 0.492 . . . . 0.0 111.657 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.4 mt -68.06 -42.88 85.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 123.095 0.558 . . . . 0.0 111.545 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.6 -36.24 60.36 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 322' ' ' TRP . 14.3 tpt85 -63.94 -41.15 97.7 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.364 0.666 . . . . 0.0 111.345 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.76 -4.59 59.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.547 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -87.92 150.3 47.51 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.59 150.24 82.9 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.817 1.678 . . . . 0.0 111.273 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.1 -29.31 3.93 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.644 3.563 . . . . 0.0 115.96 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 50.5 m -85.41 -2.06 57.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -93.44 -22.26 19.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -44.08 -52.51 7.13 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.86 1.264 . . . . 0.0 112.905 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -57.0 -53.0 63.03 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.433 0.693 . . . . 0.0 111.858 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -57.87 -50.37 73.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.983 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.67 -40.43 89.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.892 -175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.94 -57.72 11.56 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.623 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -68.89 -23.02 64.15 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -64.14 -44.8 91.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.92 0.39 . . . . 0.0 110.082 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -91.13 -8.4 48.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 89.13 32.5 10.56 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.442 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 17.6 t -94.52 122.8 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.338 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 9.3 p -97.82 -22.57 16.31 Favored 'General case' 0 C--N 1.276 -2.618 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.934 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -83.89 63.23 7.43 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.714 0.768 . . . . 0.0 110.297 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 27.6 tp . . . . . 0 C--N 1.313 -0.998 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.286 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 75.0 p . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -97.53 4.93 50.22 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.17 0.509 . . . . 0.0 110.776 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -117.0 117.6 30.11 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.689 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -85.08 -21.93 29.15 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 120.826 0.346 . . . . 0.0 110.36 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 367' ' ' LYS . 23.6 ttmm -159.67 127.38 4.77 Favored 'General case' 0 N--CA 1.391 -3.383 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.765 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 35.6 mtmm -110.75 177.35 4.7 Favored 'General case' 0 C--N 1.253 -3.615 0 O-C-N 124.28 0.987 . . . . 0.0 108.357 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.98 141.94 49.37 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.144 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.67 158.66 67.02 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.202 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -44.8 -39.81 14.09 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 123.451 2.767 . . . . 0.0 113.809 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -156.11 162.53 40.24 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -137.97 149.2 45.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -133.38 137.34 45.79 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.42 143.78 33.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.7 m -79.43 141.99 36.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -57.28 125.59 23.48 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 122.957 0.503 . . . . 0.0 110.402 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 96.47 -9.97 66.96 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.917 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -96.71 170.75 8.98 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.149 0.499 . . . . 0.0 110.791 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 6.9 mtpm? -101.08 161.05 13.88 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.729 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 18.2 tt -154.98 133.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 121.201 0.524 . . . . 0.0 110.665 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -99.99 127.47 46.2 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.546 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 420' ' ' THR . 70.3 mt -105.77 109.37 21.3 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 87.7 m -107.19 126.01 51.85 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.13 149.25 33.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.43 135.55 53.98 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 54.1 mt -104.04 165.44 11.05 Favored 'General case' 0 C--N 1.261 -3.263 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.03 -29.84 49.61 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.164 0.507 . . . . 0.0 109.929 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -112.01 146.94 37.0 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.181 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -78.9 -22.44 45.92 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -112.5 26.23 10.74 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.236 0.541 . . . . 0.0 111.398 -173.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -113.37 137.54 51.36 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -122.31 154.45 37.6 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.893 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.61 153.53 7.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.33 0.586 . . . . 0.0 111.491 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -103.43 133.37 48.6 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.428 ' CB ' HD12 ' A' ' 403' ' ' ILE . 44.8 m95 -101.51 139.06 37.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 434' ' ' TYR . 10.3 mp -121.13 143.61 49.01 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . 0.551 ' HG3' HG12 ' A' ' 403' ' ' ILE . 22.5 mtmm -103.83 108.61 20.0 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.7 p30 50.95 16.81 0.37 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 124.966 1.306 . . . . 0.0 113.998 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.15 -5.96 17.52 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.643 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -102.04 124.85 48.37 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -64.13 118.39 8.48 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.932 0.396 . . . . 0.0 111.987 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.551 HG12 ' HG3' ' A' ' 398' ' ' LYS . 41.0 mt -66.33 122.0 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.248 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -102.1 157.34 16.95 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 48.0 ttm -71.54 94.6 1.31 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.0 t -89.92 102.22 14.92 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 58.68 -114.38 5.92 Favored Glycine 0 N--CA 1.437 -1.251 0 O-C-N 124.086 0.866 . . . . 0.0 112.141 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 26.4 m -119.3 17.12 13.1 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.05 -0.575 . . . . 0.0 109.735 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -76.34 -46.39 27.76 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.864 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . 0.546 ' O ' ' HG3' ' A' ' 405' ' ' MET . 93.4 m-85 -111.62 108.44 17.93 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.89 0.376 . . . . 0.0 110.292 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 49.6 mt -107.91 113.75 44.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -87.23 105.1 16.99 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.409 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.99 138.61 41.87 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.638 0.732 . . . . 0.0 111.365 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 13.1 p -118.38 122.81 43.73 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.089 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.79 89.89 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.03 -123.83 15.69 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.41 -6.36 55.02 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.317 0.58 . . . . 0.0 110.027 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -88.85 125.26 34.84 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -113.2 137.3 51.67 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 76.9 m -142.11 122.94 14.38 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.367 0.603 . . . . 0.0 112.162 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 63.9 tp -91.19 114.32 26.82 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.441 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 43.7 m -93.97 108.08 19.92 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 50.7 mt -92.84 130.62 41.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' SER . . . . . 0.448 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 16.5 m -106.58 132.19 52.87 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.832 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 425' ' ' GLN 0.321 2.0 pt20 46.64 76.5 0.1 Allowed 'General case' 0 C--O 1.238 0.467 0 O-C-N 125.16 1.537 . . . . 0.0 114.575 177.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 60.5 m -70.28 128.39 36.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.968 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.0 m -112.9 -174.16 2.4 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.64 -19.79 62.78 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.89 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -72.55 -24.72 61.17 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.182 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.38 -21.57 42.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.13 95.54 0.41 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.412 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.95 171.51 18.58 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.2 132.74 34.24 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . 0.6 ' HA ' ' O ' ' A' ' 397' ' ' LEU . 38.7 m-85 -104.81 145.57 30.19 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.1 OUTLIER -129.62 123.28 30.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 7.8 p -94.38 118.28 31.39 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 13.0 t -111.53 121.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.28 160.06 6.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.37 112.29 4.71 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 117.764 -2.16 . . . . 0.0 110.242 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 107.52 -35.41 5.03 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 112.391 -0.283 . . . . 0.0 112.391 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -120.03 127.82 52.95 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 122.428 -0.454 . . . . 0.0 110.612 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -130.85 128.93 41.63 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.7 t -120.31 138.05 53.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 12.7 p -116.43 148.11 41.03 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 123.412 0.445 . . . . 0.0 111.013 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 12.6 t -140.54 150.92 44.3 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -101.73 119.28 38.54 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 24.4 tp -95.98 137.22 35.35 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -118.35 115.74 25.31 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.52 122.17 41.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -93.73 106.63 18.59 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.724 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--N 1.292 -1.896 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.274 179.284 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.471 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 7.2 p -51.33 -34.4 14.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 123.873 0.869 . . . . 0.0 112.209 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -55.91 -47.71 76.98 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.872 0.869 . . . . 0.0 110.92 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 11.6 pt-20 -85.85 -38.12 18.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.69 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.79 -50.47 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.311 0.1 . . . . 0.0 111.167 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.39 -32.0 70.75 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -57.87 -39.14 77.09 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.846 0.858 . . . . 0.0 112.199 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 23.2 pt20 -104.88 2.38 29.86 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.173 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -77.12 160.77 75.25 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.529 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.84 135.51 48.61 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.276 1.984 . . . . 0.0 111.029 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.445 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 53.4 Cg_endo -65.96 -4.83 10.85 Favored 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 123.759 2.972 . . . . 0.0 114.772 -173.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 24.5 p -90.25 -16.7 28.85 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.208 0.528 . . . . 0.0 111.192 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 336' ' ' ILE . 29.3 mm-40 -106.92 -0.72 22.98 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.54 -172.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.445 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 22.1 m-30 -55.73 -42.24 75.06 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -173.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.07 -44.14 97.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.528 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -59.36 -53.53 57.18 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.697 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 332' ' ' GLU . 48.5 mt -59.04 -44.06 90.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 O-C-N 123.792 0.683 . . . . 0.0 110.613 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.66 -60.79 3.28 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.126 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -67.12 -22.85 65.78 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -66.39 -45.62 79.4 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 123.2 0.6 . . . . 0.0 110.205 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . 0.471 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 80.8 m-85 -88.83 -20.19 24.98 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 112.63 14.09 10.79 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.532 -1.318 . . . . 0.0 112.551 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.37 97.14 6.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.2 m -65.06 -42.67 93.99 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.693 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -115.99 95.9 5.32 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.706 0.765 . . . . 0.0 111.409 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.6 pt? . . . . . 0 C--N 1.307 -1.243 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.104 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 111.363 0.134 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -86.14 -3.34 58.94 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.204 1.002 . . . . 0.0 108.558 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 441' ' ' GLU . 0.3 OUTLIER -91.98 126.45 37.07 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 114.226 -1.352 . . . . 0.0 107.899 173.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -93.25 -18.09 22.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.48 0.657 . . . . 0.0 110.023 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -157.24 126.08 5.8 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.721 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 37.4 mtmm -106.86 176.58 5.12 Favored 'General case' 0 C--N 1.276 -2.596 0 O-C-N 123.791 0.682 . . . . 0.0 109.841 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.517 HD13 ' SG ' ' A' ' 436' ' ' CYS . 72.3 mt -74.51 147.54 41.75 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.23 159.06 82.34 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.61 -35.85 38.86 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.277 2.651 . . . . 0.0 112.997 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -156.35 160.72 39.95 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -133.82 148.76 51.35 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -128.25 144.69 51.15 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.8 149.24 15.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 m -88.66 154.02 20.64 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.01 121.43 11.82 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.167 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 90.63 4.37 70.26 Favored Glycine 0 C--N 1.303 -1.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.16 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -98.78 176.9 5.46 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 122.434 -0.451 . . . . 0.0 110.767 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -110.42 143.13 41.17 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.044 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.479 HG23 ' SG ' ' A' ' 426' ' ' CYS . 10.0 tp -130.99 143.04 42.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -121.19 121.9 38.8 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 66.7 mt -100.17 113.33 25.91 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 26.9 m -112.14 125.21 53.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.311 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.99 157.54 40.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.11 137.32 54.58 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 417' ' ' ALA . 86.7 mt -98.8 138.13 36.39 Favored 'General case' 0 C--N 1.267 -3.007 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.64 -38.56 58.8 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -106.95 99.8 9.34 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.626 -1.625 . . . . 0.0 106.917 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -73.9 -16.64 61.1 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 120.817 0.341 . . . . 0.0 111.712 -174.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -87.28 3.97 44.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.177 0.513 . . . . 0.0 110.528 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -107.67 96.18 6.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . 0.431 ' HG2' ' NH2' ' A' ' 419' ' ' ARG . 35.0 mt-10 -75.27 159.81 31.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 8.6 p -118.11 157.95 19.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 113.485 -1.688 . . . . 0.0 109.668 -173.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -132.15 161.22 33.87 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.437 ' CE2' ' HB2' ' A' ' 421' ' ' LEU . 38.7 m95 -114.14 144.62 42.87 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.7 mp -122.74 136.41 54.86 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . 0.427 ' HG2' HG12 ' A' ' 403' ' ' ILE . 8.2 mmtp -93.17 108.62 20.19 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.479 173.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.8 p30 53.03 12.92 0.32 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 125.024 1.33 . . . . 0.0 114.078 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 108.44 9.72 26.72 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.007 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -90.77 -98.89 0.11 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 173.21 137.53 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.43 HD12 ' CB ' ' A' ' 396' ' ' TRP . 48.4 mt -97.75 120.8 47.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 120.831 0.348 . . . . 0.0 110.401 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -91.77 130.99 37.45 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 58.1 ttp -62.21 103.73 0.41 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.8 m -106.16 120.31 41.5 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.265 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 48.62 -118.89 5.21 Favored Glycine 0 C--N 1.334 0.42 0 O-C-N 125.027 1.454 . . . . 0.0 115.278 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.6 m -112.14 7.57 19.65 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.468 0.651 . . . . 0.0 109.623 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 424' ' ' SER . 82.6 tttt -83.3 -49.5 9.32 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.658 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -109.74 129.05 55.65 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.93 118.16 51.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -87.91 105.87 17.72 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -112.76 113.09 25.03 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.166 0.508 . . . . 0.0 111.73 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 37.4 t -98.22 119.42 36.86 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.84 95.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 71.32 -107.83 2.3 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 387' ' ' LEU . . . -101.6 -13.11 17.97 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.073 0.463 . . . . 0.0 109.846 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -74.86 137.61 41.92 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 121.601 0.715 . . . . 0.0 111.695 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . 0.431 ' NH2' ' HG2' ' A' ' 393' ' ' GLU . 21.8 mmt180 -122.3 112.74 18.5 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 173.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 6.8 m -116.64 122.01 43.34 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 396' ' ' TRP . 53.5 tp -96.23 111.0 23.2 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 67.4 m -92.36 109.5 20.88 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 56.4 mt -101.95 122.15 53.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 409' ' ' LYS . 18.3 m -108.42 141.08 40.8 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 64.84 58.32 0.97 Allowed 'General case' 0 C--O 1.254 1.303 0 C-N-CA 124.427 1.091 . . . . 0.0 111.782 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . 0.479 ' SG ' HG23 ' A' ' 381' ' ' ILE . 85.2 m -66.06 131.47 46.28 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.497 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 5.5 m -126.0 177.62 6.24 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 98.8 mt -67.3 -30.7 70.63 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 118.19 0.45 . . . . 0.0 111.633 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.98 -9.11 59.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.759 0.79 . . . . 0.0 110.298 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 427' ' ' SER . 18.7 t70 -97.23 -13.94 21.72 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -71.24 114.52 9.39 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.123 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -156.34 172.97 17.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.776 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.67 126.78 33.67 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -106.91 145.27 32.41 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 120.995 0.426 . . . . 0.0 110.864 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.13 143.44 24.15 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.551 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.517 ' SG ' HD13 ' A' ' 369' ' ' LEU . 59.0 m -98.26 131.87 44.23 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 56.7 t -116.04 107.98 24.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.284 0.564 . . . . 0.0 111.771 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 58.6 t -116.91 160.82 16.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 170.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -68.27 109.56 2.97 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 117.21 -2.424 . . . . 0.0 111.891 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 99.97 -36.21 4.26 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 125.861 1.696 . . . . 0.0 108.966 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 438' ' ' VAL . 6.4 mp0 -90.25 96.18 10.55 Favored 'General case' 0 N--CA 1.395 -3.196 0 C-N-CA 124.887 1.275 . . . . 0.0 112.341 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 37.9 ttmt -121.59 118.04 28.24 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 51.6 t -115.31 133.69 55.8 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 10.8 p -112.22 147.59 35.89 Favored 'General case' 0 N--CA 1.432 -1.33 0 O-C-N 123.565 0.541 . . . . 0.0 111.143 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.5 t -144.88 151.25 38.42 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -112.24 117.68 33.19 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 118.805 -1.158 . . . . 0.0 109.624 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 58.4 tp -88.0 136.54 32.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -118.52 113.5 21.39 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.13 117.26 33.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -94.06 109.32 21.09 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-O 121.386 0.612 . . . . 0.0 111.309 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.809 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 CA--C 1.495 -1.17 0 CA-C-O 121.601 0.715 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.46 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 5.3 p -54.57 -39.43 45.91 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.495 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -52.26 -57.26 10.25 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 124.202 1.001 . . . . 0.0 111.334 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.24 -35.43 68.83 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.765 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.44 -52.79 53.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.015 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.19 -34.81 73.4 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.005 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -58.89 -40.86 85.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.694 0.398 . . . . 0.0 110.986 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -93.54 2.02 56.55 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.437 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -88.89 158.2 47.75 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.362 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.93 161.63 40.9 Favored 'Trans proline' 0 CA--C 1.555 1.555 0 C-N-CA 122.539 2.159 . . . . 0.0 111.194 173.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.604 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 10.9 Cg_endo -55.35 -35.8 92.43 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.68 2.92 . . . . 0.0 114.861 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 14.8 m -72.72 -8.58 56.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.428 0.632 . . . . 0.0 112.412 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 336' ' ' ILE . 12.0 mm-40 -97.31 -22.88 16.4 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.859 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.604 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 23.3 m-30 -55.14 -50.08 70.16 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -174.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.71 -18.99 62.12 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.29 0.567 . . . . 0.0 111.207 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -82.82 -57.36 3.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.423 ' CD1' ' HB3' ' A' ' 332' ' ' GLU . 69.4 mt -58.29 -39.41 73.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.495 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.11 -59.57 4.89 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.472 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.48 -23.48 64.58 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -68.2 -36.74 80.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.07 0.462 . . . . 0.0 110.537 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . 0.46 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 85.7 m-85 -97.12 -17.35 20.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 107.15 20.78 8.46 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.93 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 15.0 t -95.41 129.67 45.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 34.2 p -94.66 -49.72 5.5 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.435 -0.906 . . . . 0.0 112.351 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.11 69.21 3.19 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -171.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.435 -1.202 0 CA-C-O 120.726 0.298 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -102.34 -19.97 14.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.7 0.762 . . . . 0.0 109.712 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -100.14 137.02 39.15 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.318 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -99.26 -16.37 18.53 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.4 OUTLIER -162.74 115.96 1.66 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 178.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 15.0 mtpp -88.51 169.41 11.77 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.22 140.37 58.86 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -60.18 147.88 79.94 Favored Pre-proline 0 C--N 1.318 -0.788 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -43.96 -47.49 10.09 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.616 2.877 . . . . 0.0 114.15 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -151.14 142.69 23.56 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.121 0.486 . . . . 0.0 111.435 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -122.14 156.59 33.33 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -142.28 134.06 27.0 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.64 156.91 20.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 15.1 m -79.76 157.23 27.16 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 2.0 tmmm? -77.34 135.56 38.38 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . 0.563 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 86.82 5.65 80.89 Favored Glycine 0 CA--C 1.494 -1.247 0 CA-C-O 121.372 0.429 . . . . 0.0 112.097 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -99.14 -170.67 1.95 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -114.84 139.36 49.81 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.1 tp -121.88 128.74 75.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -102.37 103.58 14.01 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.78 0.8 . . . . 0.0 112.319 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 65.4 mt -91.2 114.95 27.61 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.1 m -123.56 130.59 52.9 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.473 -169.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.425 HG12 ' SG ' ' A' ' 436' ' ' CYS . 14.7 m -127.96 154.09 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.054 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -120.88 142.43 49.68 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 49.6 mt -98.62 142.27 30.41 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.47 -35.18 54.02 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -125.07 142.57 51.41 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -74.48 -16.98 60.83 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.429 0.633 . . . . 0.0 110.775 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.37 11.78 22.65 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.948 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -104.2 88.76 3.07 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -78.35 147.99 33.94 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 11.8 p -106.62 157.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.761 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER -125.79 150.72 47.56 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 175.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.422 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 3.2 m-90 -121.94 123.85 42.66 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.7 mp -129.81 144.71 51.44 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 118.438 0.563 . . . . 0.0 110.689 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -123.21 121.04 34.93 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.9 p30 49.73 17.03 0.23 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.531 1.532 . . . . 0.0 114.183 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.08 -4.35 23.9 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.624 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -108.28 123.0 48.12 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 35.7 tt0 -61.45 122.63 15.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.927 0.394 . . . . 0.0 110.908 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 42.7 mt -73.78 114.6 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.972 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -99.03 147.36 25.1 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 171.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' MET . . . . . 0.464 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 0.0 OUTLIER -77.28 126.14 30.45 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.255 -176.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 15.0 m -109.68 88.57 2.78 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.22 -109.76 2.66 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.0 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 45.2 t -109.78 4.02 21.36 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 122.808 -0.231 . . . . 0.0 110.809 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . 0.501 ' HZ2' ' CG ' ' A' ' 430' ' ' ASP . 12.2 tmtt? -79.45 -34.28 41.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . 0.464 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 91.2 m-85 -126.63 117.35 22.59 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 52.8 mt -118.3 113.8 43.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.428 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.494 ' CD1' HD11 ' A' ' 421' ' ' LEU . 23.6 m-85 -87.97 109.48 19.84 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -108.05 106.31 16.47 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 50.5 m -92.28 106.28 18.31 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.84 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 58.3 mt -113.71 92.82 2.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.33 -110.45 3.42 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.572 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.68 -2.23 35.94 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.007 0.432 . . . . 0.0 110.562 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -101.85 133.85 45.97 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.512 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -111.18 110.47 21.0 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 17.4 m -108.59 118.14 36.01 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.554 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.494 HD11 ' CD1' ' A' ' 412' ' ' PHE . 22.6 tp -98.25 107.96 20.54 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 39.2 m -93.61 100.38 12.64 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.439 HG22 ' HZ3' ' A' ' 409' ' ' LYS . 49.9 mt -83.97 115.66 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 14.9 m -100.33 134.81 42.73 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 69.19 54.15 0.44 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.541 1.136 . . . . 0.0 111.002 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 1.9 p -62.38 123.94 19.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.222 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 9.2 m -114.27 169.53 8.96 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.33 -37.92 77.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.168 0.509 . . . . 0.0 111.815 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -84.29 1.24 45.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.751 0.786 . . . . 0.0 110.223 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . 0.501 ' CG ' ' HZ2' ' A' ' 409' ' ' LYS . 28.4 t70 -106.34 -17.59 14.24 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.824 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.5 125.33 17.64 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.849 174.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.47 169.11 23.68 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.994 0.426 . . . . 0.0 111.191 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -86.39 133.64 33.77 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 170.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -114.7 137.87 51.39 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.04 140.33 52.09 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.722 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 20.8 p -115.84 113.98 24.1 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 173.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.47 118.46 58.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.028 0.442 . . . . 0.0 111.863 -174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 97.0 t -114.17 161.69 12.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.24 113.06 5.52 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.831 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 100.67 -35.41 4.86 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.085 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -128.26 135.98 50.39 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 120.693 0.282 . . . . 0.0 110.889 -173.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -141.94 177.64 8.06 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.722 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 53.1 t -160.27 142.33 12.89 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 3.8 p -121.15 131.27 54.15 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 123.69 0.619 . . . . 0.0 110.197 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 14.9 t -121.61 150.71 41.3 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.72 111.12 18.7 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.21 0.529 . . . . 0.0 110.212 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 61.0 tp -90.62 140.77 29.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.596 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -115.18 108.38 16.53 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 42.3 t -90.4 109.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 376' ' ' SER . 37.8 ttpt -111.82 127.19 55.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.367 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.631 0.729 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.415 HG12 HG23 ' A' ' 342' ' ' VAL . 6.5 p -50.84 -37.23 16.04 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.587 0 C-N-CA 125.721 1.608 . . . . 0.0 113.608 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -61.79 -56.68 16.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.663 0.744 . . . . 0.0 110.732 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 13.2 pt-20 -71.96 -21.61 61.56 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.017 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.5 mt -74.29 -46.36 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.387 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.97 -40.2 84.06 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 122.905 0.482 . . . . 0.0 110.325 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -55.54 -36.83 67.19 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.194 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 20.9 pt20 -100.79 5.76 43.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.163 0.506 . . . . 0.0 111.511 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -106.62 152.83 40.86 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.587 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -62.65 138.51 70.17 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.416 2.077 . . . . 0.0 111.886 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 30.5 Cg_endo -64.7 -22.38 64.26 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.484 2.789 . . . . 0.0 112.468 -174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 2.8 p -74.59 -14.22 60.75 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.165 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -111.49 4.49 18.87 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.355 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.424 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 14.2 m-30 -49.12 -41.12 34.99 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.9 -54.21 49.17 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.511 0.507 . . . . 0.0 111.584 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -61.1 -44.97 96.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.845 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 38.6 mt -68.35 -42.49 84.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.264 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.84 -54.32 46.55 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.593 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -61.84 -32.28 72.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -61.01 -39.86 91.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.828 0.347 . . . . 0.0 110.495 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -91.75 1.35 57.22 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 86.81 23.46 42.04 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.646 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.415 HG23 HG12 ' A' ' 321' ' ' VAL . 19.0 t -107.3 134.35 49.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.8 p -110.78 -15.35 13.83 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-O 120.981 0.42 . . . . 0.0 110.651 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -95.35 45.68 1.1 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.852 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 121.449 0.642 . . . . 0.0 110.924 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.423 -1.819 0 CA-C-O 121.182 0.515 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.405 ' HB2' ' HG3' ' A' ' 441' ' ' GLU . . . -103.98 0.35 29.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 122.0 0.905 . . . . 0.0 109.598 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.81 137.76 50.66 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.415 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -103.21 -19.4 14.51 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.827 0.346 . . . . 0.0 110.104 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -156.46 125.54 6.04 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.421 ' HE2' ' SG ' ' A' ' 443' ' ' CYS . 60.6 mtpt -112.16 172.32 6.98 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 96.0 mt -72.6 117.81 14.74 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -63.65 142.17 97.98 Favored Pre-proline 0 C--N 1.314 -0.953 0 O-C-N 124.033 0.833 . . . . 0.0 108.882 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -47.72 -35.3 23.17 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 123.326 2.684 . . . . 0.0 113.129 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -127.46 128.0 45.0 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.491 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 44.9 m-85 -128.81 147.38 50.79 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -134.09 145.14 49.07 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.75 159.06 4.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 13.9 m -89.16 156.48 18.77 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -67.19 123.36 20.09 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.43 5.09 67.52 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -101.69 164.95 11.48 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.331 -0.434 . . . . 0.0 110.378 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -102.36 136.85 41.44 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.504 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.569 HG21 ' SG ' ' A' ' 426' ' ' CYS . 14.9 tt -136.35 154.69 33.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.421 ' CB ' ' HA ' ' A' ' 422' ' ' THR . 18.4 ptt180 -134.76 126.09 28.24 Favored 'General case' 0 N--CA 1.413 -2.316 0 C-N-CA 119.175 -1.01 . . . . 0.0 112.031 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.9 109.79 13.51 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 113.892 -1.504 . . . . 0.0 109.0 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' THR . . . . . 0.451 ' CG2' ' HD2' ' A' ' 418' ' ' LYS . 23.5 m -105.46 124.27 49.27 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.869 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.49 158.44 42.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -130.51 132.76 45.79 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 79.6 mt -96.61 159.79 14.74 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.49 -41.35 76.23 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -101.37 147.27 26.52 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.284 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.46 ' CD2' ' HB1' ' A' ' 417' ' ' ALA . 11.1 m170 -80.84 -24.28 38.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.27 25.6 1.16 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.448 1.499 . . . . 0.0 110.819 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -131.84 153.99 49.61 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -175.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -124.64 172.15 9.48 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 123.226 0.329 . . . . 0.0 110.629 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.38 144.25 37.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.081 0.467 . . . . 0.0 110.61 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.498 ' HZ1' ' CD ' ' A' ' 402' ' ' GLU . 24.4 mmmt -103.27 129.4 50.25 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.798 175.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.507 ' HA ' ' O ' ' A' ' 435' ' ' GLN . 34.4 m95 -110.28 128.27 55.44 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.955 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.4 139.73 50.94 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -109.2 125.56 52.36 Favored 'General case' 0 N--CA 1.407 -2.61 0 C-N-CA 118.224 -1.39 . . . . 0.0 108.906 171.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 27.3 p30 50.89 21.68 1.01 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 126.628 1.971 . . . . 0.0 114.296 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.67 12.35 56.99 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.52 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -96.14 -91.58 0.23 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.498 ' CD ' ' HZ1' ' A' ' 395' ' ' LYS . 3.4 tp10 176.02 139.85 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 396' ' ' TRP . 9.4 mt -111.51 106.15 20.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -115.2 146.46 41.39 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 51.8 ttm -55.93 104.83 0.15 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.431 0.634 . . . . 0.0 111.195 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.0 t -117.3 110.14 17.71 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 51.42 -117.34 5.6 Favored Glycine 0 C--N 1.33 0.211 0 O-C-N 124.147 0.904 . . . . 0.0 113.35 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.9 p -114.46 8.7 16.58 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.671 0.748 . . . . 0.0 110.44 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -72.74 -40.71 65.85 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.052 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -129.33 113.91 15.56 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 64.2 mt -112.88 116.92 53.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.772 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -86.61 109.55 19.23 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.765 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.03 108.13 19.1 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.6 m -103.16 104.91 15.1 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.135 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.5 mm -123.65 103.91 13.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 66.63 -113.39 5.63 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.46 ' HB1' ' CD2' ' A' ' 390' ' ' HIS . . . -99.51 -12.97 19.69 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.381 0.61 . . . . 0.0 109.601 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . 0.451 ' HD2' ' CG2' ' A' ' 384' ' ' THR . 7.8 ttpm? -86.96 136.35 32.96 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.34 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -122.33 126.44 48.07 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.3 m -127.51 125.63 40.76 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.48 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 403' ' ' ILE . 50.3 tp -100.1 103.93 15.46 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 70.0 m -89.97 116.84 28.32 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.023 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 48.8 mt -107.54 118.63 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.0 m -89.97 144.59 25.79 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 57.19 62.72 2.11 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 123.979 0.912 . . . . 0.0 112.401 174.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . 0.569 ' SG ' HG21 ' A' ' 381' ' ' ILE . 82.8 m -69.56 118.18 12.11 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' SER . . . . . 0.468 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 14.1 m -111.05 171.79 7.26 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.55 -35.12 78.44 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.079 0.466 . . . . 0.0 110.367 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.42 -7.74 56.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.789 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 427' ' ' SER . 29.5 t70 -105.34 -9.32 17.67 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.618 0.723 . . . . 0.0 109.711 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.71 112.28 2.19 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.625 -1.17 . . . . 0.0 107.872 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -153.59 168.2 26.98 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.068 0.461 . . . . 0.0 111.283 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.53 131.5 34.36 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -114.97 132.17 56.67 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 396' ' ' TRP . 0.6 OUTLIER -112.08 136.93 50.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 16.9 p -106.07 106.21 16.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.49 124.03 53.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.246 0.546 . . . . 0.0 111.513 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.91 152.06 36.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -70.08 113.33 4.89 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 118.689 -1.719 . . . . 0.0 110.901 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 109.23 -36.31 4.41 Favored Glycine 0 N--CA 1.418 -2.558 0 C-N-CA 123.306 0.479 . . . . 0.0 111.928 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 364' ' ' ALA . 6.3 mm-40 -130.21 126.32 37.1 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -136.4 146.84 46.89 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.421 ' SG ' ' HE2' ' A' ' 368' ' ' LYS . 8.9 t -144.9 160.24 41.63 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 7.6 p -142.92 133.2 24.63 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.329 0.393 . . . . 0.0 110.583 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 8.6 t -109.36 150.18 28.41 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -111.57 110.68 21.22 Favored 'General case' 0 N--CA 1.406 -2.668 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.45 145.49 31.9 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -119.13 107.6 13.66 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.18 110.41 22.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -102.15 127.81 48.91 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.437 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.412 -2.344 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.539 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 14.2 p -55.52 -28.22 22.39 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.651 0 C-N-CA 124.942 1.297 . . . . 0.0 111.911 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -57.32 -56.56 20.23 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 123.093 0.557 . . . . 0.0 110.614 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.42 -32.77 58.69 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.366 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.2 mt -71.46 -45.57 67.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.938 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 9.6 tt -73.28 -29.41 62.71 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -61.78 -42.72 99.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.445 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -89.16 -0.59 57.57 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.984 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -94.58 154.87 40.02 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.815 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.93 141.47 44.65 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.031 1.821 . . . . 0.0 111.279 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.85 -20.76 53.8 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.815 3.01 . . . . 0.0 114.049 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 5.6 m -66.71 -27.96 68.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -110.57 11.84 22.86 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -52.94 -37.73 61.23 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.81 -47.43 80.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.608 0.242 . . . . 0.0 110.99 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -62.61 -42.59 99.67 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.543 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.63 -44.99 99.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.158 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.89 -54.01 51.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.13 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -69.19 -23.11 63.87 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -69.79 -44.4 70.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.221 0.534 . . . . 0.0 109.987 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -88.47 1.23 55.22 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 72.49 35.64 59.5 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.151 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 8.2 t -103.56 111.53 33.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.1 p -84.01 -20.66 32.4 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-O 122.341 1.067 . . . . 0.0 110.15 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.46 44.18 1.19 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.149 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 C--N 1.315 -0.918 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 172.236 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.411 -2.393 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.409 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -100.31 -33.29 10.46 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -89.08 123.15 33.1 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.512 173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -87.44 -25.18 23.89 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -164.29 118.79 1.45 Allowed 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.467 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 51.3 mtmt -91.26 170.59 9.87 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 123.403 0.439 . . . . 0.0 110.452 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.521 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 76.1 mt -60.12 143.81 51.34 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 123.896 0.748 . . . . 0.0 111.582 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . 0.511 ' HB2' ' CE1' ' A' ' 373' ' ' TYR . 35.7 mm-40 -64.75 149.1 96.5 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.856 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.04 -52.37 9.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.858 2.372 . . . . 0.0 112.812 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -142.23 144.43 33.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.012 0.434 . . . . 0.0 111.666 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 370' ' ' GLU . 56.3 m-85 -123.76 163.23 21.58 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -134.06 142.84 47.72 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.5 p -144.82 157.68 14.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 48.8 m -97.23 150.28 21.09 Favored 'General case' 0 N--CA 1.412 -2.332 0 C-N-CA 120.414 -0.515 . . . . 0.0 109.688 174.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.06 128.79 37.83 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.264 0.626 . . . . 0.0 111.207 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 83.81 15.66 69.82 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.659 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -118.31 176.3 5.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.3 mtpt -102.83 146.13 28.73 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.18 0.3 . . . . 0.0 110.392 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.496 HG23 ' SG ' ' A' ' 426' ' ' CYS . 10.7 tp -135.65 156.62 38.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 30.5 ptt180 -142.64 124.43 15.09 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.587 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -94.71 126.2 39.86 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.391 -1.277 . . . . 0.0 107.924 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 68.0 m -108.63 138.91 44.18 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 11.8 m -141.43 159.67 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 C-N-CA 124.111 0.964 . . . . 0.0 108.93 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 85.9 mt-10 -130.04 136.92 49.91 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.33 148.74 23.85 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -84.47 10.03 11.9 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.456 0.646 . . . . 0.0 110.422 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -157.58 135.97 11.17 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -67.12 -24.25 65.91 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.145 0.497 . . . . 0.0 111.664 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -107.05 26.27 10.34 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.18 0.99 . . . . 0.0 110.915 -173.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -98.61 122.27 41.61 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -93.16 137.56 32.38 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 19.4 m -106.29 154.22 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.97 174.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -123.6 157.42 33.78 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.49 ' O ' HD12 ' A' ' 397' ' ' LEU . 4.4 m-90 -118.95 126.05 50.85 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 123.338 0.399 . . . . 0.0 109.969 -168.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 396' ' ' TRP . 6.5 mp -135.89 144.26 45.46 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -123.57 121.96 36.94 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 27.9 p30 46.71 22.31 0.18 Allowed 'General case' 0 N--CA 1.504 2.272 0 C-N-CA 125.614 1.566 . . . . 0.0 114.891 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 107.69 -0.21 34.33 Favored Glycine 0 C--O 1.224 -0.517 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.998 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -111.17 129.96 55.78 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -65.71 122.31 16.99 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.2 0.524 . . . . 0.0 111.035 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.415 ' HB ' ' CB ' ' A' ' 396' ' ' TRP . 57.7 mt -80.15 123.51 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -128.21 154.21 46.07 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 66.7 mtm -70.55 93.6 0.92 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.11 0.481 . . . . 0.0 111.507 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 39.8 m -92.79 100.53 12.99 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 71.77 -129.25 15.9 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.8 m -112.68 14.88 20.08 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -65.77 -42.81 90.41 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -123.9 127.73 48.43 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 50.5 mm -118.0 117.35 54.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -86.79 108.12 18.58 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.302 0.572 . . . . 0.0 109.546 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -97.45 123.85 41.44 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.842 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 35.7 t -118.8 111.98 19.13 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 70.1 mt -124.76 84.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.716 0.769 . . . . 0.0 109.247 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.12 -109.89 2.99 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.17 -20.28 16.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.904 0.383 . . . . 0.0 110.182 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 386' ' ' GLU . 22.0 ptmt -88.36 133.1 34.18 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.782 0.801 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.29 139.45 53.78 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 74.1 m -134.26 130.36 36.99 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-O 121.148 0.499 . . . . 0.0 110.884 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 382' ' ' ARG . 37.8 tp -95.64 109.39 21.66 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.0 m -97.53 118.87 35.01 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.51 124.68 55.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' SER . . . . . 0.448 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 7.1 m -101.71 132.28 47.51 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 63.91 70.27 0.52 Allowed 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 124.235 0.959 . . . . 0.0 110.919 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . 0.496 ' SG ' HG23 ' A' ' 381' ' ' ILE . 73.5 m -68.23 123.74 21.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.67 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 45.3 t -106.23 155.23 19.69 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.46 -27.13 69.07 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.129 0.572 . . . . 0.0 110.475 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -87.22 1.08 54.24 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.264 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -114.15 1.98 14.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.32 111.75 3.16 Favored 'General case' 0 C--O 1.255 1.362 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.789 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -161.71 171.4 17.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.576 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -87.68 130.89 34.65 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -111.26 138.66 47.45 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.52 141.6 50.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.402 ' SG ' HD13 ' A' ' 369' ' ' LEU . 73.7 m -109.13 111.38 22.97 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 168.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.93 119.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.281 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.85 159.82 10.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 169.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.15 113.93 6.34 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 119.269 -1.443 . . . . 0.0 111.52 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 89.04 -24.27 14.0 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 121.081 0.267 . . . . 0.0 112.824 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.409 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 4.9 mm-40 -118.29 109.89 16.86 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.479 0.712 . . . . 0.0 109.107 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -136.26 149.55 48.54 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 34.2 t -148.2 139.53 23.47 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 9.3 m -112.31 151.07 30.14 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.6 t -129.15 144.64 51.28 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -110.63 109.81 20.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 121.752 0.787 . . . . 0.0 109.108 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -93.72 129.52 40.03 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.993 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -107.82 115.4 30.07 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.377 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 38.2 t -90.08 125.58 42.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 376' ' ' SER . 12.0 pttp -116.11 146.83 41.92 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--N 1.259 -3.327 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 174.844 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.632 ' HA ' ' NE1' ' A' ' 322' ' ' TRP . 1.1 m-20 . . . . . 0 CA--C 1.496 -1.135 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.418 ' HB ' ' CB ' ' A' ' 340' ' ' TYR . 7.4 p -56.25 -38.65 55.65 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.192 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.802 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . 0.632 ' NE1' ' HA ' ' A' ' 320' ' ' ASP . 0.0 OUTLIER -45.79 -52.04 11.79 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 320' ' ' ASP . 8.4 pt-20 -85.48 -38.42 18.63 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.422 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 87.1 mt -65.46 -40.45 88.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.632 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.2 tt -75.76 -33.06 60.19 Favored 'General case' 0 C--O 1.202 -1.429 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -69.06 -36.47 77.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -85.39 -7.55 58.89 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.173 0.511 . . . . 0.0 111.329 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -84.52 161.39 54.09 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.316 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.14 135.48 51.08 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.922 2.415 . . . . 0.0 111.469 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.53 -34.61 90.32 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 124.048 3.165 . . . . 0.0 115.568 -171.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 19.5 t -83.7 -1.9 55.06 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.682 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -102.82 -4.24 25.19 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.869 0.366 . . . . 0.0 110.07 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -52.38 -42.07 63.68 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -64.5 -38.59 91.56 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.468 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -66.37 -46.3 77.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 109.485 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.06 -37.61 73.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.288 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.75 -62.45 1.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.582 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -62.19 -32.96 73.67 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -59.72 -41.2 90.32 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.806 0.842 . . . . 0.0 111.564 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . 0.418 ' CB ' ' HB ' ' A' ' 321' ' ' VAL . 95.6 m-85 -97.25 10.71 38.78 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.177 0.513 . . . . 0.0 111.962 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 86.72 15.93 62.57 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.577 174.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 4.2 t -94.12 105.57 17.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.3 p -84.23 -14.95 48.59 Favored 'General case' 0 C--N 1.267 -2.98 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -133.27 95.46 3.53 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . 0.477 HD22 ' H ' ' A' ' 345' ' ' LEU . 1.5 pt? . . . . . 0 C--N 1.306 -1.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.18 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 61.0 m . . . . . 0 N--CA 1.392 -3.334 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.522 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -93.32 -10.73 34.41 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.036 0.922 . . . . 0.0 109.494 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -100.11 127.65 46.32 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.707 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -95.39 -17.67 21.37 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -165.5 126.12 1.87 Allowed 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.582 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 33.4 mtmm -102.34 -179.49 4.0 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 65.7 mt -74.3 147.12 42.58 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.98 137.61 89.81 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -55.64 -35.81 93.59 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.497 2.132 . . . . 0.0 112.465 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -128.36 134.09 48.78 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.998 0.428 . . . . 0.0 112.025 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -133.12 155.41 49.31 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.989 0.916 . . . . 0.0 109.298 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -134.64 147.67 50.22 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.19 154.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 10.1 t -96.13 150.66 20.26 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.467 ' HD2' ' HG2' ' A' ' 451' ' ' GLU . 83.4 tttt -61.42 120.81 11.2 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 123.169 0.587 . . . . 0.0 110.978 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 97.83 -4.56 61.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.5 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -98.27 175.04 6.21 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.659 0.266 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -104.77 150.45 24.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.994 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.422 HG23 ' SG ' ' A' ' 426' ' ' CYS . 16.2 tt -141.19 136.84 33.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 120.953 0.406 . . . . 0.0 110.126 174.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -107.9 123.68 48.98 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.375 0.607 . . . . 0.0 109.896 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 68.1 mt -101.81 114.18 28.03 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 67.3 m -109.31 127.91 54.67 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 20.3 m -132.39 160.67 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.5 135.19 46.87 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . 0.419 HD12 ' CG1' ' A' ' 394' ' ' VAL . 3.1 mm? -99.57 155.92 17.33 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.23 -7.93 56.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.513 0.673 . . . . 0.0 110.506 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -129.53 140.37 51.26 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -75.52 -24.47 56.78 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -115.3 25.77 10.6 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.624 0.726 . . . . 0.0 111.638 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -97.72 133.39 42.32 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -104.72 160.18 15.18 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.479 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.419 ' CG1' HD12 ' A' ' 387' ' ' LEU . 7.6 m -109.78 154.08 11.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.614 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -105.62 116.89 32.71 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.468 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 1.2 m-90 -92.3 120.2 32.62 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.94 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.4 mp -125.9 140.36 52.7 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 118.466 0.575 . . . . 0.0 110.576 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.29 116.77 27.44 Favored 'General case' 0 N--CA 1.405 -2.699 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.9 p30 52.41 18.16 0.89 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.444 1.497 . . . . 0.0 113.816 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.56 -4.71 23.06 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.303 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -110.22 128.68 55.63 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 35.1 tt0 -62.32 121.34 12.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 0.0 110.078 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 58.4 mt -66.51 124.6 22.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.163 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -108.61 153.0 24.02 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.943 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 50.9 ttm -71.02 105.15 3.21 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 33.6 t -104.39 98.54 8.31 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 57.84 -114.42 5.66 Favored Glycine 0 C--N 1.329 0.173 0 O-C-N 123.485 0.491 . . . . 0.0 112.488 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 23.0 m -114.72 10.81 16.7 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.569 0.699 . . . . 0.0 109.837 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -77.08 -45.34 27.37 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . 0.515 ' O ' ' HG3' ' A' ' 405' ' ' MET . 65.8 m-85 -122.66 109.27 14.05 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.2 119.68 62.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 120.981 0.419 . . . . 0.0 110.909 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.502 ' CE2' HD13 ' A' ' 421' ' ' LEU . 24.6 m-85 -87.24 108.49 18.96 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.99 108.46 21.17 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.9 m -100.37 104.67 16.11 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.7 mt -121.19 83.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 66.93 -119.14 11.4 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.562 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -79.75 -23.67 42.08 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -74.81 125.27 28.42 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.73 0.776 . . . . 0.0 111.45 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -114.98 111.68 21.51 Favored 'General case' 0 N--CA 1.399 -3.018 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 63.5 m -119.82 120.57 36.89 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.368 0.604 . . . . 0.0 111.498 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.502 HD13 ' CE2' ' A' ' 412' ' ' PHE . 36.2 tp -91.81 115.6 28.19 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 45.4 m -98.2 110.34 22.94 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.3 mt -97.54 123.65 50.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 33.9 m -104.33 136.7 43.43 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 59.38 64.78 1.28 Allowed 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 124.673 1.233 . . . . 0.0 111.49 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . 0.422 ' SG ' HG23 ' A' ' 381' ' ' ILE . 58.6 m -67.33 134.75 52.14 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.941 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 20.1 m -125.57 -177.96 4.08 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 84.6 mt -79.79 -21.91 43.75 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.918 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.43 73.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.443 0.639 . . . . 0.0 109.774 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.77 -0.37 57.26 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.141 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.69 108.13 1.62 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -149.0 165.07 32.73 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.012 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.87 115.84 23.75 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -104.01 152.09 22.45 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.36 150.72 35.27 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.078 175.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 77.0 m -116.09 118.6 33.33 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 38.6 t -106.31 132.94 52.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 67.4 t -128.15 161.41 36.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -61.45 112.36 4.68 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 118.989 -1.577 . . . . 0.0 111.865 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 96.29 -35.18 4.5 Favored Glycine 0 N--CA 1.421 -2.345 0 CA-C-N 114.768 -0.716 . . . . 0.0 112.82 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 9.8 mm-40 -120.08 132.88 55.6 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.928 0.364 . . . . 0.0 110.388 -174.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -137.81 166.97 22.69 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.0 t -150.51 133.76 16.26 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 6.0 p -108.89 146.98 32.87 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 123.542 0.526 . . . . 0.0 110.378 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 11.3 t -129.66 149.7 51.3 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -116.36 113.28 22.7 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 68.4 tp -91.85 146.1 24.02 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.303 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -123.31 108.17 12.46 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.04 117.01 32.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -105.79 119.98 40.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.581 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.467 ' HG2' ' HD2' ' A' ' 377' ' ' LYS . 26.4 mt-10 . . . . . 0 C--N 1.328 -0.338 0 O-C-N 123.695 0.622 . . . . 0.0 110.872 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.34 -35.16 60.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 123.761 0.825 . . . . 0.0 111.549 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -47.18 -51.89 17.18 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.983 1.313 . . . . 0.0 110.245 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 9.8 pt-20 -85.36 -48.49 8.99 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.76 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.74 -50.73 78.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 C-N-CA 122.798 0.439 . . . . 0.0 112.063 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 47.3 tp -74.02 -20.97 60.15 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -77.68 -42.99 32.65 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.22 0.533 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 4.1 pt20 -88.35 -20.96 24.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.139 -175.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -70.66 146.45 93.65 Favored Pre-proline 0 C--N 1.31 -1.129 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.46 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.78 155.1 61.61 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.017 1.812 . . . . 0.0 110.625 175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.48 -22.05 20.35 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.255 3.304 . . . . 0.0 113.989 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 6.4 m -72.71 -21.62 61.01 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.202 0.525 . . . . 0.0 111.527 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 336' ' ' ILE . 7.7 mm-40 -88.82 -20.89 24.1 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.928 -177.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -51.44 -53.47 36.64 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -173.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -56.07 -33.01 64.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -80.66 -59.82 2.54 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.773 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 332' ' ' GLU . 79.8 mt -55.58 -49.63 72.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.124 -174.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 345' ' ' LEU . . . -58.97 -57.65 12.15 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.426 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -67.8 -26.63 66.18 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -66.33 -40.37 89.86 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -94.03 -7.95 41.24 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 98.71 16.42 31.34 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.635 -1.269 . . . . 0.0 112.958 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 10.5 t -94.05 97.27 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 5.2 m -72.35 -39.4 68.14 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.941 -172.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -101.54 88.89 3.55 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.537 1.161 . . . . 0.0 110.725 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . 0.409 ' HB3' ' CB ' ' A' ' 337' ' ' ALA . 4.5 pp . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.462 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 75.2 p . . . . . 0 N--CA 1.441 -0.895 0 CA-C-O 120.973 0.416 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.458 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -83.2 -24.34 32.46 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.544 ' CD2' ' HB3' ' A' ' 441' ' ' GLU . 7.2 m-85 -94.23 132.94 38.27 Favored 'General case' 0 N--CA 1.406 -2.659 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.557 175.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -98.01 -17.09 19.35 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -161.54 119.44 2.31 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -99.33 159.58 14.9 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.459 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 79.6 mt -61.7 133.61 55.78 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 123.363 0.415 . . . . 0.0 111.367 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.41 137.67 68.77 Favored Pre-proline 0 C--O 1.215 -0.743 0 O-C-N 124.584 1.178 . . . . 0.0 108.341 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.93 -27.24 52.95 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.71 2.273 . . . . 0.0 113.424 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -134.65 138.97 44.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.41 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 36.0 m-85 -136.93 143.88 43.15 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -128.94 142.12 51.04 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.46 155.82 20.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 16.2 m -88.06 151.89 22.42 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -72.76 116.49 13.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.282 0.563 . . . . 0.0 110.096 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.29 43.76 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -116.9 156.12 27.91 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.329 -0.936 . . . . 0.0 109.637 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -92.49 141.51 28.43 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.694 0.798 . . . . 0.0 112.121 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.573 HG22 ' SG ' ' A' ' 426' ' ' CYS . 15.6 tt -139.05 146.93 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -123.87 128.95 50.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.218 1.009 . . . . 0.0 112.084 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 420' ' ' THR . 17.8 mt -99.82 125.89 45.82 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.19 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 31.9 m -116.66 130.08 56.53 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.71 160.15 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -129.89 138.57 51.0 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 88.8 mt -101.6 139.0 37.85 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.114 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -84.6 -25.88 28.31 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -106.48 122.06 45.53 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.307 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 417' ' ' ALA . 22.7 m-70 -80.95 -7.58 59.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.756 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -91.37 11.57 23.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -129.79 158.63 38.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -130.14 164.75 23.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 29.1 m -106.73 134.84 47.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.492 0.663 . . . . 0.0 111.491 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -103.5 129.17 50.62 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.445 ' HB3' HD12 ' A' ' 403' ' ' ILE . 50.1 m95 -103.68 130.03 51.09 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 434' ' ' TYR . 8.2 mp -116.76 139.53 50.47 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . 0.524 ' HG2' HG12 ' A' ' 403' ' ' ILE . 32.8 mmtp -90.81 107.4 19.16 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 11.1 p30 48.66 12.59 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.9 4.07 15.08 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.657 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -89.38 -96.38 0.1 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 122.57 0.348 . . . . 0.0 110.353 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 175.05 139.43 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.524 HG12 ' HG2' ' A' ' 398' ' ' LYS . 47.4 mt -94.48 114.85 31.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 172.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -96.6 139.85 32.08 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 87.8 mtp -71.82 89.8 1.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.746 0.308 . . . . 0.0 110.541 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 50.9 m -79.32 98.39 6.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.81 -119.01 16.4 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.059 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 32.8 t -111.27 16.98 20.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -76.24 -47.94 22.09 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -106.82 108.68 20.31 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.19 113.2 36.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -87.08 107.21 18.34 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.912 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -105.55 107.88 19.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 50.0 m -104.97 110.56 22.99 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.31 79.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.84 -110.9 3.76 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.95 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.42 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . . . -83.47 -27.68 29.3 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.759 0.314 . . . . 0.0 110.414 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 418' ' ' LYS . 10.9 ptmm? -95.32 116.69 29.11 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 122.116 0.96 . . . . 0.0 111.394 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -108.4 139.15 43.54 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.361 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 61.6 m -136.15 130.13 32.8 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-O 121.256 0.551 . . . . 0.0 111.524 -173.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 39.8 tp -103.8 115.85 31.23 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 38.7 m -102.04 115.08 29.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 50.4 mt -100.98 119.95 49.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 2.9 m -90.53 131.96 35.96 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.222 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 58.12 67.32 0.97 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.015 0.926 . . . . 0.0 111.93 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . 0.573 ' SG ' HG22 ' A' ' 381' ' ' ILE . 64.5 m -68.48 115.17 7.58 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 79.6 p -101.44 -176.63 3.2 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.05 -22.25 63.09 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.28 0.562 . . . . 0.0 109.837 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.94 -8.54 58.26 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.376 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -99.26 -3.45 34.14 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.189 -0.319 . . . . 0.0 110.399 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.79 95.54 2.92 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -152.15 166.13 32.64 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.25 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.99 129.43 34.8 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 397' ' ' LEU . 20.3 m-85 -104.67 145.33 30.48 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.568 ' N ' HE21 ' A' ' 435' ' ' GLN . 0.0 OUTLIER -129.14 127.34 41.21 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 7.6 p -96.33 109.15 21.72 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.1 t -105.29 126.12 60.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 121.231 0.539 . . . . 0.0 111.377 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 60.0 t -129.15 161.39 38.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -66.79 113.6 5.77 Favored Glycine 0 C--N 1.315 -0.599 0 C-N-CA 119.082 -1.532 . . . . 0.0 111.104 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 98.6 -26.33 24.37 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.544 ' HB3' ' CD2' ' A' ' 365' ' ' PHE . 3.1 mm-40 -126.48 136.08 52.16 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 18.6 ptpt -147.9 160.67 42.54 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 16.9 t -155.82 134.37 11.73 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 5.5 p -106.47 126.38 52.18 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.336 0.588 . . . . 0.0 110.7 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.7 t -112.57 146.37 38.68 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.98 114.39 27.67 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.293 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.35 121.87 33.46 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.667 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -104.87 118.91 37.72 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.166 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.14 120.55 39.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . 0.444 ' HZ2' ' C ' ' A' ' 451' ' ' GLU . 0.1 OUTLIER -113.7 119.98 39.27 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.444 ' C ' ' HZ2' ' A' ' 450' ' ' LYS . 48.2 mt-10 . . . . . 0 C--N 1.308 -1.229 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.551 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 4.3 p -47.44 -37.15 4.84 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 C-N-CA 125.102 1.361 . . . . 0.0 112.365 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -57.59 -47.17 82.86 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.639 0.776 . . . . 0.0 110.762 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.9 -35.12 20.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.826 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.03 -49.54 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.795 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.32 -34.19 75.67 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.488 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -58.12 -40.37 81.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.281 0.562 . . . . 0.0 110.701 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -93.07 -4.13 52.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.331 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -89.02 153.84 49.38 Favored Pre-proline 0 C--N 1.301 -1.525 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.711 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.19 143.99 98.75 Favored 'Trans proline' 0 CA--C 1.55 1.321 0 C-N-CA 122.946 2.431 . . . . 0.0 112.763 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.522 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 10.7 Cg_endo -54.89 -34.57 86.31 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 124.216 3.277 . . . . 0.0 115.572 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 44.0 m -77.82 -5.56 51.25 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -99.67 -13.33 19.39 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.818 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 18.4 m-30 -47.86 -47.52 31.55 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -174.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.18 -35.64 78.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.8 0.333 . . . . 0.0 111.295 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -71.79 -42.88 66.58 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.818 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 59.1 mt -64.78 -38.66 83.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.464 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.09 51.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.033 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -68.9 -24.63 64.33 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.36 -39.83 94.43 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.007 0.523 . . . . 0.0 109.958 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . 0.551 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 82.5 m-85 -95.59 -4.7 44.1 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.194 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 83.38 26.52 43.11 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.498 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.32 116.96 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 3.0 p -94.52 -5.97 44.82 Favored 'General case' 0 C--N 1.268 -2.94 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.808 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.47 44.42 0.8 Allowed 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.46 0.704 . . . . 0.0 111.314 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 24.4 tp . . . . . 0 C--N 1.296 -1.721 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.779 179.786 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.427 -1.617 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.451 ' HB2' ' HG3' ' A' ' 441' ' ' GLU . . . -87.65 -27.54 22.4 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -87.13 114.37 23.69 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.66 170.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.44 -17.24 29.11 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.061 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 367' ' ' LYS . 0.0 OUTLIER -164.61 120.53 1.49 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 176.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -97.04 173.3 7.34 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.834 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 91.2 mt -71.07 142.16 50.85 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.876 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -62.04 129.93 92.34 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -43.39 -33.32 4.02 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.86 3.04 . . . . 0.0 114.819 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -146.56 120.66 9.46 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.068 -0.395 . . . . 0.0 111.239 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.563 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 59.0 m-85 -101.35 156.08 17.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -127.91 138.35 52.63 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.972 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.93 152.69 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.53 ' HB2' ' CD2' ' A' ' 379' ' ' HIS . 12.0 m -86.62 146.48 26.31 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 1.4 tmmm? -63.1 125.75 25.07 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.277 0.56 . . . . 0.0 110.006 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . 0.477 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 98.89 -3.56 58.8 Favored Glycine 0 C--N 1.304 -1.206 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.623 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 376' ' ' SER . 27.7 m-70 -95.63 169.37 10.07 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 120.889 0.376 . . . . 0.0 111.935 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -108.1 126.75 53.12 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.517 HG21 ' SG ' ' A' ' 426' ' ' CYS . 14.9 tt -128.6 158.34 40.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 41.9 mtt-85 -125.89 142.7 51.39 Favored 'General case' 0 CA--C 1.491 -1.318 0 CA-C-O 121.663 0.744 . . . . 0.0 110.589 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.31 107.47 18.48 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.8 m -105.31 126.28 51.92 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.272 -174.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 7.6 m -127.91 157.17 40.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 123.855 0.862 . . . . 0.0 109.374 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -120.36 136.61 54.65 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 392' ' ' ALA . 92.0 mt -107.88 141.33 39.65 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.19 71.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.142 0.496 . . . . 0.0 110.355 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -117.98 138.04 52.45 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -63.53 -32.57 74.07 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 123.293 0.637 . . . . 0.0 112.693 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.82 25.78 11.4 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.395 0.617 . . . . 0.0 111.879 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 387' ' ' LEU . . . -91.69 106.53 18.55 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 104.276 -2.491 . . . . 0.0 104.276 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -78.67 143.87 35.88 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.638 -172.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 4.1 m -105.98 148.3 10.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -111.22 130.07 55.76 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.436 ' HB3' HD13 ' A' ' 403' ' ' ILE . 8.2 m-90 -101.21 121.77 42.45 Favored 'General case' 0 C--N 1.26 -3.292 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.911 -173.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 402' ' ' GLU . 6.2 mp -129.19 125.53 37.19 Favored 'General case' 0 CA--C 1.482 -1.671 0 CA-C-N 117.635 0.198 . . . . 0.0 111.4 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -103.94 128.14 51.46 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 47.61 22.76 0.34 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.415 1.486 . . . . 0.0 114.24 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.16 8.05 56.86 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.379 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -92.32 -92.63 0.15 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 397' ' ' LEU . 52.7 tt0 172.69 138.53 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.436 HD13 ' HB3' ' A' ' 396' ' ' TRP . 55.4 mt -92.0 102.29 13.41 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -99.23 126.02 44.95 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.854 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -63.95 95.17 0.11 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 122.119 0.962 . . . . 0.0 112.257 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.8 m -83.67 93.32 7.88 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.946 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 64.22 -128.26 36.22 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.568 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 8.9 p -97.69 5.53 49.19 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 120.921 0.391 . . . . 0.0 111.599 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -71.79 -32.31 67.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.74 0.305 . . . . 0.0 111.636 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -123.44 112.5 17.6 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 39.6 mm -108.87 116.58 52.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.51 ' CE2' HD11 ' A' ' 421' ' ' LEU . 22.8 m-85 -87.03 105.54 17.23 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -106.49 108.56 20.13 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.478 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 27.8 t -90.54 105.38 17.78 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.0 mm -104.04 87.46 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.94 -98.6 0.64 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -120.11 -5.01 10.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.358 0.599 . . . . 0.0 109.443 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -95.23 99.69 11.61 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -92.7 132.14 37.17 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.227 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 22.5 m -125.28 129.81 50.76 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.531 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.51 HD11 ' CE2' ' A' ' 412' ' ' PHE . 22.2 tp -100.82 111.51 23.75 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 58.8 m -94.34 108.78 20.66 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.601 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 56.1 mt -96.92 116.93 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 15.1 m -90.84 136.47 33.05 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.054 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 55.72 68.63 0.84 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.0 1.72 . . . . 0.0 111.117 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . 0.517 ' SG ' HG21 ' A' ' 381' ' ' ILE . 61.7 m -68.87 113.2 6.08 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 11.0 m -103.65 -170.75 1.83 Allowed 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 89.9 mt -71.12 -23.88 62.18 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.269 0.557 . . . . 0.0 110.513 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -76.08 -15.04 60.18 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.235 0.541 . . . . 0.0 110.1 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -97.6 7.84 45.73 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.764 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.63 100.23 11.31 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -157.02 172.33 18.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.201 0.524 . . . . 0.0 111.609 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -90.51 118.08 29.7 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -107.39 131.81 53.85 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.839 -0.538 . . . . 0.0 110.252 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.483 ' HG3' ' OG ' ' A' ' 444' ' ' SER . 2.0 mp0 -122.95 146.71 47.36 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 123.345 0.658 . . . . 0.0 110.388 -175.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 78.8 m -123.28 113.26 18.64 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.14 133.94 53.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.951 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 49.2 t -125.56 161.85 29.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -57.56 112.73 3.94 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 118.955 -1.593 . . . . 0.0 111.577 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 85.36 -35.28 3.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.553 0.597 . . . . 0.0 112.714 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 364' ' ' ALA . 7.9 mm-40 -99.53 126.24 45.44 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 123.601 0.761 . . . . 0.0 110.938 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -142.22 163.67 32.22 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.754 0.312 . . . . 0.0 111.401 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 25.6 p -160.34 150.04 17.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' SER . . . . . 0.483 ' OG ' ' HG3' ' A' ' 435' ' ' GLN . 3.4 m -137.08 146.72 45.49 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.563 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 9.0 t -129.94 132.2 46.25 Favored 'General case' 0 N--CA 1.399 -2.978 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.677 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.81 110.58 21.49 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 60.5 tp -84.72 119.59 25.44 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -95.79 108.21 20.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 64.0 t -94.79 109.13 21.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -100.17 117.49 34.52 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.216 0.531 . . . . 0.0 111.082 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.288 -2.071 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.539 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.73 -32.6 31.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 C-N-CA 123.156 0.582 . . . . 0.0 112.444 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -59.32 -46.18 89.3 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 124.698 1.199 . . . . 0.0 110.873 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.22 -32.37 22.66 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.862 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.6 mt -63.23 -45.57 98.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.637 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 333' ' ' TYR . 39.8 mt -61.74 -43.42 98.88 Favored 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.681 0.613 . . . . 0.0 110.466 177.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -55.73 -42.03 74.74 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.248 0.619 . . . . 0.0 111.777 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -81.78 -10.37 59.36 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.59 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -100.6 146.81 32.68 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -63.37 138.21 64.67 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 121.589 1.526 . . . . 0.0 110.12 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.458 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 4.9 Cg_endo -48.12 -28.98 11.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.046 3.164 . . . . 0.0 114.85 -176.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 44.2 p -64.15 -25.32 68.03 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.362 0.601 . . . . 0.0 112.323 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.442 ' O ' HG13 ' A' ' 336' ' ' ILE . 7.2 mm-40 -86.44 -14.51 43.05 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.467 -175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.458 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 3.8 m-85 -49.11 -44.62 42.47 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -57.97 -31.0 66.47 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.807 0.692 . . . . 0.0 110.607 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -86.3 -51.68 6.1 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.338 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 332' ' ' GLU . 44.5 mt -60.38 -46.64 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.442 0.697 . . . . 0.0 111.692 -173.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 342' ' ' VAL . . . -51.66 -52.38 48.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.912 0.885 . . . . 0.0 111.843 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -65.42 -21.72 66.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -71.5 -34.9 70.54 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.519 0.676 . . . . 0.0 109.376 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -97.69 -12.78 21.98 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.154 -174.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 101.1 18.04 20.89 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.706 -1.235 . . . . 0.0 112.357 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 337' ' ' ALA . 17.5 t -92.75 84.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.4 m -63.57 -42.29 98.34 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.572 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -99.87 76.18 1.94 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.602 1.192 . . . . 0.0 111.412 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . 0.509 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.291 -1.957 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.372 175.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 121.355 0.598 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -89.77 -31.53 17.37 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 122.033 0.92 . . . . 0.0 108.91 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -87.93 140.81 29.12 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.336 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -96.92 -23.55 16.27 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -159.31 134.54 8.3 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -111.26 173.08 6.51 Favored 'General case' 0 C--N 1.283 -2.299 0 O-C-N 123.821 0.7 . . . . 0.0 111.56 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 87.6 mt -68.89 141.47 55.04 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.886 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -64.84 143.72 98.83 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -44.74 -38.91 13.17 Favored 'Trans proline' 0 C--O 1.257 1.454 0 C-N-CA 123.354 2.702 . . . . 0.0 113.593 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -145.09 158.75 43.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.565 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.412 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 42.6 m-85 -138.54 154.52 48.75 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -138.03 135.97 36.42 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.64 155.69 22.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.416 ' HB2' ' CD2' ' A' ' 379' ' ' HIS . 32.2 m -92.34 144.89 24.93 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -57.18 128.75 38.56 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 123.699 0.8 . . . . 0.0 110.622 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.84 8.73 63.27 Favored Glycine 0 C--N 1.317 -0.486 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.367 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . 0.416 ' CD2' ' HB2' ' A' ' 376' ' ' SER . 56.3 m-70 -112.06 -179.58 3.73 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 122.453 -0.439 . . . . 0.0 110.472 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -98.35 143.81 28.42 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.6 tp -138.15 139.23 42.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 20.6 ptt180 -134.32 122.91 23.32 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.157 0.98 . . . . 0.0 113.302 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . 0.402 ' HB3' ' CD2' ' A' ' 369' ' ' LEU . 2.1 mm? -88.5 129.12 35.53 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.293 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 34.4 m -120.76 122.62 40.77 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -173.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.26 155.32 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.966 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -126.31 140.53 52.45 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.5 mp -101.49 158.94 15.7 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.2 -24.56 57.82 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.449 0.642 . . . . 0.0 109.624 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -108.37 137.44 46.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -80.97 -28.11 35.73 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.908 0.385 . . . . 0.0 111.357 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -99.88 17.29 21.23 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.546 -174.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -116.25 148.55 40.36 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -115.43 174.14 6.16 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.403 0.621 . . . . 0.0 110.609 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.414 HG13 ' CG2' ' A' ' 438' ' ' VAL . 9.2 m -106.68 164.74 4.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.162 176.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 436' ' ' CYS . 8.1 tptp -109.23 146.14 34.71 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 175.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -115.76 111.32 20.36 Favored 'General case' 0 C--N 1.281 -2.398 0 O-C-N 123.171 0.294 . . . . 0.0 110.549 -171.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.3 mp -122.34 141.91 51.05 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.048 0.452 . . . . 0.0 111.23 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -120.87 122.56 40.52 Favored 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.1 p30 53.82 12.37 0.41 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 126.183 1.793 . . . . 0.0 113.563 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.62 11.29 29.14 Favored Glycine 0 C--O 1.22 -0.75 0 C-N-CA 121.245 -0.502 . . . . 0.0 111.964 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -118.64 120.68 38.15 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.19 125.93 25.51 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 56.5 mt -65.85 132.72 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.625 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -96.97 122.29 39.79 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 27.0 ttt -68.81 93.39 0.54 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.38 0.61 . . . . 0.0 112.543 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 409' ' ' LYS . 42.7 t -82.54 128.27 34.14 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 172.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -34.82 -70.74 0.16 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 6.4 p -101.62 18.54 20.05 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.517 0.675 . . . . 0.0 112.329 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 17.2 tppt? -104.65 -57.79 1.98 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.31 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -113.31 108.13 16.82 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 57.1 mt -108.67 114.6 47.2 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.715 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.507 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.1 m-85 -85.78 107.53 17.67 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.719 0.771 . . . . 0.0 108.924 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.2 113.13 26.37 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 16.6 m -104.45 124.63 49.59 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.2 mp -122.12 76.61 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.199 0 CA-C-O 121.546 0.689 . . . . 0.0 109.428 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.76 -86.04 0.76 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.294 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -109.45 -19.17 13.35 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.341 0.591 . . . . 0.0 109.508 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . 0.523 ' HE2' ' OG1' ' A' ' 420' ' ' THR . 82.6 tttt -86.29 118.93 26.05 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.779 -176.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -104.95 118.52 36.73 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' THR . . . . . 0.523 ' OG1' ' HE2' ' A' ' 418' ' ' LYS . 8.3 m -114.59 124.49 51.99 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.507 HD13 ' CE2' ' A' ' 412' ' ' PHE . 20.4 tp -101.29 103.85 14.85 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 27.8 m -99.76 111.12 23.47 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.108 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 45.2 mt -89.3 121.38 39.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 177.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 18.6 m -106.94 128.71 54.57 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 63.17 67.7 0.66 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.711 -1.131 . . . . 0.0 107.979 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 48.1 t -74.1 123.78 25.07 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 91.4 p -105.25 -176.72 3.16 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 97.0 mt -74.33 -25.68 59.69 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -76.09 -12.17 60.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.227 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -92.16 -21.55 20.34 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.786 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -50.76 119.62 4.03 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.421 1.076 . . . . 0.0 110.601 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -169.77 165.01 9.98 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 123.573 0.546 . . . . 0.0 109.548 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.67 124.42 32.18 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -106.44 141.7 37.31 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -175.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.71 140.76 34.94 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 121.341 0.591 . . . . 0.0 111.735 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 395' ' ' LYS . 63.8 m -105.38 128.77 53.68 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.93 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.2 t -115.74 134.63 58.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.243 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.414 ' CG2' HG13 ' A' ' 394' ' ' VAL . 97.1 t -131.57 160.94 42.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.1 114.0 6.46 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 119.148 -1.501 . . . . 0.0 110.365 175.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.76 -35.11 5.15 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-O 119.39 -0.672 . . . . 0.0 113.348 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -139.53 173.15 11.84 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 122.636 1.208 . . . . 0.0 113.997 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -149.92 166.96 28.02 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.67 -1.604 . . . . 0.0 106.933 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 27.5 p -154.4 133.28 12.3 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 172.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 5.0 m -118.04 143.23 46.6 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.301 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 13.5 t -125.59 150.79 47.21 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -110.48 110.72 21.58 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 68.1 tp -90.47 129.7 36.62 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -106.77 107.9 19.14 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.77 119.28 37.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -98.28 126.59 43.83 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--N 1.311 -1.098 0 C-N-CA 123.957 0.903 . . . . 0.0 110.119 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 122.02 0.914 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.46 -29.63 47.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.441 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -53.32 -54.51 35.37 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.471 0.708 . . . . 0.0 111.375 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.03 -38.18 53.37 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.297 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 67.9 mt -64.12 -50.64 76.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.252 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.43 -28.79 64.23 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -64.06 -43.73 94.59 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.944 0.402 . . . . 0.0 110.836 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -91.26 -0.56 57.7 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.101 0.477 . . . . 0.0 112.015 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -91.16 152.29 43.9 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.849 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.15 148.33 78.64 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.704 2.269 . . . . 0.0 112.23 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 26.7 Cg_endo -60.85 -21.96 72.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.496 2.797 . . . . 0.0 114.139 -173.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 5.1 m -85.54 -4.01 59.03 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.873 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 336' ' ' ILE . 48.9 mm-40 -99.49 -14.93 18.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.935 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 15.6 m-30 -44.15 -55.12 5.01 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -173.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -65.65 -38.22 88.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.243 0.545 . . . . 0.0 111.179 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.03 -42.48 84.8 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.659 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 332' ' ' GLU . 74.2 mt -65.04 -44.5 95.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -55.65 -58.51 7.52 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.315 0.646 . . . . 0.0 111.395 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -67.75 -23.34 65.23 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -68.01 -42.3 80.89 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.777 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -89.4 -15.51 33.08 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.193 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 100.2 34.63 4.75 Favored Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.3 t -112.21 118.24 57.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 43.4 p -97.75 -13.94 21.12 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-O 122.015 0.912 . . . . 0.0 109.21 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -82.39 47.09 1.11 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.754 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . 0.4 HD12 ' HB3' ' A' ' 333' ' ' TYR . 36.0 tp . . . . . 0 C--N 1.301 -1.522 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.732 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.429 -1.505 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.506 ' HB2' ' HG3' ' A' ' 441' ' ' GLU . . . -85.26 -13.33 50.12 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.16 117.84 29.23 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -77.17 -29.64 54.55 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.406 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -151.42 115.96 5.12 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -98.51 160.28 14.39 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 76.5 mt -70.17 144.85 51.85 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.49 151.14 96.61 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -37.96 -45.48 1.96 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 124.397 3.398 . . . . 0.0 114.022 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -148.38 153.74 38.99 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.665 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 447' ' ' LEU . 74.9 m-85 -134.19 146.03 49.77 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.01 147.07 48.1 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.37 155.96 18.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 379' ' ' HIS . 15.0 m -87.16 151.65 23.01 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.509 ' HB3' ' HZ2' ' A' ' 377' ' ' LYS . 0.0 OUTLIER -70.13 115.33 9.21 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 120.85 0.357 . . . . 0.0 110.105 -178.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 100.49 -6.06 57.39 Favored Glycine 0 CA--C 1.496 -1.11 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 376' ' ' SER . 16.3 t60 -96.11 152.9 18.11 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -96.18 143.46 27.27 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.944 0.402 . . . . 0.0 111.772 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.643 HG21 ' SG ' ' A' ' 426' ' ' CYS . 9.9 tp -121.97 129.69 75.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -109.98 112.53 24.61 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.32 0.581 . . . . 0.0 110.304 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 79.8 mt -93.96 139.11 31.32 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 64.3 m -134.55 113.38 11.72 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.686 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.86 145.39 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 22.2 mt-10 -121.54 137.69 54.62 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 417' ' ' ALA . 82.5 mt -95.57 144.81 25.72 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -83.84 -21.56 32.01 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.0 121.23 44.04 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.915 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -75.36 -27.12 59.03 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.265 0.555 . . . . 0.0 110.689 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -90.06 18.91 5.35 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.866 0.866 . . . . 0.0 111.304 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -113.55 142.43 45.96 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -110.5 165.99 11.36 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.82 144.31 38.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.256 0.551 . . . . 0.0 110.745 -176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -108.37 143.75 36.87 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.459 ' HB3' HD11 ' A' ' 403' ' ' ILE . 10.2 m-90 -113.21 119.08 36.53 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.596 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.9 mp -126.79 138.83 53.41 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -120.36 121.37 38.44 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 22.4 p30 51.22 12.72 0.14 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 126.393 1.877 . . . . 0.0 114.551 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.93 8.24 22.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.197 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -120.07 138.74 53.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.03 126.65 28.05 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 120.753 0.311 . . . . 0.0 110.57 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' A' ' 396' ' ' TRP . 34.5 mt -72.58 102.07 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -76.26 137.75 40.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 51.0 ttp -73.27 100.01 3.02 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 43.8 t -101.75 119.19 38.39 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.257 -174.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 49.64 -132.21 26.75 Favored Glycine 0 C--N 1.338 0.641 0 O-C-N 124.748 1.28 . . . . 0.0 113.959 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 24.8 t -104.79 11.95 33.24 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . 0.468 ' HD3' ' OD2' ' A' ' 430' ' ' ASP . 33.1 ttmt -75.74 -61.12 2.03 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.952 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . 0.486 ' O ' ' HG3' ' A' ' 405' ' ' MET . 82.0 m-85 -94.78 117.27 29.87 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.2 mt -121.43 113.53 39.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 421' ' ' LEU . 24.3 m-85 -86.99 112.3 21.69 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 420' ' ' THR . 41.7 mt-10 -107.7 107.04 17.65 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 32.0 t -99.22 114.68 27.61 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 123.592 0.757 . . . . 0.0 108.991 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.601 ' HB ' ' CG ' ' A' ' 418' ' ' LYS . 41.9 mm -115.26 79.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 67.25 -83.46 0.13 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.376 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 387' ' ' LEU . . . -100.9 -31.95 10.89 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.575 0.35 . . . . 0.0 110.767 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . 0.601 ' CG ' ' HB ' ' A' ' 415' ' ' ILE . 1.5 ptpp? -84.49 140.4 31.5 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.715 0.769 . . . . 0.0 111.744 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -124.18 100.77 6.87 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 413' ' ' GLU . 31.4 m -98.73 134.42 41.66 Favored 'General case' 0 C--N 1.259 -3.345 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.427 -174.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.512 HD12 ' CE1' ' A' ' 412' ' ' PHE . 33.2 tp -117.0 106.81 13.81 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.359 0.6 . . . . 0.0 109.426 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 36.3 m -97.33 109.67 22.38 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.0 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.6 mt -97.72 110.01 24.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.1 m -95.82 141.47 29.24 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 61.89 52.56 3.37 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.904 0.752 . . . . 0.0 110.479 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . 0.643 ' SG ' HG21 ' A' ' 381' ' ' ILE . 13.5 m -65.19 113.19 3.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 12.0 m -108.4 -167.69 1.26 Allowed 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.14 -20.77 60.85 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 121.703 -0.623 . . . . 0.0 111.006 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -78.83 -4.51 49.91 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.405 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . 0.468 ' OD2' ' HD3' ' A' ' 409' ' ' LYS . 18.1 m-20 -110.7 7.91 22.4 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.959 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.94 96.67 9.44 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -151.27 162.63 40.56 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.932 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.75 122.66 30.15 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -106.55 140.58 39.21 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 120.827 0.346 . . . . 0.0 110.131 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.33 137.78 30.78 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.227 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 65.5 m -103.95 128.57 51.48 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.95 130.67 73.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.366 0.603 . . . . 0.0 111.556 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 63.7 t -124.7 161.58 27.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 174.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -61.26 112.97 5.2 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 118.513 -1.804 . . . . 0.0 111.534 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 94.38 -35.3 4.26 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.632 -0.284 . . . . 0.0 112.547 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.506 ' HG3' ' HB2' ' A' ' 364' ' ' ALA . 9.1 mm-40 -105.96 138.98 41.21 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 122.467 -0.431 . . . . 0.0 110.681 -173.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.443 ' HZ1' ' HB3' ' A' ' 442' ' ' LYS . 0.1 OUTLIER -148.79 163.92 35.94 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 171.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 13.8 p -151.28 133.49 15.27 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 12.1 p -119.62 132.17 55.64 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 123.654 0.596 . . . . 0.0 110.707 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.429 ' OG1' ' HD2' ' A' ' 373' ' ' TYR . 14.6 t -124.07 147.9 47.52 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -106.04 111.02 23.47 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 373' ' ' TYR . 3.3 tm? -93.14 125.69 37.86 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -113.25 124.97 53.75 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.817 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.6 t -97.53 122.25 48.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -106.16 117.06 33.04 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.508 ' HA ' ' CB ' ' A' ' 377' ' ' LYS . 2.6 mp0 . . . . . 0 C--O 1.256 1.417 0 C-N-CA 125.234 1.413 . . . . 0.0 113.929 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.55 -37.67 39.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.717 -1.128 . . . . 0.0 113.36 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -56.3 -46.45 79.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -85.05 -29.6 24.8 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.288 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.01 -48.29 86.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.324 0.39 . . . . 0.0 110.392 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 62.9 mt -59.42 -41.23 89.07 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.119 0.485 . . . . 0.0 110.236 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -58.62 -30.01 66.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.237 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -112.9 7.14 18.19 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.26 0.552 . . . . 0.0 111.187 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -100.67 150.82 37.32 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.695 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.43 142.84 67.26 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.433 2.089 . . . . 0.0 111.389 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.515 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 18.5 Cg_endo -58.52 -21.38 54.17 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 123.813 3.008 . . . . 0.0 114.205 -176.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 36.1 p -74.34 -17.16 60.87 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.047 0.451 . . . . 0.0 112.16 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -103.97 -2.88 25.43 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.494 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 20.8 m-30 -56.89 -40.23 75.85 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -174.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.27 -30.16 70.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.989 0.423 . . . . 0.0 111.121 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -72.56 -57.72 3.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.0 -40.32 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.845 1.258 . . . . 0.0 111.792 -173.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -58.54 -60.1 4.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.639 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -67.8 -22.97 65.15 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.028 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -64.44 -34.2 77.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.384 0.674 . . . . 0.0 109.515 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.25 13.23 23.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 76.48 29.61 57.8 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.806 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.75 118.73 56.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 17.6 p -94.79 -14.19 24.91 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-O 122.115 0.96 . . . . 0.0 109.928 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -92.52 49.16 1.45 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.478 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . 0.407 ' H ' HD21 ' A' ' 345' ' ' LEU . 1.7 pt? . . . . . 0 C--N 1.314 -0.952 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.499 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.88 0.371 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.78 -13.02 61.22 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.063 0.935 . . . . 0.0 109.438 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.425 ' CG ' ' HG2' ' A' ' 368' ' ' LYS . 5.4 m-85 -107.09 120.48 42.21 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.38 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -79.77 -27.11 40.47 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.76 0.79 . . . . 0.0 109.169 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -157.01 118.23 3.7 Favored 'General case' 0 N--CA 1.403 -2.815 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.425 ' HG2' ' CG ' ' A' ' 365' ' ' PHE . 42.2 mtmt -94.89 178.42 5.57 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.45 HD13 ' SG ' ' A' ' 436' ' ' CYS . 82.5 mt -67.51 144.35 55.71 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 175.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.21 136.77 93.9 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -43.72 -34.81 5.99 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.059 3.173 . . . . 0.0 114.543 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -144.78 143.66 30.78 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.113 0.482 . . . . 0.0 112.234 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.412 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 63.2 m-85 -137.3 143.28 42.04 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.233 1.013 . . . . 0.0 109.315 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -122.27 138.98 54.31 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.76 149.39 29.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.1 m -82.2 147.7 28.84 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 1.6 tmmm? -64.6 127.11 30.15 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.312 0.577 . . . . 0.0 110.031 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . 0.505 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 95.01 -7.13 69.7 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.382 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -93.08 168.33 11.19 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.757 0.313 . . . . 0.0 111.402 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 44.6 mtmt -98.12 157.61 16.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 17.8 tt -145.73 128.58 9.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 121.576 0.703 . . . . 0.0 109.924 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -103.19 114.99 29.73 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.913 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 76.3 mt -98.0 141.07 31.41 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 35.2 m -139.81 138.49 35.86 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.416 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.0 143.16 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -116.87 126.02 52.39 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . 0.415 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 84.3 mt -91.64 139.86 30.28 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.457 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -71.73 -42.59 67.1 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.95 103.57 16.08 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.631 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -73.18 -21.83 60.6 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.181 -177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.15 26.98 3.03 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.735 1.255 . . . . 0.0 109.748 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -124.06 162.53 23.31 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.06 166.49 19.16 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.693 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 6.7 m -117.02 167.72 9.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.609 0.718 . . . . 0.0 111.91 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 436' ' ' CYS . 8.9 mmpt? -112.81 140.16 47.83 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.6 m-90 -112.38 113.56 25.82 Favored 'General case' 0 C--N 1.278 -2.523 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.0 mp -124.59 137.4 54.39 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.751 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 119.04 30.15 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 171.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.2 p30 56.05 18.11 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 126.725 2.01 . . . . 0.0 112.249 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.5 1.98 47.06 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.093 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -106.24 133.72 50.5 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.18 123.46 20.35 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.439 0.638 . . . . 0.0 111.312 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 69.6 mt -66.34 109.75 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.48 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -85.96 135.76 33.53 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 28.0 ttt -73.3 94.77 2.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.155 0.503 . . . . 0.0 110.155 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.0 p -89.04 94.4 9.93 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.05 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.17 -106.6 0.95 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.54 -0.754 . . . . 0.0 113.563 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 19.2 t -122.14 12.36 10.31 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . 0.443 ' HD2' ' CD2' ' A' ' 410' ' ' TYR . 6.2 tmtm? -74.31 -56.88 4.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . 0.522 ' O ' ' HG3' ' A' ' 405' ' ' MET . 79.8 m-85 -107.23 113.44 26.85 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 176.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.68 113.9 45.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.097 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -87.05 106.0 17.55 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 420' ' ' THR . 45.3 mt-10 -98.37 107.6 20.1 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 11.4 t -96.59 111.33 23.51 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.485 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 33.4 mm -115.1 82.02 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -174.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.91 -88.89 0.23 Allowed Glycine 0 C--O 1.236 0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 112.816 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -101.2 -29.28 12.19 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.203 0.525 . . . . 0.0 110.665 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 14.9 ptmt -94.76 127.41 40.74 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 122.143 0.973 . . . . 0.0 113.473 -171.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -100.21 105.81 17.43 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 413' ' ' GLU . 27.9 m -100.06 120.24 39.54 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.693 -174.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 45.8 tp -104.49 106.8 17.44 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.169 0.509 . . . . 0.0 110.312 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 58.5 m -95.8 111.63 23.55 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 38.3 mt -99.06 120.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 15.6 m -97.46 130.19 44.58 Favored 'General case' 0 N--CA 1.407 -2.614 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 63.32 74.68 0.42 Allowed 'General case' 0 C--O 1.243 0.751 0 O-C-N 124.168 0.918 . . . . 0.0 113.427 172.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 81.8 m -80.93 121.04 25.51 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.666 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 29.4 p -101.07 -177.26 3.4 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.56 -19.95 62.84 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.964 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -86.24 -11.65 51.79 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.73 177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -99.24 2.89 46.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.804 1.288 . . . . 0.0 108.39 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -77.54 116.91 18.49 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.46 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 447' ' ' LEU . . . -161.66 172.53 16.12 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.74 130.55 34.68 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -112.05 132.17 54.98 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.555 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.482 ' N ' HE21 ' A' ' 435' ' ' GLN . 0.0 OUTLIER -126.66 142.16 51.63 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.19 -174.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' A' ' 369' ' ' LEU . 71.7 m -123.87 120.85 33.77 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 40.7 t -115.94 128.76 73.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.932 -174.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.49 161.11 19.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 170.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.63 112.32 4.91 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.178 -1.487 . . . . 0.0 111.614 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 96.59 -35.11 4.57 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 115.344 -0.428 . . . . 0.0 112.143 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -116.09 124.63 50.89 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -174.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.01 167.54 21.88 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.702 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 41.7 t -151.79 147.2 26.38 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 80.1 p -125.92 116.59 21.73 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.412 ' OG1' ' HD2' ' A' ' 373' ' ' TYR . 9.0 t -94.93 138.92 32.04 Favored 'General case' 0 N--CA 1.401 -2.899 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -88.36 110.0 20.44 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 432' ' ' ALA . 3.4 tm? -99.47 121.79 41.65 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -116.62 114.24 23.81 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.646 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.63 119.62 39.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -109.35 130.28 55.5 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.407 -2.612 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.506 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.32 -33.62 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 C-N-CA 123.628 0.771 . . . . 0.0 109.492 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -52.97 -47.97 67.77 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 123.213 0.605 . . . . 0.0 112.085 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.64 -40.26 16.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.2 mt -63.22 -45.21 99.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 120.715 0.293 . . . . 0.0 111.439 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 9.3 tt -73.21 -31.09 63.96 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.389 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -70.36 -27.12 64.08 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 121.198 0.523 . . . . 0.0 111.22 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -97.82 -1.81 42.36 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.235 0.54 . . . . 0.0 110.988 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.88 148.24 35.28 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.84 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.6 146.49 92.64 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 122.328 2.019 . . . . 0.0 112.659 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.76 -24.1 22.46 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 124.201 3.268 . . . . 0.0 115.922 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 9.0 m -76.61 -12.93 60.09 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.498 0.666 . . . . 0.0 111.644 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.413 ' O ' HG13 ' A' ' 336' ' ' ILE . 7.1 mm-40 -94.61 -15.74 23.79 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.405 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -48.98 -49.3 41.41 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 -171.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -65.78 -31.51 72.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.157 0.503 . . . . 0.0 111.52 -174.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -69.14 -53.54 19.6 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 332' ' ' GLU . 62.6 mt -59.36 -49.86 81.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.887 -175.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -56.4 -62.06 1.98 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.933 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -62.62 -23.17 66.92 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -70.74 -39.96 73.01 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 122.782 0.433 . . . . 0.0 110.842 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -91.08 1.26 57.22 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.011 0.434 . . . . 0.0 112.078 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 87.87 25.7 31.37 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.718 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.2 t -104.81 117.17 49.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 73.9 p -95.46 -30.54 13.82 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 117.685 -1.606 . . . . 0.0 111.599 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -95.39 84.65 4.06 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 121.431 0.634 . . . . 0.0 110.589 -179.903 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.431 -1.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -88.78 -12.95 40.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.716 0.769 . . . . 0.0 109.635 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -109.74 117.57 34.24 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.522 177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -82.87 -18.86 38.8 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -160.08 116.47 2.45 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -94.69 172.76 7.98 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.63 139.26 49.22 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 174.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -56.71 146.53 56.47 Favored Pre-proline 0 C--N 1.316 -0.864 0 O-C-N 123.926 0.766 . . . . 0.0 108.998 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.09 -33.01 41.62 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 123.025 2.484 . . . . 0.0 112.986 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -147.76 144.37 28.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.846 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.546 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 51.9 m-85 -129.8 159.07 37.68 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -136.72 141.9 43.07 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.75 147.3 25.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 25.2 m -84.16 144.5 28.96 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.403 ' HD3' ' HG2' ' A' ' 451' ' ' GLU . 26.7 ttpp -60.26 128.15 35.32 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.741 0.416 . . . . 0.0 110.949 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 90.7 8.84 65.07 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.883 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -111.07 175.2 5.51 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -99.57 136.51 39.39 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.649 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.2 tp -121.36 139.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.474 ' CZ ' HG21 ' A' ' 420' ' ' THR . 35.5 ttt85 -131.74 116.66 17.58 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.187 0.994 . . . . 0.0 111.581 -173.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.08 130.4 48.66 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.974 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 21.7 m -127.61 126.11 41.46 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.415 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 5.1 m -122.04 144.2 32.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.813 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -111.91 119.25 37.89 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 86.0 mt -88.11 145.65 25.83 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.515 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -72.09 -24.26 61.47 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.058 0.456 . . . . 0.0 110.183 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -123.33 135.5 54.22 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.422 ' CD2' ' HB1' ' A' ' 417' ' ' ALA . 11.7 m-70 -70.86 -23.25 62.28 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.87 19.39 17.99 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.86 -172.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -96.59 132.64 42.0 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -98.71 156.12 17.0 Favored 'General case' 0 C--N 1.267 -2.99 0 C-N-CA 118.541 -1.263 . . . . 0.0 111.96 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.53 152.23 17.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.225 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -115.0 139.35 49.92 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -110.9 125.16 53.36 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 8.3 mp -127.47 136.23 51.5 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 117.832 0.287 . . . . 0.0 110.859 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . 0.408 ' O ' ' HD2' ' A' ' 398' ' ' LYS . 0.0 OUTLIER -111.61 115.63 29.46 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.277 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . 0.259 28.6 p30 50.88 13.71 0.15 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 126.814 2.046 . . . . 0.0 114.961 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 123.17 -7.11 9.27 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.366 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -107.51 134.15 50.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.88 120.74 16.9 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.193 0.521 . . . . 0.0 111.109 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 43.1 mt -78.87 111.97 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.915 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.6 151.14 20.84 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 61.7 ttp -62.46 102.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 27.4 t -100.78 95.91 6.96 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 55.29 -137.7 44.48 Favored Glycine 0 N--CA 1.442 -0.947 0 O-C-N 124.114 0.884 . . . . 0.0 113.04 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.3 p -95.44 8.56 42.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.385 0.612 . . . . 0.0 110.607 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 2.5 tppp? -72.5 -47.72 46.29 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . 0.472 ' O ' ' HG3' ' A' ' 405' ' ' MET . 41.1 m-85 -119.43 108.63 14.8 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 57.6 mt -108.66 112.8 41.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 CA-C-O 120.987 0.423 . . . . 0.0 109.955 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.489 ' CD2' HD13 ' A' ' 421' ' ' LEU . 22.7 m-85 -87.08 109.37 19.38 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.468 175.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -108.68 108.72 19.68 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 70.3 m -100.16 110.38 22.66 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.352 0.596 . . . . 0.0 111.172 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 36.1 mt -104.06 74.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.11 -107.05 1.71 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.404 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 390' ' ' HIS . . . -89.93 -25.64 20.83 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.664 0.386 . . . . 0.0 110.396 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -88.39 98.47 11.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -100.7 130.23 46.71 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-O 121.317 0.579 . . . . 0.0 109.722 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' THR . . . . . 0.474 HG21 ' CZ ' ' A' ' 382' ' ' ARG . 16.8 m -123.0 145.77 48.21 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.553 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.489 HD13 ' CD2' ' A' ' 412' ' ' PHE . 23.2 tp -118.56 112.63 20.13 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.353 174.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.9 m -102.07 109.87 21.69 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 33.0 mt -98.4 121.69 49.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.4 m -101.24 145.02 29.39 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.227 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 58.53 47.61 13.16 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.397 1.079 . . . . 0.0 110.836 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.64 122.86 16.9 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 11.2 m -116.63 -177.95 3.31 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.21 -29.55 69.89 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -81.76 -2.8 52.0 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -103.22 -7.05 21.5 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.2 113.84 1.54 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.841 173.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -168.79 163.05 11.8 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.914 -177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.39 129.25 34.85 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -104.61 134.31 47.99 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.0 OUTLIER -123.87 130.0 51.9 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.406 -178.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.639 ' HB2' ' SG ' ' A' ' 443' ' ' CYS . 81.4 m -107.89 111.84 24.17 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 171.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.31 128.22 53.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.756 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.12 161.3 29.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -59.96 112.93 4.84 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.278 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 93.15 -36.29 3.77 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 124.223 0.916 . . . . 0.0 112.441 175.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -116.61 134.99 54.18 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 120.732 0.301 . . . . 0.0 110.403 -173.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -134.61 162.35 32.54 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 436' ' ' CYS . 23.3 p -136.19 144.49 44.97 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 173.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 5.0 p -139.66 112.83 8.2 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 123.23 0.332 . . . . 0.0 111.348 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.546 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 9.9 t -104.13 141.54 36.06 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.78 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -102.63 110.53 22.49 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -89.11 143.71 26.65 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.924 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -118.73 128.65 54.69 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.51 115.93 45.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 450' ' ' LYS . 1.1 tpmt? -105.4 115.67 30.65 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.403 ' HG2' ' HD3' ' A' ' 377' ' ' LYS . 36.0 mt-10 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.708 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.2 -34.63 27.68 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 C-N-CA 123.238 0.615 . . . . 0.0 112.0 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -51.8 -55.25 20.97 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 124.808 1.243 . . . . 0.0 109.987 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.9 -35.57 22.07 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.843 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.75 -49.26 78.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 O-C-N 122.96 0.163 . . . . 0.0 111.375 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.4 tt -71.84 -32.71 67.8 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.994 0.426 . . . . 0.0 110.035 -177.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -64.18 -33.24 75.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.48 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -96.31 0.62 51.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.416 0.627 . . . . 0.0 110.314 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -90.44 151.93 44.85 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.72 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.39 140.65 95.35 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.701 2.267 . . . . 0.0 111.596 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 14.0 Cg_endo -55.8 -23.03 39.8 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.796 2.997 . . . . 0.0 115.072 -174.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.1 p -75.78 -21.57 57.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.273 0.559 . . . . 0.0 111.932 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -93.84 -8.28 40.87 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.511 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.418 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 4.2 m-30 -43.66 -54.86 4.72 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.505 1.122 . . . . 0.0 113.856 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.86 -49.1 79.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 339' ' ' GLN . 11.2 ttp180 -60.73 -40.27 91.71 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.305 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 34.1 mt -73.6 -37.8 50.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.173 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -61.85 -58.55 7.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.178 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -66.84 -23.03 65.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.43 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 335' ' ' ARG . 7.9 tp-100 -59.14 -43.63 92.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.267 0.627 . . . . 0.0 109.624 176.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.59 4.92 43.78 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 88.58 18.22 55.32 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.219 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 24.5 t -91.87 101.04 12.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.3 m -82.33 -40.18 21.8 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.078 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -99.69 87.75 3.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.961 0.886 . . . . 0.0 109.631 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . 0.483 ' H ' HD21 ' A' ' 345' ' ' LEU . 1.4 pt? . . . . . 0 C--N 1.301 -1.519 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.101 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.433 -1.278 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -99.33 -35.77 9.83 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -105.64 128.74 53.81 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.94 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 386' ' ' GLU . 24.3 mt-30 -83.27 -43.74 15.72 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -137.68 124.07 20.7 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.494 ' HE3' ' O ' ' A' ' 442' ' ' LYS . 56.7 mtpt -98.46 168.29 10.29 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.215 -175.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 84.5 mt -62.03 141.31 58.15 Favored 'General case' 0 C--O 1.255 1.343 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -63.16 149.11 91.69 Favored Pre-proline 0 C--N 1.302 -1.461 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.629 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.1 -35.29 25.69 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.393 2.729 . . . . 0.0 113.259 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -153.34 152.5 31.17 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -133.35 158.29 43.36 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -135.71 136.94 41.26 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.07 156.19 24.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 8.4 t -93.15 151.27 19.94 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -64.15 119.12 9.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.851 0.357 . . . . 0.0 110.777 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 99.76 -1.49 56.78 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -91.79 -177.73 4.84 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.176 0.513 . . . . 0.0 110.836 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.0 mtpt -119.34 130.39 55.34 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.623 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.0 tp -120.84 130.01 75.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.417 0.627 . . . . 0.0 110.245 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -101.76 110.09 22.0 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.078 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.65 117.83 31.21 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 16.1 m -122.95 144.36 49.29 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.943 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 9.5 m -140.72 143.24 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.403 ' HB3' HE21 ' A' ' 366' ' ' GLN . 5.9 mp0 -108.94 119.55 39.88 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.473 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 81.6 mt -85.64 143.3 28.49 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.79 -44.6 27.03 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.41 114.87 22.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.325 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -79.4 -21.53 45.53 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.018 0.437 . . . . 0.0 111.415 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -94.09 26.9 3.04 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.739 0.78 . . . . 0.0 111.59 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -128.47 161.46 29.46 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.27 176.88 7.58 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 12.1 m -116.6 164.45 12.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 120.939 0.399 . . . . 0.0 110.728 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -119.0 135.42 54.63 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -106.93 123.61 48.43 Favored 'General case' 0 C--N 1.283 -2.311 0 O-C-N 123.867 0.729 . . . . 0.0 109.979 -169.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.2 mp -131.6 144.12 50.83 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.773 -0.579 . . . . 0.0 111.425 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . 0.435 ' HB3' ' CE1' ' A' ' 434' ' ' TYR . 23.0 pttp -126.18 125.42 42.42 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 169.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 24.6 p30 54.25 17.03 1.36 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.812 1.645 . . . . 0.0 113.009 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.44 4.66 46.54 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.891 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -109.03 124.15 50.27 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.6 111.28 1.76 Allowed 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 19.3 mt -75.6 148.75 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 O-C-N 124.302 1.001 . . . . 0.0 108.415 173.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -139.94 173.85 11.11 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' MET . . . . . 0.423 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 48.6 ttm -66.96 101.57 0.86 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.9 m -97.71 97.48 9.05 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 62.97 -127.47 38.57 Favored Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.35 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.8 p -106.07 12.16 30.66 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -78.76 -60.71 2.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.085 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . 0.423 ' O ' ' HG3' ' A' ' 405' ' ' MET . 95.5 m-85 -96.55 107.62 20.06 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 49.7 mm -106.16 112.53 39.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 CA-C-O 121.178 0.513 . . . . 0.0 110.01 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.519 ' CE2' HD13 ' A' ' 421' ' ' LEU . 23.0 m-85 -86.79 115.87 24.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -110.5 108.33 18.29 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 19.3 m -98.41 111.63 23.91 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.41 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 39.4 mm -112.31 87.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.74 2.21 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -92.82 -27.0 17.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.453 0.168 . . . . 0.0 110.948 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 21.8 ptmt -83.96 141.73 31.02 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.565 0.698 . . . . 0.0 111.929 -175.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -115.22 120.9 41.24 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.115 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 53.0 m -112.67 122.38 47.5 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 412' ' ' PHE . 21.4 tp -102.41 110.16 22.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 31.3 m -95.46 102.0 13.77 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.7 mt -86.78 112.67 23.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 13.3 m -96.36 139.83 31.92 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.718 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 61.27 57.92 2.3 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.905 1.282 . . . . 0.0 110.087 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . 0.623 ' SG ' HG22 ' A' ' 381' ' ' ILE . 25.5 m -64.48 120.9 13.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.093 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 82.1 p -94.89 178.55 5.53 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.25 -19.38 61.71 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.89 -2.17 42.45 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.669 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -103.3 8.04 38.3 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.542 0.687 . . . . 0.0 109.507 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -80.21 94.76 6.11 Favored 'General case' 0 C--O 1.256 1.415 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -145.24 170.21 16.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.466 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -89.53 120.71 31.07 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 398' ' ' LYS . 89.5 m-85 -107.43 138.66 43.23 Favored 'General case' 0 C--N 1.286 -2.196 0 O-C-N 122.276 -0.265 . . . . 0.0 111.166 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.1 OUTLIER -134.4 133.98 41.15 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.841 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.613 ' HB2' ' SG ' ' A' ' 443' ' ' CYS . 85.7 m -108.13 114.12 27.78 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 169.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.6 t -109.84 132.54 57.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.481 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 73.9 t -125.9 160.74 32.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 173.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -66.26 113.24 5.55 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 119.054 -1.546 . . . . 0.0 111.888 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 107.89 -36.67 4.24 Favored Glycine 0 N--CA 1.424 -2.109 0 CA-C-N 115.088 -0.556 . . . . 0.0 112.507 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -134.99 152.58 51.86 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 117.988 0.894 . . . . 0.0 110.849 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.494 ' O ' ' HE3' ' A' ' 368' ' ' LYS . 20.0 ptpt -141.95 178.26 7.63 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 436' ' ' CYS . 5.9 p -148.0 134.3 19.52 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 8.0 p -121.32 129.36 53.05 Favored 'General case' 0 C--N 1.288 -2.077 0 O-C-N 123.798 0.686 . . . . 0.0 110.538 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 15.1 t -128.53 150.11 50.32 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -111.96 111.16 21.89 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 62.0 tp -90.83 130.01 36.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.08 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -109.83 110.59 21.62 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.0 120.67 45.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -116.05 131.42 56.95 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.973 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.529 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.85 -34.1 47.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 122.563 0.345 . . . . 0.0 110.723 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -53.53 -47.41 69.98 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.561 1.144 . . . . 0.0 111.186 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 8.6 pt-20 -85.81 -42.09 14.47 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.897 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.34 -50.47 80.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 122.671 0.388 . . . . 0.0 111.532 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.94 -27.88 64.08 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.352 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -60.63 -49.78 76.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.432 0.634 . . . . 0.0 111.78 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 19.3 pt20 -94.46 0.82 55.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.785 -174.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -81.82 153.61 70.18 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.257 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.53 143.31 94.85 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 122.157 1.904 . . . . 0.0 110.988 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 28.3 Cg_endo -60.27 -24.29 76.88 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 123.764 2.976 . . . . 0.0 113.992 -172.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.1 m -79.81 -8.81 59.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.989 0.423 . . . . 0.0 111.583 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.439 ' O ' HG13 ' A' ' 336' ' ' ILE . 20.5 mm-40 -94.66 -19.3 20.56 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.207 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 14.2 m-30 -44.24 -50.33 8.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.03 -55.76 30.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.673 0.608 . . . . 0.0 111.765 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -65.44 -41.02 93.94 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.043 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 332' ' ' GLU . 77.6 mt -59.25 -45.81 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.69 -58.83 6.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.847 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -62.11 -30.71 71.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.17 -36.54 84.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.767 0.317 . . . . 0.0 111.117 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -93.21 4.49 53.91 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 84.11 12.87 75.65 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.983 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 19.0 t -89.94 90.22 3.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -45.68 93.21 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.128 -174.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -110.98 100.79 9.43 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.757 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 345' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.411 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.412 -2.338 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.03 68.1 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.393 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -86.99 135.43 33.28 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.861 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . 0.484 ' HB3' ' CB ' ' A' ' 386' ' ' GLU . 0.0 OUTLIER -89.03 -37.68 14.98 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 177.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -157.02 135.68 11.55 Favored 'General case' 0 CA--C 1.465 -2.31 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.744 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 9.9 mtmp? -98.09 175.06 6.24 Favored 'General case' 0 C--N 1.268 -2.963 0 O-C-N 124.298 0.999 . . . . 0.0 109.756 -175.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.519 HD11 ' SG ' ' A' ' 436' ' ' CYS . 34.6 mt -61.08 155.7 19.78 Favored 'General case' 0 C--O 1.249 1.031 0 O-C-N 124.066 0.854 . . . . 0.0 111.523 178.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.48 149.32 91.05 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 170.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.81 -37.19 76.3 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.592 2.194 . . . . 0.0 113.293 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -143.8 153.15 42.09 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.638 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -135.2 163.24 30.4 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -138.05 145.34 41.66 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.3 p -148.33 155.25 9.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.456 ' HB2' ' CG ' ' A' ' 379' ' ' HIS . 49.8 m -90.96 146.86 23.52 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.452 ' NZ ' ' HB3' ' A' ' 377' ' ' LYS . 1.7 ttpm? -63.47 121.04 12.85 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.7 0.32 57.77 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.703 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . 0.456 ' CG ' ' HB2' ' A' ' 376' ' ' SER . 12.5 m170 -103.78 171.08 7.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 120.827 0.346 . . . . 0.0 111.309 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . 0.461 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.0 mtpt -101.44 143.32 31.6 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.465 HD13 ' N ' ' A' ' 382' ' ' ARG . 0.1 OUTLIER -135.92 138.57 47.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.465 ' N ' HD13 ' A' ' 381' ' ' ILE . 55.0 mtt180 -114.62 117.35 30.63 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.377 0.608 . . . . 0.0 112.244 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 420' ' ' THR . 29.7 mt -96.53 128.81 43.81 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 28.7 m -123.74 134.57 53.66 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 14.2 m -141.97 162.82 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 C-N-CA 124.211 1.004 . . . . 0.0 108.629 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.484 ' CB ' ' HB3' ' A' ' 366' ' ' GLN . 37.8 mt-10 -123.33 138.89 54.51 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 46.2 mt -105.67 146.65 29.46 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.82 -5.72 54.15 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.386 0.613 . . . . 0.0 111.242 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -135.58 138.39 42.92 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -75.54 -22.76 56.79 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.379 0.672 . . . . 0.0 112.002 -174.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -109.6 23.16 14.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 122.763 1.268 . . . . 0.0 109.29 -174.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -101.21 139.31 37.07 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -177.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -103.25 140.75 36.97 Favored 'General case' 0 N--CA 1.393 -3.313 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.93 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.4 ' CG1' ' HG2' ' A' ' 419' ' ' ARG . 6.0 p -120.04 134.1 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.405 0 CA-C-N 113.848 -1.524 . . . . 0.0 107.556 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -111.3 146.13 37.58 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.496 ' CE2' ' HB2' ' A' ' 421' ' ' LEU . 24.4 m95 -106.19 126.75 52.6 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 7.7 mp -114.34 131.44 56.54 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -98.83 110.54 23.12 Favored 'General case' 0 N--CA 1.407 -2.588 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.751 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.0 p30 56.11 2.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 127.637 2.375 . . . . 0.0 114.121 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 131.91 -5.98 5.44 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -103.33 127.89 50.56 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.74 118.86 6.66 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 123.016 0.526 . . . . 0.0 112.036 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.43 HD13 ' CB ' ' A' ' 396' ' ' TRP . 54.0 mt -79.48 114.26 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 170.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -104.28 141.26 36.61 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' MET . . . . . 0.463 ' HB3' ' CD2' ' A' ' 412' ' ' PHE . 27.1 ptt? -70.11 109.81 4.8 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.228 -176.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.3 m -103.05 102.48 12.51 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.214 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 52.1 -124.12 23.61 Favored Glycine 0 N--CA 1.445 -0.727 0 O-C-N 124.451 1.094 . . . . 0.0 114.639 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 16.1 m -91.46 -5.76 53.77 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.435 -0.382 . . . . 0.0 111.518 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -78.33 -53.5 7.22 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.585 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . 0.457 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 90.9 m-85 -110.97 121.5 45.52 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 46.2 mt -121.7 119.64 59.39 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.71 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.463 ' CD2' ' HB3' ' A' ' 405' ' ' MET . 3.1 m-30 -88.02 106.02 17.86 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -106.69 133.67 51.0 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 9.6 t -118.73 121.7 40.73 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.569 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 65.4 mt -118.84 94.94 3.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.78 -98.63 0.62 Allowed Glycine 0 C--N 1.305 -1.142 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -121.37 3.57 10.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.062 0.458 . . . . 0.0 110.166 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 21.2 ptmt -104.9 136.6 44.08 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . 0.4 ' HG2' ' CG1' ' A' ' 394' ' ' VAL . 9.7 tpp85 -110.71 139.07 46.31 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 29.9 m -131.22 125.31 32.58 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.496 ' HB2' ' CE2' ' A' ' 396' ' ' TRP . 50.6 tp -97.83 117.68 32.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 54.3 m -103.62 106.96 17.62 Favored 'General case' 0 N--CA 1.41 -2.428 0 O-C-N 123.906 0.754 . . . . 0.0 108.967 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.87 125.16 52.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' SER . . . . . 0.461 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 44.7 m -104.59 128.8 52.7 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 66.06 66.98 0.48 Allowed 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 124.552 1.158 . . . . 0.0 110.689 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.07 122.38 17.27 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.634 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 9.2 m -105.58 -177.87 3.49 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.416 HD21 ' HG3' ' A' ' 451' ' ' GLU . 71.8 mt -68.01 -28.69 67.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.976 0.417 . . . . 0.0 110.57 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -75.32 -6.27 49.04 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.344 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -101.17 -11.08 19.83 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.14 106.83 2.53 Favored 'General case' 0 C--O 1.25 1.083 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.38 165.57 30.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.533 -176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.53 129.23 34.87 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -104.97 135.35 46.48 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 1.8 mp0 -121.54 123.91 43.11 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 91.9 m -84.45 117.05 23.41 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.25 112.73 37.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.84 160.86 14.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.03 112.88 5.35 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 119.134 -1.507 . . . . 0.0 110.749 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.39 -36.21 4.5 Favored Glycine 0 N--CA 1.405 -3.4 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.109 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -137.41 170.17 16.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 22.2 ptmt -147.02 162.73 38.19 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.574 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.744 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 53.2 t -149.48 135.85 19.18 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 15.3 p -103.73 142.58 34.1 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.739 0.649 . . . . 0.0 111.353 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.422 ' CG2' HD12 ' A' ' 369' ' ' LEU . 15.1 t -131.16 150.2 52.25 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.81 112.46 19.26 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.076 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 36.4 tp -85.16 142.8 29.22 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.831 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -116.01 109.75 17.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.5 t -91.96 118.08 36.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -103.65 121.99 44.09 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . 0.416 ' HG3' HD21 ' A' ' 428' ' ' LEU . 1.8 mp0 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.62 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.503 2.18 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.95 -29.02 4.85 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 C-N-CA 125.124 1.37 . . . . 0.0 112.357 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -57.92 -55.39 35.51 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.43 0.692 . . . . 0.0 110.737 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.29 -20.64 43.91 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.163 0.506 . . . . 0.0 110.708 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 76.2 mt -72.36 -50.28 36.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.703 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.26 -34.8 78.45 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.303 0.573 . . . . 0.0 110.268 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -54.92 -39.8 69.18 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.854 1.262 . . . . 0.0 112.434 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -103.54 -1.72 27.9 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.278 0.561 . . . . 0.0 110.129 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -80.94 149.22 66.47 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.824 -174.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.47 144.42 79.46 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.325 2.016 . . . . 0.0 110.066 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 30.1 Cg_endo -63.78 -22.84 69.33 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.868 2.379 . . . . 0.0 113.384 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.5 m -78.87 -8.53 58.92 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -111.38 2.38 17.55 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 121.099 -0.241 . . . . 0.0 111.183 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 12.9 m-30 -47.85 -52.36 19.41 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.43 ' O ' ' HD2' ' A' ' 338' ' ' PHE . 39.7 tt0 -60.29 -44.43 95.37 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.654 0.596 . . . . 0.0 111.312 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -59.99 -54.18 49.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.265 0.555 . . . . 0.0 109.994 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 51.5 mt -64.88 -41.23 91.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.886 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 342' ' ' VAL . . . -60.47 -55.43 33.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.993 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . 0.43 ' HD2' ' O ' ' A' ' 334' ' ' GLU . 77.2 m-85 -68.7 -24.08 64.45 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -68.11 -40.6 82.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.552 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -93.65 -7.9 42.53 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 95.25 33.8 6.39 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.188 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 337' ' ' ALA . 8.3 t -116.57 106.35 20.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 72.0 p -91.28 -18.26 24.65 Favored 'General case' 0 C--N 1.265 -3.078 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.816 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -96.57 45.89 1.06 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.978 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 121.082 0.468 . . . . 0.0 110.799 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.431 -1.417 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -91.24 -11.06 39.31 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.726 0.774 . . . . 0.0 109.422 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.46 127.72 48.0 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -89.64 -32.06 17.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.485 0.659 . . . . 0.0 109.314 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.5 OUTLIER -148.83 116.07 6.12 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.355 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -91.17 163.9 14.1 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 59.6 mt -64.84 144.6 57.15 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 123.837 0.71 . . . . 0.0 109.272 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -67.45 146.42 98.69 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -45.89 -43.05 19.98 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 123.597 2.865 . . . . 0.0 113.821 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -148.9 155.06 40.33 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.068 0.461 . . . . 0.0 111.002 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -137.81 158.65 43.91 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -129.22 142.63 50.8 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.8 p -140.64 151.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 43.3 m -81.45 145.09 30.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -62.4 117.54 6.29 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.691 0.282 . . . . 0.0 111.163 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.09 5.13 57.41 Favored Glycine 0 CA--C 1.499 -0.914 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -104.96 163.25 12.67 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.47 148.17 24.52 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.431 HG23 ' SG ' ' A' ' 426' ' ' CYS . 15.9 tt -150.55 149.25 14.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 1.2 ptp180 -127.37 137.16 52.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.446 0.641 . . . . 0.0 112.325 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.07 153.97 20.78 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 50.7 m -139.68 138.23 35.86 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.692 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.13 144.02 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 35.1 mt-10 -121.28 137.19 54.8 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . 0.42 HD13 ' NH1' ' A' ' 419' ' ' ARG . 96.4 mt -96.67 157.13 16.04 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.472 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -86.46 -15.25 40.77 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -127.93 142.72 51.18 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -80.67 -23.35 39.68 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -106.03 21.94 16.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.307 0.575 . . . . 0.0 110.545 -174.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -99.39 159.16 15.21 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -121.79 145.81 47.69 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 118.585 -1.246 . . . . 0.0 112.983 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 11.7 m -109.94 158.85 9.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.314 175.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -132.35 133.46 44.01 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -101.03 127.41 47.55 Favored 'General case' 0 C--N 1.275 -2.634 0 O-C-N 124.458 1.099 . . . . 0.0 108.527 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 402' ' ' GLU . 10.1 mt -137.64 146.02 43.39 Favored 'General case' 0 CA--C 1.458 -2.559 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 433' ' ' ALA . 22.5 pttp -126.58 132.82 51.21 Favored 'General case' 0 N--CA 1.399 -3.002 0 C-N-CA 118.772 -1.171 . . . . 0.0 109.652 174.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.6 p30 48.41 27.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 126.438 1.895 . . . . 0.0 114.451 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.06 23.35 30.05 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.865 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 402' ' ' GLU . 6.3 tp60 -114.18 -96.22 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.559 0.219 . . . . 0.0 111.317 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 397' ' ' LEU . 43.6 tt0 176.92 135.97 0.06 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 58.1 mt -91.07 128.67 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.997 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -99.43 138.5 36.44 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' MET . . . . . 0.454 ' HB2' ' CE1' ' A' ' 412' ' ' PHE . 60.1 ttp -79.62 80.9 5.96 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 t -88.81 111.33 21.9 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.363 -171.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 54.06 -125.12 32.44 Favored Glycine 0 N--CA 1.446 -0.698 0 O-C-N 124.331 1.019 . . . . 0.0 113.443 176.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 15.3 m -106.74 3.85 27.04 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.719 0.771 . . . . 0.0 108.927 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -75.2 -41.8 57.04 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.399 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -119.27 117.98 30.03 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 43.9 mm -114.96 114.82 47.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.473 ' CE2' HD12 ' A' ' 421' ' ' LEU . 22.3 m-30 -87.42 109.96 19.94 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -105.01 108.57 20.16 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 78.6 p -99.69 121.6 41.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.235 0.541 . . . . 0.0 109.65 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.5 mm -123.64 85.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.94 -90.39 0.13 Allowed Glycine 0 C--N 1.321 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 113.825 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -102.36 -28.16 12.41 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.817 0.342 . . . . 0.0 110.332 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 386' ' ' GLU . 21.2 ptmt -93.8 134.8 35.76 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.754 0.788 . . . . 0.0 112.44 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . 0.42 ' NH1' HD13 ' A' ' 387' ' ' LEU . 10.8 mpt_? -110.86 124.36 51.92 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 28.6 m -115.89 122.26 44.8 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.473 HD12 ' CE2' ' A' ' 412' ' ' PHE . 20.2 tp -103.61 109.02 20.54 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.0 m -100.02 110.75 23.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.403 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.8 mt -96.95 141.18 16.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 31.8 m -120.72 135.89 55.01 Favored 'General case' 0 N--CA 1.388 -3.561 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 59.31 58.47 3.01 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 124.783 1.302 . . . . 0.0 111.332 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . 0.431 ' SG ' HG23 ' A' ' 381' ' ' ILE . 60.7 m -63.6 113.46 3.35 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.347 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.7 m -100.37 -176.84 3.33 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.19 -23.77 63.96 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.125 0.488 . . . . 0.0 111.184 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.29 -5.65 50.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.048 0.452 . . . . 0.0 110.867 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -98.21 -5.7 32.79 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.073 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.82 88.7 1.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -146.7 162.49 38.39 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.166 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 398' ' ' LYS . . . -85.42 129.35 34.83 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -108.26 132.47 53.64 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.6 144.93 41.26 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.484 ' SG ' HD12 ' A' ' 369' ' ' LEU . 79.1 m -122.84 103.08 8.4 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . 0.481 HG21 ' HG3' ' A' ' 442' ' ' LYS . 14.8 t -104.77 136.92 36.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.14 -174.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 441' ' ' GLU . 29.9 t -122.17 161.14 23.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 174.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -74.41 109.73 2.88 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 115.423 -3.275 . . . . 0.0 110.176 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 104.61 4.34 43.04 Favored Glycine 0 N--CA 1.42 -2.367 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 438' ' ' VAL . 4.5 tp10 -151.53 143.27 23.71 Favored 'General case' 0 N--CA 1.396 -3.14 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -176.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.481 ' HG3' HG21 ' A' ' 437' ' ' VAL . 26.9 ttpt -148.93 152.77 36.96 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.04 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 28.4 p -150.11 144.18 25.55 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 170.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 22.6 m -133.62 140.52 47.16 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 13.3 t -122.45 148.16 45.46 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.14 111.03 20.4 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 51.6 tp -84.36 134.3 34.49 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.98 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -107.89 115.09 29.5 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.27 108.38 19.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 376' ' ' SER . 3.8 tmmm? -100.21 117.82 35.24 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -176.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--N 1.303 -1.423 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.604 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 CA--C 1.501 -0.921 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 13.3 p -50.52 -44.04 24.13 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.814 0 C-N-CA 125.257 1.423 . . . . 0.0 111.442 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -59.33 -42.8 92.31 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.73 -38.28 18.43 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.8 mt -65.61 -45.83 91.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 120.74 0.305 . . . . 0.0 110.36 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.9 tt -68.23 -32.63 72.96 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.208 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -63.95 -34.63 78.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.103 0.561 . . . . 0.0 110.728 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -94.5 1.59 55.71 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.764 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.78 155.41 36.59 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.751 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . 0.431 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 15.6 Cg_endo -60.31 142.78 98.96 Favored 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 122.665 2.244 . . . . 0.0 112.422 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.27 -26.98 72.99 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.21 3.273 . . . . 0.0 114.753 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 41.7 m -83.55 -1.19 53.23 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.11 0.481 . . . . 0.0 112.231 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.431 ' CG ' ' HG2' ' A' ' 329' ' ' PRO . 63.0 mm-40 -100.39 -11.29 20.37 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -45.84 -49.07 15.68 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . 0.411 ' O ' ' HD1' ' A' ' 338' ' ' PHE . 45.4 tt0 -72.83 -34.59 66.92 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.97 0.414 . . . . 0.0 110.805 -175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -65.51 -44.32 87.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 332' ' ' GLU . 66.2 mt -67.08 -43.57 88.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.155 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.19 -54.26 48.81 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.454 0.471 . . . . 0.0 110.653 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 75.3 m-85 -69.81 -23.09 63.27 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -66.88 -36.21 81.79 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.09 0.471 . . . . 0.0 109.981 175.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -100.96 2.58 40.83 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 83.61 22.31 56.32 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.649 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.47 123.09 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 28.7 p -100.62 -28.55 12.8 Favored 'General case' 0 C--N 1.27 -2.863 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.999 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.6 56.57 3.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.715 0.769 . . . . 0.0 111.74 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.8 tp . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.469 178.588 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.421 -1.911 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -90.43 -38.2 13.44 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 368' ' ' LYS . 11.9 m-85 -86.92 146.89 26.0 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 169.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -102.38 -15.67 16.46 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -168.5 125.04 1.01 Allowed 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 62.0 mttp -100.35 169.27 9.23 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 123.452 0.47 . . . . 0.0 110.16 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 70.3 mt -64.14 143.11 58.12 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.548 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -68.25 146.76 98.15 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -45.7 -43.44 18.68 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.817 3.011 . . . . 0.0 113.837 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -149.05 137.42 20.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.327 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.411 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 78.8 m-85 -118.78 159.61 23.4 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 127.08 28.15 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.0 p -133.4 160.87 42.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 14.1 m -95.66 142.84 27.5 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.26 127.3 30.85 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.984 0.421 . . . . 0.0 110.099 -176.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 95.43 1.78 62.17 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.972 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -100.97 172.37 7.07 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.917 0.389 . . . . 0.0 110.887 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 26.5 mtpp -97.85 134.75 40.57 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 6.7 tp -130.31 135.99 59.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 26.8 ptt180 -127.58 128.74 46.11 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.406 0.622 . . . . 0.0 112.591 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -105.98 138.89 41.4 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.462 -1.244 . . . . 0.0 107.793 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 51.5 m -119.04 128.41 54.33 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.803 0.335 . . . . 0.0 111.794 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 13.5 m -126.41 145.08 34.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -118.33 136.83 53.49 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 392' ' ' ALA . 3.9 mm? -95.59 152.37 18.49 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.066 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.74 -33.41 58.14 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -101.31 154.54 18.69 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -77.37 -40.34 44.18 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -174.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -103.34 7.39 38.23 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.788 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . 0.564 ' O ' ' HG ' ' A' ' 387' ' ' LEU . . . -84.14 132.63 34.67 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 175.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.95 177.31 7.2 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.034 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.44 164.38 8.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.466 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -107.92 148.76 29.2 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.406 ' CB ' ' HB ' ' A' ' 403' ' ' ILE . 9.5 m-90 -110.22 113.01 25.34 Favored 'General case' 0 C--N 1.274 -2.699 0 O-C-N 124.144 0.902 . . . . 0.0 109.587 -171.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 401' ' ' GLN . 7.8 mp -126.35 134.26 51.12 Favored 'General case' 0 CA--C 1.48 -1.727 0 CA-C-O 120.675 0.274 . . . . 0.0 111.217 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -113.95 132.76 55.84 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 46.95 24.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.89 14.79 64.24 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.431 ' O ' ' HG ' ' A' ' 397' ' ' LEU . 24.7 tp60 -94.61 -116.29 0.1 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -174.62 128.45 0.33 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 173.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.406 ' HB ' ' CB ' ' A' ' 396' ' ' TRP . 68.4 mt -81.56 101.9 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -82.23 127.68 33.43 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.69 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -66.22 102.47 0.84 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.7 m -110.92 110.0 20.4 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.877 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 52.32 -119.16 8.64 Favored Glycine 0 N--CA 1.444 -0.801 0 O-C-N 124.408 1.067 . . . . 0.0 114.048 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.7 m -108.23 5.74 26.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.205 0.526 . . . . 0.0 110.669 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.04 -41.01 59.98 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.835 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -117.4 109.75 17.17 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.323 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 43.5 mm -108.12 114.88 47.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.466 ' CE1' HD11 ' A' ' 421' ' ' LEU . 23.0 m-85 -87.85 105.96 17.77 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -98.02 108.65 21.41 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.444 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 12.6 p -103.4 105.08 15.26 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.575 0.702 . . . . 0.0 109.85 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 51.2 mt -112.75 83.75 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 76.83 -111.6 3.31 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -97.56 -14.01 21.3 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.135 0.493 . . . . 0.0 109.923 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -78.43 119.34 21.6 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 124.047 0.939 . . . . 0.0 111.023 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . 0.426 ' HD3' HD22 ' A' ' 387' ' ' LEU . 9.9 mpt_? -111.37 113.85 26.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 99.0 m -115.06 116.17 28.0 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.577 0.703 . . . . 0.0 110.593 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 382' ' ' ARG . 26.3 tp -91.0 115.5 28.06 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.106 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.2 m -103.85 112.23 25.11 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 56.8 mt -100.26 118.13 46.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 11.3 m -96.91 138.93 33.7 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 63.15 47.65 4.05 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 124.019 0.824 . . . . 0.0 110.599 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 44.4 t -57.92 118.6 5.54 Favored 'General case' 0 C--O 1.249 1.068 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 16.1 m -107.89 -177.81 3.44 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -175.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.78 -23.11 63.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.03 0.443 . . . . 0.0 110.604 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -74.39 -5.02 39.96 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.582 0.706 . . . . 0.0 110.27 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -110.88 -9.57 14.45 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.922 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.1 98.68 0.6 Allowed 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 170.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -164.78 173.67 11.53 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.575 -169.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.4 132.05 34.29 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 444' ' ' SER . 23.7 m-85 -111.42 132.06 54.73 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.3 OUTLIER -118.1 134.4 55.03 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.009 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.441 ' SG ' HD12 ' A' ' 369' ' ' LEU . 73.4 m -109.45 113.07 25.57 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 11.0 t -105.34 125.24 60.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.732 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.62 160.92 15.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -69.73 113.2 4.89 Favored Glycine 0 N--CA 1.419 -2.435 0 C-N-CA 118.316 -1.897 . . . . 0.0 109.39 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.22 -35.75 4.79 Favored Glycine 0 N--CA 1.425 -2.046 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.937 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -135.81 158.0 45.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.576 1.188 . . . . 0.0 111.596 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -148.73 173.19 13.49 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 35.0 t -159.96 142.74 13.64 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 170.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 434' ' ' TYR . 12.3 p -122.1 130.94 53.69 Favored 'General case' 0 N--CA 1.418 -2.072 0 O-C-N 123.801 0.688 . . . . 0.0 110.09 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 10.7 t -107.02 142.3 36.86 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -98.58 110.02 22.69 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 38.7 tp -89.22 138.83 31.08 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.898 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -115.19 111.23 20.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.17 119.07 45.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . 0.489 ' HD3' ' O ' ' A' ' 450' ' ' LYS . 0.0 OUTLIER -100.23 134.59 42.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.225 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.612 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.82 -33.08 33.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 C-N-CA 123.511 0.724 . . . . 0.0 111.272 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -54.02 -46.46 71.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.907 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.13 -38.11 18.08 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.702 177.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.01 -54.91 28.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 O-C-N 123.223 0.327 . . . . 0.0 111.613 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.15 -21.29 65.83 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.652 0.739 . . . . 0.0 110.148 -175.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -72.8 -37.53 67.53 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.075 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -94.03 -23.99 17.8 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.634 0.73 . . . . 0.0 110.431 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.34 89.51 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.763 -176.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -63.85 137.55 58.75 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.509 2.139 . . . . 0.0 112.649 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.67 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 8.9 Cg_endo -52.23 -29.44 37.89 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.302 3.335 . . . . 0.0 115.555 -175.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 11.8 p -70.86 -23.84 62.39 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . 0.527 ' O ' HG13 ' A' ' 336' ' ' ILE . 22.1 mm-40 -95.27 -4.51 45.55 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -171.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . 0.67 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 21.5 m-30 -46.12 -48.59 17.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -173.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.04 -29.46 68.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.061 0.458 . . . . 0.0 111.42 -175.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -76.01 -47.29 25.42 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 332' ' ' GLU . 60.7 mt -58.45 -44.12 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.117 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.85 -58.52 8.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.305 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -68.69 -23.51 64.39 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -71.13 -35.68 71.83 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.16 0.584 . . . . 0.0 110.03 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -100.9 5.35 43.28 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 79.89 38.53 19.37 Favored Glycine 0 C--N 1.31 -0.912 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.699 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.9 t -114.82 119.14 60.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 23.6 p -99.1 -14.55 19.35 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-O 121.556 0.693 . . . . 0.0 110.751 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.79 45.43 0.97 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.327 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 C--O 1.197 -1.67 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.986 -176.95 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.433 -1.295 0 CA-C-O 121.14 0.495 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.64 -13.47 15.57 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -110.32 136.02 50.15 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.198 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -98.02 -19.78 17.8 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.389 0.614 . . . . 0.0 110.016 175.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -158.5 122.35 3.98 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.7 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 45.4 mtpt -106.69 172.33 6.87 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 80.9 mt -75.04 132.67 41.48 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.02 127.97 88.56 Favored Pre-proline 0 CA--C 1.5 -0.973 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.64 -32.18 53.32 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.279 1.986 . . . . 0.0 112.438 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -110.57 110.97 21.89 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.466 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 13.9 m-85 -118.43 151.07 38.49 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 171.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -144.87 143.54 30.64 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 10.6 p -150.63 154.89 8.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 379' ' ' HIS . 16.1 m -85.55 157.19 20.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 427' ' ' SER . 35.6 ttpt -71.98 135.35 46.38 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.782 0.325 . . . . 0.0 111.071 -177.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 85.86 15.58 65.1 Favored Glycine 0 C--N 1.318 -0.469 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.8 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . 0.521 ' CD2' ' HB2' ' A' ' 376' ' ' SER . 31.5 m-70 -105.35 -177.53 3.39 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.984 0.421 . . . . 0.0 110.317 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -114.63 138.46 50.64 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.95 130.71 73.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 CA-C-O 120.904 0.383 . . . . 0.0 109.98 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -108.27 103.62 12.83 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.161 0.505 . . . . 0.0 110.475 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.26 113.11 20.88 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 19.9 m -110.35 130.86 55.47 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.149 -171.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.7 151.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 123.55 0.74 . . . . 0.0 109.69 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.427 ' HG2' ' HB3' ' A' ' 418' ' ' LYS . 50.0 mt-10 -118.55 131.61 56.22 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.1 mt -100.91 148.94 24.41 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -81.84 3.87 24.42 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.088 0.471 . . . . 0.0 111.782 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -142.43 136.84 29.89 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -80.42 -21.87 41.76 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.564 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -102.58 4.51 38.49 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.153 0.978 . . . . 0.0 110.042 -173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -100.21 134.84 42.56 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.96 175.89 5.24 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.847 -174.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 4.8 p -131.36 141.32 46.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 120.967 0.413 . . . . 0.0 111.082 -172.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -114.02 135.85 53.55 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 175.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -104.35 134.35 47.7 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.913 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 8.3 mp -119.85 125.75 49.29 Favored 'General case' 0 CA--C 1.475 -1.909 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.031 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -102.62 127.38 49.75 Favored 'General case' 0 N--CA 1.416 -2.147 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.702 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 20.9 p30 54.95 15.38 1.14 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 127.125 2.17 . . . . 0.0 113.498 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.2 19.37 42.59 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.251 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -98.13 -89.29 0.3 Allowed 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 169.63 145.9 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 30.3 mt -99.24 108.04 21.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -95.96 134.01 39.48 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.159 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -65.74 104.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.461 0.475 . . . . 0.0 110.674 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 30.6 t -117.44 120.76 39.11 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 50.84 -122.42 13.59 Favored Glycine 0 C--N 1.336 0.579 0 O-C-N 124.25 0.969 . . . . 0.0 113.574 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 23.8 m -116.72 19.6 14.42 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -76.5 -44.6 34.53 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.01 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -122.47 108.53 13.28 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.951 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.24 114.89 45.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -88.09 104.82 17.03 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.442 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -99.37 119.14 37.47 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 13.1 t -115.26 108.18 16.24 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 66.0 mt -113.95 82.75 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.345 -174.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.21 -104.17 1.14 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.144 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -94.26 -21.89 18.74 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 122.409 0.284 . . . . 0.0 110.851 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . 0.427 ' HB3' ' HG2' ' A' ' 386' ' ' GLU . 21.5 ptmt -101.45 137.08 40.25 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.713 0.768 . . . . 0.0 111.47 -175.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -118.47 139.06 52.01 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.022 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 34.4 m -134.37 117.24 16.12 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-O 121.483 0.659 . . . . 0.0 110.503 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 57.1 tp -91.2 113.45 25.71 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 29.1 m -97.59 106.72 19.08 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.73 116.4 33.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 14.7 m -96.5 146.09 25.11 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.001 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 58.26 50.4 9.77 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.189 1.396 . . . . 0.0 110.15 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 8.0 p -60.46 112.96 2.17 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.73 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' SER . . . . . 0.428 ' HA ' ' HG3' ' A' ' 377' ' ' LYS . 17.7 m -109.98 -170.46 1.65 Allowed 'General case' 0 N--CA 1.406 -2.629 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.08 -21.06 62.28 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 118.964 0.802 . . . . 0.0 111.736 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -73.24 -14.31 61.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.375 0.607 . . . . 0.0 110.077 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -98.34 9.08 43.88 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.78 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.5 107.64 17.54 Favored 'General case' 0 C--O 1.252 1.22 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -155.44 165.01 37.93 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.99 0.424 . . . . 0.0 110.556 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -86.59 115.35 24.01 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -104.87 133.05 50.33 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.019 0.438 . . . . 0.0 110.578 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 2.0 mp0 -128.08 134.29 49.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 3.7 p -100.89 118.36 36.79 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.65 123.29 58.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 92.9 t -131.44 160.68 42.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.18 114.61 7.05 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.031 -1.081 . . . . 0.0 111.059 175.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.83 -36.49 4.32 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-O 119.31 -0.717 . . . . 0.0 113.7 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -139.16 -179.75 6.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.728 1.251 . . . . 0.0 114.228 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 443' ' ' CYS . 33.0 ttmt -149.24 157.12 43.09 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.4 t -143.63 134.43 25.24 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 171.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 12.2 p -110.15 142.77 41.2 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 123.573 0.545 . . . . 0.0 110.917 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.466 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 8.8 t -137.87 147.59 44.6 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.23 111.13 23.37 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 64.5 tp -88.82 111.3 21.86 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -93.13 107.87 19.58 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.8 t -92.22 114.23 28.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -107.2 124.13 49.29 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.427 -1.577 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.89 -36.31 49.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 123.438 0.695 . . . . 0.0 111.675 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 31.9 p-90 -58.22 -41.63 84.5 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 123.182 0.593 . . . . 0.0 111.653 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.6 -45.97 10.55 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 80.1 mt -58.2 -52.44 58.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.0 tt -66.43 -33.54 75.94 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 121.501 0.667 . . . . 0.0 109.617 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -64.47 -32.89 74.71 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 124.524 1.129 . . . . 0.0 111.446 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -96.97 -11.08 25.03 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.331 0.586 . . . . 0.0 110.845 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -83.84 161.77 54.68 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.412 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.52 142.25 58.49 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.68 2.254 . . . . 0.0 110.829 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.98 -16.69 56.31 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 123.784 2.989 . . . . 0.0 114.199 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.4 m -77.54 -17.07 58.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.719 0.295 . . . . 0.0 111.765 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -104.43 1.13 29.72 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -53.4 -42.54 67.07 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -174.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.8 -27.87 55.4 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.395 -177.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 -63.62 -54.44 35.83 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 34.0 mt -64.01 -43.41 97.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.751 -176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.47 -59.99 4.56 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.2 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.26 -22.78 66.32 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -65.67 -42.56 91.16 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.235 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -97.95 7.04 46.99 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 90.07 13.72 60.13 Favored Glycine 0 CA--C 1.499 -0.912 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.904 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.0 t -94.54 99.43 9.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.3 m -76.39 -38.75 55.25 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.082 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -110.09 94.21 4.9 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.643 0.735 . . . . 0.0 109.873 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . 0.486 HD22 ' H ' ' A' ' 345' ' ' LEU . 1.8 pt? . . . . . 0 C--N 1.303 -1.451 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.356 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.429 -1.497 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.412 ' HB1' ' HG3' ' A' ' 441' ' ' GLU . . . -86.39 -27.06 24.44 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.869 0.842 . . . . 0.0 109.482 177.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.65 127.63 35.95 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.23 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -90.54 -28.37 18.55 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' LYS . . . . . 0.452 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.4 OUTLIER -149.46 115.4 5.68 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 177.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.407 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 57.9 mtpt -89.85 162.09 15.65 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 175.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 74.5 mt -64.57 138.65 58.52 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -61.83 145.0 92.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.76 -24.09 44.8 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.6 2.2 . . . . 0.0 113.437 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -142.68 135.6 28.2 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.87 0.367 . . . . 0.0 111.668 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -135.69 146.79 48.12 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -131.05 136.04 48.1 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.47 146.41 31.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 15.5 m -82.79 142.37 31.62 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -57.38 115.84 2.96 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 122.958 0.503 . . . . 0.0 111.248 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 108.03 -18.51 33.81 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.504 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -82.25 179.98 7.61 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.114 0.483 . . . . 0.0 110.925 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . 0.436 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 54.3 mtpt -108.76 140.07 42.69 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.579 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.6 tp -127.12 133.25 68.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 176.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -105.87 112.6 25.72 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.918 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.51 110.65 22.44 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 45.0 m -108.32 128.89 55.14 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.65 143.45 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 172.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 18.0 mt-10 -120.13 138.37 53.62 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . 0.403 HD11 ' NH1' ' A' ' 419' ' ' ARG . 95.5 mt -100.19 152.35 20.37 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -85.24 -14.63 46.14 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.403 0.621 . . . . 0.0 110.081 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -117.84 141.47 48.39 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -79.99 -26.84 39.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.795 0.331 . . . . 0.0 111.718 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -108.04 25.61 11.38 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.632 1.206 . . . . 0.0 109.896 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -96.75 154.97 16.98 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.15 149.23 51.95 Favored 'General case' 0 C--N 1.274 -2.7 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.116 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 5.3 m -105.92 135.79 42.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.056 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -103.74 136.69 42.97 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' TRP . . . . . 0.495 ' HB3' HD12 ' A' ' 403' ' ' ILE . 4.8 m-90 -103.23 118.53 36.99 Favored 'General case' 0 C--N 1.264 -3.148 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.981 -170.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.7 mp -128.75 130.21 46.77 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 120.966 0.412 . . . . 0.0 111.757 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -109.22 128.06 54.75 Favored 'General case' 0 N--CA 1.412 -2.363 0 C-N-CA 118.886 -1.126 . . . . 0.0 108.894 170.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.5 p30 49.57 23.86 1.03 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.698 1.599 . . . . 0.0 113.295 -176.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.34 4.96 60.74 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.737 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -90.12 -92.26 0.13 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.501 0.191 . . . . 0.0 110.6 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 171.77 133.69 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . 0.495 HD12 ' HB3' ' A' ' 396' ' ' TRP . 15.0 mt -94.71 124.84 47.36 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 173.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -123.76 145.17 49.22 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.996 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' MET . . . . . 0.527 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 27.3 ttt -64.91 94.26 0.13 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.677 0.791 . . . . 0.0 111.32 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.6 t -93.5 101.08 13.26 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.23 -128.8 48.21 Favored Glycine 0 N--CA 1.446 -0.659 0 O-C-N 123.915 0.759 . . . . 0.0 112.191 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.7 m -105.24 18.16 22.78 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.395 0.617 . . . . 0.0 109.599 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 424' ' ' SER . 86.5 tttt -83.03 -59.76 2.38 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.359 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' TYR . . . . . 0.527 ' O ' ' HG3' ' A' ' 405' ' ' MET . 75.9 m-85 -96.44 108.12 20.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.76 115.13 48.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.189 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.548 ' CE2' HD12 ' A' ' 421' ' ' LEU . 25.4 m-85 -87.41 106.02 17.67 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.8 108.76 21.53 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 29.8 t -95.64 122.8 38.79 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.488 ' HB ' ' CG ' ' A' ' 418' ' ' LYS . 58.3 mt -129.08 85.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.75 -98.03 0.33 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.491 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -92.26 -28.96 16.66 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.849 0.357 . . . . 0.0 110.57 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' LYS . . . . . 0.488 ' CG ' ' HB ' ' A' ' 415' ' ' ILE . 23.2 ptmt -92.55 146.72 23.45 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.896 0.855 . . . . 0.0 112.143 -175.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' ARG . . . . . 0.403 ' NH1' HD11 ' A' ' 387' ' ' LEU . 11.4 mpt_? -125.25 125.07 42.99 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 173.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 34.7 m -121.18 126.61 50.11 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 120.925 0.393 . . . . 0.0 110.279 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' LEU . . . . . 0.548 HD12 ' CE2' ' A' ' 412' ' ' PHE . 33.4 tp -98.15 108.44 21.15 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.7 m -94.83 105.23 17.15 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.718 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 52.4 mt -90.06 115.7 30.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 409' ' ' LYS . 19.5 m -102.25 128.67 48.69 Favored 'General case' 0 N--CA 1.406 -2.635 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 69.97 59.93 0.27 Allowed 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 124.343 1.027 . . . . 0.0 110.148 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' CYS . . . . . 0.579 ' SG ' HG22 ' A' ' 381' ' ' ILE . 27.8 m -66.23 113.72 4.78 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.268 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 14.5 m -106.43 -166.37 1.18 Allowed 'General case' 0 N--CA 1.404 -2.762 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 54.5 mt -77.84 -22.48 49.86 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.315 -174.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -73.03 -6.41 45.34 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.64 0.733 . . . . 0.0 110.277 176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -103.69 2.71 33.45 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.077 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -87.36 100.04 12.43 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -154.58 167.19 30.95 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.78 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.66 122.9 30.42 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 170.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -108.04 132.25 53.74 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 120.754 0.311 . . . . 0.0 110.468 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.443 ' OE1' ' HB3' ' A' ' 444' ' ' SER . 2.1 mp0 -121.86 126.08 47.9 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.098 0.475 . . . . 0.0 110.668 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 10.7 p -95.48 113.95 25.67 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.4 123.91 65.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.747 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.48 162.69 32.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.5 113.09 5.55 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 118.448 -1.834 . . . . 0.0 110.727 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.26 -35.23 5.1 Favored Glycine 0 N--CA 1.429 -1.818 0 CA-C-O 119.661 -0.522 . . . . 0.0 113.524 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.412 ' HG3' ' HB1' ' A' ' 364' ' ' ALA . 3.3 mm-40 -130.84 154.2 48.29 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 117.944 0.872 . . . . 0.0 110.75 -173.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -148.58 154.65 40.05 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 435' ' ' GLN . 13.6 t -147.74 139.45 23.95 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' SER . . . . . 0.443 ' HB3' ' OE1' ' A' ' 435' ' ' GLN . 3.4 m -115.78 118.99 34.56 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.739 0.649 . . . . 0.0 109.465 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 11.0 t -105.92 146.23 30.26 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -101.59 110.29 22.25 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 66.6 tp -96.2 118.04 31.97 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -101.76 117.73 35.48 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.68 113.13 30.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -95.09 119.29 33.34 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.958 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.673 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.67 -42.33 47.73 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.918 2.412 . . . . 0.0 112.356 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 165.63 41.62 0.02 OUTLIER Glycine 0 C--N 1.304 -1.203 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 3.7 p -103.69 -174.28 2.51 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.704 -0.748 . . . . 0.0 111.114 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.463 ' C ' ' H ' ' A' ' 321' ' ' VAL . 17.6 mt-10 -83.65 -47.67 11.0 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 72.14 -21.88 0.22 Allowed 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 125.215 1.406 . . . . 0.0 113.323 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' A' ' 319' ' ' GLU . 9.0 p -45.93 -29.35 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.185 0 C-N-CA 125.957 1.703 . . . . 0.0 113.769 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -62.62 -56.38 18.37 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.807 0.843 . . . . 0.0 110.878 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.49 -31.12 66.74 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.255 0.55 . . . . 0.0 110.052 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.51 -50.58 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.364 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.67 -35.97 82.74 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.064 0.459 . . . . 0.0 110.497 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -57.61 -33.9 68.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.33 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -109.42 6.63 24.45 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.288 -175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -89.59 155.78 48.12 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -62.91 136.56 57.71 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.34 2.027 . . . . 0.0 110.508 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.527 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 9.7 Cg_endo -54.23 -34.37 79.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.731 2.954 . . . . 0.0 115.496 -172.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 37.4 t -78.74 -13.98 59.52 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.399 -0.521 . . . . 0.0 112.252 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -98.67 -0.26 43.3 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.98 -174.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.527 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 20.8 m-30 -52.36 -45.21 65.66 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.2 -37.96 78.37 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.521 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 38.8 ttm-85 -63.21 -49.41 74.32 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 339' ' ' GLN . 41.6 mt -71.12 -37.01 65.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.539 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.95 -54.75 41.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.44 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -65.13 -24.31 67.38 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 336' ' ' ILE . 35.2 tt0 -61.88 -36.63 81.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.305 0.574 . . . . 0.0 109.577 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -98.52 -1.37 41.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.028 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 102.03 -5.73 53.4 Favored Glycine 0 C--O 1.244 0.738 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.333 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.64 134.12 27.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 121.369 0.604 . . . . 0.0 109.838 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 -10.82 12.05 Favored 'General case' 0 C--N 1.266 -3.045 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.362 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -100.95 45.53 0.97 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 346' ' ' ARG . 0.0 OUTLIER -70.12 -32.36 70.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . 0.414 ' N ' HD23 ' A' ' 345' ' ' LEU . 50.9 ttp180 -63.35 -35.14 79.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.01 176.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.424 ' HA2' ' HG2' ' A' ' 350' ' ' LYS . . . -69.38 -44.49 64.83 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.344 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 59.1 ttp -62.21 -32.4 73.06 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.043 0.449 . . . . 0.0 110.607 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 98.1 mt -72.79 -48.84 34.73 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.294 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.424 ' HG2' ' HA2' ' A' ' 347' ' ' GLY . 19.2 pttp -62.73 -39.92 95.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.754 0.311 . . . . 0.0 111.688 -175.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -68.66 -26.62 65.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.586 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 13.8 tp -80.08 -24.92 40.28 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.98 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -67.0 -35.86 80.88 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 357' ' ' ARG . . . -73.55 -25.27 72.88 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 174.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 46.7 tpp -70.45 -45.69 65.29 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 123.625 0.77 . . . . 0.0 110.875 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -87.46 -2.68 58.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.868 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 354' ' ' GLY . 0.3 OUTLIER -59.47 124.48 20.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.616 178.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -55.31 127.62 30.28 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.669 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.67 84.62 2.28 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.42 138.45 56.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -85.51 -177.29 6.4 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 1.2 m 81.62 64.93 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 49.9 p -85.33 -61.77 1.69 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.703 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.402 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -85.61 -11.75 53.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.135 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.505 ' CD2' ' HB3' ' A' ' 441' ' ' GLU . 0.7 OUTLIER -94.84 145.64 24.76 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.204 175.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -108.33 -21.19 12.86 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -156.88 121.22 4.39 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.458 ' HG2' ' CD2' ' A' ' 365' ' ' PHE . 27.9 mtpp -101.3 163.12 12.43 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 54.0 mt -66.26 154.39 40.02 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 123.659 0.599 . . . . 0.0 111.118 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -68.09 161.62 66.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.093 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -55.39 -41.53 77.2 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.196 1.93 . . . . 0.0 111.362 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -154.72 162.43 41.12 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.152 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -136.2 141.46 44.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.6 132.32 55.2 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.51 153.67 37.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 379' ' ' HIS . 14.5 m -85.19 145.32 27.65 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.65 121.26 19.47 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.08 13.94 40.99 Favored Glycine 0 CA--C 1.494 -1.259 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 376' ' ' SER . 35.6 t60 -118.9 150.34 40.05 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -91.0 127.01 36.25 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.317 0.647 . . . . 0.0 111.03 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.653 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.4 tt -124.26 163.7 23.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 0.8 OUTLIER -143.58 137.37 28.34 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.941 0.401 . . . . 0.0 110.037 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -100.37 151.33 21.64 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 38.8 m -133.01 121.94 23.47 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.024 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 12.6 m -127.05 143.85 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.08 135.71 55.13 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.29 161.89 13.36 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -83.62 1.94 39.85 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.131 0.491 . . . . 0.0 110.599 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -138.85 146.37 41.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -80.73 -28.52 36.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -104.85 4.5 32.17 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.481 0.657 . . . . 0.0 111.074 -171.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -88.32 153.13 21.45 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.27 166.14 15.77 Favored 'General case' 0 C--N 1.268 -2.96 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.938 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 3.7 m -113.76 159.99 13.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.118 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 436' ' ' CYS . 31.7 mmmt -106.12 139.18 41.04 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.411 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 11.8 m-90 -113.46 111.51 22.05 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.3 mp -124.38 137.63 54.45 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.008 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -113.51 118.5 34.65 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.2 p30 50.4 18.61 0.45 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 126.104 1.762 . . . . 0.0 113.742 -175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.87 1.44 27.13 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.736 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -113.69 132.35 55.83 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 48.8 mt-10 -61.66 118.18 6.76 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 57.8 mt -71.16 108.96 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -100.41 150.72 22.33 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' MET . . . . . 0.459 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 86.7 mtp -67.63 96.88 0.57 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.101 0.477 . . . . 0.0 110.87 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.9 m -91.25 101.24 13.95 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 58.35 -130.73 51.44 Favored Glycine 0 N--CA 1.446 -0.646 0 O-C-N 123.704 0.627 . . . . 0.0 112.092 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 15.6 m -102.7 13.02 35.49 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.671 0.748 . . . . 0.0 109.307 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -82.6 -41.75 19.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.207 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . 0.459 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 72.7 m-85 -113.25 111.43 22.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 64.2 mt -122.49 117.69 52.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.05 0.452 . . . . 0.0 110.92 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.495 ' CD2' HD13 ' A' ' 421' ' ' LEU . 21.4 m-85 -87.37 109.14 19.34 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.72 108.41 19.87 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.9 p -102.19 105.55 16.25 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.743 0.782 . . . . 0.0 111.64 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.9 mm -100.37 87.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.21 -111.58 3.65 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.331 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -98.1 -6.04 32.46 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.617 0.723 . . . . 0.0 109.813 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -91.39 111.27 22.7 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.55 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -98.54 113.36 25.36 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.4 m -111.41 119.18 37.96 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.495 HD13 ' CD2' ' A' ' 412' ' ' PHE . 19.1 tp -97.09 107.47 20.0 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 96.2 m -94.26 123.05 37.41 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.409 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 59.7 mt -111.67 116.44 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 9.8 m -86.45 130.54 34.46 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.372 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 56.05 74.32 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.595 1.184 . . . . 0.0 111.697 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . 0.653 ' SG ' HG22 ' A' ' 381' ' ' ILE . 68.1 m -69.14 125.38 26.49 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.226 0.536 . . . . 0.0 111.25 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.5 p -109.28 -177.08 3.2 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 90.2 mt -72.63 -14.93 61.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.19 -20.58 48.02 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.694 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.58 -19.67 27.49 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.474 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.19 99.11 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -163.48 171.51 15.8 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.085 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -87.74 127.75 35.31 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -104.96 134.98 47.16 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.593 HE21 ' N ' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -124.34 118.38 26.62 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 395' ' ' LYS . 83.0 m -96.45 108.02 20.5 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 171.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 26.3 t -105.92 117.25 51.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.977 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.75 155.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.58 112.13 4.56 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 117.758 -2.163 . . . . 0.0 111.001 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 105.51 -17.81 42.46 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.505 ' HB3' ' CD2' ' A' ' 365' ' ' PHE . 64.8 mm-40 -141.38 112.31 7.24 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -134.23 159.6 40.42 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 435' ' ' GLN . 47.8 t -142.48 134.47 27.21 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.1 m -108.92 110.6 21.96 Favored 'General case' 0 N--CA 1.426 -1.648 0 O-C-N 124.197 0.935 . . . . 0.0 109.267 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.3 t -102.04 150.11 23.57 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -114.6 116.4 28.69 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.455 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 49.3 tp -84.66 134.22 34.37 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -112.46 109.85 19.69 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.32 112.43 26.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.306 0.574 . . . . 0.0 109.59 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.95 116.05 28.47 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.427 -1.593 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.127 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.487 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.94 28.68 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.282 2.655 . . . . 0.0 111.984 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 97.1 -89.56 1.05 Allowed Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 8.1 t -87.09 106.34 17.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 321' ' ' VAL . 50.0 mt-10 -96.01 -62.18 1.32 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.58 -7.76 0.55 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.786 1.234 . . . . 0.0 113.857 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.412 ' H ' ' C ' ' A' ' 319' ' ' GLU . 13.3 p -61.43 -23.19 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 124.068 0.947 . . . . 0.0 112.66 -175.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -68.62 -41.78 79.02 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.167 0.508 . . . . 0.0 109.939 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.9 -28.33 27.98 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.217 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 76.2 mt -69.39 -47.12 74.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.536 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.89 -34.22 77.64 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.058 0.456 . . . . 0.0 111.257 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -59.27 -41.56 89.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -99.46 -0.41 40.83 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.515 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -71.15 155.5 93.07 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.463 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.68 134.21 46.17 Favored 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.346 2.031 . . . . 0.0 110.549 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 11.7 Cg_endo -53.66 -28.68 47.65 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 124.115 3.21 . . . . 0.0 115.172 -172.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 11.7 m -86.05 -15.02 42.65 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -101.26 3.49 40.9 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.148 -172.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 22.0 m-30 -50.94 -44.73 60.4 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.545 0.528 . . . . 0.0 112.264 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -59.92 -53.64 55.48 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 123.394 0.434 . . . . 0.0 112.14 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 53.4 ttp85 -61.73 -39.34 91.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.435 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 56.4 mt -73.01 -38.96 56.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.127 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.67 -56.83 16.64 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.061 0.545 . . . . 0.0 111.027 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -67.4 -23.54 65.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -65.99 -47.28 75.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.137 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -83.88 -19.29 35.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.162 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 100.77 40.56 2.88 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.086 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.97 128.24 63.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 19.1 p -104.3 -14.48 15.77 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 121.24 0.543 . . . . 0.0 110.44 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -79.28 44.75 0.6 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.331 0.586 . . . . 0.0 111.26 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 46.3 tp -73.81 -39.56 64.01 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -66.33 -29.51 69.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.205 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 351' ' ' ARG . . . -74.96 -34.86 51.73 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 25.4 ttt -70.63 -43.35 69.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.839 0.352 . . . . 0.0 110.145 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.85 -34.7 77.21 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.814 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -54.97 -41.14 70.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.851 0.86 . . . . 0.0 109.943 174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.629 ' O ' ' HG2' ' A' ' 355' ' ' MET . 28.2 mmt180 -54.78 -45.98 74.35 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.112 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 6.9 mp -80.73 -20.94 41.67 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.149 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -71.47 -26.83 62.87 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -83.83 -29.84 30.83 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.106 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.629 ' HG2' ' O ' ' A' ' 351' ' ' ARG . 26.0 mmt -75.4 -17.09 60.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 122.831 0.453 . . . . 0.0 110.674 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 77.67 -29.12 0.16 Allowed 'General case' 0 C--O 1.246 0.892 0 C-N-CA 125.631 1.572 . . . . 0.0 112.009 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -80.25 86.69 5.62 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 122.013 0.911 . . . . 0.0 109.872 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -138.78 97.21 3.28 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.162 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 17.0 mm-40 55.77 28.58 12.49 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.467 1.107 . . . . 0.0 112.705 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -76.68 106.11 8.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.507 0.67 . . . . 0.0 109.592 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 359' ' ' GLU . 22.2 pttp 178.5 -37.05 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.595 -170.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 26.2 p 178.52 27.96 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.94 1.296 . . . . 0.0 109.829 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.417 HG21 ' OE2' ' A' ' 441' ' ' GLU . 7.3 t -74.01 -39.72 63.41 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.197 -0.94 . . . . 0.0 110.964 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.467 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -92.55 -10.47 37.49 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.924 0.392 . . . . 0.0 111.069 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.21 110.07 20.12 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.903 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -74.26 -29.3 61.61 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.527 0.679 . . . . 0.0 109.655 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 367' ' ' LYS . 34.3 ttmt -149.38 119.21 7.07 Favored 'General case' 0 N--CA 1.398 -3.026 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -176.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.658 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 57.9 mtpt -100.04 166.21 11.14 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.758 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 71.4 mt -69.12 136.42 52.19 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.541 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -59.36 150.66 63.27 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -46.66 -39.27 23.19 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 123.095 2.53 . . . . 0.0 113.115 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -147.46 165.37 30.48 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.471 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -142.45 144.39 33.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.38 140.42 52.97 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.6 p -145.93 152.74 13.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 379' ' ' HIS . 25.1 m -91.14 150.85 21.21 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.32 128.79 37.73 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.871 0.367 . . . . 0.0 110.486 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 88.34 6.77 73.78 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.6 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 376' ' ' SER . 10.1 m-70 -102.75 -178.52 3.7 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.764 0.316 . . . . 0.0 110.21 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -119.65 141.24 49.52 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.457 HG23 ' SG ' ' A' ' 426' ' ' CYS . 16.1 tt -141.4 155.42 20.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 2.6 ptm180 -141.18 134.85 30.15 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.347 0.594 . . . . 0.0 110.598 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.57 125.21 48.19 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.817 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 54.1 m -106.28 121.28 43.9 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.702 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.44 144.12 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -124.41 131.44 53.5 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.86 159.86 16.77 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.8 -25.55 56.48 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.3 0.571 . . . . 0.0 110.261 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -131.2 159.41 37.81 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.124 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -80.8 -25.33 37.92 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.261 0.553 . . . . 0.0 109.895 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.08 3.19 40.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.051 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -99.93 118.02 35.46 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -103.01 163.73 12.03 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.167 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 3.7 m -117.81 141.09 38.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.484 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -109.46 122.9 48.42 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.406 ' O ' HD13 ' A' ' 397' ' ' LEU . 3.6 m-90 -93.37 114.0 26.31 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.665 -170.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 396' ' ' TRP . 7.8 mp -127.3 137.67 52.88 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 175.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 433' ' ' ALA . 60.4 pttt -117.34 119.45 35.17 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.8 p30 50.95 20.72 0.84 Allowed 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 125.415 1.486 . . . . 0.0 113.236 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.02 2.28 48.72 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.985 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -108.58 123.43 48.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -53.01 121.13 6.79 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.515 0.509 . . . . 0.0 110.603 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 53.1 mt -79.19 102.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -100.3 145.58 27.96 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 87.8 mtp -60.63 100.74 0.11 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.301 0.572 . . . . 0.0 111.617 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.7 m -102.6 103.1 13.38 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.115 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.99 -134.41 50.83 Favored Glycine 0 N--CA 1.442 -0.95 0 O-C-N 124.008 0.817 . . . . 0.0 113.307 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.3 t -99.98 7.72 44.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 26.2 ttmt -75.7 -54.43 6.97 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.708 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -102.33 107.66 18.76 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.121 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.05 110.15 30.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.365 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.546 ' CE1' HD13 ' A' ' 421' ' ' LEU . 22.4 m-85 -87.27 106.13 17.7 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.45 108.04 19.92 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.433 0.635 . . . . 0.0 110.464 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.86 107.19 19.03 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.53 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.41 84.27 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.74 -111.3 3.4 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.84 -6.86 26.15 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.256 0.55 . . . . 0.0 110.029 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -82.44 113.01 19.9 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.721 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -108.8 107.45 17.88 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.7 m -109.36 116.92 32.76 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.128 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.546 HD13 ' CE1' ' A' ' 412' ' ' PHE . 21.0 tp -91.17 106.39 18.48 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.3 m -93.84 119.99 33.51 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 54.5 mt -107.34 115.37 48.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.5 m -99.99 131.76 45.75 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 68.52 61.65 0.36 Allowed 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.355 1.062 . . . . 0.0 111.494 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . 0.457 ' SG ' HG23 ' A' ' 381' ' ' ILE . 59.7 m -62.95 121.74 14.29 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.561 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.3 p -113.82 -175.0 2.58 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.72 -18.77 62.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.261 0.553 . . . . 0.0 110.39 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -78.92 -11.17 59.99 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.752 0.787 . . . . 0.0 110.101 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . 0.425 ' OD1' ' HD3' ' A' ' 409' ' ' LYS . 23.2 m-20 -96.49 -19.48 19.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.976 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.04 103.15 0.9 Allowed 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -165.05 167.59 18.19 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 398' ' ' LYS . . . -85.76 124.15 31.93 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -104.67 139.46 39.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.409 ' HB3' ' CB ' ' A' ' 444' ' ' SER . 0.0 OUTLIER -142.97 138.76 30.31 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 121.173 0.511 . . . . 0.0 110.767 177.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 62.2 m -101.96 112.05 24.54 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.115 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.95 110.13 23.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.708 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 57.9 t -112.41 157.07 13.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.25 113.3 5.46 Favored Glycine 0 N--CA 1.428 -1.873 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.829 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 102.6 -33.47 6.53 Favored Glycine 0 N--CA 1.425 -2.033 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.158 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 24.7 mm-40 -132.44 131.37 41.67 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.365 0.602 . . . . 0.0 111.582 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.516 ' HG2' ' N ' ' A' ' 443' ' ' CYS . 33.5 ttmt -126.36 158.03 36.95 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.658 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 49.3 t -148.39 134.0 18.78 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' SER . . . . . 0.409 ' CB ' ' HB3' ' A' ' 435' ' ' GLN . 34.0 t -123.79 139.27 54.15 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.8 t -125.62 150.48 47.51 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -106.85 110.87 23.15 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.395 0.616 . . . . 0.0 110.593 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -89.6 139.67 30.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.001 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -121.69 117.02 25.62 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 123.609 0.763 . . . . 0.0 110.891 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 56.5 t -97.51 119.47 45.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.67 137.52 48.24 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.227 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.701 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.444 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.76 -24.96 12.84 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.676 2.251 . . . . 0.0 112.273 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -172.11 -178.21 42.19 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 24.5 t -116.75 -61.23 1.75 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -119.0 9.63 11.92 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 122.657 1.218 . . . . 0.0 108.312 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.17 19.93 4.01 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.365 -1.743 . . . . 0.0 110.691 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.29 -35.52 36.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.745 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . 0.458 ' O ' ' HB2' ' A' ' 326' ' ' ARG . 17.7 m95 -56.6 -60.4 3.59 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 124.024 0.93 . . . . 0.0 110.913 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.85 -41.32 95.79 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.488 0.492 . . . . 0.0 111.657 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.4 mt -68.06 -42.88 85.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 123.095 0.558 . . . . 0.0 111.545 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.6 -36.24 60.36 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 322' ' ' TRP . 14.3 tpt85 -63.94 -41.15 97.7 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.364 0.666 . . . . 0.0 111.345 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.76 -4.59 59.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.547 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -87.92 150.3 47.51 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.59 150.24 82.9 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.817 1.678 . . . . 0.0 111.273 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.1 -29.31 3.93 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.644 3.563 . . . . 0.0 115.96 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 50.5 m -85.41 -2.06 57.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -93.44 -22.26 19.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -44.08 -52.51 7.13 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.86 1.264 . . . . 0.0 112.905 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -57.0 -53.0 63.03 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.433 0.693 . . . . 0.0 111.858 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -57.87 -50.37 73.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.983 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.67 -40.43 89.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.892 -175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.94 -57.72 11.56 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.623 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -68.89 -23.02 64.15 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -64.14 -44.8 91.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.92 0.39 . . . . 0.0 110.082 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -91.13 -8.4 48.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 89.13 32.5 10.56 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.442 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 17.6 t -94.52 122.8 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.338 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 9.3 p -97.82 -22.57 16.31 Favored 'General case' 0 C--N 1.276 -2.618 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.934 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -83.89 63.23 7.43 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.714 0.768 . . . . 0.0 110.297 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 27.6 tp -75.56 -47.16 27.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.286 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -65.79 -26.14 67.56 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 351' ' ' ARG . . . -61.86 -34.25 88.13 Favored Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.829 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 53.9 tpp -68.08 -38.75 82.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.077 0.465 . . . . 0.0 110.157 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.95 -34.25 77.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.058 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -63.0 -45.5 92.12 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 347' ' ' GLY . 83.8 mtt180 -61.18 -46.12 91.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.854 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.64 -49.88 75.89 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.728 0.811 . . . . 0.0 111.016 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.91 -15.72 60.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.071 0.462 . . . . 0.0 110.787 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -97.68 25.85 25.62 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.759 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.449 ' HE2' ' HA ' ' A' ' 355' ' ' MET . 23.6 mmt -87.25 -19.09 28.82 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -62.48 137.55 58.28 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.235 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -99.11 170.5 8.65 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.496 ' OD2' ' HG2' ' A' ' 360' ' ' LYS . 35.9 t70 -133.51 136.47 45.08 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -109.48 92.88 4.23 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.496 ' HG2' ' OD2' ' A' ' 358' ' ' ASP . 0.0 OUTLIER -101.74 -93.67 0.3 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.25 175.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.425 ' HG3' ' H ' ' A' ' 362' ' ' SER . 18.0 tptp 59.77 -170.45 0.14 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.978 0.911 . . . . 0.0 108.623 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.425 ' H ' ' HG3' ' A' ' 361' ' ' LYS . 44.8 t 63.39 30.23 15.5 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 121.489 0.661 . . . . 0.0 109.914 176.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 75.0 p -72.54 -32.24 65.93 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.402 -172.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -97.53 4.93 50.22 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.17 0.509 . . . . 0.0 110.776 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -117.0 117.6 30.11 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.689 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -85.08 -21.93 29.15 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 120.826 0.346 . . . . 0.0 110.36 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 367' ' ' LYS . 23.6 ttmm -159.67 127.38 4.77 Favored 'General case' 0 N--CA 1.391 -3.383 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.765 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 35.6 mtmm -110.75 177.35 4.7 Favored 'General case' 0 C--N 1.253 -3.615 0 O-C-N 124.28 0.987 . . . . 0.0 108.357 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.98 141.94 49.37 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.144 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.67 158.66 67.02 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.202 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -44.8 -39.81 14.09 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 123.451 2.767 . . . . 0.0 113.809 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -156.11 162.53 40.24 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -137.97 149.2 45.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -133.38 137.34 45.79 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.42 143.78 33.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.7 m -79.43 141.99 36.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -57.28 125.59 23.48 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 122.957 0.503 . . . . 0.0 110.402 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 96.47 -9.97 66.96 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.917 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -96.71 170.75 8.98 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.149 0.499 . . . . 0.0 110.791 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 6.9 mtpm? -101.08 161.05 13.88 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.729 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 18.2 tt -154.98 133.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 121.201 0.524 . . . . 0.0 110.665 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -99.99 127.47 46.2 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.546 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 420' ' ' THR . 70.3 mt -105.77 109.37 21.3 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 87.7 m -107.19 126.01 51.85 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.13 149.25 33.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.43 135.55 53.98 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 54.1 mt -104.04 165.44 11.05 Favored 'General case' 0 C--N 1.261 -3.263 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.03 -29.84 49.61 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.164 0.507 . . . . 0.0 109.929 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -112.01 146.94 37.0 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.181 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -78.9 -22.44 45.92 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -112.5 26.23 10.74 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.236 0.541 . . . . 0.0 111.398 -173.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -113.37 137.54 51.36 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -122.31 154.45 37.6 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.893 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.61 153.53 7.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.33 0.586 . . . . 0.0 111.491 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -103.43 133.37 48.6 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.428 ' CB ' HD12 ' A' ' 403' ' ' ILE . 44.8 m95 -101.51 139.06 37.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 434' ' ' TYR . 10.3 mp -121.13 143.61 49.01 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.551 ' HG3' HG12 ' A' ' 403' ' ' ILE . 22.5 mtmm -103.83 108.61 20.0 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.7 p30 50.95 16.81 0.37 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 124.966 1.306 . . . . 0.0 113.998 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.15 -5.96 17.52 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.643 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -102.04 124.85 48.37 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -64.13 118.39 8.48 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.932 0.396 . . . . 0.0 111.987 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.551 HG12 ' HG3' ' A' ' 398' ' ' LYS . 41.0 mt -66.33 122.0 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.248 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -102.1 157.34 16.95 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 48.0 ttm -71.54 94.6 1.31 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.0 t -89.92 102.22 14.92 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 58.68 -114.38 5.92 Favored Glycine 0 N--CA 1.437 -1.251 0 O-C-N 124.086 0.866 . . . . 0.0 112.141 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 26.4 m -119.3 17.12 13.1 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.05 -0.575 . . . . 0.0 109.735 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -76.34 -46.39 27.76 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.864 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . 0.546 ' O ' ' HG3' ' A' ' 405' ' ' MET . 93.4 m-85 -111.62 108.44 17.93 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.89 0.376 . . . . 0.0 110.292 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 49.6 mt -107.91 113.75 44.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -87.23 105.1 16.99 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.409 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.99 138.61 41.87 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.638 0.732 . . . . 0.0 111.365 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 13.1 p -118.38 122.81 43.73 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.089 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.79 89.89 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.03 -123.83 15.69 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.41 -6.36 55.02 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.317 0.58 . . . . 0.0 110.027 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -88.85 125.26 34.84 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -113.2 137.3 51.67 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 76.9 m -142.11 122.94 14.38 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.367 0.603 . . . . 0.0 112.162 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 63.9 tp -91.19 114.32 26.82 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.441 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 43.7 m -93.97 108.08 19.92 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 50.7 mt -92.84 130.62 41.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' SER . . . . . 0.448 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 16.5 m -106.58 132.19 52.87 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.832 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 425' ' ' GLN 0.321 2.0 pt20 46.64 76.5 0.1 Allowed 'General case' 0 C--O 1.238 0.467 0 O-C-N 125.16 1.537 . . . . 0.0 114.575 177.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 60.5 m -70.28 128.39 36.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.968 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.0 m -112.9 -174.16 2.4 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.64 -19.79 62.78 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.89 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -72.55 -24.72 61.17 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.182 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.38 -21.57 42.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.13 95.54 0.41 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.412 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.95 171.51 18.58 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.2 132.74 34.24 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . 0.6 ' HA ' ' O ' ' A' ' 397' ' ' LEU . 38.7 m-85 -104.81 145.57 30.19 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.1 OUTLIER -129.62 123.28 30.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 7.8 p -94.38 118.28 31.39 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 13.0 t -111.53 121.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.28 160.06 6.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.37 112.29 4.71 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 117.764 -2.16 . . . . 0.0 110.242 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 107.52 -35.41 5.03 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 112.391 -0.283 . . . . 0.0 112.391 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.4 ' OE1' ' HG3' ' A' ' 361' ' ' LYS . 23.3 mm-40 -120.03 127.82 52.95 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 122.428 -0.454 . . . . 0.0 110.612 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -130.85 128.93 41.63 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.7 t -120.31 138.05 53.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 12.7 p -116.43 148.11 41.03 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 123.412 0.445 . . . . 0.0 111.013 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 12.6 t -140.54 150.92 44.3 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -101.73 119.28 38.54 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 24.4 tp -95.98 137.22 35.35 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -118.35 115.74 25.31 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.52 122.17 41.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -93.73 106.63 18.59 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.724 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--N 1.292 -1.896 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.274 179.284 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.479 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.2 148.92 92.34 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.131 1.887 . . . . 0.0 109.817 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -84.0 45.19 3.44 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.864 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 3.1 p -77.3 0.42 22.24 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 123.264 0.626 . . . . 0.0 112.616 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 321' ' ' VAL . 43.5 mp0 -78.91 -24.36 44.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 69.31 -19.12 0.18 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.471 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 7.2 p -51.33 -34.4 14.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 123.873 0.869 . . . . 0.0 112.209 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -55.91 -47.71 76.98 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.872 0.869 . . . . 0.0 110.92 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 11.6 pt-20 -85.85 -38.12 18.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.69 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.79 -50.47 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.311 0.1 . . . . 0.0 111.167 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.39 -32.0 70.75 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -57.87 -39.14 77.09 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.846 0.858 . . . . 0.0 112.199 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 23.2 pt20 -104.88 2.38 29.86 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.173 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -77.12 160.77 75.25 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.529 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.84 135.51 48.61 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.276 1.984 . . . . 0.0 111.029 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.445 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 53.4 Cg_endo -65.96 -4.83 10.85 Favored 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 123.759 2.972 . . . . 0.0 114.772 -173.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 24.5 p -90.25 -16.7 28.85 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.208 0.528 . . . . 0.0 111.192 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 336' ' ' ILE . 29.3 mm-40 -106.92 -0.72 22.98 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.54 -172.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.445 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 22.1 m-30 -55.73 -42.24 75.06 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -173.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.07 -44.14 97.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.528 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -59.36 -53.53 57.18 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.697 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 332' ' ' GLU . 48.5 mt -59.04 -44.06 90.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 O-C-N 123.792 0.683 . . . . 0.0 110.613 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.66 -60.79 3.28 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.126 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -67.12 -22.85 65.78 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -66.39 -45.62 79.4 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 123.2 0.6 . . . . 0.0 110.205 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . 0.471 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 80.8 m-85 -88.83 -20.19 24.98 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 112.63 14.09 10.79 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.532 -1.318 . . . . 0.0 112.551 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.37 97.14 6.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.2 m -65.06 -42.67 93.99 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.693 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -115.99 95.9 5.32 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.706 0.765 . . . . 0.0 111.409 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.6 pt? -71.31 -28.27 63.99 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.104 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -65.74 -46.0 80.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.681 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -68.31 -23.02 74.94 Favored Glycine 0 C--O 1.239 0.448 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' MET . . . . . 0.522 ' O ' ' HG2' ' A' ' 351' ' ' ARG . 25.2 ttt -67.18 -54.64 19.32 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 350' ' ' LYS . 4.4 pp -70.06 -29.54 66.57 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.276 0.56 . . . . 0.0 111.09 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.459 ' N ' HD13 ' A' ' 349' ' ' LEU . 84.8 tttt -57.85 -46.4 84.83 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.514 1.126 . . . . 0.0 110.512 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 348' ' ' MET . 15.2 ptp180 -72.07 -22.0 61.43 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.713 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.67 -21.44 55.41 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -62.72 -53.74 49.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.76 -4.18 70.12 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.415 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 44.2 ttm -89.79 -45.25 9.42 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 122.939 0.495 . . . . 0.0 110.053 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -79.76 -79.07 0.15 Allowed 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.681 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -176.98 75.25 0.02 OUTLIER 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.218 0.532 . . . . 0.0 110.792 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 360' ' ' LYS . 34.5 t70 -121.25 11.5 10.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 123.228 1.489 . . . . 0.0 109.14 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -88.72 93.11 9.46 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 358' ' ' ASP . 3.7 mppt? -81.84 -62.21 1.7 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.534 -176.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 54.72 -158.76 0.19 Allowed 'General case' 0 C--O 1.241 0.655 0 O-C-N 124.156 0.91 . . . . 0.0 110.537 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.408 ' HA ' ' HG3' ' A' ' 441' ' ' GLU . 16.2 m 67.11 19.56 10.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.665 0.745 . . . . 0.0 109.456 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.6 t -104.62 -16.61 14.95 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.363 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -86.14 -3.34 58.94 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.204 1.002 . . . . 0.0 108.558 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 441' ' ' GLU . 0.3 OUTLIER -91.98 126.45 37.07 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 114.226 -1.352 . . . . 0.0 107.899 173.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -93.25 -18.09 22.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.48 0.657 . . . . 0.0 110.023 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -157.24 126.08 5.8 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.721 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 37.4 mtmm -106.86 176.58 5.12 Favored 'General case' 0 C--N 1.276 -2.596 0 O-C-N 123.791 0.682 . . . . 0.0 109.841 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.517 HD13 ' SG ' ' A' ' 436' ' ' CYS . 72.3 mt -74.51 147.54 41.75 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.23 159.06 82.34 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.61 -35.85 38.86 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.277 2.651 . . . . 0.0 112.997 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -156.35 160.72 39.95 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -133.82 148.76 51.35 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -128.25 144.69 51.15 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.8 149.24 15.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 m -88.66 154.02 20.64 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.01 121.43 11.82 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.167 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 90.63 4.37 70.26 Favored Glycine 0 C--N 1.303 -1.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.16 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -98.78 176.9 5.46 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 122.434 -0.451 . . . . 0.0 110.767 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -110.42 143.13 41.17 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.044 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.479 HG23 ' SG ' ' A' ' 426' ' ' CYS . 10.0 tp -130.99 143.04 42.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -121.19 121.9 38.8 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 66.7 mt -100.17 113.33 25.91 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 26.9 m -112.14 125.21 53.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.311 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.99 157.54 40.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.11 137.32 54.58 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 417' ' ' ALA . 86.7 mt -98.8 138.13 36.39 Favored 'General case' 0 C--N 1.267 -3.007 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.64 -38.56 58.8 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -106.95 99.8 9.34 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.626 -1.625 . . . . 0.0 106.917 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -73.9 -16.64 61.1 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 120.817 0.341 . . . . 0.0 111.712 -174.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -87.28 3.97 44.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.177 0.513 . . . . 0.0 110.528 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -107.67 96.18 6.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . 0.431 ' HG2' ' NH2' ' A' ' 419' ' ' ARG . 35.0 mt-10 -75.27 159.81 31.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 8.6 p -118.11 157.95 19.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 113.485 -1.688 . . . . 0.0 109.668 -173.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -132.15 161.22 33.87 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.437 ' CE2' ' HB2' ' A' ' 421' ' ' LEU . 38.7 m95 -114.14 144.62 42.87 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.7 mp -122.74 136.41 54.86 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.427 ' HG2' HG12 ' A' ' 403' ' ' ILE . 8.2 mmtp -93.17 108.62 20.19 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.479 173.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.8 p30 53.03 12.92 0.32 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 125.024 1.33 . . . . 0.0 114.078 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 108.44 9.72 26.72 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.007 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -90.77 -98.89 0.11 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 173.21 137.53 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.43 HD12 ' CB ' ' A' ' 396' ' ' TRP . 48.4 mt -97.75 120.8 47.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 120.831 0.348 . . . . 0.0 110.401 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -91.77 130.99 37.45 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 58.1 ttp -62.21 103.73 0.41 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.8 m -106.16 120.31 41.5 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.265 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 48.62 -118.89 5.21 Favored Glycine 0 C--N 1.334 0.42 0 O-C-N 125.027 1.454 . . . . 0.0 115.278 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.6 m -112.14 7.57 19.65 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.468 0.651 . . . . 0.0 109.623 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 424' ' ' SER . 82.6 tttt -83.3 -49.5 9.32 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.658 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -109.74 129.05 55.65 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.93 118.16 51.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -87.91 105.87 17.72 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -112.76 113.09 25.03 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.166 0.508 . . . . 0.0 111.73 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 37.4 t -98.22 119.42 36.86 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.84 95.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 71.32 -107.83 2.3 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 387' ' ' LEU . . . -101.6 -13.11 17.97 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.073 0.463 . . . . 0.0 109.846 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -74.86 137.61 41.92 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 121.601 0.715 . . . . 0.0 111.695 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . 0.431 ' NH2' ' HG2' ' A' ' 393' ' ' GLU . 21.8 mmt180 -122.3 112.74 18.5 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 173.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 6.8 m -116.64 122.01 43.34 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 396' ' ' TRP . 53.5 tp -96.23 111.0 23.2 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 67.4 m -92.36 109.5 20.88 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 56.4 mt -101.95 122.15 53.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 409' ' ' LYS . 18.3 m -108.42 141.08 40.8 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 64.84 58.32 0.97 Allowed 'General case' 0 C--O 1.254 1.303 0 C-N-CA 124.427 1.091 . . . . 0.0 111.782 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . 0.479 ' SG ' HG23 ' A' ' 381' ' ' ILE . 85.2 m -66.06 131.47 46.28 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.497 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 5.5 m -126.0 177.62 6.24 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 98.8 mt -67.3 -30.7 70.63 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 118.19 0.45 . . . . 0.0 111.633 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.98 -9.11 59.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.759 0.79 . . . . 0.0 110.298 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 427' ' ' SER . 18.7 t70 -97.23 -13.94 21.72 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -71.24 114.52 9.39 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.123 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -156.34 172.97 17.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.776 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.67 126.78 33.67 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -106.91 145.27 32.41 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 120.995 0.426 . . . . 0.0 110.864 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.13 143.44 24.15 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.551 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.517 ' SG ' HD13 ' A' ' 369' ' ' LEU . 59.0 m -98.26 131.87 44.23 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 56.7 t -116.04 107.98 24.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.284 0.564 . . . . 0.0 111.771 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 58.6 t -116.91 160.82 16.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 170.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -68.27 109.56 2.97 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 117.21 -2.424 . . . . 0.0 111.891 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 99.97 -36.21 4.26 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 125.861 1.696 . . . . 0.0 108.966 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 438' ' ' VAL . 6.4 mp0 -90.25 96.18 10.55 Favored 'General case' 0 N--CA 1.395 -3.196 0 C-N-CA 124.887 1.275 . . . . 0.0 112.341 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 37.9 ttmt -121.59 118.04 28.24 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 51.6 t -115.31 133.69 55.8 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 10.8 p -112.22 147.59 35.89 Favored 'General case' 0 N--CA 1.432 -1.33 0 O-C-N 123.565 0.541 . . . . 0.0 111.143 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.5 t -144.88 151.25 38.42 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -112.24 117.68 33.19 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 118.805 -1.158 . . . . 0.0 109.624 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 58.4 tp -88.0 136.54 32.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -118.52 113.5 21.39 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.13 117.26 33.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -94.06 109.32 21.09 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-O 121.386 0.612 . . . . 0.0 111.309 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.809 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.484 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.52 -3.98 11.49 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.413 2.076 . . . . 0.0 112.068 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 153.62 -163.02 30.62 Favored Glycine 0 N--CA 1.417 -2.578 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 4.4 p -81.83 -11.17 59.08 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.964 0.888 . . . . 0.0 111.053 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -132.98 151.28 52.08 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -100.11 19.49 16.29 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-O 121.601 0.715 . . . . 0.0 111.149 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.46 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 5.3 p -54.57 -39.43 45.91 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.495 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -52.26 -57.26 10.25 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 124.202 1.001 . . . . 0.0 111.334 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.24 -35.43 68.83 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.765 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.44 -52.79 53.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.015 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.19 -34.81 73.4 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.005 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -58.89 -40.86 85.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.694 0.398 . . . . 0.0 110.986 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -93.54 2.02 56.55 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.437 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -88.89 158.2 47.75 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.362 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.93 161.63 40.9 Favored 'Trans proline' 0 CA--C 1.555 1.555 0 C-N-CA 122.539 2.159 . . . . 0.0 111.194 173.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.604 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 10.9 Cg_endo -55.35 -35.8 92.43 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.68 2.92 . . . . 0.0 114.861 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 14.8 m -72.72 -8.58 56.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.428 0.632 . . . . 0.0 112.412 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 336' ' ' ILE . 12.0 mm-40 -97.31 -22.88 16.4 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.859 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.604 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 23.3 m-30 -55.14 -50.08 70.16 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -174.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.71 -18.99 62.12 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.29 0.567 . . . . 0.0 111.207 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -82.82 -57.36 3.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.423 ' CD1' ' HB3' ' A' ' 332' ' ' GLU . 69.4 mt -58.29 -39.41 73.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.495 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.11 -59.57 4.89 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.472 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.48 -23.48 64.58 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -68.2 -36.74 80.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.07 0.462 . . . . 0.0 110.537 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . 0.46 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 85.7 m-85 -97.12 -17.35 20.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 107.15 20.78 8.46 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.93 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 15.0 t -95.41 129.67 45.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 34.2 p -94.66 -49.72 5.5 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.435 -0.906 . . . . 0.0 112.351 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.11 69.21 3.19 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -171.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 0.0 OUTLIER -74.46 -26.12 59.84 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -68.28 -32.06 71.96 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -70.91 -36.86 65.27 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 27.3 ttt -65.09 -41.83 94.61 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 114.905 -0.647 . . . . 0.0 109.88 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 93.9 mt -68.7 -40.9 79.81 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.129 0.49 . . . . 0.0 110.527 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -53.65 -46.24 70.5 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.43 1.092 . . . . 0.0 110.306 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -83.12 -21.03 33.74 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.507 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 355' ' ' MET . 51.6 tp -65.97 -25.98 67.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.554 0.692 . . . . 0.0 111.281 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -72.34 -20.09 61.53 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.908 0.861 . . . . 0.0 109.821 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -118.62 27.3 7.28 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.48 ' HB2' ' HA ' ' A' ' 352' ' ' LEU . 46.8 tpp -66.65 -54.31 24.56 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -133.76 -69.2 0.55 Allowed 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.244 -1.344 . . . . 0.0 107.385 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -171.35 105.66 0.23 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 120.825 0.345 . . . . 0.0 111.026 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -123.33 148.48 45.96 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.48 63.65 1.1 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -124.52 15.67 8.87 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 171.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -85.6 173.54 10.09 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 110.984 -2.826 . . . . 0.0 111.321 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 49.7 m 68.3 40.52 2.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -172.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.8 t -86.53 -30.2 22.12 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.082 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -102.34 -19.97 14.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.7 0.762 . . . . 0.0 109.712 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -100.14 137.02 39.15 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.318 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -99.26 -16.37 18.53 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.4 OUTLIER -162.74 115.96 1.66 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 178.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 15.0 mtpp -88.51 169.41 11.77 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.22 140.37 58.86 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -60.18 147.88 79.94 Favored Pre-proline 0 C--N 1.318 -0.788 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -43.96 -47.49 10.09 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.616 2.877 . . . . 0.0 114.15 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -151.14 142.69 23.56 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.121 0.486 . . . . 0.0 111.435 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -122.14 156.59 33.33 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -142.28 134.06 27.0 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.64 156.91 20.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 15.1 m -79.76 157.23 27.16 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 2.0 tmmm? -77.34 135.56 38.38 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . 0.563 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 86.82 5.65 80.89 Favored Glycine 0 CA--C 1.494 -1.247 0 CA-C-O 121.372 0.429 . . . . 0.0 112.097 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -99.14 -170.67 1.95 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -114.84 139.36 49.81 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.1 tp -121.88 128.74 75.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -102.37 103.58 14.01 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.78 0.8 . . . . 0.0 112.319 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 65.4 mt -91.2 114.95 27.61 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.1 m -123.56 130.59 52.9 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.473 -169.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.425 HG12 ' SG ' ' A' ' 436' ' ' CYS . 14.7 m -127.96 154.09 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.054 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -120.88 142.43 49.68 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 49.6 mt -98.62 142.27 30.41 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.47 -35.18 54.02 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -125.07 142.57 51.41 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -74.48 -16.98 60.83 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.429 0.633 . . . . 0.0 110.775 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.37 11.78 22.65 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.948 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -104.2 88.76 3.07 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -78.35 147.99 33.94 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 11.8 p -106.62 157.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.761 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.404 ' HA ' ' HE3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER -125.79 150.72 47.56 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 175.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.422 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 3.2 m-90 -121.94 123.85 42.66 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.7 mp -129.81 144.71 51.44 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 118.438 0.563 . . . . 0.0 110.689 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -123.21 121.04 34.93 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.9 p30 49.73 17.03 0.23 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.531 1.532 . . . . 0.0 114.183 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.08 -4.35 23.9 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.624 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -108.28 123.0 48.12 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 35.7 tt0 -61.45 122.63 15.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.927 0.394 . . . . 0.0 110.908 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 42.7 mt -73.78 114.6 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.972 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -99.03 147.36 25.1 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 171.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' MET . . . . . 0.464 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 0.0 OUTLIER -77.28 126.14 30.45 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.255 -176.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 15.0 m -109.68 88.57 2.78 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.22 -109.76 2.66 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.0 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 45.2 t -109.78 4.02 21.36 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 122.808 -0.231 . . . . 0.0 110.809 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . 0.501 ' HZ2' ' CG ' ' A' ' 430' ' ' ASP . 12.2 tmtt? -79.45 -34.28 41.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . 0.464 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 91.2 m-85 -126.63 117.35 22.59 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 52.8 mt -118.3 113.8 43.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.428 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.494 ' CD1' HD11 ' A' ' 421' ' ' LEU . 23.6 m-85 -87.97 109.48 19.84 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -108.05 106.31 16.47 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 50.5 m -92.28 106.28 18.31 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.84 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 58.3 mt -113.71 92.82 2.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.33 -110.45 3.42 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.572 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.68 -2.23 35.94 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.007 0.432 . . . . 0.0 110.562 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -101.85 133.85 45.97 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.512 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -111.18 110.47 21.0 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 17.4 m -108.59 118.14 36.01 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.554 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.494 HD11 ' CD1' ' A' ' 412' ' ' PHE . 22.6 tp -98.25 107.96 20.54 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 39.2 m -93.61 100.38 12.64 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.439 HG22 ' HZ3' ' A' ' 409' ' ' LYS . 49.9 mt -83.97 115.66 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 14.9 m -100.33 134.81 42.73 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 69.19 54.15 0.44 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.541 1.136 . . . . 0.0 111.002 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 1.9 p -62.38 123.94 19.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.222 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 9.2 m -114.27 169.53 8.96 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.33 -37.92 77.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.168 0.509 . . . . 0.0 111.815 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -84.29 1.24 45.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.751 0.786 . . . . 0.0 110.223 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . 0.501 ' CG ' ' HZ2' ' A' ' 409' ' ' LYS . 28.4 t70 -106.34 -17.59 14.24 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.824 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.5 125.33 17.64 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.849 174.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.47 169.11 23.68 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.994 0.426 . . . . 0.0 111.191 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -86.39 133.64 33.77 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 170.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -114.7 137.87 51.39 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.04 140.33 52.09 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.722 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 20.8 p -115.84 113.98 24.1 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 173.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.47 118.46 58.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.028 0.442 . . . . 0.0 111.863 -174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 97.0 t -114.17 161.69 12.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.24 113.06 5.52 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.831 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 100.67 -35.41 4.86 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.085 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -128.26 135.98 50.39 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 120.693 0.282 . . . . 0.0 110.889 -173.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -141.94 177.64 8.06 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.722 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 53.1 t -160.27 142.33 12.89 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 3.8 p -121.15 131.27 54.15 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 123.69 0.619 . . . . 0.0 110.197 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 14.9 t -121.61 150.71 41.3 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.72 111.12 18.7 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.21 0.529 . . . . 0.0 110.212 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 61.0 tp -90.62 140.77 29.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.596 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -115.18 108.38 16.53 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 42.3 t -90.4 109.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 376' ' ' SER . 37.8 ttpt -111.82 127.19 55.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.367 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.048 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.69 -35.21 95.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.95 2.433 . . . . 0.0 112.527 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -91.15 119.37 5.65 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.782 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 19.2 m -88.25 80.03 7.66 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.385 0.612 . . . . 0.0 110.104 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -120.35 19.56 12.07 Favored 'General case' 0 C--O 1.208 -1.114 0 CA-C-O 121.269 0.557 . . . . 0.0 110.715 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.56 9.74 8.77 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.631 0.729 . . . . 0.0 110.229 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.415 HG12 HG23 ' A' ' 342' ' ' VAL . 6.5 p -50.84 -37.23 16.04 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.587 0 C-N-CA 125.721 1.608 . . . . 0.0 113.608 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -61.79 -56.68 16.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.663 0.744 . . . . 0.0 110.732 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 13.2 pt-20 -71.96 -21.61 61.56 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.017 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.5 mt -74.29 -46.36 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.387 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.97 -40.2 84.06 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 122.905 0.482 . . . . 0.0 110.325 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . 0.417 ' NH2' ' HG ' ' A' ' 352' ' ' LEU . 20.1 tpp180 -55.54 -36.83 67.19 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.194 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 20.9 pt20 -100.79 5.76 43.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.163 0.506 . . . . 0.0 111.511 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -106.62 152.83 40.86 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.587 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -62.65 138.51 70.17 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.416 2.077 . . . . 0.0 111.886 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 30.5 Cg_endo -64.7 -22.38 64.26 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.484 2.789 . . . . 0.0 112.468 -174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 2.8 p -74.59 -14.22 60.75 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.165 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -111.49 4.49 18.87 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.355 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.424 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 14.2 m-30 -49.12 -41.12 34.99 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.9 -54.21 49.17 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.511 0.507 . . . . 0.0 111.584 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -61.1 -44.97 96.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.845 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 38.6 mt -68.35 -42.49 84.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.264 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.84 -54.32 46.55 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.593 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -61.84 -32.28 72.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -61.01 -39.86 91.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.828 0.347 . . . . 0.0 110.495 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -91.75 1.35 57.22 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 86.81 23.46 42.04 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.646 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.415 HG23 HG12 ' A' ' 321' ' ' VAL . 19.0 t -107.3 134.35 49.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.8 p -110.78 -15.35 13.83 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-O 120.981 0.42 . . . . 0.0 110.651 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -95.35 45.68 1.1 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.852 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -29.21 68.13 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.449 0.642 . . . . 0.0 110.924 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -65.03 -27.47 68.83 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.27 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -69.42 -30.58 71.22 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 114.416 -1.266 . . . . 0.0 111.9 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 25.5 ttt -62.78 -43.8 97.84 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.926 0.393 . . . . 0.0 110.707 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.19 -38.94 72.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.335 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -58.3 -58.46 8.39 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.067 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 355' ' ' MET . 17.4 ptp180 -58.41 -35.54 72.21 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.417 ' HG ' ' NH2' ' A' ' 326' ' ' ARG . 4.2 mm? -71.02 -21.16 62.31 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -80.36 -34.05 36.8 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -70.3 -29.82 69.88 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.841 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 351' ' ' ARG . 25.1 ptp -128.39 93.09 3.56 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.509 0.671 . . . . 0.0 110.142 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -73.73 74.08 1.55 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -70.86 135.85 48.3 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 73.83 -55.37 0.67 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.582 1.153 . . . . 0.0 111.184 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -59.19 -22.21 60.66 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 125.941 1.696 . . . . 0.0 112.347 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.491 ' HD3' ' N ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -60.48 -26.6 66.92 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 178.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.491 ' N ' ' HD3' ' A' ' 360' ' ' LYS . 14.5 tppt? -113.87 30.67 7.08 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 123.204 1.478 . . . . 0.0 107.956 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 5.2 m -144.43 43.46 1.4 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 6.2 t -94.37 -27.3 16.14 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.228 -175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.405 ' HB2' ' HG3' ' A' ' 441' ' ' GLU . . . -103.98 0.35 29.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 122.0 0.905 . . . . 0.0 109.598 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.81 137.76 50.66 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.415 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -103.21 -19.4 14.51 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.827 0.346 . . . . 0.0 110.104 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -156.46 125.54 6.04 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.421 ' HE2' ' SG ' ' A' ' 443' ' ' CYS . 60.6 mtpt -112.16 172.32 6.98 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 96.0 mt -72.6 117.81 14.74 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -63.65 142.17 97.98 Favored Pre-proline 0 C--N 1.314 -0.953 0 O-C-N 124.033 0.833 . . . . 0.0 108.882 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -47.72 -35.3 23.17 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 123.326 2.684 . . . . 0.0 113.129 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -127.46 128.0 45.0 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.491 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 44.9 m-85 -128.81 147.38 50.79 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -134.09 145.14 49.07 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.75 159.06 4.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 13.9 m -89.16 156.48 18.77 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -67.19 123.36 20.09 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.43 5.09 67.52 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -101.69 164.95 11.48 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.331 -0.434 . . . . 0.0 110.378 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -102.36 136.85 41.44 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.504 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.569 HG21 ' SG ' ' A' ' 426' ' ' CYS . 14.9 tt -136.35 154.69 33.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.421 ' CB ' ' HA ' ' A' ' 422' ' ' THR . 18.4 ptt180 -134.76 126.09 28.24 Favored 'General case' 0 N--CA 1.413 -2.316 0 C-N-CA 119.175 -1.01 . . . . 0.0 112.031 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.9 109.79 13.51 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 113.892 -1.504 . . . . 0.0 109.0 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' THR . . . . . 0.451 ' CG2' ' HD2' ' A' ' 418' ' ' LYS . 23.5 m -105.46 124.27 49.27 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.869 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.49 158.44 42.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -130.51 132.76 45.79 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 79.6 mt -96.61 159.79 14.74 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.49 -41.35 76.23 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -101.37 147.27 26.52 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.284 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.46 ' CD2' ' HB1' ' A' ' 417' ' ' ALA . 11.1 m170 -80.84 -24.28 38.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.27 25.6 1.16 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.448 1.499 . . . . 0.0 110.819 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -131.84 153.99 49.61 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -175.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -124.64 172.15 9.48 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 123.226 0.329 . . . . 0.0 110.629 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.38 144.25 37.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.081 0.467 . . . . 0.0 110.61 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.498 ' HZ1' ' CD ' ' A' ' 402' ' ' GLU . 24.4 mmmt -103.27 129.4 50.25 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.798 175.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.507 ' HA ' ' O ' ' A' ' 435' ' ' GLN . 34.4 m95 -110.28 128.27 55.44 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.955 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.4 139.73 50.94 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -109.2 125.56 52.36 Favored 'General case' 0 N--CA 1.407 -2.61 0 C-N-CA 118.224 -1.39 . . . . 0.0 108.906 171.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 27.3 p30 50.89 21.68 1.01 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 126.628 1.971 . . . . 0.0 114.296 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.67 12.35 56.99 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.52 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -96.14 -91.58 0.23 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.498 ' CD ' ' HZ1' ' A' ' 395' ' ' LYS . 3.4 tp10 176.02 139.85 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 396' ' ' TRP . 9.4 mt -111.51 106.15 20.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -115.2 146.46 41.39 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 51.8 ttm -55.93 104.83 0.15 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.431 0.634 . . . . 0.0 111.195 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.0 t -117.3 110.14 17.71 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 51.42 -117.34 5.6 Favored Glycine 0 C--N 1.33 0.211 0 O-C-N 124.147 0.904 . . . . 0.0 113.35 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.9 p -114.46 8.7 16.58 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.671 0.748 . . . . 0.0 110.44 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -72.74 -40.71 65.85 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.052 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -129.33 113.91 15.56 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 64.2 mt -112.88 116.92 53.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.772 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -86.61 109.55 19.23 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.765 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.03 108.13 19.1 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.6 m -103.16 104.91 15.1 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.135 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.5 mm -123.65 103.91 13.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 66.63 -113.39 5.63 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.46 ' HB1' ' CD2' ' A' ' 390' ' ' HIS . . . -99.51 -12.97 19.69 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.381 0.61 . . . . 0.0 109.601 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . 0.451 ' HD2' ' CG2' ' A' ' 384' ' ' THR . 7.8 ttpm? -86.96 136.35 32.96 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.34 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -122.33 126.44 48.07 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.3 m -127.51 125.63 40.76 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.48 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 403' ' ' ILE . 50.3 tp -100.1 103.93 15.46 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 70.0 m -89.97 116.84 28.32 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.023 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 48.8 mt -107.54 118.63 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.0 m -89.97 144.59 25.79 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 57.19 62.72 2.11 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 123.979 0.912 . . . . 0.0 112.401 174.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . 0.569 ' SG ' HG21 ' A' ' 381' ' ' ILE . 82.8 m -69.56 118.18 12.11 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' SER . . . . . 0.468 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 14.1 m -111.05 171.79 7.26 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.55 -35.12 78.44 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.079 0.466 . . . . 0.0 110.367 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.42 -7.74 56.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.789 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 427' ' ' SER . 29.5 t70 -105.34 -9.32 17.67 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.618 0.723 . . . . 0.0 109.711 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.71 112.28 2.19 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.625 -1.17 . . . . 0.0 107.872 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -153.59 168.2 26.98 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.068 0.461 . . . . 0.0 111.283 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.53 131.5 34.36 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -114.97 132.17 56.67 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 396' ' ' TRP . 0.6 OUTLIER -112.08 136.93 50.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 16.9 p -106.07 106.21 16.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.49 124.03 53.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.246 0.546 . . . . 0.0 111.513 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.91 152.06 36.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -70.08 113.33 4.89 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 118.689 -1.719 . . . . 0.0 110.901 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 109.23 -36.31 4.41 Favored Glycine 0 N--CA 1.418 -2.558 0 C-N-CA 123.306 0.479 . . . . 0.0 111.928 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 364' ' ' ALA . 6.3 mm-40 -130.21 126.32 37.1 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -136.4 146.84 46.89 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.421 ' SG ' ' HE2' ' A' ' 368' ' ' LYS . 8.9 t -144.9 160.24 41.63 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 7.6 p -142.92 133.2 24.63 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.329 0.393 . . . . 0.0 110.583 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 8.6 t -109.36 150.18 28.41 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -111.57 110.68 21.22 Favored 'General case' 0 N--CA 1.406 -2.668 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.45 145.49 31.9 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -119.13 107.6 13.66 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.18 110.41 22.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -102.15 127.81 48.91 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.437 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.412 -2.344 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.539 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.688 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.88 -41.94 57.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.096 2.53 . . . . 0.0 112.074 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.04 53.28 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.447 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 36.8 p -100.65 -178.36 3.76 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 321' ' ' VAL . 3.7 mp0 -103.7 -73.61 0.66 Allowed 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 67.69 -14.2 0.22 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 125.917 1.687 . . . . 0.0 112.589 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 319' ' ' GLU . 14.2 p -55.52 -28.22 22.39 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.651 0 C-N-CA 124.942 1.297 . . . . 0.0 111.911 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -57.32 -56.56 20.23 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 123.093 0.557 . . . . 0.0 110.614 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.42 -32.77 58.69 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.366 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.2 mt -71.46 -45.57 67.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.938 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 9.6 tt -73.28 -29.41 62.71 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -61.78 -42.72 99.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.445 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -89.16 -0.59 57.57 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.984 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -94.58 154.87 40.02 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.815 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.93 141.47 44.65 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.031 1.821 . . . . 0.0 111.279 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.85 -20.76 53.8 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.815 3.01 . . . . 0.0 114.049 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 5.6 m -66.71 -27.96 68.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -110.57 11.84 22.86 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -52.94 -37.73 61.23 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.81 -47.43 80.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.608 0.242 . . . . 0.0 110.99 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -62.61 -42.59 99.67 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.543 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.63 -44.99 99.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.158 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.89 -54.01 51.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.13 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -69.19 -23.11 63.87 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -69.79 -44.4 70.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.221 0.534 . . . . 0.0 109.987 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -88.47 1.23 55.22 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 72.49 35.64 59.5 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.151 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 8.2 t -103.56 111.53 33.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.1 p -84.01 -20.66 32.4 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-O 122.341 1.067 . . . . 0.0 110.15 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.46 44.18 1.19 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.149 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 33.6 tp -73.59 -37.1 65.56 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 172.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -54.93 -46.03 74.87 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 112.485 -2.143 . . . . 0.0 111.029 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -77.2 -32.63 47.6 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.577 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 352' ' ' LEU . 14.6 tpt -62.6 -44.15 97.04 Favored 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 122.252 0.221 . . . . 0.0 110.977 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 85.0 mt -69.24 -39.47 78.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.379 0.609 . . . . 0.0 110.221 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.56 -50.33 74.19 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.778 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -77.0 -22.39 53.18 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.234 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 348' ' ' MET . 1.4 tm? -62.22 -38.21 88.28 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -75.51 -44.11 45.45 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.643 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -90.89 29.66 6.75 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.405 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 54.8 tpp -77.47 23.59 0.21 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.122 0.969 . . . . 0.0 113.013 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -80.65 -12.46 59.49 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 120.73 -1.231 . . . . 0.0 110.503 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.34 165.65 30.42 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -135.54 168.22 19.64 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -80.59 -12.2 59.54 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.546 0.689 . . . . 0.0 109.309 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -98.39 92.83 5.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.98 146.91 28.03 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 57.6 p 56.77 57.75 4.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.099 1.428 . . . . 0.0 109.45 -171.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.6 t -119.01 -21.95 7.47 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.243 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.409 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -100.31 -33.29 10.46 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -89.08 123.15 33.1 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.512 173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -87.44 -25.18 23.89 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -164.29 118.79 1.45 Allowed 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.467 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 51.3 mtmt -91.26 170.59 9.87 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 123.403 0.439 . . . . 0.0 110.452 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.521 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 76.1 mt -60.12 143.81 51.34 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 123.896 0.748 . . . . 0.0 111.582 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.511 ' HB2' ' CE1' ' A' ' 373' ' ' TYR . 35.7 mm-40 -64.75 149.1 96.5 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.856 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.04 -52.37 9.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.858 2.372 . . . . 0.0 112.812 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -142.23 144.43 33.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.012 0.434 . . . . 0.0 111.666 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 370' ' ' GLU . 56.3 m-85 -123.76 163.23 21.58 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -134.06 142.84 47.72 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.5 p -144.82 157.68 14.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 48.8 m -97.23 150.28 21.09 Favored 'General case' 0 N--CA 1.412 -2.332 0 C-N-CA 120.414 -0.515 . . . . 0.0 109.688 174.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.06 128.79 37.83 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.264 0.626 . . . . 0.0 111.207 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 83.81 15.66 69.82 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.659 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -118.31 176.3 5.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.3 mtpt -102.83 146.13 28.73 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.18 0.3 . . . . 0.0 110.392 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.496 HG23 ' SG ' ' A' ' 426' ' ' CYS . 10.7 tp -135.65 156.62 38.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 30.5 ptt180 -142.64 124.43 15.09 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.587 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -94.71 126.2 39.86 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.391 -1.277 . . . . 0.0 107.924 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 68.0 m -108.63 138.91 44.18 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 11.8 m -141.43 159.67 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 C-N-CA 124.111 0.964 . . . . 0.0 108.93 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 85.9 mt-10 -130.04 136.92 49.91 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.33 148.74 23.85 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -84.47 10.03 11.9 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.456 0.646 . . . . 0.0 110.422 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -157.58 135.97 11.17 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -67.12 -24.25 65.91 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.145 0.497 . . . . 0.0 111.664 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -107.05 26.27 10.34 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.18 0.99 . . . . 0.0 110.915 -173.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -98.61 122.27 41.61 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -93.16 137.56 32.38 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 19.4 m -106.29 154.22 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.97 174.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -123.6 157.42 33.78 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.49 ' O ' HD12 ' A' ' 397' ' ' LEU . 4.4 m-90 -118.95 126.05 50.85 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 123.338 0.399 . . . . 0.0 109.969 -168.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 396' ' ' TRP . 6.5 mp -135.89 144.26 45.46 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -123.57 121.96 36.94 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 27.9 p30 46.71 22.31 0.18 Allowed 'General case' 0 N--CA 1.504 2.272 0 C-N-CA 125.614 1.566 . . . . 0.0 114.891 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 107.69 -0.21 34.33 Favored Glycine 0 C--O 1.224 -0.517 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.998 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -111.17 129.96 55.78 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -65.71 122.31 16.99 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.2 0.524 . . . . 0.0 111.035 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.415 ' HB ' ' CB ' ' A' ' 396' ' ' TRP . 57.7 mt -80.15 123.51 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -128.21 154.21 46.07 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 66.7 mtm -70.55 93.6 0.92 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.11 0.481 . . . . 0.0 111.507 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 39.8 m -92.79 100.53 12.99 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 71.77 -129.25 15.9 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.8 m -112.68 14.88 20.08 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -65.77 -42.81 90.41 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -123.9 127.73 48.43 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 50.5 mm -118.0 117.35 54.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -86.79 108.12 18.58 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.302 0.572 . . . . 0.0 109.546 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -97.45 123.85 41.44 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.842 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 35.7 t -118.8 111.98 19.13 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 70.1 mt -124.76 84.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.716 0.769 . . . . 0.0 109.247 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.12 -109.89 2.99 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.17 -20.28 16.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.904 0.383 . . . . 0.0 110.182 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 386' ' ' GLU . 22.0 ptmt -88.36 133.1 34.18 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.782 0.801 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.29 139.45 53.78 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 74.1 m -134.26 130.36 36.99 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-O 121.148 0.499 . . . . 0.0 110.884 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 382' ' ' ARG . 37.8 tp -95.64 109.39 21.66 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.0 m -97.53 118.87 35.01 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.51 124.68 55.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' SER . . . . . 0.448 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 7.1 m -101.71 132.28 47.51 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 63.91 70.27 0.52 Allowed 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 124.235 0.959 . . . . 0.0 110.919 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . 0.496 ' SG ' HG23 ' A' ' 381' ' ' ILE . 73.5 m -68.23 123.74 21.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.67 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 45.3 t -106.23 155.23 19.69 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.46 -27.13 69.07 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.129 0.572 . . . . 0.0 110.475 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -87.22 1.08 54.24 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.264 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -114.15 1.98 14.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.32 111.75 3.16 Favored 'General case' 0 C--O 1.255 1.362 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.789 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -161.71 171.4 17.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.576 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -87.68 130.89 34.65 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -111.26 138.66 47.45 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.52 141.6 50.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.402 ' SG ' HD13 ' A' ' 369' ' ' LEU . 73.7 m -109.13 111.38 22.97 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 168.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.93 119.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.281 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.85 159.82 10.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 169.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.15 113.93 6.34 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 119.269 -1.443 . . . . 0.0 111.52 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 89.04 -24.27 14.0 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 121.081 0.267 . . . . 0.0 112.824 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.409 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 4.9 mm-40 -118.29 109.89 16.86 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.479 0.712 . . . . 0.0 109.107 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -136.26 149.55 48.54 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 34.2 t -148.2 139.53 23.47 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 9.3 m -112.31 151.07 30.14 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.6 t -129.15 144.64 51.28 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -110.63 109.81 20.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 121.752 0.787 . . . . 0.0 109.108 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -93.72 129.52 40.03 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.993 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -107.82 115.4 30.07 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.377 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 38.2 t -90.08 125.58 42.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 376' ' ' SER . 12.0 pttp -116.11 146.83 41.92 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--N 1.259 -3.327 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 174.844 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.732 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.32 -37.01 42.47 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.692 2.261 . . . . 0.0 111.264 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -62.88 98.03 0.2 Allowed Glycine 0 N--CA 1.434 -1.495 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.889 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 7.4 m -119.78 22.15 11.69 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.48 10.13 4.39 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.632 ' HA ' ' NE1' ' A' ' 322' ' ' TRP . 1.1 m-20 -78.77 46.21 0.65 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 112.644 -2.071 . . . . 0.0 112.424 -175.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.418 ' HB ' ' CB ' ' A' ' 340' ' ' TYR . 7.4 p -56.25 -38.65 55.65 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.192 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.802 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . 0.632 ' NE1' ' HA ' ' A' ' 320' ' ' ASP . 0.0 OUTLIER -45.79 -52.04 11.79 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 320' ' ' ASP . 8.4 pt-20 -85.48 -38.42 18.63 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.422 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 87.1 mt -65.46 -40.45 88.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.632 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.2 tt -75.76 -33.06 60.19 Favored 'General case' 0 C--O 1.202 -1.429 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -69.06 -36.47 77.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -85.39 -7.55 58.89 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.173 0.511 . . . . 0.0 111.329 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -84.52 161.39 54.09 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.316 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.14 135.48 51.08 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.922 2.415 . . . . 0.0 111.469 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.53 -34.61 90.32 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 124.048 3.165 . . . . 0.0 115.568 -171.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 19.5 t -83.7 -1.9 55.06 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.682 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -102.82 -4.24 25.19 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.869 0.366 . . . . 0.0 110.07 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -52.38 -42.07 63.68 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -64.5 -38.59 91.56 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.468 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -66.37 -46.3 77.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 109.485 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.06 -37.61 73.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.288 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.75 -62.45 1.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.582 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -62.19 -32.96 73.67 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -59.72 -41.2 90.32 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.806 0.842 . . . . 0.0 111.564 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . 0.418 ' CB ' ' HB ' ' A' ' 321' ' ' VAL . 95.6 m-85 -97.25 10.71 38.78 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.177 0.513 . . . . 0.0 111.962 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 86.72 15.93 62.57 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.577 174.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 4.2 t -94.12 105.57 17.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.3 p -84.23 -14.95 48.59 Favored 'General case' 0 C--N 1.267 -2.98 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -133.27 95.46 3.53 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 1.5 pt? -76.31 -21.71 55.88 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.18 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -54.97 -50.07 69.85 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.562 0.745 . . . . 0.0 110.828 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -79.25 -29.48 49.91 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.413 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -60.79 -47.62 85.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 86.5 mt -63.4 -40.42 97.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.201 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -56.64 -51.13 69.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.375 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -20.94 56.01 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 355' ' ' MET . 30.5 tp -81.85 -31.44 31.61 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -75.4 -37.21 60.62 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -91.2 36.98 3.47 Favored Glycine 0 N--CA 1.417 -2.612 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.112 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 352' ' ' LEU . 43.7 ttm -54.94 -34.39 63.16 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 125.312 1.445 . . . . 0.0 111.5 -176.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -127.18 28.15 5.79 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.696 0.76 . . . . 0.0 110.325 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -104.18 155.84 18.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.651 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -96.25 151.87 19.1 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -76.36 -70.12 0.47 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp 41.18 85.14 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 125.123 1.369 . . . . 0.0 113.185 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -132.42 41.3 3.22 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.345 -174.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 14.9 m 72.11 71.08 0.15 Allowed 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -171.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 61.0 m -85.23 -44.26 13.05 Favored 'General case' 0 N--CA 1.392 -3.334 0 CA-C-N 112.449 -2.16 . . . . 0.0 112.727 -172.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.522 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -93.32 -10.73 34.41 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.036 0.922 . . . . 0.0 109.494 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -100.11 127.65 46.32 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.707 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -95.39 -17.67 21.37 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -165.5 126.12 1.87 Allowed 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.582 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 33.4 mtmm -102.34 -179.49 4.0 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 65.7 mt -74.3 147.12 42.58 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.98 137.61 89.81 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -55.64 -35.81 93.59 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.497 2.132 . . . . 0.0 112.465 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -128.36 134.09 48.78 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.998 0.428 . . . . 0.0 112.025 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -133.12 155.41 49.31 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.989 0.916 . . . . 0.0 109.298 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -134.64 147.67 50.22 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.19 154.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 10.1 t -96.13 150.66 20.26 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.467 ' HD2' ' HG2' ' A' ' 451' ' ' GLU . 83.4 tttt -61.42 120.81 11.2 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 123.169 0.587 . . . . 0.0 110.978 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 97.83 -4.56 61.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.5 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -98.27 175.04 6.21 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.659 0.266 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -104.77 150.45 24.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.994 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.422 HG23 ' SG ' ' A' ' 426' ' ' CYS . 16.2 tt -141.19 136.84 33.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 120.953 0.406 . . . . 0.0 110.126 174.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -107.9 123.68 48.98 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.375 0.607 . . . . 0.0 109.896 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 68.1 mt -101.81 114.18 28.03 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 67.3 m -109.31 127.91 54.67 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 20.3 m -132.39 160.67 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.5 135.19 46.87 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.419 HD12 ' CG1' ' A' ' 394' ' ' VAL . 3.1 mm? -99.57 155.92 17.33 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.23 -7.93 56.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.513 0.673 . . . . 0.0 110.506 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -129.53 140.37 51.26 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -75.52 -24.47 56.78 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -115.3 25.77 10.6 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.624 0.726 . . . . 0.0 111.638 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -97.72 133.39 42.32 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -104.72 160.18 15.18 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.479 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.419 ' CG1' HD12 ' A' ' 387' ' ' LEU . 7.6 m -109.78 154.08 11.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.614 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -105.62 116.89 32.71 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.468 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 1.2 m-90 -92.3 120.2 32.62 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.94 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.4 mp -125.9 140.36 52.7 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 118.466 0.575 . . . . 0.0 110.576 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.29 116.77 27.44 Favored 'General case' 0 N--CA 1.405 -2.699 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.9 p30 52.41 18.16 0.89 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.444 1.497 . . . . 0.0 113.816 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.56 -4.71 23.06 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.303 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -110.22 128.68 55.63 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 35.1 tt0 -62.32 121.34 12.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 0.0 110.078 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 58.4 mt -66.51 124.6 22.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.163 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -108.61 153.0 24.02 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.943 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 50.9 ttm -71.02 105.15 3.21 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 33.6 t -104.39 98.54 8.31 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 57.84 -114.42 5.66 Favored Glycine 0 C--N 1.329 0.173 0 O-C-N 123.485 0.491 . . . . 0.0 112.488 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 23.0 m -114.72 10.81 16.7 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.569 0.699 . . . . 0.0 109.837 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -77.08 -45.34 27.37 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . 0.515 ' O ' ' HG3' ' A' ' 405' ' ' MET . 65.8 m-85 -122.66 109.27 14.05 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.2 119.68 62.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 120.981 0.419 . . . . 0.0 110.909 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.502 ' CE2' HD13 ' A' ' 421' ' ' LEU . 24.6 m-85 -87.24 108.49 18.96 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.99 108.46 21.17 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.9 m -100.37 104.67 16.11 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.7 mt -121.19 83.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 66.93 -119.14 11.4 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.562 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -79.75 -23.67 42.08 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -74.81 125.27 28.42 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.73 0.776 . . . . 0.0 111.45 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -114.98 111.68 21.51 Favored 'General case' 0 N--CA 1.399 -3.018 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 63.5 m -119.82 120.57 36.89 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.368 0.604 . . . . 0.0 111.498 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.502 HD13 ' CE2' ' A' ' 412' ' ' PHE . 36.2 tp -91.81 115.6 28.19 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 45.4 m -98.2 110.34 22.94 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.3 mt -97.54 123.65 50.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 33.9 m -104.33 136.7 43.43 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 59.38 64.78 1.28 Allowed 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 124.673 1.233 . . . . 0.0 111.49 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . 0.422 ' SG ' HG23 ' A' ' 381' ' ' ILE . 58.6 m -67.33 134.75 52.14 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.941 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 20.1 m -125.57 -177.96 4.08 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 84.6 mt -79.79 -21.91 43.75 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.918 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.43 73.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.443 0.639 . . . . 0.0 109.774 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.77 -0.37 57.26 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.141 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.69 108.13 1.62 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -149.0 165.07 32.73 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.012 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.87 115.84 23.75 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -104.01 152.09 22.45 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.36 150.72 35.27 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.078 175.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 77.0 m -116.09 118.6 33.33 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 38.6 t -106.31 132.94 52.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 67.4 t -128.15 161.41 36.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -61.45 112.36 4.68 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 118.989 -1.577 . . . . 0.0 111.865 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 96.29 -35.18 4.5 Favored Glycine 0 N--CA 1.421 -2.345 0 CA-C-N 114.768 -0.716 . . . . 0.0 112.82 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 9.8 mm-40 -120.08 132.88 55.6 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.928 0.364 . . . . 0.0 110.388 -174.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -137.81 166.97 22.69 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.0 t -150.51 133.76 16.26 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 6.0 p -108.89 146.98 32.87 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 123.542 0.526 . . . . 0.0 110.378 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 11.3 t -129.66 149.7 51.3 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -116.36 113.28 22.7 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 68.4 tp -91.85 146.1 24.02 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.303 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -123.31 108.17 12.46 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.04 117.01 32.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -105.79 119.98 40.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.581 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.467 ' HG2' ' HD2' ' A' ' 377' ' ' LYS . 26.4 mt-10 . . . . . 0 C--N 1.328 -0.338 0 O-C-N 123.695 0.622 . . . . 0.0 110.872 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.76 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.34 -34.25 67.39 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.961 2.441 . . . . 0.0 112.499 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 82.84 -88.59 1.48 Allowed Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 38.4 t -157.7 82.52 0.88 Allowed 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 321' ' ' VAL . 44.4 mt-10 -86.07 -63.79 1.26 Allowed 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 56.52 4.9 0.17 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.398 1.479 . . . . 0.0 113.586 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' A' ' 319' ' ' GLU . 12.3 p -60.34 -35.16 60.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 123.761 0.825 . . . . 0.0 111.549 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -47.18 -51.89 17.18 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.983 1.313 . . . . 0.0 110.245 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 9.8 pt-20 -85.36 -48.49 8.99 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.76 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.74 -50.73 78.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 C-N-CA 122.798 0.439 . . . . 0.0 112.063 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 47.3 tp -74.02 -20.97 60.15 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -77.68 -42.99 32.65 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.22 0.533 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 4.1 pt20 -88.35 -20.96 24.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.139 -175.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -70.66 146.45 93.65 Favored Pre-proline 0 C--N 1.31 -1.129 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.46 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.78 155.1 61.61 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.017 1.812 . . . . 0.0 110.625 175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.48 -22.05 20.35 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.255 3.304 . . . . 0.0 113.989 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 6.4 m -72.71 -21.62 61.01 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.202 0.525 . . . . 0.0 111.527 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 336' ' ' ILE . 7.7 mm-40 -88.82 -20.89 24.1 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.928 -177.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -51.44 -53.47 36.64 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -173.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -56.07 -33.01 64.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -80.66 -59.82 2.54 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.773 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 332' ' ' GLU . 79.8 mt -55.58 -49.63 72.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.124 -174.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 345' ' ' LEU . . . -58.97 -57.65 12.15 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.426 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -67.8 -26.63 66.18 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -66.33 -40.37 89.86 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -94.03 -7.95 41.24 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 98.71 16.42 31.34 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.635 -1.269 . . . . 0.0 112.958 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 10.5 t -94.05 97.27 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 5.2 m -72.35 -39.4 68.14 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.941 -172.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.572 ' OD1' ' HA3' ' A' ' 347' ' ' GLY . 13.7 p-10 -101.54 88.89 3.55 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.537 1.161 . . . . 0.0 110.725 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.478 HD13 ' N ' ' A' ' 346' ' ' ARG . 4.5 pp -71.36 -35.09 71.0 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.462 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . 0.478 ' N ' HD13 ' A' ' 345' ' ' LEU . 22.5 ttm180 -77.14 -16.84 58.99 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.572 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -64.15 -21.27 65.86 Favored Glycine 0 N--CA 1.42 -2.397 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.565 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' MET . . . . . 0.503 ' O ' HD22 ' A' ' 352' ' ' LEU . 40.6 ttm -60.09 -45.22 93.66 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.55 -36.48 73.68 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -57.12 -56.92 15.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.265 1.026 . . . . 0.0 110.704 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -56.6 -33.02 65.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.471 0.708 . . . . 0.0 112.456 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.503 HD22 ' O ' ' A' ' 348' ' ' MET . 4.5 mm? -81.64 -32.41 31.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.28 0.562 . . . . 0.0 111.083 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -66.49 -39.81 88.93 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.0 0.24 39.22 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.518 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 26.2 mmt -75.7 -57.28 3.98 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.93 0.365 . . . . 0.0 110.28 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -170.54 35.24 0.02 OUTLIER 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -66.46 -43.26 85.99 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.941 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -154.87 170.4 21.75 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -117.81 -83.97 0.64 Allowed 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 118.21 0.459 . . . . 0.0 110.087 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 53.34 -161.27 0.12 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.123 0.89 . . . . 0.0 110.063 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt 67.43 -74.16 0.07 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.016 0.927 . . . . 0.0 112.945 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.52 ' HA ' ' OE1' ' A' ' 441' ' ' GLU . 45.0 p 171.4 91.1 0.0 OUTLIER 'General case' 0 C--O 1.248 0.986 0 C-N-CA 126.15 1.78 . . . . 0.0 106.928 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 75.2 p -120.79 -57.19 1.9 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.973 0.416 . . . . 0.0 110.072 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.458 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -83.2 -24.34 32.46 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.544 ' CD2' ' HB3' ' A' ' 441' ' ' GLU . 7.2 m-85 -94.23 132.94 38.27 Favored 'General case' 0 N--CA 1.406 -2.659 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.557 175.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -98.01 -17.09 19.35 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -161.54 119.44 2.31 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -99.33 159.58 14.9 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.459 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 79.6 mt -61.7 133.61 55.78 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 123.363 0.415 . . . . 0.0 111.367 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.41 137.67 68.77 Favored Pre-proline 0 C--O 1.215 -0.743 0 O-C-N 124.584 1.178 . . . . 0.0 108.341 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.93 -27.24 52.95 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.71 2.273 . . . . 0.0 113.424 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -134.65 138.97 44.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.41 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 36.0 m-85 -136.93 143.88 43.15 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -128.94 142.12 51.04 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.46 155.82 20.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 16.2 m -88.06 151.89 22.42 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -72.76 116.49 13.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.282 0.563 . . . . 0.0 110.096 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.29 43.76 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -116.9 156.12 27.91 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.329 -0.936 . . . . 0.0 109.637 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -92.49 141.51 28.43 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.694 0.798 . . . . 0.0 112.121 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.573 HG22 ' SG ' ' A' ' 426' ' ' CYS . 15.6 tt -139.05 146.93 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -123.87 128.95 50.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.218 1.009 . . . . 0.0 112.084 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 420' ' ' THR . 17.8 mt -99.82 125.89 45.82 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.19 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 31.9 m -116.66 130.08 56.53 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.71 160.15 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -129.89 138.57 51.0 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 88.8 mt -101.6 139.0 37.85 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.114 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -84.6 -25.88 28.31 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -106.48 122.06 45.53 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.307 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 417' ' ' ALA . 22.7 m-70 -80.95 -7.58 59.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.756 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -91.37 11.57 23.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -129.79 158.63 38.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -130.14 164.75 23.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 29.1 m -106.73 134.84 47.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.492 0.663 . . . . 0.0 111.491 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -103.5 129.17 50.62 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.445 ' HB3' HD12 ' A' ' 403' ' ' ILE . 50.1 m95 -103.68 130.03 51.09 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 434' ' ' TYR . 8.2 mp -116.76 139.53 50.47 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.524 ' HG2' HG12 ' A' ' 403' ' ' ILE . 32.8 mmtp -90.81 107.4 19.16 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 11.1 p30 48.66 12.59 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.9 4.07 15.08 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.657 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -89.38 -96.38 0.1 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 122.57 0.348 . . . . 0.0 110.353 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 175.05 139.43 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.524 HG12 ' HG2' ' A' ' 398' ' ' LYS . 47.4 mt -94.48 114.85 31.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 172.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -96.6 139.85 32.08 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 87.8 mtp -71.82 89.8 1.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.746 0.308 . . . . 0.0 110.541 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 50.9 m -79.32 98.39 6.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.81 -119.01 16.4 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.059 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 32.8 t -111.27 16.98 20.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -76.24 -47.94 22.09 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -106.82 108.68 20.31 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.19 113.2 36.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -87.08 107.21 18.34 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.912 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -105.55 107.88 19.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 50.0 m -104.97 110.56 22.99 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.31 79.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.84 -110.9 3.76 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.95 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.42 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . . . -83.47 -27.68 29.3 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.759 0.314 . . . . 0.0 110.414 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 418' ' ' LYS . 10.9 ptmm? -95.32 116.69 29.11 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 122.116 0.96 . . . . 0.0 111.394 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -108.4 139.15 43.54 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.361 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 61.6 m -136.15 130.13 32.8 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-O 121.256 0.551 . . . . 0.0 111.524 -173.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 39.8 tp -103.8 115.85 31.23 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 38.7 m -102.04 115.08 29.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 50.4 mt -100.98 119.95 49.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 2.9 m -90.53 131.96 35.96 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.222 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 58.12 67.32 0.97 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.015 0.926 . . . . 0.0 111.93 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . 0.573 ' SG ' HG22 ' A' ' 381' ' ' ILE . 64.5 m -68.48 115.17 7.58 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 79.6 p -101.44 -176.63 3.2 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.05 -22.25 63.09 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.28 0.562 . . . . 0.0 109.837 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.94 -8.54 58.26 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.376 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -99.26 -3.45 34.14 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.189 -0.319 . . . . 0.0 110.399 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.79 95.54 2.92 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -152.15 166.13 32.64 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.25 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.99 129.43 34.8 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 397' ' ' LEU . 20.3 m-85 -104.67 145.33 30.48 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.568 HE21 ' N ' ' A' ' 435' ' ' GLN . 0.0 OUTLIER -129.14 127.34 41.21 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 7.6 p -96.33 109.15 21.72 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.1 t -105.29 126.12 60.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 121.231 0.539 . . . . 0.0 111.377 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 60.0 t -129.15 161.39 38.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -66.79 113.6 5.77 Favored Glycine 0 C--N 1.315 -0.599 0 C-N-CA 119.082 -1.532 . . . . 0.0 111.104 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 98.6 -26.33 24.37 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.544 ' HB3' ' CD2' ' A' ' 365' ' ' PHE . 3.1 mm-40 -126.48 136.08 52.16 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 18.6 ptpt -147.9 160.67 42.54 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 16.9 t -155.82 134.37 11.73 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 5.5 p -106.47 126.38 52.18 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.336 0.588 . . . . 0.0 110.7 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.7 t -112.57 146.37 38.68 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.98 114.39 27.67 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.293 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.35 121.87 33.46 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.667 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -104.87 118.91 37.72 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.166 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.14 120.55 39.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.444 ' HZ2' ' C ' ' A' ' 451' ' ' GLU . 0.1 OUTLIER -113.7 119.98 39.27 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.444 ' C ' ' HZ2' ' A' ' 450' ' ' LYS . 48.2 mt-10 . . . . . 0 C--N 1.308 -1.229 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.487 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.72 163.82 34.97 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.374 2.049 . . . . 0.0 112.708 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -171.57 141.06 6.17 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 31.7 m -147.01 -25.68 0.4 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.139 0.495 . . . . 0.0 110.559 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 321' ' ' VAL . 28.9 mm-40 -107.43 178.35 4.57 Favored 'General case' 0 CA--C 1.489 -1.377 0 C-N-CA 123.133 0.573 . . . . 0.0 110.757 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 75.81 -26.78 0.19 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.96 1.304 . . . . 0.0 112.051 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.551 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 4.3 p -47.44 -37.15 4.84 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 C-N-CA 125.102 1.361 . . . . 0.0 112.365 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -57.59 -47.17 82.86 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.639 0.776 . . . . 0.0 110.762 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.9 -35.12 20.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.826 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.03 -49.54 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.795 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.32 -34.19 75.67 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.488 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -58.12 -40.37 81.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.281 0.562 . . . . 0.0 110.701 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -93.07 -4.13 52.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.331 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -89.02 153.84 49.38 Favored Pre-proline 0 C--N 1.301 -1.525 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.711 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.19 143.99 98.75 Favored 'Trans proline' 0 CA--C 1.55 1.321 0 C-N-CA 122.946 2.431 . . . . 0.0 112.763 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.522 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 10.7 Cg_endo -54.89 -34.57 86.31 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 124.216 3.277 . . . . 0.0 115.572 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 44.0 m -77.82 -5.56 51.25 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -99.67 -13.33 19.39 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.818 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 18.4 m-30 -47.86 -47.52 31.55 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -174.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.18 -35.64 78.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.8 0.333 . . . . 0.0 111.295 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -71.79 -42.88 66.58 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.818 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 59.1 mt -64.78 -38.66 83.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.464 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.09 51.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.033 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -68.9 -24.63 64.33 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.36 -39.83 94.43 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.007 0.523 . . . . 0.0 109.958 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . 0.551 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 82.5 m-85 -95.59 -4.7 44.1 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.194 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 83.38 26.52 43.11 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.498 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.32 116.96 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 3.0 p -94.52 -5.97 44.82 Favored 'General case' 0 C--N 1.268 -2.94 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.808 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.47 44.42 0.8 Allowed 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.46 0.704 . . . . 0.0 111.314 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 24.4 tp -75.95 -64.82 1.0 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.779 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 350' ' ' LYS . 29.5 mmt180 -66.2 -31.41 72.23 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.492 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -70.67 -39.79 66.62 Favored Glycine 0 N--CA 1.442 -0.926 0 O-C-N 123.547 0.529 . . . . 0.0 112.075 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 26.6 ttt -71.19 -48.5 51.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.89 -31.27 72.11 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.705 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 346' ' ' ARG . 42.7 tttm -52.72 -44.89 66.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.949 0.88 . . . . 0.0 109.132 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 355' ' ' MET . 53.0 mtm180 -72.06 -36.93 69.72 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.824 -1.535 . . . . 0.0 112.472 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.58 -27.36 31.59 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.647 0.737 . . . . 0.0 112.703 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -86.79 -54.36 4.41 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.447 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -97.15 65.66 0.92 Allowed Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.522 ' HB3' ' O ' ' A' ' 351' ' ' ARG . 23.0 ptt? -114.58 7.05 15.98 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.138 -0.531 . . . . 0.0 110.04 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -159.26 -39.4 0.06 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -78.37 85.0 4.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 12.5 t70 179.53 125.87 0.07 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 169.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -95.13 17.71 13.6 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.421 0.629 . . . . 0.0 111.004 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . 0.302 42.4 mtmt 48.84 -104.64 0.13 Allowed 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 174.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.556 ' HG3' ' H ' ' A' ' 362' ' ' SER . 38.2 pttt -177.28 -79.17 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 O-C-N 123.19 0.306 . . . . 0.0 111.046 -175.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.556 ' H ' ' HG3' ' A' ' 361' ' ' LYS . 70.3 m -178.91 76.96 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 128.168 2.587 . . . . 0.0 105.66 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.4 t -130.13 -31.76 1.87 Allowed 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.421 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.451 ' HB2' ' HG3' ' A' ' 441' ' ' GLU . . . -87.65 -27.54 22.4 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -87.13 114.37 23.69 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.66 170.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.44 -17.24 29.11 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.061 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 367' ' ' LYS . 0.0 OUTLIER -164.61 120.53 1.49 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 176.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -97.04 173.3 7.34 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.834 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 91.2 mt -71.07 142.16 50.85 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.876 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -62.04 129.93 92.34 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -43.39 -33.32 4.02 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.86 3.04 . . . . 0.0 114.819 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -146.56 120.66 9.46 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.068 -0.395 . . . . 0.0 111.239 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.563 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 59.0 m-85 -101.35 156.08 17.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -127.91 138.35 52.63 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.972 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.93 152.69 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.53 ' HB2' ' CD2' ' A' ' 379' ' ' HIS . 12.0 m -86.62 146.48 26.31 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 1.4 tmmm? -63.1 125.75 25.07 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.277 0.56 . . . . 0.0 110.006 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . 0.477 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 98.89 -3.56 58.8 Favored Glycine 0 C--N 1.304 -1.206 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.623 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 376' ' ' SER . 27.7 m-70 -95.63 169.37 10.07 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 120.889 0.376 . . . . 0.0 111.935 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -108.1 126.75 53.12 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.517 HG21 ' SG ' ' A' ' 426' ' ' CYS . 14.9 tt -128.6 158.34 40.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 41.9 mtt-85 -125.89 142.7 51.39 Favored 'General case' 0 CA--C 1.491 -1.318 0 CA-C-O 121.663 0.744 . . . . 0.0 110.589 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.31 107.47 18.48 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.8 m -105.31 126.28 51.92 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.272 -174.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 7.6 m -127.91 157.17 40.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 123.855 0.862 . . . . 0.0 109.374 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -120.36 136.61 54.65 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 392' ' ' ALA . 92.0 mt -107.88 141.33 39.65 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.19 71.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.142 0.496 . . . . 0.0 110.355 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -117.98 138.04 52.45 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -63.53 -32.57 74.07 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 123.293 0.637 . . . . 0.0 112.693 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.82 25.78 11.4 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.395 0.617 . . . . 0.0 111.879 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 387' ' ' LEU . . . -91.69 106.53 18.55 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 104.276 -2.491 . . . . 0.0 104.276 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -78.67 143.87 35.88 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.638 -172.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 4.1 m -105.98 148.3 10.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -111.22 130.07 55.76 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.436 ' HB3' HD13 ' A' ' 403' ' ' ILE . 8.2 m-90 -101.21 121.77 42.45 Favored 'General case' 0 C--N 1.26 -3.292 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.911 -173.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 402' ' ' GLU . 6.2 mp -129.19 125.53 37.19 Favored 'General case' 0 CA--C 1.482 -1.671 0 CA-C-N 117.635 0.198 . . . . 0.0 111.4 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -103.94 128.14 51.46 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 47.61 22.76 0.34 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.415 1.486 . . . . 0.0 114.24 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.16 8.05 56.86 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.379 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -92.32 -92.63 0.15 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 397' ' ' LEU . 52.7 tt0 172.69 138.53 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.436 HD13 ' HB3' ' A' ' 396' ' ' TRP . 55.4 mt -92.0 102.29 13.41 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -99.23 126.02 44.95 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.854 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -63.95 95.17 0.11 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 122.119 0.962 . . . . 0.0 112.257 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.8 m -83.67 93.32 7.88 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.946 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 64.22 -128.26 36.22 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.568 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 8.9 p -97.69 5.53 49.19 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 120.921 0.391 . . . . 0.0 111.599 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -71.79 -32.31 67.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.74 0.305 . . . . 0.0 111.636 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -123.44 112.5 17.6 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 39.6 mm -108.87 116.58 52.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.51 ' CE2' HD11 ' A' ' 421' ' ' LEU . 22.8 m-85 -87.03 105.54 17.23 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -106.49 108.56 20.13 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.478 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 27.8 t -90.54 105.38 17.78 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.0 mm -104.04 87.46 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.94 -98.6 0.64 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -120.11 -5.01 10.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.358 0.599 . . . . 0.0 109.443 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -95.23 99.69 11.61 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -92.7 132.14 37.17 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.227 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 22.5 m -125.28 129.81 50.76 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.531 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.51 HD11 ' CE2' ' A' ' 412' ' ' PHE . 22.2 tp -100.82 111.51 23.75 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 58.8 m -94.34 108.78 20.66 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.601 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 56.1 mt -96.92 116.93 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 15.1 m -90.84 136.47 33.05 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.054 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 55.72 68.63 0.84 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.0 1.72 . . . . 0.0 111.117 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . 0.517 ' SG ' HG21 ' A' ' 381' ' ' ILE . 61.7 m -68.87 113.2 6.08 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 11.0 m -103.65 -170.75 1.83 Allowed 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 89.9 mt -71.12 -23.88 62.18 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.269 0.557 . . . . 0.0 110.513 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -76.08 -15.04 60.18 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.235 0.541 . . . . 0.0 110.1 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -97.6 7.84 45.73 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.764 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.63 100.23 11.31 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -157.02 172.33 18.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.201 0.524 . . . . 0.0 111.609 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -90.51 118.08 29.7 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -107.39 131.81 53.85 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.839 -0.538 . . . . 0.0 110.252 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.483 ' HG3' ' OG ' ' A' ' 444' ' ' SER . 2.0 mp0 -122.95 146.71 47.36 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 123.345 0.658 . . . . 0.0 110.388 -175.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 78.8 m -123.28 113.26 18.64 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.14 133.94 53.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.951 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 49.2 t -125.56 161.85 29.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -57.56 112.73 3.94 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 118.955 -1.593 . . . . 0.0 111.577 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 85.36 -35.28 3.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.553 0.597 . . . . 0.0 112.714 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 364' ' ' ALA . 7.9 mm-40 -99.53 126.24 45.44 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 123.601 0.761 . . . . 0.0 110.938 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -142.22 163.67 32.22 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.754 0.312 . . . . 0.0 111.401 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 25.6 p -160.34 150.04 17.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' SER . . . . . 0.483 ' OG ' ' HG3' ' A' ' 435' ' ' GLN . 3.4 m -137.08 146.72 45.49 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.563 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 9.0 t -129.94 132.2 46.25 Favored 'General case' 0 N--CA 1.399 -2.978 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.677 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.81 110.58 21.49 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 60.5 tp -84.72 119.59 25.44 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -95.79 108.21 20.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 64.0 t -94.79 109.13 21.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -100.17 117.49 34.52 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.216 0.531 . . . . 0.0 111.082 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.288 -2.071 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.539 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.645 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.475 ' CB ' ' HA ' ' A' ' 320' ' ' ASP . 34.1 Cg_exo -67.64 -175.81 0.8 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.911 2.407 . . . . 0.0 112.467 176.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -125.02 69.82 0.48 Allowed Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.016 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 17.4 m 77.23 -12.31 1.08 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.234 1.414 . . . . 0.0 113.719 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.8 -48.16 5.86 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 316' ' ' PRO . 2.0 m-20 65.92 11.93 8.04 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 171.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.73 -32.6 31.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 C-N-CA 123.156 0.582 . . . . 0.0 112.444 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -59.32 -46.18 89.3 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 124.698 1.199 . . . . 0.0 110.873 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.22 -32.37 22.66 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.862 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.6 mt -63.23 -45.57 98.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.637 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 333' ' ' TYR . 39.8 mt -61.74 -43.42 98.88 Favored 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.681 0.613 . . . . 0.0 110.466 177.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -55.73 -42.03 74.74 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.248 0.619 . . . . 0.0 111.777 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -81.78 -10.37 59.36 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.59 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -100.6 146.81 32.68 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -63.37 138.21 64.67 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 121.589 1.526 . . . . 0.0 110.12 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.458 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 4.9 Cg_endo -48.12 -28.98 11.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.046 3.164 . . . . 0.0 114.85 -176.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 44.2 p -64.15 -25.32 68.03 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.362 0.601 . . . . 0.0 112.323 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.442 ' O ' HG13 ' A' ' 336' ' ' ILE . 7.2 mm-40 -86.44 -14.51 43.05 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.467 -175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.458 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 3.8 m-85 -49.11 -44.62 42.47 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -57.97 -31.0 66.47 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.807 0.692 . . . . 0.0 110.607 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -86.3 -51.68 6.1 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.338 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 332' ' ' GLU . 44.5 mt -60.38 -46.64 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.442 0.697 . . . . 0.0 111.692 -173.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 342' ' ' VAL . . . -51.66 -52.38 48.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.912 0.885 . . . . 0.0 111.843 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -65.42 -21.72 66.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -71.5 -34.9 70.54 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.519 0.676 . . . . 0.0 109.376 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -97.69 -12.78 21.98 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.154 -174.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 101.1 18.04 20.89 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.706 -1.235 . . . . 0.0 112.357 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 337' ' ' ALA . 17.5 t -92.75 84.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.4 m -63.57 -42.29 98.34 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.572 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -99.87 76.18 1.94 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.602 1.192 . . . . 0.0 111.412 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.509 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.0 OUTLIER -75.22 -16.77 60.45 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.372 175.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 346' ' ' ARG . 1.8 mpt_? -69.31 -42.3 75.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 350' ' ' LYS . . . -67.9 -34.91 83.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.86 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 16.0 tpt -59.99 -43.38 95.2 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 96.4 mt -59.62 -43.96 93.62 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.066 0.46 . . . . 0.0 109.902 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.477 ' HG2' ' NH2' ' A' ' 356' ' ' ARG . 29.9 ttmt -56.73 -48.62 77.37 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.762 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 355' ' ' MET . 79.4 mtp180 -74.52 -21.21 59.66 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.068 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -82.04 -38.51 24.86 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -78.61 -47.98 16.04 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.987 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -104.68 83.27 0.38 Allowed Glycine 1 N--CA 1.396 -4.02 0 N-CA-C 104.464 -3.454 . . . . 0.0 104.464 172.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 351' ' ' ARG . 65.8 mtt -46.82 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.482 -1.639 0 O-C-N 125.888 1.581 . . . . 0.0 113.768 -172.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.477 ' NH2' ' HG2' ' A' ' 350' ' ' LYS . 76.1 mtm180 -123.19 78.63 1.59 Allowed 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 112.953 -1.931 . . . . 0.0 112.848 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -126.07 -165.58 1.45 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 172.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 360' ' ' LYS . 4.9 p-10 47.38 34.85 3.51 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.797 1.239 . . . . 0.0 113.744 173.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.45 ' C ' ' H ' ' A' ' 361' ' ' LYS . 29.2 mt-10 -81.16 22.74 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.106 0.955 . . . . 0.0 112.013 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 358' ' ' ASP . 0.0 OUTLIER -87.21 22.94 1.95 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.364 172.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 359' ' ' GLU . 37.2 ttpt -73.85 -50.96 17.9 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.011 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 48.5 p 176.49 106.13 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.574 1.15 . . . . 0.0 109.24 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 7.4 p -139.49 -49.03 0.48 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.894 0.878 . . . . 0.0 110.023 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -89.77 -31.53 17.37 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 122.033 0.92 . . . . 0.0 108.91 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -87.93 140.81 29.12 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.336 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -96.92 -23.55 16.27 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -159.31 134.54 8.3 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -111.26 173.08 6.51 Favored 'General case' 0 C--N 1.283 -2.299 0 O-C-N 123.821 0.7 . . . . 0.0 111.56 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 87.6 mt -68.89 141.47 55.04 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.886 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -64.84 143.72 98.83 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -44.74 -38.91 13.17 Favored 'Trans proline' 0 C--O 1.257 1.454 0 C-N-CA 123.354 2.702 . . . . 0.0 113.593 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -145.09 158.75 43.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.565 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.412 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 42.6 m-85 -138.54 154.52 48.75 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -138.03 135.97 36.42 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.64 155.69 22.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.416 ' HB2' ' CD2' ' A' ' 379' ' ' HIS . 32.2 m -92.34 144.89 24.93 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -57.18 128.75 38.56 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 123.699 0.8 . . . . 0.0 110.622 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.84 8.73 63.27 Favored Glycine 0 C--N 1.317 -0.486 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.367 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . 0.416 ' CD2' ' HB2' ' A' ' 376' ' ' SER . 56.3 m-70 -112.06 -179.58 3.73 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 122.453 -0.439 . . . . 0.0 110.472 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -98.35 143.81 28.42 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.6 tp -138.15 139.23 42.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 20.6 ptt180 -134.32 122.91 23.32 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.157 0.98 . . . . 0.0 113.302 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . 0.402 ' HB3' ' CD2' ' A' ' 369' ' ' LEU . 2.1 mm? -88.5 129.12 35.53 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.293 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 34.4 m -120.76 122.62 40.77 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -173.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.26 155.32 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.966 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -126.31 140.53 52.45 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.5 mp -101.49 158.94 15.7 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.2 -24.56 57.82 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.449 0.642 . . . . 0.0 109.624 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -108.37 137.44 46.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -80.97 -28.11 35.73 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.908 0.385 . . . . 0.0 111.357 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -99.88 17.29 21.23 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.546 -174.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -116.25 148.55 40.36 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -115.43 174.14 6.16 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.403 0.621 . . . . 0.0 110.609 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.414 HG13 ' CG2' ' A' ' 438' ' ' VAL . 9.2 m -106.68 164.74 4.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.162 176.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 436' ' ' CYS . 8.1 tptp -109.23 146.14 34.71 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 175.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -115.76 111.32 20.36 Favored 'General case' 0 C--N 1.281 -2.398 0 O-C-N 123.171 0.294 . . . . 0.0 110.549 -171.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.3 mp -122.34 141.91 51.05 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.048 0.452 . . . . 0.0 111.23 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -120.87 122.56 40.52 Favored 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.1 p30 53.82 12.37 0.41 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 126.183 1.793 . . . . 0.0 113.563 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.62 11.29 29.14 Favored Glycine 0 C--O 1.22 -0.75 0 C-N-CA 121.245 -0.502 . . . . 0.0 111.964 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -118.64 120.68 38.15 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.19 125.93 25.51 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 56.5 mt -65.85 132.72 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.625 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -96.97 122.29 39.79 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 27.0 ttt -68.81 93.39 0.54 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.38 0.61 . . . . 0.0 112.543 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 409' ' ' LYS . 42.7 t -82.54 128.27 34.14 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 172.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -34.82 -70.74 0.16 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 6.4 p -101.62 18.54 20.05 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.517 0.675 . . . . 0.0 112.329 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 17.2 tppt? -104.65 -57.79 1.98 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.31 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -113.31 108.13 16.82 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 57.1 mt -108.67 114.6 47.2 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.715 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.507 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.1 m-85 -85.78 107.53 17.67 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.719 0.771 . . . . 0.0 108.924 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.2 113.13 26.37 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 16.6 m -104.45 124.63 49.59 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.2 mp -122.12 76.61 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.199 0 CA-C-O 121.546 0.689 . . . . 0.0 109.428 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.76 -86.04 0.76 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.294 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -109.45 -19.17 13.35 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.341 0.591 . . . . 0.0 109.508 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . 0.523 ' HE2' ' OG1' ' A' ' 420' ' ' THR . 82.6 tttt -86.29 118.93 26.05 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.779 -176.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -104.95 118.52 36.73 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' THR . . . . . 0.523 ' OG1' ' HE2' ' A' ' 418' ' ' LYS . 8.3 m -114.59 124.49 51.99 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.507 HD13 ' CE2' ' A' ' 412' ' ' PHE . 20.4 tp -101.29 103.85 14.85 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 27.8 m -99.76 111.12 23.47 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.108 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 45.2 mt -89.3 121.38 39.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 177.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 18.6 m -106.94 128.71 54.57 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 63.17 67.7 0.66 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.711 -1.131 . . . . 0.0 107.979 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 48.1 t -74.1 123.78 25.07 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 91.4 p -105.25 -176.72 3.16 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 97.0 mt -74.33 -25.68 59.69 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -76.09 -12.17 60.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.227 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -92.16 -21.55 20.34 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.786 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -50.76 119.62 4.03 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.421 1.076 . . . . 0.0 110.601 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -169.77 165.01 9.98 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 123.573 0.546 . . . . 0.0 109.548 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.67 124.42 32.18 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -106.44 141.7 37.31 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -175.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.71 140.76 34.94 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 121.341 0.591 . . . . 0.0 111.735 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 395' ' ' LYS . 63.8 m -105.38 128.77 53.68 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.93 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.2 t -115.74 134.63 58.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.243 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.414 ' CG2' HG13 ' A' ' 394' ' ' VAL . 97.1 t -131.57 160.94 42.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.1 114.0 6.46 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 119.148 -1.501 . . . . 0.0 110.365 175.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.76 -35.11 5.15 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-O 119.39 -0.672 . . . . 0.0 113.348 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -139.53 173.15 11.84 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 122.636 1.208 . . . . 0.0 113.997 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -149.92 166.96 28.02 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.67 -1.604 . . . . 0.0 106.933 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 27.5 p -154.4 133.28 12.3 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 172.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 5.0 m -118.04 143.23 46.6 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.301 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 13.5 t -125.59 150.79 47.21 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -110.48 110.72 21.58 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 68.1 tp -90.47 129.7 36.62 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -106.77 107.9 19.14 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.77 119.28 37.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -98.28 126.59 43.83 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--N 1.311 -1.098 0 C-N-CA 123.957 0.903 . . . . 0.0 110.119 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.369 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.05 -45.88 11.64 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.01 2.474 . . . . 0.0 111.571 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -99.94 -49.84 1.44 Allowed Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 68.4 m -80.01 95.59 6.2 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 121.445 0.64 . . . . 0.0 112.203 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.33 6.26 10.68 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.836 0.826 . . . . 0.0 109.606 173.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -86.04 31.06 0.64 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.397 1.079 . . . . 0.0 111.631 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.46 -29.63 47.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.441 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -53.32 -54.51 35.37 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.471 0.708 . . . . 0.0 111.375 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.03 -38.18 53.37 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.297 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 67.9 mt -64.12 -50.64 76.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.252 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.43 -28.79 64.23 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -64.06 -43.73 94.59 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.944 0.402 . . . . 0.0 110.836 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -91.26 -0.56 57.7 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.101 0.477 . . . . 0.0 112.015 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -91.16 152.29 43.9 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.849 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.15 148.33 78.64 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.704 2.269 . . . . 0.0 112.23 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 26.7 Cg_endo -60.85 -21.96 72.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.496 2.797 . . . . 0.0 114.139 -173.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 5.1 m -85.54 -4.01 59.03 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.873 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 336' ' ' ILE . 48.9 mm-40 -99.49 -14.93 18.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.935 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 15.6 m-30 -44.15 -55.12 5.01 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -173.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -65.65 -38.22 88.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.243 0.545 . . . . 0.0 111.179 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.03 -42.48 84.8 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.659 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 332' ' ' GLU . 74.2 mt -65.04 -44.5 95.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -55.65 -58.51 7.52 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.315 0.646 . . . . 0.0 111.395 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -67.75 -23.34 65.23 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -68.01 -42.3 80.89 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.777 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -89.4 -15.51 33.08 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.193 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 100.2 34.63 4.75 Favored Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.3 t -112.21 118.24 57.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 43.4 p -97.75 -13.94 21.12 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-O 122.015 0.912 . . . . 0.0 109.21 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -82.39 47.09 1.11 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.754 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.443 ' O ' HD11 ' A' ' 349' ' ' LEU . 36.0 tp -59.75 -53.13 61.55 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.732 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -67.7 -30.61 70.16 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.301 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -68.04 -38.76 88.81 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 28.0 ttt -71.88 -42.52 66.72 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 345' ' ' LEU . 8.6 mp -61.38 -39.01 89.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.152 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -53.72 -43.87 69.4 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.864 0.727 . . . . 0.0 110.057 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 355' ' ' MET . 93.1 mtt180 -64.15 -45.74 87.12 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.39 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 355' ' ' MET . 7.7 mp -71.91 -21.59 61.61 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . 0.627 ' HE2' ' O ' ' A' ' 359' ' ' GLU . 0.0 OUTLIER -63.47 -34.71 78.36 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 173.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -84.74 -24.05 47.43 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.344 176.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.424 ' HB2' ' HA ' ' A' ' 352' ' ' LEU . 24.0 mmt -74.06 -32.75 63.43 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.882 0.372 . . . . 0.0 111.431 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -93.9 -83.95 0.32 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . 0.475 ' HD2' ' OD2' ' A' ' 358' ' ' ASP . 19.5 ttm180 166.22 -82.77 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.468 1.107 . . . . 0.0 109.821 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' A' ' 357' ' ' ARG . 3.0 p30 -112.29 2.92 16.77 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.263 -173.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.627 ' O ' ' HE2' ' A' ' 353' ' ' LYS . 1.2 tm-20 -58.66 103.13 0.14 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -128.59 170.34 13.34 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-O 122.975 1.369 . . . . 0.0 112.962 -175.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -146.23 155.87 42.99 Favored 'General case' 0 C--N 1.267 -3.021 1 N-CA-C 99.456 -4.275 . . . . 0.0 99.456 169.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.579 ' OG ' ' HB2' ' A' ' 365' ' ' PHE . 10.3 t -70.56 112.23 6.66 Favored 'General case' 0 N--CA 1.384 -3.757 0 CA-C-O 122.137 0.97 . . . . 0.0 108.668 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 7.2 t -129.52 -21.41 3.15 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.092 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.506 ' HB2' ' HG3' ' A' ' 441' ' ' GLU . . . -85.26 -13.33 50.12 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.579 ' HB2' ' OG ' ' A' ' 362' ' ' SER . 0.5 OUTLIER -90.16 117.84 29.23 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 170.027 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -77.17 -29.64 54.55 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.406 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -151.42 115.96 5.12 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 362' ' ' SER . 49.1 mtpt -98.51 160.28 14.39 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 76.5 mt -70.17 144.85 51.85 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.49 151.14 96.61 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -37.96 -45.48 1.96 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 124.397 3.398 . . . . 0.0 114.022 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -148.38 153.74 38.99 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.665 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 447' ' ' LEU . 74.9 m-85 -134.19 146.03 49.77 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.01 147.07 48.1 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.37 155.96 18.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 379' ' ' HIS . 15.0 m -87.16 151.65 23.01 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.509 ' HB3' ' HZ2' ' A' ' 377' ' ' LYS . 0.0 OUTLIER -70.13 115.33 9.21 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 120.85 0.357 . . . . 0.0 110.105 -178.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 100.49 -6.06 57.39 Favored Glycine 0 CA--C 1.496 -1.11 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 376' ' ' SER . 16.3 t60 -96.11 152.9 18.11 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -96.18 143.46 27.27 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.944 0.402 . . . . 0.0 111.772 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.643 HG21 ' SG ' ' A' ' 426' ' ' CYS . 9.9 tp -121.97 129.69 75.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -109.98 112.53 24.61 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.32 0.581 . . . . 0.0 110.304 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 79.8 mt -93.96 139.11 31.32 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 64.3 m -134.55 113.38 11.72 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.686 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.86 145.39 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 22.2 mt-10 -121.54 137.69 54.62 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 417' ' ' ALA . 82.5 mt -95.57 144.81 25.72 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -83.84 -21.56 32.01 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.0 121.23 44.04 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.915 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -75.36 -27.12 59.03 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.265 0.555 . . . . 0.0 110.689 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -90.06 18.91 5.35 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.866 0.866 . . . . 0.0 111.304 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -113.55 142.43 45.96 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -110.5 165.99 11.36 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.82 144.31 38.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.256 0.551 . . . . 0.0 110.745 -176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -108.37 143.75 36.87 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.459 ' HB3' HD11 ' A' ' 403' ' ' ILE . 10.2 m-90 -113.21 119.08 36.53 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.596 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.9 mp -126.79 138.83 53.41 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -120.36 121.37 38.44 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 22.4 p30 51.22 12.72 0.14 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 126.393 1.877 . . . . 0.0 114.551 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.93 8.24 22.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.197 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -120.07 138.74 53.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.03 126.65 28.05 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 120.753 0.311 . . . . 0.0 110.57 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' A' ' 396' ' ' TRP . 34.5 mt -72.58 102.07 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -76.26 137.75 40.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 51.0 ttp -73.27 100.01 3.02 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 43.8 t -101.75 119.19 38.39 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.257 -174.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 49.64 -132.21 26.75 Favored Glycine 0 C--N 1.338 0.641 0 O-C-N 124.748 1.28 . . . . 0.0 113.959 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 24.8 t -104.79 11.95 33.24 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . 0.468 ' HD3' ' OD2' ' A' ' 430' ' ' ASP . 33.1 ttmt -75.74 -61.12 2.03 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.952 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . 0.486 ' O ' ' HG3' ' A' ' 405' ' ' MET . 82.0 m-85 -94.78 117.27 29.87 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.2 mt -121.43 113.53 39.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 421' ' ' LEU . 24.3 m-85 -86.99 112.3 21.69 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 420' ' ' THR . 41.7 mt-10 -107.7 107.04 17.65 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 32.0 t -99.22 114.68 27.61 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 123.592 0.757 . . . . 0.0 108.991 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.601 ' HB ' ' CG ' ' A' ' 418' ' ' LYS . 41.9 mm -115.26 79.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 67.25 -83.46 0.13 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.376 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 387' ' ' LEU . . . -100.9 -31.95 10.89 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.575 0.35 . . . . 0.0 110.767 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . 0.601 ' CG ' ' HB ' ' A' ' 415' ' ' ILE . 1.5 ptpp? -84.49 140.4 31.5 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.715 0.769 . . . . 0.0 111.744 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -124.18 100.77 6.87 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 413' ' ' GLU . 31.4 m -98.73 134.42 41.66 Favored 'General case' 0 C--N 1.259 -3.345 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.427 -174.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.512 HD12 ' CE1' ' A' ' 412' ' ' PHE . 33.2 tp -117.0 106.81 13.81 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.359 0.6 . . . . 0.0 109.426 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 36.3 m -97.33 109.67 22.38 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.0 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.6 mt -97.72 110.01 24.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.1 m -95.82 141.47 29.24 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 61.89 52.56 3.37 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.904 0.752 . . . . 0.0 110.479 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . 0.643 ' SG ' HG21 ' A' ' 381' ' ' ILE . 13.5 m -65.19 113.19 3.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 12.0 m -108.4 -167.69 1.26 Allowed 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.14 -20.77 60.85 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 121.703 -0.623 . . . . 0.0 111.006 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -78.83 -4.51 49.91 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.405 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . 0.468 ' OD2' ' HD3' ' A' ' 409' ' ' LYS . 18.1 m-20 -110.7 7.91 22.4 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.959 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.94 96.67 9.44 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -151.27 162.63 40.56 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.932 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.75 122.66 30.15 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -106.55 140.58 39.21 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 120.827 0.346 . . . . 0.0 110.131 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.33 137.78 30.78 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.227 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 65.5 m -103.95 128.57 51.48 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.95 130.67 73.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.366 0.603 . . . . 0.0 111.556 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 63.7 t -124.7 161.58 27.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 174.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -61.26 112.97 5.2 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 118.513 -1.804 . . . . 0.0 111.534 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 94.38 -35.3 4.26 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.632 -0.284 . . . . 0.0 112.547 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.506 ' HG3' ' HB2' ' A' ' 364' ' ' ALA . 9.1 mm-40 -105.96 138.98 41.21 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 122.467 -0.431 . . . . 0.0 110.681 -173.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.443 ' HZ1' ' HB3' ' A' ' 442' ' ' LYS . 0.1 OUTLIER -148.79 163.92 35.94 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 171.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 13.8 p -151.28 133.49 15.27 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 12.1 p -119.62 132.17 55.64 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 123.654 0.596 . . . . 0.0 110.707 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.429 ' OG1' ' HD2' ' A' ' 373' ' ' TYR . 14.6 t -124.07 147.9 47.52 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -106.04 111.02 23.47 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 373' ' ' TYR . 3.3 tm? -93.14 125.69 37.86 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -113.25 124.97 53.75 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.817 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.6 t -97.53 122.25 48.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -106.16 117.06 33.04 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.508 ' HA ' ' CB ' ' A' ' 377' ' ' LYS . 2.6 mp0 . . . . . 0 C--O 1.256 1.417 0 C-N-CA 125.234 1.413 . . . . 0.0 113.929 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.473 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.37 113.19 2.8 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.405 2.07 . . . . 0.0 111.808 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 131.9 -140.33 11.71 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.521 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 15.6 t -129.26 31.1 4.9 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 62.92 76.42 0.37 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -108.43 -8.83 15.5 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.689 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.55 -37.67 39.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.717 -1.128 . . . . 0.0 113.36 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -56.3 -46.45 79.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -85.05 -29.6 24.8 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.288 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.01 -48.29 86.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.324 0.39 . . . . 0.0 110.392 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 62.9 mt -59.42 -41.23 89.07 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.119 0.485 . . . . 0.0 110.236 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -58.62 -30.01 66.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.237 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -112.9 7.14 18.19 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.26 0.552 . . . . 0.0 111.187 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -100.67 150.82 37.32 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.695 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.43 142.84 67.26 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.433 2.089 . . . . 0.0 111.389 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.515 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 18.5 Cg_endo -58.52 -21.38 54.17 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 123.813 3.008 . . . . 0.0 114.205 -176.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 36.1 p -74.34 -17.16 60.87 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.047 0.451 . . . . 0.0 112.16 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -103.97 -2.88 25.43 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.494 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 20.8 m-30 -56.89 -40.23 75.85 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -174.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.27 -30.16 70.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.989 0.423 . . . . 0.0 111.121 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -72.56 -57.72 3.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.0 -40.32 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.845 1.258 . . . . 0.0 111.792 -173.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -58.54 -60.1 4.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.639 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -67.8 -22.97 65.15 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.028 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -64.44 -34.2 77.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.384 0.674 . . . . 0.0 109.515 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.25 13.23 23.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 76.48 29.61 57.8 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.806 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.75 118.73 56.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 17.6 p -94.79 -14.19 24.91 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-O 122.115 0.96 . . . . 0.0 109.928 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -92.52 49.16 1.45 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.478 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.407 ' H ' HD21 ' A' ' 345' ' ' LEU . 1.7 pt? -73.04 -26.2 61.21 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.499 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -70.75 -24.21 62.57 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -64.76 -31.48 81.06 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.764 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 24.2 ttt -66.83 -45.51 78.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.81 -35.44 80.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.1 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -57.84 -32.35 67.54 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.935 0.894 . . . . 0.0 111.133 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 355' ' ' MET . 36.5 mmt180 -61.72 -42.15 98.57 Favored 'General case' 0 C--O 1.21 -0.987 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.93 -27.63 33.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.573 0.701 . . . . 0.0 110.217 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -63.8 -37.87 89.0 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.961 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -95.97 1.14 62.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.371 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 351' ' ' ARG . 43.8 tpp -88.0 60.82 6.03 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 122.629 -0.336 . . . . 0.0 110.764 -175.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 52.4 -29.11 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 118.697 2.851 . . . . 0.0 118.697 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -73.64 -35.66 65.32 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 118.509 0.595 . . . . 0.0 111.338 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.65 120.52 31.78 Favored 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.348 -171.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.37 112.58 24.35 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -92.3 -79.8 0.38 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -178.74 -51.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 O-C-N 123.615 0.572 . . . . 0.0 110.714 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 5.8 p -176.6 71.97 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.133 0.973 . . . . 0.0 110.059 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 38.2 p -103.32 -54.74 2.54 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.51 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.78 -13.02 61.22 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.063 0.935 . . . . 0.0 109.438 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.425 ' CG ' ' HG2' ' A' ' 368' ' ' LYS . 5.4 m-85 -107.09 120.48 42.21 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.38 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -79.77 -27.11 40.47 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.76 0.79 . . . . 0.0 109.169 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -157.01 118.23 3.7 Favored 'General case' 0 N--CA 1.403 -2.815 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.425 ' HG2' ' CG ' ' A' ' 365' ' ' PHE . 42.2 mtmt -94.89 178.42 5.57 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.45 HD13 ' SG ' ' A' ' 436' ' ' CYS . 82.5 mt -67.51 144.35 55.71 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 175.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.21 136.77 93.9 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -43.72 -34.81 5.99 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.059 3.173 . . . . 0.0 114.543 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -144.78 143.66 30.78 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.113 0.482 . . . . 0.0 112.234 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.412 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 63.2 m-85 -137.3 143.28 42.04 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.233 1.013 . . . . 0.0 109.315 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -122.27 138.98 54.31 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.76 149.39 29.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.1 m -82.2 147.7 28.84 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 1.6 tmmm? -64.6 127.11 30.15 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.312 0.577 . . . . 0.0 110.031 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . 0.505 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 95.01 -7.13 69.7 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.382 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -93.08 168.33 11.19 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.757 0.313 . . . . 0.0 111.402 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 44.6 mtmt -98.12 157.61 16.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 17.8 tt -145.73 128.58 9.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 121.576 0.703 . . . . 0.0 109.924 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -103.19 114.99 29.73 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.913 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 76.3 mt -98.0 141.07 31.41 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 35.2 m -139.81 138.49 35.86 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.416 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.0 143.16 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -116.87 126.02 52.39 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.415 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 84.3 mt -91.64 139.86 30.28 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.457 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -71.73 -42.59 67.1 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.95 103.57 16.08 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.631 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -73.18 -21.83 60.6 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.181 -177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.15 26.98 3.03 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.735 1.255 . . . . 0.0 109.748 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -124.06 162.53 23.31 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.06 166.49 19.16 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.693 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 6.7 m -117.02 167.72 9.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.609 0.718 . . . . 0.0 111.91 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 436' ' ' CYS . 8.9 mmpt? -112.81 140.16 47.83 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.6 m-90 -112.38 113.56 25.82 Favored 'General case' 0 C--N 1.278 -2.523 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.0 mp -124.59 137.4 54.39 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.751 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 119.04 30.15 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 171.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.2 p30 56.05 18.11 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 126.725 2.01 . . . . 0.0 112.249 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.5 1.98 47.06 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.093 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -106.24 133.72 50.5 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.18 123.46 20.35 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.439 0.638 . . . . 0.0 111.312 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 69.6 mt -66.34 109.75 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.48 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -85.96 135.76 33.53 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' MET . . . . . 0.522 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 28.0 ttt -73.3 94.77 2.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.155 0.503 . . . . 0.0 110.155 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.0 p -89.04 94.4 9.93 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.05 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.17 -106.6 0.95 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.54 -0.754 . . . . 0.0 113.563 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 19.2 t -122.14 12.36 10.31 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . 0.443 ' HD2' ' CD2' ' A' ' 410' ' ' TYR . 6.2 tmtm? -74.31 -56.88 4.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . 0.522 ' O ' ' HG3' ' A' ' 405' ' ' MET . 79.8 m-85 -107.23 113.44 26.85 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 176.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.68 113.9 45.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.097 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -87.05 106.0 17.55 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 420' ' ' THR . 45.3 mt-10 -98.37 107.6 20.1 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 11.4 t -96.59 111.33 23.51 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.485 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 33.4 mm -115.1 82.02 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -174.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.91 -88.89 0.23 Allowed Glycine 0 C--O 1.236 0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 112.816 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -101.2 -29.28 12.19 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.203 0.525 . . . . 0.0 110.665 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 14.9 ptmt -94.76 127.41 40.74 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 122.143 0.973 . . . . 0.0 113.473 -171.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -100.21 105.81 17.43 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 413' ' ' GLU . 27.9 m -100.06 120.24 39.54 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.693 -174.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 45.8 tp -104.49 106.8 17.44 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.169 0.509 . . . . 0.0 110.312 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 58.5 m -95.8 111.63 23.55 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 38.3 mt -99.06 120.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 15.6 m -97.46 130.19 44.58 Favored 'General case' 0 N--CA 1.407 -2.614 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 63.32 74.68 0.42 Allowed 'General case' 0 C--O 1.243 0.751 0 O-C-N 124.168 0.918 . . . . 0.0 113.427 172.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 81.8 m -80.93 121.04 25.51 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.666 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 29.4 p -101.07 -177.26 3.4 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.56 -19.95 62.84 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.964 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -86.24 -11.65 51.79 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.73 177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -99.24 2.89 46.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.804 1.288 . . . . 0.0 108.39 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -77.54 116.91 18.49 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.46 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 447' ' ' LEU . . . -161.66 172.53 16.12 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.74 130.55 34.68 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -112.05 132.17 54.98 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.555 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.482 ' N ' HE21 ' A' ' 435' ' ' GLN . 0.0 OUTLIER -126.66 142.16 51.63 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.19 -174.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' A' ' 369' ' ' LEU . 71.7 m -123.87 120.85 33.77 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 40.7 t -115.94 128.76 73.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.932 -174.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.49 161.11 19.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 170.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.63 112.32 4.91 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.178 -1.487 . . . . 0.0 111.614 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 96.59 -35.11 4.57 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 115.344 -0.428 . . . . 0.0 112.143 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -116.09 124.63 50.89 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -174.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.01 167.54 21.88 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.702 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 41.7 t -151.79 147.2 26.38 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 80.1 p -125.92 116.59 21.73 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.412 ' OG1' ' HD2' ' A' ' 373' ' ' TYR . 9.0 t -94.93 138.92 32.04 Favored 'General case' 0 N--CA 1.401 -2.899 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -88.36 110.0 20.44 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 432' ' ' ALA . 3.4 tm? -99.47 121.79 41.65 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -116.62 114.24 23.81 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.646 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.63 119.62 39.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -109.35 130.28 55.5 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.407 -2.612 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.506 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.445 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -66.89 -33.68 32.57 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.615 2.21 . . . . 0.0 111.827 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -96.05 175.63 32.46 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 26.1 m -82.81 114.48 21.17 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.968 0.414 . . . . 0.0 111.658 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.489 ' C ' ' H ' ' A' ' 321' ' ' VAL . 12.1 pt-20 -98.94 14.15 30.1 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -71.17 25.18 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 126.696 1.998 . . . . 0.0 112.831 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 319' ' ' GLU . 10.7 p -61.32 -33.62 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 C-N-CA 123.628 0.771 . . . . 0.0 109.492 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . 0.405 ' HA ' ' CE ' ' A' ' 348' ' ' MET . 43.7 p-90 -52.97 -47.97 67.77 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 123.213 0.605 . . . . 0.0 112.085 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.64 -40.26 16.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.2 mt -63.22 -45.21 99.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 120.715 0.293 . . . . 0.0 111.439 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 9.3 tt -73.21 -31.09 63.96 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.389 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -70.36 -27.12 64.08 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 121.198 0.523 . . . . 0.0 111.22 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -97.82 -1.81 42.36 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.235 0.54 . . . . 0.0 110.988 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.88 148.24 35.28 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.84 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.6 146.49 92.64 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 122.328 2.019 . . . . 0.0 112.659 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.76 -24.1 22.46 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 124.201 3.268 . . . . 0.0 115.922 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 9.0 m -76.61 -12.93 60.09 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.498 0.666 . . . . 0.0 111.644 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.413 ' O ' HG13 ' A' ' 336' ' ' ILE . 7.1 mm-40 -94.61 -15.74 23.79 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.405 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -48.98 -49.3 41.41 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 -171.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -65.78 -31.51 72.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.157 0.503 . . . . 0.0 111.52 -174.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -69.14 -53.54 19.6 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 332' ' ' GLU . 62.6 mt -59.36 -49.86 81.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.887 -175.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -56.4 -62.06 1.98 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.933 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -62.62 -23.17 66.92 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -70.74 -39.96 73.01 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 122.782 0.433 . . . . 0.0 110.842 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -91.08 1.26 57.22 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.011 0.434 . . . . 0.0 112.078 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 87.87 25.7 31.37 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.718 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.2 t -104.81 117.17 49.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 73.9 p -95.46 -30.54 13.82 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 117.685 -1.606 . . . . 0.0 111.599 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -95.39 84.65 4.06 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.54 -30.54 59.76 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.431 0.634 . . . . 0.0 110.589 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -73.35 -40.55 64.33 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -67.49 -17.97 69.27 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.379 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' MET . . . . . 0.588 ' O ' ' HG2' ' A' ' 351' ' ' ARG . 24.1 ttt -79.7 -56.25 4.42 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 122.887 0.475 . . . . 0.0 109.987 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.09 -20.19 66.35 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -65.94 -30.22 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.077 0.465 . . . . 0.0 111.395 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 348' ' ' MET . 24.8 ptt180 -79.65 -22.75 43.14 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.408 ' O ' ' HE2' ' A' ' 355' ' ' MET . 4.4 mm? -76.23 -21.67 56.12 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.371 1.081 . . . . 0.0 108.492 177.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -72.26 -30.23 64.66 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.905 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -93.89 -16.17 46.04 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.192 -0.913 . . . . 0.0 114.715 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' MET . . . . . 0.408 ' HE2' ' O ' ' A' ' 352' ' ' LEU . 0.0 OUTLIER -73.3 -19.89 60.94 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 117.742 0.771 . . . . 0.0 112.271 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -82.57 -27.69 31.41 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.086 0.47 . . . . 0.0 111.806 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . 0.25 0.0 OUTLIER -86.38 148.41 25.59 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -169.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -122.45 131.15 53.73 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.362 -172.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -140.76 117.51 10.99 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 170.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 360' ' ' LYS . 29.6 mmtp -113.99 130.99 56.5 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.614 0.721 . . . . 0.0 112.165 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -57.3 -16.87 9.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.911 1.685 . . . . 0.0 113.248 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 12.2 m 69.82 57.04 0.32 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.356 1.063 . . . . 0.0 109.253 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.6 t -95.48 -38.12 10.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.165 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -88.78 -12.95 40.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.716 0.769 . . . . 0.0 109.635 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -109.74 117.57 34.24 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.522 177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -82.87 -18.86 38.8 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -160.08 116.47 2.45 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -94.69 172.76 7.98 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.63 139.26 49.22 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 174.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -56.71 146.53 56.47 Favored Pre-proline 0 C--N 1.316 -0.864 0 O-C-N 123.926 0.766 . . . . 0.0 108.998 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.09 -33.01 41.62 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 123.025 2.484 . . . . 0.0 112.986 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -147.76 144.37 28.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.846 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.546 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 51.9 m-85 -129.8 159.07 37.68 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -136.72 141.9 43.07 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.75 147.3 25.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 25.2 m -84.16 144.5 28.96 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.403 ' HD3' ' HG2' ' A' ' 451' ' ' GLU . 26.7 ttpp -60.26 128.15 35.32 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.741 0.416 . . . . 0.0 110.949 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 90.7 8.84 65.07 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.883 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -111.07 175.2 5.51 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -99.57 136.51 39.39 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.649 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.2 tp -121.36 139.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.474 ' CZ ' HG21 ' A' ' 420' ' ' THR . 35.5 ttt85 -131.74 116.66 17.58 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.187 0.994 . . . . 0.0 111.581 -173.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.08 130.4 48.66 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.974 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 21.7 m -127.61 126.11 41.46 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.415 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 5.1 m -122.04 144.2 32.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.813 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -111.91 119.25 37.89 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 86.0 mt -88.11 145.65 25.83 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.515 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -72.09 -24.26 61.47 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.058 0.456 . . . . 0.0 110.183 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -123.33 135.5 54.22 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.422 ' CD2' ' HB1' ' A' ' 417' ' ' ALA . 11.7 m-70 -70.86 -23.25 62.28 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.87 19.39 17.99 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.86 -172.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -96.59 132.64 42.0 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -98.71 156.12 17.0 Favored 'General case' 0 C--N 1.267 -2.99 0 C-N-CA 118.541 -1.263 . . . . 0.0 111.96 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.53 152.23 17.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.225 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -115.0 139.35 49.92 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -110.9 125.16 53.36 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 8.3 mp -127.47 136.23 51.5 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 117.832 0.287 . . . . 0.0 110.859 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.408 ' O ' ' HD2' ' A' ' 398' ' ' LYS . 0.0 OUTLIER -111.61 115.63 29.46 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.277 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . 0.259 28.6 p30 50.88 13.71 0.15 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 126.814 2.046 . . . . 0.0 114.961 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 123.17 -7.11 9.27 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.366 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -107.51 134.15 50.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.88 120.74 16.9 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.193 0.521 . . . . 0.0 111.109 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 43.1 mt -78.87 111.97 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.915 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.6 151.14 20.84 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 61.7 ttp -62.46 102.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 27.4 t -100.78 95.91 6.96 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 55.29 -137.7 44.48 Favored Glycine 0 N--CA 1.442 -0.947 0 O-C-N 124.114 0.884 . . . . 0.0 113.04 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.3 p -95.44 8.56 42.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.385 0.612 . . . . 0.0 110.607 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 2.5 tppp? -72.5 -47.72 46.29 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . 0.472 ' O ' ' HG3' ' A' ' 405' ' ' MET . 41.1 m-85 -119.43 108.63 14.8 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 57.6 mt -108.66 112.8 41.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 CA-C-O 120.987 0.423 . . . . 0.0 109.955 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.489 ' CD2' HD13 ' A' ' 421' ' ' LEU . 22.7 m-85 -87.08 109.37 19.38 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.468 175.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -108.68 108.72 19.68 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 70.3 m -100.16 110.38 22.66 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.352 0.596 . . . . 0.0 111.172 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 36.1 mt -104.06 74.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.11 -107.05 1.71 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.404 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 390' ' ' HIS . . . -89.93 -25.64 20.83 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.664 0.386 . . . . 0.0 110.396 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -88.39 98.47 11.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -100.7 130.23 46.71 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-O 121.317 0.579 . . . . 0.0 109.722 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' THR . . . . . 0.474 HG21 ' CZ ' ' A' ' 382' ' ' ARG . 16.8 m -123.0 145.77 48.21 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.553 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.489 HD13 ' CD2' ' A' ' 412' ' ' PHE . 23.2 tp -118.56 112.63 20.13 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.353 174.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.9 m -102.07 109.87 21.69 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 33.0 mt -98.4 121.69 49.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.4 m -101.24 145.02 29.39 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.227 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 58.53 47.61 13.16 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.397 1.079 . . . . 0.0 110.836 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.64 122.86 16.9 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 11.2 m -116.63 -177.95 3.31 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.21 -29.55 69.89 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -81.76 -2.8 52.0 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -103.22 -7.05 21.5 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.2 113.84 1.54 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.841 173.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -168.79 163.05 11.8 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.914 -177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.39 129.25 34.85 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -104.61 134.31 47.99 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.0 OUTLIER -123.87 130.0 51.9 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.406 -178.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.639 ' HB2' ' SG ' ' A' ' 443' ' ' CYS . 81.4 m -107.89 111.84 24.17 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 171.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.31 128.22 53.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.756 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.12 161.3 29.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -59.96 112.93 4.84 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.278 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 93.15 -36.29 3.77 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 124.223 0.916 . . . . 0.0 112.441 175.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -116.61 134.99 54.18 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 120.732 0.301 . . . . 0.0 110.403 -173.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -134.61 162.35 32.54 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 436' ' ' CYS . 23.3 p -136.19 144.49 44.97 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 173.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 5.0 p -139.66 112.83 8.2 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 123.23 0.332 . . . . 0.0 111.348 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.546 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 9.9 t -104.13 141.54 36.06 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.78 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -102.63 110.53 22.49 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -89.11 143.71 26.65 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.924 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -118.73 128.65 54.69 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.51 115.93 45.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 450' ' ' LYS . 1.1 tpmt? -105.4 115.67 30.65 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.403 ' HG2' ' HD3' ' A' ' 377' ' ' LYS . 36.0 mt-10 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.708 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.706 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.92 132.62 25.1 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 122.457 2.105 . . . . 0.0 113.2 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -101.92 -178.65 27.93 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 57.8 m -161.53 -66.13 0.06 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.574 0.749 . . . . 0.0 109.285 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.72 -45.65 5.18 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.089 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 62.49 12.67 5.57 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.481 1.112 . . . . 0.0 113.769 172.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.2 -34.63 27.68 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 C-N-CA 123.238 0.615 . . . . 0.0 112.0 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -51.8 -55.25 20.97 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 124.808 1.243 . . . . 0.0 109.987 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.9 -35.57 22.07 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.843 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.75 -49.26 78.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 O-C-N 122.96 0.163 . . . . 0.0 111.375 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.4 tt -71.84 -32.71 67.8 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.994 0.426 . . . . 0.0 110.035 -177.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -64.18 -33.24 75.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.48 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -96.31 0.62 51.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.416 0.627 . . . . 0.0 110.314 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -90.44 151.93 44.85 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.72 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.39 140.65 95.35 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.701 2.267 . . . . 0.0 111.596 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 14.0 Cg_endo -55.8 -23.03 39.8 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.796 2.997 . . . . 0.0 115.072 -174.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.1 p -75.78 -21.57 57.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.273 0.559 . . . . 0.0 111.932 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -93.84 -8.28 40.87 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.511 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.418 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 4.2 m-30 -43.66 -54.86 4.72 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.505 1.122 . . . . 0.0 113.856 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.86 -49.1 79.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 339' ' ' GLN . 11.2 ttp180 -60.73 -40.27 91.71 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.305 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 34.1 mt -73.6 -37.8 50.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.173 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -61.85 -58.55 7.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.178 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -66.84 -23.03 65.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.43 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 335' ' ' ARG . 7.9 tp-100 -59.14 -43.63 92.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.267 0.627 . . . . 0.0 109.624 176.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.59 4.92 43.78 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 88.58 18.22 55.32 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.219 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 24.5 t -91.87 101.04 12.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.3 m -82.33 -40.18 21.8 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.078 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -99.69 87.75 3.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.961 0.886 . . . . 0.0 109.631 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.483 ' H ' HD21 ' A' ' 345' ' ' LEU . 1.4 pt? -75.59 -36.23 60.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.101 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -63.21 -38.76 92.44 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.926 -173.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -73.42 -22.1 78.95 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.745 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 56.1 ttp -73.81 -45.79 49.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.3 -32.96 73.77 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.944 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -56.04 -46.77 78.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.278 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -67.42 -41.46 84.81 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.997 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.48 -21.08 66.6 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -63.81 -42.35 97.69 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.46 -44.01 14.16 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.162 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 48.8 mtm -84.19 84.19 7.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.635 0.731 . . . . 0.0 109.905 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -73.64 -17.36 61.17 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.554 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.88 92.25 0.08 Allowed 'General case' 0 C--O 1.248 1.019 0 C-N-CA 125.392 1.477 . . . . 0.0 108.176 -175.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -121.36 121.85 38.53 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.72 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -82.57 -30.84 29.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 440' ' ' GLY . 0.0 OUTLIER -77.41 153.84 33.25 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.554 172.096 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -156.26 47.1 0.46 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.093 -167.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . 0.286 56.0 p 63.42 73.77 0.44 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.737 1.256 . . . . 0.0 110.233 -175.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 15.4 t -127.02 -18.06 4.71 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.173 -1.83 . . . . 0.0 109.277 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -99.33 -35.77 9.83 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -105.64 128.74 53.81 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.94 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 386' ' ' GLU . 24.3 mt-30 -83.27 -43.74 15.72 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -137.68 124.07 20.7 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.494 ' HE3' ' O ' ' A' ' 442' ' ' LYS . 56.7 mtpt -98.46 168.29 10.29 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.215 -175.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 84.5 mt -62.03 141.31 58.15 Favored 'General case' 0 C--O 1.255 1.343 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -63.16 149.11 91.69 Favored Pre-proline 0 C--N 1.302 -1.461 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.629 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.1 -35.29 25.69 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.393 2.729 . . . . 0.0 113.259 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -153.34 152.5 31.17 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -133.35 158.29 43.36 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -135.71 136.94 41.26 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.07 156.19 24.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 8.4 t -93.15 151.27 19.94 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -64.15 119.12 9.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.851 0.357 . . . . 0.0 110.777 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 99.76 -1.49 56.78 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -91.79 -177.73 4.84 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.176 0.513 . . . . 0.0 110.836 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.0 mtpt -119.34 130.39 55.34 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.623 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.0 tp -120.84 130.01 75.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.417 0.627 . . . . 0.0 110.245 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -101.76 110.09 22.0 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.078 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.65 117.83 31.21 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 16.1 m -122.95 144.36 49.29 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.943 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 9.5 m -140.72 143.24 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.403 ' HB3' HE21 ' A' ' 366' ' ' GLN . 5.9 mp0 -108.94 119.55 39.88 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.473 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 81.6 mt -85.64 143.3 28.49 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.79 -44.6 27.03 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.41 114.87 22.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.325 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -79.4 -21.53 45.53 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.018 0.437 . . . . 0.0 111.415 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -94.09 26.9 3.04 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.739 0.78 . . . . 0.0 111.59 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -128.47 161.46 29.46 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.27 176.88 7.58 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 12.1 m -116.6 164.45 12.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 120.939 0.399 . . . . 0.0 110.728 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -119.0 135.42 54.63 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -106.93 123.61 48.43 Favored 'General case' 0 C--N 1.283 -2.311 0 O-C-N 123.867 0.729 . . . . 0.0 109.979 -169.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.2 mp -131.6 144.12 50.83 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.773 -0.579 . . . . 0.0 111.425 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.435 ' HB3' ' CE1' ' A' ' 434' ' ' TYR . 23.0 pttp -126.18 125.42 42.42 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 169.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 24.6 p30 54.25 17.03 1.36 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.812 1.645 . . . . 0.0 113.009 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.44 4.66 46.54 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.891 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -109.03 124.15 50.27 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.6 111.28 1.76 Allowed 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 19.3 mt -75.6 148.75 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 O-C-N 124.302 1.001 . . . . 0.0 108.415 173.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -139.94 173.85 11.11 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' MET . . . . . 0.423 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 48.6 ttm -66.96 101.57 0.86 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.9 m -97.71 97.48 9.05 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 62.97 -127.47 38.57 Favored Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.35 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.8 p -106.07 12.16 30.66 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -78.76 -60.71 2.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.085 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . 0.423 ' O ' ' HG3' ' A' ' 405' ' ' MET . 95.5 m-85 -96.55 107.62 20.06 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 49.7 mm -106.16 112.53 39.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 CA-C-O 121.178 0.513 . . . . 0.0 110.01 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.519 ' CE2' HD13 ' A' ' 421' ' ' LEU . 23.0 m-85 -86.79 115.87 24.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -110.5 108.33 18.29 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 19.3 m -98.41 111.63 23.91 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.41 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 39.4 mm -112.31 87.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.74 2.21 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -92.82 -27.0 17.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.453 0.168 . . . . 0.0 110.948 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 21.8 ptmt -83.96 141.73 31.02 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.565 0.698 . . . . 0.0 111.929 -175.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -115.22 120.9 41.24 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.115 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 53.0 m -112.67 122.38 47.5 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 412' ' ' PHE . 21.4 tp -102.41 110.16 22.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 31.3 m -95.46 102.0 13.77 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.7 mt -86.78 112.67 23.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' SER . . . . . 0.407 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 13.3 m -96.36 139.83 31.92 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.718 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 61.27 57.92 2.3 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.905 1.282 . . . . 0.0 110.087 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . 0.623 ' SG ' HG22 ' A' ' 381' ' ' ILE . 25.5 m -64.48 120.9 13.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.093 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 82.1 p -94.89 178.55 5.53 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.25 -19.38 61.71 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.89 -2.17 42.45 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.669 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -103.3 8.04 38.3 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.542 0.687 . . . . 0.0 109.507 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -80.21 94.76 6.11 Favored 'General case' 0 C--O 1.256 1.415 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -145.24 170.21 16.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.466 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -89.53 120.71 31.07 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 398' ' ' LYS . 89.5 m-85 -107.43 138.66 43.23 Favored 'General case' 0 C--N 1.286 -2.196 0 O-C-N 122.276 -0.265 . . . . 0.0 111.166 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.1 OUTLIER -134.4 133.98 41.15 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.841 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.613 ' HB2' ' SG ' ' A' ' 443' ' ' CYS . 85.7 m -108.13 114.12 27.78 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 169.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.6 t -109.84 132.54 57.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.481 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 73.9 t -125.9 160.74 32.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 173.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -66.26 113.24 5.55 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 119.054 -1.546 . . . . 0.0 111.888 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . 0.572 ' O ' ' HE2' ' A' ' 360' ' ' LYS . . . 107.89 -36.67 4.24 Favored Glycine 0 N--CA 1.424 -2.109 0 CA-C-N 115.088 -0.556 . . . . 0.0 112.507 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -134.99 152.58 51.86 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 117.988 0.894 . . . . 0.0 110.849 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.494 ' O ' ' HE3' ' A' ' 368' ' ' LYS . 20.0 ptpt -141.95 178.26 7.63 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 436' ' ' CYS . 5.9 p -148.0 134.3 19.52 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 8.0 p -121.32 129.36 53.05 Favored 'General case' 0 C--N 1.288 -2.077 0 O-C-N 123.798 0.686 . . . . 0.0 110.538 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 15.1 t -128.53 150.11 50.32 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -111.96 111.16 21.89 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 62.0 tp -90.83 130.01 36.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.08 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -109.83 110.59 21.62 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.0 120.67 45.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -116.05 131.42 56.95 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.973 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.529 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.63 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -67.19 -25.79 42.91 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.548 2.166 . . . . 0.0 112.946 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -96.17 -156.35 31.22 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 35.6 m -140.2 -43.9 0.42 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 117.309 0.555 . . . . 0.0 111.989 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -115.06 5.75 15.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.585 1.183 . . . . 0.0 107.824 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.54 24.96 0.19 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.487 1.515 . . . . 0.0 112.662 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.85 -34.1 47.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 122.563 0.345 . . . . 0.0 110.723 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -53.53 -47.41 69.98 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.561 1.144 . . . . 0.0 111.186 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 8.6 pt-20 -85.81 -42.09 14.47 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.897 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.34 -50.47 80.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 122.671 0.388 . . . . 0.0 111.532 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.94 -27.88 64.08 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.352 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -60.63 -49.78 76.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.432 0.634 . . . . 0.0 111.78 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 19.3 pt20 -94.46 0.82 55.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.785 -174.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -81.82 153.61 70.18 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.257 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.53 143.31 94.85 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 122.157 1.904 . . . . 0.0 110.988 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 28.3 Cg_endo -60.27 -24.29 76.88 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 123.764 2.976 . . . . 0.0 113.992 -172.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.1 m -79.81 -8.81 59.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.989 0.423 . . . . 0.0 111.583 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.439 ' O ' HG13 ' A' ' 336' ' ' ILE . 20.5 mm-40 -94.66 -19.3 20.56 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.207 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 14.2 m-30 -44.24 -50.33 8.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.03 -55.76 30.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.673 0.608 . . . . 0.0 111.765 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -65.44 -41.02 93.94 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.043 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 332' ' ' GLU . 77.6 mt -59.25 -45.81 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.69 -58.83 6.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.847 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -62.11 -30.71 71.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.17 -36.54 84.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.767 0.317 . . . . 0.0 111.117 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -93.21 4.49 53.91 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 84.11 12.87 75.65 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.983 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 19.0 t -89.94 90.22 3.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -45.68 93.21 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.128 -174.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -110.98 100.79 9.43 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.757 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 345' ' ' LEU . 0.8 OUTLIER -75.93 -21.2 57.31 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.411 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -61.54 -44.63 96.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.856 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -63.53 -34.56 90.28 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 25.7 ttt -70.17 -48.39 57.5 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.041 0.448 . . . . 0.0 109.924 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 353' ' ' LYS . 97.5 mt -65.01 -33.62 76.48 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.292 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -59.91 -46.32 89.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.874 0.845 . . . . 0.0 108.949 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -72.43 -40.3 67.19 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.122 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 12.0 tp -70.83 -21.03 62.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.666 0.746 . . . . 0.0 110.192 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 349' ' ' LEU . 35.9 ttmt -64.83 -14.01 57.85 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.335 1.054 . . . . 0.0 110.964 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -96.26 8.69 67.18 Favored Glycine 0 C--N 1.3 -1.462 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.837 176.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 26.4 mmt -87.33 23.65 1.81 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.123 -0.633 . . . . 0.0 111.936 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 47.95 36.74 6.53 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.298 1.439 . . . . 0.0 113.538 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -119.69 -37.21 3.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.449 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -102.34 73.48 1.34 Allowed 'General case' 0 C--O 1.254 1.299 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -96.96 104.78 16.82 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.886 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -66.51 -39.87 88.89 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.088 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.496 ' HE3' ' OE1' ' A' ' 441' ' ' GLU . 15.6 ptmt -102.6 -39.8 6.92 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 2.9 m -75.62 72.35 2.57 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.887 0.851 . . . . 0.0 109.836 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 77.2 p -111.24 -45.55 3.4 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.401 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.03 68.1 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.393 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -86.99 135.43 33.28 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.861 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . 0.484 ' HB3' ' CB ' ' A' ' 386' ' ' GLU . 0.0 OUTLIER -89.03 -37.68 14.98 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 177.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -157.02 135.68 11.55 Favored 'General case' 0 CA--C 1.465 -2.31 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.744 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 9.9 mtmp? -98.09 175.06 6.24 Favored 'General case' 0 C--N 1.268 -2.963 0 O-C-N 124.298 0.999 . . . . 0.0 109.756 -175.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.519 HD11 ' SG ' ' A' ' 436' ' ' CYS . 34.6 mt -61.08 155.7 19.78 Favored 'General case' 0 C--O 1.249 1.031 0 O-C-N 124.066 0.854 . . . . 0.0 111.523 178.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.48 149.32 91.05 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 170.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.81 -37.19 76.3 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.592 2.194 . . . . 0.0 113.293 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -143.8 153.15 42.09 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.638 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -135.2 163.24 30.4 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -138.05 145.34 41.66 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.3 p -148.33 155.25 9.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.456 ' HB2' ' CG ' ' A' ' 379' ' ' HIS . 49.8 m -90.96 146.86 23.52 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.452 ' NZ ' ' HB3' ' A' ' 377' ' ' LYS . 1.7 ttpm? -63.47 121.04 12.85 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.7 0.32 57.77 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.703 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . 0.456 ' CG ' ' HB2' ' A' ' 376' ' ' SER . 12.5 m170 -103.78 171.08 7.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 120.827 0.346 . . . . 0.0 111.309 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . 0.461 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.0 mtpt -101.44 143.32 31.6 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.465 HD13 ' N ' ' A' ' 382' ' ' ARG . 0.1 OUTLIER -135.92 138.57 47.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.465 ' N ' HD13 ' A' ' 381' ' ' ILE . 55.0 mtt180 -114.62 117.35 30.63 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.377 0.608 . . . . 0.0 112.244 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 420' ' ' THR . 29.7 mt -96.53 128.81 43.81 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 28.7 m -123.74 134.57 53.66 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 14.2 m -141.97 162.82 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 C-N-CA 124.211 1.004 . . . . 0.0 108.629 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.484 ' CB ' ' HB3' ' A' ' 366' ' ' GLN . 37.8 mt-10 -123.33 138.89 54.51 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 46.2 mt -105.67 146.65 29.46 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.82 -5.72 54.15 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.386 0.613 . . . . 0.0 111.242 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -135.58 138.39 42.92 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -75.54 -22.76 56.79 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.379 0.672 . . . . 0.0 112.002 -174.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -109.6 23.16 14.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 122.763 1.268 . . . . 0.0 109.29 -174.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -101.21 139.31 37.07 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -177.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -103.25 140.75 36.97 Favored 'General case' 0 N--CA 1.393 -3.313 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.93 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.4 ' CG1' ' HG2' ' A' ' 419' ' ' ARG . 6.0 p -120.04 134.1 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.405 0 CA-C-N 113.848 -1.524 . . . . 0.0 107.556 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -111.3 146.13 37.58 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.496 ' CE2' ' HB2' ' A' ' 421' ' ' LEU . 24.4 m95 -106.19 126.75 52.6 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 7.7 mp -114.34 131.44 56.54 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -98.83 110.54 23.12 Favored 'General case' 0 N--CA 1.407 -2.588 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.751 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.0 p30 56.11 2.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 127.637 2.375 . . . . 0.0 114.121 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 131.91 -5.98 5.44 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -103.33 127.89 50.56 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.74 118.86 6.66 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 123.016 0.526 . . . . 0.0 112.036 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.43 HD13 ' CB ' ' A' ' 396' ' ' TRP . 54.0 mt -79.48 114.26 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 170.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -104.28 141.26 36.61 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' MET . . . . . 0.463 ' HB3' ' CD2' ' A' ' 412' ' ' PHE . 27.1 ptt? -70.11 109.81 4.8 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.228 -176.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.3 m -103.05 102.48 12.51 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.214 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 52.1 -124.12 23.61 Favored Glycine 0 N--CA 1.445 -0.727 0 O-C-N 124.451 1.094 . . . . 0.0 114.639 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 16.1 m -91.46 -5.76 53.77 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.435 -0.382 . . . . 0.0 111.518 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -78.33 -53.5 7.22 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.585 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . 0.457 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 90.9 m-85 -110.97 121.5 45.52 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 46.2 mt -121.7 119.64 59.39 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.71 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.463 ' CD2' ' HB3' ' A' ' 405' ' ' MET . 3.1 m-30 -88.02 106.02 17.86 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -106.69 133.67 51.0 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 9.6 t -118.73 121.7 40.73 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.569 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 65.4 mt -118.84 94.94 3.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.78 -98.63 0.62 Allowed Glycine 0 C--N 1.305 -1.142 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -121.37 3.57 10.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.062 0.458 . . . . 0.0 110.166 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 21.2 ptmt -104.9 136.6 44.08 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . 0.4 ' HG2' ' CG1' ' A' ' 394' ' ' VAL . 9.7 tpp85 -110.71 139.07 46.31 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 29.9 m -131.22 125.31 32.58 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.496 ' HB2' ' CE2' ' A' ' 396' ' ' TRP . 50.6 tp -97.83 117.68 32.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 54.3 m -103.62 106.96 17.62 Favored 'General case' 0 N--CA 1.41 -2.428 0 O-C-N 123.906 0.754 . . . . 0.0 108.967 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.87 125.16 52.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' SER . . . . . 0.461 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 44.7 m -104.59 128.8 52.7 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 66.06 66.98 0.48 Allowed 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 124.552 1.158 . . . . 0.0 110.689 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.07 122.38 17.27 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.634 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 9.2 m -105.58 -177.87 3.49 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.416 HD21 ' HG3' ' A' ' 451' ' ' GLU . 71.8 mt -68.01 -28.69 67.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.976 0.417 . . . . 0.0 110.57 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -75.32 -6.27 49.04 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.344 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -101.17 -11.08 19.83 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.14 106.83 2.53 Favored 'General case' 0 C--O 1.25 1.083 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.38 165.57 30.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.533 -176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.53 129.23 34.87 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -104.97 135.35 46.48 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 1.8 mp0 -121.54 123.91 43.11 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 91.9 m -84.45 117.05 23.41 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.25 112.73 37.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.84 160.86 14.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.03 112.88 5.35 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 119.134 -1.507 . . . . 0.0 110.749 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.39 -36.21 4.5 Favored Glycine 0 N--CA 1.405 -3.4 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.109 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.496 ' OE1' ' HE3' ' A' ' 361' ' ' LYS . 70.8 mm-40 -137.41 170.17 16.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -173.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 22.2 ptmt -147.02 162.73 38.19 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.574 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.744 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 53.2 t -149.48 135.85 19.18 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 15.3 p -103.73 142.58 34.1 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.739 0.649 . . . . 0.0 111.353 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.422 ' CG2' HD12 ' A' ' 369' ' ' LEU . 15.1 t -131.16 150.2 52.25 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.81 112.46 19.26 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.076 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 36.4 tp -85.16 142.8 29.22 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.831 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -116.01 109.75 17.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.5 t -91.96 118.08 36.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -103.65 121.99 44.09 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . 0.416 ' HG3' HD21 ' A' ' 428' ' ' LEU . 1.8 mp0 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.62 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.723 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.87 149.37 61.3 Favored 'Trans proline' 0 C--O 1.251 1.145 0 C-N-CA 123.411 2.74 . . . . 0.0 111.988 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 85.62 42.64 6.79 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.1 t -123.9 110.13 14.46 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 321' ' ' VAL . 22.1 mp0 -76.82 -39.9 49.76 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 72.74 -23.38 0.21 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 125.307 1.443 . . . . 0.0 113.061 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 319' ' ' GLU . 15.0 p -49.95 -29.02 4.85 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 C-N-CA 125.124 1.37 . . . . 0.0 112.357 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -57.92 -55.39 35.51 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.43 0.692 . . . . 0.0 110.737 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.29 -20.64 43.91 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.163 0.506 . . . . 0.0 110.708 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 76.2 mt -72.36 -50.28 36.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.703 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.26 -34.8 78.45 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.303 0.573 . . . . 0.0 110.268 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -54.92 -39.8 69.18 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.854 1.262 . . . . 0.0 112.434 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -103.54 -1.72 27.9 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.278 0.561 . . . . 0.0 110.129 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -80.94 149.22 66.47 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.824 -174.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.47 144.42 79.46 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.325 2.016 . . . . 0.0 110.066 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 30.1 Cg_endo -63.78 -22.84 69.33 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.868 2.379 . . . . 0.0 113.384 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.5 m -78.87 -8.53 58.92 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -111.38 2.38 17.55 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 121.099 -0.241 . . . . 0.0 111.183 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 12.9 m-30 -47.85 -52.36 19.41 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.43 ' O ' ' HD2' ' A' ' 338' ' ' PHE . 39.7 tt0 -60.29 -44.43 95.37 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.654 0.596 . . . . 0.0 111.312 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -59.99 -54.18 49.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.265 0.555 . . . . 0.0 109.994 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 51.5 mt -64.88 -41.23 91.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.886 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 342' ' ' VAL . . . -60.47 -55.43 33.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.993 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.43 ' HD2' ' O ' ' A' ' 334' ' ' GLU . 77.2 m-85 -68.7 -24.08 64.45 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -68.11 -40.6 82.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.552 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -93.65 -7.9 42.53 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 95.25 33.8 6.39 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.188 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 337' ' ' ALA . 8.3 t -116.57 106.35 20.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 72.0 p -91.28 -18.26 24.65 Favored 'General case' 0 C--N 1.265 -3.078 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.816 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -96.57 45.89 1.06 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.978 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -30.29 70.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.082 0.468 . . . . 0.0 110.799 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -67.99 -29.27 68.25 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' A' ' 351' ' ' ARG . . . -72.48 -37.43 58.49 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.909 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 27.4 ttt -63.25 -42.02 99.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.5 -42.49 87.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.685 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -55.96 -47.56 77.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.234 1.014 . . . . 0.0 110.331 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 347' ' ' GLY . 74.3 mtp180 -62.6 -43.81 97.87 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.969 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.76 -47.75 84.88 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.146 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.47 -8.92 57.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.964 0.411 . . . . 0.0 111.076 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -95.96 -1.2 61.56 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.737 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 25.8 mmt -77.97 -70.64 0.47 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -93.11 111.77 23.5 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.025 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.75 135.73 5.77 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -100.66 85.24 2.88 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 122.634 1.207 . . . . 0.0 111.137 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.85 111.5 18.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.622 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -134.09 141.52 47.18 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.538 178.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -125.02 -21.63 4.63 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.388 -174.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 16.3 m 63.21 65.62 0.76 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.589 1.956 . . . . 0.0 111.292 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.8 t -139.09 -30.71 0.73 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.845 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -91.24 -11.06 39.31 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.726 0.774 . . . . 0.0 109.422 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.46 127.72 48.0 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -89.64 -32.06 17.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.485 0.659 . . . . 0.0 109.314 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.5 OUTLIER -148.83 116.07 6.12 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.355 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -91.17 163.9 14.1 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 59.6 mt -64.84 144.6 57.15 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 123.837 0.71 . . . . 0.0 109.272 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -67.45 146.42 98.69 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -45.89 -43.05 19.98 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 123.597 2.865 . . . . 0.0 113.821 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -148.9 155.06 40.33 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.068 0.461 . . . . 0.0 111.002 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -137.81 158.65 43.91 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -129.22 142.63 50.8 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.8 p -140.64 151.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 43.3 m -81.45 145.09 30.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -62.4 117.54 6.29 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.691 0.282 . . . . 0.0 111.163 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.09 5.13 57.41 Favored Glycine 0 CA--C 1.499 -0.914 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -104.96 163.25 12.67 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.47 148.17 24.52 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.431 HG23 ' SG ' ' A' ' 426' ' ' CYS . 15.9 tt -150.55 149.25 14.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 1.2 ptp180 -127.37 137.16 52.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.446 0.641 . . . . 0.0 112.325 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.07 153.97 20.78 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 50.7 m -139.68 138.23 35.86 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.692 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.13 144.02 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 35.1 mt-10 -121.28 137.19 54.8 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.42 HD13 ' NH1' ' A' ' 419' ' ' ARG . 96.4 mt -96.67 157.13 16.04 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.472 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -86.46 -15.25 40.77 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -127.93 142.72 51.18 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -80.67 -23.35 39.68 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -106.03 21.94 16.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.307 0.575 . . . . 0.0 110.545 -174.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -99.39 159.16 15.21 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -121.79 145.81 47.69 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 118.585 -1.246 . . . . 0.0 112.983 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 11.7 m -109.94 158.85 9.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.314 175.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -132.35 133.46 44.01 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -101.03 127.41 47.55 Favored 'General case' 0 C--N 1.275 -2.634 0 O-C-N 124.458 1.099 . . . . 0.0 108.527 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 402' ' ' GLU . 10.1 mt -137.64 146.02 43.39 Favored 'General case' 0 CA--C 1.458 -2.559 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 433' ' ' ALA . 22.5 pttp -126.58 132.82 51.21 Favored 'General case' 0 N--CA 1.399 -3.002 0 C-N-CA 118.772 -1.171 . . . . 0.0 109.652 174.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.6 p30 48.41 27.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 126.438 1.895 . . . . 0.0 114.451 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.06 23.35 30.05 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.865 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 402' ' ' GLU . 6.3 tp60 -114.18 -96.22 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.559 0.219 . . . . 0.0 111.317 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 397' ' ' LEU . 43.6 tt0 176.92 135.97 0.06 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 58.1 mt -91.07 128.67 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.997 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -99.43 138.5 36.44 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' MET . . . . . 0.454 ' HB2' ' CE1' ' A' ' 412' ' ' PHE . 60.1 ttp -79.62 80.9 5.96 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 t -88.81 111.33 21.9 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.363 -171.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 54.06 -125.12 32.44 Favored Glycine 0 N--CA 1.446 -0.698 0 O-C-N 124.331 1.019 . . . . 0.0 113.443 176.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 15.3 m -106.74 3.85 27.04 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.719 0.771 . . . . 0.0 108.927 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -75.2 -41.8 57.04 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.399 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -119.27 117.98 30.03 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 43.9 mm -114.96 114.82 47.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.473 ' CE2' HD12 ' A' ' 421' ' ' LEU . 22.3 m-30 -87.42 109.96 19.94 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -105.01 108.57 20.16 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 78.6 p -99.69 121.6 41.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.235 0.541 . . . . 0.0 109.65 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.5 mm -123.64 85.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.94 -90.39 0.13 Allowed Glycine 0 C--N 1.321 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 113.825 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -102.36 -28.16 12.41 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.817 0.342 . . . . 0.0 110.332 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 386' ' ' GLU . 21.2 ptmt -93.8 134.8 35.76 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.754 0.788 . . . . 0.0 112.44 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . 0.42 ' NH1' HD13 ' A' ' 387' ' ' LEU . 10.8 mpt_? -110.86 124.36 51.92 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 28.6 m -115.89 122.26 44.8 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.473 HD12 ' CE2' ' A' ' 412' ' ' PHE . 20.2 tp -103.61 109.02 20.54 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.0 m -100.02 110.75 23.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.403 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.8 mt -96.95 141.18 16.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 31.8 m -120.72 135.89 55.01 Favored 'General case' 0 N--CA 1.388 -3.561 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 59.31 58.47 3.01 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 124.783 1.302 . . . . 0.0 111.332 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . 0.431 ' SG ' HG23 ' A' ' 381' ' ' ILE . 60.7 m -63.6 113.46 3.35 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.347 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.7 m -100.37 -176.84 3.33 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.19 -23.77 63.96 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.125 0.488 . . . . 0.0 111.184 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.29 -5.65 50.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.048 0.452 . . . . 0.0 110.867 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -98.21 -5.7 32.79 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.073 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.82 88.7 1.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -146.7 162.49 38.39 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.166 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 398' ' ' LYS . . . -85.42 129.35 34.83 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -108.26 132.47 53.64 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.6 144.93 41.26 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.484 ' SG ' HD12 ' A' ' 369' ' ' LEU . 79.1 m -122.84 103.08 8.4 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . 0.481 HG21 ' HG3' ' A' ' 442' ' ' LYS . 14.8 t -104.77 136.92 36.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.14 -174.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 441' ' ' GLU . 29.9 t -122.17 161.14 23.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 174.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -74.41 109.73 2.88 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 115.423 -3.275 . . . . 0.0 110.176 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 104.61 4.34 43.04 Favored Glycine 0 N--CA 1.42 -2.367 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 438' ' ' VAL . 4.5 tp10 -151.53 143.27 23.71 Favored 'General case' 0 N--CA 1.396 -3.14 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -176.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.481 ' HG3' HG21 ' A' ' 437' ' ' VAL . 26.9 ttpt -148.93 152.77 36.96 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.04 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 28.4 p -150.11 144.18 25.55 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 170.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 22.6 m -133.62 140.52 47.16 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 13.3 t -122.45 148.16 45.46 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.14 111.03 20.4 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 51.6 tp -84.36 134.3 34.49 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.98 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -107.89 115.09 29.5 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.27 108.38 19.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 376' ' ' SER . 3.8 tmmm? -100.21 117.82 35.24 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -176.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--N 1.303 -1.423 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.604 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.285 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.25 103.48 1.29 Allowed 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.409 2.073 . . . . 0.0 110.068 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -131.05 -115.65 1.74 Allowed Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.6 p -96.81 -28.48 14.24 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.629 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 321' ' ' VAL . 1.4 mp0 68.33 -52.69 0.54 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 125.509 1.524 . . . . 0.0 111.814 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 70.61 -20.6 0.2 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 125.839 1.656 . . . . 0.0 112.848 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 319' ' ' GLU . 13.3 p -50.52 -44.04 24.13 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.814 0 C-N-CA 125.257 1.423 . . . . 0.0 111.442 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -59.33 -42.8 92.31 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.73 -38.28 18.43 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.8 mt -65.61 -45.83 91.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 120.74 0.305 . . . . 0.0 110.36 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.9 tt -68.23 -32.63 72.96 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.208 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -63.95 -34.63 78.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.103 0.561 . . . . 0.0 110.728 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -94.5 1.59 55.71 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.764 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.78 155.41 36.59 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.751 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . 0.431 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 15.6 Cg_endo -60.31 142.78 98.96 Favored 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 122.665 2.244 . . . . 0.0 112.422 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.27 -26.98 72.99 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.21 3.273 . . . . 0.0 114.753 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 41.7 m -83.55 -1.19 53.23 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.11 0.481 . . . . 0.0 112.231 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.431 ' CG ' ' HG2' ' A' ' 329' ' ' PRO . 63.0 mm-40 -100.39 -11.29 20.37 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -45.84 -49.07 15.68 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . 0.411 ' O ' ' HD1' ' A' ' 338' ' ' PHE . 45.4 tt0 -72.83 -34.59 66.92 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.97 0.414 . . . . 0.0 110.805 -175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -65.51 -44.32 87.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 332' ' ' GLU . 66.2 mt -67.08 -43.57 88.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.155 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.19 -54.26 48.81 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.454 0.471 . . . . 0.0 110.653 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 75.3 m-85 -69.81 -23.09 63.27 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -66.88 -36.21 81.79 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.09 0.471 . . . . 0.0 109.981 175.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -100.96 2.58 40.83 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 83.61 22.31 56.32 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.649 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.47 123.09 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 28.7 p -100.62 -28.55 12.8 Favored 'General case' 0 C--N 1.27 -2.863 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.999 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.6 56.57 3.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.715 0.769 . . . . 0.0 111.74 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 31.8 tp -58.2 -52.97 63.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.469 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.27 -26.49 68.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.729 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -65.37 -37.02 93.4 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 26.8 ttt -67.9 -50.85 53.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.27 -30.83 71.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.55 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -57.59 -56.77 17.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.913 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -72.48 -23.7 61.07 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.042 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.03 -28.67 64.56 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 120.992 0.425 . . . . 0.0 111.341 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -86.95 -20.72 26.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.677 0.751 . . . . 0.0 109.944 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -104.73 34.59 5.67 Favored Glycine 0 C--N 1.301 -1.391 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.663 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 69.6 mtm -68.09 3.91 1.43 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -81.65 -16.82 50.17 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.631 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -103.17 -177.8 3.48 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -139.8 105.2 5.07 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.295 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -22.97 11.46 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.516 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 71.23 173.38 0.31 Allowed 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.11 1.364 . . . . 0.0 112.583 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -58.19 -30.83 66.74 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.067 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.497 ' CB ' ' HZ2' ' A' ' 368' ' ' LYS . 47.9 m 68.18 64.73 0.35 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 122.775 1.274 . . . . 0.0 110.934 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.5 t -129.17 -15.11 4.24 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.172 -1.831 . . . . 0.0 108.569 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -90.43 -38.2 13.44 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 368' ' ' LYS . 11.9 m-85 -86.92 146.89 26.0 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 169.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -102.38 -15.67 16.46 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -168.5 125.04 1.01 Allowed 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 62.0 mttp -100.35 169.27 9.23 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 123.452 0.47 . . . . 0.0 110.16 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 70.3 mt -64.14 143.11 58.12 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.548 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -68.25 146.76 98.15 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -45.7 -43.44 18.68 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.817 3.011 . . . . 0.0 113.837 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -149.05 137.42 20.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.327 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.411 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 78.8 m-85 -118.78 159.61 23.4 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 127.08 28.15 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.0 p -133.4 160.87 42.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 14.1 m -95.66 142.84 27.5 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.26 127.3 30.85 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.984 0.421 . . . . 0.0 110.099 -176.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 95.43 1.78 62.17 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.972 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -100.97 172.37 7.07 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.917 0.389 . . . . 0.0 110.887 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 26.5 mtpp -97.85 134.75 40.57 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 6.7 tp -130.31 135.99 59.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 26.8 ptt180 -127.58 128.74 46.11 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.406 0.622 . . . . 0.0 112.591 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -105.98 138.89 41.4 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.462 -1.244 . . . . 0.0 107.793 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 51.5 m -119.04 128.41 54.33 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.803 0.335 . . . . 0.0 111.794 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 13.5 m -126.41 145.08 34.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -118.33 136.83 53.49 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 392' ' ' ALA . 3.9 mm? -95.59 152.37 18.49 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.066 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.74 -33.41 58.14 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -101.31 154.54 18.69 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -77.37 -40.34 44.18 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -174.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -103.34 7.39 38.23 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.788 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . 0.564 ' O ' ' HG ' ' A' ' 387' ' ' LEU . . . -84.14 132.63 34.67 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 175.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.95 177.31 7.2 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.034 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.44 164.38 8.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.466 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -107.92 148.76 29.2 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.406 ' CB ' ' HB ' ' A' ' 403' ' ' ILE . 9.5 m-90 -110.22 113.01 25.34 Favored 'General case' 0 C--N 1.274 -2.699 0 O-C-N 124.144 0.902 . . . . 0.0 109.587 -171.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 401' ' ' GLN . 7.8 mp -126.35 134.26 51.12 Favored 'General case' 0 CA--C 1.48 -1.727 0 CA-C-O 120.675 0.274 . . . . 0.0 111.217 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -113.95 132.76 55.84 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 46.95 24.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.89 14.79 64.24 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.431 ' O ' ' HG ' ' A' ' 397' ' ' LEU . 24.7 tp60 -94.61 -116.29 0.1 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -174.62 128.45 0.33 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 173.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.406 ' HB ' ' CB ' ' A' ' 396' ' ' TRP . 68.4 mt -81.56 101.9 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -82.23 127.68 33.43 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.69 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -66.22 102.47 0.84 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.7 m -110.92 110.0 20.4 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.877 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 52.32 -119.16 8.64 Favored Glycine 0 N--CA 1.444 -0.801 0 O-C-N 124.408 1.067 . . . . 0.0 114.048 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.7 m -108.23 5.74 26.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.205 0.526 . . . . 0.0 110.669 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.04 -41.01 59.98 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.835 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -117.4 109.75 17.17 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.323 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 43.5 mm -108.12 114.88 47.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.466 ' CE1' HD11 ' A' ' 421' ' ' LEU . 23.0 m-85 -87.85 105.96 17.77 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -98.02 108.65 21.41 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.444 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 12.6 p -103.4 105.08 15.26 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.575 0.702 . . . . 0.0 109.85 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 51.2 mt -112.75 83.75 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 76.83 -111.6 3.31 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -97.56 -14.01 21.3 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.135 0.493 . . . . 0.0 109.923 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -78.43 119.34 21.6 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 124.047 0.939 . . . . 0.0 111.023 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . 0.426 ' HD3' HD22 ' A' ' 387' ' ' LEU . 9.9 mpt_? -111.37 113.85 26.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 99.0 m -115.06 116.17 28.0 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.577 0.703 . . . . 0.0 110.593 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 382' ' ' ARG . 26.3 tp -91.0 115.5 28.06 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.106 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.2 m -103.85 112.23 25.11 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 56.8 mt -100.26 118.13 46.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 11.3 m -96.91 138.93 33.7 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 63.15 47.65 4.05 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 124.019 0.824 . . . . 0.0 110.599 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 44.4 t -57.92 118.6 5.54 Favored 'General case' 0 C--O 1.249 1.068 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 16.1 m -107.89 -177.81 3.44 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -175.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.78 -23.11 63.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.03 0.443 . . . . 0.0 110.604 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -74.39 -5.02 39.96 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.582 0.706 . . . . 0.0 110.27 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -110.88 -9.57 14.45 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.922 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.1 98.68 0.6 Allowed 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 170.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -164.78 173.67 11.53 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.575 -169.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.4 132.05 34.29 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 444' ' ' SER . 23.7 m-85 -111.42 132.06 54.73 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.3 OUTLIER -118.1 134.4 55.03 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.009 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.441 ' SG ' HD12 ' A' ' 369' ' ' LEU . 73.4 m -109.45 113.07 25.57 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 11.0 t -105.34 125.24 60.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.732 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.62 160.92 15.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -69.73 113.2 4.89 Favored Glycine 0 N--CA 1.419 -2.435 0 C-N-CA 118.316 -1.897 . . . . 0.0 109.39 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.22 -35.75 4.79 Favored Glycine 0 N--CA 1.425 -2.046 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.937 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' A' ' 362' ' ' SER . 86.7 mt-10 -135.81 158.0 45.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.576 1.188 . . . . 0.0 111.596 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -148.73 173.19 13.49 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 35.0 t -159.96 142.74 13.64 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 170.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 434' ' ' TYR . 12.3 p -122.1 130.94 53.69 Favored 'General case' 0 N--CA 1.418 -2.072 0 O-C-N 123.801 0.688 . . . . 0.0 110.09 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 10.7 t -107.02 142.3 36.86 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -98.58 110.02 22.69 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 38.7 tp -89.22 138.83 31.08 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.898 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -115.19 111.23 20.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.17 119.07 45.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 450' ' ' LYS . 0.0 OUTLIER -100.23 134.59 42.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.225 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.612 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.688 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -63.3 111.49 1.46 Allowed 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.157 1.905 . . . . 0.0 109.924 174.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 107.4 13.24 21.38 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 10.1 m -125.32 0.37 7.71 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.128 0.49 . . . . 0.0 109.985 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.11 165.67 10.92 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -175.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 72.78 -4.88 2.01 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.616 1.166 . . . . 0.0 112.985 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.82 -33.08 33.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 C-N-CA 123.511 0.724 . . . . 0.0 111.272 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -54.02 -46.46 71.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.907 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.13 -38.11 18.08 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.702 177.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.01 -54.91 28.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 O-C-N 123.223 0.327 . . . . 0.0 111.613 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.15 -21.29 65.83 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.652 0.739 . . . . 0.0 110.148 -175.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -72.8 -37.53 67.53 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.075 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -94.03 -23.99 17.8 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.634 0.73 . . . . 0.0 110.431 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.34 89.51 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.763 -176.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -63.85 137.55 58.75 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.509 2.139 . . . . 0.0 112.649 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.67 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 8.9 Cg_endo -52.23 -29.44 37.89 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.302 3.335 . . . . 0.0 115.555 -175.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 11.8 p -70.86 -23.84 62.39 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . 0.527 ' O ' HG13 ' A' ' 336' ' ' ILE . 22.1 mm-40 -95.27 -4.51 45.55 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -171.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . 0.67 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 21.5 m-30 -46.12 -48.59 17.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -173.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.04 -29.46 68.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.061 0.458 . . . . 0.0 111.42 -175.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -76.01 -47.29 25.42 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 332' ' ' GLU . 60.7 mt -58.45 -44.12 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.117 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.85 -58.52 8.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.305 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -68.69 -23.51 64.39 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -71.13 -35.68 71.83 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.16 0.584 . . . . 0.0 110.03 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -100.9 5.35 43.28 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 79.89 38.53 19.37 Favored Glycine 0 C--N 1.31 -0.912 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.699 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.9 t -114.82 119.14 60.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 23.6 p -99.1 -14.55 19.35 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-O 121.556 0.693 . . . . 0.0 110.751 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.79 45.43 0.97 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.327 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 1.3 pt? -68.33 -36.12 78.79 Favored 'General case' 0 C--O 1.197 -1.67 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.986 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -71.9 -24.4 61.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.183 0.516 . . . . 0.0 111.113 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.575 ' O ' ' HG2' ' A' ' 350' ' ' LYS . . . -77.11 -28.79 57.8 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 174.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 26.6 ttt -78.67 -41.76 30.38 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.271 0.557 . . . . 0.0 109.583 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 81.4 mt -64.92 -35.12 80.13 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.844 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 347' ' ' GLY . 25.2 pttm -61.21 -27.26 68.31 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.215 0.531 . . . . 0.0 111.232 -177.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -62.47 -50.11 72.74 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.896 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.09 -32.87 30.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.413 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -68.63 -38.29 80.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.104 0.478 . . . . 0.0 110.217 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -102.4 26.82 22.87 Favored Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 35.0 tpp -85.15 -60.64 1.98 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.85 0.357 . . . . 0.0 111.083 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -91.42 -13.29 32.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.842 0.829 . . . . 0.0 110.678 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . 0.405 ' HD3' ' C ' ' A' ' 357' ' ' ARG . 1.7 tmt_? -70.94 94.93 1.11 Allowed 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 172.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -156.15 -48.81 0.08 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -66.68 -19.72 65.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.825 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 71.59 -84.82 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.871 1.268 . . . . 0.0 108.149 -172.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt 46.74 -87.22 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.263 1.425 . . . . 0.0 113.107 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 54.3 p -170.48 78.62 0.08 Allowed 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 16.7 p -111.69 -30.47 7.32 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.471 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.64 -13.47 15.57 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -110.32 136.02 50.15 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.198 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -98.02 -19.78 17.8 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.389 0.614 . . . . 0.0 110.016 175.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -158.5 122.35 3.98 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.7 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 45.4 mtpt -106.69 172.33 6.87 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 80.9 mt -75.04 132.67 41.48 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.02 127.97 88.56 Favored Pre-proline 0 CA--C 1.5 -0.973 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.64 -32.18 53.32 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.279 1.986 . . . . 0.0 112.438 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -110.57 110.97 21.89 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.466 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 13.9 m-85 -118.43 151.07 38.49 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 171.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -144.87 143.54 30.64 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 10.6 p -150.63 154.89 8.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 379' ' ' HIS . 16.1 m -85.55 157.19 20.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 427' ' ' SER . 35.6 ttpt -71.98 135.35 46.38 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.782 0.325 . . . . 0.0 111.071 -177.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 85.86 15.58 65.1 Favored Glycine 0 C--N 1.318 -0.469 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.8 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . 0.521 ' CD2' ' HB2' ' A' ' 376' ' ' SER . 31.5 m-70 -105.35 -177.53 3.39 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.984 0.421 . . . . 0.0 110.317 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -114.63 138.46 50.64 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.95 130.71 73.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 CA-C-O 120.904 0.383 . . . . 0.0 109.98 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -108.27 103.62 12.83 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.161 0.505 . . . . 0.0 110.475 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.26 113.11 20.88 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 19.9 m -110.35 130.86 55.47 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.149 -171.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.7 151.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 123.55 0.74 . . . . 0.0 109.69 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.427 ' HG2' ' HB3' ' A' ' 418' ' ' LYS . 50.0 mt-10 -118.55 131.61 56.22 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 26.1 mt -100.91 148.94 24.41 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -81.84 3.87 24.42 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.088 0.471 . . . . 0.0 111.782 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -142.43 136.84 29.89 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -80.42 -21.87 41.76 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.564 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -102.58 4.51 38.49 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.153 0.978 . . . . 0.0 110.042 -173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -100.21 134.84 42.56 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.96 175.89 5.24 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.847 -174.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 4.8 p -131.36 141.32 46.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 120.967 0.413 . . . . 0.0 111.082 -172.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -114.02 135.85 53.55 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 175.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -104.35 134.35 47.7 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.913 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 8.3 mp -119.85 125.75 49.29 Favored 'General case' 0 CA--C 1.475 -1.909 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.031 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -102.62 127.38 49.75 Favored 'General case' 0 N--CA 1.416 -2.147 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.702 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 20.9 p30 54.95 15.38 1.14 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 127.125 2.17 . . . . 0.0 113.498 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.2 19.37 42.59 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.251 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -98.13 -89.29 0.3 Allowed 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 169.63 145.9 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 30.3 mt -99.24 108.04 21.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -95.96 134.01 39.48 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.159 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -65.74 104.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.461 0.475 . . . . 0.0 110.674 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 30.6 t -117.44 120.76 39.11 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 50.84 -122.42 13.59 Favored Glycine 0 C--N 1.336 0.579 0 O-C-N 124.25 0.969 . . . . 0.0 113.574 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 23.8 m -116.72 19.6 14.42 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -76.5 -44.6 34.53 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.01 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -122.47 108.53 13.28 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.951 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.24 114.89 45.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -88.09 104.82 17.03 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.442 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -99.37 119.14 37.47 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 13.1 t -115.26 108.18 16.24 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 66.0 mt -113.95 82.75 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.345 -174.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.21 -104.17 1.14 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.144 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -94.26 -21.89 18.74 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 122.409 0.284 . . . . 0.0 110.851 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . 0.427 ' HB3' ' HG2' ' A' ' 386' ' ' GLU . 21.5 ptmt -101.45 137.08 40.25 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.713 0.768 . . . . 0.0 111.47 -175.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -118.47 139.06 52.01 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.022 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 34.4 m -134.37 117.24 16.12 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-O 121.483 0.659 . . . . 0.0 110.503 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 57.1 tp -91.2 113.45 25.71 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 29.1 m -97.59 106.72 19.08 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.73 116.4 33.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 14.7 m -96.5 146.09 25.11 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.001 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 58.26 50.4 9.77 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.189 1.396 . . . . 0.0 110.15 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 8.0 p -60.46 112.96 2.17 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.73 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' SER . . . . . 0.428 ' HA ' ' HG3' ' A' ' 377' ' ' LYS . 17.7 m -109.98 -170.46 1.65 Allowed 'General case' 0 N--CA 1.406 -2.629 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.08 -21.06 62.28 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 118.964 0.802 . . . . 0.0 111.736 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -73.24 -14.31 61.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.375 0.607 . . . . 0.0 110.077 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -98.34 9.08 43.88 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.78 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.5 107.64 17.54 Favored 'General case' 0 C--O 1.252 1.22 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -155.44 165.01 37.93 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.99 0.424 . . . . 0.0 110.556 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -86.59 115.35 24.01 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -104.87 133.05 50.33 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.019 0.438 . . . . 0.0 110.578 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 2.0 mp0 -128.08 134.29 49.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 3.7 p -100.89 118.36 36.79 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.65 123.29 58.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 92.9 t -131.44 160.68 42.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.18 114.61 7.05 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.031 -1.081 . . . . 0.0 111.059 175.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.83 -36.49 4.32 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-O 119.31 -0.717 . . . . 0.0 113.7 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -139.16 -179.75 6.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.728 1.251 . . . . 0.0 114.228 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 443' ' ' CYS . 33.0 ttmt -149.24 157.12 43.09 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.4 t -143.63 134.43 25.24 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 171.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 12.2 p -110.15 142.77 41.2 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 123.573 0.545 . . . . 0.0 110.917 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.466 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 8.8 t -137.87 147.59 44.6 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.23 111.13 23.37 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 64.5 tp -88.82 111.3 21.86 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -93.13 107.87 19.58 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.8 t -92.22 114.23 28.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -107.2 124.13 49.29 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.427 -1.577 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.836 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.08 103.13 1.7 Allowed 'Trans proline' 0 C--O 1.251 1.14 0 C-N-CA 122.621 2.214 . . . . 0.0 110.807 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -131.04 10.54 5.65 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.321 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 28.7 m -135.55 27.58 3.37 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.725 0.774 . . . . 0.0 109.543 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.38 -45.63 10.38 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.502 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 72.68 1.0 3.84 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.681 1.592 . . . . 0.0 111.902 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.89 -36.31 49.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 123.438 0.695 . . . . 0.0 111.675 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 31.9 p-90 -58.22 -41.63 84.5 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 123.182 0.593 . . . . 0.0 111.653 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.6 -45.97 10.55 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 80.1 mt -58.2 -52.44 58.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.0 tt -66.43 -33.54 75.94 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 121.501 0.667 . . . . 0.0 109.617 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -64.47 -32.89 74.71 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 124.524 1.129 . . . . 0.0 111.446 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -96.97 -11.08 25.03 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.331 0.586 . . . . 0.0 110.845 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -83.84 161.77 54.68 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.412 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.52 142.25 58.49 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.68 2.254 . . . . 0.0 110.829 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.98 -16.69 56.31 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 123.784 2.989 . . . . 0.0 114.199 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.4 m -77.54 -17.07 58.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.719 0.295 . . . . 0.0 111.765 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -104.43 1.13 29.72 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -53.4 -42.54 67.07 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -174.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.8 -27.87 55.4 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.395 -177.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 -63.62 -54.44 35.83 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 34.0 mt -64.01 -43.41 97.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.751 -176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.47 -59.99 4.56 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.2 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.26 -22.78 66.32 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -65.67 -42.56 91.16 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.235 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -97.95 7.04 46.99 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 90.07 13.72 60.13 Favored Glycine 0 CA--C 1.499 -0.912 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.904 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.0 t -94.54 99.43 9.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.3 m -76.39 -38.75 55.25 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.082 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -110.09 94.21 4.9 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.643 0.735 . . . . 0.0 109.873 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . 0.486 HD22 ' H ' ' A' ' 345' ' ' LEU . 1.8 pt? -75.65 -29.8 59.22 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.356 -178.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -63.86 -38.65 91.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.479 -174.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -66.13 -34.79 89.3 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.79 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 60.9 ttp -70.46 -43.3 70.12 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.431 ' O ' ' HG2' ' A' ' 353' ' ' LYS . 94.3 mt -62.1 -40.46 95.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.493 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -65.86 -33.4 75.75 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.854 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -70.21 -42.24 72.59 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.256 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.26 -42.16 69.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 349' ' ' LEU . 18.6 ptpt -77.06 -16.92 59.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.867 0.841 . . . . 0.0 109.224 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -83.83 0.76 89.4 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.005 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 25.5 mmt -71.7 -10.9 60.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 122.068 0.937 . . . . 0.0 108.762 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -78.3 16.95 0.69 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.123 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' ARG . . . . . 0.424 ' HD2' ' O ' ' A' ' 358' ' ' ASP . 7.6 ppt_? -66.7 -19.68 65.81 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.517 0.675 . . . . 0.0 109.961 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.424 ' O ' ' HD2' ' A' ' 357' ' ' ARG . 8.4 t70 67.04 -154.71 0.22 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.551 171.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.421 ' H ' ' CG ' ' A' ' 358' ' ' ASP . 36.9 mt-10 63.8 66.51 0.66 Allowed 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.514 1.126 . . . . 0.0 109.836 -174.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -100.82 176.84 5.15 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.667 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.51 ' C ' ' HG ' ' A' ' 362' ' ' SER . 0.0 OUTLIER 58.62 32.48 22.21 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 123.09 1.424 . . . . 0.0 107.556 -176.387 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.51 ' HG ' ' C ' ' A' ' 361' ' ' LYS . 15.6 m -158.39 45.69 0.32 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.034 -177.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.8 t -101.51 -37.36 8.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.335 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.412 ' HB1' ' HG3' ' A' ' 441' ' ' GLU . . . -86.39 -27.06 24.44 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.869 0.842 . . . . 0.0 109.482 177.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.65 127.63 35.95 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.23 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -90.54 -28.37 18.55 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' LYS . . . . . 0.452 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.4 OUTLIER -149.46 115.4 5.68 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 177.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.407 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 57.9 mtpt -89.85 162.09 15.65 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 175.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 74.5 mt -64.57 138.65 58.52 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -61.83 145.0 92.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.76 -24.09 44.8 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.6 2.2 . . . . 0.0 113.437 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -142.68 135.6 28.2 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.87 0.367 . . . . 0.0 111.668 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -135.69 146.79 48.12 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -131.05 136.04 48.1 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.47 146.41 31.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 15.5 m -82.79 142.37 31.62 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -57.38 115.84 2.96 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 122.958 0.503 . . . . 0.0 111.248 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 108.03 -18.51 33.81 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.504 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -82.25 179.98 7.61 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.114 0.483 . . . . 0.0 110.925 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . 0.436 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 54.3 mtpt -108.76 140.07 42.69 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.579 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.6 tp -127.12 133.25 68.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 176.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -105.87 112.6 25.72 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.918 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.51 110.65 22.44 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 45.0 m -108.32 128.89 55.14 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.65 143.45 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 172.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 18.0 mt-10 -120.13 138.37 53.62 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.403 HD11 ' NH1' ' A' ' 419' ' ' ARG . 95.5 mt -100.19 152.35 20.37 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -85.24 -14.63 46.14 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.403 0.621 . . . . 0.0 110.081 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -117.84 141.47 48.39 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -79.99 -26.84 39.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.795 0.331 . . . . 0.0 111.718 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -108.04 25.61 11.38 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.632 1.206 . . . . 0.0 109.896 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -96.75 154.97 16.98 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.15 149.23 51.95 Favored 'General case' 0 C--N 1.274 -2.7 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.116 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 5.3 m -105.92 135.79 42.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.056 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -103.74 136.69 42.97 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' TRP . . . . . 0.495 ' HB3' HD12 ' A' ' 403' ' ' ILE . 4.8 m-90 -103.23 118.53 36.99 Favored 'General case' 0 C--N 1.264 -3.148 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.981 -170.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.7 mp -128.75 130.21 46.77 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 120.966 0.412 . . . . 0.0 111.757 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -109.22 128.06 54.75 Favored 'General case' 0 N--CA 1.412 -2.363 0 C-N-CA 118.886 -1.126 . . . . 0.0 108.894 170.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.5 p30 49.57 23.86 1.03 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.698 1.599 . . . . 0.0 113.295 -176.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.34 4.96 60.74 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.737 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -90.12 -92.26 0.13 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.501 0.191 . . . . 0.0 110.6 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 171.77 133.69 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . 0.495 HD12 ' HB3' ' A' ' 396' ' ' TRP . 15.0 mt -94.71 124.84 47.36 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 173.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -123.76 145.17 49.22 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.996 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' MET . . . . . 0.527 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 27.3 ttt -64.91 94.26 0.13 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.677 0.791 . . . . 0.0 111.32 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.6 t -93.5 101.08 13.26 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.23 -128.8 48.21 Favored Glycine 0 N--CA 1.446 -0.659 0 O-C-N 123.915 0.759 . . . . 0.0 112.191 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.7 m -105.24 18.16 22.78 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.395 0.617 . . . . 0.0 109.599 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 424' ' ' SER . 86.5 tttt -83.03 -59.76 2.38 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.359 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' TYR . . . . . 0.527 ' O ' ' HG3' ' A' ' 405' ' ' MET . 75.9 m-85 -96.44 108.12 20.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.76 115.13 48.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.189 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.548 ' CE2' HD12 ' A' ' 421' ' ' LEU . 25.4 m-85 -87.41 106.02 17.67 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.8 108.76 21.53 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 29.8 t -95.64 122.8 38.79 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.488 ' HB ' ' CG ' ' A' ' 418' ' ' LYS . 58.3 mt -129.08 85.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.75 -98.03 0.33 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.491 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -92.26 -28.96 16.66 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.849 0.357 . . . . 0.0 110.57 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' LYS . . . . . 0.488 ' CG ' ' HB ' ' A' ' 415' ' ' ILE . 23.2 ptmt -92.55 146.72 23.45 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.896 0.855 . . . . 0.0 112.143 -175.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' ARG . . . . . 0.403 ' NH1' HD11 ' A' ' 387' ' ' LEU . 11.4 mpt_? -125.25 125.07 42.99 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 173.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 34.7 m -121.18 126.61 50.11 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 120.925 0.393 . . . . 0.0 110.279 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' LEU . . . . . 0.548 HD12 ' CE2' ' A' ' 412' ' ' PHE . 33.4 tp -98.15 108.44 21.15 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.7 m -94.83 105.23 17.15 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.718 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 52.4 mt -90.06 115.7 30.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 409' ' ' LYS . 19.5 m -102.25 128.67 48.69 Favored 'General case' 0 N--CA 1.406 -2.635 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 69.97 59.93 0.27 Allowed 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 124.343 1.027 . . . . 0.0 110.148 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' CYS . . . . . 0.579 ' SG ' HG22 ' A' ' 381' ' ' ILE . 27.8 m -66.23 113.72 4.78 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.268 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 14.5 m -106.43 -166.37 1.18 Allowed 'General case' 0 N--CA 1.404 -2.762 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 54.5 mt -77.84 -22.48 49.86 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.315 -174.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -73.03 -6.41 45.34 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.64 0.733 . . . . 0.0 110.277 176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -103.69 2.71 33.45 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.077 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -87.36 100.04 12.43 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -154.58 167.19 30.95 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.78 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.66 122.9 30.42 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 170.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -108.04 132.25 53.74 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 120.754 0.311 . . . . 0.0 110.468 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.443 ' OE1' ' HB3' ' A' ' 444' ' ' SER . 2.1 mp0 -121.86 126.08 47.9 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.098 0.475 . . . . 0.0 110.668 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 10.7 p -95.48 113.95 25.67 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.4 123.91 65.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.747 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.48 162.69 32.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.5 113.09 5.55 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 118.448 -1.834 . . . . 0.0 110.727 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.26 -35.23 5.1 Favored Glycine 0 N--CA 1.429 -1.818 0 CA-C-O 119.661 -0.522 . . . . 0.0 113.524 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.412 ' HG3' ' HB1' ' A' ' 364' ' ' ALA . 3.3 mm-40 -130.84 154.2 48.29 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 117.944 0.872 . . . . 0.0 110.75 -173.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -148.58 154.65 40.05 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 435' ' ' GLN . 13.6 t -147.74 139.45 23.95 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' SER . . . . . 0.443 ' HB3' ' OE1' ' A' ' 435' ' ' GLN . 3.4 m -115.78 118.99 34.56 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.739 0.649 . . . . 0.0 109.465 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 11.0 t -105.92 146.23 30.26 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -101.59 110.29 22.25 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 66.6 tp -96.2 118.04 31.97 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -101.76 117.73 35.48 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.68 113.13 30.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -95.09 119.29 33.34 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.958 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 9.0 p -45.93 -29.35 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.185 0 C-N-CA 125.957 1.703 . . . . 0.0 113.769 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -62.62 -56.38 18.37 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.807 0.843 . . . . 0.0 110.878 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.49 -31.12 66.74 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.255 0.55 . . . . 0.0 110.052 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.51 -50.58 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.364 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.67 -35.97 82.74 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.064 0.459 . . . . 0.0 110.497 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -57.61 -33.9 68.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.33 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -109.42 6.63 24.45 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.288 -175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -89.59 155.78 48.12 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -62.91 136.56 57.71 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.34 2.027 . . . . 0.0 110.508 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 9.7 Cg_endo -54.23 -34.37 79.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.731 2.954 . . . . 0.0 115.496 -172.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 37.4 t -78.74 -13.98 59.52 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.399 -0.521 . . . . 0.0 112.252 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -98.67 -0.26 43.3 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.98 -174.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.51 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 20.8 m-30 -52.36 -45.21 65.66 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.2 -37.96 78.37 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.521 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 38.8 ttm-85 -63.21 -49.41 74.32 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 339' ' ' GLN . 41.6 mt -71.12 -37.01 65.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.539 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.95 -54.75 41.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.44 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -65.13 -24.31 67.38 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 336' ' ' ILE . 30.5 tt0 -61.88 -36.63 81.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.305 0.574 . . . . 0.0 109.577 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -98.52 -1.37 41.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.028 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 102.03 -5.73 53.4 Favored Glycine 0 C--O 1.244 0.738 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.333 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.64 134.12 27.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 121.369 0.604 . . . . 0.0 109.838 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 -10.82 12.05 Favored 'General case' 0 C--N 1.266 -3.045 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.362 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -100.95 45.53 0.97 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 49.9 p . . . . . 0 N--CA 1.431 -1.417 0 CA-C-O 121.252 0.549 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.523 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -85.61 -11.75 53.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.135 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.516 ' CD2' ' HB3' ' A' ' 441' ' ' GLU . 0.7 OUTLIER -94.84 145.64 24.76 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.204 175.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -108.33 -21.19 12.86 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -156.88 121.22 4.39 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.473 ' HG2' ' CD2' ' A' ' 365' ' ' PHE . 27.9 mtpp -101.3 163.12 12.43 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 54.0 mt -66.26 154.39 40.02 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 123.659 0.599 . . . . 0.0 111.118 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -68.09 161.62 66.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.093 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -55.39 -41.53 77.2 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.196 1.93 . . . . 0.0 111.362 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -154.72 162.43 41.12 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.152 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -136.2 141.46 44.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.6 132.32 55.2 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' A' ' 381' ' ' ILE . 11.0 p -133.51 153.67 37.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 379' ' ' HIS . 14.5 m -85.19 145.32 27.65 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 427' ' ' SER . 0.7 OUTLIER -72.65 121.26 19.47 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.08 13.94 40.99 Favored Glycine 0 CA--C 1.494 -1.259 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 376' ' ' SER . 35.6 t60 -118.9 150.34 40.05 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -91.0 127.01 36.25 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.317 0.647 . . . . 0.0 111.03 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.667 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.4 tt -124.26 163.7 23.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 0.8 OUTLIER -143.58 137.37 28.34 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.941 0.401 . . . . 0.0 110.037 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -100.37 151.33 21.64 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 38.8 m -133.01 121.94 23.47 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.024 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 12.6 m -127.05 143.85 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.08 135.71 55.13 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.415 HD13 ' HD3' ' A' ' 419' ' ' ARG . 5.7 mp -99.29 161.89 13.36 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -83.62 1.94 39.85 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.131 0.491 . . . . 0.0 110.599 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -138.85 146.37 41.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -80.73 -28.52 36.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -104.85 4.5 32.17 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.481 0.657 . . . . 0.0 111.074 -171.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -88.32 153.13 21.45 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.27 166.14 15.77 Favored 'General case' 0 C--N 1.268 -2.96 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.938 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 3.7 m -113.76 159.99 13.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.118 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 437' ' ' VAL . 31.7 mmmt -106.12 139.18 41.04 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.418 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 11.8 m-90 -113.46 111.51 22.05 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.3 mp -124.38 137.63 54.45 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.008 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -113.51 118.5 34.65 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.2 p30 50.4 18.61 0.45 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 126.104 1.762 . . . . 0.0 113.742 -175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.87 1.44 27.13 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.736 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -113.69 132.35 55.83 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 48.8 mt-10 -61.66 118.18 6.76 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 57.8 mt -71.16 108.96 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -100.41 150.72 22.33 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.536 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 86.7 mtp -67.63 96.88 0.57 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.101 0.477 . . . . 0.0 110.87 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.9 m -91.25 101.24 13.95 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 58.35 -130.73 51.44 Favored Glycine 0 N--CA 1.446 -0.646 0 O-C-N 123.704 0.627 . . . . 0.0 112.092 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 15.6 m -102.7 13.02 35.49 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.671 0.748 . . . . 0.0 109.307 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -82.6 -41.75 19.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.207 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.536 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 72.7 m-85 -113.25 111.43 22.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 64.2 mt -122.49 117.69 52.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.05 0.452 . . . . 0.0 110.92 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.506 ' CD2' HD13 ' A' ' 421' ' ' LEU . 21.4 m-85 -87.37 109.14 19.34 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.72 108.41 19.87 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.9 p -102.19 105.55 16.25 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.743 0.782 . . . . 0.0 111.64 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.9 mm -100.37 87.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.21 -111.58 3.65 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.331 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -98.1 -6.04 32.46 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.617 0.723 . . . . 0.0 109.813 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -91.39 111.27 22.7 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.55 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' ARG . . . . . 0.415 ' HD3' HD13 ' A' ' 387' ' ' LEU . 10.8 mpt_? -98.54 113.36 25.36 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.4 m -111.41 119.18 37.96 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.506 HD13 ' CD2' ' A' ' 412' ' ' PHE . 19.1 tp -97.09 107.47 20.0 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 96.2 m -94.26 123.05 37.41 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.409 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 59.7 mt -111.67 116.44 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 9.8 m -86.45 130.54 34.46 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.372 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 56.05 74.32 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.595 1.184 . . . . 0.0 111.697 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' CYS . . . . . 0.667 ' SG ' HG22 ' A' ' 381' ' ' ILE . 68.1 m -69.14 125.38 26.49 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.226 0.536 . . . . 0.0 111.25 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' SER . . . . . 0.417 ' HA ' ' HG2' ' A' ' 377' ' ' LYS . 77.5 p -109.28 -177.08 3.2 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 90.2 mt -72.63 -14.93 61.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.19 -20.58 48.02 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.694 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.58 -19.67 27.49 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.474 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.19 99.11 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -163.48 171.51 15.8 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.085 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -87.74 127.75 35.31 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -104.96 134.98 47.16 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 24.8 mp0 -124.34 118.38 26.62 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 369' ' ' LEU . 83.0 m -96.45 108.02 20.5 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 171.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 26.3 t -105.92 117.25 51.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.977 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.75 155.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.58 112.13 4.56 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 117.758 -2.163 . . . . 0.0 111.001 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 105.51 -17.81 42.46 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.523 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 64.8 mm-40 -141.38 112.31 7.24 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -134.23 159.6 40.42 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 435' ' ' GLN . 47.8 t -142.48 134.47 27.21 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.1 m -108.92 110.6 21.96 Favored 'General case' 0 N--CA 1.426 -1.648 0 O-C-N 124.197 0.935 . . . . 0.0 109.267 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.3 t -102.04 150.11 23.57 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -114.6 116.4 28.69 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.455 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 49.3 tp -84.66 134.22 34.37 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -112.46 109.85 19.69 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.32 112.43 26.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.306 0.574 . . . . 0.0 109.59 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.95 116.05 28.47 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.427 -1.593 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.127 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.425 ' HA ' ' HB ' ' A' ' 324' ' ' ILE . 13.3 p -61.43 -23.19 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 124.068 0.947 . . . . 0.0 112.66 -175.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -68.62 -41.78 79.02 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.167 0.508 . . . . 0.0 109.939 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.9 -28.33 27.98 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.217 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 321' ' ' VAL . 76.2 mt -69.39 -47.12 74.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.536 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.89 -34.22 77.64 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.058 0.456 . . . . 0.0 111.257 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -59.27 -41.56 89.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -99.46 -0.41 40.83 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.515 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -71.15 155.5 93.07 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.463 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.68 134.21 46.17 Favored 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.346 2.031 . . . . 0.0 110.549 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 11.7 Cg_endo -53.66 -28.68 47.65 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 124.115 3.21 . . . . 0.0 115.172 -172.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 11.7 m -86.05 -15.02 42.65 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -101.26 3.49 40.9 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.148 -172.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 22.0 m-30 -50.94 -44.73 60.4 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.545 0.528 . . . . 0.0 112.264 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -59.92 -53.64 55.48 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 123.394 0.434 . . . . 0.0 112.14 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 53.4 ttp85 -61.73 -39.34 91.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.435 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 56.4 mt -73.01 -38.96 56.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.127 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.67 -56.83 16.64 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.061 0.545 . . . . 0.0 111.027 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -67.4 -23.54 65.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -65.99 -47.28 75.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.137 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -83.88 -19.29 35.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.162 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 100.77 40.56 2.88 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.086 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.97 128.24 63.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 19.1 p -104.3 -14.48 15.77 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 121.24 0.543 . . . . 0.0 110.44 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -79.28 44.75 0.6 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.331 0.586 . . . . 0.0 111.26 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 46.3 tp . . . . . 0 C--N 1.297 -1.696 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.301 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.438 HG22 ' OE2' ' A' ' 441' ' ' GLU . 7.3 t . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.556 0.217 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.563 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -92.55 -10.47 37.49 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.924 0.392 . . . . 0.0 111.069 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.21 110.07 20.12 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.903 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 386' ' ' GLU . 90.6 mt-30 -74.26 -29.3 61.61 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.527 0.679 . . . . 0.0 109.655 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 367' ' ' LYS . 34.3 ttmt -149.38 119.21 7.07 Favored 'General case' 0 N--CA 1.398 -3.026 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -176.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.662 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 57.9 mtpt -100.04 166.21 11.14 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.758 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 71.4 mt -69.12 136.42 52.19 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.541 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -59.36 150.66 63.27 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -46.66 -39.27 23.19 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 123.095 2.53 . . . . 0.0 113.115 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -147.46 165.37 30.48 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.471 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -142.45 144.39 33.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.38 140.42 52.97 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.6 p -145.93 152.74 13.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 25.1 m -91.14 150.85 21.21 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.32 128.79 37.73 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.871 0.367 . . . . 0.0 110.486 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 88.34 6.77 73.78 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.6 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 376' ' ' SER . 10.1 m-70 -102.75 -178.52 3.7 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.764 0.316 . . . . 0.0 110.21 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -119.65 141.24 49.52 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.467 HG22 ' SG ' ' A' ' 426' ' ' CYS . 16.1 tt -141.4 155.42 20.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 2.6 ptm180 -141.18 134.85 30.15 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.347 0.594 . . . . 0.0 110.598 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.57 125.21 48.19 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.817 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 54.1 m -106.28 121.28 43.9 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.702 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.44 144.12 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 366' ' ' GLN . 33.3 mt-10 -124.41 131.44 53.5 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.479 HD21 HG13 ' A' ' 394' ' ' VAL . 3.4 mm? -89.86 159.86 16.77 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.8 -25.55 56.48 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.3 0.571 . . . . 0.0 110.261 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -131.2 159.41 37.81 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.124 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -80.8 -25.33 37.92 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.261 0.553 . . . . 0.0 109.895 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.08 3.19 40.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.051 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -99.93 118.02 35.46 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -103.01 163.73 12.03 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.167 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.479 HG13 HD21 ' A' ' 387' ' ' LEU . 3.7 m -117.81 141.09 38.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.484 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -109.46 122.9 48.42 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.414 ' O ' HD12 ' A' ' 397' ' ' LEU . 3.6 m-90 -93.37 114.0 26.31 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.665 -170.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 396' ' ' TRP . 7.8 mp -127.3 137.67 52.88 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 175.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 433' ' ' ALA . 60.4 pttt -117.34 119.45 35.17 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.8 p30 50.95 20.72 0.84 Allowed 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 125.415 1.486 . . . . 0.0 113.236 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLY . . . . . 0.4 ' HA2' HD23 ' A' ' 397' ' ' LEU . . . 103.02 2.28 48.72 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.985 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -108.58 123.43 48.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -53.01 121.13 6.79 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.515 0.509 . . . . 0.0 110.603 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 53.1 mt -79.19 102.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -100.3 145.58 27.96 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.417 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 87.8 mtp -60.63 100.74 0.11 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.301 0.572 . . . . 0.0 111.617 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.7 m -102.6 103.1 13.38 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.115 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.99 -134.41 50.83 Favored Glycine 0 N--CA 1.442 -0.95 0 O-C-N 124.008 0.817 . . . . 0.0 113.307 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.3 t -99.98 7.72 44.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 26.2 ttmt -75.7 -54.43 6.97 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.708 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.417 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 60.4 m-85 -102.33 107.66 18.76 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.121 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.05 110.15 30.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.365 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.564 ' CE1' HD13 ' A' ' 421' ' ' LEU . 22.4 m-85 -87.27 106.13 17.7 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.45 108.04 19.92 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.433 0.635 . . . . 0.0 110.464 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.86 107.19 19.03 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.53 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.41 84.27 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.74 -111.3 3.4 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.84 -6.86 26.15 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.256 0.55 . . . . 0.0 110.029 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -82.44 113.01 19.9 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.721 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -108.8 107.45 17.88 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.7 m -109.36 116.92 32.76 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.128 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.564 HD13 ' CE1' ' A' ' 412' ' ' PHE . 21.0 tp -91.17 106.39 18.48 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.3 m -93.84 119.99 33.51 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 54.5 mt -107.34 115.37 48.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.5 m -99.99 131.76 45.75 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 68.52 61.65 0.36 Allowed 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.355 1.062 . . . . 0.0 111.494 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' CYS . . . . . 0.467 ' SG ' HG22 ' A' ' 381' ' ' ILE . 59.7 m -62.95 121.74 14.29 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.561 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.3 p -113.82 -175.0 2.58 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.72 -18.77 62.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.261 0.553 . . . . 0.0 110.39 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -78.92 -11.17 59.99 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.752 0.787 . . . . 0.0 110.101 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' ASP . . . . . 0.429 ' OD1' ' HD3' ' A' ' 409' ' ' LYS . 23.2 m-20 -96.49 -19.48 19.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.976 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.04 103.15 0.9 Allowed 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -165.05 167.59 18.19 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 398' ' ' LYS . . . -85.76 124.15 31.93 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -104.67 139.46 39.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.426 ' HB3' ' CB ' ' A' ' 444' ' ' SER . 0.0 OUTLIER -142.97 138.76 30.31 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 121.173 0.511 . . . . 0.0 110.767 177.27 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 62.2 m -101.96 112.05 24.54 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.115 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.95 110.13 23.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.708 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 57.9 t -112.41 157.07 13.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.25 113.3 5.46 Favored Glycine 0 N--CA 1.428 -1.873 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.829 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 102.6 -33.47 6.53 Favored Glycine 0 N--CA 1.425 -2.033 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.158 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 24.7 mm-40 -132.44 131.37 41.67 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.365 0.602 . . . . 0.0 111.582 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 443' ' ' CYS . 33.5 ttmt -126.36 158.03 36.95 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 49.3 t -148.39 134.0 18.78 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 435' ' ' GLN . 34.0 t -123.79 139.27 54.15 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.8 t -125.62 150.48 47.51 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -106.85 110.87 23.15 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.395 0.616 . . . . 0.0 110.593 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -89.6 139.67 30.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.001 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 450' ' ' LYS . 53.9 t80 -121.69 117.02 25.62 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 123.609 0.763 . . . . 0.0 110.891 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 56.5 t -97.51 119.47 45.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 376' ' ' SER . 0.0 OUTLIER -110.67 137.52 48.24 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.227 174.3 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.701 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.501 -0.922 0 CA-C-O 120.642 0.258 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.29 -35.52 36.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.745 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' TRP . . . . . 0.475 ' O ' ' HB2' ' A' ' 326' ' ' ARG . 17.7 m95 -56.6 -60.4 3.59 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 124.024 0.93 . . . . 0.0 110.913 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.85 -41.32 95.79 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.488 0.492 . . . . 0.0 111.657 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.4 mt -68.06 -42.88 85.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 123.095 0.558 . . . . 0.0 111.545 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.6 -36.24 60.36 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 322' ' ' TRP . 14.3 tpt85 -63.94 -41.15 97.7 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.364 0.666 . . . . 0.0 111.345 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.76 -4.59 59.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.547 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -87.92 150.3 47.51 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.59 150.24 82.9 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.817 1.678 . . . . 0.0 111.273 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.1 -29.31 3.93 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.644 3.563 . . . . 0.0 115.96 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 50.5 m -85.41 -2.06 57.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -93.44 -22.26 19.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -44.08 -52.51 7.13 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.86 1.264 . . . . 0.0 112.905 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -57.0 -53.0 63.03 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.433 0.693 . . . . 0.0 111.858 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -57.87 -50.37 73.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.983 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.67 -40.43 89.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.892 -175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.94 -57.72 11.56 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.623 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -68.89 -23.02 64.15 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.14 -44.8 91.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.92 0.39 . . . . 0.0 110.082 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -91.13 -8.4 48.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 89.13 32.5 10.56 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.442 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 17.6 t -94.52 122.8 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.338 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 9.3 p -97.82 -22.57 16.31 Favored 'General case' 0 C--N 1.276 -2.618 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.934 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -83.89 63.23 7.43 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.714 0.768 . . . . 0.0 110.297 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 27.6 tp . . . . . 0 C--N 1.313 -0.998 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.286 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 75.0 p . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -97.53 4.93 50.22 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.17 0.509 . . . . 0.0 110.776 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -117.0 117.6 30.11 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.689 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -85.08 -21.93 29.15 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 120.826 0.346 . . . . 0.0 110.36 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 367' ' ' LYS . 23.6 ttmm -159.67 127.38 4.77 Favored 'General case' 0 N--CA 1.391 -3.383 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 35.6 mtmm -110.75 177.35 4.7 Favored 'General case' 0 C--N 1.253 -3.615 0 O-C-N 124.28 0.987 . . . . 0.0 108.357 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.424 HD13 HG22 ' A' ' 445' ' ' THR . 86.4 mt -71.98 141.94 49.37 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.144 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.67 158.66 67.02 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.202 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -44.8 -39.81 14.09 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 123.451 2.767 . . . . 0.0 113.809 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -156.11 162.53 40.24 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -137.97 149.2 45.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -133.38 137.34 45.79 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.42 143.78 33.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.7 m -79.43 141.99 36.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -57.28 125.59 23.48 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 122.957 0.503 . . . . 0.0 110.402 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 96.47 -9.97 66.96 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.917 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -96.71 170.75 8.98 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.149 0.499 . . . . 0.0 110.791 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 6.9 mtpm? -101.08 161.05 13.88 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.729 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 18.2 tt -154.98 133.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 121.201 0.524 . . . . 0.0 110.665 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -99.99 127.47 46.2 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.546 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 420' ' ' THR . 70.3 mt -105.77 109.37 21.3 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 87.7 m -107.19 126.01 51.85 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.13 149.25 33.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 418' ' ' LYS . 41.5 mt-10 -114.43 135.55 53.98 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 54.1 mt -104.04 165.44 11.05 Favored 'General case' 0 C--N 1.261 -3.263 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.03 -29.84 49.61 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.164 0.507 . . . . 0.0 109.929 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -112.01 146.94 37.0 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.181 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -78.9 -22.44 45.92 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -112.5 26.23 10.74 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.236 0.541 . . . . 0.0 111.398 -173.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -113.37 137.54 51.36 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -122.31 154.45 37.6 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.893 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.61 153.53 7.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.33 0.586 . . . . 0.0 111.491 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -103.43 133.37 48.6 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.453 ' CB ' HD12 ' A' ' 403' ' ' ILE . 44.8 m95 -101.51 139.06 37.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 434' ' ' TYR . 10.3 mp -121.13 143.61 49.01 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 398' ' ' LYS . . . . . 0.644 ' HG3' HG12 ' A' ' 403' ' ' ILE . 22.5 mtmm -103.83 108.61 20.0 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.7 p30 50.95 16.81 0.37 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 124.966 1.306 . . . . 0.0 113.998 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.15 -5.96 17.52 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.643 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -102.04 124.85 48.37 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -64.13 118.39 8.48 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.932 0.396 . . . . 0.0 111.987 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.644 HG12 ' HG3' ' A' ' 398' ' ' LYS . 41.0 mt -66.33 122.0 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.248 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -102.1 157.34 16.95 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.557 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 48.0 ttm -71.54 94.6 1.31 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.0 t -89.92 102.22 14.92 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 58.68 -114.38 5.92 Favored Glycine 0 N--CA 1.437 -1.251 0 O-C-N 124.086 0.866 . . . . 0.0 112.141 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 26.4 m -119.3 17.12 13.1 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.05 -0.575 . . . . 0.0 109.735 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -76.34 -46.39 27.76 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.864 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.557 ' O ' ' HG3' ' A' ' 405' ' ' MET . 93.4 m-85 -111.62 108.44 17.93 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.89 0.376 . . . . 0.0 110.292 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 49.6 mt -107.91 113.75 44.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -87.23 105.1 16.99 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.409 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.99 138.61 41.87 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.638 0.732 . . . . 0.0 111.365 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 13.1 p -118.38 122.81 43.73 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.089 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.79 89.89 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.03 -123.83 15.69 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.41 -6.36 55.02 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.317 0.58 . . . . 0.0 110.027 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.407 ' HG3' ' HG2' ' A' ' 386' ' ' GLU . 31.2 ttpt -88.85 125.26 34.84 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' A' ' 419' ' ' ARG . 2.5 tpp180 -113.2 137.3 51.67 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 76.9 m -142.11 122.94 14.38 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.367 0.603 . . . . 0.0 112.162 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 410' ' ' TYR . 63.9 tp -91.19 114.32 26.82 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 43.7 m -93.97 108.08 19.92 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 50.7 mt -92.84 130.62 41.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' SER . . . . . 0.5 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 16.5 m -106.58 132.19 52.87 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.832 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . 0.321 10.4 pt20 46.64 76.5 0.1 Allowed 'General case' 0 C--O 1.238 0.467 0 O-C-N 125.16 1.537 . . . . 0.0 114.575 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 60.5 m -70.28 128.39 36.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.968 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.0 m -112.9 -174.16 2.4 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.64 -19.79 62.78 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.89 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -72.55 -24.72 61.17 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.182 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.38 -21.57 42.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.13 95.54 0.41 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.412 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.95 171.51 18.58 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.2 132.74 34.24 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' TYR . . . . . 0.59 ' HA ' ' O ' ' A' ' 397' ' ' LEU . 38.7 m-85 -104.81 145.57 30.19 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.6 OUTLIER -129.62 123.28 30.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.195 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 7.8 p -94.38 118.28 31.39 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 13.0 t -111.53 121.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.28 160.06 6.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.37 112.29 4.71 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 117.764 -2.16 . . . . 0.0 110.242 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 107.52 -35.41 5.03 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 112.391 -0.283 . . . . 0.0 112.391 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -120.03 127.82 52.95 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 122.428 -0.454 . . . . 0.0 110.612 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -130.85 128.93 41.63 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.7 t -120.31 138.05 53.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 434' ' ' TYR . 12.7 p -116.43 148.11 41.03 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 123.412 0.445 . . . . 0.0 111.013 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.424 HG22 HD13 ' A' ' 369' ' ' LEU . 12.6 t -140.54 150.92 44.3 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -101.73 119.28 38.54 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 24.4 tp -95.98 137.22 35.35 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -118.35 115.74 25.31 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.52 122.17 41.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -93.73 106.63 18.59 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.724 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--N 1.292 -1.896 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.274 179.284 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.476 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 7.2 p -51.33 -34.4 14.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 123.873 0.869 . . . . 0.0 112.209 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -55.91 -47.71 76.98 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.872 0.869 . . . . 0.0 110.92 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 11.6 pt-20 -85.85 -38.12 18.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.69 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.79 -50.47 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.311 0.1 . . . . 0.0 111.167 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.39 -32.0 70.75 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -57.87 -39.14 77.09 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.846 0.858 . . . . 0.0 112.199 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 23.2 pt20 -104.88 2.38 29.86 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.173 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -77.12 160.77 75.25 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.529 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.84 135.51 48.61 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.276 1.984 . . . . 0.0 111.029 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -65.96 -4.83 10.85 Favored 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 123.759 2.972 . . . . 0.0 114.772 -173.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 24.5 p -90.25 -16.7 28.85 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.208 0.528 . . . . 0.0 111.192 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.403 ' O ' HG13 ' A' ' 336' ' ' ILE . 29.3 mm-40 -106.92 -0.72 22.98 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.54 -172.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -55.73 -42.24 75.06 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.07 -44.14 97.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.528 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -59.36 -53.53 57.18 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.697 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 332' ' ' GLU . 48.5 mt -59.04 -44.06 90.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 O-C-N 123.792 0.683 . . . . 0.0 110.613 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.66 -60.79 3.28 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.126 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -67.12 -22.85 65.78 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -66.39 -45.62 79.4 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 123.2 0.6 . . . . 0.0 110.205 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' TYR . . . . . 0.476 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 80.8 m-85 -88.83 -20.19 24.98 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 112.63 14.09 10.79 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.532 -1.318 . . . . 0.0 112.551 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.37 97.14 6.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.2 m -65.06 -42.67 93.99 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.693 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -115.99 95.9 5.32 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.706 0.765 . . . . 0.0 111.409 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.647 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.6 pt? . . . . . 0 C--N 1.307 -1.243 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.104 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 111.363 0.134 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -86.14 -3.34 58.94 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.204 1.002 . . . . 0.0 108.558 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.47 ' CD1' ' HB3' ' A' ' 441' ' ' GLU . 0.3 OUTLIER -91.98 126.45 37.07 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 114.226 -1.352 . . . . 0.0 107.899 173.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -93.25 -18.09 22.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.48 0.657 . . . . 0.0 110.023 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -157.24 126.08 5.8 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.728 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 37.4 mtmm -106.86 176.58 5.12 Favored 'General case' 0 C--N 1.276 -2.596 0 O-C-N 123.791 0.682 . . . . 0.0 109.841 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.528 HD11 ' SG ' ' A' ' 436' ' ' CYS . 72.3 mt -74.51 147.54 41.75 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.23 159.06 82.34 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.61 -35.85 38.86 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.277 2.651 . . . . 0.0 112.997 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -156.35 160.72 39.95 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -133.82 148.76 51.35 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -128.25 144.69 51.15 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.8 149.24 15.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 m -88.66 154.02 20.64 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.01 121.43 11.82 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.167 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 90.63 4.37 70.26 Favored Glycine 0 C--N 1.303 -1.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.16 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -98.78 176.9 5.46 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 122.434 -0.451 . . . . 0.0 110.767 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -110.42 143.13 41.17 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.044 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.464 HG22 ' SG ' ' A' ' 426' ' ' CYS . 10.0 tp -130.99 143.04 42.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -121.19 121.9 38.8 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 66.7 mt -100.17 113.33 25.91 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 26.9 m -112.14 125.21 53.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.311 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.99 157.54 40.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.502 ' HG2' ' HG2' ' A' ' 418' ' ' LYS . 46.5 mt-10 -124.11 137.32 54.58 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.535 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 86.7 mt -98.8 138.13 36.39 Favored 'General case' 0 C--N 1.267 -3.007 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.64 -38.56 58.8 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -106.95 99.8 9.34 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.626 -1.625 . . . . 0.0 106.917 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 417' ' ' ALA . 20.3 p80 -73.9 -16.64 61.1 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 120.817 0.341 . . . . 0.0 111.712 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -87.28 3.97 44.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.177 0.513 . . . . 0.0 110.528 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -107.67 96.18 6.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' GLU . . . . . 0.434 ' HG2' ' NH2' ' A' ' 419' ' ' ARG . 35.0 mt-10 -75.27 159.81 31.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 8.6 p -118.11 157.95 19.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 113.485 -1.688 . . . . 0.0 109.668 -173.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -132.15 161.22 33.87 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.46 ' CB ' HD12 ' A' ' 403' ' ' ILE . 38.7 m95 -114.14 144.62 42.87 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.7 mp -122.74 136.41 54.86 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' LYS . . . . . 0.53 ' HG2' HG12 ' A' ' 403' ' ' ILE . 8.2 mmtp -93.17 108.62 20.19 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.479 173.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.8 p30 53.03 12.92 0.32 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 125.024 1.33 . . . . 0.0 114.078 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 108.44 9.72 26.72 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.007 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -90.77 -98.89 0.11 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 173.21 137.53 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.53 HG12 ' HG2' ' A' ' 398' ' ' LYS . 48.4 mt -97.75 120.8 47.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 120.831 0.348 . . . . 0.0 110.401 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -91.77 130.99 37.45 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 58.1 ttp -62.21 103.73 0.41 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.8 m -106.16 120.31 41.5 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.265 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 48.62 -118.89 5.21 Favored Glycine 0 C--N 1.334 0.42 0 O-C-N 125.027 1.454 . . . . 0.0 115.278 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.6 m -112.14 7.57 19.65 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.468 0.651 . . . . 0.0 109.623 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 424' ' ' SER . 82.6 tttt -83.3 -49.5 9.32 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.658 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -109.74 129.05 55.65 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.93 118.16 51.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -87.91 105.87 17.72 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -112.76 113.09 25.03 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.166 0.508 . . . . 0.0 111.73 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 37.4 t -98.22 119.42 36.86 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.84 95.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 71.32 -107.83 2.3 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.535 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -101.6 -13.11 17.97 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.073 0.463 . . . . 0.0 109.846 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.502 ' HG2' ' HG2' ' A' ' 386' ' ' GLU . 60.4 mtpt -74.86 137.61 41.92 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 121.601 0.715 . . . . 0.0 111.695 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' ARG . . . . . 0.434 ' NH2' ' HG2' ' A' ' 393' ' ' GLU . 21.8 mmt180 -122.3 112.74 18.5 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 173.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 6.8 m -116.64 122.01 43.34 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.449 ' HB2' ' CE2' ' A' ' 396' ' ' TRP . 53.5 tp -96.23 111.0 23.2 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 67.4 m -92.36 109.5 20.88 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 56.4 mt -101.95 122.15 53.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 409' ' ' LYS . 18.3 m -108.42 141.08 40.8 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 64.84 58.32 0.97 Allowed 'General case' 0 C--O 1.254 1.303 0 C-N-CA 124.427 1.091 . . . . 0.0 111.782 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' CYS . . . . . 0.464 ' SG ' HG22 ' A' ' 381' ' ' ILE . 85.2 m -66.06 131.47 46.28 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.497 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' SER . . . . . 0.491 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 5.5 m -126.0 177.62 6.24 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 98.8 mt -67.3 -30.7 70.63 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 118.19 0.45 . . . . 0.0 111.633 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.98 -9.11 59.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.759 0.79 . . . . 0.0 110.298 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' ASP . . . . . 0.491 ' HB3' ' H ' ' A' ' 427' ' ' SER . 18.7 t70 -97.23 -13.94 21.72 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -71.24 114.52 9.39 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.123 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -156.34 172.97 17.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.776 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.67 126.78 33.67 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -106.91 145.27 32.41 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 120.995 0.426 . . . . 0.0 110.864 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.13 143.44 24.15 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.551 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' A' ' 369' ' ' LEU . 59.0 m -98.26 131.87 44.23 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 56.7 t -116.04 107.98 24.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.284 0.564 . . . . 0.0 111.771 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 58.6 t -116.91 160.82 16.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 170.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -68.27 109.56 2.97 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 117.21 -2.424 . . . . 0.0 111.891 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 99.97 -36.21 4.26 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 125.861 1.696 . . . . 0.0 108.966 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 438' ' ' VAL . 6.4 mp0 -90.25 96.18 10.55 Favored 'General case' 0 N--CA 1.395 -3.196 0 C-N-CA 124.887 1.275 . . . . 0.0 112.341 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 37.9 ttmt -121.59 118.04 28.24 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 51.6 t -115.31 133.69 55.8 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 10.8 p -112.22 147.59 35.89 Favored 'General case' 0 N--CA 1.432 -1.33 0 O-C-N 123.565 0.541 . . . . 0.0 111.143 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.515 HG22 HD13 ' A' ' 369' ' ' LEU . 14.5 t -144.88 151.25 38.42 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -112.24 117.68 33.19 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 118.805 -1.158 . . . . 0.0 109.624 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 58.4 tp -88.0 136.54 32.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -118.52 113.5 21.39 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.13 117.26 33.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -94.06 109.32 21.09 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-O 121.386 0.612 . . . . 0.0 111.309 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.809 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 CA--C 1.495 -1.17 0 CA-C-O 121.601 0.715 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.463 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 5.3 p -54.57 -39.43 45.91 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.495 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -52.26 -57.26 10.25 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 124.202 1.001 . . . . 0.0 111.334 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.24 -35.43 68.83 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.765 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.44 -52.79 53.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.015 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.19 -34.81 73.4 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.005 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -58.89 -40.86 85.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.694 0.398 . . . . 0.0 110.986 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -93.54 2.02 56.55 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.437 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -88.89 158.2 47.75 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.362 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.93 161.63 40.9 Favored 'Trans proline' 0 CA--C 1.555 1.555 0 C-N-CA 122.539 2.159 . . . . 0.0 111.194 173.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.61 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 10.9 Cg_endo -55.35 -35.8 92.43 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.68 2.92 . . . . 0.0 114.861 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 14.8 m -72.72 -8.58 56.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.428 0.632 . . . . 0.0 112.412 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.504 ' HB3' HD11 ' A' ' 336' ' ' ILE . 12.0 mm-40 -97.31 -22.88 16.4 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.859 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.61 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 23.3 m-30 -55.14 -50.08 70.16 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -174.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.71 -18.99 62.12 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.29 0.567 . . . . 0.0 111.207 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -82.82 -57.36 3.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.504 HD11 ' HB3' ' A' ' 332' ' ' GLU . 69.4 mt -58.29 -39.41 73.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.495 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.11 -59.57 4.89 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.472 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.48 -23.48 64.58 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -68.2 -36.74 80.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.07 0.462 . . . . 0.0 110.537 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' TYR . . . . . 0.463 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 85.7 m-85 -97.12 -17.35 20.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 107.15 20.78 8.46 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.93 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 15.0 t -95.41 129.67 45.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 34.2 p -94.66 -49.72 5.5 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.435 -0.906 . . . . 0.0 112.351 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.11 69.21 3.19 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -171.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.435 -1.202 0 CA-C-O 120.726 0.298 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.453 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -102.34 -19.97 14.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.7 0.762 . . . . 0.0 109.712 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -100.14 137.02 39.15 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.318 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -99.26 -16.37 18.53 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.4 OUTLIER -162.74 115.96 1.66 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 178.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.62 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 15.0 mtpp -88.51 169.41 11.77 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.422 HD13 HG22 ' A' ' 445' ' ' THR . 87.9 mt -64.22 140.37 58.86 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -60.18 147.88 79.94 Favored Pre-proline 0 C--N 1.318 -0.788 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -43.96 -47.49 10.09 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.616 2.877 . . . . 0.0 114.15 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -151.14 142.69 23.56 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.121 0.486 . . . . 0.0 111.435 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -122.14 156.59 33.33 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -142.28 134.06 27.0 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.64 156.91 20.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 15.1 m -79.76 157.23 27.16 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 2.0 tmmm? -77.34 135.56 38.38 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.56 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 86.82 5.65 80.89 Favored Glycine 0 CA--C 1.494 -1.247 0 CA-C-O 121.372 0.429 . . . . 0.0 112.097 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -99.14 -170.67 1.95 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -114.84 139.36 49.81 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.1 tp -121.88 128.74 75.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -102.37 103.58 14.01 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.78 0.8 . . . . 0.0 112.319 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 65.4 mt -91.2 114.95 27.61 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.1 m -123.56 130.59 52.9 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.473 -169.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.438 HG11 ' SG ' ' A' ' 436' ' ' CYS . 14.7 m -127.96 154.09 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.054 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -120.88 142.43 49.68 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 49.6 mt -98.62 142.27 30.41 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.47 -35.18 54.02 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -125.07 142.57 51.41 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -74.48 -16.98 60.83 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.429 0.633 . . . . 0.0 110.775 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.37 11.78 22.65 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.948 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -104.2 88.76 3.07 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -78.35 147.99 33.94 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 11.8 p -106.62 157.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.761 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.477 ' HA ' ' HE3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER -125.79 150.72 47.56 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 175.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.436 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 3.2 m-90 -121.94 123.85 42.66 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.7 mp -129.81 144.71 51.44 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 118.438 0.563 . . . . 0.0 110.689 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -123.21 121.04 34.93 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.9 p30 49.73 17.03 0.23 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.531 1.532 . . . . 0.0 114.183 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.08 -4.35 23.9 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.624 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -108.28 123.0 48.12 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 35.7 tt0 -61.45 122.63 15.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.927 0.394 . . . . 0.0 110.908 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 42.7 mt -73.78 114.6 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.972 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -99.03 147.36 25.1 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 171.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.612 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 0.0 OUTLIER -77.28 126.14 30.45 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.255 -176.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 15.0 m -109.68 88.57 2.78 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.22 -109.76 2.66 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.0 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 45.2 t -109.78 4.02 21.36 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 122.808 -0.231 . . . . 0.0 110.809 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 409' ' ' LYS . 12.2 tmtt? -79.45 -34.28 41.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.612 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 91.2 m-85 -126.63 117.35 22.59 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 52.8 mt -118.3 113.8 43.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.428 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.505 ' CD1' HD13 ' A' ' 421' ' ' LEU . 23.6 m-85 -87.97 109.48 19.84 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -108.05 106.31 16.47 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 50.5 m -92.28 106.28 18.31 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.84 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 58.3 mt -113.71 92.82 2.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.33 -110.45 3.42 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.572 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.68 -2.23 35.94 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.007 0.432 . . . . 0.0 110.562 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -101.85 133.85 45.97 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.512 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -111.18 110.47 21.0 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 17.4 m -108.59 118.14 36.01 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.554 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.505 HD13 ' CD1' ' A' ' 412' ' ' PHE . 22.6 tp -98.25 107.96 20.54 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 39.2 m -93.61 100.38 12.64 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.9 mt -83.97 115.66 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 14.9 m -100.33 134.81 42.73 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 69.19 54.15 0.44 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.541 1.136 . . . . 0.0 111.002 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 1.9 p -62.38 123.94 19.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.222 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' SER . . . . . 0.426 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 9.2 m -114.27 169.53 8.96 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -173.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.33 -37.92 77.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.168 0.509 . . . . 0.0 111.815 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -84.29 1.24 45.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.751 0.786 . . . . 0.0 110.223 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 427' ' ' SER . 28.4 t70 -106.34 -17.59 14.24 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.824 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.5 125.33 17.64 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.849 174.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.47 169.11 23.68 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.994 0.426 . . . . 0.0 111.191 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -86.39 133.64 33.77 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 170.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -114.7 137.87 51.39 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.04 140.33 52.09 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 20.8 p -115.84 113.98 24.1 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 173.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 47.0 t -113.47 118.46 58.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.028 0.442 . . . . 0.0 111.863 -174.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 97.0 t -114.17 161.69 12.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.24 113.06 5.52 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.831 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 100.67 -35.41 4.86 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.085 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 31.1 mm-40 -128.26 135.98 50.39 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 120.693 0.282 . . . . 0.0 110.889 -173.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -141.94 177.64 8.06 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 53.1 t -160.27 142.33 12.89 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 3.8 p -121.15 131.27 54.15 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 123.69 0.619 . . . . 0.0 110.197 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.422 HG22 HD13 ' A' ' 369' ' ' LEU . 14.9 t -121.61 150.71 41.3 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.72 111.12 18.7 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.21 0.529 . . . . 0.0 110.212 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 61.0 tp -90.62 140.77 29.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.596 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -115.18 108.38 16.53 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 42.3 t -90.4 109.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 376' ' ' SER . 37.8 ttpt -111.82 127.19 55.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.367 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.631 0.729 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.528 HG11 HG21 ' A' ' 342' ' ' VAL . 6.5 p -50.84 -37.23 16.04 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.587 0 C-N-CA 125.721 1.608 . . . . 0.0 113.608 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -61.79 -56.68 16.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.663 0.744 . . . . 0.0 110.732 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 13.2 pt-20 -71.96 -21.61 61.56 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.017 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.5 mt -74.29 -46.36 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.387 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.97 -40.2 84.06 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 122.905 0.482 . . . . 0.0 110.325 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -55.54 -36.83 67.19 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.194 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 20.9 pt20 -100.79 5.76 43.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.163 0.506 . . . . 0.0 111.511 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -106.62 152.83 40.86 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.587 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -62.65 138.51 70.17 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.416 2.077 . . . . 0.0 111.886 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.7 -22.38 64.26 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.484 2.789 . . . . 0.0 112.468 -174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 2.8 p -74.59 -14.22 60.75 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.165 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -111.49 4.49 18.87 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.355 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -49.12 -41.12 34.99 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.9 -54.21 49.17 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.511 0.507 . . . . 0.0 111.584 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -61.1 -44.97 96.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.845 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 38.6 mt -68.35 -42.49 84.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.264 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.84 -54.32 46.55 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.593 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -61.84 -32.28 72.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -61.01 -39.86 91.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.828 0.347 . . . . 0.0 110.495 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -91.75 1.35 57.22 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 86.81 23.46 42.04 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.646 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.528 HG21 HG11 ' A' ' 321' ' ' VAL . 19.0 t -107.3 134.35 49.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.8 p -110.78 -15.35 13.83 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-O 120.981 0.42 . . . . 0.0 110.651 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -95.35 45.68 1.1 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.852 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 121.449 0.642 . . . . 0.0 110.924 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.423 -1.819 0 CA-C-O 121.182 0.515 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -103.98 0.35 29.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 122.0 0.905 . . . . 0.0 109.598 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.81 137.76 50.66 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.415 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -103.21 -19.4 14.51 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.827 0.346 . . . . 0.0 110.104 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -156.46 125.54 6.04 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.438 ' HE2' ' SG ' ' A' ' 443' ' ' CYS . 60.6 mtpt -112.16 172.32 6.98 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 96.0 mt -72.6 117.81 14.74 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -63.65 142.17 97.98 Favored Pre-proline 0 C--N 1.314 -0.953 0 O-C-N 124.033 0.833 . . . . 0.0 108.882 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -47.72 -35.3 23.17 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 123.326 2.684 . . . . 0.0 113.129 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -127.46 128.0 45.0 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.493 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 44.9 m-85 -128.81 147.38 50.79 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -134.09 145.14 49.07 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.75 159.06 4.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.401 ' HB2' ' CG ' ' A' ' 379' ' ' HIS . 13.9 m -89.16 156.48 18.77 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -67.19 123.36 20.09 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.43 5.09 67.52 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' HIS . . . . . 0.401 ' CG ' ' HB2' ' A' ' 376' ' ' SER . 12.4 m170 -101.69 164.95 11.48 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.331 -0.434 . . . . 0.0 110.378 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -102.36 136.85 41.44 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.504 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.58 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.9 tt -136.35 154.69 33.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.418 ' CB ' ' HA ' ' A' ' 422' ' ' THR . 18.4 ptt180 -134.76 126.09 28.24 Favored 'General case' 0 N--CA 1.413 -2.316 0 C-N-CA 119.175 -1.01 . . . . 0.0 112.031 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' LEU . . . . . 0.401 ' HB3' HD21 ' A' ' 369' ' ' LEU . 3.0 mm? -78.9 109.79 13.51 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 113.892 -1.504 . . . . 0.0 109.0 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' THR . . . . . 0.461 ' CG2' ' HD2' ' A' ' 418' ' ' LYS . 23.5 m -105.46 124.27 49.27 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.869 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.49 158.44 42.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -130.51 132.76 45.79 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 79.6 mt -96.61 159.79 14.74 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.49 -41.35 76.23 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -101.37 147.27 26.52 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.284 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.84 -24.28 38.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.27 25.6 1.16 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.448 1.499 . . . . 0.0 110.819 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -131.84 153.99 49.61 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -175.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -124.64 172.15 9.48 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 123.226 0.329 . . . . 0.0 110.629 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.38 144.25 37.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.081 0.467 . . . . 0.0 110.61 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -103.27 129.4 50.25 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.798 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.663 ' HB3' HD12 ' A' ' 403' ' ' ILE . 34.4 m95 -110.28 128.27 55.44 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.955 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.4 139.73 50.94 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -109.2 125.56 52.36 Favored 'General case' 0 N--CA 1.407 -2.61 0 C-N-CA 118.224 -1.39 . . . . 0.0 108.906 171.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 27.3 p30 50.89 21.68 1.01 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 126.628 1.971 . . . . 0.0 114.296 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.67 12.35 56.99 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.52 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -96.14 -91.58 0.23 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 176.02 139.85 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.663 HD12 ' HB3' ' A' ' 396' ' ' TRP . 9.4 mt -111.51 106.15 20.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -115.2 146.46 41.39 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 51.8 ttm -55.93 104.83 0.15 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.431 0.634 . . . . 0.0 111.195 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.0 t -117.3 110.14 17.71 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 51.42 -117.34 5.6 Favored Glycine 0 C--N 1.33 0.211 0 O-C-N 124.147 0.904 . . . . 0.0 113.35 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.9 p -114.46 8.7 16.58 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.671 0.748 . . . . 0.0 110.44 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -72.74 -40.71 65.85 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.052 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -129.33 113.91 15.56 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 64.2 mt -112.88 116.92 53.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.772 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -86.61 109.55 19.23 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.765 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.03 108.13 19.1 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.6 m -103.16 104.91 15.1 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.135 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.5 mm -123.65 103.91 13.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 66.63 -113.39 5.63 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.51 -12.97 19.69 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.381 0.61 . . . . 0.0 109.601 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.461 ' HD2' ' CG2' ' A' ' 384' ' ' THR . 7.8 ttpm? -86.96 136.35 32.96 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.34 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -122.33 126.44 48.07 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.3 m -127.51 125.63 40.76 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.48 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.456 HD21 HG21 ' A' ' 403' ' ' ILE . 50.3 tp -100.1 103.93 15.46 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.492 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 70.0 m -89.97 116.84 28.32 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.023 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 48.8 mt -107.54 118.63 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.0 m -89.97 144.59 25.79 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 57.19 62.72 2.11 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 123.979 0.912 . . . . 0.0 112.401 174.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' CYS . . . . . 0.58 ' SG ' HG22 ' A' ' 381' ' ' ILE . 82.8 m -69.56 118.18 12.11 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' SER . . . . . 0.533 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 14.1 m -111.05 171.79 7.26 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.55 -35.12 78.44 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.079 0.466 . . . . 0.0 110.367 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.42 -7.74 56.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.789 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' ASP . . . . . 0.533 ' HB3' ' H ' ' A' ' 427' ' ' SER . 29.5 t70 -105.34 -9.32 17.67 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.618 0.723 . . . . 0.0 109.711 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.71 112.28 2.19 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.625 -1.17 . . . . 0.0 107.872 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -153.59 168.2 26.98 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.068 0.461 . . . . 0.0 111.283 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.53 131.5 34.36 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -114.97 132.17 56.67 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 396' ' ' TRP . 0.6 OUTLIER -112.08 136.93 50.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.061 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 16.9 p -106.07 106.21 16.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.49 124.03 53.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.246 0.546 . . . . 0.0 111.513 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.91 152.06 36.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -70.08 113.33 4.89 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 118.689 -1.719 . . . . 0.0 110.901 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 109.23 -36.31 4.41 Favored Glycine 0 N--CA 1.418 -2.558 0 C-N-CA 123.306 0.479 . . . . 0.0 111.928 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.514 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 6.3 mm-40 -130.21 126.32 37.1 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -136.4 146.84 46.89 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.438 ' SG ' ' HE2' ' A' ' 368' ' ' LYS . 8.9 t -144.9 160.24 41.63 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 7.6 p -142.92 133.2 24.63 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.329 0.393 . . . . 0.0 110.583 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 8.6 t -109.36 150.18 28.41 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -111.57 110.68 21.22 Favored 'General case' 0 N--CA 1.406 -2.668 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.45 145.49 31.9 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -119.13 107.6 13.66 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.18 110.41 22.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -102.15 127.81 48.91 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.437 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.412 -2.344 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.539 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 342' ' ' VAL . 14.2 p -55.52 -28.22 22.39 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.651 0 C-N-CA 124.942 1.297 . . . . 0.0 111.911 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -57.32 -56.56 20.23 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 123.093 0.557 . . . . 0.0 110.614 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.42 -32.77 58.69 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.366 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.2 mt -71.46 -45.57 67.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.938 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 9.6 tt -73.28 -29.41 62.71 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -61.78 -42.72 99.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.445 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -89.16 -0.59 57.57 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.984 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -94.58 154.87 40.02 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.815 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.93 141.47 44.65 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.031 1.821 . . . . 0.0 111.279 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.85 -20.76 53.8 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.815 3.01 . . . . 0.0 114.049 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 5.6 m -66.71 -27.96 68.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.471 ' HG3' HD11 ' A' ' 336' ' ' ILE . 7.9 pt-20 -110.57 11.84 22.86 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -52.94 -37.73 61.23 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.415 ' HA ' HD22 ' A' ' 345' ' ' LEU . 40.1 tt0 -63.81 -47.43 80.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.608 0.242 . . . . 0.0 110.99 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -62.61 -42.59 99.67 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.543 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.471 HD11 ' HG3' ' A' ' 332' ' ' GLU . 74.1 mt -61.63 -44.99 99.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.158 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.89 -54.01 51.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.13 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -69.19 -23.11 63.87 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -69.79 -44.4 70.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.221 0.534 . . . . 0.0 109.987 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -88.47 1.23 55.22 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 72.49 35.64 59.5 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.151 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.404 HG21 HG11 ' A' ' 321' ' ' VAL . 8.2 t -103.56 111.53 33.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.1 p -84.01 -20.66 32.4 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-O 122.341 1.067 . . . . 0.0 110.15 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.46 44.18 1.19 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.149 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 334' ' ' GLU . 33.6 tp . . . . . 0 C--N 1.315 -0.918 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 172.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.411 -2.393 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.544 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -100.31 -33.29 10.46 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -89.08 123.15 33.1 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.512 173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -87.44 -25.18 23.89 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 367' ' ' LYS . 36.9 ttmt -164.29 118.79 1.45 Allowed 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.484 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 51.3 mtmt -91.26 170.59 9.87 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 123.403 0.439 . . . . 0.0 110.452 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.635 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 76.1 mt -60.12 143.81 51.34 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 123.896 0.748 . . . . 0.0 111.582 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' GLU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 373' ' ' TYR . 35.7 mm-40 -64.75 149.1 96.5 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.856 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.04 -52.37 9.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.858 2.372 . . . . 0.0 112.812 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -142.23 144.43 33.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.012 0.434 . . . . 0.0 111.666 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 370' ' ' GLU . 56.3 m-85 -123.76 163.23 21.58 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -134.06 142.84 47.72 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.5 p -144.82 157.68 14.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 48.8 m -97.23 150.28 21.09 Favored 'General case' 0 N--CA 1.412 -2.332 0 C-N-CA 120.414 -0.515 . . . . 0.0 109.688 174.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.06 128.79 37.83 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.264 0.626 . . . . 0.0 111.207 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 83.81 15.66 69.82 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.659 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -118.31 176.3 5.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.3 mtpt -102.83 146.13 28.73 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.18 0.3 . . . . 0.0 110.392 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.489 HG22 ' SG ' ' A' ' 426' ' ' CYS . 10.7 tp -135.65 156.62 38.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 30.5 ptt180 -142.64 124.43 15.09 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.587 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -94.71 126.2 39.86 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.391 -1.277 . . . . 0.0 107.924 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 68.0 m -108.63 138.91 44.18 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 11.8 m -141.43 159.67 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 C-N-CA 124.111 0.964 . . . . 0.0 108.93 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 85.9 mt-10 -130.04 136.92 49.91 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.33 148.74 23.85 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -84.47 10.03 11.9 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.456 0.646 . . . . 0.0 110.422 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -157.58 135.97 11.17 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -67.12 -24.25 65.91 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.145 0.497 . . . . 0.0 111.664 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -107.05 26.27 10.34 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.18 0.99 . . . . 0.0 110.915 -173.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -98.61 122.27 41.61 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -93.16 137.56 32.38 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 19.4 m -106.29 154.22 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.97 174.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 15.3 tptm -123.6 157.42 33.78 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.498 ' O ' HD12 ' A' ' 397' ' ' LEU . 4.4 m-90 -118.95 126.05 50.85 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 123.338 0.399 . . . . 0.0 109.969 -168.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 396' ' ' TRP . 6.5 mp -135.89 144.26 45.46 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -123.57 121.96 36.94 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 27.9 p30 46.71 22.31 0.18 Allowed 'General case' 0 N--CA 1.504 2.272 0 C-N-CA 125.614 1.566 . . . . 0.0 114.891 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 107.69 -0.21 34.33 Favored Glycine 0 C--O 1.224 -0.517 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.998 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -111.17 129.96 55.78 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -65.71 122.31 16.99 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.2 0.524 . . . . 0.0 111.035 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.434 ' HB ' ' CB ' ' A' ' 396' ' ' TRP . 57.7 mt -80.15 123.51 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -128.21 154.21 46.07 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.41 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 66.7 mtm -70.55 93.6 0.92 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.11 0.481 . . . . 0.0 111.507 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 39.8 m -92.79 100.53 12.99 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 71.77 -129.25 15.9 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.8 m -112.68 14.88 20.08 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -65.77 -42.81 90.41 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 94.0 m-85 -123.9 127.73 48.43 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 50.5 mm -118.0 117.35 54.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -86.79 108.12 18.58 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.302 0.572 . . . . 0.0 109.546 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -97.45 123.85 41.44 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.842 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 35.7 t -118.8 111.98 19.13 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 70.1 mt -124.76 84.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.716 0.769 . . . . 0.0 109.247 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.12 -109.89 2.99 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.17 -20.28 16.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.904 0.383 . . . . 0.0 110.182 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 386' ' ' GLU . 22.0 ptmt -88.36 133.1 34.18 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.782 0.801 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.29 139.45 53.78 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' THR . . . . . 0.402 ' CG2' ' HB2' ' A' ' 382' ' ' ARG . 74.1 m -134.26 130.36 36.99 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-O 121.148 0.499 . . . . 0.0 110.884 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 382' ' ' ARG . 37.8 tp -95.64 109.39 21.66 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.0 m -97.53 118.87 35.01 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.51 124.68 55.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 7.1 m -101.71 132.28 47.51 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 63.91 70.27 0.52 Allowed 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 124.235 0.959 . . . . 0.0 110.919 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' CYS . . . . . 0.489 ' SG ' HG22 ' A' ' 381' ' ' ILE . 73.5 m -68.23 123.74 21.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.67 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 45.3 t -106.23 155.23 19.69 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.46 -27.13 69.07 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.129 0.572 . . . . 0.0 110.475 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -87.22 1.08 54.24 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.264 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -114.15 1.98 14.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.32 111.75 3.16 Favored 'General case' 0 C--O 1.255 1.362 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.789 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -161.71 171.4 17.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.576 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -87.68 130.89 34.65 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -111.26 138.66 47.45 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 444' ' ' SER . 0.2 OUTLIER -120.52 141.6 50.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.411 ' SG ' HD11 ' A' ' 369' ' ' LEU . 73.7 m -109.13 111.38 22.97 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 168.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.93 119.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.281 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 47.6 t -110.85 159.82 10.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 169.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.15 113.93 6.34 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 119.269 -1.443 . . . . 0.0 111.52 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 89.04 -24.27 14.0 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 121.081 0.267 . . . . 0.0 112.824 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.544 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 4.9 mm-40 -118.29 109.89 16.86 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.479 0.712 . . . . 0.0 109.107 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -136.26 149.55 48.54 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 34.2 t -148.2 139.53 23.47 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 435' ' ' GLN . 9.3 m -112.31 151.07 30.14 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.6 t -129.15 144.64 51.28 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -110.63 109.81 20.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 121.752 0.787 . . . . 0.0 109.108 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -93.72 129.52 40.03 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.993 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -107.82 115.4 30.07 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.377 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 38.2 t -90.08 125.58 42.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 376' ' ' SER . 12.0 pttp -116.11 146.83 41.92 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--N 1.259 -3.327 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 174.844 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.635 ' HA ' ' NE1' ' A' ' 322' ' ' TRP . 1.1 m-20 . . . . . 0 CA--C 1.496 -1.135 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 340' ' ' TYR . 7.4 p -56.25 -38.65 55.65 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.192 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.802 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' TRP . . . . . 0.635 ' NE1' ' HA ' ' A' ' 320' ' ' ASP . 0.0 OUTLIER -45.79 -52.04 11.79 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.616 ' HG2' ' HB3' ' A' ' 320' ' ' ASP . 8.4 pt-20 -85.48 -38.42 18.63 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.422 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 87.1 mt -65.46 -40.45 88.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.632 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.2 tt -75.76 -33.06 60.19 Favored 'General case' 0 C--O 1.202 -1.429 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -69.06 -36.47 77.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -85.39 -7.55 58.89 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.173 0.511 . . . . 0.0 111.329 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -84.52 161.39 54.09 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.316 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.14 135.48 51.08 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.922 2.415 . . . . 0.0 111.469 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.53 -34.61 90.32 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 124.048 3.165 . . . . 0.0 115.568 -171.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 19.5 t -83.7 -1.9 55.06 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.682 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -102.82 -4.24 25.19 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.869 0.366 . . . . 0.0 110.07 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -52.38 -42.07 63.68 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -64.5 -38.59 91.56 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.468 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -66.37 -46.3 77.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 109.485 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.06 -37.61 73.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.288 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.75 -62.45 1.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.582 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -62.19 -32.96 73.67 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -59.72 -41.2 90.32 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.806 0.842 . . . . 0.0 111.564 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' TYR . . . . . 0.425 ' CB ' ' HB ' ' A' ' 321' ' ' VAL . 95.6 m-85 -97.25 10.71 38.78 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.177 0.513 . . . . 0.0 111.962 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 86.72 15.93 62.57 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.577 174.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 4.2 t -94.12 105.57 17.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.3 p -84.23 -14.95 48.59 Favored 'General case' 0 C--N 1.267 -2.98 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -133.27 95.46 3.53 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.5 pt? . . . . . 0 C--N 1.306 -1.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.18 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 61.0 m . . . . . 0 N--CA 1.392 -3.334 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.602 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -93.32 -10.73 34.41 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.036 0.922 . . . . 0.0 109.494 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -100.11 127.65 46.32 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.707 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -95.39 -17.67 21.37 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -165.5 126.12 1.87 Allowed 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.592 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 33.4 mtmm -102.34 -179.49 4.0 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 65.7 mt -74.3 147.12 42.58 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.98 137.61 89.81 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -55.64 -35.81 93.59 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.497 2.132 . . . . 0.0 112.465 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -128.36 134.09 48.78 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.998 0.428 . . . . 0.0 112.025 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -133.12 155.41 49.31 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.989 0.916 . . . . 0.0 109.298 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -134.64 147.67 50.22 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.19 154.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 10.1 t -96.13 150.66 20.26 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.523 ' HD2' ' HG2' ' A' ' 451' ' ' GLU . 83.4 tttt -61.42 120.81 11.2 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 123.169 0.587 . . . . 0.0 110.978 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 97.83 -4.56 61.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.5 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -98.27 175.04 6.21 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.659 0.266 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -104.77 150.45 24.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.994 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.434 HG22 ' SG ' ' A' ' 426' ' ' CYS . 16.2 tt -141.19 136.84 33.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 120.953 0.406 . . . . 0.0 110.126 174.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -107.9 123.68 48.98 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.375 0.607 . . . . 0.0 109.896 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 68.1 mt -101.81 114.18 28.03 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 67.3 m -109.31 127.91 54.67 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 20.3 m -132.39 160.67 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.5 135.19 46.87 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.438 HD11 ' CG1' ' A' ' 394' ' ' VAL . 3.1 mm? -99.57 155.92 17.33 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.23 -7.93 56.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.513 0.673 . . . . 0.0 110.506 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 392' ' ' ALA . 13.1 t70 -129.53 140.37 51.26 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -75.52 -24.47 56.78 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -115.3 25.77 10.6 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.624 0.726 . . . . 0.0 111.638 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 389' ' ' ASP . . . -97.72 133.39 42.32 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 175.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -104.72 160.18 15.18 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.479 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.438 ' CG1' HD11 ' A' ' 387' ' ' LEU . 7.6 m -109.78 154.08 11.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.614 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -105.62 116.89 32.71 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.47 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 1.2 m-90 -92.3 120.2 32.62 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.94 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.4 mp -125.9 140.36 52.7 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 118.466 0.575 . . . . 0.0 110.576 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.29 116.77 27.44 Favored 'General case' 0 N--CA 1.405 -2.699 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.9 p30 52.41 18.16 0.89 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.444 1.497 . . . . 0.0 113.816 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.56 -4.71 23.06 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.303 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -110.22 128.68 55.63 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 35.1 tt0 -62.32 121.34 12.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 0.0 110.078 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 396' ' ' TRP . 58.4 mt -66.51 124.6 22.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.163 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -108.61 153.0 24.02 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.943 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 50.9 ttm -71.02 105.15 3.21 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 33.6 t -104.39 98.54 8.31 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 57.84 -114.42 5.66 Favored Glycine 0 C--N 1.329 0.173 0 O-C-N 123.485 0.491 . . . . 0.0 112.488 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' SER . . . . . 0.441 ' HA ' HD11 ' A' ' 411' ' ' ILE . 23.0 m -114.72 10.81 16.7 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.569 0.699 . . . . 0.0 109.837 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -77.08 -45.34 27.37 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.526 ' O ' ' HG3' ' A' ' 405' ' ' MET . 65.8 m-85 -122.66 109.27 14.05 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.441 HD11 ' HA ' ' A' ' 408' ' ' SER . 48.3 mm -115.2 119.68 62.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 120.981 0.419 . . . . 0.0 110.909 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.522 ' CE2' HD13 ' A' ' 421' ' ' LEU . 24.6 m-85 -87.24 108.49 18.96 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.99 108.46 21.17 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.9 m -100.37 104.67 16.11 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.7 mt -121.19 83.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 66.93 -119.14 11.4 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.562 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -79.75 -23.67 42.08 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -74.81 125.27 28.42 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.73 0.776 . . . . 0.0 111.45 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 419' ' ' ARG . 1.9 tpp180 -114.98 111.68 21.51 Favored 'General case' 0 N--CA 1.399 -3.018 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 170.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 63.5 m -119.82 120.57 36.89 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.368 0.604 . . . . 0.0 111.498 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.522 HD13 ' CE2' ' A' ' 412' ' ' PHE . 36.2 tp -91.81 115.6 28.19 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 45.4 m -98.2 110.34 22.94 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.3 mt -97.54 123.65 50.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 33.9 m -104.33 136.7 43.43 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 59.38 64.78 1.28 Allowed 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 124.673 1.233 . . . . 0.0 111.49 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' CYS . . . . . 0.434 ' SG ' HG22 ' A' ' 381' ' ' ILE . 58.6 m -67.33 134.75 52.14 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.941 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 20.1 m -125.57 -177.96 4.08 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 84.6 mt -79.79 -21.91 43.75 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.918 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.43 73.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.443 0.639 . . . . 0.0 109.774 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.77 -0.37 57.26 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.141 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.69 108.13 1.62 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -149.0 165.07 32.73 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.012 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.87 115.84 23.75 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -104.01 152.09 22.45 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 18.5 pm0 -147.36 150.72 35.27 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.078 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 77.0 m -116.09 118.6 33.33 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 38.6 t -106.31 132.94 52.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 67.4 t -128.15 161.41 36.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -61.45 112.36 4.68 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 118.989 -1.577 . . . . 0.0 111.865 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 96.29 -35.18 4.5 Favored Glycine 0 N--CA 1.421 -2.345 0 CA-C-N 114.768 -0.716 . . . . 0.0 112.82 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.602 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 9.8 mm-40 -120.08 132.88 55.6 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.928 0.364 . . . . 0.0 110.388 -174.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -137.81 166.97 22.69 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.0 t -150.51 133.76 16.26 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 6.0 p -108.89 146.98 32.87 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 123.542 0.526 . . . . 0.0 110.378 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 11.3 t -129.66 149.7 51.3 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -116.36 113.28 22.7 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 68.4 tp -91.85 146.1 24.02 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.303 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -123.31 108.17 12.46 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.04 117.01 32.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 376' ' ' SER . 38.7 ttpt -105.79 119.98 40.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.581 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.523 ' HG2' ' HD2' ' A' ' 377' ' ' LYS . 26.4 mt-10 . . . . . 0 C--N 1.328 -0.338 0 O-C-N 123.695 0.622 . . . . 0.0 110.872 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.476 HG21 HG21 ' A' ' 342' ' ' VAL . 12.3 p -60.34 -35.16 60.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 123.761 0.825 . . . . 0.0 111.549 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -47.18 -51.89 17.18 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.983 1.313 . . . . 0.0 110.245 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 9.8 pt-20 -85.36 -48.49 8.99 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.76 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.74 -50.73 78.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 C-N-CA 122.798 0.439 . . . . 0.0 112.063 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.4 HD13 ' HB ' ' A' ' 336' ' ' ILE . 47.3 tp -74.02 -20.97 60.15 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 -175.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -77.68 -42.99 32.65 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.22 0.533 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 13.7 pt20 -88.35 -20.96 24.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.139 -175.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -70.66 146.45 93.65 Favored Pre-proline 0 C--N 1.31 -1.129 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.46 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.78 155.1 61.61 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.017 1.812 . . . . 0.0 110.625 175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.48 -22.05 20.35 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.255 3.304 . . . . 0.0 113.989 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 6.4 m -72.71 -21.62 61.01 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.202 0.525 . . . . 0.0 111.527 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.519 ' HB3' HD11 ' A' ' 336' ' ' ILE . 7.7 mm-40 -88.82 -20.89 24.1 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.928 -177.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -51.44 -53.47 36.64 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -173.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -56.07 -33.01 64.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -80.66 -59.82 2.54 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.773 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' A' ' 332' ' ' GLU . 79.8 mt -55.58 -49.63 72.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.124 -174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 345' ' ' LEU . . . -58.97 -57.65 12.15 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.426 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -67.8 -26.63 66.18 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -66.33 -40.37 89.86 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -94.03 -7.95 41.24 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 98.71 16.42 31.34 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.635 -1.269 . . . . 0.0 112.958 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.476 HG21 HG21 ' A' ' 321' ' ' VAL . 10.5 t -94.05 97.27 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 5.2 m -72.35 -39.4 68.14 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.941 -172.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -101.54 88.89 3.55 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.537 1.161 . . . . 0.0 110.725 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.425 ' HB3' ' CB ' ' A' ' 337' ' ' ALA . 4.5 pp . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.462 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 75.2 p . . . . . 0 N--CA 1.441 -0.895 0 CA-C-O 120.973 0.416 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.569 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -83.2 -24.34 32.46 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.56 ' CD2' ' HB3' ' A' ' 441' ' ' GLU . 7.2 m-85 -94.23 132.94 38.27 Favored 'General case' 0 N--CA 1.406 -2.659 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.557 175.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -98.01 -17.09 19.35 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -161.54 119.44 2.31 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -99.33 159.58 14.9 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 79.6 mt -61.7 133.61 55.78 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 123.363 0.415 . . . . 0.0 111.367 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.41 137.67 68.77 Favored Pre-proline 0 C--O 1.215 -0.743 0 O-C-N 124.584 1.178 . . . . 0.0 108.341 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.93 -27.24 52.95 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.71 2.273 . . . . 0.0 113.424 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -134.65 138.97 44.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.412 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 36.0 m-85 -136.93 143.88 43.15 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -128.94 142.12 51.04 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.46 155.82 20.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 16.2 m -88.06 151.89 22.42 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -72.76 116.49 13.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.282 0.563 . . . . 0.0 110.096 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.29 43.76 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -116.9 156.12 27.91 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.329 -0.936 . . . . 0.0 109.637 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -92.49 141.51 28.43 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.694 0.798 . . . . 0.0 112.121 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.58 HG22 ' SG ' ' A' ' 426' ' ' CYS . 15.6 tt -139.05 146.93 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -123.87 128.95 50.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.218 1.009 . . . . 0.0 112.084 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 420' ' ' THR . 17.8 mt -99.82 125.89 45.82 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.19 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 31.9 m -116.66 130.08 56.53 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.71 160.15 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 418' ' ' LYS . 64.3 mt-10 -129.89 138.57 51.0 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 88.8 mt -101.6 139.0 37.85 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.114 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -84.6 -25.88 28.31 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -106.48 122.06 45.53 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.307 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -80.95 -7.58 59.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.756 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -91.37 11.57 23.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -129.79 158.63 38.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -130.14 164.75 23.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 29.1 m -106.73 134.84 47.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.492 0.663 . . . . 0.0 111.491 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -103.5 129.17 50.62 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.678 ' HB3' HD12 ' A' ' 403' ' ' ILE . 50.1 m95 -103.68 130.03 51.09 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 434' ' ' TYR . 8.2 mp -116.76 139.53 50.47 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' LYS . . . . . 0.647 ' HG2' HG12 ' A' ' 403' ' ' ILE . 32.8 mmtp -90.81 107.4 19.16 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 11.1 p30 48.66 12.59 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.9 4.07 15.08 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.657 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -89.38 -96.38 0.1 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 122.57 0.348 . . . . 0.0 110.353 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 175.05 139.43 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.678 HD12 ' HB3' ' A' ' 396' ' ' TRP . 47.4 mt -94.48 114.85 31.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 172.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -96.6 139.85 32.08 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 87.8 mtp -71.82 89.8 1.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.746 0.308 . . . . 0.0 110.541 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 50.9 m -79.32 98.39 6.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.81 -119.01 16.4 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.059 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 32.8 t -111.27 16.98 20.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -76.24 -47.94 22.09 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -106.82 108.68 20.31 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.19 113.2 36.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -87.08 107.21 18.34 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.912 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -105.55 107.88 19.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 50.0 m -104.97 110.56 22.99 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.31 79.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.84 -110.9 3.76 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.95 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -83.47 -27.68 29.3 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.759 0.314 . . . . 0.0 110.414 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.43 ' HB3' ' HG2' ' A' ' 386' ' ' GLU . 10.9 ptmm? -95.32 116.69 29.11 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 122.116 0.96 . . . . 0.0 111.394 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -108.4 139.15 43.54 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.361 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 61.6 m -136.15 130.13 32.8 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-O 121.256 0.551 . . . . 0.0 111.524 -173.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 39.8 tp -103.8 115.85 31.23 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 38.7 m -102.04 115.08 29.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 50.4 mt -100.98 119.95 49.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 2.9 m -90.53 131.96 35.96 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.222 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 58.12 67.32 0.97 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.015 0.926 . . . . 0.0 111.93 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' CYS . . . . . 0.58 ' SG ' HG22 ' A' ' 381' ' ' ILE . 64.5 m -68.48 115.17 7.58 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' SER . . . . . 0.411 ' O ' HG21 ' A' ' 449' ' ' VAL . 79.6 p -101.44 -176.63 3.2 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.05 -22.25 63.09 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.28 0.562 . . . . 0.0 109.837 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.94 -8.54 58.26 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.376 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -99.26 -3.45 34.14 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.189 -0.319 . . . . 0.0 110.399 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.79 95.54 2.92 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -152.15 166.13 32.64 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.25 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.99 129.43 34.8 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 397' ' ' LEU . 20.3 m-85 -104.67 145.33 30.48 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.457 ' HG3' ' HB3' ' A' ' 444' ' ' SER . 23.7 mp0 -129.14 127.34 41.21 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 7.6 p -96.33 109.15 21.72 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.1 t -105.29 126.12 60.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 121.231 0.539 . . . . 0.0 111.377 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 60.0 t -129.15 161.39 38.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -66.79 113.6 5.77 Favored Glycine 0 C--N 1.315 -0.599 0 C-N-CA 119.082 -1.532 . . . . 0.0 111.104 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 98.6 -26.33 24.37 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.569 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 3.1 mm-40 -126.48 136.08 52.16 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 18.6 ptpt -147.9 160.67 42.54 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 16.9 t -155.82 134.37 11.73 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.457 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 5.5 p -106.47 126.38 52.18 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.336 0.588 . . . . 0.0 110.7 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.7 t -112.57 146.37 38.68 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.98 114.39 27.67 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.293 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.35 121.87 33.46 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.667 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -104.87 118.91 37.72 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.166 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 427' ' ' SER . 57.3 t -90.14 120.55 39.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 376' ' ' SER . 0.1 OUTLIER -113.7 119.98 39.27 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--N 1.308 -1.229 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.366 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.561 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 4.3 p -47.44 -37.15 4.84 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 C-N-CA 125.102 1.361 . . . . 0.0 112.365 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -57.59 -47.17 82.86 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.639 0.776 . . . . 0.0 110.762 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.9 -35.12 20.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.826 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.03 -49.54 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.795 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.32 -34.19 75.67 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.488 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -58.12 -40.37 81.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.281 0.562 . . . . 0.0 110.701 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -93.07 -4.13 52.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.331 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -89.02 153.84 49.38 Favored Pre-proline 0 C--N 1.301 -1.525 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.711 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' PRO . . . . . 0.412 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 23.6 Cg_endo -61.19 143.99 98.75 Favored 'Trans proline' 0 CA--C 1.55 1.321 0 C-N-CA 122.946 2.431 . . . . 0.0 112.763 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.481 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 10.7 Cg_endo -54.89 -34.57 86.31 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 124.216 3.277 . . . . 0.0 115.572 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 44.0 m -77.82 -5.56 51.25 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.412 ' CG ' ' HG2' ' A' ' 329' ' ' PRO . 15.0 mm-40 -99.67 -13.33 19.39 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.818 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.481 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 18.4 m-30 -47.86 -47.52 31.55 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -174.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.441 ' HA ' HD22 ' A' ' 345' ' ' LEU . 37.4 tt0 -68.18 -35.64 78.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.8 0.333 . . . . 0.0 111.295 -174.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -71.79 -42.88 66.58 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.818 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 59.1 mt -64.78 -38.66 83.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.464 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.09 51.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.033 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -68.9 -24.63 64.33 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -62.36 -39.83 94.43 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.007 0.523 . . . . 0.0 109.958 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' TYR . . . . . 0.561 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 82.5 m-85 -95.59 -4.7 44.1 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.194 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 83.38 26.52 43.11 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.498 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.32 116.96 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 3.0 p -94.52 -5.97 44.82 Favored 'General case' 0 C--N 1.268 -2.94 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.808 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.47 44.42 0.8 Allowed 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.46 0.704 . . . . 0.0 111.314 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 334' ' ' GLU . 24.4 tp . . . . . 0 C--N 1.296 -1.721 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.779 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.427 -1.617 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.671 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -87.65 -27.54 22.4 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -87.13 114.37 23.69 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.66 170.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -89.44 -17.24 29.11 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.061 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 367' ' ' LYS . 0.0 OUTLIER -164.61 120.53 1.49 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 176.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -97.04 173.3 7.34 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.834 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.465 HD13 HG22 ' A' ' 445' ' ' THR . 91.2 mt -71.07 142.16 50.85 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.876 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -62.04 129.93 92.34 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -43.39 -33.32 4.02 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.86 3.04 . . . . 0.0 114.819 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -146.56 120.66 9.46 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.068 -0.395 . . . . 0.0 111.239 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.565 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 59.0 m-85 -101.35 156.08 17.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -127.91 138.35 52.63 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.972 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.93 152.69 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 12.0 m -86.62 146.48 26.31 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 1.4 tmmm? -63.1 125.75 25.07 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.277 0.56 . . . . 0.0 110.006 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.475 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 98.89 -3.56 58.8 Favored Glycine 0 C--N 1.304 -1.206 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.623 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -95.63 169.37 10.07 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 120.889 0.376 . . . . 0.0 111.935 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -108.1 126.75 53.12 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.524 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.9 tt -128.6 158.34 40.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 41.9 mtt-85 -125.89 142.7 51.39 Favored 'General case' 0 CA--C 1.491 -1.318 0 CA-C-O 121.663 0.744 . . . . 0.0 110.589 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.31 107.47 18.48 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.8 m -105.31 126.28 51.92 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.272 -174.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 7.6 m -127.91 157.17 40.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 123.855 0.862 . . . . 0.0 109.374 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -120.36 136.61 54.65 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 392' ' ' ALA . 92.0 mt -107.88 141.33 39.65 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.19 71.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.142 0.496 . . . . 0.0 110.355 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -117.98 138.04 52.45 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -63.53 -32.57 74.07 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 123.293 0.637 . . . . 0.0 112.693 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.82 25.78 11.4 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.395 0.617 . . . . 0.0 111.879 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' ALA . . . . . 0.533 ' O ' HD13 ' A' ' 387' ' ' LEU . . . -91.69 106.53 18.55 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 104.276 -2.491 . . . . 0.0 104.276 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -78.67 143.87 35.88 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.638 -172.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 4.1 m -105.98 148.3 10.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -111.22 130.07 55.76 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.46 ' HB3' HD12 ' A' ' 403' ' ' ILE . 8.2 m-90 -101.21 121.77 42.45 Favored 'General case' 0 C--N 1.26 -3.292 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.911 -173.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 402' ' ' GLU . 6.2 mp -129.19 125.53 37.19 Favored 'General case' 0 CA--C 1.482 -1.671 0 CA-C-N 117.635 0.198 . . . . 0.0 111.4 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' LYS . . . . . 0.436 ' HB3' HG12 ' A' ' 403' ' ' ILE . 28.8 pttt -103.94 128.14 51.46 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 47.61 22.76 0.34 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.415 1.486 . . . . 0.0 114.24 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.16 8.05 56.86 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.379 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -92.32 -92.63 0.15 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 397' ' ' LEU . 52.7 tt0 172.69 138.53 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 396' ' ' TRP . 55.4 mt -92.0 102.29 13.41 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -99.23 126.02 44.95 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.854 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.454 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 18.3 ptt? -63.95 95.17 0.11 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 122.119 0.962 . . . . 0.0 112.257 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' SER . . . . . 0.42 ' H ' ' HD2' ' A' ' 410' ' ' TYR . 14.8 m -83.67 93.32 7.88 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.946 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 64.22 -128.26 36.22 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.568 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 8.9 p -97.69 5.53 49.19 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 120.921 0.391 . . . . 0.0 111.599 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -71.79 -32.31 67.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.74 0.305 . . . . 0.0 111.636 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.454 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 69.5 m-85 -123.44 112.5 17.6 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 39.6 mm -108.87 116.58 52.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.8 m-85 -87.03 105.54 17.23 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -106.49 108.56 20.13 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.478 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 27.8 t -90.54 105.38 17.78 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.0 mm -104.04 87.46 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.94 -98.6 0.64 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -120.11 -5.01 10.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.358 0.599 . . . . 0.0 109.443 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -95.23 99.69 11.61 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -92.7 132.14 37.17 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.227 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 22.5 m -125.28 129.81 50.76 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.531 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.532 HD13 ' CE2' ' A' ' 412' ' ' PHE . 22.2 tp -100.82 111.51 23.75 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 58.8 m -94.34 108.78 20.66 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.601 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 56.1 mt -96.92 116.93 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 15.1 m -90.84 136.47 33.05 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.054 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 55.72 68.63 0.84 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.0 1.72 . . . . 0.0 111.117 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' CYS . . . . . 0.524 ' SG ' HG22 ' A' ' 381' ' ' ILE . 61.7 m -68.87 113.2 6.08 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 11.0 m -103.65 -170.75 1.83 Allowed 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 89.9 mt -71.12 -23.88 62.18 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.269 0.557 . . . . 0.0 110.513 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -76.08 -15.04 60.18 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.235 0.541 . . . . 0.0 110.1 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -97.6 7.84 45.73 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.764 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.63 100.23 11.31 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -157.02 172.33 18.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.201 0.524 . . . . 0.0 111.609 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -90.51 118.08 29.7 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -107.39 131.81 53.85 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.839 -0.538 . . . . 0.0 110.252 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.496 ' HG3' ' OG ' ' A' ' 444' ' ' SER . 2.0 mp0 -122.95 146.71 47.36 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 123.345 0.658 . . . . 0.0 110.388 -175.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 78.8 m -123.28 113.26 18.64 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.14 133.94 53.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.951 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 49.2 t -125.56 161.85 29.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -57.56 112.73 3.94 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 118.955 -1.593 . . . . 0.0 111.577 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 85.36 -35.28 3.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.553 0.597 . . . . 0.0 112.714 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.671 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 7.9 mm-40 -99.53 126.24 45.44 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 123.601 0.761 . . . . 0.0 110.938 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -142.22 163.67 32.22 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.754 0.312 . . . . 0.0 111.401 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 25.6 p -160.34 150.04 17.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.496 ' OG ' ' HG3' ' A' ' 435' ' ' GLN . 3.4 m -137.08 146.72 45.49 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.565 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 9.0 t -129.94 132.2 46.25 Favored 'General case' 0 N--CA 1.399 -2.978 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.677 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.81 110.58 21.49 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 60.5 tp -84.72 119.59 25.44 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -95.79 108.21 20.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 64.0 t -94.79 109.13 21.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -100.17 117.49 34.52 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.216 0.531 . . . . 0.0 111.082 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.288 -2.071 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.539 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.73 -32.6 31.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 C-N-CA 123.156 0.582 . . . . 0.0 112.444 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -59.32 -46.18 89.3 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 124.698 1.199 . . . . 0.0 110.873 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.22 -32.37 22.66 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.862 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.6 mt -63.23 -45.57 98.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.637 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 333' ' ' TYR . 39.8 mt -61.74 -43.42 98.88 Favored 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.681 0.613 . . . . 0.0 110.466 177.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -55.73 -42.03 74.74 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.248 0.619 . . . . 0.0 111.777 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -81.78 -10.37 59.36 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.59 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -100.6 146.81 32.68 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -63.37 138.21 64.67 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 121.589 1.526 . . . . 0.0 110.12 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.51 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 4.9 Cg_endo -48.12 -28.98 11.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.046 3.164 . . . . 0.0 114.85 -176.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 44.2 p -64.15 -25.32 68.03 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.362 0.601 . . . . 0.0 112.323 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 336' ' ' ILE . 7.2 mm-40 -86.44 -14.51 43.05 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.467 -175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 3.8 m-85 -49.11 -44.62 42.47 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -57.97 -31.0 66.47 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.807 0.692 . . . . 0.0 110.607 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 339' ' ' GLN . 42.3 ttp180 -86.3 -51.68 6.1 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.338 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 332' ' ' GLU . 44.5 mt -60.38 -46.64 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.442 0.697 . . . . 0.0 111.692 -173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 342' ' ' VAL . . . -51.66 -52.38 48.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.912 0.885 . . . . 0.0 111.843 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -65.42 -21.72 66.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 335' ' ' ARG . 57.4 mt-30 -71.5 -34.9 70.54 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.519 0.676 . . . . 0.0 109.376 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -97.69 -12.78 21.98 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.154 -174.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 101.1 18.04 20.89 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.706 -1.235 . . . . 0.0 112.357 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.423 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 17.5 t -92.75 84.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.4 m -63.57 -42.29 98.34 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.572 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -99.87 76.18 1.94 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.602 1.192 . . . . 0.0 111.412 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.633 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.291 -1.957 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.372 175.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 121.355 0.598 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -89.77 -31.53 17.37 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 122.033 0.92 . . . . 0.0 108.91 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -87.93 140.81 29.12 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.336 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -96.92 -23.55 16.27 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -159.31 134.54 8.3 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' A' ' 443' ' ' CYS . 94.7 mttt -111.26 173.08 6.51 Favored 'General case' 0 C--N 1.283 -2.299 0 O-C-N 123.821 0.7 . . . . 0.0 111.56 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.56 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 87.6 mt -68.89 141.47 55.04 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.886 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -64.84 143.72 98.83 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -44.74 -38.91 13.17 Favored 'Trans proline' 0 C--O 1.257 1.454 0 C-N-CA 123.354 2.702 . . . . 0.0 113.593 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -145.09 158.75 43.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.565 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.418 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 42.6 m-85 -138.54 154.52 48.75 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -138.03 135.97 36.42 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.439 HG21 ' HB ' ' A' ' 381' ' ' ILE . 11.1 p -140.64 155.69 22.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.2 m -92.34 144.89 24.93 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.402 ' HB3' ' NZ ' ' A' ' 377' ' ' LYS . 3.0 ttpm? -57.18 128.75 38.56 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 123.699 0.8 . . . . 0.0 110.622 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.84 8.73 63.27 Favored Glycine 0 C--N 1.317 -0.486 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.367 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -112.06 -179.58 3.73 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 122.453 -0.439 . . . . 0.0 110.472 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -98.35 143.81 28.42 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.439 ' HB ' HG21 ' A' ' 375' ' ' VAL . 7.6 tp -138.15 139.23 42.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 20.6 ptt180 -134.32 122.91 23.32 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.157 0.98 . . . . 0.0 113.302 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' LEU . . . . . 0.411 ' HB3' ' CD2' ' A' ' 369' ' ' LEU . 2.1 mm? -88.5 129.12 35.53 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.293 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 34.4 m -120.76 122.62 40.77 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -173.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.26 155.32 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.966 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -126.31 140.53 52.45 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.486 HD11 HG13 ' A' ' 394' ' ' VAL . 5.5 mp -101.49 158.94 15.7 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.2 -24.56 57.82 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.449 0.642 . . . . 0.0 109.624 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -108.37 137.44 46.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -80.97 -28.11 35.73 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.908 0.385 . . . . 0.0 111.357 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -99.88 17.29 21.23 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.546 -174.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -116.25 148.55 40.36 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -115.43 174.14 6.16 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.403 0.621 . . . . 0.0 110.609 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.486 HG13 HD11 ' A' ' 387' ' ' LEU . 9.2 m -106.68 164.74 4.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.162 176.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 436' ' ' CYS . 8.1 tptp -109.23 146.14 34.71 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 175.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -115.76 111.32 20.36 Favored 'General case' 0 C--N 1.281 -2.398 0 O-C-N 123.171 0.294 . . . . 0.0 110.549 -171.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.3 mp -122.34 141.91 51.05 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.048 0.452 . . . . 0.0 111.23 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -120.87 122.56 40.52 Favored 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.1 p30 53.82 12.37 0.41 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 126.183 1.793 . . . . 0.0 113.563 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.62 11.29 29.14 Favored Glycine 0 C--O 1.22 -0.75 0 C-N-CA 121.245 -0.502 . . . . 0.0 111.964 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -118.64 120.68 38.15 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.19 125.93 25.51 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 56.5 mt -65.85 132.72 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.625 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -96.97 122.29 39.79 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 27.0 ttt -68.81 93.39 0.54 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.38 0.61 . . . . 0.0 112.543 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 409' ' ' LYS . 42.7 t -82.54 128.27 34.14 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 172.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -34.82 -70.74 0.16 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 6.4 p -101.62 18.54 20.05 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.517 0.675 . . . . 0.0 112.329 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 406' ' ' SER . 17.2 tppt? -104.65 -57.79 1.98 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.31 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -113.31 108.13 16.82 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 57.1 mt -108.67 114.6 47.2 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.715 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.1 m-85 -85.78 107.53 17.67 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.719 0.771 . . . . 0.0 108.924 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.2 113.13 26.37 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 16.6 m -104.45 124.63 49.59 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.2 mp -122.12 76.61 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.199 0 CA-C-O 121.546 0.689 . . . . 0.0 109.428 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.76 -86.04 0.76 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.294 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -109.45 -19.17 13.35 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.341 0.591 . . . . 0.0 109.508 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.546 ' HE2' ' OG1' ' A' ' 420' ' ' THR . 82.6 tttt -86.29 118.93 26.05 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.779 -176.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -104.95 118.52 36.73 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' THR . . . . . 0.546 ' OG1' ' HE2' ' A' ' 418' ' ' LYS . 8.3 m -114.59 124.49 51.99 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.527 HD13 ' CE2' ' A' ' 412' ' ' PHE . 20.4 tp -101.29 103.85 14.85 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 27.8 m -99.76 111.12 23.47 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.108 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 45.2 mt -89.3 121.38 39.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 177.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 18.6 m -106.94 128.71 54.57 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 63.17 67.7 0.66 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.711 -1.131 . . . . 0.0 107.979 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 48.1 t -74.1 123.78 25.07 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 91.4 p -105.25 -176.72 3.16 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 97.0 mt -74.33 -25.68 59.69 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -76.09 -12.17 60.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.227 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -92.16 -21.55 20.34 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.786 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -50.76 119.62 4.03 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.421 1.076 . . . . 0.0 110.601 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -169.77 165.01 9.98 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 123.573 0.546 . . . . 0.0 109.548 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.67 124.42 32.18 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -106.44 141.7 37.31 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -175.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.71 140.76 34.94 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 121.341 0.591 . . . . 0.0 111.735 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 395' ' ' LYS . 63.8 m -105.38 128.77 53.68 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.93 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.2 t -115.74 134.63 58.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.243 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.459 ' CG2' HG12 ' A' ' 394' ' ' VAL . 97.1 t -131.57 160.94 42.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.1 114.0 6.46 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 119.148 -1.501 . . . . 0.0 110.365 175.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.76 -35.11 5.15 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-O 119.39 -0.672 . . . . 0.0 113.348 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -139.53 173.15 11.84 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 122.636 1.208 . . . . 0.0 113.997 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -149.92 166.96 28.02 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.67 -1.604 . . . . 0.0 106.933 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.424 ' HB3' ' HD3' ' A' ' 368' ' ' LYS . 27.5 p -154.4 133.28 12.3 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 172.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 5.0 m -118.04 143.23 46.6 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.301 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 13.5 t -125.59 150.79 47.21 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -110.48 110.72 21.58 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 68.1 tp -90.47 129.7 36.62 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -106.77 107.9 19.14 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.77 119.28 37.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -98.28 126.59 43.83 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--N 1.311 -1.098 0 C-N-CA 123.957 0.903 . . . . 0.0 110.119 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 122.02 0.914 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.46 -29.63 47.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.441 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -53.32 -54.51 35.37 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.471 0.708 . . . . 0.0 111.375 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.03 -38.18 53.37 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.297 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 67.9 mt -64.12 -50.64 76.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.252 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.43 -28.79 64.23 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -64.06 -43.73 94.59 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.944 0.402 . . . . 0.0 110.836 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -91.26 -0.56 57.7 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.101 0.477 . . . . 0.0 112.015 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -91.16 152.29 43.9 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.849 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' PRO . . . . . 0.405 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 9.4 Cg_endo -58.15 148.33 78.64 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.704 2.269 . . . . 0.0 112.23 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 26.7 Cg_endo -60.85 -21.96 72.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.496 2.797 . . . . 0.0 114.139 -173.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 5.1 m -85.54 -4.01 59.03 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.873 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 336' ' ' ILE . 48.9 mm-40 -99.49 -14.93 18.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.935 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.454 ' HB3' HD11 ' A' ' 345' ' ' LEU . 15.6 m-30 -44.15 -55.12 5.01 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -173.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -65.65 -38.22 88.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.243 0.545 . . . . 0.0 111.179 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.03 -42.48 84.8 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.659 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 332' ' ' GLU . 74.2 mt -65.04 -44.5 95.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -55.65 -58.51 7.52 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.315 0.646 . . . . 0.0 111.395 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -67.75 -23.34 65.23 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.01 -42.3 80.89 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.777 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -89.4 -15.51 33.08 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.193 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 100.2 34.63 4.75 Favored Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.3 t -112.21 118.24 57.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 43.4 p -97.75 -13.94 21.12 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-O 122.015 0.912 . . . . 0.0 109.21 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -82.39 47.09 1.11 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.754 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 333' ' ' TYR . 36.0 tp . . . . . 0 C--N 1.301 -1.522 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.732 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.429 -1.505 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.747 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -85.26 -13.33 50.12 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.16 117.84 29.23 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -77.17 -29.64 54.55 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.406 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -151.42 115.96 5.12 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -98.51 160.28 14.39 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 76.5 mt -70.17 144.85 51.85 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.49 151.14 96.61 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -37.96 -45.48 1.96 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 124.397 3.398 . . . . 0.0 114.022 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -148.38 153.74 38.99 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.665 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 447' ' ' LEU . 74.9 m-85 -134.19 146.03 49.77 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.01 147.07 48.1 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.37 155.96 18.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' A' ' 379' ' ' HIS . 15.0 m -87.16 151.65 23.01 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.527 ' CB ' ' HA ' ' A' ' 451' ' ' GLU . 0.0 OUTLIER -70.13 115.33 9.21 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 120.85 0.357 . . . . 0.0 110.105 -178.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 100.49 -6.06 57.39 Favored Glycine 0 CA--C 1.496 -1.11 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 376' ' ' SER . 39.7 t-80 -96.11 152.9 18.11 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -96.18 143.46 27.27 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.944 0.402 . . . . 0.0 111.772 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.65 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.9 tp -121.97 129.69 75.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -109.98 112.53 24.61 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.32 0.581 . . . . 0.0 110.304 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 79.8 mt -93.96 139.11 31.32 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 64.3 m -134.55 113.38 11.72 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.686 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.86 145.39 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 22.2 mt-10 -121.54 137.69 54.62 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.497 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 82.5 mt -95.57 144.81 25.72 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -83.84 -21.56 32.01 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.0 121.23 44.04 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.915 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -75.36 -27.12 59.03 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.265 0.555 . . . . 0.0 110.689 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -90.06 18.91 5.35 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.866 0.866 . . . . 0.0 111.304 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -113.55 142.43 45.96 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -110.5 165.99 11.36 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.82 144.31 38.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.256 0.551 . . . . 0.0 110.745 -176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -108.37 143.75 36.87 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.545 ' HB3' HD12 ' A' ' 403' ' ' ILE . 10.2 m-90 -113.21 119.08 36.53 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.596 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.9 mp -126.79 138.83 53.41 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -120.36 121.37 38.44 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 22.4 p30 51.22 12.72 0.14 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 126.393 1.877 . . . . 0.0 114.551 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.93 8.24 22.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.197 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -120.07 138.74 53.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.03 126.65 28.05 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 120.753 0.311 . . . . 0.0 110.57 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 396' ' ' TRP . 34.5 mt -72.58 102.07 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -76.26 137.75 40.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 51.0 ttp -73.27 100.01 3.02 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' SER . . . . . 0.432 ' H ' ' HD1' ' A' ' 410' ' ' TYR . 43.8 t -101.75 119.19 38.39 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.257 -174.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 49.64 -132.21 26.75 Favored Glycine 0 C--N 1.338 0.641 0 O-C-N 124.748 1.28 . . . . 0.0 113.959 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 24.8 t -104.79 11.95 33.24 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' LYS . . . . . 0.477 ' HD3' ' OD2' ' A' ' 430' ' ' ASP . 33.1 ttmt -75.74 -61.12 2.03 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.952 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.5 ' O ' ' HG3' ' A' ' 405' ' ' MET . 82.0 m-85 -94.78 117.27 29.87 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.2 mt -121.43 113.53 39.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.524 ' CE1' HD13 ' A' ' 421' ' ' LEU . 24.3 m-85 -86.99 112.3 21.69 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' GLU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 420' ' ' THR . 41.7 mt-10 -107.7 107.04 17.65 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 32.0 t -99.22 114.68 27.61 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 123.592 0.757 . . . . 0.0 108.991 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.614 ' HB ' ' CG ' ' A' ' 418' ' ' LYS . 41.9 mm -115.26 79.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 67.25 -83.46 0.13 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.376 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -100.9 -31.95 10.89 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.575 0.35 . . . . 0.0 110.767 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.614 ' CG ' ' HB ' ' A' ' 415' ' ' ILE . 1.5 ptpp? -84.49 140.4 31.5 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.715 0.769 . . . . 0.0 111.744 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -124.18 100.77 6.87 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 413' ' ' GLU . 31.4 m -98.73 134.42 41.66 Favored 'General case' 0 C--N 1.259 -3.345 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.427 -174.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.524 HD13 ' CE1' ' A' ' 412' ' ' PHE . 33.2 tp -117.0 106.81 13.81 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.359 0.6 . . . . 0.0 109.426 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 36.3 m -97.33 109.67 22.38 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.0 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.6 mt -97.72 110.01 24.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.1 m -95.82 141.47 29.24 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 61.89 52.56 3.37 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.904 0.752 . . . . 0.0 110.479 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' CYS . . . . . 0.65 ' SG ' HG22 ' A' ' 381' ' ' ILE . 13.5 m -65.19 113.19 3.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 12.0 m -108.4 -167.69 1.26 Allowed 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.14 -20.77 60.85 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 121.703 -0.623 . . . . 0.0 111.006 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -78.83 -4.51 49.91 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.405 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' ASP . . . . . 0.477 ' OD2' ' HD3' ' A' ' 409' ' ' LYS . 18.1 m-20 -110.7 7.91 22.4 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.959 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.94 96.67 9.44 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -151.27 162.63 40.56 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.932 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.75 122.66 30.15 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' TYR . . . . . 0.524 ' HD2' HD11 ' A' ' 403' ' ' ILE . 93.5 m-85 -106.55 140.58 39.21 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 120.827 0.346 . . . . 0.0 110.131 -175.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.33 137.78 30.78 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.227 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 65.5 m -103.95 128.57 51.48 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.95 130.67 73.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.366 0.603 . . . . 0.0 111.556 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 63.7 t -124.7 161.58 27.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 174.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -61.26 112.97 5.2 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 118.513 -1.804 . . . . 0.0 111.534 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 94.38 -35.3 4.26 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.632 -0.284 . . . . 0.0 112.547 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.747 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 9.1 mm-40 -105.96 138.98 41.21 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 122.467 -0.431 . . . . 0.0 110.681 -173.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.79 163.92 35.94 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 171.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 13.8 p -151.28 133.49 15.27 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 12.1 p -119.62 132.17 55.64 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 123.654 0.596 . . . . 0.0 110.707 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.431 ' OG1' ' HD2' ' A' ' 373' ' ' TYR . 14.6 t -124.07 147.9 47.52 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -106.04 111.02 23.47 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 373' ' ' TYR . 3.3 tm? -93.14 125.69 37.86 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -113.25 124.97 53.75 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.817 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.6 t -97.53 122.25 48.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -106.16 117.06 33.04 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 377' ' ' LYS . 2.6 mp0 . . . . . 0 C--O 1.256 1.417 0 C-N-CA 125.234 1.413 . . . . 0.0 113.929 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.55 -37.67 39.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.717 -1.128 . . . . 0.0 113.36 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -56.3 -46.45 79.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -85.05 -29.6 24.8 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.288 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.01 -48.29 86.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.324 0.39 . . . . 0.0 110.392 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 62.9 mt -59.42 -41.23 89.07 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.119 0.485 . . . . 0.0 110.236 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -58.62 -30.01 66.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.237 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -112.9 7.14 18.19 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.26 0.552 . . . . 0.0 111.187 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -100.67 150.82 37.32 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.695 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' PRO . . . . . 0.457 ' HG2' ' HG2' ' A' ' 332' ' ' GLU . 19.2 Cg_endo -66.43 142.84 67.26 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.433 2.089 . . . . 0.0 111.389 175.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.476 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 18.5 Cg_endo -58.52 -21.38 54.17 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 123.813 3.008 . . . . 0.0 114.205 -176.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 36.1 p -74.34 -17.16 60.87 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.047 0.451 . . . . 0.0 112.16 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.457 ' HG2' ' HG2' ' A' ' 329' ' ' PRO . 19.9 mm-40 -103.97 -2.88 25.43 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.494 -175.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 20.8 m-30 -56.89 -40.23 75.85 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -174.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.27 -30.16 70.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.989 0.423 . . . . 0.0 111.121 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -72.56 -57.72 3.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.0 -40.32 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.845 1.258 . . . . 0.0 111.792 -173.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -58.54 -60.1 4.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.639 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -67.8 -22.97 65.15 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.028 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -64.44 -34.2 77.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.384 0.674 . . . . 0.0 109.515 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.25 13.23 23.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 76.48 29.61 57.8 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.806 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.75 118.73 56.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 17.6 p -94.79 -14.19 24.91 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-O 122.115 0.96 . . . . 0.0 109.928 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -92.52 49.16 1.45 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.478 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.7 pt? . . . . . 0 C--N 1.314 -0.952 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.499 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.88 0.371 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.78 -13.02 61.22 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.063 0.935 . . . . 0.0 109.438 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.434 ' CG ' ' HG2' ' A' ' 368' ' ' LYS . 5.4 m-85 -107.09 120.48 42.21 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.38 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -79.77 -27.11 40.47 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.76 0.79 . . . . 0.0 109.169 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -157.01 118.23 3.7 Favored 'General case' 0 N--CA 1.403 -2.815 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.434 ' HG2' ' CG ' ' A' ' 365' ' ' PHE . 42.2 mtmt -94.89 178.42 5.57 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.445 HD11 ' SG ' ' A' ' 436' ' ' CYS . 82.5 mt -67.51 144.35 55.71 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 175.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.21 136.77 93.9 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -43.72 -34.81 5.99 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.059 3.173 . . . . 0.0 114.543 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -144.78 143.66 30.78 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.113 0.482 . . . . 0.0 112.234 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.413 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 63.2 m-85 -137.3 143.28 42.04 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.233 1.013 . . . . 0.0 109.315 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -122.27 138.98 54.31 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.76 149.39 29.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.1 m -82.2 147.7 28.84 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 1.6 tmmm? -64.6 127.11 30.15 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.312 0.577 . . . . 0.0 110.031 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.501 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 95.01 -7.13 69.7 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.382 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -93.08 168.33 11.19 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.757 0.313 . . . . 0.0 111.402 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 44.6 mtmt -98.12 157.61 16.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 17.8 tt -145.73 128.58 9.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 121.576 0.703 . . . . 0.0 109.924 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -103.19 114.99 29.73 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.913 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 76.3 mt -98.0 141.07 31.41 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 35.2 m -139.81 138.49 35.86 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.416 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.0 143.16 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -116.87 126.02 52.39 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.412 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 84.3 mt -91.64 139.86 30.28 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.457 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -71.73 -42.59 67.1 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.95 103.57 16.08 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.631 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -73.18 -21.83 60.6 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.181 -177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.15 26.98 3.03 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.735 1.255 . . . . 0.0 109.748 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -124.06 162.53 23.31 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.06 166.49 19.16 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.693 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 6.7 m -117.02 167.72 9.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.609 0.718 . . . . 0.0 111.91 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.498 ' HA ' ' HE2' ' A' ' 395' ' ' LYS . 8.9 mmpt? -112.81 140.16 47.83 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.403 ' HB3' HD12 ' A' ' 403' ' ' ILE . 11.6 m-90 -112.38 113.56 25.82 Favored 'General case' 0 C--N 1.278 -2.523 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.0 mp -124.59 137.4 54.39 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.751 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 119.04 30.15 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 171.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.2 p30 56.05 18.11 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 126.725 2.01 . . . . 0.0 112.249 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.5 1.98 47.06 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.093 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -106.24 133.72 50.5 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.18 123.46 20.35 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.439 0.638 . . . . 0.0 111.312 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 396' ' ' TRP . 69.6 mt -66.34 109.75 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.48 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -85.96 135.76 33.53 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 28.0 ttt -73.3 94.77 2.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.155 0.503 . . . . 0.0 110.155 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.0 p -89.04 94.4 9.93 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.05 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.17 -106.6 0.95 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.54 -0.754 . . . . 0.0 113.563 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 19.2 t -122.14 12.36 10.31 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' LYS . . . . . 0.457 ' HD2' ' CD2' ' A' ' 410' ' ' TYR . 6.2 tmtm? -74.31 -56.88 4.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.536 ' O ' ' HG3' ' A' ' 405' ' ' MET . 79.8 m-85 -107.23 113.44 26.85 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 176.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.68 113.9 45.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.097 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.401 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.0 m-85 -87.05 106.0 17.55 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 420' ' ' THR . 45.3 mt-10 -98.37 107.6 20.1 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 11.4 t -96.59 111.33 23.51 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.499 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 33.4 mm -115.1 82.02 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -174.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.91 -88.89 0.23 Allowed Glycine 0 C--O 1.236 0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 112.816 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -101.2 -29.28 12.19 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.203 0.525 . . . . 0.0 110.665 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 14.9 ptmt -94.76 127.41 40.74 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 122.143 0.973 . . . . 0.0 113.473 -171.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -100.21 105.81 17.43 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 413' ' ' GLU . 27.9 m -100.06 120.24 39.54 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.693 -174.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.401 HD13 ' CE2' ' A' ' 412' ' ' PHE . 45.8 tp -104.49 106.8 17.44 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.169 0.509 . . . . 0.0 110.312 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 58.5 m -95.8 111.63 23.55 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 38.3 mt -99.06 120.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 15.6 m -97.46 130.19 44.58 Favored 'General case' 0 N--CA 1.407 -2.614 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 63.32 74.68 0.42 Allowed 'General case' 0 C--O 1.243 0.751 0 O-C-N 124.168 0.918 . . . . 0.0 113.427 172.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 81.8 m -80.93 121.04 25.51 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.666 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 29.4 p -101.07 -177.26 3.4 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.56 -19.95 62.84 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.964 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -86.24 -11.65 51.79 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.73 177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -99.24 2.89 46.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.804 1.288 . . . . 0.0 108.39 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -77.54 116.91 18.49 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.46 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 447' ' ' LEU . . . -161.66 172.53 16.12 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.74 130.55 34.68 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -112.05 132.17 54.98 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.555 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -126.66 142.16 51.63 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.19 -174.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.445 ' SG ' HD11 ' A' ' 369' ' ' LEU . 71.7 m -123.87 120.85 33.77 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 40.7 t -115.94 128.76 73.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.932 -174.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.49 161.11 19.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 170.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.63 112.32 4.91 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.178 -1.487 . . . . 0.0 111.614 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 96.59 -35.11 4.57 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 115.344 -0.428 . . . . 0.0 112.143 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -116.09 124.63 50.89 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -174.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.01 167.54 21.88 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.702 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 41.7 t -151.79 147.2 26.38 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 80.1 p -125.92 116.59 21.73 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.0 t -94.93 138.92 32.04 Favored 'General case' 0 N--CA 1.401 -2.899 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -88.36 110.0 20.44 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 432' ' ' ALA . 3.4 tm? -99.47 121.79 41.65 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -116.62 114.24 23.81 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.646 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.63 119.62 39.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -109.35 130.28 55.5 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.407 -2.612 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.506 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.32 -33.62 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 C-N-CA 123.628 0.771 . . . . 0.0 109.492 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -52.97 -47.97 67.77 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 123.213 0.605 . . . . 0.0 112.085 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.64 -40.26 16.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.2 mt -63.22 -45.21 99.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 120.715 0.293 . . . . 0.0 111.439 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 9.3 tt -73.21 -31.09 63.96 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.389 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -70.36 -27.12 64.08 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 121.198 0.523 . . . . 0.0 111.22 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -97.82 -1.81 42.36 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.235 0.54 . . . . 0.0 110.988 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.88 148.24 35.28 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.84 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.6 146.49 92.64 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 122.328 2.019 . . . . 0.0 112.659 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.415 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 10.8 Cg_endo -52.76 -24.1 22.46 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 124.201 3.268 . . . . 0.0 115.922 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 9.0 m -76.61 -12.93 60.09 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.498 0.666 . . . . 0.0 111.644 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.409 ' O ' HG13 ' A' ' 336' ' ' ILE . 7.1 mm-40 -94.61 -15.74 23.79 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.405 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 9.5 m-30 -48.98 -49.3 41.41 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 -171.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -65.78 -31.51 72.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.157 0.503 . . . . 0.0 111.52 -174.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -69.14 -53.54 19.6 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 332' ' ' GLU . 62.6 mt -59.36 -49.86 81.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.887 -175.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -56.4 -62.06 1.98 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.933 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -62.62 -23.17 66.92 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -70.74 -39.96 73.01 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 122.782 0.433 . . . . 0.0 110.842 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -91.08 1.26 57.22 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.011 0.434 . . . . 0.0 112.078 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 87.87 25.7 31.37 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.718 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.2 t -104.81 117.17 49.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 73.9 p -95.46 -30.54 13.82 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 117.685 -1.606 . . . . 0.0 111.599 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -95.39 84.65 4.06 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 121.431 0.634 . . . . 0.0 110.589 -179.903 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.431 -1.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.473 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -88.78 -12.95 40.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.716 0.769 . . . . 0.0 109.635 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -109.74 117.57 34.24 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.522 177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -82.87 -18.86 38.8 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -160.08 116.47 2.45 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -94.69 172.76 7.98 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 96.8 mt -71.63 139.26 49.22 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 174.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -56.71 146.53 56.47 Favored Pre-proline 0 C--N 1.316 -0.864 0 O-C-N 123.926 0.766 . . . . 0.0 108.998 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.09 -33.01 41.62 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 123.025 2.484 . . . . 0.0 112.986 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -147.76 144.37 28.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.846 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.549 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 51.9 m-85 -129.8 159.07 37.68 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -136.72 141.9 43.07 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.75 147.3 25.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 25.2 m -84.16 144.5 28.96 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.424 ' HD3' ' HG2' ' A' ' 451' ' ' GLU . 26.7 ttpp -60.26 128.15 35.32 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.741 0.416 . . . . 0.0 110.949 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 90.7 8.84 65.07 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.883 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -111.07 175.2 5.51 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -99.57 136.51 39.39 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.649 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.2 tp -121.36 139.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.478 ' CZ ' HG21 ' A' ' 420' ' ' THR . 35.5 ttt85 -131.74 116.66 17.58 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.187 0.994 . . . . 0.0 111.581 -173.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.08 130.4 48.66 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.974 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 21.7 m -127.61 126.11 41.46 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.415 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 5.1 m -122.04 144.2 32.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.813 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.414 ' HG2' ' HG3' ' A' ' 418' ' ' LYS . 48.0 mt-10 -111.91 119.25 37.89 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 86.0 mt -88.11 145.65 25.83 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.515 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -72.09 -24.26 61.47 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.058 0.456 . . . . 0.0 110.183 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -123.33 135.5 54.22 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -70.86 -23.25 62.28 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.87 19.39 17.99 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.86 -172.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -96.59 132.64 42.0 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -98.71 156.12 17.0 Favored 'General case' 0 C--N 1.267 -2.99 0 C-N-CA 118.541 -1.263 . . . . 0.0 111.96 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.53 152.23 17.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.225 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -115.0 139.35 49.92 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 403' ' ' ILE . 5.8 m-90 -110.9 125.16 53.36 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -173.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 8.3 mp -127.47 136.23 51.5 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 117.832 0.287 . . . . 0.0 110.859 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' LYS . . . . . 0.432 ' HB3' HD11 ' A' ' 403' ' ' ILE . 0.0 OUTLIER -111.61 115.63 29.46 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.277 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . 0.259 28.6 p30 50.88 13.71 0.15 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 126.814 2.046 . . . . 0.0 114.961 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 123.17 -7.11 9.27 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.366 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -107.51 134.15 50.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.88 120.74 16.9 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.193 0.521 . . . . 0.0 111.109 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 398' ' ' LYS . 43.1 mt -78.87 111.97 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.915 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -91.6 151.14 20.84 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 61.7 ttp -62.46 102.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 409' ' ' LYS . 27.4 t -100.78 95.91 6.96 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 55.29 -137.7 44.48 Favored Glycine 0 N--CA 1.442 -0.947 0 O-C-N 124.114 0.884 . . . . 0.0 113.04 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.3 p -95.44 8.56 42.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.385 0.612 . . . . 0.0 110.607 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 2.5 tppp? -72.5 -47.72 46.29 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.486 ' O ' ' HG3' ' A' ' 405' ' ' MET . 41.1 m-85 -119.43 108.63 14.8 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 57.6 mt -108.66 112.8 41.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 CA-C-O 120.987 0.423 . . . . 0.0 109.955 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.503 ' CD2' HD13 ' A' ' 421' ' ' LEU . 22.7 m-85 -87.08 109.37 19.38 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.468 175.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -108.68 108.72 19.68 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 70.3 m -100.16 110.38 22.66 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.352 0.596 . . . . 0.0 111.172 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 36.1 mt -104.06 74.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.11 -107.05 1.71 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.404 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -89.93 -25.64 20.83 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.664 0.386 . . . . 0.0 110.396 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.414 ' HG3' ' HG2' ' A' ' 386' ' ' GLU . 31.1 ttpt -88.39 98.47 11.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -100.7 130.23 46.71 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-O 121.317 0.579 . . . . 0.0 109.722 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' THR . . . . . 0.478 HG21 ' CZ ' ' A' ' 382' ' ' ARG . 16.8 m -123.0 145.77 48.21 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.553 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.503 HD13 ' CD2' ' A' ' 412' ' ' PHE . 23.2 tp -118.56 112.63 20.13 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.353 174.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.9 m -102.07 109.87 21.69 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 33.0 mt -98.4 121.69 49.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.4 m -101.24 145.02 29.39 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.227 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 58.53 47.61 13.16 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.397 1.079 . . . . 0.0 110.836 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.64 122.86 16.9 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 11.2 m -116.63 -177.95 3.31 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.21 -29.55 69.89 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -81.76 -2.8 52.0 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -103.22 -7.05 21.5 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.2 113.84 1.54 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.841 173.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -168.79 163.05 11.8 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.914 -177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.39 129.25 34.85 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -104.61 134.31 47.99 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' A' ' 444' ' ' SER . 22.8 mp0 -123.87 130.0 51.9 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.406 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 443' ' ' CYS . 81.4 m -107.89 111.84 24.17 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 171.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.31 128.22 53.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.756 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.12 161.3 29.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -59.96 112.93 4.84 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.278 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 93.15 -36.29 3.77 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 124.223 0.916 . . . . 0.0 112.441 175.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 12.6 mm-40 -116.61 134.99 54.18 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 120.732 0.301 . . . . 0.0 110.403 -173.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -134.61 162.35 32.54 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 436' ' ' CYS . 23.3 p -136.19 144.49 44.97 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 173.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.478 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 5.0 p -139.66 112.83 8.2 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 123.23 0.332 . . . . 0.0 111.348 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.549 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 9.9 t -104.13 141.54 36.06 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.78 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -102.63 110.53 22.49 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -89.11 143.71 26.65 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.924 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -118.73 128.65 54.69 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.51 115.93 45.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.51 ' HE3' ' HA ' ' A' ' 450' ' ' LYS . 1.1 tpmt? -105.4 115.67 30.65 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.424 ' HG2' ' HD3' ' A' ' 377' ' ' LYS . 36.0 mt-10 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.708 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.2 -34.63 27.68 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 C-N-CA 123.238 0.615 . . . . 0.0 112.0 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -51.8 -55.25 20.97 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 124.808 1.243 . . . . 0.0 109.987 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.9 -35.57 22.07 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.843 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.75 -49.26 78.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 O-C-N 122.96 0.163 . . . . 0.0 111.375 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.4 tt -71.84 -32.71 67.8 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.994 0.426 . . . . 0.0 110.035 -177.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -64.18 -33.24 75.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.48 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -96.31 0.62 51.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.416 0.627 . . . . 0.0 110.314 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -90.44 151.93 44.85 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.72 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.39 140.65 95.35 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.701 2.267 . . . . 0.0 111.596 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.472 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 14.0 Cg_endo -55.8 -23.03 39.8 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.796 2.997 . . . . 0.0 115.072 -174.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.1 p -75.78 -21.57 57.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.273 0.559 . . . . 0.0 111.932 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -93.84 -8.28 40.87 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.511 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.472 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 4.2 m-30 -43.66 -54.86 4.72 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.505 1.122 . . . . 0.0 113.856 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.86 -49.1 79.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 339' ' ' GLN . 11.2 ttp180 -60.73 -40.27 91.71 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.305 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 34.1 mt -73.6 -37.8 50.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.173 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -61.85 -58.55 7.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.178 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -66.84 -23.03 65.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.43 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 335' ' ' ARG . 57.9 tp60 -59.14 -43.63 92.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.267 0.627 . . . . 0.0 109.624 176.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.59 4.92 43.78 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 88.58 18.22 55.32 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.219 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 24.5 t -91.87 101.04 12.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.3 m -82.33 -40.18 21.8 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.078 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -99.69 87.75 3.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.961 0.886 . . . . 0.0 109.631 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.597 HD23 ' H ' ' A' ' 345' ' ' LEU . 1.4 pt? . . . . . 0 C--N 1.301 -1.519 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.101 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.433 -1.278 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -99.33 -35.77 9.83 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -105.64 128.74 53.81 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.94 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -83.27 -43.74 15.72 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' LYS . . . . . 0.458 ' HA ' ' HE2' ' A' ' 367' ' ' LYS . 6.0 mmpt? -137.68 124.07 20.7 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 442' ' ' LYS . 56.7 mtpt -98.46 168.29 10.29 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.215 -175.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 84.5 mt -62.03 141.31 58.15 Favored 'General case' 0 C--O 1.255 1.343 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -63.16 149.11 91.69 Favored Pre-proline 0 C--N 1.302 -1.461 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.629 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.1 -35.29 25.69 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.393 2.729 . . . . 0.0 113.259 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -153.34 152.5 31.17 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -133.35 158.29 43.36 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -135.71 136.94 41.26 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.07 156.19 24.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 8.4 t -93.15 151.27 19.94 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -64.15 119.12 9.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.851 0.357 . . . . 0.0 110.777 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 99.76 -1.49 56.78 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -91.79 -177.73 4.84 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.176 0.513 . . . . 0.0 110.836 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.0 mtpt -119.34 130.39 55.34 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.617 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.0 tp -120.84 130.01 75.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.417 0.627 . . . . 0.0 110.245 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 74.3 mtt180 -101.76 110.09 22.0 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.078 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.65 117.83 31.21 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 16.1 m -122.95 144.36 49.29 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.943 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 9.5 m -140.72 143.24 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -108.94 119.55 39.88 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.473 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 81.6 mt -85.64 143.3 28.49 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.79 -44.6 27.03 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.41 114.87 22.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.325 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -79.4 -21.53 45.53 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.018 0.437 . . . . 0.0 111.415 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -94.09 26.9 3.04 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.739 0.78 . . . . 0.0 111.59 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -128.47 161.46 29.46 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.27 176.88 7.58 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 12.1 m -116.6 164.45 12.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 120.939 0.399 . . . . 0.0 110.728 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -119.0 135.42 54.63 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -106.93 123.61 48.43 Favored 'General case' 0 C--N 1.283 -2.311 0 O-C-N 123.867 0.729 . . . . 0.0 109.979 -169.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.2 mp -131.6 144.12 50.83 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.773 -0.579 . . . . 0.0 111.425 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' LYS . . . . . 0.427 ' HB3' HD11 ' A' ' 403' ' ' ILE . 23.0 pttp -126.18 125.42 42.42 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 169.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 24.6 p30 54.25 17.03 1.36 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.812 1.645 . . . . 0.0 113.009 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.44 4.66 46.54 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.891 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -109.03 124.15 50.27 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.6 111.28 1.76 Allowed 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 398' ' ' LYS . 19.3 mt -75.6 148.75 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 O-C-N 124.302 1.001 . . . . 0.0 108.415 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -139.94 173.85 11.11 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 48.6 ttm -66.96 101.57 0.86 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.9 m -97.71 97.48 9.05 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 62.97 -127.47 38.57 Favored Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.35 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.8 p -106.07 12.16 30.66 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -78.76 -60.71 2.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.085 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' ' 405' ' ' MET . 95.5 m-85 -96.55 107.62 20.06 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 49.7 mm -106.16 112.53 39.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 CA-C-O 121.178 0.513 . . . . 0.0 110.01 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' A' ' 421' ' ' LEU . 23.0 m-85 -86.79 115.87 24.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -110.5 108.33 18.29 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 19.3 m -98.41 111.63 23.91 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 39.4 mm -112.31 87.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.74 2.21 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -92.82 -27.0 17.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.453 0.168 . . . . 0.0 110.948 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 21.8 ptmt -83.96 141.73 31.02 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.565 0.698 . . . . 0.0 111.929 -175.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -115.22 120.9 41.24 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.115 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 53.0 m -112.67 122.38 47.5 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.526 HD13 ' CE2' ' A' ' 412' ' ' PHE . 21.4 tp -102.41 110.16 22.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 31.3 m -95.46 102.0 13.77 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.7 mt -86.78 112.67 23.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 13.3 m -96.36 139.83 31.92 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.718 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 61.27 57.92 2.3 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.905 1.282 . . . . 0.0 110.087 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 381' ' ' ILE . 25.5 m -64.48 120.9 13.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.093 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 82.1 p -94.89 178.55 5.53 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.25 -19.38 61.71 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.89 -2.17 42.45 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.669 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -103.3 8.04 38.3 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.542 0.687 . . . . 0.0 109.507 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -80.21 94.76 6.11 Favored 'General case' 0 C--O 1.256 1.415 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -145.24 170.21 16.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.466 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -89.53 120.71 31.07 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 398' ' ' LYS . 89.5 m-85 -107.43 138.66 43.23 Favored 'General case' 0 C--N 1.286 -2.196 0 O-C-N 122.276 -0.265 . . . . 0.0 111.166 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.1 OUTLIER -134.4 133.98 41.15 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.841 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 443' ' ' CYS . 85.7 m -108.13 114.12 27.78 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 169.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.6 t -109.84 132.54 57.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.481 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 73.9 t -125.9 160.74 32.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 173.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -66.26 113.24 5.55 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 119.054 -1.546 . . . . 0.0 111.888 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 107.89 -36.67 4.24 Favored Glycine 0 N--CA 1.424 -2.109 0 CA-C-N 115.088 -0.556 . . . . 0.0 112.507 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -134.99 152.58 51.86 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 117.988 0.894 . . . . 0.0 110.849 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.502 ' O ' ' HE3' ' A' ' 368' ' ' LYS . 20.0 ptpt -141.95 178.26 7.63 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 436' ' ' CYS . 5.9 p -148.0 134.3 19.52 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 8.0 p -121.32 129.36 53.05 Favored 'General case' 0 C--N 1.288 -2.077 0 O-C-N 123.798 0.686 . . . . 0.0 110.538 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 15.1 t -128.53 150.11 50.32 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -111.96 111.16 21.89 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 62.0 tp -90.83 130.01 36.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.08 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -109.83 110.59 21.62 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.0 120.67 45.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 376' ' ' SER . 20.0 ttpp -116.05 131.42 56.95 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.973 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.529 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.85 -34.1 47.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 122.563 0.345 . . . . 0.0 110.723 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -53.53 -47.41 69.98 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.561 1.144 . . . . 0.0 111.186 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 8.6 pt-20 -85.81 -42.09 14.47 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.897 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.34 -50.47 80.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 122.671 0.388 . . . . 0.0 111.532 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.94 -27.88 64.08 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.352 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -60.63 -49.78 76.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.432 0.634 . . . . 0.0 111.78 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLN . . . . . 0.468 ' H ' ' HG2' ' A' ' 327' ' ' GLN . 19.3 pt20 -94.46 0.82 55.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.785 -174.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -81.82 153.61 70.18 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.257 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.53 143.31 94.85 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 122.157 1.904 . . . . 0.0 110.988 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 28.3 Cg_endo -60.27 -24.29 76.88 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 123.764 2.976 . . . . 0.0 113.992 -172.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.1 m -79.81 -8.81 59.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.989 0.423 . . . . 0.0 111.583 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 336' ' ' ILE . 20.5 mm-40 -94.66 -19.3 20.56 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.207 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 14.2 m-30 -44.24 -50.33 8.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.03 -55.76 30.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.673 0.608 . . . . 0.0 111.765 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -65.44 -41.02 93.94 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.043 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 332' ' ' GLU . 77.6 mt -59.25 -45.81 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.69 -58.83 6.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.847 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -62.11 -30.71 71.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.17 -36.54 84.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.767 0.317 . . . . 0.0 111.117 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -93.21 4.49 53.91 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 84.11 12.87 75.65 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.983 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 19.0 t -89.94 90.22 3.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -45.68 93.21 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.128 -174.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -110.98 100.79 9.43 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.757 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 345' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.411 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.412 -2.338 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.03 68.1 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.393 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -86.99 135.43 33.28 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.861 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' GLN . . . . . 0.505 ' HB3' ' CB ' ' A' ' 386' ' ' GLU . 0.0 OUTLIER -89.03 -37.68 14.98 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 177.48 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -157.02 135.68 11.55 Favored 'General case' 0 CA--C 1.465 -2.31 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 9.9 mtmp? -98.09 175.06 6.24 Favored 'General case' 0 C--N 1.268 -2.963 0 O-C-N 124.298 0.999 . . . . 0.0 109.756 -175.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.521 HD11 ' SG ' ' A' ' 436' ' ' CYS . 34.6 mt -61.08 155.7 19.78 Favored 'General case' 0 C--O 1.249 1.031 0 O-C-N 124.066 0.854 . . . . 0.0 111.523 178.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.48 149.32 91.05 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 170.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.81 -37.19 76.3 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.592 2.194 . . . . 0.0 113.293 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -143.8 153.15 42.09 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.638 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -135.2 163.24 30.4 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -138.05 145.34 41.66 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 381' ' ' ILE . 13.3 p -148.33 155.25 9.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.471 ' HB2' ' CG ' ' A' ' 379' ' ' HIS . 49.8 m -90.96 146.86 23.52 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.46 ' HB3' ' NZ ' ' A' ' 377' ' ' LYS . 1.7 ttpm? -63.47 121.04 12.85 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.7 0.32 57.77 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.703 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' HIS . . . . . 0.471 ' CG ' ' HB2' ' A' ' 376' ' ' SER . 12.5 m170 -103.78 171.08 7.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 120.827 0.346 . . . . 0.0 111.309 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.0 mtpt -101.44 143.32 31.6 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 382' ' ' ARG . 0.1 OUTLIER -135.92 138.57 47.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.476 ' N ' HD13 ' A' ' 381' ' ' ILE . 55.0 mtt180 -114.62 117.35 30.63 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.377 0.608 . . . . 0.0 112.244 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 420' ' ' THR . 29.7 mt -96.53 128.81 43.81 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 28.7 m -123.74 134.57 53.66 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 14.2 m -141.97 162.82 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 C-N-CA 124.211 1.004 . . . . 0.0 108.629 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.505 ' CB ' ' HB3' ' A' ' 366' ' ' GLN . 37.8 mt-10 -123.33 138.89 54.51 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 46.2 mt -105.67 146.65 29.46 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.82 -5.72 54.15 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.386 0.613 . . . . 0.0 111.242 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 392' ' ' ALA . 21.5 t70 -135.58 138.39 42.92 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -75.54 -22.76 56.79 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.379 0.672 . . . . 0.0 112.002 -174.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -109.6 23.16 14.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 122.763 1.268 . . . . 0.0 109.29 -174.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 389' ' ' ASP . . . -101.21 139.31 37.07 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -177.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -103.25 140.75 36.97 Favored 'General case' 0 N--CA 1.393 -3.313 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.93 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.408 ' CG1' ' HG2' ' A' ' 419' ' ' ARG . 6.0 p -120.04 134.1 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.405 0 CA-C-N 113.848 -1.524 . . . . 0.0 107.556 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -111.3 146.13 37.58 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 421' ' ' LEU . 24.4 m95 -106.19 126.75 52.6 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 7.7 mp -114.34 131.44 56.54 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -98.83 110.54 23.12 Favored 'General case' 0 N--CA 1.407 -2.588 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.751 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.0 p30 56.11 2.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 127.637 2.375 . . . . 0.0 114.121 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 131.91 -5.98 5.44 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -103.33 127.89 50.56 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.74 118.86 6.66 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 123.016 0.526 . . . . 0.0 112.036 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.431 HD12 ' CB ' ' A' ' 396' ' ' TRP . 54.0 mt -79.48 114.26 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 170.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -104.28 141.26 36.61 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.563 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 27.1 ptt? -70.11 109.81 4.8 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.228 -176.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.3 m -103.05 102.48 12.51 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.214 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 52.1 -124.12 23.61 Favored Glycine 0 N--CA 1.445 -0.727 0 O-C-N 124.451 1.094 . . . . 0.0 114.639 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 16.1 m -91.46 -5.76 53.77 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.435 -0.382 . . . . 0.0 111.518 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -78.33 -53.5 7.22 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.585 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 90.9 m-85 -110.97 121.5 45.52 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 46.2 mt -121.7 119.64 59.39 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.71 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 405' ' ' MET . 3.1 m-30 -88.02 106.02 17.86 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -106.69 133.67 51.0 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 9.6 t -118.73 121.7 40.73 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.585 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 65.4 mt -118.84 94.94 3.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.78 -98.63 0.62 Allowed Glycine 0 C--N 1.305 -1.142 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -121.37 3.57 10.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.062 0.458 . . . . 0.0 110.166 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 21.2 ptmt -104.9 136.6 44.08 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 419' ' ' ARG . . . . . 0.408 ' HG2' ' CG1' ' A' ' 394' ' ' VAL . 9.7 tpp85 -110.71 139.07 46.31 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 29.9 m -131.22 125.31 32.58 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.507 ' HB2' ' CE2' ' A' ' 396' ' ' TRP . 50.6 tp -97.83 117.68 32.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 54.3 m -103.62 106.96 17.62 Favored 'General case' 0 N--CA 1.41 -2.428 0 O-C-N 123.906 0.754 . . . . 0.0 108.967 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 52.6 mt -98.87 125.16 52.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 44.7 m -104.59 128.8 52.7 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 66.06 66.98 0.48 Allowed 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 124.552 1.158 . . . . 0.0 110.689 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.07 122.38 17.27 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.634 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 9.2 m -105.58 -177.87 3.49 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 451' ' ' GLU . 71.8 mt -68.01 -28.69 67.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.976 0.417 . . . . 0.0 110.57 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -75.32 -6.27 49.04 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.344 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -101.17 -11.08 19.83 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.14 106.83 2.53 Favored 'General case' 0 C--O 1.25 1.083 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.38 165.57 30.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.533 -176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.53 129.23 34.87 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -104.97 135.35 46.48 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 25.9 mp0 -121.54 123.91 43.11 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 91.9 m -84.45 117.05 23.41 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.25 112.73 37.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.84 160.86 14.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.03 112.88 5.35 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 119.134 -1.507 . . . . 0.0 110.749 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.39 -36.21 4.5 Favored Glycine 0 N--CA 1.405 -3.4 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.109 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -137.41 170.17 16.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 22.2 ptmt -147.02 162.73 38.19 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.574 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 53.2 t -149.48 135.85 19.18 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.416 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 15.3 p -103.73 142.58 34.1 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.739 0.649 . . . . 0.0 111.353 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.429 ' CG2' HD13 ' A' ' 369' ' ' LEU . 15.1 t -131.16 150.2 52.25 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.81 112.46 19.26 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.076 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 36.4 tp -85.16 142.8 29.22 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.831 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -116.01 109.75 17.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.5 t -91.96 118.08 36.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -103.65 121.99 44.09 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.519 ' HG3' HD21 ' A' ' 428' ' ' LEU . 1.8 mp0 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.62 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.503 2.18 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 321' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 324' ' ' ILE . 15.0 p -49.95 -29.02 4.85 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 C-N-CA 125.124 1.37 . . . . 0.0 112.357 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -57.92 -55.39 35.51 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.43 0.692 . . . . 0.0 110.737 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.29 -20.64 43.91 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.163 0.506 . . . . 0.0 110.708 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 321' ' ' VAL . 76.2 mt -72.36 -50.28 36.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.703 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.26 -34.8 78.45 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.303 0.573 . . . . 0.0 110.268 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -54.92 -39.8 69.18 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.854 1.262 . . . . 0.0 112.434 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -103.54 -1.72 27.9 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.278 0.561 . . . . 0.0 110.129 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -80.94 149.22 66.47 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.824 -174.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' PRO . . . . . 0.422 ' HG2' ' HG3' ' A' ' 332' ' ' GLU . 21.5 Cg_endo -65.47 144.42 79.46 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.325 2.016 . . . . 0.0 110.066 173.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.78 -22.84 69.33 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.868 2.379 . . . . 0.0 113.384 -174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.5 m -78.87 -8.53 58.92 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.422 ' HG3' ' HG2' ' A' ' 329' ' ' PRO . 5.4 mm-40 -111.38 2.38 17.55 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 121.099 -0.241 . . . . 0.0 111.183 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -47.85 -52.36 19.41 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.429 ' O ' ' HD2' ' A' ' 338' ' ' PHE . 39.7 tt0 -60.29 -44.43 95.37 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.654 0.596 . . . . 0.0 111.312 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -59.99 -54.18 49.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.265 0.555 . . . . 0.0 109.994 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 51.5 mt -64.88 -41.23 91.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.886 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 342' ' ' VAL . . . -60.47 -55.43 33.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.993 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' PHE . . . . . 0.429 ' HD2' ' O ' ' A' ' 334' ' ' GLU . 77.2 m-85 -68.7 -24.08 64.45 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -68.11 -40.6 82.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.552 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -93.65 -7.9 42.53 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 95.25 33.8 6.39 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.188 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.426 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 8.3 t -116.57 106.35 20.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 72.0 p -91.28 -18.26 24.65 Favored 'General case' 0 C--N 1.265 -3.078 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.816 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -96.57 45.89 1.06 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.978 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 121.082 0.468 . . . . 0.0 110.799 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.431 -1.417 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -91.24 -11.06 39.31 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.726 0.774 . . . . 0.0 109.422 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.46 127.72 48.0 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -89.64 -32.06 17.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.485 0.659 . . . . 0.0 109.314 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.5 OUTLIER -148.83 116.07 6.12 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.355 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -91.17 163.9 14.1 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.607 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 59.6 mt -64.84 144.6 57.15 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 123.837 0.71 . . . . 0.0 109.272 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -67.45 146.42 98.69 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -45.89 -43.05 19.98 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 123.597 2.865 . . . . 0.0 113.821 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -148.9 155.06 40.33 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.068 0.461 . . . . 0.0 111.002 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -137.81 158.65 43.91 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -129.22 142.63 50.8 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.8 p -140.64 151.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 43.3 m -81.45 145.09 30.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -62.4 117.54 6.29 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.691 0.282 . . . . 0.0 111.163 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.09 5.13 57.41 Favored Glycine 0 CA--C 1.499 -0.914 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -104.96 163.25 12.67 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.47 148.17 24.52 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.439 HG22 ' SG ' ' A' ' 426' ' ' CYS . 15.9 tt -150.55 149.25 14.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 1.2 ptp180 -127.37 137.16 52.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.446 0.641 . . . . 0.0 112.325 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.07 153.97 20.78 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 50.7 m -139.68 138.23 35.86 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.692 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.13 144.02 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 35.1 mt-10 -121.28 137.19 54.8 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.429 HD12 ' NH1' ' A' ' 419' ' ' ARG . 96.4 mt -96.67 157.13 16.04 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.472 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -86.46 -15.25 40.77 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -127.93 142.72 51.18 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -80.67 -23.35 39.68 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -106.03 21.94 16.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.307 0.575 . . . . 0.0 110.545 -174.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -99.39 159.16 15.21 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -121.79 145.81 47.69 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 118.585 -1.246 . . . . 0.0 112.983 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.424 HG12 HG22 ' A' ' 438' ' ' VAL . 11.7 m -109.94 158.85 9.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.314 175.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.3 tptm -132.35 133.46 44.01 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -101.03 127.41 47.55 Favored 'General case' 0 C--N 1.275 -2.634 0 O-C-N 124.458 1.099 . . . . 0.0 108.527 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 402' ' ' GLU . 10.1 mt -137.64 146.02 43.39 Favored 'General case' 0 CA--C 1.458 -2.559 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 398' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 433' ' ' ALA . 22.5 pttp -126.58 132.82 51.21 Favored 'General case' 0 N--CA 1.399 -3.002 0 C-N-CA 118.772 -1.171 . . . . 0.0 109.652 174.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.6 p30 48.41 27.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 126.438 1.895 . . . . 0.0 114.451 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.06 23.35 30.05 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.865 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -114.18 -96.22 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.559 0.219 . . . . 0.0 111.317 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' GLU . . . . . 0.708 ' HA ' HD23 ' A' ' 397' ' ' LEU . 43.6 tt0 176.92 135.97 0.06 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 58.1 mt -91.07 128.67 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.997 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -99.43 138.5 36.44 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.462 ' HB2' ' CE1' ' A' ' 412' ' ' PHE . 60.1 ttp -79.62 80.9 5.96 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 t -88.81 111.33 21.9 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.363 -171.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 54.06 -125.12 32.44 Favored Glycine 0 N--CA 1.446 -0.698 0 O-C-N 124.331 1.019 . . . . 0.0 113.443 176.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' SER . . . . . 0.55 ' HA ' HD11 ' A' ' 411' ' ' ILE . 15.3 m -106.74 3.85 27.04 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.719 0.771 . . . . 0.0 108.927 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -75.2 -41.8 57.04 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.399 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.433 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 99.4 m-85 -119.27 117.98 30.03 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 408' ' ' SER . 43.9 mm -114.96 114.82 47.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.482 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.3 m-30 -87.42 109.96 19.94 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -105.01 108.57 20.16 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 78.6 p -99.69 121.6 41.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.235 0.541 . . . . 0.0 109.65 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.435 ' HB ' ' HG3' ' A' ' 418' ' ' LYS . 43.5 mm -123.64 85.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.94 -90.39 0.13 Allowed Glycine 0 C--N 1.321 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 113.825 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -102.36 -28.16 12.41 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.817 0.342 . . . . 0.0 110.332 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 386' ' ' GLU . 21.2 ptmt -93.8 134.8 35.76 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.754 0.788 . . . . 0.0 112.44 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' ARG . . . . . 0.429 ' NH1' HD12 ' A' ' 387' ' ' LEU . 10.8 mpt_? -110.86 124.36 51.92 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 28.6 m -115.89 122.26 44.8 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.482 HD13 ' CE2' ' A' ' 412' ' ' PHE . 20.2 tp -103.61 109.02 20.54 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.0 m -100.02 110.75 23.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.403 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.8 mt -96.95 141.18 16.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 31.8 m -120.72 135.89 55.01 Favored 'General case' 0 N--CA 1.388 -3.561 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 59.31 58.47 3.01 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 124.783 1.302 . . . . 0.0 111.332 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 381' ' ' ILE . 60.7 m -63.6 113.46 3.35 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.347 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.7 m -100.37 -176.84 3.33 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.19 -23.77 63.96 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.125 0.488 . . . . 0.0 111.184 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.29 -5.65 50.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.048 0.452 . . . . 0.0 110.867 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -98.21 -5.7 32.79 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.073 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.82 88.7 1.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -146.7 162.49 38.39 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.166 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 398' ' ' LYS . . . -85.42 129.35 34.83 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -108.26 132.47 53.64 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.6 144.93 41.26 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.49 ' SG ' HD11 ' A' ' 369' ' ' LEU . 79.1 m -122.84 103.08 8.4 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.578 HG22 ' HG3' ' A' ' 442' ' ' LYS . 14.8 t -104.77 136.92 36.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.14 -174.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 441' ' ' GLU . 29.9 t -122.17 161.14 23.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 174.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -74.41 109.73 2.88 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 115.423 -3.275 . . . . 0.0 110.176 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 104.61 4.34 43.04 Favored Glycine 0 N--CA 1.42 -2.367 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 438' ' ' VAL . 4.5 tp10 -151.53 143.27 23.71 Favored 'General case' 0 N--CA 1.396 -3.14 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -176.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.578 ' HG3' HG22 ' A' ' 437' ' ' VAL . 26.9 ttpt -148.93 152.77 36.96 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.04 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 28.4 p -150.11 144.18 25.55 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 170.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 22.6 m -133.62 140.52 47.16 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 13.3 t -122.45 148.16 45.46 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.14 111.03 20.4 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 51.6 tp -84.36 134.3 34.49 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.98 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -107.89 115.09 29.5 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.27 108.38 19.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 376' ' ' SER . 3.8 tmmm? -100.21 117.82 35.24 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -176.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--N 1.303 -1.423 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.604 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 CA--C 1.501 -0.921 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 13.3 p -50.52 -44.04 24.13 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.814 0 C-N-CA 125.257 1.423 . . . . 0.0 111.442 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -59.33 -42.8 92.31 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.73 -38.28 18.43 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.8 mt -65.61 -45.83 91.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 120.74 0.305 . . . . 0.0 110.36 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.9 tt -68.23 -32.63 72.96 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.208 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -63.95 -34.63 78.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.103 0.561 . . . . 0.0 110.728 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -94.5 1.59 55.71 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.764 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.78 155.41 36.59 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.751 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' PRO . . . . . 0.449 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 15.6 Cg_endo -60.31 142.78 98.96 Favored 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 122.665 2.244 . . . . 0.0 112.422 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.27 -26.98 72.99 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.21 3.273 . . . . 0.0 114.753 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 41.7 m -83.55 -1.19 53.23 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.11 0.481 . . . . 0.0 112.231 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.449 ' CG ' ' HG2' ' A' ' 329' ' ' PRO . 63.0 mm-40 -100.39 -11.29 20.37 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -45.84 -49.07 15.68 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' GLU . . . . . 0.41 ' HA ' HD22 ' A' ' 345' ' ' LEU . 45.4 tt0 -72.83 -34.59 66.92 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.97 0.414 . . . . 0.0 110.805 -175.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -65.51 -44.32 87.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 332' ' ' GLU . 66.2 mt -67.08 -43.57 88.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.155 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.19 -54.26 48.81 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.454 0.471 . . . . 0.0 110.653 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 75.3 m-85 -69.81 -23.09 63.27 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -66.88 -36.21 81.79 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.09 0.471 . . . . 0.0 109.981 175.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -100.96 2.58 40.83 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 83.61 22.31 56.32 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.649 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.47 123.09 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 28.7 p -100.62 -28.55 12.8 Favored 'General case' 0 C--N 1.27 -2.863 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.999 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.6 56.57 3.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.715 0.769 . . . . 0.0 111.74 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 334' ' ' GLU . 31.8 tp . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.469 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.421 -1.911 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -90.43 -38.2 13.44 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 368' ' ' LYS . 11.9 m-85 -86.92 146.89 26.0 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 169.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -102.38 -15.67 16.46 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -168.5 125.04 1.01 Allowed 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.534 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 62.0 mttp -100.35 169.27 9.23 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 123.452 0.47 . . . . 0.0 110.16 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 70.3 mt -64.14 143.11 58.12 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.548 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -68.25 146.76 98.15 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -45.7 -43.44 18.68 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.817 3.011 . . . . 0.0 113.837 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -149.05 137.42 20.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.327 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.413 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 78.8 m-85 -118.78 159.61 23.4 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 127.08 28.15 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' VAL . . . . . 0.486 HG21 ' HB ' ' A' ' 381' ' ' ILE . 14.0 p -133.4 160.87 42.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 14.1 m -95.66 142.84 27.5 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.403 ' HE2' ' OE2' ' A' ' 451' ' ' GLU . 0.4 OUTLIER -64.26 127.3 30.85 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.984 0.421 . . . . 0.0 110.099 -176.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 95.43 1.78 62.17 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.972 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -100.97 172.37 7.07 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.917 0.389 . . . . 0.0 110.887 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 26.5 mtpp -97.85 134.75 40.57 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.486 ' HB ' HG21 ' A' ' 375' ' ' VAL . 6.7 tp -130.31 135.99 59.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 26.8 ptt180 -127.58 128.74 46.11 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.406 0.622 . . . . 0.0 112.591 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 420' ' ' THR . 1.1 mm? -105.98 138.89 41.4 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.462 -1.244 . . . . 0.0 107.793 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 51.5 m -119.04 128.41 54.33 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.803 0.335 . . . . 0.0 111.794 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 13.5 m -126.41 145.08 34.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -118.33 136.83 53.49 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.607 HD23 ' HD3' ' A' ' 419' ' ' ARG . 3.9 mm? -95.59 152.37 18.49 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.066 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.74 -33.41 58.14 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -101.31 154.54 18.69 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -77.37 -40.34 44.18 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -174.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -103.34 7.39 38.23 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.788 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' ALA . . . . . 0.579 ' O ' ' HG ' ' A' ' 387' ' ' LEU . . . -84.14 132.63 34.67 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 175.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.95 177.31 7.2 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.034 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 438' ' ' VAL . 15.8 m -112.44 164.38 8.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.466 -175.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -107.92 148.76 29.2 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.42 ' CB ' ' HB ' ' A' ' 403' ' ' ILE . 9.5 m-90 -110.22 113.01 25.34 Favored 'General case' 0 C--N 1.274 -2.699 0 O-C-N 124.144 0.902 . . . . 0.0 109.587 -171.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 401' ' ' GLN . 7.8 mp -126.35 134.26 51.12 Favored 'General case' 0 CA--C 1.48 -1.727 0 CA-C-O 120.675 0.274 . . . . 0.0 111.217 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -113.95 132.76 55.84 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 46.95 24.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.89 14.79 64.24 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.43 ' O ' ' HG ' ' A' ' 397' ' ' LEU . 24.7 tp60 -94.61 -116.29 0.1 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -174.62 128.45 0.33 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 173.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.42 ' HB ' ' CB ' ' A' ' 396' ' ' TRP . 68.4 mt -81.56 101.9 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -82.23 127.68 33.43 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.69 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -66.22 102.47 0.84 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.7 m -110.92 110.0 20.4 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.877 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 52.32 -119.16 8.64 Favored Glycine 0 N--CA 1.444 -0.801 0 O-C-N 124.408 1.067 . . . . 0.0 114.048 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.7 m -108.23 5.74 26.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.205 0.526 . . . . 0.0 110.669 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.04 -41.01 59.98 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.835 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -117.4 109.75 17.17 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.323 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 43.5 mm -108.12 114.88 47.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.497 ' CE1' HD13 ' A' ' 421' ' ' LEU . 23.0 m-85 -87.85 105.96 17.77 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -98.02 108.65 21.41 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.444 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 12.6 p -103.4 105.08 15.26 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.575 0.702 . . . . 0.0 109.85 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 51.2 mt -112.75 83.75 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 76.83 -111.6 3.31 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -97.56 -14.01 21.3 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.135 0.493 . . . . 0.0 109.923 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -78.43 119.34 21.6 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 124.047 0.939 . . . . 0.0 111.023 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' ARG . . . . . 0.607 ' HD3' HD23 ' A' ' 387' ' ' LEU . 9.9 mpt_? -111.37 113.85 26.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 99.0 m -115.06 116.17 28.0 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.577 0.703 . . . . 0.0 110.593 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 382' ' ' ARG . 26.3 tp -91.0 115.5 28.06 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.106 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.2 m -103.85 112.23 25.11 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 56.8 mt -100.26 118.13 46.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 11.3 m -96.91 138.93 33.7 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 63.15 47.65 4.05 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 124.019 0.824 . . . . 0.0 110.599 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 44.4 t -57.92 118.6 5.54 Favored 'General case' 0 C--O 1.249 1.068 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 16.1 m -107.89 -177.81 3.44 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -175.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.78 -23.11 63.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.03 0.443 . . . . 0.0 110.604 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -74.39 -5.02 39.96 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.582 0.706 . . . . 0.0 110.27 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -110.88 -9.57 14.45 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.922 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.1 98.68 0.6 Allowed 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 170.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -164.78 173.67 11.53 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.575 -169.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.4 132.05 34.29 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 444' ' ' SER . 23.7 m-85 -111.42 132.06 54.73 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.1 134.4 55.03 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.447 ' SG ' HD11 ' A' ' 369' ' ' LEU . 73.4 m -109.45 113.07 25.57 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 11.0 t -105.34 125.24 60.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.732 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 394' ' ' VAL . 39.4 t -116.62 160.92 15.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -69.73 113.2 4.89 Favored Glycine 0 N--CA 1.419 -2.435 0 C-N-CA 118.316 -1.897 . . . . 0.0 109.39 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.22 -35.75 4.79 Favored Glycine 0 N--CA 1.425 -2.046 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.937 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -135.81 158.0 45.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.576 1.188 . . . . 0.0 111.596 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -148.73 173.19 13.49 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 35.0 t -159.96 142.74 13.64 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 170.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 434' ' ' TYR . 12.3 p -122.1 130.94 53.69 Favored 'General case' 0 N--CA 1.418 -2.072 0 O-C-N 123.801 0.688 . . . . 0.0 110.09 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 10.7 t -107.02 142.3 36.86 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -98.58 110.02 22.69 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 38.7 tp -89.22 138.83 31.08 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.898 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -115.19 111.23 20.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.17 119.07 45.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 450' ' ' LYS . 0.0 OUTLIER -100.23 134.59 42.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.225 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 451' ' ' GLU . . . . . 0.403 ' OE2' ' HE2' ' A' ' 377' ' ' LYS . 44.9 tt0 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.82 -33.08 33.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 C-N-CA 123.511 0.724 . . . . 0.0 111.272 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -54.02 -46.46 71.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.907 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.13 -38.11 18.08 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.702 177.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.01 -54.91 28.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 O-C-N 123.223 0.327 . . . . 0.0 111.613 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.15 -21.29 65.83 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.652 0.739 . . . . 0.0 110.148 -175.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -72.8 -37.53 67.53 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.075 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -94.03 -23.99 17.8 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.634 0.73 . . . . 0.0 110.431 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.34 89.51 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.763 -176.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' PRO . . . . . 0.406 ' HG2' ' HG2' ' A' ' 332' ' ' GLU . 24.5 Cg_endo -63.85 137.55 58.75 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.509 2.139 . . . . 0.0 112.649 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.638 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 8.9 Cg_endo -52.23 -29.44 37.89 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.302 3.335 . . . . 0.0 115.555 -175.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 11.8 p -70.86 -23.84 62.39 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' ' 336' ' ' ILE . 22.1 mm-40 -95.27 -4.51 45.55 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -171.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.638 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 21.5 m-30 -46.12 -48.59 17.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -173.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.04 -29.46 68.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.061 0.458 . . . . 0.0 111.42 -175.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -76.01 -47.29 25.42 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 332' ' ' GLU . 60.7 mt -58.45 -44.12 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.117 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.85 -58.52 8.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.305 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -68.69 -23.51 64.39 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -71.13 -35.68 71.83 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.16 0.584 . . . . 0.0 110.03 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -100.9 5.35 43.28 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 79.89 38.53 19.37 Favored Glycine 0 C--N 1.31 -0.912 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.699 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.9 t -114.82 119.14 60.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 23.6 p -99.1 -14.55 19.35 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-O 121.556 0.693 . . . . 0.0 110.751 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.79 45.43 0.97 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.327 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 C--O 1.197 -1.67 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.986 -176.95 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.433 -1.295 0 CA-C-O 121.14 0.495 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.64 -13.47 15.57 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -110.32 136.02 50.15 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.198 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -98.02 -19.78 17.8 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.389 0.614 . . . . 0.0 110.016 175.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -158.5 122.35 3.98 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.721 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 45.4 mtpt -106.69 172.33 6.87 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 80.9 mt -75.04 132.67 41.48 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.02 127.97 88.56 Favored Pre-proline 0 CA--C 1.5 -0.973 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.64 -32.18 53.32 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.279 1.986 . . . . 0.0 112.438 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -110.57 110.97 21.89 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.467 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 13.9 m-85 -118.43 151.07 38.49 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 171.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -144.87 143.54 30.64 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 10.6 p -150.63 154.89 8.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 16.1 m -85.55 157.19 20.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' LYS . . . . . 0.526 ' HG3' ' HA ' ' A' ' 427' ' ' SER . 35.6 ttpt -71.98 135.35 46.38 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.782 0.325 . . . . 0.0 111.071 -177.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 85.86 15.58 65.1 Favored Glycine 0 C--N 1.318 -0.469 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.8 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -105.35 -177.53 3.39 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.984 0.421 . . . . 0.0 110.317 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -114.63 138.46 50.64 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.95 130.71 73.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 CA-C-O 120.904 0.383 . . . . 0.0 109.98 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -108.27 103.62 12.83 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.161 0.505 . . . . 0.0 110.475 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.26 113.11 20.88 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 19.9 m -110.35 130.86 55.47 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.149 -171.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.7 151.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 123.55 0.74 . . . . 0.0 109.69 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.486 ' HG2' ' HB3' ' A' ' 418' ' ' LYS . 50.0 mt-10 -118.55 131.61 56.22 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.457 HD22 HG21 ' A' ' 438' ' ' VAL . 26.1 mt -100.91 148.94 24.41 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -81.84 3.87 24.42 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.088 0.471 . . . . 0.0 111.782 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -142.43 136.84 29.89 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -80.42 -21.87 41.76 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.564 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -102.58 4.51 38.49 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.153 0.978 . . . . 0.0 110.042 -173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -100.21 134.84 42.56 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.96 175.89 5.24 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.847 -174.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 4.8 p -131.36 141.32 46.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 120.967 0.413 . . . . 0.0 111.082 -172.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -114.02 135.85 53.55 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 175.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.683 ' HB3' HD12 ' A' ' 403' ' ' ILE . 68.4 m95 -104.35 134.35 47.7 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.913 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 8.3 mp -119.85 125.75 49.29 Favored 'General case' 0 CA--C 1.475 -1.909 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.031 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -102.62 127.38 49.75 Favored 'General case' 0 N--CA 1.416 -2.147 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.702 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 20.9 p30 54.95 15.38 1.14 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 127.125 2.17 . . . . 0.0 113.498 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.2 19.37 42.59 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.251 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -98.13 -89.29 0.3 Allowed 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 169.63 145.9 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.695 HD11 ' HD1' ' A' ' 434' ' ' TYR . 30.3 mt -99.24 108.04 21.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -95.96 134.01 39.48 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.159 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -65.74 104.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.461 0.475 . . . . 0.0 110.674 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 30.6 t -117.44 120.76 39.11 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 50.84 -122.42 13.59 Favored Glycine 0 C--N 1.336 0.579 0 O-C-N 124.25 0.969 . . . . 0.0 113.574 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 23.8 m -116.72 19.6 14.42 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -76.5 -44.6 34.53 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.01 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -122.47 108.53 13.28 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.951 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 3.7 mp -105.24 114.89 45.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -88.09 104.82 17.03 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.442 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -99.37 119.14 37.47 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 13.1 t -115.26 108.18 16.24 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 66.0 mt -113.95 82.75 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.345 -174.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.21 -104.17 1.14 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.144 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -94.26 -21.89 18.74 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 122.409 0.284 . . . . 0.0 110.851 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 386' ' ' GLU . 21.5 ptmt -101.45 137.08 40.25 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.713 0.768 . . . . 0.0 111.47 -175.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -118.47 139.06 52.01 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.022 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 34.4 m -134.37 117.24 16.12 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-O 121.483 0.659 . . . . 0.0 110.503 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 57.1 tp -91.2 113.45 25.71 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.415 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 29.1 m -97.59 106.72 19.08 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.73 116.4 33.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 14.7 m -96.5 146.09 25.11 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.001 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 58.26 50.4 9.77 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.189 1.396 . . . . 0.0 110.15 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 8.0 p -60.46 112.96 2.17 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.73 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' SER . . . . . 0.526 ' HA ' ' HG3' ' A' ' 377' ' ' LYS . 17.7 m -109.98 -170.46 1.65 Allowed 'General case' 0 N--CA 1.406 -2.629 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.08 -21.06 62.28 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 118.964 0.802 . . . . 0.0 111.736 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -73.24 -14.31 61.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.375 0.607 . . . . 0.0 110.077 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -98.34 9.08 43.88 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.78 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.5 107.64 17.54 Favored 'General case' 0 C--O 1.252 1.22 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -155.44 165.01 37.93 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.99 0.424 . . . . 0.0 110.556 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -86.59 115.35 24.01 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' TYR . . . . . 0.695 ' HD1' HD11 ' A' ' 403' ' ' ILE . 98.5 m-85 -104.87 133.05 50.33 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.019 0.438 . . . . 0.0 110.578 -175.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 2.0 mp0 -128.08 134.29 49.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 3.7 p -100.89 118.36 36.79 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.65 123.29 58.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.457 HG21 HD22 ' A' ' 387' ' ' LEU . 92.9 t -131.44 160.68 42.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.18 114.61 7.05 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.031 -1.081 . . . . 0.0 111.059 175.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.83 -36.49 4.32 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-O 119.31 -0.717 . . . . 0.0 113.7 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -139.16 -179.75 6.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.728 1.251 . . . . 0.0 114.228 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 443' ' ' CYS . 33.0 ttmt -149.24 157.12 43.09 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.4 t -143.63 134.43 25.24 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 171.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.42 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 12.2 p -110.15 142.77 41.2 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 123.573 0.545 . . . . 0.0 110.917 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.467 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 8.8 t -137.87 147.59 44.6 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.23 111.13 23.37 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 64.5 tp -88.82 111.3 21.86 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -93.13 107.87 19.58 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.8 t -92.22 114.23 28.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -107.2 124.13 49.29 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.427 -1.577 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.975 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.89 -36.31 49.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 123.438 0.695 . . . . 0.0 111.675 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 31.9 p-90 -58.22 -41.63 84.5 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 123.182 0.593 . . . . 0.0 111.653 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.6 -45.97 10.55 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 80.1 mt -58.2 -52.44 58.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.0 tt -66.43 -33.54 75.94 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 121.501 0.667 . . . . 0.0 109.617 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -64.47 -32.89 74.71 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 124.524 1.129 . . . . 0.0 111.446 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.97 -11.08 25.03 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.331 0.586 . . . . 0.0 110.845 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -83.84 161.77 54.68 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.412 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.52 142.25 58.49 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.68 2.254 . . . . 0.0 110.829 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.98 -16.69 56.31 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 123.784 2.989 . . . . 0.0 114.199 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.4 m -77.54 -17.07 58.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.719 0.295 . . . . 0.0 111.765 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -104.43 1.13 29.72 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' TYR . . . . . 0.404 ' HB3' ' CD1' ' A' ' 345' ' ' LEU . 8.8 m-30 -53.4 -42.54 67.07 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -174.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.8 -27.87 55.4 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.395 -177.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 -63.62 -54.44 35.83 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 34.0 mt -64.01 -43.41 97.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.751 -176.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.47 -59.99 4.56 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.2 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.26 -22.78 66.32 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -65.67 -42.56 91.16 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.235 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -97.95 7.04 46.99 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 90.07 13.72 60.13 Favored Glycine 0 CA--C 1.499 -0.912 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.904 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.0 t -94.54 99.43 9.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.3 m -76.39 -38.75 55.25 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.082 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -110.09 94.21 4.9 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.643 0.735 . . . . 0.0 109.873 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' LEU . . . . . 0.615 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.8 pt? . . . . . 0 C--N 1.303 -1.451 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.356 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.429 -1.497 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.511 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -86.39 -27.06 24.44 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.869 0.842 . . . . 0.0 109.482 177.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.65 127.63 35.95 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.23 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -90.54 -28.37 18.55 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.4 OUTLIER -149.46 115.4 5.68 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 177.552 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.428 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 57.9 mtpt -89.85 162.09 15.65 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 175.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 74.5 mt -64.57 138.65 58.52 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -61.83 145.0 92.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.76 -24.09 44.8 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.6 2.2 . . . . 0.0 113.437 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -142.68 135.6 28.2 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.87 0.367 . . . . 0.0 111.668 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -135.69 146.79 48.12 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -131.05 136.04 48.1 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.47 146.41 31.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 15.5 m -82.79 142.37 31.62 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -57.38 115.84 2.96 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 122.958 0.503 . . . . 0.0 111.248 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 108.03 -18.51 33.81 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.504 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -82.25 179.98 7.61 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.114 0.483 . . . . 0.0 110.925 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 54.3 mtpt -108.76 140.07 42.69 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.574 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.6 tp -127.12 133.25 68.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 176.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -105.87 112.6 25.72 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.918 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.51 110.65 22.44 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 45.0 m -108.32 128.89 55.14 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.65 143.45 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 172.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 18.0 mt-10 -120.13 138.37 53.62 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.41 HD12 ' NH1' ' A' ' 419' ' ' ARG . 95.5 mt -100.19 152.35 20.37 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -85.24 -14.63 46.14 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.403 0.621 . . . . 0.0 110.081 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 392' ' ' ALA . 10.6 t70 -117.84 141.47 48.39 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -79.99 -26.84 39.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.795 0.331 . . . . 0.0 111.718 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -108.04 25.61 11.38 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.632 1.206 . . . . 0.0 109.896 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 389' ' ' ASP . . . -96.75 154.97 16.98 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.15 149.23 51.95 Favored 'General case' 0 C--N 1.274 -2.7 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.116 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 5.3 m -105.92 135.79 42.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.056 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.1 tptm -103.74 136.69 42.97 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 173.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' TRP . . . . . 0.544 ' HB3' HD12 ' A' ' 403' ' ' ILE . 4.8 m-90 -103.23 118.53 36.99 Favored 'General case' 0 C--N 1.264 -3.148 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.981 -170.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.7 mp -128.75 130.21 46.77 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 120.966 0.412 . . . . 0.0 111.757 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -109.22 128.06 54.75 Favored 'General case' 0 N--CA 1.412 -2.363 0 C-N-CA 118.886 -1.126 . . . . 0.0 108.894 170.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.5 p30 49.57 23.86 1.03 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.698 1.599 . . . . 0.0 113.295 -176.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.34 4.96 60.74 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.737 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -90.12 -92.26 0.13 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.501 0.191 . . . . 0.0 110.6 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 171.77 133.69 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.544 HD12 ' HB3' ' A' ' 396' ' ' TRP . 15.0 mt -94.71 124.84 47.36 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 173.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -123.76 145.17 49.22 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.996 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 27.3 ttt -64.91 94.26 0.13 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.677 0.791 . . . . 0.0 111.32 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.6 t -93.5 101.08 13.26 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.23 -128.8 48.21 Favored Glycine 0 N--CA 1.446 -0.659 0 O-C-N 123.915 0.759 . . . . 0.0 112.191 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.7 m -105.24 18.16 22.78 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.395 0.617 . . . . 0.0 109.599 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 424' ' ' SER . 86.5 tttt -83.03 -59.76 2.38 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.359 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' TYR . . . . . 0.533 ' O ' ' HG3' ' A' ' 405' ' ' MET . 75.9 m-85 -96.44 108.12 20.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.76 115.13 48.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.189 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 421' ' ' LEU . 25.4 m-85 -87.41 106.02 17.67 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.8 108.76 21.53 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 29.8 t -95.64 122.8 38.79 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.498 ' HB ' ' CG ' ' A' ' 418' ' ' LYS . 58.3 mt -129.08 85.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.75 -98.03 0.33 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.491 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -92.26 -28.96 16.66 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.849 0.357 . . . . 0.0 110.57 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' LYS . . . . . 0.498 ' CG ' ' HB ' ' A' ' 415' ' ' ILE . 23.2 ptmt -92.55 146.72 23.45 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.896 0.855 . . . . 0.0 112.143 -175.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' ARG . . . . . 0.41 ' NH1' HD12 ' A' ' 387' ' ' LEU . 11.4 mpt_? -125.25 125.07 42.99 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 173.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 34.7 m -121.18 126.61 50.11 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 120.925 0.393 . . . . 0.0 110.279 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' LEU . . . . . 0.56 HD13 ' CE2' ' A' ' 412' ' ' PHE . 33.4 tp -98.15 108.44 21.15 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.7 m -94.83 105.23 17.15 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.718 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 52.4 mt -90.06 115.7 30.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 19.5 m -102.25 128.67 48.69 Favored 'General case' 0 N--CA 1.406 -2.635 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 69.97 59.93 0.27 Allowed 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 124.343 1.027 . . . . 0.0 110.148 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 381' ' ' ILE . 27.8 m -66.23 113.72 4.78 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.268 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 14.5 m -106.43 -166.37 1.18 Allowed 'General case' 0 N--CA 1.404 -2.762 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 54.5 mt -77.84 -22.48 49.86 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.315 -174.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -73.03 -6.41 45.34 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.64 0.733 . . . . 0.0 110.277 176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -103.69 2.71 33.45 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.077 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -87.36 100.04 12.43 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -154.58 167.19 30.95 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.78 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.66 122.9 30.42 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 170.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' TYR . . . . . 0.534 ' HD2' HD11 ' A' ' 403' ' ' ILE . 94.8 m-85 -108.04 132.25 53.74 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 120.754 0.311 . . . . 0.0 110.468 -176.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 2.1 mp0 -121.86 126.08 47.9 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.098 0.475 . . . . 0.0 110.668 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 10.7 p -95.48 113.95 25.67 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.4 123.91 65.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.747 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.48 162.69 32.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.5 113.09 5.55 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 118.448 -1.834 . . . . 0.0 110.727 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.26 -35.23 5.1 Favored Glycine 0 N--CA 1.429 -1.818 0 CA-C-O 119.661 -0.522 . . . . 0.0 113.524 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.511 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 3.3 mm-40 -130.84 154.2 48.29 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 117.944 0.872 . . . . 0.0 110.75 -173.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -148.58 154.65 40.05 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 435' ' ' GLN . 13.6 t -147.74 139.45 23.95 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.419 ' HB3' ' OE1' ' A' ' 435' ' ' GLN . 3.4 m -115.78 118.99 34.56 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.739 0.649 . . . . 0.0 109.465 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 11.0 t -105.92 146.23 30.26 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -101.59 110.29 22.25 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 66.6 tp -96.2 118.04 31.97 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -101.76 117.73 35.48 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.68 113.13 30.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -95.09 119.29 33.34 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.958 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.673 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.67 -42.33 47.73 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.918 2.412 . . . . 0.0 112.356 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 165.63 41.62 0.02 OUTLIER Glycine 0 C--N 1.304 -1.203 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 3.7 p -103.69 -174.28 2.51 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.704 -0.748 . . . . 0.0 111.114 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.413 ' C ' ' H ' ' A' ' 321' ' ' VAL . 17.6 mt-10 -83.65 -47.67 11.0 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 72.14 -21.88 0.22 Allowed 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 125.215 1.406 . . . . 0.0 113.323 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' A' ' 319' ' ' GLU . 9.0 p -45.93 -29.35 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.185 0 C-N-CA 125.957 1.703 . . . . 0.0 113.769 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -62.62 -56.38 18.37 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.807 0.843 . . . . 0.0 110.878 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.49 -31.12 66.74 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.255 0.55 . . . . 0.0 110.052 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.51 -50.58 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.364 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.67 -35.97 82.74 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.064 0.459 . . . . 0.0 110.497 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -57.61 -33.9 68.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.33 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -109.42 6.63 24.45 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.288 -175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -89.59 155.78 48.12 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -62.91 136.56 57.71 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.34 2.027 . . . . 0.0 110.508 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 9.7 Cg_endo -54.23 -34.37 79.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.731 2.954 . . . . 0.0 115.496 -172.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 37.4 t -78.74 -13.98 59.52 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.399 -0.521 . . . . 0.0 112.252 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -98.67 -0.26 43.3 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.98 -174.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.51 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 20.8 m-30 -52.36 -45.21 65.66 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.2 -37.96 78.37 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.521 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 38.8 ttm-85 -63.21 -49.41 74.32 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 339' ' ' GLN . 41.6 mt -71.12 -37.01 65.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.539 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.95 -54.75 41.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.44 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -65.13 -24.31 67.38 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 336' ' ' ILE . 30.5 tt0 -61.88 -36.63 81.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.305 0.574 . . . . 0.0 109.577 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -98.52 -1.37 41.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.028 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 102.03 -5.73 53.4 Favored Glycine 0 C--O 1.244 0.738 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.333 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.64 134.12 27.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 121.369 0.604 . . . . 0.0 109.838 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 -10.82 12.05 Favored 'General case' 0 C--N 1.266 -3.045 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.362 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -100.95 45.53 0.97 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 346' ' ' ARG . 0.0 OUTLIER -70.12 -32.36 70.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.043 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ARG . . . . . 0.42 ' N ' HD22 ' A' ' 345' ' ' LEU . 50.9 ttp180 -63.35 -35.14 79.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.01 176.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 350' ' ' LYS . . . -69.38 -44.49 64.83 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.344 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 59.1 ttp -62.21 -32.4 73.06 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.043 0.449 . . . . 0.0 110.607 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 98.1 mt -72.79 -48.84 34.73 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.294 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.454 ' HG2' ' HA2' ' A' ' 347' ' ' GLY . 19.2 pttp -62.73 -39.92 95.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.754 0.311 . . . . 0.0 111.688 -175.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -68.66 -26.62 65.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.586 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 13.8 tp -80.08 -24.92 40.28 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.98 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 350' ' ' LYS . 54.4 mtmt -67.0 -35.86 80.88 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 357' ' ' ARG . . . -73.55 -25.27 72.88 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 174.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 46.7 tpp -70.45 -45.69 65.29 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 123.625 0.77 . . . . 0.0 110.875 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -87.46 -2.68 58.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.868 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 354' ' ' GLY . 0.3 OUTLIER -59.47 124.48 20.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.616 178.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -55.31 127.62 30.28 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.669 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.67 84.62 2.28 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.42 138.45 56.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' A' ' 362' ' ' SER . 20.9 ttmm -85.51 -177.29 6.4 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.447 ' H ' ' HG2' ' A' ' 361' ' ' LYS . 1.2 m 81.62 64.93 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -172.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 49.9 p -85.33 -61.77 1.69 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.703 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.523 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -85.61 -11.75 53.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.135 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.516 ' CD2' ' HB3' ' A' ' 441' ' ' GLU . 0.7 OUTLIER -94.84 145.64 24.76 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.204 175.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -108.33 -21.19 12.86 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -156.88 121.22 4.39 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.473 ' HG2' ' CD2' ' A' ' 365' ' ' PHE . 27.9 mtpp -101.3 163.12 12.43 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 54.0 mt -66.26 154.39 40.02 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 123.659 0.599 . . . . 0.0 111.118 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -68.09 161.62 66.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.093 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -55.39 -41.53 77.2 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.196 1.93 . . . . 0.0 111.362 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -154.72 162.43 41.12 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.152 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -136.2 141.46 44.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.6 132.32 55.2 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' A' ' 381' ' ' ILE . 11.0 p -133.51 153.67 37.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 379' ' ' HIS . 14.5 m -85.19 145.32 27.65 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 427' ' ' SER . 0.7 OUTLIER -72.65 121.26 19.47 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.08 13.94 40.99 Favored Glycine 0 CA--C 1.494 -1.259 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 376' ' ' SER . 35.6 t60 -118.9 150.34 40.05 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -91.0 127.01 36.25 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.317 0.647 . . . . 0.0 111.03 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.667 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.4 tt -124.26 163.7 23.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 0.8 OUTLIER -143.58 137.37 28.34 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.941 0.401 . . . . 0.0 110.037 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -100.37 151.33 21.64 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 38.8 m -133.01 121.94 23.47 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.024 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 12.6 m -127.05 143.85 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.08 135.71 55.13 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.415 HD13 ' HD3' ' A' ' 419' ' ' ARG . 5.7 mp -99.29 161.89 13.36 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -83.62 1.94 39.85 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.131 0.491 . . . . 0.0 110.599 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -138.85 146.37 41.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -80.73 -28.52 36.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -104.85 4.5 32.17 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.481 0.657 . . . . 0.0 111.074 -171.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -88.32 153.13 21.45 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.27 166.14 15.77 Favored 'General case' 0 C--N 1.268 -2.96 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.938 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 3.7 m -113.76 159.99 13.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.118 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 437' ' ' VAL . 31.7 mmmt -106.12 139.18 41.04 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.418 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 11.8 m-90 -113.46 111.51 22.05 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.3 mp -124.38 137.63 54.45 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.008 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -113.51 118.5 34.65 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.2 p30 50.4 18.61 0.45 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 126.104 1.762 . . . . 0.0 113.742 -175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.87 1.44 27.13 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.736 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -113.69 132.35 55.83 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 48.8 mt-10 -61.66 118.18 6.76 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 57.8 mt -71.16 108.96 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -100.41 150.72 22.33 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.536 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 86.7 mtp -67.63 96.88 0.57 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.101 0.477 . . . . 0.0 110.87 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.9 m -91.25 101.24 13.95 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 58.35 -130.73 51.44 Favored Glycine 0 N--CA 1.446 -0.646 0 O-C-N 123.704 0.627 . . . . 0.0 112.092 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 15.6 m -102.7 13.02 35.49 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.671 0.748 . . . . 0.0 109.307 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -82.6 -41.75 19.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.207 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.536 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 72.7 m-85 -113.25 111.43 22.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 64.2 mt -122.49 117.69 52.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.05 0.452 . . . . 0.0 110.92 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.506 ' CD2' HD13 ' A' ' 421' ' ' LEU . 21.4 m-85 -87.37 109.14 19.34 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.72 108.41 19.87 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.9 p -102.19 105.55 16.25 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.743 0.782 . . . . 0.0 111.64 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.9 mm -100.37 87.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.21 -111.58 3.65 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.331 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -98.1 -6.04 32.46 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.617 0.723 . . . . 0.0 109.813 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -91.39 111.27 22.7 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.55 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' ARG . . . . . 0.415 ' HD3' HD13 ' A' ' 387' ' ' LEU . 10.8 mpt_? -98.54 113.36 25.36 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.4 m -111.41 119.18 37.96 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.506 HD13 ' CD2' ' A' ' 412' ' ' PHE . 19.1 tp -97.09 107.47 20.0 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 96.2 m -94.26 123.05 37.41 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.409 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 59.7 mt -111.67 116.44 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 9.8 m -86.45 130.54 34.46 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.372 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 56.05 74.32 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.595 1.184 . . . . 0.0 111.697 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' CYS . . . . . 0.667 ' SG ' HG22 ' A' ' 381' ' ' ILE . 68.1 m -69.14 125.38 26.49 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.226 0.536 . . . . 0.0 111.25 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' SER . . . . . 0.417 ' HA ' ' HG2' ' A' ' 377' ' ' LYS . 77.5 p -109.28 -177.08 3.2 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 90.2 mt -72.63 -14.93 61.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.19 -20.58 48.02 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.694 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.58 -19.67 27.49 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.474 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.19 99.11 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -163.48 171.51 15.8 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.085 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -87.74 127.75 35.31 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -104.96 134.98 47.16 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 24.8 mp0 -124.34 118.38 26.62 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 369' ' ' LEU . 83.0 m -96.45 108.02 20.5 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 171.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 26.3 t -105.92 117.25 51.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.977 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.75 155.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.58 112.13 4.56 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 117.758 -2.163 . . . . 0.0 111.001 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 105.51 -17.81 42.46 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.523 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 64.8 mm-40 -141.38 112.31 7.24 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -134.23 159.6 40.42 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 435' ' ' GLN . 47.8 t -142.48 134.47 27.21 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.1 m -108.92 110.6 21.96 Favored 'General case' 0 N--CA 1.426 -1.648 0 O-C-N 124.197 0.935 . . . . 0.0 109.267 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.3 t -102.04 150.11 23.57 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -114.6 116.4 28.69 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.455 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 49.3 tp -84.66 134.22 34.37 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -112.46 109.85 19.69 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.32 112.43 26.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.306 0.574 . . . . 0.0 109.59 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.95 116.05 28.47 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.427 -1.593 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.127 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.487 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.472 ' HD2' ' HG2' ' A' ' 319' ' ' GLU . 60.6 Cg_endo -88.94 28.68 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.282 2.655 . . . . 0.0 111.984 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 97.1 -89.56 1.05 Allowed Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 8.1 t -87.09 106.34 17.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.472 ' HG2' ' HD2' ' A' ' 316' ' ' PRO . 50.0 mt-10 -96.01 -62.18 1.32 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.58 -7.76 0.55 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.786 1.234 . . . . 0.0 113.857 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.425 ' HA ' ' HB ' ' A' ' 324' ' ' ILE . 13.3 p -61.43 -23.19 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 124.068 0.947 . . . . 0.0 112.66 -175.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -68.62 -41.78 79.02 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.167 0.508 . . . . 0.0 109.939 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.9 -28.33 27.98 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.217 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 321' ' ' VAL . 76.2 mt -69.39 -47.12 74.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.536 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.89 -34.22 77.64 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.058 0.456 . . . . 0.0 111.257 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -59.27 -41.56 89.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -99.46 -0.41 40.83 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.515 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -71.15 155.5 93.07 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.463 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.68 134.21 46.17 Favored 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.346 2.031 . . . . 0.0 110.549 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 11.7 Cg_endo -53.66 -28.68 47.65 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 124.115 3.21 . . . . 0.0 115.172 -172.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 11.7 m -86.05 -15.02 42.65 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -101.26 3.49 40.9 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.148 -172.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 22.0 m-30 -50.94 -44.73 60.4 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.545 0.528 . . . . 0.0 112.264 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -59.92 -53.64 55.48 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 123.394 0.434 . . . . 0.0 112.14 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 53.4 ttp85 -61.73 -39.34 91.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.435 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 56.4 mt -73.01 -38.96 56.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.127 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.67 -56.83 16.64 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.061 0.545 . . . . 0.0 111.027 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -67.4 -23.54 65.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -65.99 -47.28 75.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.137 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -83.88 -19.29 35.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.162 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 100.77 40.56 2.88 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.086 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.97 128.24 63.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 19.1 p -104.3 -14.48 15.77 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 121.24 0.543 . . . . 0.0 110.44 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -79.28 44.75 0.6 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.331 0.586 . . . . 0.0 111.26 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 46.3 tp -73.81 -39.56 64.01 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -66.33 -29.51 69.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.205 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 351' ' ' ARG . . . -74.96 -34.86 51.73 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 25.4 ttt -70.63 -43.35 69.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.839 0.352 . . . . 0.0 110.145 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.85 -34.7 77.21 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.814 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -54.97 -41.14 70.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.851 0.86 . . . . 0.0 109.943 174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.628 ' O ' ' HG2' ' A' ' 355' ' ' MET . 28.2 mmt180 -54.78 -45.98 74.35 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.112 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 6.9 mp -80.73 -20.94 41.67 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.149 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -71.47 -26.83 62.87 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -83.83 -29.84 30.83 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.106 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.628 ' HG2' ' O ' ' A' ' 351' ' ' ARG . 26.0 mmt -75.4 -17.09 60.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 122.831 0.453 . . . . 0.0 110.674 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 77.67 -29.12 0.16 Allowed 'General case' 0 C--O 1.246 0.892 0 C-N-CA 125.631 1.572 . . . . 0.0 112.009 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -80.25 86.69 5.62 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 122.013 0.911 . . . . 0.0 109.872 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -138.78 97.21 3.28 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.162 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 17.0 mm-40 55.77 28.58 12.49 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.467 1.107 . . . . 0.0 112.705 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -76.68 106.11 8.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.507 0.67 . . . . 0.0 109.592 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 359' ' ' GLU . 22.2 pttp 178.5 -37.05 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.595 -170.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 26.2 p 178.52 27.96 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.94 1.296 . . . . 0.0 109.829 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.438 HG22 ' OE2' ' A' ' 441' ' ' GLU . 7.3 t -74.01 -39.72 63.41 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.197 -0.94 . . . . 0.0 110.964 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.563 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -92.55 -10.47 37.49 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.924 0.392 . . . . 0.0 111.069 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.21 110.07 20.12 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.903 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 386' ' ' GLU . 90.6 mt-30 -74.26 -29.3 61.61 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.527 0.679 . . . . 0.0 109.655 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 367' ' ' LYS . 34.3 ttmt -149.38 119.21 7.07 Favored 'General case' 0 N--CA 1.398 -3.026 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -176.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.662 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 57.9 mtpt -100.04 166.21 11.14 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.758 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 71.4 mt -69.12 136.42 52.19 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.541 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -59.36 150.66 63.27 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -46.66 -39.27 23.19 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 123.095 2.53 . . . . 0.0 113.115 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -147.46 165.37 30.48 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.471 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -142.45 144.39 33.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.38 140.42 52.97 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.6 p -145.93 152.74 13.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 25.1 m -91.14 150.85 21.21 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.32 128.79 37.73 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.871 0.367 . . . . 0.0 110.486 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 88.34 6.77 73.78 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.6 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 376' ' ' SER . 10.1 m-70 -102.75 -178.52 3.7 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.764 0.316 . . . . 0.0 110.21 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -119.65 141.24 49.52 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.467 HG22 ' SG ' ' A' ' 426' ' ' CYS . 16.1 tt -141.4 155.42 20.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 2.6 ptm180 -141.18 134.85 30.15 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.347 0.594 . . . . 0.0 110.598 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.57 125.21 48.19 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.817 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 54.1 m -106.28 121.28 43.9 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.702 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.44 144.12 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 366' ' ' GLN . 33.3 mt-10 -124.41 131.44 53.5 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.479 HD21 HG13 ' A' ' 394' ' ' VAL . 3.4 mm? -89.86 159.86 16.77 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.8 -25.55 56.48 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.3 0.571 . . . . 0.0 110.261 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -131.2 159.41 37.81 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.124 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -80.8 -25.33 37.92 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.261 0.553 . . . . 0.0 109.895 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.08 3.19 40.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.051 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -99.93 118.02 35.46 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -103.01 163.73 12.03 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.167 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.479 HG13 HD21 ' A' ' 387' ' ' LEU . 3.7 m -117.81 141.09 38.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.484 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -109.46 122.9 48.42 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.414 ' O ' HD12 ' A' ' 397' ' ' LEU . 3.6 m-90 -93.37 114.0 26.31 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.665 -170.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 396' ' ' TRP . 7.8 mp -127.3 137.67 52.88 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 175.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 433' ' ' ALA . 60.4 pttt -117.34 119.45 35.17 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.8 p30 50.95 20.72 0.84 Allowed 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 125.415 1.486 . . . . 0.0 113.236 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLY . . . . . 0.4 ' HA2' HD23 ' A' ' 397' ' ' LEU . . . 103.02 2.28 48.72 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.985 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -108.58 123.43 48.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -53.01 121.13 6.79 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.515 0.509 . . . . 0.0 110.603 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 53.1 mt -79.19 102.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -100.3 145.58 27.96 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.417 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 87.8 mtp -60.63 100.74 0.11 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.301 0.572 . . . . 0.0 111.617 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.7 m -102.6 103.1 13.38 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.115 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.99 -134.41 50.83 Favored Glycine 0 N--CA 1.442 -0.95 0 O-C-N 124.008 0.817 . . . . 0.0 113.307 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.3 t -99.98 7.72 44.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 26.2 ttmt -75.7 -54.43 6.97 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.708 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.417 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 60.4 m-85 -102.33 107.66 18.76 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.121 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.05 110.15 30.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.365 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.564 ' CE1' HD13 ' A' ' 421' ' ' LEU . 22.4 m-85 -87.27 106.13 17.7 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.45 108.04 19.92 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.433 0.635 . . . . 0.0 110.464 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.86 107.19 19.03 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.53 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.41 84.27 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.74 -111.3 3.4 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.84 -6.86 26.15 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.256 0.55 . . . . 0.0 110.029 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -82.44 113.01 19.9 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.721 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -108.8 107.45 17.88 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.7 m -109.36 116.92 32.76 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.128 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.564 HD13 ' CE1' ' A' ' 412' ' ' PHE . 21.0 tp -91.17 106.39 18.48 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.3 m -93.84 119.99 33.51 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 54.5 mt -107.34 115.37 48.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.5 m -99.99 131.76 45.75 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 68.52 61.65 0.36 Allowed 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.355 1.062 . . . . 0.0 111.494 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' CYS . . . . . 0.467 ' SG ' HG22 ' A' ' 381' ' ' ILE . 59.7 m -62.95 121.74 14.29 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.561 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.3 p -113.82 -175.0 2.58 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.72 -18.77 62.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.261 0.553 . . . . 0.0 110.39 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -78.92 -11.17 59.99 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.752 0.787 . . . . 0.0 110.101 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' ASP . . . . . 0.429 ' OD1' ' HD3' ' A' ' 409' ' ' LYS . 23.2 m-20 -96.49 -19.48 19.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.976 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.04 103.15 0.9 Allowed 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -165.05 167.59 18.19 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 398' ' ' LYS . . . -85.76 124.15 31.93 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -104.67 139.46 39.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.426 ' HB3' ' CB ' ' A' ' 444' ' ' SER . 0.0 OUTLIER -142.97 138.76 30.31 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 121.173 0.511 . . . . 0.0 110.767 177.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 62.2 m -101.96 112.05 24.54 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.115 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.95 110.13 23.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.708 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 57.9 t -112.41 157.07 13.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.25 113.3 5.46 Favored Glycine 0 N--CA 1.428 -1.873 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.829 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 102.6 -33.47 6.53 Favored Glycine 0 N--CA 1.425 -2.033 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.158 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 24.7 mm-40 -132.44 131.37 41.67 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.365 0.602 . . . . 0.0 111.582 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 443' ' ' CYS . 33.5 ttmt -126.36 158.03 36.95 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 49.3 t -148.39 134.0 18.78 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 435' ' ' GLN . 34.0 t -123.79 139.27 54.15 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.8 t -125.62 150.48 47.51 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -106.85 110.87 23.15 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.395 0.616 . . . . 0.0 110.593 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -89.6 139.67 30.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.001 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 450' ' ' LYS . 53.9 t80 -121.69 117.02 25.62 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 123.609 0.763 . . . . 0.0 110.891 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 56.5 t -97.51 119.47 45.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 376' ' ' SER . 0.0 OUTLIER -110.67 137.52 48.24 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.227 174.3 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.701 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.444 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.76 -24.96 12.84 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.676 2.251 . . . . 0.0 112.273 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -172.11 -178.21 42.19 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 24.5 t -116.75 -61.23 1.75 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -119.0 9.63 11.92 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 122.657 1.218 . . . . 0.0 108.312 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.17 19.93 4.01 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.365 -1.743 . . . . 0.0 110.691 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.29 -35.52 36.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.745 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' TRP . . . . . 0.475 ' O ' ' HB2' ' A' ' 326' ' ' ARG . 17.7 m95 -56.6 -60.4 3.59 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 124.024 0.93 . . . . 0.0 110.913 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.85 -41.32 95.79 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.488 0.492 . . . . 0.0 111.657 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.4 mt -68.06 -42.88 85.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 123.095 0.558 . . . . 0.0 111.545 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.6 -36.24 60.36 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 322' ' ' TRP . 14.3 tpt85 -63.94 -41.15 97.7 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.364 0.666 . . . . 0.0 111.345 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.76 -4.59 59.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.547 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -87.92 150.3 47.51 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.59 150.24 82.9 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.817 1.678 . . . . 0.0 111.273 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.1 -29.31 3.93 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.644 3.563 . . . . 0.0 115.96 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 50.5 m -85.41 -2.06 57.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -93.44 -22.26 19.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -44.08 -52.51 7.13 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.86 1.264 . . . . 0.0 112.905 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -57.0 -53.0 63.03 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.433 0.693 . . . . 0.0 111.858 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -57.87 -50.37 73.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.983 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.67 -40.43 89.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.892 -175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.94 -57.72 11.56 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.623 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -68.89 -23.02 64.15 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -64.14 -44.8 91.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.92 0.39 . . . . 0.0 110.082 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -91.13 -8.4 48.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 89.13 32.5 10.56 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.442 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 17.6 t -94.52 122.8 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.338 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 9.3 p -97.82 -22.57 16.31 Favored 'General case' 0 C--N 1.276 -2.618 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.934 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -83.89 63.23 7.43 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.714 0.768 . . . . 0.0 110.297 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 27.6 tp -75.56 -47.16 27.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.286 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -65.79 -26.14 67.56 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 351' ' ' ARG . . . -61.86 -34.25 88.13 Favored Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.829 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 53.9 tpp -68.08 -38.75 82.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.077 0.465 . . . . 0.0 110.157 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.95 -34.25 77.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.058 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -63.0 -45.5 92.12 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 347' ' ' GLY . 83.8 mtt180 -61.18 -46.12 91.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.854 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.64 -49.88 75.89 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.728 0.811 . . . . 0.0 111.016 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.91 -15.72 60.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.071 0.462 . . . . 0.0 110.787 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -97.68 25.85 25.62 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.759 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 23.6 mmt -87.25 -19.09 28.82 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -62.48 137.55 58.28 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.235 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -99.11 170.5 8.65 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.508 ' OD2' ' HG2' ' A' ' 360' ' ' LYS . 35.9 t70 -133.51 136.47 45.08 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -109.48 92.88 4.23 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.561 ' HE3' ' HA ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -101.74 -93.67 0.3 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.25 175.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.441 ' HG3' ' H ' ' A' ' 362' ' ' SER . 18.0 tptp 59.77 -170.45 0.14 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.978 0.911 . . . . 0.0 108.623 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.441 ' H ' ' HG3' ' A' ' 361' ' ' LYS . 44.8 t 63.39 30.23 15.5 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 121.489 0.661 . . . . 0.0 109.914 176.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 75.0 p -72.54 -32.24 65.93 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.402 -172.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -97.53 4.93 50.22 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.17 0.509 . . . . 0.0 110.776 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -117.0 117.6 30.11 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.689 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -85.08 -21.93 29.15 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 120.826 0.346 . . . . 0.0 110.36 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' LYS . . . . . 0.426 ' HB2' ' HE2' ' A' ' 367' ' ' LYS . 23.6 ttmm -159.67 127.38 4.77 Favored 'General case' 0 N--CA 1.391 -3.383 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 35.6 mtmm -110.75 177.35 4.7 Favored 'General case' 0 C--N 1.253 -3.615 0 O-C-N 124.28 0.987 . . . . 0.0 108.357 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.424 HD13 HG22 ' A' ' 445' ' ' THR . 86.4 mt -71.98 141.94 49.37 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.144 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.67 158.66 67.02 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.202 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -44.8 -39.81 14.09 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 123.451 2.767 . . . . 0.0 113.809 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -156.11 162.53 40.24 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -137.97 149.2 45.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -133.38 137.34 45.79 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.42 143.78 33.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.7 m -79.43 141.99 36.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -57.28 125.59 23.48 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 122.957 0.503 . . . . 0.0 110.402 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 96.47 -9.97 66.96 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.917 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -96.71 170.75 8.98 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.149 0.499 . . . . 0.0 110.791 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 6.9 mtpm? -101.08 161.05 13.88 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.729 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 18.2 tt -154.98 133.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 121.201 0.524 . . . . 0.0 110.665 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -99.99 127.47 46.2 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.546 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 420' ' ' THR . 70.3 mt -105.77 109.37 21.3 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 87.7 m -107.19 126.01 51.85 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.13 149.25 33.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 418' ' ' LYS . 41.5 mt-10 -114.43 135.55 53.98 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 54.1 mt -104.04 165.44 11.05 Favored 'General case' 0 C--N 1.261 -3.263 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.03 -29.84 49.61 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.164 0.507 . . . . 0.0 109.929 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -112.01 146.94 37.0 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.181 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -78.9 -22.44 45.92 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -112.5 26.23 10.74 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.236 0.541 . . . . 0.0 111.398 -173.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -113.37 137.54 51.36 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -122.31 154.45 37.6 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.893 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.61 153.53 7.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.33 0.586 . . . . 0.0 111.491 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -103.43 133.37 48.6 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.453 ' CB ' HD12 ' A' ' 403' ' ' ILE . 44.8 m95 -101.51 139.06 37.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 434' ' ' TYR . 10.3 mp -121.13 143.61 49.01 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.644 ' HG3' HG12 ' A' ' 403' ' ' ILE . 22.5 mtmm -103.83 108.61 20.0 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.7 p30 50.95 16.81 0.37 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 124.966 1.306 . . . . 0.0 113.998 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.15 -5.96 17.52 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.643 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -102.04 124.85 48.37 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -64.13 118.39 8.48 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.932 0.396 . . . . 0.0 111.987 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.644 HG12 ' HG3' ' A' ' 398' ' ' LYS . 41.0 mt -66.33 122.0 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.248 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -102.1 157.34 16.95 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.557 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 48.0 ttm -71.54 94.6 1.31 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.0 t -89.92 102.22 14.92 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 58.68 -114.38 5.92 Favored Glycine 0 N--CA 1.437 -1.251 0 O-C-N 124.086 0.866 . . . . 0.0 112.141 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 26.4 m -119.3 17.12 13.1 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.05 -0.575 . . . . 0.0 109.735 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -76.34 -46.39 27.76 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.864 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.557 ' O ' ' HG3' ' A' ' 405' ' ' MET . 93.4 m-85 -111.62 108.44 17.93 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.89 0.376 . . . . 0.0 110.292 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 49.6 mt -107.91 113.75 44.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -87.23 105.1 16.99 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.409 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.99 138.61 41.87 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.638 0.732 . . . . 0.0 111.365 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 13.1 p -118.38 122.81 43.73 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.089 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.79 89.89 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.03 -123.83 15.69 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.41 -6.36 55.02 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.317 0.58 . . . . 0.0 110.027 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.407 ' HG3' ' HG2' ' A' ' 386' ' ' GLU . 31.2 ttpt -88.85 125.26 34.84 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' ARG . . . . . 0.444 ' HD3' ' HA ' ' A' ' 419' ' ' ARG . 2.5 tpp180 -113.2 137.3 51.67 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 76.9 m -142.11 122.94 14.38 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.367 0.603 . . . . 0.0 112.162 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 410' ' ' TYR . 63.9 tp -91.19 114.32 26.82 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 43.7 m -93.97 108.08 19.92 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 50.7 mt -92.84 130.62 41.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' SER . . . . . 0.5 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 16.5 m -106.58 132.19 52.87 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.832 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . 0.321 10.4 pt20 46.64 76.5 0.1 Allowed 'General case' 0 C--O 1.238 0.467 0 O-C-N 125.16 1.537 . . . . 0.0 114.575 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 60.5 m -70.28 128.39 36.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.968 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.0 m -112.9 -174.16 2.4 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.64 -19.79 62.78 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.89 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -72.55 -24.72 61.17 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.182 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.38 -21.57 42.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.13 95.54 0.41 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.412 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.95 171.51 18.58 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.2 132.74 34.24 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' TYR . . . . . 0.59 ' HA ' ' O ' ' A' ' 397' ' ' LEU . 38.7 m-85 -104.81 145.57 30.19 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.6 OUTLIER -129.62 123.28 30.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.195 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 7.8 p -94.38 118.28 31.39 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 13.0 t -111.53 121.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.28 160.06 6.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.37 112.29 4.71 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 117.764 -2.16 . . . . 0.0 110.242 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 107.52 -35.41 5.03 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 112.391 -0.283 . . . . 0.0 112.391 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.408 ' OE1' ' HG3' ' A' ' 361' ' ' LYS . 23.3 mm-40 -120.03 127.82 52.95 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 122.428 -0.454 . . . . 0.0 110.612 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -130.85 128.93 41.63 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.7 t -120.31 138.05 53.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 434' ' ' TYR . 12.7 p -116.43 148.11 41.03 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 123.412 0.445 . . . . 0.0 111.013 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.424 HG22 HD13 ' A' ' 369' ' ' LEU . 12.6 t -140.54 150.92 44.3 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -101.73 119.28 38.54 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 24.4 tp -95.98 137.22 35.35 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -118.35 115.74 25.31 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.52 122.17 41.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -93.73 106.63 18.59 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.724 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--N 1.292 -1.896 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.274 179.284 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.479 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.2 148.92 92.34 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.131 1.887 . . . . 0.0 109.817 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -84.0 45.19 3.44 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.864 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 3.1 p -77.3 0.42 22.24 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 123.264 0.626 . . . . 0.0 112.616 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 43.5 mp0 -78.91 -24.36 44.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 69.31 -19.12 0.18 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.476 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 7.2 p -51.33 -34.4 14.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 123.873 0.869 . . . . 0.0 112.209 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -55.91 -47.71 76.98 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.872 0.869 . . . . 0.0 110.92 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 11.6 pt-20 -85.85 -38.12 18.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.69 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.79 -50.47 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.311 0.1 . . . . 0.0 111.167 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.39 -32.0 70.75 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -57.87 -39.14 77.09 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.846 0.858 . . . . 0.0 112.199 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 23.2 pt20 -104.88 2.38 29.86 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.173 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -77.12 160.77 75.25 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.529 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.84 135.51 48.61 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.276 1.984 . . . . 0.0 111.029 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -65.96 -4.83 10.85 Favored 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 123.759 2.972 . . . . 0.0 114.772 -173.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 24.5 p -90.25 -16.7 28.85 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.208 0.528 . . . . 0.0 111.192 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.403 ' O ' HG13 ' A' ' 336' ' ' ILE . 29.3 mm-40 -106.92 -0.72 22.98 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.54 -172.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -55.73 -42.24 75.06 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.07 -44.14 97.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.528 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -59.36 -53.53 57.18 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.697 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 332' ' ' GLU . 48.5 mt -59.04 -44.06 90.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 O-C-N 123.792 0.683 . . . . 0.0 110.613 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.66 -60.79 3.28 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.126 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -67.12 -22.85 65.78 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -66.39 -45.62 79.4 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 123.2 0.6 . . . . 0.0 110.205 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' TYR . . . . . 0.476 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 80.8 m-85 -88.83 -20.19 24.98 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 112.63 14.09 10.79 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.532 -1.318 . . . . 0.0 112.551 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.37 97.14 6.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.2 m -65.06 -42.67 93.99 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.693 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -115.99 95.9 5.32 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.706 0.765 . . . . 0.0 111.409 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.647 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.6 pt? -71.31 -28.27 63.99 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.104 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -65.74 -46.0 80.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.681 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -68.31 -23.02 74.94 Favored Glycine 0 C--O 1.239 0.448 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' MET . . . . . 0.539 ' O ' ' HG2' ' A' ' 351' ' ' ARG . 25.2 ttt -67.18 -54.64 19.32 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 350' ' ' LYS . 4.4 pp -70.06 -29.54 66.57 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.276 0.56 . . . . 0.0 111.09 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.433 ' N ' HD12 ' A' ' 349' ' ' LEU . 84.8 tttt -57.85 -46.4 84.83 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.514 1.126 . . . . 0.0 110.512 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 348' ' ' MET . 15.2 ptp180 -72.07 -22.0 61.43 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.713 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.67 -21.44 55.41 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -62.72 -53.74 49.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.76 -4.18 70.12 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.415 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 44.2 ttm -89.79 -45.25 9.42 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 122.939 0.495 . . . . 0.0 110.053 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -79.76 -79.07 0.15 Allowed 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.681 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -176.98 75.25 0.02 OUTLIER 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.218 0.532 . . . . 0.0 110.792 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 360' ' ' LYS . 34.5 t70 -121.25 11.5 10.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 123.228 1.489 . . . . 0.0 109.14 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -88.72 93.11 9.46 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 358' ' ' ASP . 3.7 mppt? -81.84 -62.21 1.7 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.534 -176.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.433 ' HB3' ' H ' ' A' ' 362' ' ' SER . 14.1 mptt 54.72 -158.76 0.19 Allowed 'General case' 0 C--O 1.241 0.655 0 O-C-N 124.156 0.91 . . . . 0.0 110.537 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.433 ' H ' ' HB3' ' A' ' 361' ' ' LYS . 16.2 m 67.11 19.56 10.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.665 0.745 . . . . 0.0 109.456 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.6 t -104.62 -16.61 14.95 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.363 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -86.14 -3.34 58.94 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.204 1.002 . . . . 0.0 108.558 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.47 ' CD1' ' HB3' ' A' ' 441' ' ' GLU . 0.3 OUTLIER -91.98 126.45 37.07 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 114.226 -1.352 . . . . 0.0 107.899 173.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -93.25 -18.09 22.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.48 0.657 . . . . 0.0 110.023 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -157.24 126.08 5.8 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.728 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 37.4 mtmm -106.86 176.58 5.12 Favored 'General case' 0 C--N 1.276 -2.596 0 O-C-N 123.791 0.682 . . . . 0.0 109.841 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.528 HD11 ' SG ' ' A' ' 436' ' ' CYS . 72.3 mt -74.51 147.54 41.75 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.23 159.06 82.34 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.61 -35.85 38.86 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.277 2.651 . . . . 0.0 112.997 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -156.35 160.72 39.95 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -133.82 148.76 51.35 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -128.25 144.69 51.15 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.8 149.24 15.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 m -88.66 154.02 20.64 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.01 121.43 11.82 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.167 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 90.63 4.37 70.26 Favored Glycine 0 C--N 1.303 -1.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.16 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -98.78 176.9 5.46 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 122.434 -0.451 . . . . 0.0 110.767 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -110.42 143.13 41.17 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.044 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.464 HG22 ' SG ' ' A' ' 426' ' ' CYS . 10.0 tp -130.99 143.04 42.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -121.19 121.9 38.8 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 66.7 mt -100.17 113.33 25.91 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 26.9 m -112.14 125.21 53.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.311 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.99 157.54 40.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.502 ' HG2' ' HG2' ' A' ' 418' ' ' LYS . 46.5 mt-10 -124.11 137.32 54.58 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.535 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 86.7 mt -98.8 138.13 36.39 Favored 'General case' 0 C--N 1.267 -3.007 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.64 -38.56 58.8 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -106.95 99.8 9.34 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.626 -1.625 . . . . 0.0 106.917 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 417' ' ' ALA . 20.3 p80 -73.9 -16.64 61.1 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 120.817 0.341 . . . . 0.0 111.712 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -87.28 3.97 44.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.177 0.513 . . . . 0.0 110.528 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -107.67 96.18 6.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.434 ' HG2' ' NH2' ' A' ' 419' ' ' ARG . 35.0 mt-10 -75.27 159.81 31.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 8.6 p -118.11 157.95 19.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 113.485 -1.688 . . . . 0.0 109.668 -173.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -132.15 161.22 33.87 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.46 ' CB ' HD12 ' A' ' 403' ' ' ILE . 38.7 m95 -114.14 144.62 42.87 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.7 mp -122.74 136.41 54.86 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.53 ' HG2' HG12 ' A' ' 403' ' ' ILE . 8.2 mmtp -93.17 108.62 20.19 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.479 173.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.8 p30 53.03 12.92 0.32 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 125.024 1.33 . . . . 0.0 114.078 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 108.44 9.72 26.72 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.007 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -90.77 -98.89 0.11 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 173.21 137.53 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.53 HG12 ' HG2' ' A' ' 398' ' ' LYS . 48.4 mt -97.75 120.8 47.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 120.831 0.348 . . . . 0.0 110.401 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -91.77 130.99 37.45 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 58.1 ttp -62.21 103.73 0.41 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.8 m -106.16 120.31 41.5 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.265 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 48.62 -118.89 5.21 Favored Glycine 0 C--N 1.334 0.42 0 O-C-N 125.027 1.454 . . . . 0.0 115.278 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.6 m -112.14 7.57 19.65 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.468 0.651 . . . . 0.0 109.623 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 424' ' ' SER . 82.6 tttt -83.3 -49.5 9.32 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.658 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -109.74 129.05 55.65 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.93 118.16 51.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -87.91 105.87 17.72 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -112.76 113.09 25.03 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.166 0.508 . . . . 0.0 111.73 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 37.4 t -98.22 119.42 36.86 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.84 95.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 71.32 -107.83 2.3 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.535 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -101.6 -13.11 17.97 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.073 0.463 . . . . 0.0 109.846 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.502 ' HG2' ' HG2' ' A' ' 386' ' ' GLU . 60.4 mtpt -74.86 137.61 41.92 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 121.601 0.715 . . . . 0.0 111.695 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' ARG . . . . . 0.434 ' NH2' ' HG2' ' A' ' 393' ' ' GLU . 21.8 mmt180 -122.3 112.74 18.5 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 173.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 6.8 m -116.64 122.01 43.34 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.449 ' HB2' ' CE2' ' A' ' 396' ' ' TRP . 53.5 tp -96.23 111.0 23.2 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 67.4 m -92.36 109.5 20.88 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 56.4 mt -101.95 122.15 53.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 409' ' ' LYS . 18.3 m -108.42 141.08 40.8 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 64.84 58.32 0.97 Allowed 'General case' 0 C--O 1.254 1.303 0 C-N-CA 124.427 1.091 . . . . 0.0 111.782 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' CYS . . . . . 0.464 ' SG ' HG22 ' A' ' 381' ' ' ILE . 85.2 m -66.06 131.47 46.28 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.497 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' SER . . . . . 0.491 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 5.5 m -126.0 177.62 6.24 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 98.8 mt -67.3 -30.7 70.63 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 118.19 0.45 . . . . 0.0 111.633 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.98 -9.11 59.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.759 0.79 . . . . 0.0 110.298 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' ASP . . . . . 0.491 ' HB3' ' H ' ' A' ' 427' ' ' SER . 18.7 t70 -97.23 -13.94 21.72 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -71.24 114.52 9.39 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.123 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -156.34 172.97 17.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.776 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.67 126.78 33.67 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -106.91 145.27 32.41 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 120.995 0.426 . . . . 0.0 110.864 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.13 143.44 24.15 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.551 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' A' ' 369' ' ' LEU . 59.0 m -98.26 131.87 44.23 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 56.7 t -116.04 107.98 24.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.284 0.564 . . . . 0.0 111.771 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 58.6 t -116.91 160.82 16.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 170.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -68.27 109.56 2.97 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 117.21 -2.424 . . . . 0.0 111.891 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 99.97 -36.21 4.26 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 125.861 1.696 . . . . 0.0 108.966 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 438' ' ' VAL . 6.4 mp0 -90.25 96.18 10.55 Favored 'General case' 0 N--CA 1.395 -3.196 0 C-N-CA 124.887 1.275 . . . . 0.0 112.341 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 37.9 ttmt -121.59 118.04 28.24 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 51.6 t -115.31 133.69 55.8 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 10.8 p -112.22 147.59 35.89 Favored 'General case' 0 N--CA 1.432 -1.33 0 O-C-N 123.565 0.541 . . . . 0.0 111.143 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.515 HG22 HD13 ' A' ' 369' ' ' LEU . 14.5 t -144.88 151.25 38.42 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -112.24 117.68 33.19 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 118.805 -1.158 . . . . 0.0 109.624 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 58.4 tp -88.0 136.54 32.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -118.52 113.5 21.39 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.13 117.26 33.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -94.06 109.32 21.09 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-O 121.386 0.612 . . . . 0.0 111.309 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.809 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.484 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.52 -3.98 11.49 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.413 2.076 . . . . 0.0 112.068 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 153.62 -163.02 30.62 Favored Glycine 0 N--CA 1.417 -2.578 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 4.4 p -81.83 -11.17 59.08 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.964 0.888 . . . . 0.0 111.053 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -132.98 151.28 52.08 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -100.11 19.49 16.29 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-O 121.601 0.715 . . . . 0.0 111.149 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.463 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 5.3 p -54.57 -39.43 45.91 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.495 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -52.26 -57.26 10.25 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 124.202 1.001 . . . . 0.0 111.334 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.24 -35.43 68.83 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.765 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.44 -52.79 53.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.015 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.19 -34.81 73.4 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.005 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -58.89 -40.86 85.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.694 0.398 . . . . 0.0 110.986 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -93.54 2.02 56.55 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.437 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -88.89 158.2 47.75 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.362 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.93 161.63 40.9 Favored 'Trans proline' 0 CA--C 1.555 1.555 0 C-N-CA 122.539 2.159 . . . . 0.0 111.194 173.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.61 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 10.9 Cg_endo -55.35 -35.8 92.43 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.68 2.92 . . . . 0.0 114.861 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 14.8 m -72.72 -8.58 56.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.428 0.632 . . . . 0.0 112.412 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.504 ' HB3' HD11 ' A' ' 336' ' ' ILE . 12.0 mm-40 -97.31 -22.88 16.4 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.859 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.61 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 23.3 m-30 -55.14 -50.08 70.16 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -174.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.71 -18.99 62.12 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.29 0.567 . . . . 0.0 111.207 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -82.82 -57.36 3.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.504 HD11 ' HB3' ' A' ' 332' ' ' GLU . 69.4 mt -58.29 -39.41 73.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.495 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.11 -59.57 4.89 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.472 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.48 -23.48 64.58 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -68.2 -36.74 80.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.07 0.462 . . . . 0.0 110.537 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' TYR . . . . . 0.463 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 85.7 m-85 -97.12 -17.35 20.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 107.15 20.78 8.46 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.93 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 15.0 t -95.41 129.67 45.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 34.2 p -94.66 -49.72 5.5 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.435 -0.906 . . . . 0.0 112.351 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.11 69.21 3.19 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -171.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 0.0 OUTLIER -74.46 -26.12 59.84 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -68.28 -32.06 71.96 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -70.91 -36.86 65.27 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 27.3 ttt -65.09 -41.83 94.61 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 114.905 -0.647 . . . . 0.0 109.88 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 93.9 mt -68.7 -40.9 79.81 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.129 0.49 . . . . 0.0 110.527 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 353' ' ' LYS . 86.5 tttt -53.65 -46.24 70.5 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.43 1.092 . . . . 0.0 110.306 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -83.12 -21.03 33.74 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.507 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 355' ' ' MET . 51.6 tp -65.97 -25.98 67.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.554 0.692 . . . . 0.0 111.281 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 350' ' ' LYS . 54.6 mtmt -72.34 -20.09 61.53 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.908 0.861 . . . . 0.0 109.821 177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -118.62 27.3 7.28 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.529 ' HB2' ' HA ' ' A' ' 352' ' ' LEU . 46.8 tpp -66.65 -54.31 24.56 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -133.76 -69.2 0.55 Allowed 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.244 -1.344 . . . . 0.0 107.385 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -171.35 105.66 0.23 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 120.825 0.345 . . . . 0.0 111.026 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -123.33 148.48 45.96 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.48 63.65 1.1 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 360' ' ' LYS . 41.3 mmtm -124.52 15.67 8.87 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 171.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -85.6 173.54 10.09 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 110.984 -2.826 . . . . 0.0 111.321 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 49.7 m 68.3 40.52 2.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -172.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.8 t -86.53 -30.2 22.12 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.082 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.453 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -102.34 -19.97 14.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.7 0.762 . . . . 0.0 109.712 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -100.14 137.02 39.15 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.318 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -99.26 -16.37 18.53 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.4 OUTLIER -162.74 115.96 1.66 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 178.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.62 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 15.0 mtpp -88.51 169.41 11.77 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.422 HD13 HG22 ' A' ' 445' ' ' THR . 87.9 mt -64.22 140.37 58.86 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -60.18 147.88 79.94 Favored Pre-proline 0 C--N 1.318 -0.788 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -43.96 -47.49 10.09 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.616 2.877 . . . . 0.0 114.15 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -151.14 142.69 23.56 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.121 0.486 . . . . 0.0 111.435 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -122.14 156.59 33.33 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -142.28 134.06 27.0 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.64 156.91 20.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 15.1 m -79.76 157.23 27.16 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 2.0 tmmm? -77.34 135.56 38.38 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.56 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 86.82 5.65 80.89 Favored Glycine 0 CA--C 1.494 -1.247 0 CA-C-O 121.372 0.429 . . . . 0.0 112.097 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -99.14 -170.67 1.95 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -114.84 139.36 49.81 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.1 tp -121.88 128.74 75.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -102.37 103.58 14.01 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.78 0.8 . . . . 0.0 112.319 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 65.4 mt -91.2 114.95 27.61 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.1 m -123.56 130.59 52.9 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.473 -169.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.438 HG11 ' SG ' ' A' ' 436' ' ' CYS . 14.7 m -127.96 154.09 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.054 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -120.88 142.43 49.68 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 49.6 mt -98.62 142.27 30.41 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.47 -35.18 54.02 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -125.07 142.57 51.41 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -74.48 -16.98 60.83 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.429 0.633 . . . . 0.0 110.775 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.37 11.78 22.65 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.948 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -104.2 88.76 3.07 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -78.35 147.99 33.94 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 11.8 p -106.62 157.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.761 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.477 ' HA ' ' HE3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER -125.79 150.72 47.56 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 175.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.436 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 3.2 m-90 -121.94 123.85 42.66 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.7 mp -129.81 144.71 51.44 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 118.438 0.563 . . . . 0.0 110.689 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -123.21 121.04 34.93 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.9 p30 49.73 17.03 0.23 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.531 1.532 . . . . 0.0 114.183 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.08 -4.35 23.9 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.624 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -108.28 123.0 48.12 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 35.7 tt0 -61.45 122.63 15.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.927 0.394 . . . . 0.0 110.908 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 42.7 mt -73.78 114.6 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.972 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -99.03 147.36 25.1 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 171.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.612 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 0.0 OUTLIER -77.28 126.14 30.45 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.255 -176.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 15.0 m -109.68 88.57 2.78 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.22 -109.76 2.66 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.0 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 45.2 t -109.78 4.02 21.36 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 122.808 -0.231 . . . . 0.0 110.809 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 409' ' ' LYS . 12.2 tmtt? -79.45 -34.28 41.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.612 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 91.2 m-85 -126.63 117.35 22.59 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 52.8 mt -118.3 113.8 43.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.428 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.505 ' CD1' HD13 ' A' ' 421' ' ' LEU . 23.6 m-85 -87.97 109.48 19.84 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -108.05 106.31 16.47 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 50.5 m -92.28 106.28 18.31 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.84 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 58.3 mt -113.71 92.82 2.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.33 -110.45 3.42 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.572 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.68 -2.23 35.94 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.007 0.432 . . . . 0.0 110.562 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -101.85 133.85 45.97 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.512 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -111.18 110.47 21.0 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 17.4 m -108.59 118.14 36.01 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.554 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.505 HD13 ' CD1' ' A' ' 412' ' ' PHE . 22.6 tp -98.25 107.96 20.54 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 39.2 m -93.61 100.38 12.64 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.9 mt -83.97 115.66 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 14.9 m -100.33 134.81 42.73 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 69.19 54.15 0.44 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.541 1.136 . . . . 0.0 111.002 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 1.9 p -62.38 123.94 19.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.222 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' SER . . . . . 0.426 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 9.2 m -114.27 169.53 8.96 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -173.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.33 -37.92 77.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.168 0.509 . . . . 0.0 111.815 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -84.29 1.24 45.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.751 0.786 . . . . 0.0 110.223 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 427' ' ' SER . 28.4 t70 -106.34 -17.59 14.24 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.824 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.5 125.33 17.64 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.849 174.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.47 169.11 23.68 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.994 0.426 . . . . 0.0 111.191 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -86.39 133.64 33.77 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 170.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -114.7 137.87 51.39 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.04 140.33 52.09 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 20.8 p -115.84 113.98 24.1 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 173.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 47.0 t -113.47 118.46 58.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.028 0.442 . . . . 0.0 111.863 -174.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 97.0 t -114.17 161.69 12.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.24 113.06 5.52 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.831 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 100.67 -35.41 4.86 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.085 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 31.1 mm-40 -128.26 135.98 50.39 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 120.693 0.282 . . . . 0.0 110.889 -173.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -141.94 177.64 8.06 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 53.1 t -160.27 142.33 12.89 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 3.8 p -121.15 131.27 54.15 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 123.69 0.619 . . . . 0.0 110.197 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.422 HG22 HD13 ' A' ' 369' ' ' LEU . 14.9 t -121.61 150.71 41.3 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.72 111.12 18.7 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.21 0.529 . . . . 0.0 110.212 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 61.0 tp -90.62 140.77 29.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.596 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -115.18 108.38 16.53 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 42.3 t -90.4 109.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 376' ' ' SER . 37.8 ttpt -111.82 127.19 55.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.367 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.048 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.69 -35.21 95.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.95 2.433 . . . . 0.0 112.527 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -91.15 119.37 5.65 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.782 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 19.2 m -88.25 80.03 7.66 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.385 0.612 . . . . 0.0 110.104 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -120.35 19.56 12.07 Favored 'General case' 0 C--O 1.208 -1.114 0 CA-C-O 121.269 0.557 . . . . 0.0 110.715 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.56 9.74 8.77 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.631 0.729 . . . . 0.0 110.229 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.528 HG11 HG21 ' A' ' 342' ' ' VAL . 6.5 p -50.84 -37.23 16.04 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.587 0 C-N-CA 125.721 1.608 . . . . 0.0 113.608 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -61.79 -56.68 16.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.663 0.744 . . . . 0.0 110.732 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 13.2 pt-20 -71.96 -21.61 61.56 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.017 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.5 mt -74.29 -46.36 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.387 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.97 -40.2 84.06 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 122.905 0.482 . . . . 0.0 110.325 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ARG . . . . . 0.416 ' NH2' ' HG ' ' A' ' 352' ' ' LEU . 20.1 tpp180 -55.54 -36.83 67.19 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.194 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 20.9 pt20 -100.79 5.76 43.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.163 0.506 . . . . 0.0 111.511 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -106.62 152.83 40.86 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.587 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -62.65 138.51 70.17 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.416 2.077 . . . . 0.0 111.886 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.7 -22.38 64.26 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.484 2.789 . . . . 0.0 112.468 -174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 2.8 p -74.59 -14.22 60.75 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.165 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -111.49 4.49 18.87 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.355 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -49.12 -41.12 34.99 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.9 -54.21 49.17 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.511 0.507 . . . . 0.0 111.584 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -61.1 -44.97 96.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.845 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 38.6 mt -68.35 -42.49 84.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.264 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.84 -54.32 46.55 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.593 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -61.84 -32.28 72.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -61.01 -39.86 91.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.828 0.347 . . . . 0.0 110.495 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -91.75 1.35 57.22 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 86.81 23.46 42.04 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.646 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.528 HG21 HG11 ' A' ' 321' ' ' VAL . 19.0 t -107.3 134.35 49.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.8 p -110.78 -15.35 13.83 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-O 120.981 0.42 . . . . 0.0 110.651 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -95.35 45.68 1.1 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.852 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -29.21 68.13 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.449 0.642 . . . . 0.0 110.924 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -65.03 -27.47 68.83 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.27 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -69.42 -30.58 71.22 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 114.416 -1.266 . . . . 0.0 111.9 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 25.5 ttt -62.78 -43.8 97.84 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.926 0.393 . . . . 0.0 110.707 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.19 -38.94 72.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.335 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -58.3 -58.46 8.39 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.067 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 355' ' ' MET . 17.4 ptp180 -58.41 -35.54 72.21 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.416 ' HG ' ' NH2' ' A' ' 326' ' ' ARG . 4.2 mm? -71.02 -21.16 62.31 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -80.36 -34.05 36.8 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -70.3 -29.82 69.88 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.841 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' A' ' 351' ' ' ARG . 25.1 ptp -128.39 93.09 3.56 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.509 0.671 . . . . 0.0 110.142 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 359' ' ' GLU . 72.2 mtm180 -73.73 74.08 1.55 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -70.86 135.85 48.3 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 73.83 -55.37 0.67 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.582 1.153 . . . . 0.0 111.184 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 356' ' ' ARG . 56.2 mm-40 -59.19 -22.21 60.66 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 125.941 1.696 . . . . 0.0 112.347 -176.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.481 ' HD3' ' N ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -60.48 -26.6 66.92 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 178.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.481 ' N ' ' HD3' ' A' ' 360' ' ' LYS . 14.5 tppt? -113.87 30.67 7.08 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 123.204 1.478 . . . . 0.0 107.956 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 5.2 m -144.43 43.46 1.4 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 6.2 t -94.37 -27.3 16.14 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.228 -175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -103.98 0.35 29.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 122.0 0.905 . . . . 0.0 109.598 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.81 137.76 50.66 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.415 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -103.21 -19.4 14.51 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.827 0.346 . . . . 0.0 110.104 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -156.46 125.54 6.04 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.438 ' HE2' ' SG ' ' A' ' 443' ' ' CYS . 60.6 mtpt -112.16 172.32 6.98 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 96.0 mt -72.6 117.81 14.74 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -63.65 142.17 97.98 Favored Pre-proline 0 C--N 1.314 -0.953 0 O-C-N 124.033 0.833 . . . . 0.0 108.882 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -47.72 -35.3 23.17 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 123.326 2.684 . . . . 0.0 113.129 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -127.46 128.0 45.0 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.493 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 44.9 m-85 -128.81 147.38 50.79 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -134.09 145.14 49.07 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.75 159.06 4.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.401 ' HB2' ' CG ' ' A' ' 379' ' ' HIS . 13.9 m -89.16 156.48 18.77 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -67.19 123.36 20.09 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.43 5.09 67.52 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' HIS . . . . . 0.401 ' CG ' ' HB2' ' A' ' 376' ' ' SER . 12.4 m170 -101.69 164.95 11.48 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.331 -0.434 . . . . 0.0 110.378 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -102.36 136.85 41.44 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.504 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.58 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.9 tt -136.35 154.69 33.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.418 ' CB ' ' HA ' ' A' ' 422' ' ' THR . 18.4 ptt180 -134.76 126.09 28.24 Favored 'General case' 0 N--CA 1.413 -2.316 0 C-N-CA 119.175 -1.01 . . . . 0.0 112.031 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.401 ' HB3' HD21 ' A' ' 369' ' ' LEU . 3.0 mm? -78.9 109.79 13.51 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 113.892 -1.504 . . . . 0.0 109.0 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.461 ' CG2' ' HD2' ' A' ' 418' ' ' LYS . 23.5 m -105.46 124.27 49.27 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.869 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.49 158.44 42.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -130.51 132.76 45.79 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 79.6 mt -96.61 159.79 14.74 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.49 -41.35 76.23 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -101.37 147.27 26.52 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.284 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.84 -24.28 38.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.27 25.6 1.16 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.448 1.499 . . . . 0.0 110.819 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -131.84 153.99 49.61 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -175.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -124.64 172.15 9.48 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 123.226 0.329 . . . . 0.0 110.629 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.38 144.25 37.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.081 0.467 . . . . 0.0 110.61 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -103.27 129.4 50.25 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.798 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.663 ' HB3' HD12 ' A' ' 403' ' ' ILE . 34.4 m95 -110.28 128.27 55.44 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.955 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.4 139.73 50.94 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -109.2 125.56 52.36 Favored 'General case' 0 N--CA 1.407 -2.61 0 C-N-CA 118.224 -1.39 . . . . 0.0 108.906 171.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 27.3 p30 50.89 21.68 1.01 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 126.628 1.971 . . . . 0.0 114.296 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.67 12.35 56.99 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.52 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -96.14 -91.58 0.23 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 176.02 139.85 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.663 HD12 ' HB3' ' A' ' 396' ' ' TRP . 9.4 mt -111.51 106.15 20.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -115.2 146.46 41.39 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 51.8 ttm -55.93 104.83 0.15 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.431 0.634 . . . . 0.0 111.195 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.0 t -117.3 110.14 17.71 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 51.42 -117.34 5.6 Favored Glycine 0 C--N 1.33 0.211 0 O-C-N 124.147 0.904 . . . . 0.0 113.35 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.9 p -114.46 8.7 16.58 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.671 0.748 . . . . 0.0 110.44 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -72.74 -40.71 65.85 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.052 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -129.33 113.91 15.56 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 64.2 mt -112.88 116.92 53.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.772 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -86.61 109.55 19.23 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.765 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.03 108.13 19.1 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.6 m -103.16 104.91 15.1 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.135 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.5 mm -123.65 103.91 13.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 66.63 -113.39 5.63 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.51 -12.97 19.69 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.381 0.61 . . . . 0.0 109.601 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.461 ' HD2' ' CG2' ' A' ' 384' ' ' THR . 7.8 ttpm? -86.96 136.35 32.96 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.34 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -122.33 126.44 48.07 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.3 m -127.51 125.63 40.76 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.48 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.456 HD21 HG21 ' A' ' 403' ' ' ILE . 50.3 tp -100.1 103.93 15.46 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.492 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 70.0 m -89.97 116.84 28.32 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.023 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 48.8 mt -107.54 118.63 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.0 m -89.97 144.59 25.79 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 57.19 62.72 2.11 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 123.979 0.912 . . . . 0.0 112.401 174.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' CYS . . . . . 0.58 ' SG ' HG22 ' A' ' 381' ' ' ILE . 82.8 m -69.56 118.18 12.11 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' SER . . . . . 0.533 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 14.1 m -111.05 171.79 7.26 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.55 -35.12 78.44 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.079 0.466 . . . . 0.0 110.367 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.42 -7.74 56.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.789 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' ASP . . . . . 0.533 ' HB3' ' H ' ' A' ' 427' ' ' SER . 29.5 t70 -105.34 -9.32 17.67 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.618 0.723 . . . . 0.0 109.711 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.71 112.28 2.19 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.625 -1.17 . . . . 0.0 107.872 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -153.59 168.2 26.98 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.068 0.461 . . . . 0.0 111.283 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.53 131.5 34.36 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -114.97 132.17 56.67 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 396' ' ' TRP . 0.6 OUTLIER -112.08 136.93 50.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.061 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 16.9 p -106.07 106.21 16.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.49 124.03 53.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.246 0.546 . . . . 0.0 111.513 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.91 152.06 36.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -70.08 113.33 4.89 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 118.689 -1.719 . . . . 0.0 110.901 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 109.23 -36.31 4.41 Favored Glycine 0 N--CA 1.418 -2.558 0 C-N-CA 123.306 0.479 . . . . 0.0 111.928 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.514 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 6.3 mm-40 -130.21 126.32 37.1 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -136.4 146.84 46.89 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.438 ' SG ' ' HE2' ' A' ' 368' ' ' LYS . 8.9 t -144.9 160.24 41.63 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 7.6 p -142.92 133.2 24.63 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.329 0.393 . . . . 0.0 110.583 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 8.6 t -109.36 150.18 28.41 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -111.57 110.68 21.22 Favored 'General case' 0 N--CA 1.406 -2.668 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.45 145.49 31.9 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -119.13 107.6 13.66 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.18 110.41 22.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -102.15 127.81 48.91 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.437 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.412 -2.344 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.539 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.688 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.88 -41.94 57.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.096 2.53 . . . . 0.0 112.074 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.04 53.28 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.447 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 36.8 p -100.65 -178.36 3.76 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 321' ' ' VAL . 3.7 mp0 -103.7 -73.61 0.66 Allowed 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 67.69 -14.2 0.22 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 125.917 1.687 . . . . 0.0 112.589 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.48 ' H ' ' C ' ' A' ' 319' ' ' GLU . 14.2 p -55.52 -28.22 22.39 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.651 0 C-N-CA 124.942 1.297 . . . . 0.0 111.911 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -57.32 -56.56 20.23 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 123.093 0.557 . . . . 0.0 110.614 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.42 -32.77 58.69 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.366 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.2 mt -71.46 -45.57 67.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.938 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 9.6 tt -73.28 -29.41 62.71 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -61.78 -42.72 99.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.445 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -89.16 -0.59 57.57 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.984 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -94.58 154.87 40.02 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.815 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.93 141.47 44.65 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.031 1.821 . . . . 0.0 111.279 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.85 -20.76 53.8 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.815 3.01 . . . . 0.0 114.049 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 5.6 m -66.71 -27.96 68.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.471 ' HG3' HD11 ' A' ' 336' ' ' ILE . 7.9 pt-20 -110.57 11.84 22.86 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -52.94 -37.73 61.23 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.415 ' HA ' HD22 ' A' ' 345' ' ' LEU . 40.1 tt0 -63.81 -47.43 80.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.608 0.242 . . . . 0.0 110.99 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -62.61 -42.59 99.67 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.543 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.471 HD11 ' HG3' ' A' ' 332' ' ' GLU . 74.1 mt -61.63 -44.99 99.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.158 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.89 -54.01 51.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.13 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -69.19 -23.11 63.87 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -69.79 -44.4 70.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.221 0.534 . . . . 0.0 109.987 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -88.47 1.23 55.22 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 72.49 35.64 59.5 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.151 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.404 HG21 HG11 ' A' ' 321' ' ' VAL . 8.2 t -103.56 111.53 33.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.1 p -84.01 -20.66 32.4 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-O 122.341 1.067 . . . . 0.0 110.15 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.46 44.18 1.19 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.149 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 334' ' ' GLU . 33.6 tp -73.59 -37.1 65.56 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 172.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -54.93 -46.03 74.87 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 112.485 -2.143 . . . . 0.0 111.029 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -77.2 -32.63 47.6 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.577 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' MET . . . . . 0.479 ' O ' ' HB2' ' A' ' 352' ' ' LEU . 14.6 tpt -62.6 -44.15 97.04 Favored 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 122.252 0.221 . . . . 0.0 110.977 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 85.0 mt -69.24 -39.47 78.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.379 0.609 . . . . 0.0 110.221 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.56 -50.33 74.19 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.778 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -77.0 -22.39 53.18 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.234 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 348' ' ' MET . 1.4 tm? -62.22 -38.21 88.28 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -75.51 -44.11 45.45 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.643 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -90.89 29.66 6.75 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.405 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 54.8 tpp -77.47 23.59 0.21 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.122 0.969 . . . . 0.0 113.013 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -80.65 -12.46 59.49 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 120.73 -1.231 . . . . 0.0 110.503 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.34 165.65 30.42 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -135.54 168.22 19.64 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -80.59 -12.2 59.54 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.546 0.689 . . . . 0.0 109.309 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -98.39 92.83 5.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.98 146.91 28.03 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 57.6 p 56.77 57.75 4.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.099 1.428 . . . . 0.0 109.45 -171.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.6 t -119.01 -21.95 7.47 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.243 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.544 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -100.31 -33.29 10.46 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -89.08 123.15 33.1 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.512 173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -87.44 -25.18 23.89 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 367' ' ' LYS . 36.9 ttmt -164.29 118.79 1.45 Allowed 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.484 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 51.3 mtmt -91.26 170.59 9.87 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 123.403 0.439 . . . . 0.0 110.452 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.635 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 76.1 mt -60.12 143.81 51.34 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 123.896 0.748 . . . . 0.0 111.582 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 373' ' ' TYR . 35.7 mm-40 -64.75 149.1 96.5 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.856 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.04 -52.37 9.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.858 2.372 . . . . 0.0 112.812 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -142.23 144.43 33.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.012 0.434 . . . . 0.0 111.666 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 370' ' ' GLU . 56.3 m-85 -123.76 163.23 21.58 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -134.06 142.84 47.72 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.5 p -144.82 157.68 14.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 48.8 m -97.23 150.28 21.09 Favored 'General case' 0 N--CA 1.412 -2.332 0 C-N-CA 120.414 -0.515 . . . . 0.0 109.688 174.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.06 128.79 37.83 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.264 0.626 . . . . 0.0 111.207 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 83.81 15.66 69.82 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.659 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -118.31 176.3 5.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.3 mtpt -102.83 146.13 28.73 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.18 0.3 . . . . 0.0 110.392 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.489 HG22 ' SG ' ' A' ' 426' ' ' CYS . 10.7 tp -135.65 156.62 38.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 30.5 ptt180 -142.64 124.43 15.09 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.587 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -94.71 126.2 39.86 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.391 -1.277 . . . . 0.0 107.924 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 68.0 m -108.63 138.91 44.18 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 11.8 m -141.43 159.67 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 C-N-CA 124.111 0.964 . . . . 0.0 108.93 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 85.9 mt-10 -130.04 136.92 49.91 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.33 148.74 23.85 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -84.47 10.03 11.9 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.456 0.646 . . . . 0.0 110.422 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -157.58 135.97 11.17 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -67.12 -24.25 65.91 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.145 0.497 . . . . 0.0 111.664 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -107.05 26.27 10.34 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.18 0.99 . . . . 0.0 110.915 -173.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -98.61 122.27 41.61 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -93.16 137.56 32.38 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 19.4 m -106.29 154.22 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.97 174.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 15.3 tptm -123.6 157.42 33.78 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.498 ' O ' HD12 ' A' ' 397' ' ' LEU . 4.4 m-90 -118.95 126.05 50.85 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 123.338 0.399 . . . . 0.0 109.969 -168.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 396' ' ' TRP . 6.5 mp -135.89 144.26 45.46 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -123.57 121.96 36.94 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 27.9 p30 46.71 22.31 0.18 Allowed 'General case' 0 N--CA 1.504 2.272 0 C-N-CA 125.614 1.566 . . . . 0.0 114.891 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 107.69 -0.21 34.33 Favored Glycine 0 C--O 1.224 -0.517 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.998 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -111.17 129.96 55.78 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -65.71 122.31 16.99 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.2 0.524 . . . . 0.0 111.035 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.434 ' HB ' ' CB ' ' A' ' 396' ' ' TRP . 57.7 mt -80.15 123.51 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -128.21 154.21 46.07 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.41 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 66.7 mtm -70.55 93.6 0.92 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.11 0.481 . . . . 0.0 111.507 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 39.8 m -92.79 100.53 12.99 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 71.77 -129.25 15.9 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.8 m -112.68 14.88 20.08 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -65.77 -42.81 90.41 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 94.0 m-85 -123.9 127.73 48.43 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 50.5 mm -118.0 117.35 54.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -86.79 108.12 18.58 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.302 0.572 . . . . 0.0 109.546 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -97.45 123.85 41.44 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.842 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 35.7 t -118.8 111.98 19.13 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 70.1 mt -124.76 84.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.716 0.769 . . . . 0.0 109.247 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.12 -109.89 2.99 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.17 -20.28 16.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.904 0.383 . . . . 0.0 110.182 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 386' ' ' GLU . 22.0 ptmt -88.36 133.1 34.18 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.782 0.801 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.29 139.45 53.78 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' THR . . . . . 0.402 ' CG2' ' HB2' ' A' ' 382' ' ' ARG . 74.1 m -134.26 130.36 36.99 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-O 121.148 0.499 . . . . 0.0 110.884 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 382' ' ' ARG . 37.8 tp -95.64 109.39 21.66 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.0 m -97.53 118.87 35.01 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.51 124.68 55.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 7.1 m -101.71 132.28 47.51 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 63.91 70.27 0.52 Allowed 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 124.235 0.959 . . . . 0.0 110.919 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' CYS . . . . . 0.489 ' SG ' HG22 ' A' ' 381' ' ' ILE . 73.5 m -68.23 123.74 21.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.67 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 45.3 t -106.23 155.23 19.69 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.46 -27.13 69.07 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.129 0.572 . . . . 0.0 110.475 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -87.22 1.08 54.24 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.264 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -114.15 1.98 14.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.32 111.75 3.16 Favored 'General case' 0 C--O 1.255 1.362 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.789 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -161.71 171.4 17.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.576 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -87.68 130.89 34.65 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -111.26 138.66 47.45 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 444' ' ' SER . 0.2 OUTLIER -120.52 141.6 50.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.411 ' SG ' HD11 ' A' ' 369' ' ' LEU . 73.7 m -109.13 111.38 22.97 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 168.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.93 119.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.281 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 47.6 t -110.85 159.82 10.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 169.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.15 113.93 6.34 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 119.269 -1.443 . . . . 0.0 111.52 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 89.04 -24.27 14.0 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 121.081 0.267 . . . . 0.0 112.824 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.544 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 4.9 mm-40 -118.29 109.89 16.86 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.479 0.712 . . . . 0.0 109.107 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -136.26 149.55 48.54 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 34.2 t -148.2 139.53 23.47 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 435' ' ' GLN . 9.3 m -112.31 151.07 30.14 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.6 t -129.15 144.64 51.28 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -110.63 109.81 20.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 121.752 0.787 . . . . 0.0 109.108 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -93.72 129.52 40.03 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.993 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -107.82 115.4 30.07 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.377 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 38.2 t -90.08 125.58 42.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 376' ' ' SER . 12.0 pttp -116.11 146.83 41.92 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--N 1.259 -3.327 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 174.844 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.732 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.32 -37.01 42.47 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.692 2.261 . . . . 0.0 111.264 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -62.88 98.03 0.2 Allowed Glycine 0 N--CA 1.434 -1.495 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.889 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 7.4 m -119.78 22.15 11.69 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.48 10.13 4.39 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.635 ' HA ' ' NE1' ' A' ' 322' ' ' TRP . 1.1 m-20 -78.77 46.21 0.65 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 112.644 -2.071 . . . . 0.0 112.424 -175.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 340' ' ' TYR . 7.4 p -56.25 -38.65 55.65 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.192 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.802 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' TRP . . . . . 0.635 ' NE1' ' HA ' ' A' ' 320' ' ' ASP . 0.0 OUTLIER -45.79 -52.04 11.79 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.616 ' HG2' ' HB3' ' A' ' 320' ' ' ASP . 8.4 pt-20 -85.48 -38.42 18.63 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.422 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 87.1 mt -65.46 -40.45 88.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.632 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.2 tt -75.76 -33.06 60.19 Favored 'General case' 0 C--O 1.202 -1.429 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -69.06 -36.47 77.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -85.39 -7.55 58.89 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.173 0.511 . . . . 0.0 111.329 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -84.52 161.39 54.09 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.316 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.14 135.48 51.08 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.922 2.415 . . . . 0.0 111.469 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.53 -34.61 90.32 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 124.048 3.165 . . . . 0.0 115.568 -171.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 19.5 t -83.7 -1.9 55.06 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.682 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -102.82 -4.24 25.19 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.869 0.366 . . . . 0.0 110.07 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -52.38 -42.07 63.68 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -64.5 -38.59 91.56 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.468 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -66.37 -46.3 77.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 109.485 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.06 -37.61 73.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.288 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.75 -62.45 1.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.582 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -62.19 -32.96 73.67 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -59.72 -41.2 90.32 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.806 0.842 . . . . 0.0 111.564 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' TYR . . . . . 0.425 ' CB ' ' HB ' ' A' ' 321' ' ' VAL . 95.6 m-85 -97.25 10.71 38.78 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.177 0.513 . . . . 0.0 111.962 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 86.72 15.93 62.57 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.577 174.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 4.2 t -94.12 105.57 17.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.3 p -84.23 -14.95 48.59 Favored 'General case' 0 C--N 1.267 -2.98 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -133.27 95.46 3.53 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.5 pt? -76.31 -21.71 55.88 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.18 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -54.97 -50.07 69.85 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.562 0.745 . . . . 0.0 110.828 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -79.25 -29.48 49.91 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.413 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -60.79 -47.62 85.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 86.5 mt -63.4 -40.42 97.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.201 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -56.64 -51.13 69.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.375 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -20.94 56.01 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 355' ' ' MET . 30.5 tp -81.85 -31.44 31.61 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -75.4 -37.21 60.62 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -91.2 36.98 3.47 Favored Glycine 0 N--CA 1.417 -2.612 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.112 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.532 ' HB2' ' O ' ' A' ' 352' ' ' LEU . 43.7 ttm -54.94 -34.39 63.16 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 125.312 1.445 . . . . 0.0 111.5 -176.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -127.18 28.15 5.79 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.696 0.76 . . . . 0.0 110.325 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -104.18 155.84 18.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.651 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -96.25 151.87 19.1 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -76.36 -70.12 0.47 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp 41.18 85.14 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 125.123 1.369 . . . . 0.0 113.185 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -132.42 41.3 3.22 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.345 -174.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 14.9 m 72.11 71.08 0.15 Allowed 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -171.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 61.0 m -85.23 -44.26 13.05 Favored 'General case' 0 N--CA 1.392 -3.334 0 CA-C-N 112.449 -2.16 . . . . 0.0 112.727 -172.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.602 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -93.32 -10.73 34.41 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.036 0.922 . . . . 0.0 109.494 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -100.11 127.65 46.32 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.707 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -95.39 -17.67 21.37 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -165.5 126.12 1.87 Allowed 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.592 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 33.4 mtmm -102.34 -179.49 4.0 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 65.7 mt -74.3 147.12 42.58 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.98 137.61 89.81 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -55.64 -35.81 93.59 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.497 2.132 . . . . 0.0 112.465 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -128.36 134.09 48.78 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.998 0.428 . . . . 0.0 112.025 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -133.12 155.41 49.31 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.989 0.916 . . . . 0.0 109.298 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -134.64 147.67 50.22 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.19 154.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 10.1 t -96.13 150.66 20.26 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.523 ' HD2' ' HG2' ' A' ' 451' ' ' GLU . 83.4 tttt -61.42 120.81 11.2 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 123.169 0.587 . . . . 0.0 110.978 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 97.83 -4.56 61.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.5 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -98.27 175.04 6.21 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.659 0.266 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -104.77 150.45 24.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.994 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.434 HG22 ' SG ' ' A' ' 426' ' ' CYS . 16.2 tt -141.19 136.84 33.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 120.953 0.406 . . . . 0.0 110.126 174.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -107.9 123.68 48.98 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.375 0.607 . . . . 0.0 109.896 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 68.1 mt -101.81 114.18 28.03 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 67.3 m -109.31 127.91 54.67 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 20.3 m -132.39 160.67 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.5 135.19 46.87 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.438 HD11 ' CG1' ' A' ' 394' ' ' VAL . 3.1 mm? -99.57 155.92 17.33 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.23 -7.93 56.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.513 0.673 . . . . 0.0 110.506 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 392' ' ' ALA . 13.1 t70 -129.53 140.37 51.26 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -75.52 -24.47 56.78 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -115.3 25.77 10.6 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.624 0.726 . . . . 0.0 111.638 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 389' ' ' ASP . . . -97.72 133.39 42.32 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 175.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -104.72 160.18 15.18 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.479 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.438 ' CG1' HD11 ' A' ' 387' ' ' LEU . 7.6 m -109.78 154.08 11.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.614 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -105.62 116.89 32.71 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.47 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 1.2 m-90 -92.3 120.2 32.62 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.94 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.4 mp -125.9 140.36 52.7 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 118.466 0.575 . . . . 0.0 110.576 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.29 116.77 27.44 Favored 'General case' 0 N--CA 1.405 -2.699 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.9 p30 52.41 18.16 0.89 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.444 1.497 . . . . 0.0 113.816 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.56 -4.71 23.06 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.303 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -110.22 128.68 55.63 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 35.1 tt0 -62.32 121.34 12.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 0.0 110.078 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 396' ' ' TRP . 58.4 mt -66.51 124.6 22.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.163 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -108.61 153.0 24.02 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.943 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 50.9 ttm -71.02 105.15 3.21 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 33.6 t -104.39 98.54 8.31 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 57.84 -114.42 5.66 Favored Glycine 0 C--N 1.329 0.173 0 O-C-N 123.485 0.491 . . . . 0.0 112.488 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' SER . . . . . 0.441 ' HA ' HD11 ' A' ' 411' ' ' ILE . 23.0 m -114.72 10.81 16.7 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.569 0.699 . . . . 0.0 109.837 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -77.08 -45.34 27.37 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.526 ' O ' ' HG3' ' A' ' 405' ' ' MET . 65.8 m-85 -122.66 109.27 14.05 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.441 HD11 ' HA ' ' A' ' 408' ' ' SER . 48.3 mm -115.2 119.68 62.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 120.981 0.419 . . . . 0.0 110.909 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.522 ' CE2' HD13 ' A' ' 421' ' ' LEU . 24.6 m-85 -87.24 108.49 18.96 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.99 108.46 21.17 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.9 m -100.37 104.67 16.11 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.7 mt -121.19 83.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 66.93 -119.14 11.4 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.562 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -79.75 -23.67 42.08 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -74.81 125.27 28.42 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.73 0.776 . . . . 0.0 111.45 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 419' ' ' ARG . 1.9 tpp180 -114.98 111.68 21.51 Favored 'General case' 0 N--CA 1.399 -3.018 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 170.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 63.5 m -119.82 120.57 36.89 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.368 0.604 . . . . 0.0 111.498 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.522 HD13 ' CE2' ' A' ' 412' ' ' PHE . 36.2 tp -91.81 115.6 28.19 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 45.4 m -98.2 110.34 22.94 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.3 mt -97.54 123.65 50.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 33.9 m -104.33 136.7 43.43 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 59.38 64.78 1.28 Allowed 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 124.673 1.233 . . . . 0.0 111.49 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' CYS . . . . . 0.434 ' SG ' HG22 ' A' ' 381' ' ' ILE . 58.6 m -67.33 134.75 52.14 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.941 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 20.1 m -125.57 -177.96 4.08 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 84.6 mt -79.79 -21.91 43.75 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.918 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.43 73.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.443 0.639 . . . . 0.0 109.774 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.77 -0.37 57.26 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.141 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.69 108.13 1.62 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -149.0 165.07 32.73 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.012 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.87 115.84 23.75 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -104.01 152.09 22.45 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 18.5 pm0 -147.36 150.72 35.27 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.078 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 77.0 m -116.09 118.6 33.33 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 38.6 t -106.31 132.94 52.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 67.4 t -128.15 161.41 36.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -61.45 112.36 4.68 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 118.989 -1.577 . . . . 0.0 111.865 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 96.29 -35.18 4.5 Favored Glycine 0 N--CA 1.421 -2.345 0 CA-C-N 114.768 -0.716 . . . . 0.0 112.82 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.602 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 9.8 mm-40 -120.08 132.88 55.6 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.928 0.364 . . . . 0.0 110.388 -174.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -137.81 166.97 22.69 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.0 t -150.51 133.76 16.26 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 6.0 p -108.89 146.98 32.87 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 123.542 0.526 . . . . 0.0 110.378 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 11.3 t -129.66 149.7 51.3 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -116.36 113.28 22.7 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 68.4 tp -91.85 146.1 24.02 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.303 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -123.31 108.17 12.46 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.04 117.01 32.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 376' ' ' SER . 38.7 ttpt -105.79 119.98 40.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.581 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.523 ' HG2' ' HD2' ' A' ' 377' ' ' LYS . 26.4 mt-10 . . . . . 0 C--N 1.328 -0.338 0 O-C-N 123.695 0.622 . . . . 0.0 110.872 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.76 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.34 -34.25 67.39 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.961 2.441 . . . . 0.0 112.499 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 82.84 -88.59 1.48 Allowed Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 38.4 t -157.7 82.52 0.88 Allowed 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.07 -63.79 1.26 Allowed 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 56.52 4.9 0.17 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.398 1.479 . . . . 0.0 113.586 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.476 HG21 HG21 ' A' ' 342' ' ' VAL . 12.3 p -60.34 -35.16 60.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 123.761 0.825 . . . . 0.0 111.549 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -47.18 -51.89 17.18 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.983 1.313 . . . . 0.0 110.245 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 9.8 pt-20 -85.36 -48.49 8.99 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.76 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.74 -50.73 78.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 C-N-CA 122.798 0.439 . . . . 0.0 112.063 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.4 HD13 ' HB ' ' A' ' 336' ' ' ILE . 47.3 tp -74.02 -20.97 60.15 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 -175.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -77.68 -42.99 32.65 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.22 0.533 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 13.7 pt20 -88.35 -20.96 24.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.139 -175.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -70.66 146.45 93.65 Favored Pre-proline 0 C--N 1.31 -1.129 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.46 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.78 155.1 61.61 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.017 1.812 . . . . 0.0 110.625 175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.48 -22.05 20.35 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.255 3.304 . . . . 0.0 113.989 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 6.4 m -72.71 -21.62 61.01 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.202 0.525 . . . . 0.0 111.527 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.519 ' HB3' HD11 ' A' ' 336' ' ' ILE . 7.7 mm-40 -88.82 -20.89 24.1 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.928 -177.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -51.44 -53.47 36.64 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -173.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -56.07 -33.01 64.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -80.66 -59.82 2.54 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.773 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' A' ' 332' ' ' GLU . 79.8 mt -55.58 -49.63 72.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.124 -174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 345' ' ' LEU . . . -58.97 -57.65 12.15 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.426 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -67.8 -26.63 66.18 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -66.33 -40.37 89.86 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -94.03 -7.95 41.24 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 98.71 16.42 31.34 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.635 -1.269 . . . . 0.0 112.958 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.476 HG21 HG21 ' A' ' 321' ' ' VAL . 10.5 t -94.05 97.27 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 5.2 m -72.35 -39.4 68.14 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.941 -172.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.582 ' OD1' ' HA3' ' A' ' 347' ' ' GLY . 13.7 p-10 -101.54 88.89 3.55 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.537 1.161 . . . . 0.0 110.725 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 346' ' ' ARG . 4.5 pp -71.36 -35.09 71.0 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.462 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ARG . . . . . 0.482 ' N ' HD12 ' A' ' 345' ' ' LEU . 22.5 ttm180 -77.14 -16.84 58.99 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.582 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -64.15 -21.27 65.86 Favored Glycine 0 N--CA 1.42 -2.397 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.565 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' MET . . . . . 0.504 ' O ' HD23 ' A' ' 352' ' ' LEU . 40.6 ttm -60.09 -45.22 93.66 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.55 -36.48 73.68 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.419 ' HE2' ' HA2' ' A' ' 347' ' ' GLY . 36.2 ttpt -57.12 -56.92 15.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.265 1.026 . . . . 0.0 110.704 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -56.6 -33.02 65.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.471 0.708 . . . . 0.0 112.456 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 348' ' ' MET . 4.5 mm? -81.64 -32.41 31.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.28 0.562 . . . . 0.0 111.083 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -66.49 -39.81 88.93 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.0 0.24 39.22 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.518 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 26.2 mmt -75.7 -57.28 3.98 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.93 0.365 . . . . 0.0 110.28 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -170.54 35.24 0.02 OUTLIER 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -66.46 -43.26 85.99 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.941 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -154.87 170.4 21.75 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -117.81 -83.97 0.64 Allowed 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 118.21 0.459 . . . . 0.0 110.087 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 53.34 -161.27 0.12 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.123 0.89 . . . . 0.0 110.063 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt 67.43 -74.16 0.07 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.016 0.927 . . . . 0.0 112.945 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.478 ' HA ' ' OE1' ' A' ' 441' ' ' GLU . 45.0 p 171.4 91.1 0.0 OUTLIER 'General case' 0 C--O 1.248 0.986 0 C-N-CA 126.15 1.78 . . . . 0.0 106.928 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 75.2 p -120.79 -57.19 1.9 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.973 0.416 . . . . 0.0 110.072 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.569 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -83.2 -24.34 32.46 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.56 ' CD2' ' HB3' ' A' ' 441' ' ' GLU . 7.2 m-85 -94.23 132.94 38.27 Favored 'General case' 0 N--CA 1.406 -2.659 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.557 175.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -98.01 -17.09 19.35 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -161.54 119.44 2.31 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -99.33 159.58 14.9 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 79.6 mt -61.7 133.61 55.78 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 123.363 0.415 . . . . 0.0 111.367 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.41 137.67 68.77 Favored Pre-proline 0 C--O 1.215 -0.743 0 O-C-N 124.584 1.178 . . . . 0.0 108.341 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.93 -27.24 52.95 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.71 2.273 . . . . 0.0 113.424 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -134.65 138.97 44.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.412 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 36.0 m-85 -136.93 143.88 43.15 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -128.94 142.12 51.04 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.46 155.82 20.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 16.2 m -88.06 151.89 22.42 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -72.76 116.49 13.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.282 0.563 . . . . 0.0 110.096 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.29 43.76 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -116.9 156.12 27.91 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.329 -0.936 . . . . 0.0 109.637 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -92.49 141.51 28.43 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.694 0.798 . . . . 0.0 112.121 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.58 HG22 ' SG ' ' A' ' 426' ' ' CYS . 15.6 tt -139.05 146.93 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -123.87 128.95 50.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.218 1.009 . . . . 0.0 112.084 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 420' ' ' THR . 17.8 mt -99.82 125.89 45.82 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.19 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 31.9 m -116.66 130.08 56.53 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.71 160.15 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 418' ' ' LYS . 64.3 mt-10 -129.89 138.57 51.0 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 88.8 mt -101.6 139.0 37.85 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.114 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -84.6 -25.88 28.31 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -106.48 122.06 45.53 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.307 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -80.95 -7.58 59.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.756 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -91.37 11.57 23.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -129.79 158.63 38.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -130.14 164.75 23.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 29.1 m -106.73 134.84 47.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.492 0.663 . . . . 0.0 111.491 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -103.5 129.17 50.62 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.678 ' HB3' HD12 ' A' ' 403' ' ' ILE . 50.1 m95 -103.68 130.03 51.09 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 434' ' ' TYR . 8.2 mp -116.76 139.53 50.47 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.647 ' HG2' HG12 ' A' ' 403' ' ' ILE . 32.8 mmtp -90.81 107.4 19.16 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 11.1 p30 48.66 12.59 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.9 4.07 15.08 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.657 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -89.38 -96.38 0.1 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 122.57 0.348 . . . . 0.0 110.353 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 175.05 139.43 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.678 HD12 ' HB3' ' A' ' 396' ' ' TRP . 47.4 mt -94.48 114.85 31.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 172.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -96.6 139.85 32.08 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 87.8 mtp -71.82 89.8 1.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.746 0.308 . . . . 0.0 110.541 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 50.9 m -79.32 98.39 6.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.81 -119.01 16.4 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.059 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 32.8 t -111.27 16.98 20.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -76.24 -47.94 22.09 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -106.82 108.68 20.31 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.19 113.2 36.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -87.08 107.21 18.34 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.912 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -105.55 107.88 19.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 50.0 m -104.97 110.56 22.99 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.31 79.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.84 -110.9 3.76 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.95 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -83.47 -27.68 29.3 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.759 0.314 . . . . 0.0 110.414 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.43 ' HB3' ' HG2' ' A' ' 386' ' ' GLU . 10.9 ptmm? -95.32 116.69 29.11 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 122.116 0.96 . . . . 0.0 111.394 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -108.4 139.15 43.54 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.361 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 61.6 m -136.15 130.13 32.8 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-O 121.256 0.551 . . . . 0.0 111.524 -173.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 39.8 tp -103.8 115.85 31.23 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 38.7 m -102.04 115.08 29.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 50.4 mt -100.98 119.95 49.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 2.9 m -90.53 131.96 35.96 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.222 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 58.12 67.32 0.97 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.015 0.926 . . . . 0.0 111.93 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' CYS . . . . . 0.58 ' SG ' HG22 ' A' ' 381' ' ' ILE . 64.5 m -68.48 115.17 7.58 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' SER . . . . . 0.411 ' O ' HG21 ' A' ' 449' ' ' VAL . 79.6 p -101.44 -176.63 3.2 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.05 -22.25 63.09 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.28 0.562 . . . . 0.0 109.837 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.94 -8.54 58.26 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.376 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -99.26 -3.45 34.14 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.189 -0.319 . . . . 0.0 110.399 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.79 95.54 2.92 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -152.15 166.13 32.64 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.25 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.99 129.43 34.8 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 397' ' ' LEU . 20.3 m-85 -104.67 145.33 30.48 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.457 ' HG3' ' HB3' ' A' ' 444' ' ' SER . 23.7 mp0 -129.14 127.34 41.21 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 7.6 p -96.33 109.15 21.72 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.1 t -105.29 126.12 60.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 121.231 0.539 . . . . 0.0 111.377 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 60.0 t -129.15 161.39 38.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -66.79 113.6 5.77 Favored Glycine 0 C--N 1.315 -0.599 0 C-N-CA 119.082 -1.532 . . . . 0.0 111.104 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 98.6 -26.33 24.37 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.569 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 3.1 mm-40 -126.48 136.08 52.16 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 18.6 ptpt -147.9 160.67 42.54 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 16.9 t -155.82 134.37 11.73 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.457 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 5.5 p -106.47 126.38 52.18 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.336 0.588 . . . . 0.0 110.7 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.7 t -112.57 146.37 38.68 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.98 114.39 27.67 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.293 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.35 121.87 33.46 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.667 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -104.87 118.91 37.72 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.166 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 427' ' ' SER . 57.3 t -90.14 120.55 39.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 376' ' ' SER . 0.1 OUTLIER -113.7 119.98 39.27 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--N 1.308 -1.229 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.366 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.487 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.72 163.82 34.97 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.374 2.049 . . . . 0.0 112.708 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -171.57 141.06 6.17 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 31.7 m -147.01 -25.68 0.4 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.139 0.495 . . . . 0.0 110.559 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 321' ' ' VAL . 28.9 mm-40 -107.43 178.35 4.57 Favored 'General case' 0 CA--C 1.489 -1.377 0 C-N-CA 123.133 0.573 . . . . 0.0 110.757 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 75.81 -26.78 0.19 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.96 1.304 . . . . 0.0 112.051 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.561 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 4.3 p -47.44 -37.15 4.84 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 C-N-CA 125.102 1.361 . . . . 0.0 112.365 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -57.59 -47.17 82.86 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.639 0.776 . . . . 0.0 110.762 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.9 -35.12 20.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.826 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.03 -49.54 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.795 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.32 -34.19 75.67 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.488 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -58.12 -40.37 81.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.281 0.562 . . . . 0.0 110.701 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -93.07 -4.13 52.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.331 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -89.02 153.84 49.38 Favored Pre-proline 0 C--N 1.301 -1.525 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.711 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' PRO . . . . . 0.412 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 23.6 Cg_endo -61.19 143.99 98.75 Favored 'Trans proline' 0 CA--C 1.55 1.321 0 C-N-CA 122.946 2.431 . . . . 0.0 112.763 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.481 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 10.7 Cg_endo -54.89 -34.57 86.31 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 124.216 3.277 . . . . 0.0 115.572 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 44.0 m -77.82 -5.56 51.25 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.412 ' CG ' ' HG2' ' A' ' 329' ' ' PRO . 15.0 mm-40 -99.67 -13.33 19.39 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.818 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.481 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 18.4 m-30 -47.86 -47.52 31.55 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -174.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.441 ' HA ' HD22 ' A' ' 345' ' ' LEU . 37.4 tt0 -68.18 -35.64 78.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.8 0.333 . . . . 0.0 111.295 -174.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -71.79 -42.88 66.58 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.818 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 59.1 mt -64.78 -38.66 83.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.464 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.09 51.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.033 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -68.9 -24.63 64.33 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -62.36 -39.83 94.43 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.007 0.523 . . . . 0.0 109.958 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' TYR . . . . . 0.561 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 82.5 m-85 -95.59 -4.7 44.1 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.194 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 83.38 26.52 43.11 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.498 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.32 116.96 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 3.0 p -94.52 -5.97 44.82 Favored 'General case' 0 C--N 1.268 -2.94 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.808 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.47 44.42 0.8 Allowed 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.46 0.704 . . . . 0.0 111.314 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 334' ' ' GLU . 24.4 tp -75.95 -64.82 1.0 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.779 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 350' ' ' LYS . 29.5 mmt180 -66.2 -31.41 72.23 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.492 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -70.67 -39.79 66.62 Favored Glycine 0 N--CA 1.442 -0.926 0 O-C-N 123.547 0.529 . . . . 0.0 112.075 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 26.6 ttt -71.19 -48.5 51.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.89 -31.27 72.11 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.705 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 346' ' ' ARG . 42.7 tttm -52.72 -44.89 66.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.949 0.88 . . . . 0.0 109.132 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.526 ' O ' ' HB3' ' A' ' 355' ' ' MET . 53.0 mtm180 -72.06 -36.93 69.72 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.824 -1.535 . . . . 0.0 112.472 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.58 -27.36 31.59 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.647 0.737 . . . . 0.0 112.703 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -86.79 -54.36 4.41 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.447 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -97.15 65.66 0.92 Allowed Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.526 ' HB3' ' O ' ' A' ' 351' ' ' ARG . 23.0 ptt? -114.58 7.05 15.98 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.138 -0.531 . . . . 0.0 110.04 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -159.26 -39.4 0.06 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -78.37 85.0 4.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 12.5 t70 179.53 125.87 0.07 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 169.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -95.13 17.71 13.6 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.421 0.629 . . . . 0.0 111.004 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.416 ' HE3' ' HG2' ' A' ' 441' ' ' GLU 0.302 42.4 mtmt 48.84 -104.64 0.13 Allowed 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 174.33 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.617 ' HG3' ' H ' ' A' ' 362' ' ' SER . 38.2 pttt -177.28 -79.17 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 O-C-N 123.19 0.306 . . . . 0.0 111.046 -175.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.617 ' H ' ' HG3' ' A' ' 361' ' ' LYS . 70.3 m -178.91 76.96 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 128.168 2.587 . . . . 0.0 105.66 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.4 t -130.13 -31.76 1.87 Allowed 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.421 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.671 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -87.65 -27.54 22.4 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -87.13 114.37 23.69 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.66 170.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -89.44 -17.24 29.11 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.061 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 367' ' ' LYS . 0.0 OUTLIER -164.61 120.53 1.49 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 176.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -97.04 173.3 7.34 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.834 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.465 HD13 HG22 ' A' ' 445' ' ' THR . 91.2 mt -71.07 142.16 50.85 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.876 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -62.04 129.93 92.34 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -43.39 -33.32 4.02 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.86 3.04 . . . . 0.0 114.819 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -146.56 120.66 9.46 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.068 -0.395 . . . . 0.0 111.239 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.565 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 59.0 m-85 -101.35 156.08 17.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -127.91 138.35 52.63 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.972 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.93 152.69 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 12.0 m -86.62 146.48 26.31 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 1.4 tmmm? -63.1 125.75 25.07 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.277 0.56 . . . . 0.0 110.006 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.475 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 98.89 -3.56 58.8 Favored Glycine 0 C--N 1.304 -1.206 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.623 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -95.63 169.37 10.07 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 120.889 0.376 . . . . 0.0 111.935 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -108.1 126.75 53.12 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.524 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.9 tt -128.6 158.34 40.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 41.9 mtt-85 -125.89 142.7 51.39 Favored 'General case' 0 CA--C 1.491 -1.318 0 CA-C-O 121.663 0.744 . . . . 0.0 110.589 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.31 107.47 18.48 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.8 m -105.31 126.28 51.92 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.272 -174.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 7.6 m -127.91 157.17 40.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 123.855 0.862 . . . . 0.0 109.374 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -120.36 136.61 54.65 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 392' ' ' ALA . 92.0 mt -107.88 141.33 39.65 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.19 71.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.142 0.496 . . . . 0.0 110.355 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -117.98 138.04 52.45 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -63.53 -32.57 74.07 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 123.293 0.637 . . . . 0.0 112.693 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.82 25.78 11.4 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.395 0.617 . . . . 0.0 111.879 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' ALA . . . . . 0.533 ' O ' HD13 ' A' ' 387' ' ' LEU . . . -91.69 106.53 18.55 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 104.276 -2.491 . . . . 0.0 104.276 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -78.67 143.87 35.88 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.638 -172.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 4.1 m -105.98 148.3 10.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -111.22 130.07 55.76 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.46 ' HB3' HD12 ' A' ' 403' ' ' ILE . 8.2 m-90 -101.21 121.77 42.45 Favored 'General case' 0 C--N 1.26 -3.292 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.911 -173.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 402' ' ' GLU . 6.2 mp -129.19 125.53 37.19 Favored 'General case' 0 CA--C 1.482 -1.671 0 CA-C-N 117.635 0.198 . . . . 0.0 111.4 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.436 ' HB3' HG12 ' A' ' 403' ' ' ILE . 28.8 pttt -103.94 128.14 51.46 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 47.61 22.76 0.34 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.415 1.486 . . . . 0.0 114.24 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.16 8.05 56.86 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.379 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -92.32 -92.63 0.15 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 397' ' ' LEU . 52.7 tt0 172.69 138.53 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 396' ' ' TRP . 55.4 mt -92.0 102.29 13.41 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -99.23 126.02 44.95 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.854 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.454 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 18.3 ptt? -63.95 95.17 0.11 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 122.119 0.962 . . . . 0.0 112.257 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' SER . . . . . 0.42 ' H ' ' HD2' ' A' ' 410' ' ' TYR . 14.8 m -83.67 93.32 7.88 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.946 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 64.22 -128.26 36.22 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.568 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 8.9 p -97.69 5.53 49.19 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 120.921 0.391 . . . . 0.0 111.599 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -71.79 -32.31 67.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.74 0.305 . . . . 0.0 111.636 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.454 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 69.5 m-85 -123.44 112.5 17.6 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 39.6 mm -108.87 116.58 52.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.8 m-85 -87.03 105.54 17.23 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -106.49 108.56 20.13 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.478 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 27.8 t -90.54 105.38 17.78 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.0 mm -104.04 87.46 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.94 -98.6 0.64 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -120.11 -5.01 10.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.358 0.599 . . . . 0.0 109.443 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -95.23 99.69 11.61 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -92.7 132.14 37.17 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.227 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 22.5 m -125.28 129.81 50.76 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.531 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.532 HD13 ' CE2' ' A' ' 412' ' ' PHE . 22.2 tp -100.82 111.51 23.75 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 58.8 m -94.34 108.78 20.66 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.601 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 56.1 mt -96.92 116.93 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 15.1 m -90.84 136.47 33.05 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.054 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 55.72 68.63 0.84 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.0 1.72 . . . . 0.0 111.117 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' CYS . . . . . 0.524 ' SG ' HG22 ' A' ' 381' ' ' ILE . 61.7 m -68.87 113.2 6.08 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 11.0 m -103.65 -170.75 1.83 Allowed 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 89.9 mt -71.12 -23.88 62.18 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.269 0.557 . . . . 0.0 110.513 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -76.08 -15.04 60.18 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.235 0.541 . . . . 0.0 110.1 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -97.6 7.84 45.73 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.764 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.63 100.23 11.31 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -157.02 172.33 18.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.201 0.524 . . . . 0.0 111.609 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -90.51 118.08 29.7 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -107.39 131.81 53.85 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.839 -0.538 . . . . 0.0 110.252 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.496 ' HG3' ' OG ' ' A' ' 444' ' ' SER . 2.0 mp0 -122.95 146.71 47.36 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 123.345 0.658 . . . . 0.0 110.388 -175.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 78.8 m -123.28 113.26 18.64 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.14 133.94 53.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.951 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 49.2 t -125.56 161.85 29.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -57.56 112.73 3.94 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 118.955 -1.593 . . . . 0.0 111.577 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 85.36 -35.28 3.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.553 0.597 . . . . 0.0 112.714 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.671 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 7.9 mm-40 -99.53 126.24 45.44 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 123.601 0.761 . . . . 0.0 110.938 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -142.22 163.67 32.22 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.754 0.312 . . . . 0.0 111.401 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 25.6 p -160.34 150.04 17.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.496 ' OG ' ' HG3' ' A' ' 435' ' ' GLN . 3.4 m -137.08 146.72 45.49 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.565 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 9.0 t -129.94 132.2 46.25 Favored 'General case' 0 N--CA 1.399 -2.978 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.677 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.81 110.58 21.49 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 60.5 tp -84.72 119.59 25.44 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -95.79 108.21 20.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 64.0 t -94.79 109.13 21.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -100.17 117.49 34.52 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.216 0.531 . . . . 0.0 111.082 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.288 -2.071 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.539 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.645 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.517 ' CB ' ' HA ' ' A' ' 320' ' ' ASP . 34.1 Cg_exo -67.64 -175.81 0.8 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.911 2.407 . . . . 0.0 112.467 176.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -125.02 69.82 0.48 Allowed Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.016 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 17.4 m 77.23 -12.31 1.08 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.234 1.414 . . . . 0.0 113.719 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.8 -48.16 5.86 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.517 ' HA ' ' CB ' ' A' ' 316' ' ' PRO . 2.0 m-20 65.92 11.93 8.04 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 171.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.73 -32.6 31.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 C-N-CA 123.156 0.582 . . . . 0.0 112.444 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -59.32 -46.18 89.3 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 124.698 1.199 . . . . 0.0 110.873 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.22 -32.37 22.66 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.862 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.6 mt -63.23 -45.57 98.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.637 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 333' ' ' TYR . 39.8 mt -61.74 -43.42 98.88 Favored 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.681 0.613 . . . . 0.0 110.466 177.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -55.73 -42.03 74.74 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.248 0.619 . . . . 0.0 111.777 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -81.78 -10.37 59.36 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.59 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -100.6 146.81 32.68 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -63.37 138.21 64.67 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 121.589 1.526 . . . . 0.0 110.12 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.51 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 4.9 Cg_endo -48.12 -28.98 11.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.046 3.164 . . . . 0.0 114.85 -176.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 44.2 p -64.15 -25.32 68.03 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.362 0.601 . . . . 0.0 112.323 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 336' ' ' ILE . 7.2 mm-40 -86.44 -14.51 43.05 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.467 -175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 3.8 m-85 -49.11 -44.62 42.47 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -57.97 -31.0 66.47 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.807 0.692 . . . . 0.0 110.607 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 339' ' ' GLN . 42.3 ttp180 -86.3 -51.68 6.1 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.338 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 332' ' ' GLU . 44.5 mt -60.38 -46.64 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.442 0.697 . . . . 0.0 111.692 -173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 342' ' ' VAL . . . -51.66 -52.38 48.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.912 0.885 . . . . 0.0 111.843 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -65.42 -21.72 66.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 335' ' ' ARG . 57.4 mt-30 -71.5 -34.9 70.54 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.519 0.676 . . . . 0.0 109.376 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -97.69 -12.78 21.98 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.154 -174.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 101.1 18.04 20.89 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.706 -1.235 . . . . 0.0 112.357 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.423 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 17.5 t -92.75 84.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.4 m -63.57 -42.29 98.34 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.572 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -99.87 76.18 1.94 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.602 1.192 . . . . 0.0 111.412 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.633 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.0 OUTLIER -75.22 -16.77 60.45 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.372 175.372 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ARG . . . . . 0.496 ' H ' ' HD2' ' A' ' 346' ' ' ARG . 1.8 mpt_? -69.31 -42.3 75.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 350' ' ' LYS . . . -67.9 -34.91 83.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.86 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 16.0 tpt -59.99 -43.38 95.2 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 96.4 mt -59.62 -43.96 93.62 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.066 0.46 . . . . 0.0 109.902 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.494 ' HG2' ' NH2' ' A' ' 356' ' ' ARG . 29.9 ttmt -56.73 -48.62 77.37 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.762 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 355' ' ' MET . 79.4 mtp180 -74.52 -21.21 59.66 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.068 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -82.04 -38.51 24.86 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -78.61 -47.98 16.04 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.987 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -104.68 83.27 0.38 Allowed Glycine 1 N--CA 1.396 -4.02 0 N-CA-C 104.464 -3.454 . . . . 0.0 104.464 172.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 351' ' ' ARG . 65.8 mtt -46.82 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.482 -1.639 0 O-C-N 125.888 1.581 . . . . 0.0 113.768 -172.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.494 ' NH2' ' HG2' ' A' ' 350' ' ' LYS . 76.1 mtm180 -123.19 78.63 1.59 Allowed 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 112.953 -1.931 . . . . 0.0 112.848 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -126.07 -165.58 1.45 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 172.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 47.38 34.85 3.51 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.797 1.239 . . . . 0.0 113.744 173.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.16 22.74 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.106 0.955 . . . . 0.0 112.013 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.21 22.94 1.95 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.364 172.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -73.85 -50.96 17.9 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.011 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 48.5 p 176.49 106.13 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.574 1.15 . . . . 0.0 109.24 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 7.4 p -139.49 -49.03 0.48 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.894 0.878 . . . . 0.0 110.023 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -89.77 -31.53 17.37 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 122.033 0.92 . . . . 0.0 108.91 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -87.93 140.81 29.12 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.336 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -96.92 -23.55 16.27 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -159.31 134.54 8.3 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' A' ' 443' ' ' CYS . 94.7 mttt -111.26 173.08 6.51 Favored 'General case' 0 C--N 1.283 -2.299 0 O-C-N 123.821 0.7 . . . . 0.0 111.56 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.56 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 87.6 mt -68.89 141.47 55.04 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.886 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -64.84 143.72 98.83 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -44.74 -38.91 13.17 Favored 'Trans proline' 0 C--O 1.257 1.454 0 C-N-CA 123.354 2.702 . . . . 0.0 113.593 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -145.09 158.75 43.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.565 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.418 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 42.6 m-85 -138.54 154.52 48.75 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -138.03 135.97 36.42 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.439 HG21 ' HB ' ' A' ' 381' ' ' ILE . 11.1 p -140.64 155.69 22.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.2 m -92.34 144.89 24.93 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.402 ' HB3' ' NZ ' ' A' ' 377' ' ' LYS . 3.0 ttpm? -57.18 128.75 38.56 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 123.699 0.8 . . . . 0.0 110.622 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.84 8.73 63.27 Favored Glycine 0 C--N 1.317 -0.486 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.367 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -112.06 -179.58 3.73 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 122.453 -0.439 . . . . 0.0 110.472 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -98.35 143.81 28.42 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.439 ' HB ' HG21 ' A' ' 375' ' ' VAL . 7.6 tp -138.15 139.23 42.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 20.6 ptt180 -134.32 122.91 23.32 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.157 0.98 . . . . 0.0 113.302 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.411 ' HB3' ' CD2' ' A' ' 369' ' ' LEU . 2.1 mm? -88.5 129.12 35.53 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.293 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 34.4 m -120.76 122.62 40.77 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -173.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.26 155.32 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.966 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -126.31 140.53 52.45 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.486 HD11 HG13 ' A' ' 394' ' ' VAL . 5.5 mp -101.49 158.94 15.7 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.2 -24.56 57.82 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.449 0.642 . . . . 0.0 109.624 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -108.37 137.44 46.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -80.97 -28.11 35.73 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.908 0.385 . . . . 0.0 111.357 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -99.88 17.29 21.23 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.546 -174.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -116.25 148.55 40.36 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -115.43 174.14 6.16 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.403 0.621 . . . . 0.0 110.609 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.486 HG13 HD11 ' A' ' 387' ' ' LEU . 9.2 m -106.68 164.74 4.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.162 176.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 436' ' ' CYS . 8.1 tptp -109.23 146.14 34.71 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 175.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -115.76 111.32 20.36 Favored 'General case' 0 C--N 1.281 -2.398 0 O-C-N 123.171 0.294 . . . . 0.0 110.549 -171.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.3 mp -122.34 141.91 51.05 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.048 0.452 . . . . 0.0 111.23 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -120.87 122.56 40.52 Favored 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.1 p30 53.82 12.37 0.41 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 126.183 1.793 . . . . 0.0 113.563 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.62 11.29 29.14 Favored Glycine 0 C--O 1.22 -0.75 0 C-N-CA 121.245 -0.502 . . . . 0.0 111.964 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -118.64 120.68 38.15 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.19 125.93 25.51 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 56.5 mt -65.85 132.72 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.625 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -96.97 122.29 39.79 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 27.0 ttt -68.81 93.39 0.54 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.38 0.61 . . . . 0.0 112.543 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 409' ' ' LYS . 42.7 t -82.54 128.27 34.14 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 172.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -34.82 -70.74 0.16 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 6.4 p -101.62 18.54 20.05 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.517 0.675 . . . . 0.0 112.329 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 406' ' ' SER . 17.2 tppt? -104.65 -57.79 1.98 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.31 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -113.31 108.13 16.82 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 57.1 mt -108.67 114.6 47.2 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.715 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.1 m-85 -85.78 107.53 17.67 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.719 0.771 . . . . 0.0 108.924 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.2 113.13 26.37 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 16.6 m -104.45 124.63 49.59 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.2 mp -122.12 76.61 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.199 0 CA-C-O 121.546 0.689 . . . . 0.0 109.428 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.76 -86.04 0.76 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.294 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -109.45 -19.17 13.35 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.341 0.591 . . . . 0.0 109.508 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.546 ' HE2' ' OG1' ' A' ' 420' ' ' THR . 82.6 tttt -86.29 118.93 26.05 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.779 -176.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -104.95 118.52 36.73 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' THR . . . . . 0.546 ' OG1' ' HE2' ' A' ' 418' ' ' LYS . 8.3 m -114.59 124.49 51.99 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.527 HD13 ' CE2' ' A' ' 412' ' ' PHE . 20.4 tp -101.29 103.85 14.85 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 27.8 m -99.76 111.12 23.47 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.108 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 45.2 mt -89.3 121.38 39.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 177.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 18.6 m -106.94 128.71 54.57 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 63.17 67.7 0.66 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.711 -1.131 . . . . 0.0 107.979 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 48.1 t -74.1 123.78 25.07 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 91.4 p -105.25 -176.72 3.16 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 97.0 mt -74.33 -25.68 59.69 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -76.09 -12.17 60.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.227 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -92.16 -21.55 20.34 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.786 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -50.76 119.62 4.03 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.421 1.076 . . . . 0.0 110.601 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -169.77 165.01 9.98 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 123.573 0.546 . . . . 0.0 109.548 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.67 124.42 32.18 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -106.44 141.7 37.31 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -175.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.71 140.76 34.94 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 121.341 0.591 . . . . 0.0 111.735 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 395' ' ' LYS . 63.8 m -105.38 128.77 53.68 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.93 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.2 t -115.74 134.63 58.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.243 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.459 ' CG2' HG12 ' A' ' 394' ' ' VAL . 97.1 t -131.57 160.94 42.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.1 114.0 6.46 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 119.148 -1.501 . . . . 0.0 110.365 175.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.76 -35.11 5.15 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-O 119.39 -0.672 . . . . 0.0 113.348 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -139.53 173.15 11.84 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 122.636 1.208 . . . . 0.0 113.997 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -149.92 166.96 28.02 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.67 -1.604 . . . . 0.0 106.933 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.424 ' HB3' ' HD3' ' A' ' 368' ' ' LYS . 27.5 p -154.4 133.28 12.3 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 172.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 5.0 m -118.04 143.23 46.6 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.301 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 13.5 t -125.59 150.79 47.21 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -110.48 110.72 21.58 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 68.1 tp -90.47 129.7 36.62 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -106.77 107.9 19.14 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.77 119.28 37.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -98.28 126.59 43.83 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--N 1.311 -1.098 0 C-N-CA 123.957 0.903 . . . . 0.0 110.119 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.369 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.05 -45.88 11.64 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.01 2.474 . . . . 0.0 111.571 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -99.94 -49.84 1.44 Allowed Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 68.4 m -80.01 95.59 6.2 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 121.445 0.64 . . . . 0.0 112.203 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.33 6.26 10.68 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.836 0.826 . . . . 0.0 109.606 173.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -86.04 31.06 0.64 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.397 1.079 . . . . 0.0 111.631 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.46 -29.63 47.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.441 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -53.32 -54.51 35.37 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.471 0.708 . . . . 0.0 111.375 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.03 -38.18 53.37 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.297 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 67.9 mt -64.12 -50.64 76.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.252 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.43 -28.79 64.23 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -64.06 -43.73 94.59 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.944 0.402 . . . . 0.0 110.836 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -91.26 -0.56 57.7 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.101 0.477 . . . . 0.0 112.015 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -91.16 152.29 43.9 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.849 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' PRO . . . . . 0.405 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 9.4 Cg_endo -58.15 148.33 78.64 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.704 2.269 . . . . 0.0 112.23 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 26.7 Cg_endo -60.85 -21.96 72.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.496 2.797 . . . . 0.0 114.139 -173.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 5.1 m -85.54 -4.01 59.03 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.873 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 336' ' ' ILE . 48.9 mm-40 -99.49 -14.93 18.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.935 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.454 ' HB3' HD11 ' A' ' 345' ' ' LEU . 15.6 m-30 -44.15 -55.12 5.01 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -173.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -65.65 -38.22 88.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.243 0.545 . . . . 0.0 111.179 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.03 -42.48 84.8 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.659 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 332' ' ' GLU . 74.2 mt -65.04 -44.5 95.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -55.65 -58.51 7.52 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.315 0.646 . . . . 0.0 111.395 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -67.75 -23.34 65.23 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.01 -42.3 80.89 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.777 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -89.4 -15.51 33.08 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.193 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 100.2 34.63 4.75 Favored Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.3 t -112.21 118.24 57.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 43.4 p -97.75 -13.94 21.12 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-O 122.015 0.912 . . . . 0.0 109.21 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -82.39 47.09 1.11 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.754 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 333' ' ' TYR . 36.0 tp -59.75 -53.13 61.55 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.732 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -67.7 -30.61 70.16 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.301 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -68.04 -38.76 88.81 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 28.0 ttt -71.88 -42.52 66.72 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 345' ' ' LEU . 8.6 mp -61.38 -39.01 89.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.152 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -53.72 -43.87 69.4 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.864 0.727 . . . . 0.0 110.057 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 355' ' ' MET . 93.1 mtt180 -64.15 -45.74 87.12 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.39 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 355' ' ' MET . 7.7 mp -71.91 -21.59 61.61 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' LYS . . . . . 0.635 ' HE2' ' O ' ' A' ' 359' ' ' GLU . 0.0 OUTLIER -63.47 -34.71 78.36 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 173.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -84.74 -24.05 47.43 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.344 176.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 352' ' ' LEU . 24.0 mmt -74.06 -32.75 63.43 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.882 0.372 . . . . 0.0 111.431 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -93.9 -83.95 0.32 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' ARG . . . . . 0.488 ' HD2' ' OD2' ' A' ' 358' ' ' ASP . 19.5 ttm180 166.22 -82.77 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.468 1.107 . . . . 0.0 109.821 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.488 ' OD2' ' HD2' ' A' ' 357' ' ' ARG . 3.0 p30 -112.29 2.92 16.77 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.263 -173.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.635 ' O ' ' HE2' ' A' ' 353' ' ' LYS . 1.2 tm-20 -58.66 103.13 0.14 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -128.59 170.34 13.34 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-O 122.975 1.369 . . . . 0.0 112.962 -175.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -146.23 155.87 42.99 Favored 'General case' 0 C--N 1.267 -3.021 1 N-CA-C 99.456 -4.275 . . . . 0.0 99.456 169.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.611 ' OG ' ' HB2' ' A' ' 365' ' ' PHE . 10.3 t -70.56 112.23 6.66 Favored 'General case' 0 N--CA 1.384 -3.757 0 CA-C-O 122.137 0.97 . . . . 0.0 108.668 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 7.2 t -129.52 -21.41 3.15 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.092 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.747 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -85.26 -13.33 50.12 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.611 ' HB2' ' OG ' ' A' ' 362' ' ' SER . 0.5 OUTLIER -90.16 117.84 29.23 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 170.027 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -77.17 -29.64 54.55 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.406 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -151.42 115.96 5.12 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.434 ' HD2' ' HB3' ' A' ' 362' ' ' SER . 49.1 mtpt -98.51 160.28 14.39 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 76.5 mt -70.17 144.85 51.85 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.49 151.14 96.61 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -37.96 -45.48 1.96 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 124.397 3.398 . . . . 0.0 114.022 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -148.38 153.74 38.99 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.665 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 447' ' ' LEU . 74.9 m-85 -134.19 146.03 49.77 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.01 147.07 48.1 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.37 155.96 18.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' A' ' 379' ' ' HIS . 15.0 m -87.16 151.65 23.01 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.527 ' CB ' ' HA ' ' A' ' 451' ' ' GLU . 0.0 OUTLIER -70.13 115.33 9.21 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 120.85 0.357 . . . . 0.0 110.105 -178.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 100.49 -6.06 57.39 Favored Glycine 0 CA--C 1.496 -1.11 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 376' ' ' SER . 39.7 t-80 -96.11 152.9 18.11 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -96.18 143.46 27.27 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.944 0.402 . . . . 0.0 111.772 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.65 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.9 tp -121.97 129.69 75.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -109.98 112.53 24.61 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.32 0.581 . . . . 0.0 110.304 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 79.8 mt -93.96 139.11 31.32 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 64.3 m -134.55 113.38 11.72 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.686 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.86 145.39 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 22.2 mt-10 -121.54 137.69 54.62 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.497 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 82.5 mt -95.57 144.81 25.72 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -83.84 -21.56 32.01 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.0 121.23 44.04 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.915 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -75.36 -27.12 59.03 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.265 0.555 . . . . 0.0 110.689 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -90.06 18.91 5.35 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.866 0.866 . . . . 0.0 111.304 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -113.55 142.43 45.96 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -110.5 165.99 11.36 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.82 144.31 38.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.256 0.551 . . . . 0.0 110.745 -176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -108.37 143.75 36.87 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.545 ' HB3' HD12 ' A' ' 403' ' ' ILE . 10.2 m-90 -113.21 119.08 36.53 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.596 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.9 mp -126.79 138.83 53.41 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -120.36 121.37 38.44 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 22.4 p30 51.22 12.72 0.14 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 126.393 1.877 . . . . 0.0 114.551 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.93 8.24 22.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.197 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -120.07 138.74 53.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.03 126.65 28.05 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 120.753 0.311 . . . . 0.0 110.57 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 396' ' ' TRP . 34.5 mt -72.58 102.07 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -76.26 137.75 40.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 51.0 ttp -73.27 100.01 3.02 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' SER . . . . . 0.432 ' H ' ' HD1' ' A' ' 410' ' ' TYR . 43.8 t -101.75 119.19 38.39 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.257 -174.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 49.64 -132.21 26.75 Favored Glycine 0 C--N 1.338 0.641 0 O-C-N 124.748 1.28 . . . . 0.0 113.959 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 24.8 t -104.79 11.95 33.24 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' LYS . . . . . 0.477 ' HD3' ' OD2' ' A' ' 430' ' ' ASP . 33.1 ttmt -75.74 -61.12 2.03 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.952 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.5 ' O ' ' HG3' ' A' ' 405' ' ' MET . 82.0 m-85 -94.78 117.27 29.87 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.2 mt -121.43 113.53 39.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.524 ' CE1' HD13 ' A' ' 421' ' ' LEU . 24.3 m-85 -86.99 112.3 21.69 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 420' ' ' THR . 41.7 mt-10 -107.7 107.04 17.65 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 32.0 t -99.22 114.68 27.61 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 123.592 0.757 . . . . 0.0 108.991 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.614 ' HB ' ' CG ' ' A' ' 418' ' ' LYS . 41.9 mm -115.26 79.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 67.25 -83.46 0.13 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.376 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -100.9 -31.95 10.89 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.575 0.35 . . . . 0.0 110.767 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.614 ' CG ' ' HB ' ' A' ' 415' ' ' ILE . 1.5 ptpp? -84.49 140.4 31.5 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.715 0.769 . . . . 0.0 111.744 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -124.18 100.77 6.87 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 413' ' ' GLU . 31.4 m -98.73 134.42 41.66 Favored 'General case' 0 C--N 1.259 -3.345 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.427 -174.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.524 HD13 ' CE1' ' A' ' 412' ' ' PHE . 33.2 tp -117.0 106.81 13.81 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.359 0.6 . . . . 0.0 109.426 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 36.3 m -97.33 109.67 22.38 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.0 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.6 mt -97.72 110.01 24.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.1 m -95.82 141.47 29.24 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 61.89 52.56 3.37 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.904 0.752 . . . . 0.0 110.479 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' CYS . . . . . 0.65 ' SG ' HG22 ' A' ' 381' ' ' ILE . 13.5 m -65.19 113.19 3.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 12.0 m -108.4 -167.69 1.26 Allowed 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.14 -20.77 60.85 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 121.703 -0.623 . . . . 0.0 111.006 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -78.83 -4.51 49.91 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.405 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' ASP . . . . . 0.477 ' OD2' ' HD3' ' A' ' 409' ' ' LYS . 18.1 m-20 -110.7 7.91 22.4 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.959 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.94 96.67 9.44 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -151.27 162.63 40.56 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.932 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.75 122.66 30.15 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' TYR . . . . . 0.524 ' HD2' HD11 ' A' ' 403' ' ' ILE . 93.5 m-85 -106.55 140.58 39.21 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 120.827 0.346 . . . . 0.0 110.131 -175.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.33 137.78 30.78 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.227 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 65.5 m -103.95 128.57 51.48 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.95 130.67 73.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.366 0.603 . . . . 0.0 111.556 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 63.7 t -124.7 161.58 27.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 174.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -61.26 112.97 5.2 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 118.513 -1.804 . . . . 0.0 111.534 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 94.38 -35.3 4.26 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.632 -0.284 . . . . 0.0 112.547 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.747 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 9.1 mm-40 -105.96 138.98 41.21 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 122.467 -0.431 . . . . 0.0 110.681 -173.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.79 163.92 35.94 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 171.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 13.8 p -151.28 133.49 15.27 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 12.1 p -119.62 132.17 55.64 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 123.654 0.596 . . . . 0.0 110.707 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.431 ' OG1' ' HD2' ' A' ' 373' ' ' TYR . 14.6 t -124.07 147.9 47.52 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -106.04 111.02 23.47 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 373' ' ' TYR . 3.3 tm? -93.14 125.69 37.86 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -113.25 124.97 53.75 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.817 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.6 t -97.53 122.25 48.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -106.16 117.06 33.04 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 377' ' ' LYS . 2.6 mp0 . . . . . 0 C--O 1.256 1.417 0 C-N-CA 125.234 1.413 . . . . 0.0 113.929 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.473 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.37 113.19 2.8 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.405 2.07 . . . . 0.0 111.808 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 131.9 -140.33 11.71 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.521 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 15.6 t -129.26 31.1 4.9 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 62.92 76.42 0.37 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -108.43 -8.83 15.5 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.689 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.55 -37.67 39.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.717 -1.128 . . . . 0.0 113.36 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -56.3 -46.45 79.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -85.05 -29.6 24.8 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.288 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.01 -48.29 86.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.324 0.39 . . . . 0.0 110.392 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 62.9 mt -59.42 -41.23 89.07 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.119 0.485 . . . . 0.0 110.236 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -58.62 -30.01 66.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.237 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -112.9 7.14 18.19 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.26 0.552 . . . . 0.0 111.187 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -100.67 150.82 37.32 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.695 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' PRO . . . . . 0.457 ' HG2' ' HG2' ' A' ' 332' ' ' GLU . 19.2 Cg_endo -66.43 142.84 67.26 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.433 2.089 . . . . 0.0 111.389 175.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.476 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 18.5 Cg_endo -58.52 -21.38 54.17 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 123.813 3.008 . . . . 0.0 114.205 -176.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 36.1 p -74.34 -17.16 60.87 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.047 0.451 . . . . 0.0 112.16 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.457 ' HG2' ' HG2' ' A' ' 329' ' ' PRO . 19.9 mm-40 -103.97 -2.88 25.43 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.494 -175.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 20.8 m-30 -56.89 -40.23 75.85 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -174.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.27 -30.16 70.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.989 0.423 . . . . 0.0 111.121 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -72.56 -57.72 3.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.0 -40.32 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.845 1.258 . . . . 0.0 111.792 -173.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -58.54 -60.1 4.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.639 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -67.8 -22.97 65.15 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.028 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -64.44 -34.2 77.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.384 0.674 . . . . 0.0 109.515 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.25 13.23 23.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 76.48 29.61 57.8 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.806 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.75 118.73 56.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 17.6 p -94.79 -14.19 24.91 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-O 122.115 0.96 . . . . 0.0 109.928 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -92.52 49.16 1.45 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.478 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.7 pt? -73.04 -26.2 61.21 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.499 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -70.75 -24.21 62.57 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -64.76 -31.48 81.06 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.764 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 24.2 ttt -66.83 -45.51 78.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.81 -35.44 80.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.1 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -57.84 -32.35 67.54 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.935 0.894 . . . . 0.0 111.133 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 355' ' ' MET . 36.5 mmt180 -61.72 -42.15 98.57 Favored 'General case' 0 C--O 1.21 -0.987 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.93 -27.63 33.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.573 0.701 . . . . 0.0 110.217 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -63.8 -37.87 89.0 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.961 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -95.97 1.14 62.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.371 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 351' ' ' ARG . 43.8 tpp -88.0 60.82 6.03 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 122.629 -0.336 . . . . 0.0 110.764 -175.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 52.4 -29.11 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 118.697 2.851 . . . . 0.0 118.697 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -73.64 -35.66 65.32 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 118.509 0.595 . . . . 0.0 111.338 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.65 120.52 31.78 Favored 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.348 -171.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.37 112.58 24.35 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.403 ' HE2' ' CD ' ' A' ' 441' ' ' GLU . 3.2 mppt? -92.3 -79.8 0.38 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -178.74 -51.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 O-C-N 123.615 0.572 . . . . 0.0 110.714 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 5.8 p -176.6 71.97 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.133 0.973 . . . . 0.0 110.059 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 38.2 p -103.32 -54.74 2.54 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.51 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.78 -13.02 61.22 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.063 0.935 . . . . 0.0 109.438 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.434 ' CG ' ' HG2' ' A' ' 368' ' ' LYS . 5.4 m-85 -107.09 120.48 42.21 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.38 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -79.77 -27.11 40.47 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.76 0.79 . . . . 0.0 109.169 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -157.01 118.23 3.7 Favored 'General case' 0 N--CA 1.403 -2.815 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.434 ' HG2' ' CG ' ' A' ' 365' ' ' PHE . 42.2 mtmt -94.89 178.42 5.57 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.445 HD11 ' SG ' ' A' ' 436' ' ' CYS . 82.5 mt -67.51 144.35 55.71 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 175.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.21 136.77 93.9 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -43.72 -34.81 5.99 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.059 3.173 . . . . 0.0 114.543 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -144.78 143.66 30.78 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.113 0.482 . . . . 0.0 112.234 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.413 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 63.2 m-85 -137.3 143.28 42.04 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.233 1.013 . . . . 0.0 109.315 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -122.27 138.98 54.31 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.76 149.39 29.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.1 m -82.2 147.7 28.84 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 1.6 tmmm? -64.6 127.11 30.15 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.312 0.577 . . . . 0.0 110.031 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.501 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 95.01 -7.13 69.7 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.382 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -93.08 168.33 11.19 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.757 0.313 . . . . 0.0 111.402 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 44.6 mtmt -98.12 157.61 16.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 17.8 tt -145.73 128.58 9.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 121.576 0.703 . . . . 0.0 109.924 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -103.19 114.99 29.73 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.913 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 76.3 mt -98.0 141.07 31.41 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 35.2 m -139.81 138.49 35.86 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.416 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.0 143.16 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -116.87 126.02 52.39 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.412 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 84.3 mt -91.64 139.86 30.28 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.457 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -71.73 -42.59 67.1 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.95 103.57 16.08 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.631 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -73.18 -21.83 60.6 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.181 -177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.15 26.98 3.03 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.735 1.255 . . . . 0.0 109.748 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -124.06 162.53 23.31 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.06 166.49 19.16 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.693 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 6.7 m -117.02 167.72 9.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.609 0.718 . . . . 0.0 111.91 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.498 ' HA ' ' HE2' ' A' ' 395' ' ' LYS . 8.9 mmpt? -112.81 140.16 47.83 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.403 ' HB3' HD12 ' A' ' 403' ' ' ILE . 11.6 m-90 -112.38 113.56 25.82 Favored 'General case' 0 C--N 1.278 -2.523 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.0 mp -124.59 137.4 54.39 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.751 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 119.04 30.15 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 171.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.2 p30 56.05 18.11 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 126.725 2.01 . . . . 0.0 112.249 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.5 1.98 47.06 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.093 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -106.24 133.72 50.5 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.18 123.46 20.35 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.439 0.638 . . . . 0.0 111.312 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 396' ' ' TRP . 69.6 mt -66.34 109.75 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.48 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -85.96 135.76 33.53 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 28.0 ttt -73.3 94.77 2.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.155 0.503 . . . . 0.0 110.155 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.0 p -89.04 94.4 9.93 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.05 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.17 -106.6 0.95 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.54 -0.754 . . . . 0.0 113.563 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 19.2 t -122.14 12.36 10.31 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' LYS . . . . . 0.457 ' HD2' ' CD2' ' A' ' 410' ' ' TYR . 6.2 tmtm? -74.31 -56.88 4.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.536 ' O ' ' HG3' ' A' ' 405' ' ' MET . 79.8 m-85 -107.23 113.44 26.85 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 176.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.68 113.9 45.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.097 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.401 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.0 m-85 -87.05 106.0 17.55 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 420' ' ' THR . 45.3 mt-10 -98.37 107.6 20.1 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 11.4 t -96.59 111.33 23.51 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.499 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 33.4 mm -115.1 82.02 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -174.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.91 -88.89 0.23 Allowed Glycine 0 C--O 1.236 0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 112.816 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -101.2 -29.28 12.19 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.203 0.525 . . . . 0.0 110.665 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 14.9 ptmt -94.76 127.41 40.74 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 122.143 0.973 . . . . 0.0 113.473 -171.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -100.21 105.81 17.43 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 413' ' ' GLU . 27.9 m -100.06 120.24 39.54 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.693 -174.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.401 HD13 ' CE2' ' A' ' 412' ' ' PHE . 45.8 tp -104.49 106.8 17.44 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.169 0.509 . . . . 0.0 110.312 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 58.5 m -95.8 111.63 23.55 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 38.3 mt -99.06 120.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 15.6 m -97.46 130.19 44.58 Favored 'General case' 0 N--CA 1.407 -2.614 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 63.32 74.68 0.42 Allowed 'General case' 0 C--O 1.243 0.751 0 O-C-N 124.168 0.918 . . . . 0.0 113.427 172.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 81.8 m -80.93 121.04 25.51 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.666 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 29.4 p -101.07 -177.26 3.4 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.56 -19.95 62.84 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.964 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -86.24 -11.65 51.79 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.73 177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -99.24 2.89 46.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.804 1.288 . . . . 0.0 108.39 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -77.54 116.91 18.49 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.46 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 447' ' ' LEU . . . -161.66 172.53 16.12 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.74 130.55 34.68 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -112.05 132.17 54.98 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.555 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -126.66 142.16 51.63 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.19 -174.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.445 ' SG ' HD11 ' A' ' 369' ' ' LEU . 71.7 m -123.87 120.85 33.77 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 40.7 t -115.94 128.76 73.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.932 -174.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.49 161.11 19.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 170.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.63 112.32 4.91 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.178 -1.487 . . . . 0.0 111.614 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 96.59 -35.11 4.57 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 115.344 -0.428 . . . . 0.0 112.143 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.403 ' CD ' ' HE2' ' A' ' 360' ' ' LYS . 6.0 mm-40 -116.09 124.63 50.89 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -174.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.01 167.54 21.88 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.702 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 41.7 t -151.79 147.2 26.38 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 80.1 p -125.92 116.59 21.73 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.0 t -94.93 138.92 32.04 Favored 'General case' 0 N--CA 1.401 -2.899 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -88.36 110.0 20.44 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 432' ' ' ALA . 3.4 tm? -99.47 121.79 41.65 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -116.62 114.24 23.81 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.646 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.63 119.62 39.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -109.35 130.28 55.5 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.407 -2.612 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.506 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 316' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.445 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 315' ' ' GLY . 28.1 Cg_exo -66.89 -33.68 32.57 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.615 2.21 . . . . 0.0 111.827 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -96.05 175.63 32.46 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 26.1 m -82.81 114.48 21.17 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.968 0.414 . . . . 0.0 111.658 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 321' ' ' VAL . 12.1 pt-20 -98.94 14.15 30.1 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -71.17 25.18 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 126.696 1.998 . . . . 0.0 112.831 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' A' ' 319' ' ' GLU . 10.7 p -61.32 -33.62 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 C-N-CA 123.628 0.771 . . . . 0.0 109.492 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' TRP . . . . . 0.404 ' HA ' ' CE ' ' A' ' 348' ' ' MET . 43.7 p-90 -52.97 -47.97 67.77 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 123.213 0.605 . . . . 0.0 112.085 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.64 -40.26 16.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.2 mt -63.22 -45.21 99.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 120.715 0.293 . . . . 0.0 111.439 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 9.3 tt -73.21 -31.09 63.96 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.389 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -70.36 -27.12 64.08 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 121.198 0.523 . . . . 0.0 111.22 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -97.82 -1.81 42.36 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.235 0.54 . . . . 0.0 110.988 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.88 148.24 35.28 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.84 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.6 146.49 92.64 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 122.328 2.019 . . . . 0.0 112.659 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.415 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 10.8 Cg_endo -52.76 -24.1 22.46 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 124.201 3.268 . . . . 0.0 115.922 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 9.0 m -76.61 -12.93 60.09 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.498 0.666 . . . . 0.0 111.644 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.409 ' O ' HG13 ' A' ' 336' ' ' ILE . 7.1 mm-40 -94.61 -15.74 23.79 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.405 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 9.5 m-30 -48.98 -49.3 41.41 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 -171.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -65.78 -31.51 72.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.157 0.503 . . . . 0.0 111.52 -174.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -69.14 -53.54 19.6 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 332' ' ' GLU . 62.6 mt -59.36 -49.86 81.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.887 -175.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -56.4 -62.06 1.98 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.933 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -62.62 -23.17 66.92 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -70.74 -39.96 73.01 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 122.782 0.433 . . . . 0.0 110.842 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -91.08 1.26 57.22 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.011 0.434 . . . . 0.0 112.078 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 87.87 25.7 31.37 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.718 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.2 t -104.81 117.17 49.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 73.9 p -95.46 -30.54 13.82 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 117.685 -1.606 . . . . 0.0 111.599 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -95.39 84.65 4.06 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.54 -30.54 59.76 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.431 0.634 . . . . 0.0 110.589 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -73.35 -40.55 64.33 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -67.49 -17.97 69.27 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.379 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' MET . . . . . 0.597 ' O ' ' HG2' ' A' ' 351' ' ' ARG . 24.1 ttt -79.7 -56.25 4.42 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 122.887 0.475 . . . . 0.0 109.987 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.09 -20.19 66.35 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 353' ' ' LYS . 22.6 pttp -65.94 -30.22 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.077 0.465 . . . . 0.0 111.395 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 348' ' ' MET . 24.8 ptt180 -79.65 -22.75 43.14 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.23 -21.67 56.12 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.371 1.081 . . . . 0.0 108.492 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 356' ' ' ARG . 11.8 tppt? -72.26 -30.23 64.66 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.905 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -93.89 -16.17 46.04 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.192 -0.913 . . . . 0.0 114.715 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -19.89 60.94 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 117.742 0.771 . . . . 0.0 112.271 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 353' ' ' LYS . 21.5 ptt180 -82.57 -27.69 31.41 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.086 0.47 . . . . 0.0 111.806 -177.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . 0.25 0.0 OUTLIER -86.38 148.41 25.59 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -169.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -122.45 131.15 53.73 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.362 -172.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -140.76 117.51 10.99 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 170.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 360' ' ' LYS . 29.6 mmtp -113.99 130.99 56.5 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.614 0.721 . . . . 0.0 112.165 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -57.3 -16.87 9.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.911 1.685 . . . . 0.0 113.248 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 12.2 m 69.82 57.04 0.32 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.356 1.063 . . . . 0.0 109.253 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.6 t -95.48 -38.12 10.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.165 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.473 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -88.78 -12.95 40.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.716 0.769 . . . . 0.0 109.635 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -109.74 117.57 34.24 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.522 177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -82.87 -18.86 38.8 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -160.08 116.47 2.45 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -94.69 172.76 7.98 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 96.8 mt -71.63 139.26 49.22 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 174.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -56.71 146.53 56.47 Favored Pre-proline 0 C--N 1.316 -0.864 0 O-C-N 123.926 0.766 . . . . 0.0 108.998 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.09 -33.01 41.62 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 123.025 2.484 . . . . 0.0 112.986 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -147.76 144.37 28.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.846 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.549 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 51.9 m-85 -129.8 159.07 37.68 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -136.72 141.9 43.07 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.75 147.3 25.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 25.2 m -84.16 144.5 28.96 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.424 ' HD3' ' HG2' ' A' ' 451' ' ' GLU . 26.7 ttpp -60.26 128.15 35.32 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.741 0.416 . . . . 0.0 110.949 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 90.7 8.84 65.07 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.883 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -111.07 175.2 5.51 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -99.57 136.51 39.39 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.649 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.2 tp -121.36 139.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.478 ' CZ ' HG21 ' A' ' 420' ' ' THR . 35.5 ttt85 -131.74 116.66 17.58 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.187 0.994 . . . . 0.0 111.581 -173.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.08 130.4 48.66 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.974 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 21.7 m -127.61 126.11 41.46 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.415 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 5.1 m -122.04 144.2 32.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.813 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.414 ' HG2' ' HG3' ' A' ' 418' ' ' LYS . 48.0 mt-10 -111.91 119.25 37.89 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 86.0 mt -88.11 145.65 25.83 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.515 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -72.09 -24.26 61.47 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.058 0.456 . . . . 0.0 110.183 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -123.33 135.5 54.22 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -70.86 -23.25 62.28 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.87 19.39 17.99 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.86 -172.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -96.59 132.64 42.0 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -98.71 156.12 17.0 Favored 'General case' 0 C--N 1.267 -2.99 0 C-N-CA 118.541 -1.263 . . . . 0.0 111.96 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.53 152.23 17.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.225 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -115.0 139.35 49.92 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 403' ' ' ILE . 5.8 m-90 -110.9 125.16 53.36 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -173.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 8.3 mp -127.47 136.23 51.5 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 117.832 0.287 . . . . 0.0 110.859 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.432 ' HB3' HD11 ' A' ' 403' ' ' ILE . 0.0 OUTLIER -111.61 115.63 29.46 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.277 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . 0.259 28.6 p30 50.88 13.71 0.15 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 126.814 2.046 . . . . 0.0 114.961 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 123.17 -7.11 9.27 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.366 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -107.51 134.15 50.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.88 120.74 16.9 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.193 0.521 . . . . 0.0 111.109 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 398' ' ' LYS . 43.1 mt -78.87 111.97 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.915 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -91.6 151.14 20.84 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 61.7 ttp -62.46 102.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 409' ' ' LYS . 27.4 t -100.78 95.91 6.96 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 55.29 -137.7 44.48 Favored Glycine 0 N--CA 1.442 -0.947 0 O-C-N 124.114 0.884 . . . . 0.0 113.04 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.3 p -95.44 8.56 42.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.385 0.612 . . . . 0.0 110.607 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 2.5 tppp? -72.5 -47.72 46.29 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.486 ' O ' ' HG3' ' A' ' 405' ' ' MET . 41.1 m-85 -119.43 108.63 14.8 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 57.6 mt -108.66 112.8 41.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 CA-C-O 120.987 0.423 . . . . 0.0 109.955 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.503 ' CD2' HD13 ' A' ' 421' ' ' LEU . 22.7 m-85 -87.08 109.37 19.38 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.468 175.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -108.68 108.72 19.68 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 70.3 m -100.16 110.38 22.66 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.352 0.596 . . . . 0.0 111.172 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 36.1 mt -104.06 74.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.11 -107.05 1.71 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.404 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -89.93 -25.64 20.83 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.664 0.386 . . . . 0.0 110.396 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.414 ' HG3' ' HG2' ' A' ' 386' ' ' GLU . 31.1 ttpt -88.39 98.47 11.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -100.7 130.23 46.71 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-O 121.317 0.579 . . . . 0.0 109.722 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' THR . . . . . 0.478 HG21 ' CZ ' ' A' ' 382' ' ' ARG . 16.8 m -123.0 145.77 48.21 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.553 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.503 HD13 ' CD2' ' A' ' 412' ' ' PHE . 23.2 tp -118.56 112.63 20.13 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.353 174.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.9 m -102.07 109.87 21.69 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 33.0 mt -98.4 121.69 49.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.4 m -101.24 145.02 29.39 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.227 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 58.53 47.61 13.16 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.397 1.079 . . . . 0.0 110.836 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.64 122.86 16.9 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 11.2 m -116.63 -177.95 3.31 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.21 -29.55 69.89 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -81.76 -2.8 52.0 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -103.22 -7.05 21.5 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.2 113.84 1.54 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.841 173.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -168.79 163.05 11.8 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.914 -177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.39 129.25 34.85 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -104.61 134.31 47.99 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' A' ' 444' ' ' SER . 22.8 mp0 -123.87 130.0 51.9 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.406 -178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 443' ' ' CYS . 81.4 m -107.89 111.84 24.17 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 171.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.31 128.22 53.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.756 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.12 161.3 29.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -59.96 112.93 4.84 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.278 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 93.15 -36.29 3.77 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 124.223 0.916 . . . . 0.0 112.441 175.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 12.6 mm-40 -116.61 134.99 54.18 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 120.732 0.301 . . . . 0.0 110.403 -173.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -134.61 162.35 32.54 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 436' ' ' CYS . 23.3 p -136.19 144.49 44.97 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 173.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.478 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 5.0 p -139.66 112.83 8.2 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 123.23 0.332 . . . . 0.0 111.348 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.549 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 9.9 t -104.13 141.54 36.06 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.78 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -102.63 110.53 22.49 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -89.11 143.71 26.65 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.924 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -118.73 128.65 54.69 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.51 115.93 45.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.51 ' HA ' ' HE3' ' A' ' 450' ' ' LYS . 1.1 tpmt? -105.4 115.67 30.65 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.424 ' HG2' ' HD3' ' A' ' 377' ' ' LYS . 36.0 mt-10 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.708 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.706 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.92 132.62 25.1 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 122.457 2.105 . . . . 0.0 113.2 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -101.92 -178.65 27.93 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 57.8 m -161.53 -66.13 0.06 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.574 0.749 . . . . 0.0 109.285 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.72 -45.65 5.18 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.089 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 62.49 12.67 5.57 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.481 1.112 . . . . 0.0 113.769 172.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.2 -34.63 27.68 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 C-N-CA 123.238 0.615 . . . . 0.0 112.0 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -51.8 -55.25 20.97 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 124.808 1.243 . . . . 0.0 109.987 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.9 -35.57 22.07 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.843 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.75 -49.26 78.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 O-C-N 122.96 0.163 . . . . 0.0 111.375 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.4 tt -71.84 -32.71 67.8 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.994 0.426 . . . . 0.0 110.035 -177.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -64.18 -33.24 75.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.48 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -96.31 0.62 51.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.416 0.627 . . . . 0.0 110.314 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -90.44 151.93 44.85 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.72 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.39 140.65 95.35 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.701 2.267 . . . . 0.0 111.596 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.472 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 14.0 Cg_endo -55.8 -23.03 39.8 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.796 2.997 . . . . 0.0 115.072 -174.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.1 p -75.78 -21.57 57.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.273 0.559 . . . . 0.0 111.932 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -93.84 -8.28 40.87 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.511 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.472 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 4.2 m-30 -43.66 -54.86 4.72 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.505 1.122 . . . . 0.0 113.856 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.86 -49.1 79.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 339' ' ' GLN . 11.2 ttp180 -60.73 -40.27 91.71 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.305 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 34.1 mt -73.6 -37.8 50.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.173 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -61.85 -58.55 7.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.178 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -66.84 -23.03 65.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.43 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 335' ' ' ARG . 57.9 tp60 -59.14 -43.63 92.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.267 0.627 . . . . 0.0 109.624 176.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.59 4.92 43.78 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 88.58 18.22 55.32 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.219 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 24.5 t -91.87 101.04 12.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.3 m -82.33 -40.18 21.8 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.078 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -99.69 87.75 3.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.961 0.886 . . . . 0.0 109.631 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.4 pt? -75.59 -36.23 60.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.101 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -63.21 -38.76 92.44 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.926 -173.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -73.42 -22.1 78.95 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.745 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 56.1 ttp -73.81 -45.79 49.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.3 -32.96 73.77 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.944 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -56.04 -46.77 78.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.278 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -67.42 -41.46 84.81 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.997 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.48 -21.08 66.6 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -63.81 -42.35 97.69 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.46 -44.01 14.16 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.162 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 48.8 mtm -84.19 84.19 7.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.635 0.731 . . . . 0.0 109.905 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -73.64 -17.36 61.17 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.554 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' ARG . . . . . 0.407 ' HD3' ' C ' ' A' ' 357' ' ' ARG . 0.0 OUTLIER 74.88 92.25 0.08 Allowed 'General case' 0 C--O 1.248 1.019 0 C-N-CA 125.392 1.477 . . . . 0.0 108.176 -175.378 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -121.36 121.85 38.53 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.72 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -82.57 -30.84 29.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.569 ' HE2' ' O ' ' A' ' 440' ' ' GLY . 0.0 OUTLIER -77.41 153.84 33.25 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.554 172.096 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -156.26 47.1 0.46 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.093 -167.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . 0.286 56.0 p 63.42 73.77 0.44 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.737 1.256 . . . . 0.0 110.233 -175.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 15.4 t -127.02 -18.06 4.71 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.173 -1.83 . . . . 0.0 109.277 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -99.33 -35.77 9.83 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -105.64 128.74 53.81 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.94 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -83.27 -43.74 15.72 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 6.0 mmpt? -137.68 124.07 20.7 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 442' ' ' LYS . 56.7 mtpt -98.46 168.29 10.29 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.215 -175.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 84.5 mt -62.03 141.31 58.15 Favored 'General case' 0 C--O 1.255 1.343 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -63.16 149.11 91.69 Favored Pre-proline 0 C--N 1.302 -1.461 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.629 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.1 -35.29 25.69 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.393 2.729 . . . . 0.0 113.259 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -153.34 152.5 31.17 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -133.35 158.29 43.36 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -135.71 136.94 41.26 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.07 156.19 24.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 8.4 t -93.15 151.27 19.94 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -64.15 119.12 9.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.851 0.357 . . . . 0.0 110.777 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 99.76 -1.49 56.78 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -91.79 -177.73 4.84 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.176 0.513 . . . . 0.0 110.836 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.0 mtpt -119.34 130.39 55.34 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.617 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.0 tp -120.84 130.01 75.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.417 0.627 . . . . 0.0 110.245 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 74.3 mtt180 -101.76 110.09 22.0 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.078 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.65 117.83 31.21 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 16.1 m -122.95 144.36 49.29 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.943 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 9.5 m -140.72 143.24 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -108.94 119.55 39.88 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.473 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 81.6 mt -85.64 143.3 28.49 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.79 -44.6 27.03 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.41 114.87 22.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.325 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -79.4 -21.53 45.53 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.018 0.437 . . . . 0.0 111.415 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -94.09 26.9 3.04 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.739 0.78 . . . . 0.0 111.59 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -128.47 161.46 29.46 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.27 176.88 7.58 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 12.1 m -116.6 164.45 12.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 120.939 0.399 . . . . 0.0 110.728 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -119.0 135.42 54.63 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -106.93 123.61 48.43 Favored 'General case' 0 C--N 1.283 -2.311 0 O-C-N 123.867 0.729 . . . . 0.0 109.979 -169.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.2 mp -131.6 144.12 50.83 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.773 -0.579 . . . . 0.0 111.425 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.427 ' HB3' HD11 ' A' ' 403' ' ' ILE . 23.0 pttp -126.18 125.42 42.42 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 169.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 24.6 p30 54.25 17.03 1.36 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.812 1.645 . . . . 0.0 113.009 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.44 4.66 46.54 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.891 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -109.03 124.15 50.27 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.6 111.28 1.76 Allowed 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 398' ' ' LYS . 19.3 mt -75.6 148.75 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 O-C-N 124.302 1.001 . . . . 0.0 108.415 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -139.94 173.85 11.11 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 48.6 ttm -66.96 101.57 0.86 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.9 m -97.71 97.48 9.05 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 62.97 -127.47 38.57 Favored Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.35 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.8 p -106.07 12.16 30.66 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -78.76 -60.71 2.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.085 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' ' 405' ' ' MET . 95.5 m-85 -96.55 107.62 20.06 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 49.7 mm -106.16 112.53 39.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 CA-C-O 121.178 0.513 . . . . 0.0 110.01 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' A' ' 421' ' ' LEU . 23.0 m-85 -86.79 115.87 24.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -110.5 108.33 18.29 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 19.3 m -98.41 111.63 23.91 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 39.4 mm -112.31 87.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.74 2.21 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -92.82 -27.0 17.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.453 0.168 . . . . 0.0 110.948 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 21.8 ptmt -83.96 141.73 31.02 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.565 0.698 . . . . 0.0 111.929 -175.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -115.22 120.9 41.24 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.115 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 53.0 m -112.67 122.38 47.5 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.526 HD13 ' CE2' ' A' ' 412' ' ' PHE . 21.4 tp -102.41 110.16 22.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 31.3 m -95.46 102.0 13.77 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.7 mt -86.78 112.67 23.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 13.3 m -96.36 139.83 31.92 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.718 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 61.27 57.92 2.3 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.905 1.282 . . . . 0.0 110.087 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 381' ' ' ILE . 25.5 m -64.48 120.9 13.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.093 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 82.1 p -94.89 178.55 5.53 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.25 -19.38 61.71 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.89 -2.17 42.45 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.669 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -103.3 8.04 38.3 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.542 0.687 . . . . 0.0 109.507 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -80.21 94.76 6.11 Favored 'General case' 0 C--O 1.256 1.415 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -145.24 170.21 16.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.466 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -89.53 120.71 31.07 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 398' ' ' LYS . 89.5 m-85 -107.43 138.66 43.23 Favored 'General case' 0 C--N 1.286 -2.196 0 O-C-N 122.276 -0.265 . . . . 0.0 111.166 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.1 OUTLIER -134.4 133.98 41.15 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.841 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 443' ' ' CYS . 85.7 m -108.13 114.12 27.78 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 169.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.6 t -109.84 132.54 57.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.481 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 73.9 t -125.9 160.74 32.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 173.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -66.26 113.24 5.55 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 119.054 -1.546 . . . . 0.0 111.888 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' GLY . . . . . 0.569 ' O ' ' HE2' ' A' ' 360' ' ' LYS . . . 107.89 -36.67 4.24 Favored Glycine 0 N--CA 1.424 -2.109 0 CA-C-N 115.088 -0.556 . . . . 0.0 112.507 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -134.99 152.58 51.86 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 117.988 0.894 . . . . 0.0 110.849 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.502 ' O ' ' HE3' ' A' ' 368' ' ' LYS . 20.0 ptpt -141.95 178.26 7.63 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 436' ' ' CYS . 5.9 p -148.0 134.3 19.52 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 8.0 p -121.32 129.36 53.05 Favored 'General case' 0 C--N 1.288 -2.077 0 O-C-N 123.798 0.686 . . . . 0.0 110.538 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 15.1 t -128.53 150.11 50.32 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -111.96 111.16 21.89 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 62.0 tp -90.83 130.01 36.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.08 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -109.83 110.59 21.62 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.0 120.67 45.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 376' ' ' SER . 20.0 ttpp -116.05 131.42 56.95 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.973 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.529 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.63 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -67.19 -25.79 42.91 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.548 2.166 . . . . 0.0 112.946 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -96.17 -156.35 31.22 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 35.6 m -140.2 -43.9 0.42 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 117.309 0.555 . . . . 0.0 111.989 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -115.06 5.75 15.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.585 1.183 . . . . 0.0 107.824 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.54 24.96 0.19 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.487 1.515 . . . . 0.0 112.662 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.85 -34.1 47.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 122.563 0.345 . . . . 0.0 110.723 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -53.53 -47.41 69.98 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.561 1.144 . . . . 0.0 111.186 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 8.6 pt-20 -85.81 -42.09 14.47 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.897 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.34 -50.47 80.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 122.671 0.388 . . . . 0.0 111.532 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.94 -27.88 64.08 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.352 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -60.63 -49.78 76.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.432 0.634 . . . . 0.0 111.78 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLN . . . . . 0.468 ' H ' ' HG2' ' A' ' 327' ' ' GLN . 19.3 pt20 -94.46 0.82 55.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.785 -174.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -81.82 153.61 70.18 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.257 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.53 143.31 94.85 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 122.157 1.904 . . . . 0.0 110.988 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 28.3 Cg_endo -60.27 -24.29 76.88 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 123.764 2.976 . . . . 0.0 113.992 -172.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.1 m -79.81 -8.81 59.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.989 0.423 . . . . 0.0 111.583 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 336' ' ' ILE . 20.5 mm-40 -94.66 -19.3 20.56 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.207 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 14.2 m-30 -44.24 -50.33 8.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.03 -55.76 30.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.673 0.608 . . . . 0.0 111.765 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -65.44 -41.02 93.94 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.043 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 332' ' ' GLU . 77.6 mt -59.25 -45.81 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.69 -58.83 6.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.847 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -62.11 -30.71 71.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.17 -36.54 84.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.767 0.317 . . . . 0.0 111.117 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -93.21 4.49 53.91 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 84.11 12.87 75.65 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.983 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 19.0 t -89.94 90.22 3.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -45.68 93.21 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.128 -174.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -110.98 100.79 9.43 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.757 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 345' ' ' LEU . 0.8 OUTLIER -75.93 -21.2 57.31 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.411 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -61.54 -44.63 96.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.856 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -63.53 -34.56 90.28 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 25.7 ttt -70.17 -48.39 57.5 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.041 0.448 . . . . 0.0 109.924 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 353' ' ' LYS . 97.5 mt -65.01 -33.62 76.48 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.292 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -59.91 -46.32 89.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.874 0.845 . . . . 0.0 108.949 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -72.43 -40.3 67.19 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.122 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 12.0 tp -70.83 -21.03 62.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.666 0.746 . . . . 0.0 110.192 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 349' ' ' LEU . 35.9 ttmt -64.83 -14.01 57.85 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.335 1.054 . . . . 0.0 110.964 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -96.26 8.69 67.18 Favored Glycine 0 C--N 1.3 -1.462 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.837 176.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 26.4 mmt -87.33 23.65 1.81 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.123 -0.633 . . . . 0.0 111.936 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 47.95 36.74 6.53 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.298 1.439 . . . . 0.0 113.538 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -119.69 -37.21 3.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.449 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -102.34 73.48 1.34 Allowed 'General case' 0 C--O 1.254 1.299 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -96.96 104.78 16.82 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.886 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -66.51 -39.87 88.89 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.088 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.505 ' HE3' ' OE1' ' A' ' 441' ' ' GLU . 15.6 ptmt -102.6 -39.8 6.92 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 2.9 m -75.62 72.35 2.57 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.887 0.851 . . . . 0.0 109.836 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 77.2 p -111.24 -45.55 3.4 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.401 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.03 68.1 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.393 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -86.99 135.43 33.28 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.861 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' GLN . . . . . 0.505 ' HB3' ' CB ' ' A' ' 386' ' ' GLU . 0.0 OUTLIER -89.03 -37.68 14.98 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 177.48 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -157.02 135.68 11.55 Favored 'General case' 0 CA--C 1.465 -2.31 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 9.9 mtmp? -98.09 175.06 6.24 Favored 'General case' 0 C--N 1.268 -2.963 0 O-C-N 124.298 0.999 . . . . 0.0 109.756 -175.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.521 HD11 ' SG ' ' A' ' 436' ' ' CYS . 34.6 mt -61.08 155.7 19.78 Favored 'General case' 0 C--O 1.249 1.031 0 O-C-N 124.066 0.854 . . . . 0.0 111.523 178.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.48 149.32 91.05 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 170.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.81 -37.19 76.3 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.592 2.194 . . . . 0.0 113.293 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -143.8 153.15 42.09 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.638 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -135.2 163.24 30.4 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -138.05 145.34 41.66 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 381' ' ' ILE . 13.3 p -148.33 155.25 9.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.471 ' HB2' ' CG ' ' A' ' 379' ' ' HIS . 49.8 m -90.96 146.86 23.52 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.46 ' HB3' ' NZ ' ' A' ' 377' ' ' LYS . 1.7 ttpm? -63.47 121.04 12.85 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.7 0.32 57.77 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.703 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' HIS . . . . . 0.471 ' CG ' ' HB2' ' A' ' 376' ' ' SER . 12.5 m170 -103.78 171.08 7.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 120.827 0.346 . . . . 0.0 111.309 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.0 mtpt -101.44 143.32 31.6 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 382' ' ' ARG . 0.1 OUTLIER -135.92 138.57 47.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.476 ' N ' HD13 ' A' ' 381' ' ' ILE . 55.0 mtt180 -114.62 117.35 30.63 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.377 0.608 . . . . 0.0 112.244 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 420' ' ' THR . 29.7 mt -96.53 128.81 43.81 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 28.7 m -123.74 134.57 53.66 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 14.2 m -141.97 162.82 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 C-N-CA 124.211 1.004 . . . . 0.0 108.629 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.505 ' CB ' ' HB3' ' A' ' 366' ' ' GLN . 37.8 mt-10 -123.33 138.89 54.51 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 46.2 mt -105.67 146.65 29.46 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.82 -5.72 54.15 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.386 0.613 . . . . 0.0 111.242 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 392' ' ' ALA . 21.5 t70 -135.58 138.39 42.92 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -75.54 -22.76 56.79 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.379 0.672 . . . . 0.0 112.002 -174.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -109.6 23.16 14.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 122.763 1.268 . . . . 0.0 109.29 -174.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 389' ' ' ASP . . . -101.21 139.31 37.07 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -177.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -103.25 140.75 36.97 Favored 'General case' 0 N--CA 1.393 -3.313 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.93 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.408 ' CG1' ' HG2' ' A' ' 419' ' ' ARG . 6.0 p -120.04 134.1 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.405 0 CA-C-N 113.848 -1.524 . . . . 0.0 107.556 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -111.3 146.13 37.58 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 421' ' ' LEU . 24.4 m95 -106.19 126.75 52.6 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 7.7 mp -114.34 131.44 56.54 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -98.83 110.54 23.12 Favored 'General case' 0 N--CA 1.407 -2.588 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.751 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.0 p30 56.11 2.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 127.637 2.375 . . . . 0.0 114.121 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 131.91 -5.98 5.44 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -103.33 127.89 50.56 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.74 118.86 6.66 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 123.016 0.526 . . . . 0.0 112.036 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.431 HD12 ' CB ' ' A' ' 396' ' ' TRP . 54.0 mt -79.48 114.26 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 170.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -104.28 141.26 36.61 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.563 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 27.1 ptt? -70.11 109.81 4.8 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.228 -176.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.3 m -103.05 102.48 12.51 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.214 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 52.1 -124.12 23.61 Favored Glycine 0 N--CA 1.445 -0.727 0 O-C-N 124.451 1.094 . . . . 0.0 114.639 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 16.1 m -91.46 -5.76 53.77 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.435 -0.382 . . . . 0.0 111.518 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -78.33 -53.5 7.22 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.585 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 90.9 m-85 -110.97 121.5 45.52 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 46.2 mt -121.7 119.64 59.39 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.71 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 405' ' ' MET . 3.1 m-30 -88.02 106.02 17.86 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -106.69 133.67 51.0 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 9.6 t -118.73 121.7 40.73 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.585 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 65.4 mt -118.84 94.94 3.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.78 -98.63 0.62 Allowed Glycine 0 C--N 1.305 -1.142 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -121.37 3.57 10.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.062 0.458 . . . . 0.0 110.166 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 21.2 ptmt -104.9 136.6 44.08 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' ARG . . . . . 0.408 ' HG2' ' CG1' ' A' ' 394' ' ' VAL . 9.7 tpp85 -110.71 139.07 46.31 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 29.9 m -131.22 125.31 32.58 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.507 ' HB2' ' CE2' ' A' ' 396' ' ' TRP . 50.6 tp -97.83 117.68 32.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 54.3 m -103.62 106.96 17.62 Favored 'General case' 0 N--CA 1.41 -2.428 0 O-C-N 123.906 0.754 . . . . 0.0 108.967 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 52.6 mt -98.87 125.16 52.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 44.7 m -104.59 128.8 52.7 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 66.06 66.98 0.48 Allowed 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 124.552 1.158 . . . . 0.0 110.689 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.07 122.38 17.27 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.634 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 9.2 m -105.58 -177.87 3.49 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 451' ' ' GLU . 71.8 mt -68.01 -28.69 67.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.976 0.417 . . . . 0.0 110.57 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -75.32 -6.27 49.04 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.344 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -101.17 -11.08 19.83 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.14 106.83 2.53 Favored 'General case' 0 C--O 1.25 1.083 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.38 165.57 30.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.533 -176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.53 129.23 34.87 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -104.97 135.35 46.48 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 25.9 mp0 -121.54 123.91 43.11 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 91.9 m -84.45 117.05 23.41 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.25 112.73 37.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.84 160.86 14.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.03 112.88 5.35 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 119.134 -1.507 . . . . 0.0 110.749 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.39 -36.21 4.5 Favored Glycine 0 N--CA 1.405 -3.4 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.109 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.505 ' OE1' ' HE3' ' A' ' 361' ' ' LYS . 70.8 mm-40 -137.41 170.17 16.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -173.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 22.2 ptmt -147.02 162.73 38.19 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.574 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 53.2 t -149.48 135.85 19.18 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.416 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 15.3 p -103.73 142.58 34.1 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.739 0.649 . . . . 0.0 111.353 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.429 ' CG2' HD13 ' A' ' 369' ' ' LEU . 15.1 t -131.16 150.2 52.25 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.81 112.46 19.26 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.076 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 36.4 tp -85.16 142.8 29.22 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.831 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -116.01 109.75 17.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.5 t -91.96 118.08 36.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -103.65 121.99 44.09 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.519 ' HG3' HD21 ' A' ' 428' ' ' LEU . 1.8 mp0 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.62 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.723 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.87 149.37 61.3 Favored 'Trans proline' 0 C--O 1.251 1.145 0 C-N-CA 123.411 2.74 . . . . 0.0 111.988 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 85.62 42.64 6.79 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.1 t -123.9 110.13 14.46 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 321' ' ' VAL . 22.1 mp0 -76.82 -39.9 49.76 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 72.74 -23.38 0.21 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 125.307 1.443 . . . . 0.0 113.061 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.425 ' H ' ' C ' ' A' ' 319' ' ' GLU . 15.0 p -49.95 -29.02 4.85 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 C-N-CA 125.124 1.37 . . . . 0.0 112.357 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -57.92 -55.39 35.51 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.43 0.692 . . . . 0.0 110.737 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.29 -20.64 43.91 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.163 0.506 . . . . 0.0 110.708 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 321' ' ' VAL . 76.2 mt -72.36 -50.28 36.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.703 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.26 -34.8 78.45 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.303 0.573 . . . . 0.0 110.268 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -54.92 -39.8 69.18 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.854 1.262 . . . . 0.0 112.434 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -103.54 -1.72 27.9 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.278 0.561 . . . . 0.0 110.129 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -80.94 149.22 66.47 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.824 -174.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' PRO . . . . . 0.422 ' HG2' ' HG3' ' A' ' 332' ' ' GLU . 21.5 Cg_endo -65.47 144.42 79.46 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.325 2.016 . . . . 0.0 110.066 173.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.78 -22.84 69.33 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.868 2.379 . . . . 0.0 113.384 -174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.5 m -78.87 -8.53 58.92 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.422 ' HG3' ' HG2' ' A' ' 329' ' ' PRO . 5.4 mm-40 -111.38 2.38 17.55 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 121.099 -0.241 . . . . 0.0 111.183 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -47.85 -52.36 19.41 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.429 ' O ' ' HD2' ' A' ' 338' ' ' PHE . 39.7 tt0 -60.29 -44.43 95.37 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.654 0.596 . . . . 0.0 111.312 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -59.99 -54.18 49.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.265 0.555 . . . . 0.0 109.994 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 51.5 mt -64.88 -41.23 91.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.886 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 342' ' ' VAL . . . -60.47 -55.43 33.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.993 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.429 ' HD2' ' O ' ' A' ' 334' ' ' GLU . 77.2 m-85 -68.7 -24.08 64.45 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -68.11 -40.6 82.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.552 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -93.65 -7.9 42.53 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 95.25 33.8 6.39 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.188 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.426 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 8.3 t -116.57 106.35 20.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 72.0 p -91.28 -18.26 24.65 Favored 'General case' 0 C--N 1.265 -3.078 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.816 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -96.57 45.89 1.06 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.978 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -30.29 70.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.082 0.468 . . . . 0.0 110.799 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -67.99 -29.27 68.25 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.502 ' O ' ' HG3' ' A' ' 351' ' ' ARG . . . -72.48 -37.43 58.49 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.909 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 27.4 ttt -63.25 -42.02 99.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.5 -42.49 87.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.685 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -55.96 -47.56 77.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.234 1.014 . . . . 0.0 110.331 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 347' ' ' GLY . 74.3 mtp180 -62.6 -43.81 97.87 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.969 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.76 -47.75 84.88 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.146 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.47 -8.92 57.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.964 0.411 . . . . 0.0 111.076 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -95.96 -1.2 61.56 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.737 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 25.8 mmt -77.97 -70.64 0.47 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -93.11 111.77 23.5 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.025 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.75 135.73 5.77 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -100.66 85.24 2.88 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 122.634 1.207 . . . . 0.0 111.137 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.85 111.5 18.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.622 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.455 ' HB3' ' H ' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -134.09 141.52 47.18 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.538 178.265 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' A' ' 363' ' ' THR . 22.9 mtpp -125.02 -21.63 4.63 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.388 -174.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 16.3 m 63.21 65.62 0.76 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.589 1.956 . . . . 0.0 111.292 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 361' ' ' LYS . 9.8 t -139.09 -30.71 0.73 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.845 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -91.24 -11.06 39.31 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.726 0.774 . . . . 0.0 109.422 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.46 127.72 48.0 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -89.64 -32.06 17.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.485 0.659 . . . . 0.0 109.314 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.5 OUTLIER -148.83 116.07 6.12 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.355 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -91.17 163.9 14.1 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.607 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 59.6 mt -64.84 144.6 57.15 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 123.837 0.71 . . . . 0.0 109.272 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -67.45 146.42 98.69 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -45.89 -43.05 19.98 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 123.597 2.865 . . . . 0.0 113.821 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -148.9 155.06 40.33 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.068 0.461 . . . . 0.0 111.002 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -137.81 158.65 43.91 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -129.22 142.63 50.8 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.8 p -140.64 151.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 43.3 m -81.45 145.09 30.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -62.4 117.54 6.29 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.691 0.282 . . . . 0.0 111.163 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.09 5.13 57.41 Favored Glycine 0 CA--C 1.499 -0.914 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -104.96 163.25 12.67 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.47 148.17 24.52 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.439 HG22 ' SG ' ' A' ' 426' ' ' CYS . 15.9 tt -150.55 149.25 14.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 1.2 ptp180 -127.37 137.16 52.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.446 0.641 . . . . 0.0 112.325 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.07 153.97 20.78 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 50.7 m -139.68 138.23 35.86 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.692 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.13 144.02 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 35.1 mt-10 -121.28 137.19 54.8 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.429 HD12 ' NH1' ' A' ' 419' ' ' ARG . 96.4 mt -96.67 157.13 16.04 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.472 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -86.46 -15.25 40.77 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -127.93 142.72 51.18 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -80.67 -23.35 39.68 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -106.03 21.94 16.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.307 0.575 . . . . 0.0 110.545 -174.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -99.39 159.16 15.21 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -121.79 145.81 47.69 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 118.585 -1.246 . . . . 0.0 112.983 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.424 HG12 HG22 ' A' ' 438' ' ' VAL . 11.7 m -109.94 158.85 9.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.314 175.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.3 tptm -132.35 133.46 44.01 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -101.03 127.41 47.55 Favored 'General case' 0 C--N 1.275 -2.634 0 O-C-N 124.458 1.099 . . . . 0.0 108.527 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 402' ' ' GLU . 10.1 mt -137.64 146.02 43.39 Favored 'General case' 0 CA--C 1.458 -2.559 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 433' ' ' ALA . 22.5 pttp -126.58 132.82 51.21 Favored 'General case' 0 N--CA 1.399 -3.002 0 C-N-CA 118.772 -1.171 . . . . 0.0 109.652 174.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.6 p30 48.41 27.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 126.438 1.895 . . . . 0.0 114.451 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.06 23.35 30.05 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.865 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -114.18 -96.22 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.559 0.219 . . . . 0.0 111.317 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' GLU . . . . . 0.708 ' HA ' HD23 ' A' ' 397' ' ' LEU . 43.6 tt0 176.92 135.97 0.06 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 58.1 mt -91.07 128.67 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.997 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -99.43 138.5 36.44 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.462 ' HB2' ' CE1' ' A' ' 412' ' ' PHE . 60.1 ttp -79.62 80.9 5.96 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 t -88.81 111.33 21.9 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.363 -171.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 54.06 -125.12 32.44 Favored Glycine 0 N--CA 1.446 -0.698 0 O-C-N 124.331 1.019 . . . . 0.0 113.443 176.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' SER . . . . . 0.55 ' HA ' HD11 ' A' ' 411' ' ' ILE . 15.3 m -106.74 3.85 27.04 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.719 0.771 . . . . 0.0 108.927 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -75.2 -41.8 57.04 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.399 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.433 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 99.4 m-85 -119.27 117.98 30.03 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 408' ' ' SER . 43.9 mm -114.96 114.82 47.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.482 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.3 m-30 -87.42 109.96 19.94 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -105.01 108.57 20.16 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 78.6 p -99.69 121.6 41.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.235 0.541 . . . . 0.0 109.65 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.435 ' HB ' ' HG3' ' A' ' 418' ' ' LYS . 43.5 mm -123.64 85.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.94 -90.39 0.13 Allowed Glycine 0 C--N 1.321 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 113.825 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -102.36 -28.16 12.41 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.817 0.342 . . . . 0.0 110.332 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 386' ' ' GLU . 21.2 ptmt -93.8 134.8 35.76 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.754 0.788 . . . . 0.0 112.44 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' ARG . . . . . 0.429 ' NH1' HD12 ' A' ' 387' ' ' LEU . 10.8 mpt_? -110.86 124.36 51.92 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 28.6 m -115.89 122.26 44.8 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.482 HD13 ' CE2' ' A' ' 412' ' ' PHE . 20.2 tp -103.61 109.02 20.54 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.0 m -100.02 110.75 23.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.403 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.8 mt -96.95 141.18 16.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 31.8 m -120.72 135.89 55.01 Favored 'General case' 0 N--CA 1.388 -3.561 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 59.31 58.47 3.01 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 124.783 1.302 . . . . 0.0 111.332 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 381' ' ' ILE . 60.7 m -63.6 113.46 3.35 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.347 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.7 m -100.37 -176.84 3.33 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.19 -23.77 63.96 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.125 0.488 . . . . 0.0 111.184 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.29 -5.65 50.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.048 0.452 . . . . 0.0 110.867 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -98.21 -5.7 32.79 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.073 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.82 88.7 1.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -146.7 162.49 38.39 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.166 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 398' ' ' LYS . . . -85.42 129.35 34.83 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -108.26 132.47 53.64 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.6 144.93 41.26 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.49 ' SG ' HD11 ' A' ' 369' ' ' LEU . 79.1 m -122.84 103.08 8.4 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.578 HG22 ' HG3' ' A' ' 442' ' ' LYS . 14.8 t -104.77 136.92 36.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.14 -174.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 441' ' ' GLU . 29.9 t -122.17 161.14 23.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 174.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -74.41 109.73 2.88 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 115.423 -3.275 . . . . 0.0 110.176 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 104.61 4.34 43.04 Favored Glycine 0 N--CA 1.42 -2.367 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 438' ' ' VAL . 4.5 tp10 -151.53 143.27 23.71 Favored 'General case' 0 N--CA 1.396 -3.14 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -176.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.578 ' HG3' HG22 ' A' ' 437' ' ' VAL . 26.9 ttpt -148.93 152.77 36.96 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.04 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 28.4 p -150.11 144.18 25.55 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 170.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 22.6 m -133.62 140.52 47.16 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 13.3 t -122.45 148.16 45.46 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.14 111.03 20.4 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 51.6 tp -84.36 134.3 34.49 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.98 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -107.89 115.09 29.5 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.27 108.38 19.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 376' ' ' SER . 3.8 tmmm? -100.21 117.82 35.24 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -176.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--N 1.303 -1.423 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.604 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.285 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.25 103.48 1.29 Allowed 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.409 2.073 . . . . 0.0 110.068 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -131.05 -115.65 1.74 Allowed Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.6 p -96.81 -28.48 14.24 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.629 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.608 ' HB3' HG12 ' A' ' 321' ' ' VAL . 1.4 mp0 68.33 -52.69 0.54 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 125.509 1.524 . . . . 0.0 111.814 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 70.61 -20.6 0.2 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 125.839 1.656 . . . . 0.0 112.848 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' VAL . . . . . 0.608 HG12 ' HB3' ' A' ' 319' ' ' GLU . 13.3 p -50.52 -44.04 24.13 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.814 0 C-N-CA 125.257 1.423 . . . . 0.0 111.442 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -59.33 -42.8 92.31 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.73 -38.28 18.43 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.8 mt -65.61 -45.83 91.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 120.74 0.305 . . . . 0.0 110.36 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.9 tt -68.23 -32.63 72.96 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.208 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -63.95 -34.63 78.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.103 0.561 . . . . 0.0 110.728 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -94.5 1.59 55.71 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.764 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.78 155.41 36.59 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.751 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' PRO . . . . . 0.449 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 15.6 Cg_endo -60.31 142.78 98.96 Favored 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 122.665 2.244 . . . . 0.0 112.422 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.27 -26.98 72.99 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.21 3.273 . . . . 0.0 114.753 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 41.7 m -83.55 -1.19 53.23 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.11 0.481 . . . . 0.0 112.231 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.449 ' CG ' ' HG2' ' A' ' 329' ' ' PRO . 63.0 mm-40 -100.39 -11.29 20.37 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -45.84 -49.07 15.68 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' GLU . . . . . 0.41 ' HA ' HD22 ' A' ' 345' ' ' LEU . 45.4 tt0 -72.83 -34.59 66.92 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.97 0.414 . . . . 0.0 110.805 -175.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -65.51 -44.32 87.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 332' ' ' GLU . 66.2 mt -67.08 -43.57 88.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.155 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.19 -54.26 48.81 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.454 0.471 . . . . 0.0 110.653 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 75.3 m-85 -69.81 -23.09 63.27 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -66.88 -36.21 81.79 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.09 0.471 . . . . 0.0 109.981 175.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -100.96 2.58 40.83 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 83.61 22.31 56.32 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.649 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.47 123.09 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 28.7 p -100.62 -28.55 12.8 Favored 'General case' 0 C--N 1.27 -2.863 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.999 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.6 56.57 3.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.715 0.769 . . . . 0.0 111.74 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 334' ' ' GLU . 31.8 tp -58.2 -52.97 63.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.469 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.27 -26.49 68.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.729 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -65.37 -37.02 93.4 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 26.8 ttt -67.9 -50.85 53.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.27 -30.83 71.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.55 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -57.59 -56.77 17.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.913 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -72.48 -23.7 61.07 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.042 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.03 -28.67 64.56 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 120.992 0.425 . . . . 0.0 111.341 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -86.95 -20.72 26.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.677 0.751 . . . . 0.0 109.944 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -104.73 34.59 5.67 Favored Glycine 0 C--N 1.301 -1.391 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.663 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 69.6 mtm -68.09 3.91 1.43 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -81.65 -16.82 50.17 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.631 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -103.17 -177.8 3.48 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -139.8 105.2 5.07 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.295 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -22.97 11.46 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.516 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 71.23 173.38 0.31 Allowed 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.11 1.364 . . . . 0.0 112.583 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -58.19 -30.83 66.74 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.067 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.525 ' CB ' ' HZ3' ' A' ' 368' ' ' LYS . 47.9 m 68.18 64.73 0.35 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 122.775 1.274 . . . . 0.0 110.934 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.5 t -129.17 -15.11 4.24 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.172 -1.831 . . . . 0.0 108.569 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -90.43 -38.2 13.44 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 368' ' ' LYS . 11.9 m-85 -86.92 146.89 26.0 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 169.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -102.38 -15.67 16.46 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -168.5 125.04 1.01 Allowed 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.534 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 62.0 mttp -100.35 169.27 9.23 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 123.452 0.47 . . . . 0.0 110.16 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 70.3 mt -64.14 143.11 58.12 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.548 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -68.25 146.76 98.15 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -45.7 -43.44 18.68 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.817 3.011 . . . . 0.0 113.837 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -149.05 137.42 20.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.327 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.413 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 78.8 m-85 -118.78 159.61 23.4 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 127.08 28.15 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.486 HG21 ' HB ' ' A' ' 381' ' ' ILE . 14.0 p -133.4 160.87 42.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 14.1 m -95.66 142.84 27.5 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.403 ' HE2' ' OE2' ' A' ' 451' ' ' GLU . 0.4 OUTLIER -64.26 127.3 30.85 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.984 0.421 . . . . 0.0 110.099 -176.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 95.43 1.78 62.17 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.972 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -100.97 172.37 7.07 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.917 0.389 . . . . 0.0 110.887 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 26.5 mtpp -97.85 134.75 40.57 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.486 ' HB ' HG21 ' A' ' 375' ' ' VAL . 6.7 tp -130.31 135.99 59.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 26.8 ptt180 -127.58 128.74 46.11 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.406 0.622 . . . . 0.0 112.591 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 420' ' ' THR . 1.1 mm? -105.98 138.89 41.4 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.462 -1.244 . . . . 0.0 107.793 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 51.5 m -119.04 128.41 54.33 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.803 0.335 . . . . 0.0 111.794 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 13.5 m -126.41 145.08 34.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -118.33 136.83 53.49 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.607 HD23 ' HD3' ' A' ' 419' ' ' ARG . 3.9 mm? -95.59 152.37 18.49 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.066 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.74 -33.41 58.14 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -101.31 154.54 18.69 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -77.37 -40.34 44.18 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -174.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -103.34 7.39 38.23 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.788 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' ALA . . . . . 0.579 ' O ' ' HG ' ' A' ' 387' ' ' LEU . . . -84.14 132.63 34.67 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 175.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.95 177.31 7.2 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.034 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 438' ' ' VAL . 15.8 m -112.44 164.38 8.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.466 -175.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -107.92 148.76 29.2 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.42 ' CB ' ' HB ' ' A' ' 403' ' ' ILE . 9.5 m-90 -110.22 113.01 25.34 Favored 'General case' 0 C--N 1.274 -2.699 0 O-C-N 124.144 0.902 . . . . 0.0 109.587 -171.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 401' ' ' GLN . 7.8 mp -126.35 134.26 51.12 Favored 'General case' 0 CA--C 1.48 -1.727 0 CA-C-O 120.675 0.274 . . . . 0.0 111.217 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -113.95 132.76 55.84 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 46.95 24.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.89 14.79 64.24 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.43 ' O ' ' HG ' ' A' ' 397' ' ' LEU . 24.7 tp60 -94.61 -116.29 0.1 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -174.62 128.45 0.33 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 173.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.42 ' HB ' ' CB ' ' A' ' 396' ' ' TRP . 68.4 mt -81.56 101.9 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -82.23 127.68 33.43 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.69 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -66.22 102.47 0.84 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.7 m -110.92 110.0 20.4 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.877 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 52.32 -119.16 8.64 Favored Glycine 0 N--CA 1.444 -0.801 0 O-C-N 124.408 1.067 . . . . 0.0 114.048 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.7 m -108.23 5.74 26.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.205 0.526 . . . . 0.0 110.669 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.04 -41.01 59.98 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.835 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -117.4 109.75 17.17 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.323 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 43.5 mm -108.12 114.88 47.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.497 ' CE1' HD13 ' A' ' 421' ' ' LEU . 23.0 m-85 -87.85 105.96 17.77 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -98.02 108.65 21.41 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.444 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 12.6 p -103.4 105.08 15.26 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.575 0.702 . . . . 0.0 109.85 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 51.2 mt -112.75 83.75 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 76.83 -111.6 3.31 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -97.56 -14.01 21.3 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.135 0.493 . . . . 0.0 109.923 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -78.43 119.34 21.6 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 124.047 0.939 . . . . 0.0 111.023 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' ARG . . . . . 0.607 ' HD3' HD23 ' A' ' 387' ' ' LEU . 9.9 mpt_? -111.37 113.85 26.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 99.0 m -115.06 116.17 28.0 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.577 0.703 . . . . 0.0 110.593 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 382' ' ' ARG . 26.3 tp -91.0 115.5 28.06 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.106 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.2 m -103.85 112.23 25.11 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 56.8 mt -100.26 118.13 46.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 11.3 m -96.91 138.93 33.7 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 63.15 47.65 4.05 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 124.019 0.824 . . . . 0.0 110.599 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 44.4 t -57.92 118.6 5.54 Favored 'General case' 0 C--O 1.249 1.068 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 16.1 m -107.89 -177.81 3.44 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -175.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.78 -23.11 63.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.03 0.443 . . . . 0.0 110.604 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -74.39 -5.02 39.96 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.582 0.706 . . . . 0.0 110.27 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -110.88 -9.57 14.45 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.922 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.1 98.68 0.6 Allowed 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 170.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -164.78 173.67 11.53 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.575 -169.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.4 132.05 34.29 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 444' ' ' SER . 23.7 m-85 -111.42 132.06 54.73 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.1 134.4 55.03 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.447 ' SG ' HD11 ' A' ' 369' ' ' LEU . 73.4 m -109.45 113.07 25.57 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 11.0 t -105.34 125.24 60.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.732 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 394' ' ' VAL . 39.4 t -116.62 160.92 15.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -69.73 113.2 4.89 Favored Glycine 0 N--CA 1.419 -2.435 0 C-N-CA 118.316 -1.897 . . . . 0.0 109.39 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.22 -35.75 4.79 Favored Glycine 0 N--CA 1.425 -2.046 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.937 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' A' ' 362' ' ' SER . 86.7 mt-10 -135.81 158.0 45.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.576 1.188 . . . . 0.0 111.596 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -148.73 173.19 13.49 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 35.0 t -159.96 142.74 13.64 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 170.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 434' ' ' TYR . 12.3 p -122.1 130.94 53.69 Favored 'General case' 0 N--CA 1.418 -2.072 0 O-C-N 123.801 0.688 . . . . 0.0 110.09 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 10.7 t -107.02 142.3 36.86 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -98.58 110.02 22.69 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 38.7 tp -89.22 138.83 31.08 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.898 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -115.19 111.23 20.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.17 119.07 45.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 450' ' ' LYS . 0.0 OUTLIER -100.23 134.59 42.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.225 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 451' ' ' GLU . . . . . 0.403 ' OE2' ' HE2' ' A' ' 377' ' ' LYS . 44.9 tt0 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.643 ' N ' ' HG ' ' A' ' 318' ' ' SER . . . . . . . . 0 CA--C 1.503 -0.688 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -63.3 111.49 1.46 Allowed 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.157 1.905 . . . . 0.0 109.924 174.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 107.4 13.24 21.38 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' SER . . . . . 0.643 ' HG ' ' N ' ' A' ' 315' ' ' GLY . 10.1 m -125.32 0.37 7.71 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.128 0.49 . . . . 0.0 109.985 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.11 165.67 10.92 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -175.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 72.78 -4.88 2.01 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.616 1.166 . . . . 0.0 112.985 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.82 -33.08 33.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 C-N-CA 123.511 0.724 . . . . 0.0 111.272 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -54.02 -46.46 71.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.907 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.13 -38.11 18.08 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.702 177.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.01 -54.91 28.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 O-C-N 123.223 0.327 . . . . 0.0 111.613 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.15 -21.29 65.83 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.652 0.739 . . . . 0.0 110.148 -175.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -72.8 -37.53 67.53 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.075 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -94.03 -23.99 17.8 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.634 0.73 . . . . 0.0 110.431 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.34 89.51 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.763 -176.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' PRO . . . . . 0.406 ' HG2' ' HG2' ' A' ' 332' ' ' GLU . 24.5 Cg_endo -63.85 137.55 58.75 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.509 2.139 . . . . 0.0 112.649 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.638 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 8.9 Cg_endo -52.23 -29.44 37.89 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.302 3.335 . . . . 0.0 115.555 -175.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 11.8 p -70.86 -23.84 62.39 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' ' 336' ' ' ILE . 22.1 mm-40 -95.27 -4.51 45.55 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -171.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.638 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 21.5 m-30 -46.12 -48.59 17.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -173.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.04 -29.46 68.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.061 0.458 . . . . 0.0 111.42 -175.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -76.01 -47.29 25.42 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 332' ' ' GLU . 60.7 mt -58.45 -44.12 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.117 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.85 -58.52 8.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.305 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -68.69 -23.51 64.39 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -71.13 -35.68 71.83 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.16 0.584 . . . . 0.0 110.03 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -100.9 5.35 43.28 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 79.89 38.53 19.37 Favored Glycine 0 C--N 1.31 -0.912 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.699 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.9 t -114.82 119.14 60.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 23.6 p -99.1 -14.55 19.35 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-O 121.556 0.693 . . . . 0.0 110.751 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.79 45.43 0.97 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.327 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.617 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 1.3 pt? -68.33 -36.12 78.79 Favored 'General case' 0 C--O 1.197 -1.67 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.986 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -71.9 -24.4 61.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.183 0.516 . . . . 0.0 111.113 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.589 ' O ' ' HG2' ' A' ' 350' ' ' LYS . . . -77.11 -28.79 57.8 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 174.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 26.6 ttt -78.67 -41.76 30.38 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.271 0.557 . . . . 0.0 109.583 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 81.4 mt -64.92 -35.12 80.13 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.844 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 347' ' ' GLY . 25.2 pttm -61.21 -27.26 68.31 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.215 0.531 . . . . 0.0 111.232 -177.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -62.47 -50.11 72.74 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.896 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.09 -32.87 30.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.413 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -68.63 -38.29 80.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.104 0.478 . . . . 0.0 110.217 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -102.4 26.82 22.87 Favored Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 35.0 tpp -85.15 -60.64 1.98 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.85 0.357 . . . . 0.0 111.083 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -91.42 -13.29 32.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.842 0.829 . . . . 0.0 110.678 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' ARG . . . . . 0.406 ' C ' ' HD3' ' A' ' 357' ' ' ARG . 1.7 tmt_? -70.94 94.93 1.11 Allowed 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 172.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -156.15 -48.81 0.08 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -66.68 -19.72 65.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.825 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 71.59 -84.82 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.871 1.268 . . . . 0.0 108.149 -172.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt 46.74 -87.22 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.263 1.425 . . . . 0.0 113.107 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 54.3 p -170.48 78.62 0.08 Allowed 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 16.7 p -111.69 -30.47 7.32 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.471 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.64 -13.47 15.57 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -110.32 136.02 50.15 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.198 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -98.02 -19.78 17.8 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.389 0.614 . . . . 0.0 110.016 175.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -158.5 122.35 3.98 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.721 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 45.4 mtpt -106.69 172.33 6.87 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 80.9 mt -75.04 132.67 41.48 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.02 127.97 88.56 Favored Pre-proline 0 CA--C 1.5 -0.973 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.64 -32.18 53.32 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.279 1.986 . . . . 0.0 112.438 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -110.57 110.97 21.89 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.467 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 13.9 m-85 -118.43 151.07 38.49 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 171.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -144.87 143.54 30.64 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 10.6 p -150.63 154.89 8.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 16.1 m -85.55 157.19 20.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' LYS . . . . . 0.526 ' HG3' ' HA ' ' A' ' 427' ' ' SER . 35.6 ttpt -71.98 135.35 46.38 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.782 0.325 . . . . 0.0 111.071 -177.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 85.86 15.58 65.1 Favored Glycine 0 C--N 1.318 -0.469 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.8 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -105.35 -177.53 3.39 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.984 0.421 . . . . 0.0 110.317 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -114.63 138.46 50.64 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.95 130.71 73.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 CA-C-O 120.904 0.383 . . . . 0.0 109.98 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -108.27 103.62 12.83 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.161 0.505 . . . . 0.0 110.475 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.26 113.11 20.88 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 19.9 m -110.35 130.86 55.47 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.149 -171.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.7 151.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 123.55 0.74 . . . . 0.0 109.69 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.486 ' HG2' ' HB3' ' A' ' 418' ' ' LYS . 50.0 mt-10 -118.55 131.61 56.22 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.457 HD22 HG21 ' A' ' 438' ' ' VAL . 26.1 mt -100.91 148.94 24.41 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -81.84 3.87 24.42 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.088 0.471 . . . . 0.0 111.782 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -142.43 136.84 29.89 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -80.42 -21.87 41.76 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.564 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -102.58 4.51 38.49 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.153 0.978 . . . . 0.0 110.042 -173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -100.21 134.84 42.56 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.96 175.89 5.24 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.847 -174.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 4.8 p -131.36 141.32 46.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 120.967 0.413 . . . . 0.0 111.082 -172.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -114.02 135.85 53.55 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 175.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.683 ' HB3' HD12 ' A' ' 403' ' ' ILE . 68.4 m95 -104.35 134.35 47.7 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.913 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 8.3 mp -119.85 125.75 49.29 Favored 'General case' 0 CA--C 1.475 -1.909 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.031 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -102.62 127.38 49.75 Favored 'General case' 0 N--CA 1.416 -2.147 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.702 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 20.9 p30 54.95 15.38 1.14 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 127.125 2.17 . . . . 0.0 113.498 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.2 19.37 42.59 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.251 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -98.13 -89.29 0.3 Allowed 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 169.63 145.9 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.695 HD11 ' HD1' ' A' ' 434' ' ' TYR . 30.3 mt -99.24 108.04 21.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -95.96 134.01 39.48 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.159 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -65.74 104.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.461 0.475 . . . . 0.0 110.674 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 30.6 t -117.44 120.76 39.11 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 50.84 -122.42 13.59 Favored Glycine 0 C--N 1.336 0.579 0 O-C-N 124.25 0.969 . . . . 0.0 113.574 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 23.8 m -116.72 19.6 14.42 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -76.5 -44.6 34.53 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.01 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -122.47 108.53 13.28 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.951 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 3.7 mp -105.24 114.89 45.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -88.09 104.82 17.03 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.442 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -99.37 119.14 37.47 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 13.1 t -115.26 108.18 16.24 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 66.0 mt -113.95 82.75 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.345 -174.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.21 -104.17 1.14 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.144 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -94.26 -21.89 18.74 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 122.409 0.284 . . . . 0.0 110.851 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 386' ' ' GLU . 21.5 ptmt -101.45 137.08 40.25 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.713 0.768 . . . . 0.0 111.47 -175.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -118.47 139.06 52.01 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.022 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 34.4 m -134.37 117.24 16.12 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-O 121.483 0.659 . . . . 0.0 110.503 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 57.1 tp -91.2 113.45 25.71 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.415 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 29.1 m -97.59 106.72 19.08 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.73 116.4 33.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 14.7 m -96.5 146.09 25.11 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.001 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 58.26 50.4 9.77 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.189 1.396 . . . . 0.0 110.15 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 8.0 p -60.46 112.96 2.17 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.73 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' SER . . . . . 0.526 ' HA ' ' HG3' ' A' ' 377' ' ' LYS . 17.7 m -109.98 -170.46 1.65 Allowed 'General case' 0 N--CA 1.406 -2.629 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.08 -21.06 62.28 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 118.964 0.802 . . . . 0.0 111.736 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -73.24 -14.31 61.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.375 0.607 . . . . 0.0 110.077 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -98.34 9.08 43.88 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.78 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.5 107.64 17.54 Favored 'General case' 0 C--O 1.252 1.22 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -155.44 165.01 37.93 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.99 0.424 . . . . 0.0 110.556 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -86.59 115.35 24.01 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' TYR . . . . . 0.695 ' HD1' HD11 ' A' ' 403' ' ' ILE . 98.5 m-85 -104.87 133.05 50.33 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.019 0.438 . . . . 0.0 110.578 -175.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 2.0 mp0 -128.08 134.29 49.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 3.7 p -100.89 118.36 36.79 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.65 123.29 58.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.457 HG21 HD22 ' A' ' 387' ' ' LEU . 92.9 t -131.44 160.68 42.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.18 114.61 7.05 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.031 -1.081 . . . . 0.0 111.059 175.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.83 -36.49 4.32 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-O 119.31 -0.717 . . . . 0.0 113.7 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -139.16 -179.75 6.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.728 1.251 . . . . 0.0 114.228 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 443' ' ' CYS . 33.0 ttmt -149.24 157.12 43.09 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.4 t -143.63 134.43 25.24 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 171.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.42 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 12.2 p -110.15 142.77 41.2 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 123.573 0.545 . . . . 0.0 110.917 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.467 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 8.8 t -137.87 147.59 44.6 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.23 111.13 23.37 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 64.5 tp -88.82 111.3 21.86 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -93.13 107.87 19.58 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.8 t -92.22 114.23 28.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -107.2 124.13 49.29 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.427 -1.577 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.975 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.836 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.08 103.13 1.7 Allowed 'Trans proline' 0 C--O 1.251 1.14 0 C-N-CA 122.621 2.214 . . . . 0.0 110.807 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -131.04 10.54 5.65 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.321 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 28.7 m -135.55 27.58 3.37 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.725 0.774 . . . . 0.0 109.543 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.38 -45.63 10.38 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.502 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 72.68 1.0 3.84 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.681 1.592 . . . . 0.0 111.902 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.89 -36.31 49.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 123.438 0.695 . . . . 0.0 111.675 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 31.9 p-90 -58.22 -41.63 84.5 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 123.182 0.593 . . . . 0.0 111.653 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.6 -45.97 10.55 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 80.1 mt -58.2 -52.44 58.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.0 tt -66.43 -33.54 75.94 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 121.501 0.667 . . . . 0.0 109.617 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -64.47 -32.89 74.71 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 124.524 1.129 . . . . 0.0 111.446 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.97 -11.08 25.03 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.331 0.586 . . . . 0.0 110.845 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -83.84 161.77 54.68 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.412 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.52 142.25 58.49 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.68 2.254 . . . . 0.0 110.829 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.98 -16.69 56.31 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 123.784 2.989 . . . . 0.0 114.199 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.4 m -77.54 -17.07 58.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.719 0.295 . . . . 0.0 111.765 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -104.43 1.13 29.72 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' TYR . . . . . 0.404 ' HB3' ' CD1' ' A' ' 345' ' ' LEU . 8.8 m-30 -53.4 -42.54 67.07 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -174.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.8 -27.87 55.4 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.395 -177.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 -63.62 -54.44 35.83 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 34.0 mt -64.01 -43.41 97.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.751 -176.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.47 -59.99 4.56 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.2 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.26 -22.78 66.32 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -65.67 -42.56 91.16 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.235 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -97.95 7.04 46.99 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 90.07 13.72 60.13 Favored Glycine 0 CA--C 1.499 -0.912 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.904 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.0 t -94.54 99.43 9.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.3 m -76.39 -38.75 55.25 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.082 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -110.09 94.21 4.9 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.643 0.735 . . . . 0.0 109.873 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.615 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.8 pt? -75.65 -29.8 59.22 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.356 -178.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -63.86 -38.65 91.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.479 -174.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -66.13 -34.79 89.3 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.79 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 60.9 ttp -70.46 -43.3 70.12 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 353' ' ' LYS . 94.3 mt -62.1 -40.46 95.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.493 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -65.86 -33.4 75.75 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.854 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -70.21 -42.24 72.59 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.256 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.26 -42.16 69.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 349' ' ' LEU . 18.6 ptpt -77.06 -16.92 59.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.867 0.841 . . . . 0.0 109.224 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -83.83 0.76 89.4 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.005 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 25.5 mmt -71.7 -10.9 60.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 122.068 0.937 . . . . 0.0 108.762 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -78.3 16.95 0.69 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.123 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 358' ' ' ASP . 7.6 ppt_? -66.7 -19.68 65.81 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.517 0.675 . . . . 0.0 109.961 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.439 ' O ' ' HD2' ' A' ' 357' ' ' ARG . 8.4 t70 67.04 -154.71 0.22 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.551 171.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 63.8 66.51 0.66 Allowed 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.514 1.126 . . . . 0.0 109.836 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -100.82 176.84 5.15 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.667 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.62 32.48 22.21 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 123.09 1.424 . . . . 0.0 107.556 -176.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 15.6 m -158.39 45.69 0.32 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.034 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.8 t -101.51 -37.36 8.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.335 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.511 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -86.39 -27.06 24.44 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.869 0.842 . . . . 0.0 109.482 177.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.65 127.63 35.95 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.23 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -90.54 -28.37 18.55 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.4 OUTLIER -149.46 115.4 5.68 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 177.552 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.428 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 57.9 mtpt -89.85 162.09 15.65 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 175.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 74.5 mt -64.57 138.65 58.52 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -61.83 145.0 92.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.76 -24.09 44.8 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.6 2.2 . . . . 0.0 113.437 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -142.68 135.6 28.2 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.87 0.367 . . . . 0.0 111.668 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -135.69 146.79 48.12 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -131.05 136.04 48.1 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.47 146.41 31.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 15.5 m -82.79 142.37 31.62 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -57.38 115.84 2.96 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 122.958 0.503 . . . . 0.0 111.248 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 108.03 -18.51 33.81 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.504 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -82.25 179.98 7.61 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.114 0.483 . . . . 0.0 110.925 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 54.3 mtpt -108.76 140.07 42.69 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.574 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.6 tp -127.12 133.25 68.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 176.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -105.87 112.6 25.72 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.918 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.51 110.65 22.44 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 45.0 m -108.32 128.89 55.14 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.65 143.45 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 172.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 18.0 mt-10 -120.13 138.37 53.62 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.41 HD12 ' NH1' ' A' ' 419' ' ' ARG . 95.5 mt -100.19 152.35 20.37 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -85.24 -14.63 46.14 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.403 0.621 . . . . 0.0 110.081 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 392' ' ' ALA . 10.6 t70 -117.84 141.47 48.39 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -79.99 -26.84 39.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.795 0.331 . . . . 0.0 111.718 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -108.04 25.61 11.38 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.632 1.206 . . . . 0.0 109.896 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 389' ' ' ASP . . . -96.75 154.97 16.98 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.15 149.23 51.95 Favored 'General case' 0 C--N 1.274 -2.7 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.116 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 5.3 m -105.92 135.79 42.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.056 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.1 tptm -103.74 136.69 42.97 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 173.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' TRP . . . . . 0.544 ' HB3' HD12 ' A' ' 403' ' ' ILE . 4.8 m-90 -103.23 118.53 36.99 Favored 'General case' 0 C--N 1.264 -3.148 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.981 -170.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.7 mp -128.75 130.21 46.77 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 120.966 0.412 . . . . 0.0 111.757 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -109.22 128.06 54.75 Favored 'General case' 0 N--CA 1.412 -2.363 0 C-N-CA 118.886 -1.126 . . . . 0.0 108.894 170.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.5 p30 49.57 23.86 1.03 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.698 1.599 . . . . 0.0 113.295 -176.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.34 4.96 60.74 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.737 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -90.12 -92.26 0.13 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.501 0.191 . . . . 0.0 110.6 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 171.77 133.69 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.544 HD12 ' HB3' ' A' ' 396' ' ' TRP . 15.0 mt -94.71 124.84 47.36 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 173.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -123.76 145.17 49.22 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.996 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 27.3 ttt -64.91 94.26 0.13 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.677 0.791 . . . . 0.0 111.32 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.6 t -93.5 101.08 13.26 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.23 -128.8 48.21 Favored Glycine 0 N--CA 1.446 -0.659 0 O-C-N 123.915 0.759 . . . . 0.0 112.191 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.7 m -105.24 18.16 22.78 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.395 0.617 . . . . 0.0 109.599 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 424' ' ' SER . 86.5 tttt -83.03 -59.76 2.38 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.359 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' TYR . . . . . 0.533 ' O ' ' HG3' ' A' ' 405' ' ' MET . 75.9 m-85 -96.44 108.12 20.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.76 115.13 48.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.189 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 421' ' ' LEU . 25.4 m-85 -87.41 106.02 17.67 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.8 108.76 21.53 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 29.8 t -95.64 122.8 38.79 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.498 ' HB ' ' CG ' ' A' ' 418' ' ' LYS . 58.3 mt -129.08 85.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.75 -98.03 0.33 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.491 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -92.26 -28.96 16.66 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.849 0.357 . . . . 0.0 110.57 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' LYS . . . . . 0.498 ' CG ' ' HB ' ' A' ' 415' ' ' ILE . 23.2 ptmt -92.55 146.72 23.45 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.896 0.855 . . . . 0.0 112.143 -175.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' ARG . . . . . 0.41 ' NH1' HD12 ' A' ' 387' ' ' LEU . 11.4 mpt_? -125.25 125.07 42.99 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 173.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 34.7 m -121.18 126.61 50.11 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 120.925 0.393 . . . . 0.0 110.279 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' LEU . . . . . 0.56 HD13 ' CE2' ' A' ' 412' ' ' PHE . 33.4 tp -98.15 108.44 21.15 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.7 m -94.83 105.23 17.15 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.718 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 52.4 mt -90.06 115.7 30.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 19.5 m -102.25 128.67 48.69 Favored 'General case' 0 N--CA 1.406 -2.635 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 69.97 59.93 0.27 Allowed 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 124.343 1.027 . . . . 0.0 110.148 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 381' ' ' ILE . 27.8 m -66.23 113.72 4.78 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.268 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 14.5 m -106.43 -166.37 1.18 Allowed 'General case' 0 N--CA 1.404 -2.762 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 54.5 mt -77.84 -22.48 49.86 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.315 -174.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -73.03 -6.41 45.34 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.64 0.733 . . . . 0.0 110.277 176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -103.69 2.71 33.45 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.077 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -87.36 100.04 12.43 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -154.58 167.19 30.95 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.78 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.66 122.9 30.42 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 170.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' TYR . . . . . 0.534 ' HD2' HD11 ' A' ' 403' ' ' ILE . 94.8 m-85 -108.04 132.25 53.74 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 120.754 0.311 . . . . 0.0 110.468 -176.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 2.1 mp0 -121.86 126.08 47.9 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.098 0.475 . . . . 0.0 110.668 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 10.7 p -95.48 113.95 25.67 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.4 123.91 65.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.747 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.48 162.69 32.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.5 113.09 5.55 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 118.448 -1.834 . . . . 0.0 110.727 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.26 -35.23 5.1 Favored Glycine 0 N--CA 1.429 -1.818 0 CA-C-O 119.661 -0.522 . . . . 0.0 113.524 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.511 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 3.3 mm-40 -130.84 154.2 48.29 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 117.944 0.872 . . . . 0.0 110.75 -173.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -148.58 154.65 40.05 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 435' ' ' GLN . 13.6 t -147.74 139.45 23.95 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.419 ' HB3' ' OE1' ' A' ' 435' ' ' GLN . 3.4 m -115.78 118.99 34.56 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.739 0.649 . . . . 0.0 109.465 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 11.0 t -105.92 146.23 30.26 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -101.59 110.29 22.25 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 66.6 tp -96.2 118.04 31.97 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -101.76 117.73 35.48 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.68 113.13 30.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -95.09 119.29 33.34 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 9.0 p -45.93 -29.35 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.185 0 C-N-CA 125.957 1.703 . . . . 0.0 113.769 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -62.62 -56.38 18.37 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.807 0.843 . . . . 0.0 110.878 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.49 -31.12 66.74 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.255 0.55 . . . . 0.0 110.052 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.51 -50.58 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.364 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.67 -35.97 82.74 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.064 0.459 . . . . 0.0 110.497 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -57.61 -33.9 68.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.33 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -109.42 6.63 24.45 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.288 -175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -89.59 155.78 48.12 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -62.91 136.56 57.71 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.34 2.027 . . . . 0.0 110.508 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 9.7 Cg_endo -54.23 -34.37 79.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.731 2.954 . . . . 0.0 115.496 -172.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 37.4 t -78.74 -13.98 59.52 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.399 -0.521 . . . . 0.0 112.252 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -98.67 -0.26 43.3 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.98 -174.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.51 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 20.8 m-30 -52.36 -45.21 65.66 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.2 -37.96 78.37 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.521 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 38.8 ttm-85 -63.21 -49.41 74.32 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 339' ' ' GLN . 41.6 mt -71.12 -37.01 65.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.539 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.95 -54.75 41.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.44 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -65.13 -24.31 67.38 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 336' ' ' ILE . 35.2 tt0 -61.88 -36.63 81.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.305 0.574 . . . . 0.0 109.577 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -98.52 -1.37 41.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.028 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 102.03 -5.73 53.4 Favored Glycine 0 C--O 1.244 0.738 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.333 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.64 134.12 27.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 121.369 0.604 . . . . 0.0 109.838 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 -10.82 12.05 Favored 'General case' 0 C--N 1.266 -3.045 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.362 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -100.95 45.53 0.97 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 49.9 p . . . . . 0 N--CA 1.431 -1.417 0 CA-C-O 121.252 0.549 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.523 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -85.61 -11.75 53.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.135 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.516 ' CD2' ' HB3' ' A' ' 441' ' ' GLU . 0.7 OUTLIER -94.84 145.64 24.76 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.204 175.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -108.33 -21.19 12.86 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -156.88 121.22 4.39 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.473 ' HG2' ' CD2' ' A' ' 365' ' ' PHE . 27.9 mtpp -101.3 163.12 12.43 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 54.0 mt -66.26 154.39 40.02 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 123.659 0.599 . . . . 0.0 111.118 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -68.09 161.62 66.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.093 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -55.39 -41.53 77.2 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.196 1.93 . . . . 0.0 111.362 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -154.72 162.43 41.12 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.152 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -136.2 141.46 44.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.6 132.32 55.2 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' A' ' 381' ' ' ILE . 11.0 p -133.51 153.67 37.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 379' ' ' HIS . 14.5 m -85.19 145.32 27.65 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 427' ' ' SER . 0.7 OUTLIER -72.65 121.26 19.47 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.08 13.94 40.99 Favored Glycine 0 CA--C 1.494 -1.259 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 376' ' ' SER . 35.6 t60 -118.9 150.34 40.05 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -91.0 127.01 36.25 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.317 0.647 . . . . 0.0 111.03 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.667 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.4 tt -124.26 163.7 23.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 0.8 OUTLIER -143.58 137.37 28.34 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.941 0.401 . . . . 0.0 110.037 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -100.37 151.33 21.64 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 38.8 m -133.01 121.94 23.47 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.024 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 12.6 m -127.05 143.85 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.08 135.71 55.13 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.415 HD13 ' HD3' ' A' ' 419' ' ' ARG . 5.7 mp -99.29 161.89 13.36 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -83.62 1.94 39.85 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.131 0.491 . . . . 0.0 110.599 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -138.85 146.37 41.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -80.73 -28.52 36.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -104.85 4.5 32.17 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.481 0.657 . . . . 0.0 111.074 -171.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -88.32 153.13 21.45 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.27 166.14 15.77 Favored 'General case' 0 C--N 1.268 -2.96 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.938 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 3.7 m -113.76 159.99 13.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.118 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 437' ' ' VAL . 31.7 mmmt -106.12 139.18 41.04 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.418 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 11.8 m-90 -113.46 111.51 22.05 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.3 mp -124.38 137.63 54.45 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.008 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -113.51 118.5 34.65 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.2 p30 50.4 18.61 0.45 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 126.104 1.762 . . . . 0.0 113.742 -175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.87 1.44 27.13 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.736 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -113.69 132.35 55.83 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 48.8 mt-10 -61.66 118.18 6.76 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 57.8 mt -71.16 108.96 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -100.41 150.72 22.33 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.536 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 86.7 mtp -67.63 96.88 0.57 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.101 0.477 . . . . 0.0 110.87 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.9 m -91.25 101.24 13.95 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 58.35 -130.73 51.44 Favored Glycine 0 N--CA 1.446 -0.646 0 O-C-N 123.704 0.627 . . . . 0.0 112.092 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 15.6 m -102.7 13.02 35.49 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.671 0.748 . . . . 0.0 109.307 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -82.6 -41.75 19.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.207 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.536 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 72.7 m-85 -113.25 111.43 22.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 64.2 mt -122.49 117.69 52.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.05 0.452 . . . . 0.0 110.92 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.506 ' CD2' HD13 ' A' ' 421' ' ' LEU . 21.4 m-85 -87.37 109.14 19.34 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.72 108.41 19.87 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.9 p -102.19 105.55 16.25 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.743 0.782 . . . . 0.0 111.64 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.9 mm -100.37 87.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.21 -111.58 3.65 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.331 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -98.1 -6.04 32.46 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.617 0.723 . . . . 0.0 109.813 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -91.39 111.27 22.7 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.55 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . 0.415 ' HD3' HD13 ' A' ' 387' ' ' LEU . 10.8 mpt_? -98.54 113.36 25.36 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.4 m -111.41 119.18 37.96 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.506 HD13 ' CD2' ' A' ' 412' ' ' PHE . 19.1 tp -97.09 107.47 20.0 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 96.2 m -94.26 123.05 37.41 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.409 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 59.7 mt -111.67 116.44 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 9.8 m -86.45 130.54 34.46 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.372 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 56.05 74.32 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.595 1.184 . . . . 0.0 111.697 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . 0.667 ' SG ' HG22 ' A' ' 381' ' ' ILE . 68.1 m -69.14 125.38 26.49 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.226 0.536 . . . . 0.0 111.25 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . 0.417 ' HA ' ' HG2' ' A' ' 377' ' ' LYS . 77.5 p -109.28 -177.08 3.2 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 90.2 mt -72.63 -14.93 61.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.19 -20.58 48.02 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.694 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.58 -19.67 27.49 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.474 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.19 99.11 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -163.48 171.51 15.8 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.085 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -87.74 127.75 35.31 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -104.96 134.98 47.16 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.635 ' N ' HE21 ' A' ' 435' ' ' GLN . 0.0 OUTLIER -124.34 118.38 26.62 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 369' ' ' LEU . 83.0 m -96.45 108.02 20.5 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 171.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 26.3 t -105.92 117.25 51.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.977 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.75 155.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.58 112.13 4.56 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 117.758 -2.163 . . . . 0.0 111.001 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 105.51 -17.81 42.46 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.523 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 64.8 mm-40 -141.38 112.31 7.24 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -134.23 159.6 40.42 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 435' ' ' GLN . 47.8 t -142.48 134.47 27.21 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.1 m -108.92 110.6 21.96 Favored 'General case' 0 N--CA 1.426 -1.648 0 O-C-N 124.197 0.935 . . . . 0.0 109.267 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.3 t -102.04 150.11 23.57 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -114.6 116.4 28.69 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.455 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 49.3 tp -84.66 134.22 34.37 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -112.46 109.85 19.69 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.32 112.43 26.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.306 0.574 . . . . 0.0 109.59 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.95 116.05 28.47 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.427 -1.593 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.127 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.425 ' HA ' ' HB ' ' A' ' 324' ' ' ILE . 13.3 p -61.43 -23.19 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 124.068 0.947 . . . . 0.0 112.66 -175.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -68.62 -41.78 79.02 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.167 0.508 . . . . 0.0 109.939 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.9 -28.33 27.98 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.217 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 321' ' ' VAL . 76.2 mt -69.39 -47.12 74.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.536 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.89 -34.22 77.64 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.058 0.456 . . . . 0.0 111.257 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -59.27 -41.56 89.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -99.46 -0.41 40.83 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.515 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -71.15 155.5 93.07 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.463 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.68 134.21 46.17 Favored 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.346 2.031 . . . . 0.0 110.549 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 11.7 Cg_endo -53.66 -28.68 47.65 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 124.115 3.21 . . . . 0.0 115.172 -172.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 11.7 m -86.05 -15.02 42.65 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -101.26 3.49 40.9 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.148 -172.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 22.0 m-30 -50.94 -44.73 60.4 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.545 0.528 . . . . 0.0 112.264 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -59.92 -53.64 55.48 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 123.394 0.434 . . . . 0.0 112.14 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 53.4 ttp85 -61.73 -39.34 91.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.435 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 56.4 mt -73.01 -38.96 56.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.127 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.67 -56.83 16.64 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.061 0.545 . . . . 0.0 111.027 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -67.4 -23.54 65.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -65.99 -47.28 75.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.137 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -83.88 -19.29 35.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.162 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 100.77 40.56 2.88 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.086 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.97 128.24 63.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 19.1 p -104.3 -14.48 15.77 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 121.24 0.543 . . . . 0.0 110.44 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -79.28 44.75 0.6 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.331 0.586 . . . . 0.0 111.26 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 46.3 tp . . . . . 0 C--N 1.297 -1.696 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.301 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.438 HG22 ' OE2' ' A' ' 441' ' ' GLU . 7.3 t . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.556 0.217 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.563 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -92.55 -10.47 37.49 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.924 0.392 . . . . 0.0 111.069 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.21 110.07 20.12 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.903 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 386' ' ' GLU . 25.8 mt-30 -74.26 -29.3 61.61 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.527 0.679 . . . . 0.0 109.655 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 367' ' ' LYS . 34.3 ttmt -149.38 119.21 7.07 Favored 'General case' 0 N--CA 1.398 -3.026 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -176.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.662 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 57.9 mtpt -100.04 166.21 11.14 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.758 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 71.4 mt -69.12 136.42 52.19 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.541 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -59.36 150.66 63.27 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -46.66 -39.27 23.19 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 123.095 2.53 . . . . 0.0 113.115 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -147.46 165.37 30.48 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.471 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -142.45 144.39 33.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.38 140.42 52.97 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.6 p -145.93 152.74 13.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 25.1 m -91.14 150.85 21.21 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.32 128.79 37.73 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.871 0.367 . . . . 0.0 110.486 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 88.34 6.77 73.78 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.6 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 376' ' ' SER . 10.1 m-70 -102.75 -178.52 3.7 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.764 0.316 . . . . 0.0 110.21 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -119.65 141.24 49.52 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.467 HG22 ' SG ' ' A' ' 426' ' ' CYS . 16.1 tt -141.4 155.42 20.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 2.6 ptm180 -141.18 134.85 30.15 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.347 0.594 . . . . 0.0 110.598 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.57 125.21 48.19 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.817 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 54.1 m -106.28 121.28 43.9 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.702 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.44 144.12 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 366' ' ' GLN . 33.3 mt-10 -124.41 131.44 53.5 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.479 HD21 HG13 ' A' ' 394' ' ' VAL . 3.4 mm? -89.86 159.86 16.77 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.8 -25.55 56.48 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.3 0.571 . . . . 0.0 110.261 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -131.2 159.41 37.81 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.124 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -80.8 -25.33 37.92 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.261 0.553 . . . . 0.0 109.895 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.08 3.19 40.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.051 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -99.93 118.02 35.46 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -103.01 163.73 12.03 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.167 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.479 HG13 HD21 ' A' ' 387' ' ' LEU . 3.7 m -117.81 141.09 38.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.484 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -109.46 122.9 48.42 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.414 ' O ' HD12 ' A' ' 397' ' ' LEU . 3.6 m-90 -93.37 114.0 26.31 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.665 -170.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 396' ' ' TRP . 7.8 mp -127.3 137.67 52.88 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 175.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 433' ' ' ALA . 60.4 pttt -117.34 119.45 35.17 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.8 p30 50.95 20.72 0.84 Allowed 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 125.415 1.486 . . . . 0.0 113.236 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . 0.4 ' HA2' HD23 ' A' ' 397' ' ' LEU . . . 103.02 2.28 48.72 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.985 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -108.58 123.43 48.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -53.01 121.13 6.79 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.515 0.509 . . . . 0.0 110.603 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 53.1 mt -79.19 102.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -100.3 145.58 27.96 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.417 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 87.8 mtp -60.63 100.74 0.11 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.301 0.572 . . . . 0.0 111.617 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.7 m -102.6 103.1 13.38 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.115 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.99 -134.41 50.83 Favored Glycine 0 N--CA 1.442 -0.95 0 O-C-N 124.008 0.817 . . . . 0.0 113.307 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.3 t -99.98 7.72 44.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 26.2 ttmt -75.7 -54.43 6.97 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.708 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.417 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 60.4 m-85 -102.33 107.66 18.76 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.121 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.05 110.15 30.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.365 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.564 ' CE1' HD13 ' A' ' 421' ' ' LEU . 22.4 m-85 -87.27 106.13 17.7 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.45 108.04 19.92 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.433 0.635 . . . . 0.0 110.464 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.86 107.19 19.03 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.53 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.41 84.27 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.74 -111.3 3.4 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.84 -6.86 26.15 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.256 0.55 . . . . 0.0 110.029 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -82.44 113.01 19.9 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.721 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -108.8 107.45 17.88 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.7 m -109.36 116.92 32.76 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.128 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.564 HD13 ' CE1' ' A' ' 412' ' ' PHE . 21.0 tp -91.17 106.39 18.48 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.3 m -93.84 119.99 33.51 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 54.5 mt -107.34 115.37 48.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.5 m -99.99 131.76 45.75 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 68.52 61.65 0.36 Allowed 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.355 1.062 . . . . 0.0 111.494 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . 0.467 ' SG ' HG22 ' A' ' 381' ' ' ILE . 59.7 m -62.95 121.74 14.29 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.561 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.3 p -113.82 -175.0 2.58 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.72 -18.77 62.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.261 0.553 . . . . 0.0 110.39 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -78.92 -11.17 59.99 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.752 0.787 . . . . 0.0 110.101 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . 0.429 ' OD1' ' HD3' ' A' ' 409' ' ' LYS . 23.2 m-20 -96.49 -19.48 19.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.976 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.04 103.15 0.9 Allowed 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -165.05 167.59 18.19 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 398' ' ' LYS . . . -85.76 124.15 31.93 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -104.67 139.46 39.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.426 ' HB3' ' CB ' ' A' ' 444' ' ' SER . 0.0 OUTLIER -142.97 138.76 30.31 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 121.173 0.511 . . . . 0.0 110.767 177.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 62.2 m -101.96 112.05 24.54 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.115 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.95 110.13 23.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.708 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 57.9 t -112.41 157.07 13.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.25 113.3 5.46 Favored Glycine 0 N--CA 1.428 -1.873 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.829 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 102.6 -33.47 6.53 Favored Glycine 0 N--CA 1.425 -2.033 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.158 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 24.7 mm-40 -132.44 131.37 41.67 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.365 0.602 . . . . 0.0 111.582 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 443' ' ' CYS . 33.5 ttmt -126.36 158.03 36.95 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 49.3 t -148.39 134.0 18.78 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 435' ' ' GLN . 34.0 t -123.79 139.27 54.15 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.8 t -125.62 150.48 47.51 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -106.85 110.87 23.15 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.395 0.616 . . . . 0.0 110.593 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -89.6 139.67 30.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.001 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 450' ' ' LYS . 53.9 t80 -121.69 117.02 25.62 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 123.609 0.763 . . . . 0.0 110.891 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 56.5 t -97.51 119.47 45.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 376' ' ' SER . 0.0 OUTLIER -110.67 137.52 48.24 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.227 174.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.701 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.501 -0.922 0 CA-C-O 120.642 0.258 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.29 -35.52 36.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.745 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . 0.475 ' O ' ' HB2' ' A' ' 326' ' ' ARG . 17.7 m95 -56.6 -60.4 3.59 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 124.024 0.93 . . . . 0.0 110.913 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.85 -41.32 95.79 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.488 0.492 . . . . 0.0 111.657 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.4 mt -68.06 -42.88 85.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 123.095 0.558 . . . . 0.0 111.545 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.6 -36.24 60.36 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 322' ' ' TRP . 14.3 tpt85 -63.94 -41.15 97.7 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.364 0.666 . . . . 0.0 111.345 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.76 -4.59 59.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.547 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -87.92 150.3 47.51 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.59 150.24 82.9 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.817 1.678 . . . . 0.0 111.273 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.1 -29.31 3.93 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.644 3.563 . . . . 0.0 115.96 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 50.5 m -85.41 -2.06 57.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -93.44 -22.26 19.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -44.08 -52.51 7.13 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.86 1.264 . . . . 0.0 112.905 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -57.0 -53.0 63.03 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.433 0.693 . . . . 0.0 111.858 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -57.87 -50.37 73.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.983 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.67 -40.43 89.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.892 -175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.94 -57.72 11.56 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.623 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -68.89 -23.02 64.15 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -64.14 -44.8 91.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.92 0.39 . . . . 0.0 110.082 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -91.13 -8.4 48.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 89.13 32.5 10.56 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.442 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 17.6 t -94.52 122.8 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.338 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 9.3 p -97.82 -22.57 16.31 Favored 'General case' 0 C--N 1.276 -2.618 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.934 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -83.89 63.23 7.43 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.714 0.768 . . . . 0.0 110.297 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 27.6 tp . . . . . 0 C--N 1.313 -0.998 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.286 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 75.0 p . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -97.53 4.93 50.22 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.17 0.509 . . . . 0.0 110.776 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -117.0 117.6 30.11 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.689 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -85.08 -21.93 29.15 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 120.826 0.346 . . . . 0.0 110.36 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . 0.426 ' HB2' ' HE2' ' A' ' 367' ' ' LYS . 23.6 ttmm -159.67 127.38 4.77 Favored 'General case' 0 N--CA 1.391 -3.383 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 35.6 mtmm -110.75 177.35 4.7 Favored 'General case' 0 C--N 1.253 -3.615 0 O-C-N 124.28 0.987 . . . . 0.0 108.357 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.424 HD13 HG22 ' A' ' 445' ' ' THR . 86.4 mt -71.98 141.94 49.37 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.144 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.67 158.66 67.02 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.202 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -44.8 -39.81 14.09 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 123.451 2.767 . . . . 0.0 113.809 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -156.11 162.53 40.24 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -137.97 149.2 45.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -133.38 137.34 45.79 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.42 143.78 33.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.7 m -79.43 141.99 36.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -57.28 125.59 23.48 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 122.957 0.503 . . . . 0.0 110.402 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 96.47 -9.97 66.96 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.917 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -96.71 170.75 8.98 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.149 0.499 . . . . 0.0 110.791 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 6.9 mtpm? -101.08 161.05 13.88 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.729 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 18.2 tt -154.98 133.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 121.201 0.524 . . . . 0.0 110.665 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -99.99 127.47 46.2 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.546 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 420' ' ' THR . 70.3 mt -105.77 109.37 21.3 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 87.7 m -107.19 126.01 51.85 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.13 149.25 33.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 418' ' ' LYS . 41.5 mt-10 -114.43 135.55 53.98 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 54.1 mt -104.04 165.44 11.05 Favored 'General case' 0 C--N 1.261 -3.263 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.03 -29.84 49.61 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.164 0.507 . . . . 0.0 109.929 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -112.01 146.94 37.0 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.181 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -78.9 -22.44 45.92 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -112.5 26.23 10.74 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.236 0.541 . . . . 0.0 111.398 -173.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -113.37 137.54 51.36 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -122.31 154.45 37.6 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.893 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.61 153.53 7.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.33 0.586 . . . . 0.0 111.491 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -103.43 133.37 48.6 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.453 ' CB ' HD12 ' A' ' 403' ' ' ILE . 44.8 m95 -101.51 139.06 37.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 434' ' ' TYR . 10.3 mp -121.13 143.61 49.01 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . 0.644 ' HG3' HG12 ' A' ' 403' ' ' ILE . 22.5 mtmm -103.83 108.61 20.0 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.7 p30 50.95 16.81 0.37 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 124.966 1.306 . . . . 0.0 113.998 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.15 -5.96 17.52 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.643 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -102.04 124.85 48.37 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -64.13 118.39 8.48 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.932 0.396 . . . . 0.0 111.987 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.644 HG12 ' HG3' ' A' ' 398' ' ' LYS . 41.0 mt -66.33 122.0 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.248 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -102.1 157.34 16.95 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.557 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 48.0 ttm -71.54 94.6 1.31 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.0 t -89.92 102.22 14.92 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 58.68 -114.38 5.92 Favored Glycine 0 N--CA 1.437 -1.251 0 O-C-N 124.086 0.866 . . . . 0.0 112.141 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 26.4 m -119.3 17.12 13.1 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.05 -0.575 . . . . 0.0 109.735 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -76.34 -46.39 27.76 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.864 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.557 ' O ' ' HG3' ' A' ' 405' ' ' MET . 93.4 m-85 -111.62 108.44 17.93 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.89 0.376 . . . . 0.0 110.292 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 49.6 mt -107.91 113.75 44.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -87.23 105.1 16.99 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.409 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.99 138.61 41.87 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.638 0.732 . . . . 0.0 111.365 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 13.1 p -118.38 122.81 43.73 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.089 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.79 89.89 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.03 -123.83 15.69 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.41 -6.36 55.02 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.317 0.58 . . . . 0.0 110.027 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.407 ' HG3' ' HG2' ' A' ' 386' ' ' GLU . 31.2 ttpt -88.85 125.26 34.84 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . 0.444 ' HD3' ' HA ' ' A' ' 419' ' ' ARG . 2.5 tpp180 -113.2 137.3 51.67 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 76.9 m -142.11 122.94 14.38 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.367 0.603 . . . . 0.0 112.162 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 410' ' ' TYR . 63.9 tp -91.19 114.32 26.82 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 43.7 m -93.97 108.08 19.92 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 50.7 mt -92.84 130.62 41.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . 0.5 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 16.5 m -106.58 132.19 52.87 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.832 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 425' ' ' GLN 0.321 2.0 pt20 46.64 76.5 0.1 Allowed 'General case' 0 C--O 1.238 0.467 0 O-C-N 125.16 1.537 . . . . 0.0 114.575 177.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 60.5 m -70.28 128.39 36.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.968 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.0 m -112.9 -174.16 2.4 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.64 -19.79 62.78 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.89 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -72.55 -24.72 61.17 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.182 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.38 -21.57 42.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.13 95.54 0.41 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.412 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.95 171.51 18.58 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.2 132.74 34.24 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . 0.59 ' HA ' ' O ' ' A' ' 397' ' ' LEU . 38.7 m-85 -104.81 145.57 30.19 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.1 OUTLIER -129.62 123.28 30.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 7.8 p -94.38 118.28 31.39 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 13.0 t -111.53 121.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.28 160.06 6.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.37 112.29 4.71 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 117.764 -2.16 . . . . 0.0 110.242 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 107.52 -35.41 5.03 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 112.391 -0.283 . . . . 0.0 112.391 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -120.03 127.82 52.95 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 122.428 -0.454 . . . . 0.0 110.612 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -130.85 128.93 41.63 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.7 t -120.31 138.05 53.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 434' ' ' TYR . 12.7 p -116.43 148.11 41.03 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 123.412 0.445 . . . . 0.0 111.013 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.424 HG22 HD13 ' A' ' 369' ' ' LEU . 12.6 t -140.54 150.92 44.3 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -101.73 119.28 38.54 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 24.4 tp -95.98 137.22 35.35 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -118.35 115.74 25.31 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.52 122.17 41.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -93.73 106.63 18.59 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.724 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--N 1.292 -1.896 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.274 179.284 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.476 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 7.2 p -51.33 -34.4 14.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 123.873 0.869 . . . . 0.0 112.209 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -55.91 -47.71 76.98 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.872 0.869 . . . . 0.0 110.92 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 11.6 pt-20 -85.85 -38.12 18.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.69 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.79 -50.47 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.311 0.1 . . . . 0.0 111.167 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.39 -32.0 70.75 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -57.87 -39.14 77.09 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.846 0.858 . . . . 0.0 112.199 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 23.2 pt20 -104.88 2.38 29.86 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.173 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -77.12 160.77 75.25 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.529 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.84 135.51 48.61 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.276 1.984 . . . . 0.0 111.029 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -65.96 -4.83 10.85 Favored 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 123.759 2.972 . . . . 0.0 114.772 -173.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 24.5 p -90.25 -16.7 28.85 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.208 0.528 . . . . 0.0 111.192 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.403 ' O ' HG13 ' A' ' 336' ' ' ILE . 29.3 mm-40 -106.92 -0.72 22.98 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.54 -172.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -55.73 -42.24 75.06 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.07 -44.14 97.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.528 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -59.36 -53.53 57.18 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.697 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 332' ' ' GLU . 48.5 mt -59.04 -44.06 90.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 O-C-N 123.792 0.683 . . . . 0.0 110.613 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.66 -60.79 3.28 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.126 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -67.12 -22.85 65.78 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -66.39 -45.62 79.4 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 123.2 0.6 . . . . 0.0 110.205 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . 0.476 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 80.8 m-85 -88.83 -20.19 24.98 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 112.63 14.09 10.79 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.532 -1.318 . . . . 0.0 112.551 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.37 97.14 6.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.2 m -65.06 -42.67 93.99 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.693 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -115.99 95.9 5.32 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.706 0.765 . . . . 0.0 111.409 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.647 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.6 pt? . . . . . 0 C--N 1.307 -1.243 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.104 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 111.363 0.134 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -86.14 -3.34 58.94 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.204 1.002 . . . . 0.0 108.558 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.47 ' CD1' ' HB3' ' A' ' 441' ' ' GLU . 0.3 OUTLIER -91.98 126.45 37.07 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 114.226 -1.352 . . . . 0.0 107.899 173.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -93.25 -18.09 22.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.48 0.657 . . . . 0.0 110.023 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -157.24 126.08 5.8 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.728 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 37.4 mtmm -106.86 176.58 5.12 Favored 'General case' 0 C--N 1.276 -2.596 0 O-C-N 123.791 0.682 . . . . 0.0 109.841 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.528 HD11 ' SG ' ' A' ' 436' ' ' CYS . 72.3 mt -74.51 147.54 41.75 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.23 159.06 82.34 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.61 -35.85 38.86 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.277 2.651 . . . . 0.0 112.997 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -156.35 160.72 39.95 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -133.82 148.76 51.35 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -128.25 144.69 51.15 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.8 149.24 15.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 m -88.66 154.02 20.64 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.01 121.43 11.82 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.167 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 90.63 4.37 70.26 Favored Glycine 0 C--N 1.303 -1.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.16 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -98.78 176.9 5.46 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 122.434 -0.451 . . . . 0.0 110.767 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -110.42 143.13 41.17 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.044 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.464 HG22 ' SG ' ' A' ' 426' ' ' CYS . 10.0 tp -130.99 143.04 42.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -121.19 121.9 38.8 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 66.7 mt -100.17 113.33 25.91 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 26.9 m -112.14 125.21 53.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.311 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.99 157.54 40.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.502 ' HG2' ' HG2' ' A' ' 418' ' ' LYS . 46.5 mt-10 -124.11 137.32 54.58 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.535 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 86.7 mt -98.8 138.13 36.39 Favored 'General case' 0 C--N 1.267 -3.007 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.64 -38.56 58.8 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -106.95 99.8 9.34 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.626 -1.625 . . . . 0.0 106.917 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 417' ' ' ALA . 20.3 p80 -73.9 -16.64 61.1 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 120.817 0.341 . . . . 0.0 111.712 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -87.28 3.97 44.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.177 0.513 . . . . 0.0 110.528 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -107.67 96.18 6.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . 0.434 ' HG2' ' NH2' ' A' ' 419' ' ' ARG . 35.0 mt-10 -75.27 159.81 31.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 8.6 p -118.11 157.95 19.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 113.485 -1.688 . . . . 0.0 109.668 -173.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -132.15 161.22 33.87 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.46 ' CB ' HD12 ' A' ' 403' ' ' ILE . 38.7 m95 -114.14 144.62 42.87 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.7 mp -122.74 136.41 54.86 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . 0.53 ' HG2' HG12 ' A' ' 403' ' ' ILE . 8.2 mmtp -93.17 108.62 20.19 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.479 173.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.8 p30 53.03 12.92 0.32 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 125.024 1.33 . . . . 0.0 114.078 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 108.44 9.72 26.72 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.007 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -90.77 -98.89 0.11 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 173.21 137.53 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.53 HG12 ' HG2' ' A' ' 398' ' ' LYS . 48.4 mt -97.75 120.8 47.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 120.831 0.348 . . . . 0.0 110.401 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -91.77 130.99 37.45 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 58.1 ttp -62.21 103.73 0.41 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.8 m -106.16 120.31 41.5 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.265 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 48.62 -118.89 5.21 Favored Glycine 0 C--N 1.334 0.42 0 O-C-N 125.027 1.454 . . . . 0.0 115.278 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.6 m -112.14 7.57 19.65 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.468 0.651 . . . . 0.0 109.623 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 424' ' ' SER . 82.6 tttt -83.3 -49.5 9.32 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.658 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -109.74 129.05 55.65 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.93 118.16 51.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -87.91 105.87 17.72 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -112.76 113.09 25.03 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.166 0.508 . . . . 0.0 111.73 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 37.4 t -98.22 119.42 36.86 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.84 95.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 71.32 -107.83 2.3 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.535 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -101.6 -13.11 17.97 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.073 0.463 . . . . 0.0 109.846 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.502 ' HG2' ' HG2' ' A' ' 386' ' ' GLU . 60.4 mtpt -74.86 137.61 41.92 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 121.601 0.715 . . . . 0.0 111.695 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . 0.434 ' NH2' ' HG2' ' A' ' 393' ' ' GLU . 21.8 mmt180 -122.3 112.74 18.5 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 173.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 6.8 m -116.64 122.01 43.34 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.449 ' HB2' ' CE2' ' A' ' 396' ' ' TRP . 53.5 tp -96.23 111.0 23.2 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 67.4 m -92.36 109.5 20.88 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 56.4 mt -101.95 122.15 53.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 409' ' ' LYS . 18.3 m -108.42 141.08 40.8 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 64.84 58.32 0.97 Allowed 'General case' 0 C--O 1.254 1.303 0 C-N-CA 124.427 1.091 . . . . 0.0 111.782 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . 0.464 ' SG ' HG22 ' A' ' 381' ' ' ILE . 85.2 m -66.06 131.47 46.28 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.497 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . 0.491 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 5.5 m -126.0 177.62 6.24 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 98.8 mt -67.3 -30.7 70.63 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 118.19 0.45 . . . . 0.0 111.633 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.98 -9.11 59.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.759 0.79 . . . . 0.0 110.298 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . 0.491 ' HB3' ' H ' ' A' ' 427' ' ' SER . 18.7 t70 -97.23 -13.94 21.72 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -71.24 114.52 9.39 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.123 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -156.34 172.97 17.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.776 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.67 126.78 33.67 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -106.91 145.27 32.41 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 120.995 0.426 . . . . 0.0 110.864 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.13 143.44 24.15 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.551 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' A' ' 369' ' ' LEU . 59.0 m -98.26 131.87 44.23 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 56.7 t -116.04 107.98 24.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.284 0.564 . . . . 0.0 111.771 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 58.6 t -116.91 160.82 16.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 170.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -68.27 109.56 2.97 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 117.21 -2.424 . . . . 0.0 111.891 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 99.97 -36.21 4.26 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 125.861 1.696 . . . . 0.0 108.966 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 438' ' ' VAL . 6.4 mp0 -90.25 96.18 10.55 Favored 'General case' 0 N--CA 1.395 -3.196 0 C-N-CA 124.887 1.275 . . . . 0.0 112.341 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 37.9 ttmt -121.59 118.04 28.24 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 51.6 t -115.31 133.69 55.8 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 10.8 p -112.22 147.59 35.89 Favored 'General case' 0 N--CA 1.432 -1.33 0 O-C-N 123.565 0.541 . . . . 0.0 111.143 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.515 HG22 HD13 ' A' ' 369' ' ' LEU . 14.5 t -144.88 151.25 38.42 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -112.24 117.68 33.19 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 118.805 -1.158 . . . . 0.0 109.624 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 58.4 tp -88.0 136.54 32.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -118.52 113.5 21.39 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.13 117.26 33.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -94.06 109.32 21.09 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-O 121.386 0.612 . . . . 0.0 111.309 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.809 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 CA--C 1.495 -1.17 0 CA-C-O 121.601 0.715 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.463 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 5.3 p -54.57 -39.43 45.91 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.495 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -52.26 -57.26 10.25 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 124.202 1.001 . . . . 0.0 111.334 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.24 -35.43 68.83 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.765 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.44 -52.79 53.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.015 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.19 -34.81 73.4 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.005 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -58.89 -40.86 85.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.694 0.398 . . . . 0.0 110.986 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -93.54 2.02 56.55 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.437 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -88.89 158.2 47.75 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.362 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.93 161.63 40.9 Favored 'Trans proline' 0 CA--C 1.555 1.555 0 C-N-CA 122.539 2.159 . . . . 0.0 111.194 173.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.61 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 10.9 Cg_endo -55.35 -35.8 92.43 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.68 2.92 . . . . 0.0 114.861 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 14.8 m -72.72 -8.58 56.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.428 0.632 . . . . 0.0 112.412 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.504 ' HB3' HD11 ' A' ' 336' ' ' ILE . 12.0 mm-40 -97.31 -22.88 16.4 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.859 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.61 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 23.3 m-30 -55.14 -50.08 70.16 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -174.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.71 -18.99 62.12 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.29 0.567 . . . . 0.0 111.207 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -82.82 -57.36 3.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.504 HD11 ' HB3' ' A' ' 332' ' ' GLU . 69.4 mt -58.29 -39.41 73.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.495 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.11 -59.57 4.89 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.472 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.48 -23.48 64.58 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -68.2 -36.74 80.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.07 0.462 . . . . 0.0 110.537 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . 0.463 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 85.7 m-85 -97.12 -17.35 20.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 107.15 20.78 8.46 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.93 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 15.0 t -95.41 129.67 45.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 34.2 p -94.66 -49.72 5.5 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.435 -0.906 . . . . 0.0 112.351 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.11 69.21 3.19 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -171.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.435 -1.202 0 CA-C-O 120.726 0.298 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.453 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -102.34 -19.97 14.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.7 0.762 . . . . 0.0 109.712 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -100.14 137.02 39.15 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.318 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -99.26 -16.37 18.53 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.4 OUTLIER -162.74 115.96 1.66 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 178.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.62 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 15.0 mtpp -88.51 169.41 11.77 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.422 HD13 HG22 ' A' ' 445' ' ' THR . 87.9 mt -64.22 140.37 58.86 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -60.18 147.88 79.94 Favored Pre-proline 0 C--N 1.318 -0.788 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -43.96 -47.49 10.09 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.616 2.877 . . . . 0.0 114.15 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -151.14 142.69 23.56 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.121 0.486 . . . . 0.0 111.435 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -122.14 156.59 33.33 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -142.28 134.06 27.0 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.64 156.91 20.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 15.1 m -79.76 157.23 27.16 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 2.0 tmmm? -77.34 135.56 38.38 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.56 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 86.82 5.65 80.89 Favored Glycine 0 CA--C 1.494 -1.247 0 CA-C-O 121.372 0.429 . . . . 0.0 112.097 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -99.14 -170.67 1.95 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -114.84 139.36 49.81 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.1 tp -121.88 128.74 75.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -102.37 103.58 14.01 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.78 0.8 . . . . 0.0 112.319 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 65.4 mt -91.2 114.95 27.61 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.1 m -123.56 130.59 52.9 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.473 -169.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.438 HG11 ' SG ' ' A' ' 436' ' ' CYS . 14.7 m -127.96 154.09 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.054 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -120.88 142.43 49.68 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 49.6 mt -98.62 142.27 30.41 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.47 -35.18 54.02 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -125.07 142.57 51.41 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -74.48 -16.98 60.83 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.429 0.633 . . . . 0.0 110.775 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.37 11.78 22.65 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.948 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -104.2 88.76 3.07 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -78.35 147.99 33.94 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 11.8 p -106.62 157.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.761 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.477 ' HA ' ' HE3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER -125.79 150.72 47.56 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 175.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.436 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 3.2 m-90 -121.94 123.85 42.66 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.7 mp -129.81 144.71 51.44 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 118.438 0.563 . . . . 0.0 110.689 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -123.21 121.04 34.93 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.9 p30 49.73 17.03 0.23 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.531 1.532 . . . . 0.0 114.183 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.08 -4.35 23.9 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.624 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -108.28 123.0 48.12 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 35.7 tt0 -61.45 122.63 15.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.927 0.394 . . . . 0.0 110.908 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 42.7 mt -73.78 114.6 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.972 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -99.03 147.36 25.1 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 171.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.612 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 0.0 OUTLIER -77.28 126.14 30.45 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.255 -176.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 15.0 m -109.68 88.57 2.78 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.22 -109.76 2.66 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.0 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 45.2 t -109.78 4.02 21.36 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 122.808 -0.231 . . . . 0.0 110.809 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 409' ' ' LYS . 12.2 tmtt? -79.45 -34.28 41.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.612 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 91.2 m-85 -126.63 117.35 22.59 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 52.8 mt -118.3 113.8 43.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.428 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.505 ' CD1' HD13 ' A' ' 421' ' ' LEU . 23.6 m-85 -87.97 109.48 19.84 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -108.05 106.31 16.47 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 50.5 m -92.28 106.28 18.31 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.84 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 58.3 mt -113.71 92.82 2.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.33 -110.45 3.42 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.572 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.68 -2.23 35.94 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.007 0.432 . . . . 0.0 110.562 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -101.85 133.85 45.97 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.512 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -111.18 110.47 21.0 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 17.4 m -108.59 118.14 36.01 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.554 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.505 HD13 ' CD1' ' A' ' 412' ' ' PHE . 22.6 tp -98.25 107.96 20.54 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 39.2 m -93.61 100.38 12.64 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.9 mt -83.97 115.66 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 14.9 m -100.33 134.81 42.73 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 69.19 54.15 0.44 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.541 1.136 . . . . 0.0 111.002 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 1.9 p -62.38 123.94 19.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.222 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . 0.426 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 9.2 m -114.27 169.53 8.96 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -173.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.33 -37.92 77.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.168 0.509 . . . . 0.0 111.815 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -84.29 1.24 45.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.751 0.786 . . . . 0.0 110.223 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 427' ' ' SER . 28.4 t70 -106.34 -17.59 14.24 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.824 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.5 125.33 17.64 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.849 174.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.47 169.11 23.68 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.994 0.426 . . . . 0.0 111.191 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -86.39 133.64 33.77 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 170.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -114.7 137.87 51.39 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.04 140.33 52.09 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 20.8 p -115.84 113.98 24.1 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 173.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 47.0 t -113.47 118.46 58.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.028 0.442 . . . . 0.0 111.863 -174.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 97.0 t -114.17 161.69 12.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.24 113.06 5.52 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.831 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 100.67 -35.41 4.86 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.085 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 31.1 mm-40 -128.26 135.98 50.39 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 120.693 0.282 . . . . 0.0 110.889 -173.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -141.94 177.64 8.06 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 53.1 t -160.27 142.33 12.89 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 3.8 p -121.15 131.27 54.15 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 123.69 0.619 . . . . 0.0 110.197 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.422 HG22 HD13 ' A' ' 369' ' ' LEU . 14.9 t -121.61 150.71 41.3 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.72 111.12 18.7 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.21 0.529 . . . . 0.0 110.212 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 61.0 tp -90.62 140.77 29.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.596 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -115.18 108.38 16.53 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 42.3 t -90.4 109.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 376' ' ' SER . 37.8 ttpt -111.82 127.19 55.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.367 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.631 0.729 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.528 HG11 HG21 ' A' ' 342' ' ' VAL . 6.5 p -50.84 -37.23 16.04 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.587 0 C-N-CA 125.721 1.608 . . . . 0.0 113.608 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -61.79 -56.68 16.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.663 0.744 . . . . 0.0 110.732 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 13.2 pt-20 -71.96 -21.61 61.56 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.017 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.5 mt -74.29 -46.36 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.387 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.97 -40.2 84.06 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 122.905 0.482 . . . . 0.0 110.325 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -55.54 -36.83 67.19 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.194 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 20.9 pt20 -100.79 5.76 43.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.163 0.506 . . . . 0.0 111.511 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -106.62 152.83 40.86 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.587 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -62.65 138.51 70.17 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.416 2.077 . . . . 0.0 111.886 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.7 -22.38 64.26 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.484 2.789 . . . . 0.0 112.468 -174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 2.8 p -74.59 -14.22 60.75 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.165 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -111.49 4.49 18.87 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.355 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -49.12 -41.12 34.99 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.9 -54.21 49.17 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.511 0.507 . . . . 0.0 111.584 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -61.1 -44.97 96.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.845 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 38.6 mt -68.35 -42.49 84.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.264 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.84 -54.32 46.55 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.593 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -61.84 -32.28 72.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -61.01 -39.86 91.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.828 0.347 . . . . 0.0 110.495 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -91.75 1.35 57.22 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 86.81 23.46 42.04 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.646 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.528 HG21 HG11 ' A' ' 321' ' ' VAL . 19.0 t -107.3 134.35 49.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.8 p -110.78 -15.35 13.83 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-O 120.981 0.42 . . . . 0.0 110.651 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -95.35 45.68 1.1 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.852 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 121.449 0.642 . . . . 0.0 110.924 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.423 -1.819 0 CA-C-O 121.182 0.515 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -103.98 0.35 29.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 122.0 0.905 . . . . 0.0 109.598 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.81 137.76 50.66 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.415 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -103.21 -19.4 14.51 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.827 0.346 . . . . 0.0 110.104 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -156.46 125.54 6.04 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.438 ' HE2' ' SG ' ' A' ' 443' ' ' CYS . 60.6 mtpt -112.16 172.32 6.98 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 96.0 mt -72.6 117.81 14.74 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -63.65 142.17 97.98 Favored Pre-proline 0 C--N 1.314 -0.953 0 O-C-N 124.033 0.833 . . . . 0.0 108.882 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -47.72 -35.3 23.17 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 123.326 2.684 . . . . 0.0 113.129 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -127.46 128.0 45.0 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.493 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 44.9 m-85 -128.81 147.38 50.79 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -134.09 145.14 49.07 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.75 159.06 4.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.401 ' HB2' ' CG ' ' A' ' 379' ' ' HIS . 13.9 m -89.16 156.48 18.77 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -67.19 123.36 20.09 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.43 5.09 67.52 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . 0.401 ' CG ' ' HB2' ' A' ' 376' ' ' SER . 12.4 m170 -101.69 164.95 11.48 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.331 -0.434 . . . . 0.0 110.378 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -102.36 136.85 41.44 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.504 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.58 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.9 tt -136.35 154.69 33.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.418 ' CB ' ' HA ' ' A' ' 422' ' ' THR . 18.4 ptt180 -134.76 126.09 28.24 Favored 'General case' 0 N--CA 1.413 -2.316 0 C-N-CA 119.175 -1.01 . . . . 0.0 112.031 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . 0.401 ' HB3' HD21 ' A' ' 369' ' ' LEU . 3.0 mm? -78.9 109.79 13.51 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 113.892 -1.504 . . . . 0.0 109.0 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . 0.461 ' CG2' ' HD2' ' A' ' 418' ' ' LYS . 23.5 m -105.46 124.27 49.27 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.869 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.49 158.44 42.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -130.51 132.76 45.79 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 79.6 mt -96.61 159.79 14.74 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.49 -41.35 76.23 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -101.37 147.27 26.52 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.284 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.472 ' CD2' ' HB2' ' A' ' 417' ' ' ALA . 11.1 m170 -80.84 -24.28 38.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.27 25.6 1.16 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.448 1.499 . . . . 0.0 110.819 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -131.84 153.99 49.61 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -175.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -124.64 172.15 9.48 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 123.226 0.329 . . . . 0.0 110.629 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.38 144.25 37.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.081 0.467 . . . . 0.0 110.61 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -103.27 129.4 50.25 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.798 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.663 ' HB3' HD12 ' A' ' 403' ' ' ILE . 34.4 m95 -110.28 128.27 55.44 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.955 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.4 139.73 50.94 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -109.2 125.56 52.36 Favored 'General case' 0 N--CA 1.407 -2.61 0 C-N-CA 118.224 -1.39 . . . . 0.0 108.906 171.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 27.3 p30 50.89 21.68 1.01 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 126.628 1.971 . . . . 0.0 114.296 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.67 12.35 56.99 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.52 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -96.14 -91.58 0.23 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 176.02 139.85 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.663 HD12 ' HB3' ' A' ' 396' ' ' TRP . 9.4 mt -111.51 106.15 20.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -115.2 146.46 41.39 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 51.8 ttm -55.93 104.83 0.15 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.431 0.634 . . . . 0.0 111.195 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.0 t -117.3 110.14 17.71 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 51.42 -117.34 5.6 Favored Glycine 0 C--N 1.33 0.211 0 O-C-N 124.147 0.904 . . . . 0.0 113.35 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.9 p -114.46 8.7 16.58 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.671 0.748 . . . . 0.0 110.44 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -72.74 -40.71 65.85 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.052 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -129.33 113.91 15.56 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 64.2 mt -112.88 116.92 53.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.772 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -86.61 109.55 19.23 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.765 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.03 108.13 19.1 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.6 m -103.16 104.91 15.1 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.135 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.5 mm -123.65 103.91 13.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 66.63 -113.39 5.63 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.472 ' HB2' ' CD2' ' A' ' 390' ' ' HIS . . . -99.51 -12.97 19.69 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.381 0.61 . . . . 0.0 109.601 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.461 ' HD2' ' CG2' ' A' ' 384' ' ' THR . 7.8 ttpm? -86.96 136.35 32.96 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.34 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -122.33 126.44 48.07 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.3 m -127.51 125.63 40.76 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.48 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.456 HD21 HG21 ' A' ' 403' ' ' ILE . 50.3 tp -100.1 103.93 15.46 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.492 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 70.0 m -89.97 116.84 28.32 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.023 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 48.8 mt -107.54 118.63 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.0 m -89.97 144.59 25.79 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 57.19 62.72 2.11 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 123.979 0.912 . . . . 0.0 112.401 174.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . 0.58 ' SG ' HG22 ' A' ' 381' ' ' ILE . 82.8 m -69.56 118.18 12.11 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . 0.533 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 14.1 m -111.05 171.79 7.26 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.55 -35.12 78.44 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.079 0.466 . . . . 0.0 110.367 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.42 -7.74 56.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.789 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . 0.533 ' HB3' ' H ' ' A' ' 427' ' ' SER . 29.5 t70 -105.34 -9.32 17.67 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.618 0.723 . . . . 0.0 109.711 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.71 112.28 2.19 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.625 -1.17 . . . . 0.0 107.872 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -153.59 168.2 26.98 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.068 0.461 . . . . 0.0 111.283 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.53 131.5 34.36 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -114.97 132.17 56.67 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 396' ' ' TRP . 0.6 OUTLIER -112.08 136.93 50.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 16.9 p -106.07 106.21 16.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.49 124.03 53.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.246 0.546 . . . . 0.0 111.513 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.91 152.06 36.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -70.08 113.33 4.89 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 118.689 -1.719 . . . . 0.0 110.901 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 109.23 -36.31 4.41 Favored Glycine 0 N--CA 1.418 -2.558 0 C-N-CA 123.306 0.479 . . . . 0.0 111.928 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.514 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 6.3 mm-40 -130.21 126.32 37.1 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -136.4 146.84 46.89 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.438 ' SG ' ' HE2' ' A' ' 368' ' ' LYS . 8.9 t -144.9 160.24 41.63 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 7.6 p -142.92 133.2 24.63 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.329 0.393 . . . . 0.0 110.583 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 8.6 t -109.36 150.18 28.41 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -111.57 110.68 21.22 Favored 'General case' 0 N--CA 1.406 -2.668 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.45 145.49 31.9 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -119.13 107.6 13.66 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.18 110.41 22.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -102.15 127.81 48.91 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.437 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.412 -2.344 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.539 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.404 HG11 HG21 ' A' ' 342' ' ' VAL . 14.2 p -55.52 -28.22 22.39 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.651 0 C-N-CA 124.942 1.297 . . . . 0.0 111.911 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -57.32 -56.56 20.23 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 123.093 0.557 . . . . 0.0 110.614 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.42 -32.77 58.69 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.366 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.2 mt -71.46 -45.57 67.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.938 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 9.6 tt -73.28 -29.41 62.71 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -61.78 -42.72 99.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.445 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -89.16 -0.59 57.57 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.984 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -94.58 154.87 40.02 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.815 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.93 141.47 44.65 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.031 1.821 . . . . 0.0 111.279 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.85 -20.76 53.8 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.815 3.01 . . . . 0.0 114.049 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 5.6 m -66.71 -27.96 68.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.471 ' HG3' HD11 ' A' ' 336' ' ' ILE . 7.9 pt-20 -110.57 11.84 22.86 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -52.94 -37.73 61.23 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.415 ' HA ' HD22 ' A' ' 345' ' ' LEU . 40.1 tt0 -63.81 -47.43 80.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.608 0.242 . . . . 0.0 110.99 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -62.61 -42.59 99.67 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.543 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.471 HD11 ' HG3' ' A' ' 332' ' ' GLU . 74.1 mt -61.63 -44.99 99.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.158 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.89 -54.01 51.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.13 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -69.19 -23.11 63.87 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -69.79 -44.4 70.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.221 0.534 . . . . 0.0 109.987 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -88.47 1.23 55.22 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 72.49 35.64 59.5 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.151 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.404 HG21 HG11 ' A' ' 321' ' ' VAL . 8.2 t -103.56 111.53 33.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.1 p -84.01 -20.66 32.4 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-O 122.341 1.067 . . . . 0.0 110.15 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.46 44.18 1.19 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.149 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 334' ' ' GLU . 33.6 tp . . . . . 0 C--N 1.315 -0.918 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 172.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.411 -2.393 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.544 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -100.31 -33.29 10.46 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -89.08 123.15 33.1 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.512 173.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -87.44 -25.18 23.89 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 367' ' ' LYS . 36.9 ttmt -164.29 118.79 1.45 Allowed 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.484 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 51.3 mtmt -91.26 170.59 9.87 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 123.403 0.439 . . . . 0.0 110.452 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.635 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 76.1 mt -60.12 143.81 51.34 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 123.896 0.748 . . . . 0.0 111.582 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 373' ' ' TYR . 35.7 mm-40 -64.75 149.1 96.5 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.856 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.04 -52.37 9.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.858 2.372 . . . . 0.0 112.812 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -142.23 144.43 33.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.012 0.434 . . . . 0.0 111.666 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 370' ' ' GLU . 56.3 m-85 -123.76 163.23 21.58 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -134.06 142.84 47.72 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.5 p -144.82 157.68 14.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 48.8 m -97.23 150.28 21.09 Favored 'General case' 0 N--CA 1.412 -2.332 0 C-N-CA 120.414 -0.515 . . . . 0.0 109.688 174.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.06 128.79 37.83 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.264 0.626 . . . . 0.0 111.207 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 83.81 15.66 69.82 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.659 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -118.31 176.3 5.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.3 mtpt -102.83 146.13 28.73 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.18 0.3 . . . . 0.0 110.392 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.489 HG22 ' SG ' ' A' ' 426' ' ' CYS . 10.7 tp -135.65 156.62 38.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 30.5 ptt180 -142.64 124.43 15.09 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.587 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -94.71 126.2 39.86 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.391 -1.277 . . . . 0.0 107.924 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 68.0 m -108.63 138.91 44.18 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 11.8 m -141.43 159.67 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 C-N-CA 124.111 0.964 . . . . 0.0 108.93 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 85.9 mt-10 -130.04 136.92 49.91 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.33 148.74 23.85 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -84.47 10.03 11.9 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.456 0.646 . . . . 0.0 110.422 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -157.58 135.97 11.17 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -67.12 -24.25 65.91 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.145 0.497 . . . . 0.0 111.664 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -107.05 26.27 10.34 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.18 0.99 . . . . 0.0 110.915 -173.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -98.61 122.27 41.61 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -93.16 137.56 32.38 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 19.4 m -106.29 154.22 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.97 174.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 15.3 tptm -123.6 157.42 33.78 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.498 ' O ' HD12 ' A' ' 397' ' ' LEU . 4.4 m-90 -118.95 126.05 50.85 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 123.338 0.399 . . . . 0.0 109.969 -168.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 396' ' ' TRP . 6.5 mp -135.89 144.26 45.46 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -123.57 121.96 36.94 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 27.9 p30 46.71 22.31 0.18 Allowed 'General case' 0 N--CA 1.504 2.272 0 C-N-CA 125.614 1.566 . . . . 0.0 114.891 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 107.69 -0.21 34.33 Favored Glycine 0 C--O 1.224 -0.517 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.998 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -111.17 129.96 55.78 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -65.71 122.31 16.99 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.2 0.524 . . . . 0.0 111.035 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.434 ' HB ' ' CB ' ' A' ' 396' ' ' TRP . 57.7 mt -80.15 123.51 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -128.21 154.21 46.07 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.41 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 66.7 mtm -70.55 93.6 0.92 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.11 0.481 . . . . 0.0 111.507 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 39.8 m -92.79 100.53 12.99 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 71.77 -129.25 15.9 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.8 m -112.68 14.88 20.08 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -65.77 -42.81 90.41 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 94.0 m-85 -123.9 127.73 48.43 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 50.5 mm -118.0 117.35 54.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -86.79 108.12 18.58 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.302 0.572 . . . . 0.0 109.546 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -97.45 123.85 41.44 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.842 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 35.7 t -118.8 111.98 19.13 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 70.1 mt -124.76 84.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.716 0.769 . . . . 0.0 109.247 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.12 -109.89 2.99 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.17 -20.28 16.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.904 0.383 . . . . 0.0 110.182 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 386' ' ' GLU . 22.0 ptmt -88.36 133.1 34.18 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.782 0.801 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.29 139.45 53.78 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . 0.402 ' CG2' ' HB2' ' A' ' 382' ' ' ARG . 74.1 m -134.26 130.36 36.99 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-O 121.148 0.499 . . . . 0.0 110.884 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 382' ' ' ARG . 37.8 tp -95.64 109.39 21.66 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.0 m -97.53 118.87 35.01 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.51 124.68 55.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 7.1 m -101.71 132.28 47.51 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 63.91 70.27 0.52 Allowed 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 124.235 0.959 . . . . 0.0 110.919 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . 0.489 ' SG ' HG22 ' A' ' 381' ' ' ILE . 73.5 m -68.23 123.74 21.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.67 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 45.3 t -106.23 155.23 19.69 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.46 -27.13 69.07 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.129 0.572 . . . . 0.0 110.475 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -87.22 1.08 54.24 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.264 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -114.15 1.98 14.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.32 111.75 3.16 Favored 'General case' 0 C--O 1.255 1.362 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.789 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -161.71 171.4 17.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.576 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -87.68 130.89 34.65 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -111.26 138.66 47.45 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 444' ' ' SER . 0.4 OUTLIER -120.52 141.6 50.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.411 ' SG ' HD11 ' A' ' 369' ' ' LEU . 73.7 m -109.13 111.38 22.97 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 168.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.93 119.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.281 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 47.6 t -110.85 159.82 10.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 169.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.15 113.93 6.34 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 119.269 -1.443 . . . . 0.0 111.52 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 89.04 -24.27 14.0 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 121.081 0.267 . . . . 0.0 112.824 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.544 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 4.9 mm-40 -118.29 109.89 16.86 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.479 0.712 . . . . 0.0 109.107 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -136.26 149.55 48.54 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 34.2 t -148.2 139.53 23.47 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 435' ' ' GLN . 9.3 m -112.31 151.07 30.14 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.6 t -129.15 144.64 51.28 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -110.63 109.81 20.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 121.752 0.787 . . . . 0.0 109.108 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -93.72 129.52 40.03 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.993 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -107.82 115.4 30.07 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.377 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 38.2 t -90.08 125.58 42.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 376' ' ' SER . 12.0 pttp -116.11 146.83 41.92 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--N 1.259 -3.327 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 174.844 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.635 ' HA ' ' NE1' ' A' ' 322' ' ' TRP . 1.1 m-20 . . . . . 0 CA--C 1.496 -1.135 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 340' ' ' TYR . 7.4 p -56.25 -38.65 55.65 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.192 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.802 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . 0.635 ' NE1' ' HA ' ' A' ' 320' ' ' ASP . 0.0 OUTLIER -45.79 -52.04 11.79 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.616 ' HG2' ' HB3' ' A' ' 320' ' ' ASP . 8.4 pt-20 -85.48 -38.42 18.63 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.422 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 87.1 mt -65.46 -40.45 88.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.632 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.2 tt -75.76 -33.06 60.19 Favored 'General case' 0 C--O 1.202 -1.429 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -69.06 -36.47 77.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -85.39 -7.55 58.89 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.173 0.511 . . . . 0.0 111.329 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -84.52 161.39 54.09 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.316 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.14 135.48 51.08 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.922 2.415 . . . . 0.0 111.469 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.53 -34.61 90.32 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 124.048 3.165 . . . . 0.0 115.568 -171.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 19.5 t -83.7 -1.9 55.06 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.682 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -102.82 -4.24 25.19 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.869 0.366 . . . . 0.0 110.07 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -52.38 -42.07 63.68 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -64.5 -38.59 91.56 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.468 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -66.37 -46.3 77.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 109.485 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.06 -37.61 73.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.288 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.75 -62.45 1.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.582 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -62.19 -32.96 73.67 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -59.72 -41.2 90.32 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.806 0.842 . . . . 0.0 111.564 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . 0.425 ' CB ' ' HB ' ' A' ' 321' ' ' VAL . 95.6 m-85 -97.25 10.71 38.78 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.177 0.513 . . . . 0.0 111.962 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 86.72 15.93 62.57 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.577 174.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 4.2 t -94.12 105.57 17.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.3 p -84.23 -14.95 48.59 Favored 'General case' 0 C--N 1.267 -2.98 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -133.27 95.46 3.53 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.5 pt? . . . . . 0 C--N 1.306 -1.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.18 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 61.0 m . . . . . 0 N--CA 1.392 -3.334 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.602 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -93.32 -10.73 34.41 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.036 0.922 . . . . 0.0 109.494 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -100.11 127.65 46.32 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.707 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -95.39 -17.67 21.37 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -165.5 126.12 1.87 Allowed 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.592 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 33.4 mtmm -102.34 -179.49 4.0 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 65.7 mt -74.3 147.12 42.58 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.98 137.61 89.81 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -55.64 -35.81 93.59 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.497 2.132 . . . . 0.0 112.465 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -128.36 134.09 48.78 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.998 0.428 . . . . 0.0 112.025 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -133.12 155.41 49.31 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.989 0.916 . . . . 0.0 109.298 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -134.64 147.67 50.22 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.19 154.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 10.1 t -96.13 150.66 20.26 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.523 ' HD2' ' HG2' ' A' ' 451' ' ' GLU . 83.4 tttt -61.42 120.81 11.2 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 123.169 0.587 . . . . 0.0 110.978 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 97.83 -4.56 61.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.5 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -98.27 175.04 6.21 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.659 0.266 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -104.77 150.45 24.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.994 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.434 HG22 ' SG ' ' A' ' 426' ' ' CYS . 16.2 tt -141.19 136.84 33.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 120.953 0.406 . . . . 0.0 110.126 174.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -107.9 123.68 48.98 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.375 0.607 . . . . 0.0 109.896 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 68.1 mt -101.81 114.18 28.03 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 67.3 m -109.31 127.91 54.67 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 20.3 m -132.39 160.67 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.5 135.19 46.87 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.438 HD11 ' CG1' ' A' ' 394' ' ' VAL . 3.1 mm? -99.57 155.92 17.33 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.23 -7.93 56.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.513 0.673 . . . . 0.0 110.506 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 392' ' ' ALA . 13.1 t70 -129.53 140.37 51.26 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -75.52 -24.47 56.78 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -115.3 25.77 10.6 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.624 0.726 . . . . 0.0 111.638 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 389' ' ' ASP . . . -97.72 133.39 42.32 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 175.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -104.72 160.18 15.18 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.479 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.438 ' CG1' HD11 ' A' ' 387' ' ' LEU . 7.6 m -109.78 154.08 11.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.614 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -105.62 116.89 32.71 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.47 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 1.2 m-90 -92.3 120.2 32.62 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.94 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.4 mp -125.9 140.36 52.7 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 118.466 0.575 . . . . 0.0 110.576 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.29 116.77 27.44 Favored 'General case' 0 N--CA 1.405 -2.699 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.9 p30 52.41 18.16 0.89 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.444 1.497 . . . . 0.0 113.816 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.56 -4.71 23.06 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.303 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -110.22 128.68 55.63 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 35.1 tt0 -62.32 121.34 12.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 0.0 110.078 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 396' ' ' TRP . 58.4 mt -66.51 124.6 22.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.163 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -108.61 153.0 24.02 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.943 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 50.9 ttm -71.02 105.15 3.21 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 33.6 t -104.39 98.54 8.31 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 57.84 -114.42 5.66 Favored Glycine 0 C--N 1.329 0.173 0 O-C-N 123.485 0.491 . . . . 0.0 112.488 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . 0.441 ' HA ' HD11 ' A' ' 411' ' ' ILE . 23.0 m -114.72 10.81 16.7 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.569 0.699 . . . . 0.0 109.837 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -77.08 -45.34 27.37 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.526 ' O ' ' HG3' ' A' ' 405' ' ' MET . 65.8 m-85 -122.66 109.27 14.05 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.441 HD11 ' HA ' ' A' ' 408' ' ' SER . 48.3 mm -115.2 119.68 62.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 120.981 0.419 . . . . 0.0 110.909 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.522 ' CE2' HD13 ' A' ' 421' ' ' LEU . 24.6 m-85 -87.24 108.49 18.96 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.99 108.46 21.17 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.9 m -100.37 104.67 16.11 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.7 mt -121.19 83.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 66.93 -119.14 11.4 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.562 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -79.75 -23.67 42.08 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -74.81 125.27 28.42 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.73 0.776 . . . . 0.0 111.45 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 419' ' ' ARG . 1.9 tpp180 -114.98 111.68 21.51 Favored 'General case' 0 N--CA 1.399 -3.018 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 170.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 63.5 m -119.82 120.57 36.89 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.368 0.604 . . . . 0.0 111.498 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.522 HD13 ' CE2' ' A' ' 412' ' ' PHE . 36.2 tp -91.81 115.6 28.19 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 45.4 m -98.2 110.34 22.94 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.3 mt -97.54 123.65 50.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 33.9 m -104.33 136.7 43.43 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 59.38 64.78 1.28 Allowed 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 124.673 1.233 . . . . 0.0 111.49 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . 0.434 ' SG ' HG22 ' A' ' 381' ' ' ILE . 58.6 m -67.33 134.75 52.14 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.941 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 20.1 m -125.57 -177.96 4.08 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 84.6 mt -79.79 -21.91 43.75 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.918 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.43 73.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.443 0.639 . . . . 0.0 109.774 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.77 -0.37 57.26 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.141 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.69 108.13 1.62 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -149.0 165.07 32.73 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.012 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.87 115.84 23.75 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -104.01 152.09 22.45 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.36 150.72 35.27 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.078 175.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 77.0 m -116.09 118.6 33.33 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 38.6 t -106.31 132.94 52.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 67.4 t -128.15 161.41 36.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -61.45 112.36 4.68 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 118.989 -1.577 . . . . 0.0 111.865 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 96.29 -35.18 4.5 Favored Glycine 0 N--CA 1.421 -2.345 0 CA-C-N 114.768 -0.716 . . . . 0.0 112.82 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.602 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 9.8 mm-40 -120.08 132.88 55.6 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.928 0.364 . . . . 0.0 110.388 -174.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -137.81 166.97 22.69 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.0 t -150.51 133.76 16.26 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 6.0 p -108.89 146.98 32.87 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 123.542 0.526 . . . . 0.0 110.378 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 11.3 t -129.66 149.7 51.3 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -116.36 113.28 22.7 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 68.4 tp -91.85 146.1 24.02 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.303 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -123.31 108.17 12.46 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.04 117.01 32.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 376' ' ' SER . 38.7 ttpt -105.79 119.98 40.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.581 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.523 ' HG2' ' HD2' ' A' ' 377' ' ' LYS . 26.4 mt-10 . . . . . 0 C--N 1.328 -0.338 0 O-C-N 123.695 0.622 . . . . 0.0 110.872 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.476 HG21 HG21 ' A' ' 342' ' ' VAL . 12.3 p -60.34 -35.16 60.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 123.761 0.825 . . . . 0.0 111.549 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -47.18 -51.89 17.18 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.983 1.313 . . . . 0.0 110.245 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 9.8 pt-20 -85.36 -48.49 8.99 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.76 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.74 -50.73 78.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 C-N-CA 122.798 0.439 . . . . 0.0 112.063 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.4 HD13 ' HB ' ' A' ' 336' ' ' ILE . 47.3 tp -74.02 -20.97 60.15 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 -175.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -77.68 -42.99 32.65 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.22 0.533 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 4.1 pt20 -88.35 -20.96 24.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.139 -175.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -70.66 146.45 93.65 Favored Pre-proline 0 C--N 1.31 -1.129 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.46 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.78 155.1 61.61 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.017 1.812 . . . . 0.0 110.625 175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.48 -22.05 20.35 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.255 3.304 . . . . 0.0 113.989 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 6.4 m -72.71 -21.62 61.01 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.202 0.525 . . . . 0.0 111.527 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.519 ' HB3' HD11 ' A' ' 336' ' ' ILE . 7.7 mm-40 -88.82 -20.89 24.1 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.928 -177.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -51.44 -53.47 36.64 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -173.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -56.07 -33.01 64.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -80.66 -59.82 2.54 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.773 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' A' ' 332' ' ' GLU . 79.8 mt -55.58 -49.63 72.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.124 -174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 345' ' ' LEU . . . -58.97 -57.65 12.15 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.426 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -67.8 -26.63 66.18 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -66.33 -40.37 89.86 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -94.03 -7.95 41.24 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 98.71 16.42 31.34 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.635 -1.269 . . . . 0.0 112.958 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.476 HG21 HG21 ' A' ' 321' ' ' VAL . 10.5 t -94.05 97.27 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 5.2 m -72.35 -39.4 68.14 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.941 -172.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -101.54 88.89 3.55 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.537 1.161 . . . . 0.0 110.725 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.425 ' HB3' ' CB ' ' A' ' 337' ' ' ALA . 4.5 pp . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.462 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 75.2 p . . . . . 0 N--CA 1.441 -0.895 0 CA-C-O 120.973 0.416 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.569 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -83.2 -24.34 32.46 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.56 ' CD2' ' HB3' ' A' ' 441' ' ' GLU . 7.2 m-85 -94.23 132.94 38.27 Favored 'General case' 0 N--CA 1.406 -2.659 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.557 175.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -98.01 -17.09 19.35 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -161.54 119.44 2.31 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -99.33 159.58 14.9 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 79.6 mt -61.7 133.61 55.78 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 123.363 0.415 . . . . 0.0 111.367 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.41 137.67 68.77 Favored Pre-proline 0 C--O 1.215 -0.743 0 O-C-N 124.584 1.178 . . . . 0.0 108.341 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.93 -27.24 52.95 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.71 2.273 . . . . 0.0 113.424 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -134.65 138.97 44.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.412 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 36.0 m-85 -136.93 143.88 43.15 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -128.94 142.12 51.04 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.46 155.82 20.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 16.2 m -88.06 151.89 22.42 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -72.76 116.49 13.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.282 0.563 . . . . 0.0 110.096 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.29 43.76 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -116.9 156.12 27.91 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.329 -0.936 . . . . 0.0 109.637 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -92.49 141.51 28.43 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.694 0.798 . . . . 0.0 112.121 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.58 HG22 ' SG ' ' A' ' 426' ' ' CYS . 15.6 tt -139.05 146.93 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -123.87 128.95 50.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.218 1.009 . . . . 0.0 112.084 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 420' ' ' THR . 17.8 mt -99.82 125.89 45.82 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.19 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 31.9 m -116.66 130.08 56.53 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.71 160.15 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 418' ' ' LYS . 64.3 mt-10 -129.89 138.57 51.0 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 88.8 mt -101.6 139.0 37.85 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.114 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -84.6 -25.88 28.31 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -106.48 122.06 45.53 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.307 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 417' ' ' ALA . 22.7 m-70 -80.95 -7.58 59.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.756 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -91.37 11.57 23.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -129.79 158.63 38.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -130.14 164.75 23.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 29.1 m -106.73 134.84 47.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.492 0.663 . . . . 0.0 111.491 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -103.5 129.17 50.62 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.678 ' HB3' HD12 ' A' ' 403' ' ' ILE . 50.1 m95 -103.68 130.03 51.09 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 434' ' ' TYR . 8.2 mp -116.76 139.53 50.47 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . 0.647 ' HG2' HG12 ' A' ' 403' ' ' ILE . 32.8 mmtp -90.81 107.4 19.16 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 11.1 p30 48.66 12.59 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.9 4.07 15.08 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.657 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -89.38 -96.38 0.1 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 122.57 0.348 . . . . 0.0 110.353 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 175.05 139.43 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.678 HD12 ' HB3' ' A' ' 396' ' ' TRP . 47.4 mt -94.48 114.85 31.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 172.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -96.6 139.85 32.08 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 87.8 mtp -71.82 89.8 1.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.746 0.308 . . . . 0.0 110.541 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 50.9 m -79.32 98.39 6.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.81 -119.01 16.4 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.059 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 32.8 t -111.27 16.98 20.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -76.24 -47.94 22.09 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -106.82 108.68 20.31 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.19 113.2 36.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -87.08 107.21 18.34 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.912 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -105.55 107.88 19.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 50.0 m -104.97 110.56 22.99 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.31 79.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.84 -110.9 3.76 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.95 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.429 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . . . -83.47 -27.68 29.3 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.759 0.314 . . . . 0.0 110.414 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.43 ' HB3' ' HG2' ' A' ' 386' ' ' GLU . 10.9 ptmm? -95.32 116.69 29.11 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 122.116 0.96 . . . . 0.0 111.394 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -108.4 139.15 43.54 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.361 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 61.6 m -136.15 130.13 32.8 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-O 121.256 0.551 . . . . 0.0 111.524 -173.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 39.8 tp -103.8 115.85 31.23 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 38.7 m -102.04 115.08 29.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 50.4 mt -100.98 119.95 49.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 2.9 m -90.53 131.96 35.96 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.222 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 58.12 67.32 0.97 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.015 0.926 . . . . 0.0 111.93 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . 0.58 ' SG ' HG22 ' A' ' 381' ' ' ILE . 64.5 m -68.48 115.17 7.58 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . 0.411 ' O ' HG21 ' A' ' 449' ' ' VAL . 79.6 p -101.44 -176.63 3.2 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.05 -22.25 63.09 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.28 0.562 . . . . 0.0 109.837 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.94 -8.54 58.26 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.376 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -99.26 -3.45 34.14 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.189 -0.319 . . . . 0.0 110.399 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.79 95.54 2.92 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -152.15 166.13 32.64 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.25 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.99 129.43 34.8 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 397' ' ' LEU . 20.3 m-85 -104.67 145.33 30.48 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.595 ' N ' HE21 ' A' ' 435' ' ' GLN . 0.0 OUTLIER -129.14 127.34 41.21 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 7.6 p -96.33 109.15 21.72 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.1 t -105.29 126.12 60.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 121.231 0.539 . . . . 0.0 111.377 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 60.0 t -129.15 161.39 38.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -66.79 113.6 5.77 Favored Glycine 0 C--N 1.315 -0.599 0 C-N-CA 119.082 -1.532 . . . . 0.0 111.104 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 98.6 -26.33 24.37 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.569 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 3.1 mm-40 -126.48 136.08 52.16 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 18.6 ptpt -147.9 160.67 42.54 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 16.9 t -155.82 134.37 11.73 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.457 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 5.5 p -106.47 126.38 52.18 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.336 0.588 . . . . 0.0 110.7 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.7 t -112.57 146.37 38.68 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.98 114.39 27.67 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.293 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.35 121.87 33.46 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.667 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -104.87 118.91 37.72 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.166 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 427' ' ' SER . 57.3 t -90.14 120.55 39.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 376' ' ' SER . 0.1 OUTLIER -113.7 119.98 39.27 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--N 1.308 -1.229 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.366 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.561 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 4.3 p -47.44 -37.15 4.84 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 C-N-CA 125.102 1.361 . . . . 0.0 112.365 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -57.59 -47.17 82.86 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.639 0.776 . . . . 0.0 110.762 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.9 -35.12 20.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.826 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.03 -49.54 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.795 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.32 -34.19 75.67 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.488 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -58.12 -40.37 81.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.281 0.562 . . . . 0.0 110.701 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -93.07 -4.13 52.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.331 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -89.02 153.84 49.38 Favored Pre-proline 0 C--N 1.301 -1.525 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.711 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . 0.412 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 23.6 Cg_endo -61.19 143.99 98.75 Favored 'Trans proline' 0 CA--C 1.55 1.321 0 C-N-CA 122.946 2.431 . . . . 0.0 112.763 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.481 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 10.7 Cg_endo -54.89 -34.57 86.31 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 124.216 3.277 . . . . 0.0 115.572 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 44.0 m -77.82 -5.56 51.25 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.412 ' CG ' ' HG2' ' A' ' 329' ' ' PRO . 15.0 mm-40 -99.67 -13.33 19.39 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.818 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.481 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 18.4 m-30 -47.86 -47.52 31.55 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -174.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.441 ' HA ' HD22 ' A' ' 345' ' ' LEU . 37.4 tt0 -68.18 -35.64 78.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.8 0.333 . . . . 0.0 111.295 -174.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -71.79 -42.88 66.58 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.818 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 59.1 mt -64.78 -38.66 83.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.464 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.09 51.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.033 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -68.9 -24.63 64.33 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.36 -39.83 94.43 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.007 0.523 . . . . 0.0 109.958 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . 0.561 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 82.5 m-85 -95.59 -4.7 44.1 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.194 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 83.38 26.52 43.11 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.498 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.32 116.96 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 3.0 p -94.52 -5.97 44.82 Favored 'General case' 0 C--N 1.268 -2.94 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.808 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.47 44.42 0.8 Allowed 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.46 0.704 . . . . 0.0 111.314 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 334' ' ' GLU . 24.4 tp . . . . . 0 C--N 1.296 -1.721 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.779 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.427 -1.617 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.671 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -87.65 -27.54 22.4 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -87.13 114.37 23.69 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.66 170.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.44 -17.24 29.11 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.061 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 367' ' ' LYS . 0.0 OUTLIER -164.61 120.53 1.49 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 176.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -97.04 173.3 7.34 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.834 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.465 HD13 HG22 ' A' ' 445' ' ' THR . 91.2 mt -71.07 142.16 50.85 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.876 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -62.04 129.93 92.34 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -43.39 -33.32 4.02 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.86 3.04 . . . . 0.0 114.819 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -146.56 120.66 9.46 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.068 -0.395 . . . . 0.0 111.239 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.565 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 59.0 m-85 -101.35 156.08 17.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -127.91 138.35 52.63 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.972 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.93 152.69 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.552 ' HB2' ' CD2' ' A' ' 379' ' ' HIS . 12.0 m -86.62 146.48 26.31 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 1.4 tmmm? -63.1 125.75 25.07 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.277 0.56 . . . . 0.0 110.006 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.475 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 98.89 -3.56 58.8 Favored Glycine 0 C--N 1.304 -1.206 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.623 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' A' ' 376' ' ' SER . 27.7 m-70 -95.63 169.37 10.07 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 120.889 0.376 . . . . 0.0 111.935 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -108.1 126.75 53.12 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.524 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.9 tt -128.6 158.34 40.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 41.9 mtt-85 -125.89 142.7 51.39 Favored 'General case' 0 CA--C 1.491 -1.318 0 CA-C-O 121.663 0.744 . . . . 0.0 110.589 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.31 107.47 18.48 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.8 m -105.31 126.28 51.92 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.272 -174.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 7.6 m -127.91 157.17 40.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 123.855 0.862 . . . . 0.0 109.374 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -120.36 136.61 54.65 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 392' ' ' ALA . 92.0 mt -107.88 141.33 39.65 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.19 71.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.142 0.496 . . . . 0.0 110.355 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -117.98 138.04 52.45 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -63.53 -32.57 74.07 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 123.293 0.637 . . . . 0.0 112.693 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.82 25.78 11.4 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.395 0.617 . . . . 0.0 111.879 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . 0.533 ' O ' HD13 ' A' ' 387' ' ' LEU . . . -91.69 106.53 18.55 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 104.276 -2.491 . . . . 0.0 104.276 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -78.67 143.87 35.88 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.638 -172.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 4.1 m -105.98 148.3 10.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -111.22 130.07 55.76 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.46 ' HB3' HD12 ' A' ' 403' ' ' ILE . 8.2 m-90 -101.21 121.77 42.45 Favored 'General case' 0 C--N 1.26 -3.292 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.911 -173.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 402' ' ' GLU . 6.2 mp -129.19 125.53 37.19 Favored 'General case' 0 CA--C 1.482 -1.671 0 CA-C-N 117.635 0.198 . . . . 0.0 111.4 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . 0.436 ' HB3' HG12 ' A' ' 403' ' ' ILE . 28.8 pttt -103.94 128.14 51.46 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 47.61 22.76 0.34 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.415 1.486 . . . . 0.0 114.24 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.16 8.05 56.86 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.379 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -92.32 -92.63 0.15 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 397' ' ' LEU . 52.7 tt0 172.69 138.53 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 396' ' ' TRP . 55.4 mt -92.0 102.29 13.41 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -99.23 126.02 44.95 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.854 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.454 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 18.3 ptt? -63.95 95.17 0.11 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 122.119 0.962 . . . . 0.0 112.257 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . 0.42 ' H ' ' HD2' ' A' ' 410' ' ' TYR . 14.8 m -83.67 93.32 7.88 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.946 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 64.22 -128.26 36.22 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.568 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 8.9 p -97.69 5.53 49.19 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 120.921 0.391 . . . . 0.0 111.599 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -71.79 -32.31 67.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.74 0.305 . . . . 0.0 111.636 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.454 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 69.5 m-85 -123.44 112.5 17.6 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 39.6 mm -108.87 116.58 52.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.8 m-85 -87.03 105.54 17.23 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -106.49 108.56 20.13 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.478 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 27.8 t -90.54 105.38 17.78 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.0 mm -104.04 87.46 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.94 -98.6 0.64 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -120.11 -5.01 10.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.358 0.599 . . . . 0.0 109.443 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -95.23 99.69 11.61 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -92.7 132.14 37.17 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.227 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 22.5 m -125.28 129.81 50.76 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.531 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.532 HD13 ' CE2' ' A' ' 412' ' ' PHE . 22.2 tp -100.82 111.51 23.75 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 58.8 m -94.34 108.78 20.66 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.601 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 56.1 mt -96.92 116.93 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 15.1 m -90.84 136.47 33.05 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.054 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 55.72 68.63 0.84 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.0 1.72 . . . . 0.0 111.117 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . 0.524 ' SG ' HG22 ' A' ' 381' ' ' ILE . 61.7 m -68.87 113.2 6.08 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 11.0 m -103.65 -170.75 1.83 Allowed 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 89.9 mt -71.12 -23.88 62.18 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.269 0.557 . . . . 0.0 110.513 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -76.08 -15.04 60.18 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.235 0.541 . . . . 0.0 110.1 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -97.6 7.84 45.73 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.764 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.63 100.23 11.31 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -157.02 172.33 18.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.201 0.524 . . . . 0.0 111.609 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -90.51 118.08 29.7 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -107.39 131.81 53.85 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.839 -0.538 . . . . 0.0 110.252 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.496 ' HG3' ' OG ' ' A' ' 444' ' ' SER . 2.0 mp0 -122.95 146.71 47.36 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 123.345 0.658 . . . . 0.0 110.388 -175.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 78.8 m -123.28 113.26 18.64 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.14 133.94 53.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.951 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 49.2 t -125.56 161.85 29.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -57.56 112.73 3.94 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 118.955 -1.593 . . . . 0.0 111.577 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 85.36 -35.28 3.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.553 0.597 . . . . 0.0 112.714 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.671 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 7.9 mm-40 -99.53 126.24 45.44 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 123.601 0.761 . . . . 0.0 110.938 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -142.22 163.67 32.22 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.754 0.312 . . . . 0.0 111.401 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 25.6 p -160.34 150.04 17.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.496 ' OG ' ' HG3' ' A' ' 435' ' ' GLN . 3.4 m -137.08 146.72 45.49 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.565 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 9.0 t -129.94 132.2 46.25 Favored 'General case' 0 N--CA 1.399 -2.978 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.677 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.81 110.58 21.49 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 60.5 tp -84.72 119.59 25.44 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -95.79 108.21 20.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 64.0 t -94.79 109.13 21.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -100.17 117.49 34.52 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.216 0.531 . . . . 0.0 111.082 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.288 -2.071 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.539 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.73 -32.6 31.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 C-N-CA 123.156 0.582 . . . . 0.0 112.444 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -59.32 -46.18 89.3 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 124.698 1.199 . . . . 0.0 110.873 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.22 -32.37 22.66 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.862 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.6 mt -63.23 -45.57 98.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.637 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 333' ' ' TYR . 39.8 mt -61.74 -43.42 98.88 Favored 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.681 0.613 . . . . 0.0 110.466 177.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -55.73 -42.03 74.74 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.248 0.619 . . . . 0.0 111.777 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -81.78 -10.37 59.36 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.59 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -100.6 146.81 32.68 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -63.37 138.21 64.67 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 121.589 1.526 . . . . 0.0 110.12 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.51 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 4.9 Cg_endo -48.12 -28.98 11.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.046 3.164 . . . . 0.0 114.85 -176.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 44.2 p -64.15 -25.32 68.03 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.362 0.601 . . . . 0.0 112.323 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 336' ' ' ILE . 7.2 mm-40 -86.44 -14.51 43.05 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.467 -175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 3.8 m-85 -49.11 -44.62 42.47 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -57.97 -31.0 66.47 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.807 0.692 . . . . 0.0 110.607 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 339' ' ' GLN . 42.3 ttp180 -86.3 -51.68 6.1 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.338 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 332' ' ' GLU . 44.5 mt -60.38 -46.64 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.442 0.697 . . . . 0.0 111.692 -173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 342' ' ' VAL . . . -51.66 -52.38 48.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.912 0.885 . . . . 0.0 111.843 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -65.42 -21.72 66.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 335' ' ' ARG . 57.4 mt-30 -71.5 -34.9 70.54 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.519 0.676 . . . . 0.0 109.376 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -97.69 -12.78 21.98 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.154 -174.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 101.1 18.04 20.89 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.706 -1.235 . . . . 0.0 112.357 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.423 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 17.5 t -92.75 84.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.4 m -63.57 -42.29 98.34 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.572 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -99.87 76.18 1.94 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.602 1.192 . . . . 0.0 111.412 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.633 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.291 -1.957 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.372 175.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 121.355 0.598 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -89.77 -31.53 17.37 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 122.033 0.92 . . . . 0.0 108.91 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -87.93 140.81 29.12 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.336 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -96.92 -23.55 16.27 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -159.31 134.54 8.3 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' A' ' 443' ' ' CYS . 94.7 mttt -111.26 173.08 6.51 Favored 'General case' 0 C--N 1.283 -2.299 0 O-C-N 123.821 0.7 . . . . 0.0 111.56 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.56 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 87.6 mt -68.89 141.47 55.04 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.886 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -64.84 143.72 98.83 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -44.74 -38.91 13.17 Favored 'Trans proline' 0 C--O 1.257 1.454 0 C-N-CA 123.354 2.702 . . . . 0.0 113.593 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -145.09 158.75 43.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.565 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.418 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 42.6 m-85 -138.54 154.52 48.75 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -138.03 135.97 36.42 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.439 HG21 ' HB ' ' A' ' 381' ' ' ILE . 11.1 p -140.64 155.69 22.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.437 ' HB2' ' CD2' ' A' ' 379' ' ' HIS . 32.2 m -92.34 144.89 24.93 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.402 ' HB3' ' NZ ' ' A' ' 377' ' ' LYS . 3.0 ttpm? -57.18 128.75 38.56 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 123.699 0.8 . . . . 0.0 110.622 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.84 8.73 63.27 Favored Glycine 0 C--N 1.317 -0.486 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.367 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . 0.437 ' CD2' ' HB2' ' A' ' 376' ' ' SER . 56.3 m-70 -112.06 -179.58 3.73 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 122.453 -0.439 . . . . 0.0 110.472 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -98.35 143.81 28.42 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.439 ' HB ' HG21 ' A' ' 375' ' ' VAL . 7.6 tp -138.15 139.23 42.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 20.6 ptt180 -134.32 122.91 23.32 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.157 0.98 . . . . 0.0 113.302 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . 0.411 ' HB3' ' CD2' ' A' ' 369' ' ' LEU . 2.1 mm? -88.5 129.12 35.53 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.293 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 34.4 m -120.76 122.62 40.77 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -173.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.26 155.32 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.966 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -126.31 140.53 52.45 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.486 HD11 HG13 ' A' ' 394' ' ' VAL . 5.5 mp -101.49 158.94 15.7 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.2 -24.56 57.82 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.449 0.642 . . . . 0.0 109.624 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -108.37 137.44 46.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -80.97 -28.11 35.73 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.908 0.385 . . . . 0.0 111.357 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -99.88 17.29 21.23 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.546 -174.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -116.25 148.55 40.36 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -115.43 174.14 6.16 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.403 0.621 . . . . 0.0 110.609 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.486 HG13 HD11 ' A' ' 387' ' ' LEU . 9.2 m -106.68 164.74 4.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.162 176.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 436' ' ' CYS . 8.1 tptp -109.23 146.14 34.71 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 175.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -115.76 111.32 20.36 Favored 'General case' 0 C--N 1.281 -2.398 0 O-C-N 123.171 0.294 . . . . 0.0 110.549 -171.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.3 mp -122.34 141.91 51.05 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.048 0.452 . . . . 0.0 111.23 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -120.87 122.56 40.52 Favored 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.1 p30 53.82 12.37 0.41 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 126.183 1.793 . . . . 0.0 113.563 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.62 11.29 29.14 Favored Glycine 0 C--O 1.22 -0.75 0 C-N-CA 121.245 -0.502 . . . . 0.0 111.964 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -118.64 120.68 38.15 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.19 125.93 25.51 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 56.5 mt -65.85 132.72 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.625 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -96.97 122.29 39.79 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 27.0 ttt -68.81 93.39 0.54 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.38 0.61 . . . . 0.0 112.543 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 409' ' ' LYS . 42.7 t -82.54 128.27 34.14 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 172.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -34.82 -70.74 0.16 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 6.4 p -101.62 18.54 20.05 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.517 0.675 . . . . 0.0 112.329 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 406' ' ' SER . 17.2 tppt? -104.65 -57.79 1.98 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.31 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -113.31 108.13 16.82 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 57.1 mt -108.67 114.6 47.2 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.715 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.1 m-85 -85.78 107.53 17.67 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.719 0.771 . . . . 0.0 108.924 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.2 113.13 26.37 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 16.6 m -104.45 124.63 49.59 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.2 mp -122.12 76.61 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.199 0 CA-C-O 121.546 0.689 . . . . 0.0 109.428 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.76 -86.04 0.76 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.294 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -109.45 -19.17 13.35 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.341 0.591 . . . . 0.0 109.508 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.546 ' HE2' ' OG1' ' A' ' 420' ' ' THR . 82.6 tttt -86.29 118.93 26.05 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.779 -176.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -104.95 118.52 36.73 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . 0.546 ' OG1' ' HE2' ' A' ' 418' ' ' LYS . 8.3 m -114.59 124.49 51.99 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.527 HD13 ' CE2' ' A' ' 412' ' ' PHE . 20.4 tp -101.29 103.85 14.85 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 27.8 m -99.76 111.12 23.47 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.108 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 45.2 mt -89.3 121.38 39.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 177.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 18.6 m -106.94 128.71 54.57 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 63.17 67.7 0.66 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.711 -1.131 . . . . 0.0 107.979 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 48.1 t -74.1 123.78 25.07 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 91.4 p -105.25 -176.72 3.16 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 97.0 mt -74.33 -25.68 59.69 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -76.09 -12.17 60.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.227 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -92.16 -21.55 20.34 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.786 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -50.76 119.62 4.03 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.421 1.076 . . . . 0.0 110.601 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -169.77 165.01 9.98 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 123.573 0.546 . . . . 0.0 109.548 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.67 124.42 32.18 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -106.44 141.7 37.31 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -175.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.71 140.76 34.94 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 121.341 0.591 . . . . 0.0 111.735 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 395' ' ' LYS . 63.8 m -105.38 128.77 53.68 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.93 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.2 t -115.74 134.63 58.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.243 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.459 ' CG2' HG12 ' A' ' 394' ' ' VAL . 97.1 t -131.57 160.94 42.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.1 114.0 6.46 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 119.148 -1.501 . . . . 0.0 110.365 175.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.76 -35.11 5.15 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-O 119.39 -0.672 . . . . 0.0 113.348 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -139.53 173.15 11.84 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 122.636 1.208 . . . . 0.0 113.997 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -149.92 166.96 28.02 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.67 -1.604 . . . . 0.0 106.933 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.424 ' HB3' ' HD3' ' A' ' 368' ' ' LYS . 27.5 p -154.4 133.28 12.3 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 172.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 5.0 m -118.04 143.23 46.6 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.301 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 13.5 t -125.59 150.79 47.21 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -110.48 110.72 21.58 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 68.1 tp -90.47 129.7 36.62 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -106.77 107.9 19.14 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.77 119.28 37.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -98.28 126.59 43.83 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--N 1.311 -1.098 0 C-N-CA 123.957 0.903 . . . . 0.0 110.119 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 122.02 0.914 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.46 -29.63 47.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.441 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -53.32 -54.51 35.37 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.471 0.708 . . . . 0.0 111.375 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.03 -38.18 53.37 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.297 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 67.9 mt -64.12 -50.64 76.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.252 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.43 -28.79 64.23 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -64.06 -43.73 94.59 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.944 0.402 . . . . 0.0 110.836 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -91.26 -0.56 57.7 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.101 0.477 . . . . 0.0 112.015 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -91.16 152.29 43.9 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.849 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . 0.405 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 9.4 Cg_endo -58.15 148.33 78.64 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.704 2.269 . . . . 0.0 112.23 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 26.7 Cg_endo -60.85 -21.96 72.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.496 2.797 . . . . 0.0 114.139 -173.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 5.1 m -85.54 -4.01 59.03 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.873 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 336' ' ' ILE . 48.9 mm-40 -99.49 -14.93 18.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.935 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.454 ' HB3' HD11 ' A' ' 345' ' ' LEU . 15.6 m-30 -44.15 -55.12 5.01 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -173.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -65.65 -38.22 88.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.243 0.545 . . . . 0.0 111.179 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.03 -42.48 84.8 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.659 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 332' ' ' GLU . 74.2 mt -65.04 -44.5 95.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -55.65 -58.51 7.52 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.315 0.646 . . . . 0.0 111.395 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -67.75 -23.34 65.23 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -68.01 -42.3 80.89 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.777 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -89.4 -15.51 33.08 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.193 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 100.2 34.63 4.75 Favored Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.3 t -112.21 118.24 57.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 43.4 p -97.75 -13.94 21.12 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-O 122.015 0.912 . . . . 0.0 109.21 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -82.39 47.09 1.11 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.754 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 333' ' ' TYR . 36.0 tp . . . . . 0 C--N 1.301 -1.522 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.732 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.429 -1.505 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.747 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -85.26 -13.33 50.12 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.16 117.84 29.23 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -77.17 -29.64 54.55 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.406 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -151.42 115.96 5.12 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -98.51 160.28 14.39 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 76.5 mt -70.17 144.85 51.85 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.49 151.14 96.61 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -37.96 -45.48 1.96 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 124.397 3.398 . . . . 0.0 114.022 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -148.38 153.74 38.99 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.665 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 447' ' ' LEU . 74.9 m-85 -134.19 146.03 49.77 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.01 147.07 48.1 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.37 155.96 18.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' A' ' 379' ' ' HIS . 15.0 m -87.16 151.65 23.01 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.527 ' CB ' ' HA ' ' A' ' 451' ' ' GLU . 0.0 OUTLIER -70.13 115.33 9.21 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 120.85 0.357 . . . . 0.0 110.105 -178.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 100.49 -6.06 57.39 Favored Glycine 0 CA--C 1.496 -1.11 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 376' ' ' SER . 16.3 t60 -96.11 152.9 18.11 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -96.18 143.46 27.27 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.944 0.402 . . . . 0.0 111.772 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.65 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.9 tp -121.97 129.69 75.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -109.98 112.53 24.61 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.32 0.581 . . . . 0.0 110.304 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 79.8 mt -93.96 139.11 31.32 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 64.3 m -134.55 113.38 11.72 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.686 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.86 145.39 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 22.2 mt-10 -121.54 137.69 54.62 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.497 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 82.5 mt -95.57 144.81 25.72 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -83.84 -21.56 32.01 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.0 121.23 44.04 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.915 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -75.36 -27.12 59.03 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.265 0.555 . . . . 0.0 110.689 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -90.06 18.91 5.35 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.866 0.866 . . . . 0.0 111.304 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -113.55 142.43 45.96 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -110.5 165.99 11.36 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.82 144.31 38.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.256 0.551 . . . . 0.0 110.745 -176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -108.37 143.75 36.87 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.545 ' HB3' HD12 ' A' ' 403' ' ' ILE . 10.2 m-90 -113.21 119.08 36.53 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.596 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.9 mp -126.79 138.83 53.41 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -120.36 121.37 38.44 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 22.4 p30 51.22 12.72 0.14 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 126.393 1.877 . . . . 0.0 114.551 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.93 8.24 22.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.197 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -120.07 138.74 53.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.03 126.65 28.05 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 120.753 0.311 . . . . 0.0 110.57 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 396' ' ' TRP . 34.5 mt -72.58 102.07 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -76.26 137.75 40.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 51.0 ttp -73.27 100.01 3.02 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . 0.432 ' H ' ' HD1' ' A' ' 410' ' ' TYR . 43.8 t -101.75 119.19 38.39 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.257 -174.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 49.64 -132.21 26.75 Favored Glycine 0 C--N 1.338 0.641 0 O-C-N 124.748 1.28 . . . . 0.0 113.959 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 24.8 t -104.79 11.95 33.24 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . 0.477 ' HD3' ' OD2' ' A' ' 430' ' ' ASP . 33.1 ttmt -75.74 -61.12 2.03 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.952 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.5 ' O ' ' HG3' ' A' ' 405' ' ' MET . 82.0 m-85 -94.78 117.27 29.87 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.2 mt -121.43 113.53 39.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.524 ' CE1' HD13 ' A' ' 421' ' ' LEU . 24.3 m-85 -86.99 112.3 21.69 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 420' ' ' THR . 41.7 mt-10 -107.7 107.04 17.65 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 32.0 t -99.22 114.68 27.61 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 123.592 0.757 . . . . 0.0 108.991 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.614 ' HB ' ' CG ' ' A' ' 418' ' ' LYS . 41.9 mm -115.26 79.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 67.25 -83.46 0.13 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.376 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -100.9 -31.95 10.89 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.575 0.35 . . . . 0.0 110.767 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.614 ' CG ' ' HB ' ' A' ' 415' ' ' ILE . 1.5 ptpp? -84.49 140.4 31.5 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.715 0.769 . . . . 0.0 111.744 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -124.18 100.77 6.87 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 413' ' ' GLU . 31.4 m -98.73 134.42 41.66 Favored 'General case' 0 C--N 1.259 -3.345 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.427 -174.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.524 HD13 ' CE1' ' A' ' 412' ' ' PHE . 33.2 tp -117.0 106.81 13.81 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.359 0.6 . . . . 0.0 109.426 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 36.3 m -97.33 109.67 22.38 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.0 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.6 mt -97.72 110.01 24.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.1 m -95.82 141.47 29.24 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 61.89 52.56 3.37 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.904 0.752 . . . . 0.0 110.479 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . 0.65 ' SG ' HG22 ' A' ' 381' ' ' ILE . 13.5 m -65.19 113.19 3.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 12.0 m -108.4 -167.69 1.26 Allowed 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.14 -20.77 60.85 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 121.703 -0.623 . . . . 0.0 111.006 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -78.83 -4.51 49.91 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.405 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . 0.477 ' OD2' ' HD3' ' A' ' 409' ' ' LYS . 18.1 m-20 -110.7 7.91 22.4 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.959 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.94 96.67 9.44 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -151.27 162.63 40.56 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.932 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.75 122.66 30.15 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . 0.524 ' HD2' HD11 ' A' ' 403' ' ' ILE . 93.5 m-85 -106.55 140.58 39.21 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 120.827 0.346 . . . . 0.0 110.131 -175.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.33 137.78 30.78 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.227 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 65.5 m -103.95 128.57 51.48 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.95 130.67 73.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.366 0.603 . . . . 0.0 111.556 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 63.7 t -124.7 161.58 27.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 174.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -61.26 112.97 5.2 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 118.513 -1.804 . . . . 0.0 111.534 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 94.38 -35.3 4.26 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.632 -0.284 . . . . 0.0 112.547 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.747 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 9.1 mm-40 -105.96 138.98 41.21 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 122.467 -0.431 . . . . 0.0 110.681 -173.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.79 163.92 35.94 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 171.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 13.8 p -151.28 133.49 15.27 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 12.1 p -119.62 132.17 55.64 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 123.654 0.596 . . . . 0.0 110.707 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.431 ' OG1' ' HD2' ' A' ' 373' ' ' TYR . 14.6 t -124.07 147.9 47.52 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -106.04 111.02 23.47 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 373' ' ' TYR . 3.3 tm? -93.14 125.69 37.86 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -113.25 124.97 53.75 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.817 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.6 t -97.53 122.25 48.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -106.16 117.06 33.04 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 377' ' ' LYS . 2.6 mp0 . . . . . 0 C--O 1.256 1.417 0 C-N-CA 125.234 1.413 . . . . 0.0 113.929 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.55 -37.67 39.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.717 -1.128 . . . . 0.0 113.36 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -56.3 -46.45 79.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -85.05 -29.6 24.8 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.288 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.01 -48.29 86.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.324 0.39 . . . . 0.0 110.392 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 62.9 mt -59.42 -41.23 89.07 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.119 0.485 . . . . 0.0 110.236 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -58.62 -30.01 66.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.237 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -112.9 7.14 18.19 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.26 0.552 . . . . 0.0 111.187 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -100.67 150.82 37.32 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.695 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . 0.457 ' HG2' ' HG2' ' A' ' 332' ' ' GLU . 19.2 Cg_endo -66.43 142.84 67.26 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.433 2.089 . . . . 0.0 111.389 175.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.476 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 18.5 Cg_endo -58.52 -21.38 54.17 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 123.813 3.008 . . . . 0.0 114.205 -176.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 36.1 p -74.34 -17.16 60.87 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.047 0.451 . . . . 0.0 112.16 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.457 ' HG2' ' HG2' ' A' ' 329' ' ' PRO . 19.9 mm-40 -103.97 -2.88 25.43 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.494 -175.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 20.8 m-30 -56.89 -40.23 75.85 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -174.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.27 -30.16 70.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.989 0.423 . . . . 0.0 111.121 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -72.56 -57.72 3.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.0 -40.32 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.845 1.258 . . . . 0.0 111.792 -173.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -58.54 -60.1 4.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.639 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -67.8 -22.97 65.15 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.028 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -64.44 -34.2 77.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.384 0.674 . . . . 0.0 109.515 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.25 13.23 23.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 76.48 29.61 57.8 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.806 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.75 118.73 56.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 17.6 p -94.79 -14.19 24.91 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-O 122.115 0.96 . . . . 0.0 109.928 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -92.52 49.16 1.45 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.478 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.7 pt? . . . . . 0 C--N 1.314 -0.952 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.499 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.88 0.371 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.78 -13.02 61.22 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.063 0.935 . . . . 0.0 109.438 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.434 ' CG ' ' HG2' ' A' ' 368' ' ' LYS . 5.4 m-85 -107.09 120.48 42.21 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.38 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -79.77 -27.11 40.47 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.76 0.79 . . . . 0.0 109.169 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -157.01 118.23 3.7 Favored 'General case' 0 N--CA 1.403 -2.815 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.434 ' HG2' ' CG ' ' A' ' 365' ' ' PHE . 42.2 mtmt -94.89 178.42 5.57 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.445 HD11 ' SG ' ' A' ' 436' ' ' CYS . 82.5 mt -67.51 144.35 55.71 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 175.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.21 136.77 93.9 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -43.72 -34.81 5.99 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.059 3.173 . . . . 0.0 114.543 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -144.78 143.66 30.78 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.113 0.482 . . . . 0.0 112.234 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.413 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 63.2 m-85 -137.3 143.28 42.04 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.233 1.013 . . . . 0.0 109.315 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -122.27 138.98 54.31 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.76 149.39 29.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.1 m -82.2 147.7 28.84 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 1.6 tmmm? -64.6 127.11 30.15 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.312 0.577 . . . . 0.0 110.031 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.501 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 95.01 -7.13 69.7 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.382 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -93.08 168.33 11.19 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.757 0.313 . . . . 0.0 111.402 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 44.6 mtmt -98.12 157.61 16.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 17.8 tt -145.73 128.58 9.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 121.576 0.703 . . . . 0.0 109.924 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -103.19 114.99 29.73 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.913 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 76.3 mt -98.0 141.07 31.41 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 35.2 m -139.81 138.49 35.86 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.416 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.0 143.16 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -116.87 126.02 52.39 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.412 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 84.3 mt -91.64 139.86 30.28 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.457 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -71.73 -42.59 67.1 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.95 103.57 16.08 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.631 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -73.18 -21.83 60.6 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.181 -177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.15 26.98 3.03 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.735 1.255 . . . . 0.0 109.748 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -124.06 162.53 23.31 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.06 166.49 19.16 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.693 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 6.7 m -117.02 167.72 9.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.609 0.718 . . . . 0.0 111.91 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.498 ' HA ' ' HE2' ' A' ' 395' ' ' LYS . 8.9 mmpt? -112.81 140.16 47.83 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.403 ' HB3' HD12 ' A' ' 403' ' ' ILE . 11.6 m-90 -112.38 113.56 25.82 Favored 'General case' 0 C--N 1.278 -2.523 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.0 mp -124.59 137.4 54.39 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.751 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 119.04 30.15 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 171.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.2 p30 56.05 18.11 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 126.725 2.01 . . . . 0.0 112.249 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.5 1.98 47.06 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.093 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -106.24 133.72 50.5 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.18 123.46 20.35 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.439 0.638 . . . . 0.0 111.312 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 396' ' ' TRP . 69.6 mt -66.34 109.75 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.48 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -85.96 135.76 33.53 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 28.0 ttt -73.3 94.77 2.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.155 0.503 . . . . 0.0 110.155 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.0 p -89.04 94.4 9.93 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.05 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.17 -106.6 0.95 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.54 -0.754 . . . . 0.0 113.563 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 19.2 t -122.14 12.36 10.31 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . 0.457 ' HD2' ' CD2' ' A' ' 410' ' ' TYR . 6.2 tmtm? -74.31 -56.88 4.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.536 ' O ' ' HG3' ' A' ' 405' ' ' MET . 79.8 m-85 -107.23 113.44 26.85 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 176.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.68 113.9 45.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.097 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.401 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.0 m-85 -87.05 106.0 17.55 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 420' ' ' THR . 45.3 mt-10 -98.37 107.6 20.1 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 11.4 t -96.59 111.33 23.51 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.499 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 33.4 mm -115.1 82.02 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -174.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.91 -88.89 0.23 Allowed Glycine 0 C--O 1.236 0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 112.816 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -101.2 -29.28 12.19 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.203 0.525 . . . . 0.0 110.665 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 14.9 ptmt -94.76 127.41 40.74 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 122.143 0.973 . . . . 0.0 113.473 -171.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -100.21 105.81 17.43 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 413' ' ' GLU . 27.9 m -100.06 120.24 39.54 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.693 -174.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.401 HD13 ' CE2' ' A' ' 412' ' ' PHE . 45.8 tp -104.49 106.8 17.44 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.169 0.509 . . . . 0.0 110.312 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 58.5 m -95.8 111.63 23.55 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 38.3 mt -99.06 120.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 15.6 m -97.46 130.19 44.58 Favored 'General case' 0 N--CA 1.407 -2.614 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 63.32 74.68 0.42 Allowed 'General case' 0 C--O 1.243 0.751 0 O-C-N 124.168 0.918 . . . . 0.0 113.427 172.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 81.8 m -80.93 121.04 25.51 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.666 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 29.4 p -101.07 -177.26 3.4 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.56 -19.95 62.84 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.964 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -86.24 -11.65 51.79 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.73 177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -99.24 2.89 46.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.804 1.288 . . . . 0.0 108.39 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -77.54 116.91 18.49 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.46 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 447' ' ' LEU . . . -161.66 172.53 16.12 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.74 130.55 34.68 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -112.05 132.17 54.98 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.555 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.531 ' N ' HE21 ' A' ' 435' ' ' GLN . 0.0 OUTLIER -126.66 142.16 51.63 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.19 -174.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.445 ' SG ' HD11 ' A' ' 369' ' ' LEU . 71.7 m -123.87 120.85 33.77 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 40.7 t -115.94 128.76 73.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.932 -174.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.49 161.11 19.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 170.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.63 112.32 4.91 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.178 -1.487 . . . . 0.0 111.614 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 96.59 -35.11 4.57 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 115.344 -0.428 . . . . 0.0 112.143 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -116.09 124.63 50.89 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -174.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.01 167.54 21.88 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.702 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 41.7 t -151.79 147.2 26.38 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 80.1 p -125.92 116.59 21.73 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.0 t -94.93 138.92 32.04 Favored 'General case' 0 N--CA 1.401 -2.899 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -88.36 110.0 20.44 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 432' ' ' ALA . 3.4 tm? -99.47 121.79 41.65 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -116.62 114.24 23.81 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.646 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.63 119.62 39.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -109.35 130.28 55.5 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.407 -2.612 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.506 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.32 -33.62 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 C-N-CA 123.628 0.771 . . . . 0.0 109.492 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -52.97 -47.97 67.77 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 123.213 0.605 . . . . 0.0 112.085 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.64 -40.26 16.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.2 mt -63.22 -45.21 99.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 120.715 0.293 . . . . 0.0 111.439 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 9.3 tt -73.21 -31.09 63.96 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.389 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -70.36 -27.12 64.08 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 121.198 0.523 . . . . 0.0 111.22 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -97.82 -1.81 42.36 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.235 0.54 . . . . 0.0 110.988 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.88 148.24 35.28 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.84 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.6 146.49 92.64 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 122.328 2.019 . . . . 0.0 112.659 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.415 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 10.8 Cg_endo -52.76 -24.1 22.46 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 124.201 3.268 . . . . 0.0 115.922 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 9.0 m -76.61 -12.93 60.09 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.498 0.666 . . . . 0.0 111.644 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.409 ' O ' HG13 ' A' ' 336' ' ' ILE . 7.1 mm-40 -94.61 -15.74 23.79 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.405 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 9.5 m-30 -48.98 -49.3 41.41 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 -171.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -65.78 -31.51 72.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.157 0.503 . . . . 0.0 111.52 -174.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -69.14 -53.54 19.6 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 332' ' ' GLU . 62.6 mt -59.36 -49.86 81.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.887 -175.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -56.4 -62.06 1.98 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.933 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -62.62 -23.17 66.92 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -70.74 -39.96 73.01 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 122.782 0.433 . . . . 0.0 110.842 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -91.08 1.26 57.22 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.011 0.434 . . . . 0.0 112.078 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 87.87 25.7 31.37 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.718 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.2 t -104.81 117.17 49.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 73.9 p -95.46 -30.54 13.82 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 117.685 -1.606 . . . . 0.0 111.599 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -95.39 84.65 4.06 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 121.431 0.634 . . . . 0.0 110.589 -179.903 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.431 -1.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.473 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -88.78 -12.95 40.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.716 0.769 . . . . 0.0 109.635 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -109.74 117.57 34.24 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.522 177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -82.87 -18.86 38.8 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -160.08 116.47 2.45 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -94.69 172.76 7.98 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 96.8 mt -71.63 139.26 49.22 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 174.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -56.71 146.53 56.47 Favored Pre-proline 0 C--N 1.316 -0.864 0 O-C-N 123.926 0.766 . . . . 0.0 108.998 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.09 -33.01 41.62 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 123.025 2.484 . . . . 0.0 112.986 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -147.76 144.37 28.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.846 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.549 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 51.9 m-85 -129.8 159.07 37.68 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -136.72 141.9 43.07 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.75 147.3 25.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 25.2 m -84.16 144.5 28.96 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.424 ' HD3' ' HG2' ' A' ' 451' ' ' GLU . 26.7 ttpp -60.26 128.15 35.32 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.741 0.416 . . . . 0.0 110.949 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 90.7 8.84 65.07 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.883 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -111.07 175.2 5.51 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -99.57 136.51 39.39 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.649 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.2 tp -121.36 139.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.478 ' CZ ' HG21 ' A' ' 420' ' ' THR . 35.5 ttt85 -131.74 116.66 17.58 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.187 0.994 . . . . 0.0 111.581 -173.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.08 130.4 48.66 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.974 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 21.7 m -127.61 126.11 41.46 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.415 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 5.1 m -122.04 144.2 32.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.813 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.414 ' HG2' ' HG3' ' A' ' 418' ' ' LYS . 48.0 mt-10 -111.91 119.25 37.89 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 86.0 mt -88.11 145.65 25.83 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.515 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -72.09 -24.26 61.47 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.058 0.456 . . . . 0.0 110.183 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -123.33 135.5 54.22 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.426 ' CD2' ' HB2' ' A' ' 417' ' ' ALA . 11.7 m-70 -70.86 -23.25 62.28 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.87 19.39 17.99 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.86 -172.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -96.59 132.64 42.0 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -98.71 156.12 17.0 Favored 'General case' 0 C--N 1.267 -2.99 0 C-N-CA 118.541 -1.263 . . . . 0.0 111.96 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.53 152.23 17.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.225 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -115.0 139.35 49.92 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 403' ' ' ILE . 5.8 m-90 -110.9 125.16 53.36 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -173.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 8.3 mp -127.47 136.23 51.5 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 117.832 0.287 . . . . 0.0 110.859 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . 0.432 ' HB3' HD11 ' A' ' 403' ' ' ILE . 0.0 OUTLIER -111.61 115.63 29.46 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.277 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . 0.259 28.6 p30 50.88 13.71 0.15 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 126.814 2.046 . . . . 0.0 114.961 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 123.17 -7.11 9.27 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.366 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -107.51 134.15 50.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.88 120.74 16.9 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.193 0.521 . . . . 0.0 111.109 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 398' ' ' LYS . 43.1 mt -78.87 111.97 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.915 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.6 151.14 20.84 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 61.7 ttp -62.46 102.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 409' ' ' LYS . 27.4 t -100.78 95.91 6.96 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 55.29 -137.7 44.48 Favored Glycine 0 N--CA 1.442 -0.947 0 O-C-N 124.114 0.884 . . . . 0.0 113.04 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.3 p -95.44 8.56 42.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.385 0.612 . . . . 0.0 110.607 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 2.5 tppp? -72.5 -47.72 46.29 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.486 ' O ' ' HG3' ' A' ' 405' ' ' MET . 41.1 m-85 -119.43 108.63 14.8 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 57.6 mt -108.66 112.8 41.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 CA-C-O 120.987 0.423 . . . . 0.0 109.955 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.503 ' CD2' HD13 ' A' ' 421' ' ' LEU . 22.7 m-85 -87.08 109.37 19.38 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.468 175.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -108.68 108.72 19.68 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 70.3 m -100.16 110.38 22.66 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.352 0.596 . . . . 0.0 111.172 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 36.1 mt -104.06 74.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.11 -107.05 1.71 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.404 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.426 ' HB2' ' CD2' ' A' ' 390' ' ' HIS . . . -89.93 -25.64 20.83 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.664 0.386 . . . . 0.0 110.396 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.414 ' HG3' ' HG2' ' A' ' 386' ' ' GLU . 31.1 ttpt -88.39 98.47 11.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -100.7 130.23 46.71 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-O 121.317 0.579 . . . . 0.0 109.722 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . 0.478 HG21 ' CZ ' ' A' ' 382' ' ' ARG . 16.8 m -123.0 145.77 48.21 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.553 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.503 HD13 ' CD2' ' A' ' 412' ' ' PHE . 23.2 tp -118.56 112.63 20.13 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.353 174.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.9 m -102.07 109.87 21.69 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 33.0 mt -98.4 121.69 49.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.4 m -101.24 145.02 29.39 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.227 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 58.53 47.61 13.16 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.397 1.079 . . . . 0.0 110.836 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.64 122.86 16.9 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 11.2 m -116.63 -177.95 3.31 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.21 -29.55 69.89 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -81.76 -2.8 52.0 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -103.22 -7.05 21.5 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.2 113.84 1.54 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.841 173.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -168.79 163.05 11.8 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.914 -177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.39 129.25 34.85 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -104.61 134.31 47.99 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' A' ' 444' ' ' SER . 0.0 OUTLIER -123.87 130.0 51.9 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.406 -178.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 443' ' ' CYS . 81.4 m -107.89 111.84 24.17 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 171.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.31 128.22 53.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.756 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.12 161.3 29.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -59.96 112.93 4.84 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.278 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 93.15 -36.29 3.77 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 124.223 0.916 . . . . 0.0 112.441 175.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 12.6 mm-40 -116.61 134.99 54.18 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 120.732 0.301 . . . . 0.0 110.403 -173.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -134.61 162.35 32.54 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 436' ' ' CYS . 23.3 p -136.19 144.49 44.97 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 173.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.478 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 5.0 p -139.66 112.83 8.2 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 123.23 0.332 . . . . 0.0 111.348 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.549 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 9.9 t -104.13 141.54 36.06 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.78 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -102.63 110.53 22.49 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -89.11 143.71 26.65 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.924 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -118.73 128.65 54.69 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.51 115.93 45.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.51 ' HA ' ' HE3' ' A' ' 450' ' ' LYS . 1.1 tpmt? -105.4 115.67 30.65 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.424 ' HG2' ' HD3' ' A' ' 377' ' ' LYS . 36.0 mt-10 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.708 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.2 -34.63 27.68 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 C-N-CA 123.238 0.615 . . . . 0.0 112.0 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -51.8 -55.25 20.97 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 124.808 1.243 . . . . 0.0 109.987 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.9 -35.57 22.07 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.843 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.75 -49.26 78.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 O-C-N 122.96 0.163 . . . . 0.0 111.375 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.4 tt -71.84 -32.71 67.8 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.994 0.426 . . . . 0.0 110.035 -177.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -64.18 -33.24 75.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.48 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -96.31 0.62 51.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.416 0.627 . . . . 0.0 110.314 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -90.44 151.93 44.85 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.72 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.39 140.65 95.35 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.701 2.267 . . . . 0.0 111.596 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.472 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 14.0 Cg_endo -55.8 -23.03 39.8 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.796 2.997 . . . . 0.0 115.072 -174.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.1 p -75.78 -21.57 57.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.273 0.559 . . . . 0.0 111.932 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -93.84 -8.28 40.87 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.511 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.472 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 4.2 m-30 -43.66 -54.86 4.72 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.505 1.122 . . . . 0.0 113.856 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.86 -49.1 79.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 339' ' ' GLN . 11.2 ttp180 -60.73 -40.27 91.71 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.305 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 34.1 mt -73.6 -37.8 50.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.173 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -61.85 -58.55 7.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.178 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -66.84 -23.03 65.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.43 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 335' ' ' ARG . 7.9 tp-100 -59.14 -43.63 92.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.267 0.627 . . . . 0.0 109.624 176.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.59 4.92 43.78 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 88.58 18.22 55.32 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.219 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 24.5 t -91.87 101.04 12.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.3 m -82.33 -40.18 21.8 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.078 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -99.69 87.75 3.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.961 0.886 . . . . 0.0 109.631 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.4 pt? . . . . . 0 C--N 1.301 -1.519 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.101 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.433 -1.278 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -99.33 -35.77 9.83 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -105.64 128.74 53.81 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.94 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . 0.484 HE21 ' HB3' ' A' ' 386' ' ' GLU . 24.3 mt-30 -83.27 -43.74 15.72 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 6.0 mmpt? -137.68 124.07 20.7 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 442' ' ' LYS . 56.7 mtpt -98.46 168.29 10.29 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.215 -175.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 84.5 mt -62.03 141.31 58.15 Favored 'General case' 0 C--O 1.255 1.343 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -63.16 149.11 91.69 Favored Pre-proline 0 C--N 1.302 -1.461 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.629 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.1 -35.29 25.69 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.393 2.729 . . . . 0.0 113.259 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -153.34 152.5 31.17 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -133.35 158.29 43.36 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -135.71 136.94 41.26 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.07 156.19 24.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 8.4 t -93.15 151.27 19.94 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -64.15 119.12 9.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.851 0.357 . . . . 0.0 110.777 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 99.76 -1.49 56.78 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -91.79 -177.73 4.84 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.176 0.513 . . . . 0.0 110.836 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.0 mtpt -119.34 130.39 55.34 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.617 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.0 tp -120.84 130.01 75.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.417 0.627 . . . . 0.0 110.245 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 74.3 mtt180 -101.76 110.09 22.0 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.078 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.65 117.83 31.21 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 16.1 m -122.95 144.36 49.29 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.943 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 9.5 m -140.72 143.24 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.484 ' HB3' HE21 ' A' ' 366' ' ' GLN . 5.9 mp0 -108.94 119.55 39.88 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.473 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 81.6 mt -85.64 143.3 28.49 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.79 -44.6 27.03 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.41 114.87 22.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.325 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -79.4 -21.53 45.53 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.018 0.437 . . . . 0.0 111.415 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -94.09 26.9 3.04 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.739 0.78 . . . . 0.0 111.59 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -128.47 161.46 29.46 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.27 176.88 7.58 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 12.1 m -116.6 164.45 12.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 120.939 0.399 . . . . 0.0 110.728 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -119.0 135.42 54.63 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -106.93 123.61 48.43 Favored 'General case' 0 C--N 1.283 -2.311 0 O-C-N 123.867 0.729 . . . . 0.0 109.979 -169.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.2 mp -131.6 144.12 50.83 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.773 -0.579 . . . . 0.0 111.425 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . 0.427 ' HB3' HD11 ' A' ' 403' ' ' ILE . 23.0 pttp -126.18 125.42 42.42 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 169.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 24.6 p30 54.25 17.03 1.36 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.812 1.645 . . . . 0.0 113.009 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.44 4.66 46.54 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.891 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -109.03 124.15 50.27 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.6 111.28 1.76 Allowed 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 398' ' ' LYS . 19.3 mt -75.6 148.75 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 O-C-N 124.302 1.001 . . . . 0.0 108.415 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -139.94 173.85 11.11 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 48.6 ttm -66.96 101.57 0.86 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.9 m -97.71 97.48 9.05 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 62.97 -127.47 38.57 Favored Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.35 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.8 p -106.07 12.16 30.66 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -78.76 -60.71 2.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.085 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' ' 405' ' ' MET . 95.5 m-85 -96.55 107.62 20.06 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 49.7 mm -106.16 112.53 39.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 CA-C-O 121.178 0.513 . . . . 0.0 110.01 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' A' ' 421' ' ' LEU . 23.0 m-85 -86.79 115.87 24.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -110.5 108.33 18.29 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 19.3 m -98.41 111.63 23.91 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 39.4 mm -112.31 87.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.74 2.21 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -92.82 -27.0 17.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.453 0.168 . . . . 0.0 110.948 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 21.8 ptmt -83.96 141.73 31.02 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.565 0.698 . . . . 0.0 111.929 -175.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -115.22 120.9 41.24 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.115 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 53.0 m -112.67 122.38 47.5 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.526 HD13 ' CE2' ' A' ' 412' ' ' PHE . 21.4 tp -102.41 110.16 22.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 31.3 m -95.46 102.0 13.77 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.7 mt -86.78 112.67 23.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 13.3 m -96.36 139.83 31.92 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.718 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 61.27 57.92 2.3 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.905 1.282 . . . . 0.0 110.087 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 381' ' ' ILE . 25.5 m -64.48 120.9 13.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.093 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 82.1 p -94.89 178.55 5.53 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.25 -19.38 61.71 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.89 -2.17 42.45 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.669 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -103.3 8.04 38.3 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.542 0.687 . . . . 0.0 109.507 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -80.21 94.76 6.11 Favored 'General case' 0 C--O 1.256 1.415 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -145.24 170.21 16.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.466 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -89.53 120.71 31.07 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 398' ' ' LYS . 89.5 m-85 -107.43 138.66 43.23 Favored 'General case' 0 C--N 1.286 -2.196 0 O-C-N 122.276 -0.265 . . . . 0.0 111.166 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.1 OUTLIER -134.4 133.98 41.15 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.841 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 443' ' ' CYS . 85.7 m -108.13 114.12 27.78 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 169.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.6 t -109.84 132.54 57.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.481 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 73.9 t -125.9 160.74 32.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 173.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -66.26 113.24 5.55 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 119.054 -1.546 . . . . 0.0 111.888 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 107.89 -36.67 4.24 Favored Glycine 0 N--CA 1.424 -2.109 0 CA-C-N 115.088 -0.556 . . . . 0.0 112.507 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -134.99 152.58 51.86 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 117.988 0.894 . . . . 0.0 110.849 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.502 ' O ' ' HE3' ' A' ' 368' ' ' LYS . 20.0 ptpt -141.95 178.26 7.63 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 436' ' ' CYS . 5.9 p -148.0 134.3 19.52 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 8.0 p -121.32 129.36 53.05 Favored 'General case' 0 C--N 1.288 -2.077 0 O-C-N 123.798 0.686 . . . . 0.0 110.538 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 15.1 t -128.53 150.11 50.32 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -111.96 111.16 21.89 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 62.0 tp -90.83 130.01 36.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.08 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -109.83 110.59 21.62 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.0 120.67 45.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 376' ' ' SER . 20.0 ttpp -116.05 131.42 56.95 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.973 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.529 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.85 -34.1 47.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 122.563 0.345 . . . . 0.0 110.723 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -53.53 -47.41 69.98 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.561 1.144 . . . . 0.0 111.186 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 8.6 pt-20 -85.81 -42.09 14.47 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.897 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.34 -50.47 80.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 122.671 0.388 . . . . 0.0 111.532 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.94 -27.88 64.08 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.352 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -60.63 -49.78 76.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.432 0.634 . . . . 0.0 111.78 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . 0.468 ' H ' ' HG2' ' A' ' 327' ' ' GLN . 19.3 pt20 -94.46 0.82 55.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.785 -174.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -81.82 153.61 70.18 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.257 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.53 143.31 94.85 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 122.157 1.904 . . . . 0.0 110.988 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 28.3 Cg_endo -60.27 -24.29 76.88 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 123.764 2.976 . . . . 0.0 113.992 -172.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.1 m -79.81 -8.81 59.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.989 0.423 . . . . 0.0 111.583 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 336' ' ' ILE . 20.5 mm-40 -94.66 -19.3 20.56 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.207 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 14.2 m-30 -44.24 -50.33 8.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.03 -55.76 30.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.673 0.608 . . . . 0.0 111.765 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -65.44 -41.02 93.94 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.043 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 332' ' ' GLU . 77.6 mt -59.25 -45.81 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.69 -58.83 6.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.847 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -62.11 -30.71 71.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.17 -36.54 84.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.767 0.317 . . . . 0.0 111.117 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -93.21 4.49 53.91 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 84.11 12.87 75.65 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.983 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 19.0 t -89.94 90.22 3.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -45.68 93.21 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.128 -174.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -110.98 100.79 9.43 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.757 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 345' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.411 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.412 -2.338 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.03 68.1 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.393 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -86.99 135.43 33.28 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.861 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . 0.505 ' HB3' ' CB ' ' A' ' 386' ' ' GLU . 0.0 OUTLIER -89.03 -37.68 14.98 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 177.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -157.02 135.68 11.55 Favored 'General case' 0 CA--C 1.465 -2.31 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 9.9 mtmp? -98.09 175.06 6.24 Favored 'General case' 0 C--N 1.268 -2.963 0 O-C-N 124.298 0.999 . . . . 0.0 109.756 -175.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.521 HD11 ' SG ' ' A' ' 436' ' ' CYS . 34.6 mt -61.08 155.7 19.78 Favored 'General case' 0 C--O 1.249 1.031 0 O-C-N 124.066 0.854 . . . . 0.0 111.523 178.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.48 149.32 91.05 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 170.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.81 -37.19 76.3 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.592 2.194 . . . . 0.0 113.293 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -143.8 153.15 42.09 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.638 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -135.2 163.24 30.4 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -138.05 145.34 41.66 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 381' ' ' ILE . 13.3 p -148.33 155.25 9.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.471 ' HB2' ' CG ' ' A' ' 379' ' ' HIS . 49.8 m -90.96 146.86 23.52 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.46 ' HB3' ' NZ ' ' A' ' 377' ' ' LYS . 1.7 ttpm? -63.47 121.04 12.85 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.7 0.32 57.77 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.703 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . 0.471 ' CG ' ' HB2' ' A' ' 376' ' ' SER . 12.5 m170 -103.78 171.08 7.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 120.827 0.346 . . . . 0.0 111.309 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.0 mtpt -101.44 143.32 31.6 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 382' ' ' ARG . 0.1 OUTLIER -135.92 138.57 47.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.476 ' N ' HD13 ' A' ' 381' ' ' ILE . 55.0 mtt180 -114.62 117.35 30.63 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.377 0.608 . . . . 0.0 112.244 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 420' ' ' THR . 29.7 mt -96.53 128.81 43.81 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 28.7 m -123.74 134.57 53.66 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 14.2 m -141.97 162.82 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 C-N-CA 124.211 1.004 . . . . 0.0 108.629 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.505 ' CB ' ' HB3' ' A' ' 366' ' ' GLN . 37.8 mt-10 -123.33 138.89 54.51 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 46.2 mt -105.67 146.65 29.46 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.82 -5.72 54.15 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.386 0.613 . . . . 0.0 111.242 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 392' ' ' ALA . 21.5 t70 -135.58 138.39 42.92 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -75.54 -22.76 56.79 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.379 0.672 . . . . 0.0 112.002 -174.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -109.6 23.16 14.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 122.763 1.268 . . . . 0.0 109.29 -174.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 389' ' ' ASP . . . -101.21 139.31 37.07 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -177.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -103.25 140.75 36.97 Favored 'General case' 0 N--CA 1.393 -3.313 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.93 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.408 ' CG1' ' HG2' ' A' ' 419' ' ' ARG . 6.0 p -120.04 134.1 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.405 0 CA-C-N 113.848 -1.524 . . . . 0.0 107.556 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -111.3 146.13 37.58 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 421' ' ' LEU . 24.4 m95 -106.19 126.75 52.6 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 7.7 mp -114.34 131.44 56.54 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -98.83 110.54 23.12 Favored 'General case' 0 N--CA 1.407 -2.588 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.751 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.0 p30 56.11 2.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 127.637 2.375 . . . . 0.0 114.121 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 131.91 -5.98 5.44 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -103.33 127.89 50.56 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.74 118.86 6.66 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 123.016 0.526 . . . . 0.0 112.036 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.431 HD12 ' CB ' ' A' ' 396' ' ' TRP . 54.0 mt -79.48 114.26 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 170.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -104.28 141.26 36.61 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.563 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 27.1 ptt? -70.11 109.81 4.8 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.228 -176.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.3 m -103.05 102.48 12.51 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.214 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 52.1 -124.12 23.61 Favored Glycine 0 N--CA 1.445 -0.727 0 O-C-N 124.451 1.094 . . . . 0.0 114.639 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 16.1 m -91.46 -5.76 53.77 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.435 -0.382 . . . . 0.0 111.518 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -78.33 -53.5 7.22 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.585 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 90.9 m-85 -110.97 121.5 45.52 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 46.2 mt -121.7 119.64 59.39 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.71 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 405' ' ' MET . 3.1 m-30 -88.02 106.02 17.86 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -106.69 133.67 51.0 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 9.6 t -118.73 121.7 40.73 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.585 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 65.4 mt -118.84 94.94 3.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.78 -98.63 0.62 Allowed Glycine 0 C--N 1.305 -1.142 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -121.37 3.57 10.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.062 0.458 . . . . 0.0 110.166 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 21.2 ptmt -104.9 136.6 44.08 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . 0.408 ' HG2' ' CG1' ' A' ' 394' ' ' VAL . 9.7 tpp85 -110.71 139.07 46.31 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 29.9 m -131.22 125.31 32.58 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.507 ' HB2' ' CE2' ' A' ' 396' ' ' TRP . 50.6 tp -97.83 117.68 32.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 54.3 m -103.62 106.96 17.62 Favored 'General case' 0 N--CA 1.41 -2.428 0 O-C-N 123.906 0.754 . . . . 0.0 108.967 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 52.6 mt -98.87 125.16 52.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 44.7 m -104.59 128.8 52.7 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 66.06 66.98 0.48 Allowed 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 124.552 1.158 . . . . 0.0 110.689 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.07 122.38 17.27 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.634 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 9.2 m -105.58 -177.87 3.49 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 451' ' ' GLU . 71.8 mt -68.01 -28.69 67.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.976 0.417 . . . . 0.0 110.57 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -75.32 -6.27 49.04 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.344 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -101.17 -11.08 19.83 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.14 106.83 2.53 Favored 'General case' 0 C--O 1.25 1.083 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.38 165.57 30.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.533 -176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.53 129.23 34.87 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -104.97 135.35 46.48 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 1.8 mp0 -121.54 123.91 43.11 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 91.9 m -84.45 117.05 23.41 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.25 112.73 37.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.84 160.86 14.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.03 112.88 5.35 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 119.134 -1.507 . . . . 0.0 110.749 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.39 -36.21 4.5 Favored Glycine 0 N--CA 1.405 -3.4 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.109 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -137.41 170.17 16.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 22.2 ptmt -147.02 162.73 38.19 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.574 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 53.2 t -149.48 135.85 19.18 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.416 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 15.3 p -103.73 142.58 34.1 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.739 0.649 . . . . 0.0 111.353 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.429 ' CG2' HD13 ' A' ' 369' ' ' LEU . 15.1 t -131.16 150.2 52.25 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.81 112.46 19.26 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.076 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 36.4 tp -85.16 142.8 29.22 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.831 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -116.01 109.75 17.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.5 t -91.96 118.08 36.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -103.65 121.99 44.09 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.519 ' HG3' HD21 ' A' ' 428' ' ' LEU . 1.8 mp0 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.62 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.503 2.18 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 324' ' ' ILE . 15.0 p -49.95 -29.02 4.85 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 C-N-CA 125.124 1.37 . . . . 0.0 112.357 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -57.92 -55.39 35.51 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.43 0.692 . . . . 0.0 110.737 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.29 -20.64 43.91 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.163 0.506 . . . . 0.0 110.708 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 321' ' ' VAL . 76.2 mt -72.36 -50.28 36.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.703 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.26 -34.8 78.45 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.303 0.573 . . . . 0.0 110.268 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -54.92 -39.8 69.18 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.854 1.262 . . . . 0.0 112.434 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -103.54 -1.72 27.9 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.278 0.561 . . . . 0.0 110.129 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -80.94 149.22 66.47 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.824 -174.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . 0.422 ' HG2' ' HG3' ' A' ' 332' ' ' GLU . 21.5 Cg_endo -65.47 144.42 79.46 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.325 2.016 . . . . 0.0 110.066 173.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.78 -22.84 69.33 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.868 2.379 . . . . 0.0 113.384 -174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.5 m -78.87 -8.53 58.92 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.422 ' HG3' ' HG2' ' A' ' 329' ' ' PRO . 5.4 mm-40 -111.38 2.38 17.55 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 121.099 -0.241 . . . . 0.0 111.183 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -47.85 -52.36 19.41 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.429 ' O ' ' HD2' ' A' ' 338' ' ' PHE . 39.7 tt0 -60.29 -44.43 95.37 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.654 0.596 . . . . 0.0 111.312 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -59.99 -54.18 49.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.265 0.555 . . . . 0.0 109.994 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 51.5 mt -64.88 -41.23 91.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.886 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 342' ' ' VAL . . . -60.47 -55.43 33.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.993 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . 0.429 ' HD2' ' O ' ' A' ' 334' ' ' GLU . 77.2 m-85 -68.7 -24.08 64.45 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -68.11 -40.6 82.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.552 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -93.65 -7.9 42.53 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 95.25 33.8 6.39 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.188 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.426 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 8.3 t -116.57 106.35 20.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 72.0 p -91.28 -18.26 24.65 Favored 'General case' 0 C--N 1.265 -3.078 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.816 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -96.57 45.89 1.06 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.978 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 121.082 0.468 . . . . 0.0 110.799 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.431 -1.417 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -91.24 -11.06 39.31 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.726 0.774 . . . . 0.0 109.422 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.46 127.72 48.0 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -89.64 -32.06 17.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.485 0.659 . . . . 0.0 109.314 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.5 OUTLIER -148.83 116.07 6.12 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.355 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -91.17 163.9 14.1 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.607 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 59.6 mt -64.84 144.6 57.15 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 123.837 0.71 . . . . 0.0 109.272 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -67.45 146.42 98.69 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -45.89 -43.05 19.98 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 123.597 2.865 . . . . 0.0 113.821 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -148.9 155.06 40.33 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.068 0.461 . . . . 0.0 111.002 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -137.81 158.65 43.91 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -129.22 142.63 50.8 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.8 p -140.64 151.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 43.3 m -81.45 145.09 30.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -62.4 117.54 6.29 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.691 0.282 . . . . 0.0 111.163 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.09 5.13 57.41 Favored Glycine 0 CA--C 1.499 -0.914 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -104.96 163.25 12.67 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.47 148.17 24.52 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.439 HG22 ' SG ' ' A' ' 426' ' ' CYS . 15.9 tt -150.55 149.25 14.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 1.2 ptp180 -127.37 137.16 52.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.446 0.641 . . . . 0.0 112.325 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.07 153.97 20.78 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 50.7 m -139.68 138.23 35.86 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.692 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.13 144.02 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 35.1 mt-10 -121.28 137.19 54.8 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.429 HD12 ' NH1' ' A' ' 419' ' ' ARG . 96.4 mt -96.67 157.13 16.04 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.472 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -86.46 -15.25 40.77 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -127.93 142.72 51.18 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -80.67 -23.35 39.68 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -106.03 21.94 16.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.307 0.575 . . . . 0.0 110.545 -174.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -99.39 159.16 15.21 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -121.79 145.81 47.69 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 118.585 -1.246 . . . . 0.0 112.983 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.424 HG12 HG22 ' A' ' 438' ' ' VAL . 11.7 m -109.94 158.85 9.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.314 175.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.3 tptm -132.35 133.46 44.01 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -101.03 127.41 47.55 Favored 'General case' 0 C--N 1.275 -2.634 0 O-C-N 124.458 1.099 . . . . 0.0 108.527 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 402' ' ' GLU . 10.1 mt -137.64 146.02 43.39 Favored 'General case' 0 CA--C 1.458 -2.559 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 433' ' ' ALA . 22.5 pttp -126.58 132.82 51.21 Favored 'General case' 0 N--CA 1.399 -3.002 0 C-N-CA 118.772 -1.171 . . . . 0.0 109.652 174.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.6 p30 48.41 27.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 126.438 1.895 . . . . 0.0 114.451 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.06 23.35 30.05 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.865 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -114.18 -96.22 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.559 0.219 . . . . 0.0 111.317 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . 0.708 ' HA ' HD23 ' A' ' 397' ' ' LEU . 43.6 tt0 176.92 135.97 0.06 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 58.1 mt -91.07 128.67 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.997 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -99.43 138.5 36.44 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.462 ' HB2' ' CE1' ' A' ' 412' ' ' PHE . 60.1 ttp -79.62 80.9 5.96 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 t -88.81 111.33 21.9 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.363 -171.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 54.06 -125.12 32.44 Favored Glycine 0 N--CA 1.446 -0.698 0 O-C-N 124.331 1.019 . . . . 0.0 113.443 176.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . 0.55 ' HA ' HD11 ' A' ' 411' ' ' ILE . 15.3 m -106.74 3.85 27.04 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.719 0.771 . . . . 0.0 108.927 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -75.2 -41.8 57.04 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.399 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.433 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 99.4 m-85 -119.27 117.98 30.03 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 408' ' ' SER . 43.9 mm -114.96 114.82 47.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.482 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.3 m-30 -87.42 109.96 19.94 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -105.01 108.57 20.16 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 78.6 p -99.69 121.6 41.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.235 0.541 . . . . 0.0 109.65 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.435 ' HB ' ' HG3' ' A' ' 418' ' ' LYS . 43.5 mm -123.64 85.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.94 -90.39 0.13 Allowed Glycine 0 C--N 1.321 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 113.825 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -102.36 -28.16 12.41 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.817 0.342 . . . . 0.0 110.332 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 386' ' ' GLU . 21.2 ptmt -93.8 134.8 35.76 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.754 0.788 . . . . 0.0 112.44 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . 0.429 ' NH1' HD12 ' A' ' 387' ' ' LEU . 10.8 mpt_? -110.86 124.36 51.92 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 28.6 m -115.89 122.26 44.8 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.482 HD13 ' CE2' ' A' ' 412' ' ' PHE . 20.2 tp -103.61 109.02 20.54 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.0 m -100.02 110.75 23.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.403 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.8 mt -96.95 141.18 16.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 31.8 m -120.72 135.89 55.01 Favored 'General case' 0 N--CA 1.388 -3.561 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 59.31 58.47 3.01 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 124.783 1.302 . . . . 0.0 111.332 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 381' ' ' ILE . 60.7 m -63.6 113.46 3.35 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.347 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.7 m -100.37 -176.84 3.33 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.19 -23.77 63.96 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.125 0.488 . . . . 0.0 111.184 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.29 -5.65 50.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.048 0.452 . . . . 0.0 110.867 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -98.21 -5.7 32.79 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.073 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.82 88.7 1.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -146.7 162.49 38.39 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.166 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 398' ' ' LYS . . . -85.42 129.35 34.83 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -108.26 132.47 53.64 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.6 144.93 41.26 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.49 ' SG ' HD11 ' A' ' 369' ' ' LEU . 79.1 m -122.84 103.08 8.4 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.578 HG22 ' HG3' ' A' ' 442' ' ' LYS . 14.8 t -104.77 136.92 36.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.14 -174.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 441' ' ' GLU . 29.9 t -122.17 161.14 23.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 174.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -74.41 109.73 2.88 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 115.423 -3.275 . . . . 0.0 110.176 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 104.61 4.34 43.04 Favored Glycine 0 N--CA 1.42 -2.367 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 438' ' ' VAL . 4.5 tp10 -151.53 143.27 23.71 Favored 'General case' 0 N--CA 1.396 -3.14 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -176.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.578 ' HG3' HG22 ' A' ' 437' ' ' VAL . 26.9 ttpt -148.93 152.77 36.96 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.04 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 28.4 p -150.11 144.18 25.55 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 170.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 22.6 m -133.62 140.52 47.16 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 13.3 t -122.45 148.16 45.46 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.14 111.03 20.4 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 51.6 tp -84.36 134.3 34.49 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.98 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -107.89 115.09 29.5 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.27 108.38 19.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 376' ' ' SER . 3.8 tmmm? -100.21 117.82 35.24 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -176.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--N 1.303 -1.423 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.604 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 CA--C 1.501 -0.921 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 13.3 p -50.52 -44.04 24.13 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.814 0 C-N-CA 125.257 1.423 . . . . 0.0 111.442 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -59.33 -42.8 92.31 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.73 -38.28 18.43 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.8 mt -65.61 -45.83 91.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 120.74 0.305 . . . . 0.0 110.36 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.9 tt -68.23 -32.63 72.96 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.208 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -63.95 -34.63 78.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.103 0.561 . . . . 0.0 110.728 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -94.5 1.59 55.71 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.764 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.78 155.41 36.59 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.751 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . 0.449 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 15.6 Cg_endo -60.31 142.78 98.96 Favored 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 122.665 2.244 . . . . 0.0 112.422 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.27 -26.98 72.99 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.21 3.273 . . . . 0.0 114.753 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 41.7 m -83.55 -1.19 53.23 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.11 0.481 . . . . 0.0 112.231 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.449 ' CG ' ' HG2' ' A' ' 329' ' ' PRO . 63.0 mm-40 -100.39 -11.29 20.37 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -45.84 -49.07 15.68 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . 0.41 ' HA ' HD22 ' A' ' 345' ' ' LEU . 45.4 tt0 -72.83 -34.59 66.92 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.97 0.414 . . . . 0.0 110.805 -175.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -65.51 -44.32 87.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 332' ' ' GLU . 66.2 mt -67.08 -43.57 88.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.155 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.19 -54.26 48.81 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.454 0.471 . . . . 0.0 110.653 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 75.3 m-85 -69.81 -23.09 63.27 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -66.88 -36.21 81.79 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.09 0.471 . . . . 0.0 109.981 175.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -100.96 2.58 40.83 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 83.61 22.31 56.32 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.649 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.47 123.09 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 28.7 p -100.62 -28.55 12.8 Favored 'General case' 0 C--N 1.27 -2.863 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.999 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.6 56.57 3.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.715 0.769 . . . . 0.0 111.74 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 334' ' ' GLU . 31.8 tp . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.469 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.421 -1.911 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -90.43 -38.2 13.44 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 368' ' ' LYS . 11.9 m-85 -86.92 146.89 26.0 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 169.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -102.38 -15.67 16.46 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -168.5 125.04 1.01 Allowed 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.534 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 62.0 mttp -100.35 169.27 9.23 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 123.452 0.47 . . . . 0.0 110.16 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 70.3 mt -64.14 143.11 58.12 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.548 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -68.25 146.76 98.15 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -45.7 -43.44 18.68 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.817 3.011 . . . . 0.0 113.837 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -149.05 137.42 20.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.327 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.413 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 78.8 m-85 -118.78 159.61 23.4 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 127.08 28.15 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . 0.486 HG21 ' HB ' ' A' ' 381' ' ' ILE . 14.0 p -133.4 160.87 42.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 14.1 m -95.66 142.84 27.5 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.403 ' HE2' ' OE2' ' A' ' 451' ' ' GLU . 0.4 OUTLIER -64.26 127.3 30.85 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.984 0.421 . . . . 0.0 110.099 -176.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 95.43 1.78 62.17 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.972 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -100.97 172.37 7.07 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.917 0.389 . . . . 0.0 110.887 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 26.5 mtpp -97.85 134.75 40.57 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.486 ' HB ' HG21 ' A' ' 375' ' ' VAL . 6.7 tp -130.31 135.99 59.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 26.8 ptt180 -127.58 128.74 46.11 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.406 0.622 . . . . 0.0 112.591 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 420' ' ' THR . 1.1 mm? -105.98 138.89 41.4 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.462 -1.244 . . . . 0.0 107.793 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 51.5 m -119.04 128.41 54.33 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.803 0.335 . . . . 0.0 111.794 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 13.5 m -126.41 145.08 34.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -118.33 136.83 53.49 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.607 HD23 ' HD3' ' A' ' 419' ' ' ARG . 3.9 mm? -95.59 152.37 18.49 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.066 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.74 -33.41 58.14 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -101.31 154.54 18.69 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -77.37 -40.34 44.18 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -174.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -103.34 7.39 38.23 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.788 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . 0.579 ' O ' ' HG ' ' A' ' 387' ' ' LEU . . . -84.14 132.63 34.67 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 175.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.95 177.31 7.2 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.034 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 438' ' ' VAL . 15.8 m -112.44 164.38 8.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.466 -175.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -107.92 148.76 29.2 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.42 ' CB ' ' HB ' ' A' ' 403' ' ' ILE . 9.5 m-90 -110.22 113.01 25.34 Favored 'General case' 0 C--N 1.274 -2.699 0 O-C-N 124.144 0.902 . . . . 0.0 109.587 -171.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 401' ' ' GLN . 7.8 mp -126.35 134.26 51.12 Favored 'General case' 0 CA--C 1.48 -1.727 0 CA-C-O 120.675 0.274 . . . . 0.0 111.217 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -113.95 132.76 55.84 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 46.95 24.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.89 14.79 64.24 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.43 ' O ' ' HG ' ' A' ' 397' ' ' LEU . 24.7 tp60 -94.61 -116.29 0.1 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -174.62 128.45 0.33 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 173.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.42 ' HB ' ' CB ' ' A' ' 396' ' ' TRP . 68.4 mt -81.56 101.9 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -82.23 127.68 33.43 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.69 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -66.22 102.47 0.84 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.7 m -110.92 110.0 20.4 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.877 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 52.32 -119.16 8.64 Favored Glycine 0 N--CA 1.444 -0.801 0 O-C-N 124.408 1.067 . . . . 0.0 114.048 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.7 m -108.23 5.74 26.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.205 0.526 . . . . 0.0 110.669 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.04 -41.01 59.98 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.835 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -117.4 109.75 17.17 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.323 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 43.5 mm -108.12 114.88 47.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.497 ' CE1' HD13 ' A' ' 421' ' ' LEU . 23.0 m-85 -87.85 105.96 17.77 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -98.02 108.65 21.41 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.444 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 12.6 p -103.4 105.08 15.26 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.575 0.702 . . . . 0.0 109.85 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 51.2 mt -112.75 83.75 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 76.83 -111.6 3.31 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -97.56 -14.01 21.3 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.135 0.493 . . . . 0.0 109.923 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -78.43 119.34 21.6 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 124.047 0.939 . . . . 0.0 111.023 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . 0.607 ' HD3' HD23 ' A' ' 387' ' ' LEU . 9.9 mpt_? -111.37 113.85 26.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 99.0 m -115.06 116.17 28.0 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.577 0.703 . . . . 0.0 110.593 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 382' ' ' ARG . 26.3 tp -91.0 115.5 28.06 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.106 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.2 m -103.85 112.23 25.11 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 56.8 mt -100.26 118.13 46.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 11.3 m -96.91 138.93 33.7 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 63.15 47.65 4.05 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 124.019 0.824 . . . . 0.0 110.599 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 44.4 t -57.92 118.6 5.54 Favored 'General case' 0 C--O 1.249 1.068 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 16.1 m -107.89 -177.81 3.44 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -175.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.78 -23.11 63.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.03 0.443 . . . . 0.0 110.604 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -74.39 -5.02 39.96 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.582 0.706 . . . . 0.0 110.27 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -110.88 -9.57 14.45 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.922 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.1 98.68 0.6 Allowed 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 170.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -164.78 173.67 11.53 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.575 -169.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.4 132.05 34.29 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 444' ' ' SER . 23.7 m-85 -111.42 132.06 54.73 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.1 134.4 55.03 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.447 ' SG ' HD11 ' A' ' 369' ' ' LEU . 73.4 m -109.45 113.07 25.57 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 11.0 t -105.34 125.24 60.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.732 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 394' ' ' VAL . 39.4 t -116.62 160.92 15.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -69.73 113.2 4.89 Favored Glycine 0 N--CA 1.419 -2.435 0 C-N-CA 118.316 -1.897 . . . . 0.0 109.39 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.22 -35.75 4.79 Favored Glycine 0 N--CA 1.425 -2.046 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.937 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -135.81 158.0 45.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.576 1.188 . . . . 0.0 111.596 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -148.73 173.19 13.49 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 35.0 t -159.96 142.74 13.64 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 170.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 434' ' ' TYR . 12.3 p -122.1 130.94 53.69 Favored 'General case' 0 N--CA 1.418 -2.072 0 O-C-N 123.801 0.688 . . . . 0.0 110.09 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 10.7 t -107.02 142.3 36.86 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -98.58 110.02 22.69 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 38.7 tp -89.22 138.83 31.08 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.898 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -115.19 111.23 20.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.17 119.07 45.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 450' ' ' LYS . 0.0 OUTLIER -100.23 134.59 42.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.225 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . 0.403 ' OE2' ' HE2' ' A' ' 377' ' ' LYS . 44.9 tt0 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.82 -33.08 33.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 C-N-CA 123.511 0.724 . . . . 0.0 111.272 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -54.02 -46.46 71.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.907 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.13 -38.11 18.08 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.702 177.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.01 -54.91 28.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 O-C-N 123.223 0.327 . . . . 0.0 111.613 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.15 -21.29 65.83 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.652 0.739 . . . . 0.0 110.148 -175.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -72.8 -37.53 67.53 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.075 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -94.03 -23.99 17.8 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.634 0.73 . . . . 0.0 110.431 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.34 89.51 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.763 -176.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . 0.406 ' HG2' ' HG2' ' A' ' 332' ' ' GLU . 24.5 Cg_endo -63.85 137.55 58.75 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.509 2.139 . . . . 0.0 112.649 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.638 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 8.9 Cg_endo -52.23 -29.44 37.89 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.302 3.335 . . . . 0.0 115.555 -175.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 11.8 p -70.86 -23.84 62.39 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' ' 336' ' ' ILE . 22.1 mm-40 -95.27 -4.51 45.55 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -171.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.638 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 21.5 m-30 -46.12 -48.59 17.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -173.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.04 -29.46 68.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.061 0.458 . . . . 0.0 111.42 -175.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -76.01 -47.29 25.42 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 332' ' ' GLU . 60.7 mt -58.45 -44.12 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.117 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.85 -58.52 8.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.305 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -68.69 -23.51 64.39 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -71.13 -35.68 71.83 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.16 0.584 . . . . 0.0 110.03 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -100.9 5.35 43.28 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 79.89 38.53 19.37 Favored Glycine 0 C--N 1.31 -0.912 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.699 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.9 t -114.82 119.14 60.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 23.6 p -99.1 -14.55 19.35 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-O 121.556 0.693 . . . . 0.0 110.751 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.79 45.43 0.97 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.327 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 C--O 1.197 -1.67 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.986 -176.95 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.433 -1.295 0 CA-C-O 121.14 0.495 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.64 -13.47 15.57 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -110.32 136.02 50.15 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.198 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -98.02 -19.78 17.8 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.389 0.614 . . . . 0.0 110.016 175.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -158.5 122.35 3.98 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.721 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 45.4 mtpt -106.69 172.33 6.87 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 80.9 mt -75.04 132.67 41.48 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.02 127.97 88.56 Favored Pre-proline 0 CA--C 1.5 -0.973 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.64 -32.18 53.32 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.279 1.986 . . . . 0.0 112.438 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -110.57 110.97 21.89 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.467 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 13.9 m-85 -118.43 151.07 38.49 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 171.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -144.87 143.54 30.64 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 10.6 p -150.63 154.89 8.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.546 ' HB2' ' CD2' ' A' ' 379' ' ' HIS . 16.1 m -85.55 157.19 20.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . 0.526 ' HG3' ' HA ' ' A' ' 427' ' ' SER . 35.6 ttpt -71.98 135.35 46.38 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.782 0.325 . . . . 0.0 111.071 -177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 85.86 15.58 65.1 Favored Glycine 0 C--N 1.318 -0.469 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.8 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . 0.546 ' CD2' ' HB2' ' A' ' 376' ' ' SER . 31.5 m-70 -105.35 -177.53 3.39 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.984 0.421 . . . . 0.0 110.317 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -114.63 138.46 50.64 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.95 130.71 73.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 CA-C-O 120.904 0.383 . . . . 0.0 109.98 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -108.27 103.62 12.83 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.161 0.505 . . . . 0.0 110.475 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.26 113.11 20.88 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 19.9 m -110.35 130.86 55.47 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.149 -171.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.7 151.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 123.55 0.74 . . . . 0.0 109.69 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.486 ' HG2' ' HB3' ' A' ' 418' ' ' LYS . 50.0 mt-10 -118.55 131.61 56.22 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.457 HD22 HG21 ' A' ' 438' ' ' VAL . 26.1 mt -100.91 148.94 24.41 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -81.84 3.87 24.42 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.088 0.471 . . . . 0.0 111.782 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -142.43 136.84 29.89 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -80.42 -21.87 41.76 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.564 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -102.58 4.51 38.49 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.153 0.978 . . . . 0.0 110.042 -173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -100.21 134.84 42.56 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.96 175.89 5.24 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.847 -174.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 4.8 p -131.36 141.32 46.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 120.967 0.413 . . . . 0.0 111.082 -172.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -114.02 135.85 53.55 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 175.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.683 ' HB3' HD12 ' A' ' 403' ' ' ILE . 68.4 m95 -104.35 134.35 47.7 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.913 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 8.3 mp -119.85 125.75 49.29 Favored 'General case' 0 CA--C 1.475 -1.909 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.031 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -102.62 127.38 49.75 Favored 'General case' 0 N--CA 1.416 -2.147 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.702 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 20.9 p30 54.95 15.38 1.14 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 127.125 2.17 . . . . 0.0 113.498 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.2 19.37 42.59 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.251 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -98.13 -89.29 0.3 Allowed 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 169.63 145.9 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.695 HD11 ' HD1' ' A' ' 434' ' ' TYR . 30.3 mt -99.24 108.04 21.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -95.96 134.01 39.48 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.159 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -65.74 104.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.461 0.475 . . . . 0.0 110.674 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 30.6 t -117.44 120.76 39.11 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 50.84 -122.42 13.59 Favored Glycine 0 C--N 1.336 0.579 0 O-C-N 124.25 0.969 . . . . 0.0 113.574 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 23.8 m -116.72 19.6 14.42 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -76.5 -44.6 34.53 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.01 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -122.47 108.53 13.28 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.951 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 3.7 mp -105.24 114.89 45.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -88.09 104.82 17.03 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.442 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -99.37 119.14 37.47 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 13.1 t -115.26 108.18 16.24 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 66.0 mt -113.95 82.75 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.345 -174.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.21 -104.17 1.14 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.144 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -94.26 -21.89 18.74 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 122.409 0.284 . . . . 0.0 110.851 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 386' ' ' GLU . 21.5 ptmt -101.45 137.08 40.25 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.713 0.768 . . . . 0.0 111.47 -175.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -118.47 139.06 52.01 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.022 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 34.4 m -134.37 117.24 16.12 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-O 121.483 0.659 . . . . 0.0 110.503 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 57.1 tp -91.2 113.45 25.71 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.415 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 29.1 m -97.59 106.72 19.08 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.73 116.4 33.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 14.7 m -96.5 146.09 25.11 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.001 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 58.26 50.4 9.77 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.189 1.396 . . . . 0.0 110.15 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 8.0 p -60.46 112.96 2.17 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.73 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . 0.526 ' HA ' ' HG3' ' A' ' 377' ' ' LYS . 17.7 m -109.98 -170.46 1.65 Allowed 'General case' 0 N--CA 1.406 -2.629 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.08 -21.06 62.28 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 118.964 0.802 . . . . 0.0 111.736 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -73.24 -14.31 61.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.375 0.607 . . . . 0.0 110.077 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -98.34 9.08 43.88 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.78 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.5 107.64 17.54 Favored 'General case' 0 C--O 1.252 1.22 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -155.44 165.01 37.93 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.99 0.424 . . . . 0.0 110.556 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -86.59 115.35 24.01 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . 0.695 ' HD1' HD11 ' A' ' 403' ' ' ILE . 98.5 m-85 -104.87 133.05 50.33 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.019 0.438 . . . . 0.0 110.578 -175.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 2.0 mp0 -128.08 134.29 49.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 3.7 p -100.89 118.36 36.79 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.65 123.29 58.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.457 HG21 HD22 ' A' ' 387' ' ' LEU . 92.9 t -131.44 160.68 42.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.18 114.61 7.05 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.031 -1.081 . . . . 0.0 111.059 175.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.83 -36.49 4.32 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-O 119.31 -0.717 . . . . 0.0 113.7 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -139.16 -179.75 6.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.728 1.251 . . . . 0.0 114.228 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 443' ' ' CYS . 33.0 ttmt -149.24 157.12 43.09 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.4 t -143.63 134.43 25.24 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 171.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.42 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 12.2 p -110.15 142.77 41.2 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 123.573 0.545 . . . . 0.0 110.917 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.467 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 8.8 t -137.87 147.59 44.6 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.23 111.13 23.37 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 64.5 tp -88.82 111.3 21.86 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -93.13 107.87 19.58 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.8 t -92.22 114.23 28.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -107.2 124.13 49.29 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.427 -1.577 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.89 -36.31 49.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 123.438 0.695 . . . . 0.0 111.675 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 31.9 p-90 -58.22 -41.63 84.5 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 123.182 0.593 . . . . 0.0 111.653 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.6 -45.97 10.55 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 80.1 mt -58.2 -52.44 58.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.0 tt -66.43 -33.54 75.94 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 121.501 0.667 . . . . 0.0 109.617 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -64.47 -32.89 74.71 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 124.524 1.129 . . . . 0.0 111.446 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -96.97 -11.08 25.03 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.331 0.586 . . . . 0.0 110.845 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -83.84 161.77 54.68 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.412 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.52 142.25 58.49 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.68 2.254 . . . . 0.0 110.829 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.98 -16.69 56.31 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 123.784 2.989 . . . . 0.0 114.199 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.4 m -77.54 -17.07 58.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.719 0.295 . . . . 0.0 111.765 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -104.43 1.13 29.72 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' TYR . . . . . 0.404 ' HB3' ' CD1' ' A' ' 345' ' ' LEU . 8.8 m-30 -53.4 -42.54 67.07 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -174.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.8 -27.87 55.4 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.395 -177.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 -63.62 -54.44 35.83 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 34.0 mt -64.01 -43.41 97.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.751 -176.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.47 -59.99 4.56 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.2 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.26 -22.78 66.32 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -65.67 -42.56 91.16 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.235 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -97.95 7.04 46.99 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 90.07 13.72 60.13 Favored Glycine 0 CA--C 1.499 -0.912 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.904 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.0 t -94.54 99.43 9.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.3 m -76.39 -38.75 55.25 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.082 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -110.09 94.21 4.9 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.643 0.735 . . . . 0.0 109.873 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . 0.615 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.8 pt? . . . . . 0 C--N 1.303 -1.451 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.356 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.429 -1.497 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.511 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -86.39 -27.06 24.44 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.869 0.842 . . . . 0.0 109.482 177.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.65 127.63 35.95 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.23 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -90.54 -28.37 18.55 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.4 OUTLIER -149.46 115.4 5.68 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 177.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.428 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 57.9 mtpt -89.85 162.09 15.65 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 175.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 74.5 mt -64.57 138.65 58.52 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -61.83 145.0 92.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.76 -24.09 44.8 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.6 2.2 . . . . 0.0 113.437 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -142.68 135.6 28.2 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.87 0.367 . . . . 0.0 111.668 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -135.69 146.79 48.12 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -131.05 136.04 48.1 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.47 146.41 31.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 15.5 m -82.79 142.37 31.62 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -57.38 115.84 2.96 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 122.958 0.503 . . . . 0.0 111.248 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 108.03 -18.51 33.81 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.504 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -82.25 179.98 7.61 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.114 0.483 . . . . 0.0 110.925 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 54.3 mtpt -108.76 140.07 42.69 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.574 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.6 tp -127.12 133.25 68.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 176.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -105.87 112.6 25.72 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.918 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.51 110.65 22.44 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 45.0 m -108.32 128.89 55.14 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.65 143.45 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 172.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 18.0 mt-10 -120.13 138.37 53.62 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.41 HD12 ' NH1' ' A' ' 419' ' ' ARG . 95.5 mt -100.19 152.35 20.37 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -85.24 -14.63 46.14 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.403 0.621 . . . . 0.0 110.081 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 392' ' ' ALA . 10.6 t70 -117.84 141.47 48.39 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -79.99 -26.84 39.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.795 0.331 . . . . 0.0 111.718 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -108.04 25.61 11.38 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.632 1.206 . . . . 0.0 109.896 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 389' ' ' ASP . . . -96.75 154.97 16.98 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.15 149.23 51.95 Favored 'General case' 0 C--N 1.274 -2.7 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.116 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 5.3 m -105.92 135.79 42.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.056 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.1 tptm -103.74 136.69 42.97 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 173.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' TRP . . . . . 0.544 ' HB3' HD12 ' A' ' 403' ' ' ILE . 4.8 m-90 -103.23 118.53 36.99 Favored 'General case' 0 C--N 1.264 -3.148 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.981 -170.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.7 mp -128.75 130.21 46.77 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 120.966 0.412 . . . . 0.0 111.757 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -109.22 128.06 54.75 Favored 'General case' 0 N--CA 1.412 -2.363 0 C-N-CA 118.886 -1.126 . . . . 0.0 108.894 170.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.5 p30 49.57 23.86 1.03 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.698 1.599 . . . . 0.0 113.295 -176.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.34 4.96 60.74 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.737 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -90.12 -92.26 0.13 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.501 0.191 . . . . 0.0 110.6 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 171.77 133.69 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.544 HD12 ' HB3' ' A' ' 396' ' ' TRP . 15.0 mt -94.71 124.84 47.36 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 173.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -123.76 145.17 49.22 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.996 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 27.3 ttt -64.91 94.26 0.13 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.677 0.791 . . . . 0.0 111.32 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.6 t -93.5 101.08 13.26 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.23 -128.8 48.21 Favored Glycine 0 N--CA 1.446 -0.659 0 O-C-N 123.915 0.759 . . . . 0.0 112.191 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.7 m -105.24 18.16 22.78 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.395 0.617 . . . . 0.0 109.599 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 424' ' ' SER . 86.5 tttt -83.03 -59.76 2.38 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.359 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' TYR . . . . . 0.533 ' O ' ' HG3' ' A' ' 405' ' ' MET . 75.9 m-85 -96.44 108.12 20.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.76 115.13 48.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.189 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 421' ' ' LEU . 25.4 m-85 -87.41 106.02 17.67 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.8 108.76 21.53 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 29.8 t -95.64 122.8 38.79 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.498 ' HB ' ' CG ' ' A' ' 418' ' ' LYS . 58.3 mt -129.08 85.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.75 -98.03 0.33 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.491 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -92.26 -28.96 16.66 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.849 0.357 . . . . 0.0 110.57 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' LYS . . . . . 0.498 ' CG ' ' HB ' ' A' ' 415' ' ' ILE . 23.2 ptmt -92.55 146.72 23.45 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.896 0.855 . . . . 0.0 112.143 -175.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' ARG . . . . . 0.41 ' NH1' HD12 ' A' ' 387' ' ' LEU . 11.4 mpt_? -125.25 125.07 42.99 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 173.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 34.7 m -121.18 126.61 50.11 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 120.925 0.393 . . . . 0.0 110.279 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' LEU . . . . . 0.56 HD13 ' CE2' ' A' ' 412' ' ' PHE . 33.4 tp -98.15 108.44 21.15 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.7 m -94.83 105.23 17.15 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.718 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 52.4 mt -90.06 115.7 30.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 19.5 m -102.25 128.67 48.69 Favored 'General case' 0 N--CA 1.406 -2.635 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 69.97 59.93 0.27 Allowed 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 124.343 1.027 . . . . 0.0 110.148 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 381' ' ' ILE . 27.8 m -66.23 113.72 4.78 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.268 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 14.5 m -106.43 -166.37 1.18 Allowed 'General case' 0 N--CA 1.404 -2.762 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 54.5 mt -77.84 -22.48 49.86 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.315 -174.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -73.03 -6.41 45.34 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.64 0.733 . . . . 0.0 110.277 176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -103.69 2.71 33.45 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.077 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -87.36 100.04 12.43 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -154.58 167.19 30.95 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.78 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.66 122.9 30.42 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 170.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' TYR . . . . . 0.534 ' HD2' HD11 ' A' ' 403' ' ' ILE . 94.8 m-85 -108.04 132.25 53.74 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 120.754 0.311 . . . . 0.0 110.468 -176.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 2.1 mp0 -121.86 126.08 47.9 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.098 0.475 . . . . 0.0 110.668 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 10.7 p -95.48 113.95 25.67 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.4 123.91 65.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.747 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.48 162.69 32.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.5 113.09 5.55 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 118.448 -1.834 . . . . 0.0 110.727 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.26 -35.23 5.1 Favored Glycine 0 N--CA 1.429 -1.818 0 CA-C-O 119.661 -0.522 . . . . 0.0 113.524 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.511 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 3.3 mm-40 -130.84 154.2 48.29 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 117.944 0.872 . . . . 0.0 110.75 -173.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -148.58 154.65 40.05 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 435' ' ' GLN . 13.6 t -147.74 139.45 23.95 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.419 ' HB3' ' OE1' ' A' ' 435' ' ' GLN . 3.4 m -115.78 118.99 34.56 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.739 0.649 . . . . 0.0 109.465 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 11.0 t -105.92 146.23 30.26 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -101.59 110.29 22.25 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 66.6 tp -96.2 118.04 31.97 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -101.76 117.73 35.48 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.68 113.13 30.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -95.09 119.29 33.34 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.673 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.67 -42.33 47.73 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.918 2.412 . . . . 0.0 112.356 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 165.63 41.62 0.02 OUTLIER Glycine 0 C--N 1.304 -1.203 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 3.7 p -103.69 -174.28 2.51 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.704 -0.748 . . . . 0.0 111.114 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.413 ' C ' ' H ' ' A' ' 321' ' ' VAL . 17.6 mt-10 -83.65 -47.67 11.0 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 72.14 -21.88 0.22 Allowed 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 125.215 1.406 . . . . 0.0 113.323 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' A' ' 319' ' ' GLU . 9.0 p -45.93 -29.35 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.185 0 C-N-CA 125.957 1.703 . . . . 0.0 113.769 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -62.62 -56.38 18.37 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.807 0.843 . . . . 0.0 110.878 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.49 -31.12 66.74 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.255 0.55 . . . . 0.0 110.052 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.51 -50.58 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.364 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.67 -35.97 82.74 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.064 0.459 . . . . 0.0 110.497 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -57.61 -33.9 68.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.33 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -109.42 6.63 24.45 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.288 -175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -89.59 155.78 48.12 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.089 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -62.91 136.56 57.71 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.34 2.027 . . . . 0.0 110.508 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 9.7 Cg_endo -54.23 -34.37 79.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.731 2.954 . . . . 0.0 115.496 -172.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 37.4 t -78.74 -13.98 59.52 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.399 -0.521 . . . . 0.0 112.252 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -98.67 -0.26 43.3 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.98 -174.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.51 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 20.8 m-30 -52.36 -45.21 65.66 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -176.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.2 -37.96 78.37 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.521 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 38.8 ttm-85 -63.21 -49.41 74.32 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 339' ' ' GLN . 41.6 mt -71.12 -37.01 65.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.539 -176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.95 -54.75 41.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.44 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -65.13 -24.31 67.38 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 336' ' ' ILE . 35.2 tt0 -61.88 -36.63 81.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.305 0.574 . . . . 0.0 109.577 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -98.52 -1.37 41.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.028 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 102.03 -5.73 53.4 Favored Glycine 0 C--O 1.244 0.738 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.333 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.64 134.12 27.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 121.369 0.604 . . . . 0.0 109.838 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 -10.82 12.05 Favored 'General case' 0 C--N 1.266 -3.045 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.362 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -100.95 45.53 0.97 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 346' ' ' ARG . 0.0 OUTLIER -70.12 -32.36 70.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . 0.42 ' N ' HD22 ' A' ' 345' ' ' LEU . 50.9 ttp180 -63.35 -35.14 79.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.01 176.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 350' ' ' LYS . . . -69.38 -44.49 64.83 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.344 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 59.1 ttp -62.21 -32.4 73.06 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.043 0.449 . . . . 0.0 110.607 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 98.1 mt -72.79 -48.84 34.73 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.294 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.454 ' HG2' ' HA2' ' A' ' 347' ' ' GLY . 19.2 pttp -62.73 -39.92 95.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.754 0.311 . . . . 0.0 111.688 -175.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -68.66 -26.62 65.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.586 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 13.8 tp -80.08 -24.92 40.28 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.98 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 350' ' ' LYS . 54.4 mtmt -67.0 -35.86 80.88 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 357' ' ' ARG . . . -73.55 -25.27 72.88 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 174.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 46.7 tpp -70.45 -45.69 65.29 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 123.625 0.77 . . . . 0.0 110.875 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -87.46 -2.68 58.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.868 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 354' ' ' GLY . 0.3 OUTLIER -59.47 124.48 20.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.616 178.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -55.31 127.62 30.28 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.669 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.67 84.62 2.28 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.42 138.45 56.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' A' ' 362' ' ' SER . 20.9 ttmm -85.51 -177.29 6.4 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.447 ' H ' ' HG2' ' A' ' 361' ' ' LYS . 1.2 m 81.62 64.93 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -172.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 49.9 p -85.33 -61.77 1.69 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.703 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.523 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -85.61 -11.75 53.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.135 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.516 ' CD2' ' HB3' ' A' ' 441' ' ' GLU . 0.7 OUTLIER -94.84 145.64 24.76 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.204 175.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -108.33 -21.19 12.86 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -156.88 121.22 4.39 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.473 ' HG2' ' CD2' ' A' ' 365' ' ' PHE . 27.9 mtpp -101.3 163.12 12.43 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 54.0 mt -66.26 154.39 40.02 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 123.659 0.599 . . . . 0.0 111.118 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -68.09 161.62 66.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.093 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -55.39 -41.53 77.2 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.196 1.93 . . . . 0.0 111.362 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -154.72 162.43 41.12 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.152 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -136.2 141.46 44.01 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.6 132.32 55.2 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' A' ' 381' ' ' ILE . 11.0 p -133.51 153.67 37.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 379' ' ' HIS . 14.5 m -85.19 145.32 27.65 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 427' ' ' SER . 0.7 OUTLIER -72.65 121.26 19.47 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.08 13.94 40.99 Favored Glycine 0 CA--C 1.494 -1.259 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 376' ' ' SER . 35.6 t60 -118.9 150.34 40.05 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -91.0 127.01 36.25 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.317 0.647 . . . . 0.0 111.03 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.667 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.4 tt -124.26 163.7 23.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 0.8 OUTLIER -143.58 137.37 28.34 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.941 0.401 . . . . 0.0 110.037 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -100.37 151.33 21.64 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 38.8 m -133.01 121.94 23.47 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.024 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 12.6 m -127.05 143.85 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.08 135.71 55.13 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.415 HD13 ' HD3' ' A' ' 419' ' ' ARG . 5.7 mp -99.29 161.89 13.36 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -83.62 1.94 39.85 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.131 0.491 . . . . 0.0 110.599 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -138.85 146.37 41.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -80.73 -28.52 36.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -175.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -104.85 4.5 32.17 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.481 0.657 . . . . 0.0 111.074 -171.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -88.32 153.13 21.45 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.27 166.14 15.77 Favored 'General case' 0 C--N 1.268 -2.96 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.938 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 3.7 m -113.76 159.99 13.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.118 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 437' ' ' VAL . 31.7 mmmt -106.12 139.18 41.04 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.418 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 11.8 m-90 -113.46 111.51 22.05 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.3 mp -124.38 137.63 54.45 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.008 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -113.51 118.5 34.65 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.2 p30 50.4 18.61 0.45 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 126.104 1.762 . . . . 0.0 113.742 -175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.87 1.44 27.13 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.736 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -113.69 132.35 55.83 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 48.8 mt-10 -61.66 118.18 6.76 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 57.8 mt -71.16 108.96 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -100.41 150.72 22.33 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.536 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 86.7 mtp -67.63 96.88 0.57 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.101 0.477 . . . . 0.0 110.87 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.9 m -91.25 101.24 13.95 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 58.35 -130.73 51.44 Favored Glycine 0 N--CA 1.446 -0.646 0 O-C-N 123.704 0.627 . . . . 0.0 112.092 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 15.6 m -102.7 13.02 35.49 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.671 0.748 . . . . 0.0 109.307 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -82.6 -41.75 19.14 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.207 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.536 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 72.7 m-85 -113.25 111.43 22.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 64.2 mt -122.49 117.69 52.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.05 0.452 . . . . 0.0 110.92 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.506 ' CD2' HD13 ' A' ' 421' ' ' LEU . 21.4 m-85 -87.37 109.14 19.34 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.72 108.41 19.87 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.9 p -102.19 105.55 16.25 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.743 0.782 . . . . 0.0 111.64 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.9 mm -100.37 87.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.21 -111.58 3.65 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.331 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -98.1 -6.04 32.46 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.617 0.723 . . . . 0.0 109.813 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -91.39 111.27 22.7 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.55 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . 0.415 ' HD3' HD13 ' A' ' 387' ' ' LEU . 10.8 mpt_? -98.54 113.36 25.36 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.4 m -111.41 119.18 37.96 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.506 HD13 ' CD2' ' A' ' 412' ' ' PHE . 19.1 tp -97.09 107.47 20.0 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 96.2 m -94.26 123.05 37.41 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.409 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 59.7 mt -111.67 116.44 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 9.8 m -86.45 130.54 34.46 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.372 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 56.05 74.32 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 124.595 1.184 . . . . 0.0 111.697 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . 0.667 ' SG ' HG22 ' A' ' 381' ' ' ILE . 68.1 m -69.14 125.38 26.49 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.226 0.536 . . . . 0.0 111.25 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . 0.417 ' HA ' ' HG2' ' A' ' 377' ' ' LYS . 77.5 p -109.28 -177.08 3.2 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 90.2 mt -72.63 -14.93 61.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.19 -20.58 48.02 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.694 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.58 -19.67 27.49 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.474 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.19 99.11 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -163.48 171.51 15.8 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.085 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -87.74 127.75 35.31 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -104.96 134.98 47.16 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.635 ' N ' HE21 ' A' ' 435' ' ' GLN . 0.0 OUTLIER -124.34 118.38 26.62 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 369' ' ' LEU . 83.0 m -96.45 108.02 20.5 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 171.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 26.3 t -105.92 117.25 51.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.977 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.75 155.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 169.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.58 112.13 4.56 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 117.758 -2.163 . . . . 0.0 111.001 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 105.51 -17.81 42.46 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.523 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 64.8 mm-40 -141.38 112.31 7.24 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -134.23 159.6 40.42 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 435' ' ' GLN . 47.8 t -142.48 134.47 27.21 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 4.1 m -108.92 110.6 21.96 Favored 'General case' 0 N--CA 1.426 -1.648 0 O-C-N 124.197 0.935 . . . . 0.0 109.267 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.3 t -102.04 150.11 23.57 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -114.6 116.4 28.69 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.455 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 49.3 tp -84.66 134.22 34.37 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -112.46 109.85 19.69 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.32 112.43 26.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.306 0.574 . . . . 0.0 109.59 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.95 116.05 28.47 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.427 -1.593 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.127 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.487 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.472 ' HD2' ' HG2' ' A' ' 319' ' ' GLU . 60.6 Cg_endo -88.94 28.68 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.282 2.655 . . . . 0.0 111.984 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 97.1 -89.56 1.05 Allowed Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 8.1 t -87.09 106.34 17.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.472 ' HG2' ' HD2' ' A' ' 316' ' ' PRO . 50.0 mt-10 -96.01 -62.18 1.32 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.58 -7.76 0.55 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.786 1.234 . . . . 0.0 113.857 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.425 ' HA ' ' HB ' ' A' ' 324' ' ' ILE . 13.3 p -61.43 -23.19 29.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 124.068 0.947 . . . . 0.0 112.66 -175.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -68.62 -41.78 79.02 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.167 0.508 . . . . 0.0 109.939 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.9 -28.33 27.98 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.217 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 321' ' ' VAL . 76.2 mt -69.39 -47.12 74.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.536 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.89 -34.22 77.64 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.058 0.456 . . . . 0.0 111.257 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -59.27 -41.56 89.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.704 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -99.46 -0.41 40.83 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.515 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -71.15 155.5 93.07 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.463 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.68 134.21 46.17 Favored 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.346 2.031 . . . . 0.0 110.549 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 11.7 Cg_endo -53.66 -28.68 47.65 Favored 'Trans proline' 0 N--CA 1.476 0.455 0 C-N-CA 124.115 3.21 . . . . 0.0 115.172 -172.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 11.7 m -86.05 -15.02 42.65 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -101.26 3.49 40.9 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.148 -172.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 22.0 m-30 -50.94 -44.73 60.4 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.545 0.528 . . . . 0.0 112.264 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -59.92 -53.64 55.48 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 123.394 0.434 . . . . 0.0 112.14 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 53.4 ttp85 -61.73 -39.34 91.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.435 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 56.4 mt -73.01 -38.96 56.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.127 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.67 -56.83 16.64 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.061 0.545 . . . . 0.0 111.027 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -67.4 -23.54 65.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -65.99 -47.28 75.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.137 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -83.88 -19.29 35.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.162 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 100.77 40.56 2.88 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.086 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.97 128.24 63.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 19.1 p -104.3 -14.48 15.77 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 121.24 0.543 . . . . 0.0 110.44 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -79.28 44.75 0.6 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.331 0.586 . . . . 0.0 111.26 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 46.3 tp -73.81 -39.56 64.01 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -66.33 -29.51 69.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.205 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 351' ' ' ARG . . . -74.96 -34.86 51.73 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 25.4 ttt -70.63 -43.35 69.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.839 0.352 . . . . 0.0 110.145 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.85 -34.7 77.21 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.814 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -54.97 -41.14 70.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.851 0.86 . . . . 0.0 109.943 174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.628 ' O ' ' HG2' ' A' ' 355' ' ' MET . 28.2 mmt180 -54.78 -45.98 74.35 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.112 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 6.9 mp -80.73 -20.94 41.67 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.149 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -71.47 -26.83 62.87 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -83.83 -29.84 30.83 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.106 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.628 ' HG2' ' O ' ' A' ' 351' ' ' ARG . 26.0 mmt -75.4 -17.09 60.28 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 122.831 0.453 . . . . 0.0 110.674 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 77.67 -29.12 0.16 Allowed 'General case' 0 C--O 1.246 0.892 0 C-N-CA 125.631 1.572 . . . . 0.0 112.009 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -80.25 86.69 5.62 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 122.013 0.911 . . . . 0.0 109.872 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -138.78 97.21 3.28 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.162 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 17.0 mm-40 55.77 28.58 12.49 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.467 1.107 . . . . 0.0 112.705 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -76.68 106.11 8.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.507 0.67 . . . . 0.0 109.592 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 359' ' ' GLU . 22.2 pttp 178.5 -37.05 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.595 -170.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 26.2 p 178.52 27.96 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.94 1.296 . . . . 0.0 109.829 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.438 HG22 ' OE2' ' A' ' 441' ' ' GLU . 7.3 t -74.01 -39.72 63.41 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.197 -0.94 . . . . 0.0 110.964 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.563 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -92.55 -10.47 37.49 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.924 0.392 . . . . 0.0 111.069 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.21 110.07 20.12 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.903 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 386' ' ' GLU . 25.8 mt-30 -74.26 -29.3 61.61 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-O 121.527 0.679 . . . . 0.0 109.655 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 367' ' ' LYS . 34.3 ttmt -149.38 119.21 7.07 Favored 'General case' 0 N--CA 1.398 -3.026 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -176.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.662 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 57.9 mtpt -100.04 166.21 11.14 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.758 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 71.4 mt -69.12 136.42 52.19 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.541 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -59.36 150.66 63.27 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -46.66 -39.27 23.19 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 123.095 2.53 . . . . 0.0 113.115 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -147.46 165.37 30.48 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.471 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -142.45 144.39 33.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.38 140.42 52.97 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.6 p -145.93 152.74 13.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 25.1 m -91.14 150.85 21.21 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.32 128.79 37.73 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.871 0.367 . . . . 0.0 110.486 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 88.34 6.77 73.78 Favored Glycine 0 C--N 1.314 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.6 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 376' ' ' SER . 10.1 m-70 -102.75 -178.52 3.7 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.764 0.316 . . . . 0.0 110.21 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -119.65 141.24 49.52 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.467 HG22 ' SG ' ' A' ' 426' ' ' CYS . 16.1 tt -141.4 155.42 20.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 175.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 2.6 ptm180 -141.18 134.85 30.15 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.347 0.594 . . . . 0.0 110.598 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.57 125.21 48.19 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.817 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 54.1 m -106.28 121.28 43.9 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.702 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.44 144.12 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 366' ' ' GLN . 33.3 mt-10 -124.41 131.44 53.5 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.479 HD21 HG13 ' A' ' 394' ' ' VAL . 3.4 mm? -89.86 159.86 16.77 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.8 -25.55 56.48 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.3 0.571 . . . . 0.0 110.261 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -131.2 159.41 37.81 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.124 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -80.8 -25.33 37.92 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.261 0.553 . . . . 0.0 109.895 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.08 3.19 40.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.051 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -99.93 118.02 35.46 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -103.01 163.73 12.03 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.167 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.479 HG13 HD21 ' A' ' 387' ' ' LEU . 3.7 m -117.81 141.09 38.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.484 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -109.46 122.9 48.42 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.414 ' O ' HD12 ' A' ' 397' ' ' LEU . 3.6 m-90 -93.37 114.0 26.31 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.665 -170.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 396' ' ' TRP . 7.8 mp -127.3 137.67 52.88 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 175.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 433' ' ' ALA . 60.4 pttt -117.34 119.45 35.17 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.8 p30 50.95 20.72 0.84 Allowed 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 125.415 1.486 . . . . 0.0 113.236 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . 0.4 ' HA2' HD23 ' A' ' 397' ' ' LEU . . . 103.02 2.28 48.72 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.985 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -108.58 123.43 48.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -53.01 121.13 6.79 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.515 0.509 . . . . 0.0 110.603 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 53.1 mt -79.19 102.04 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -100.3 145.58 27.96 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.417 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 87.8 mtp -60.63 100.74 0.11 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.301 0.572 . . . . 0.0 111.617 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.7 m -102.6 103.1 13.38 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.115 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.99 -134.41 50.83 Favored Glycine 0 N--CA 1.442 -0.95 0 O-C-N 124.008 0.817 . . . . 0.0 113.307 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.3 t -99.98 7.72 44.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 26.2 ttmt -75.7 -54.43 6.97 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.708 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.417 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 60.4 m-85 -102.33 107.66 18.76 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.121 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.05 110.15 30.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.365 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.564 ' CE1' HD13 ' A' ' 421' ' ' LEU . 22.4 m-85 -87.27 106.13 17.7 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.45 108.04 19.92 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.433 0.635 . . . . 0.0 110.464 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.86 107.19 19.03 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.53 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.41 84.27 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 73.74 -111.3 3.4 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.84 -6.86 26.15 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.256 0.55 . . . . 0.0 110.029 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -82.44 113.01 19.9 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.721 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -108.8 107.45 17.88 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.7 m -109.36 116.92 32.76 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.128 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.564 HD13 ' CE1' ' A' ' 412' ' ' PHE . 21.0 tp -91.17 106.39 18.48 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.3 m -93.84 119.99 33.51 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 54.5 mt -107.34 115.37 48.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.5 m -99.99 131.76 45.75 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 68.52 61.65 0.36 Allowed 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.355 1.062 . . . . 0.0 111.494 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . 0.467 ' SG ' HG22 ' A' ' 381' ' ' ILE . 59.7 m -62.95 121.74 14.29 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.561 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.3 p -113.82 -175.0 2.58 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.72 -18.77 62.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.261 0.553 . . . . 0.0 110.39 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -78.92 -11.17 59.99 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.752 0.787 . . . . 0.0 110.101 176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . 0.429 ' OD1' ' HD3' ' A' ' 409' ' ' LYS . 23.2 m-20 -96.49 -19.48 19.1 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.976 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.04 103.15 0.9 Allowed 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -165.05 167.59 18.19 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 398' ' ' LYS . . . -85.76 124.15 31.93 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -104.67 139.46 39.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.426 ' HB3' ' CB ' ' A' ' 444' ' ' SER . 0.0 OUTLIER -142.97 138.76 30.31 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 121.173 0.511 . . . . 0.0 110.767 177.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 62.2 m -101.96 112.05 24.54 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.115 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.95 110.13 23.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.708 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 57.9 t -112.41 157.07 13.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.25 113.3 5.46 Favored Glycine 0 N--CA 1.428 -1.873 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.829 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 102.6 -33.47 6.53 Favored Glycine 0 N--CA 1.425 -2.033 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.158 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 24.7 mm-40 -132.44 131.37 41.67 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.365 0.602 . . . . 0.0 111.582 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 443' ' ' CYS . 33.5 ttmt -126.36 158.03 36.95 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 49.3 t -148.39 134.0 18.78 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 171.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 435' ' ' GLN . 34.0 t -123.79 139.27 54.15 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.8 t -125.62 150.48 47.51 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -106.85 110.87 23.15 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.395 0.616 . . . . 0.0 110.593 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -89.6 139.67 30.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.001 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 450' ' ' LYS . 53.9 t80 -121.69 117.02 25.62 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 123.609 0.763 . . . . 0.0 110.891 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 56.5 t -97.51 119.47 45.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 376' ' ' SER . 0.0 OUTLIER -110.67 137.52 48.24 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.227 174.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--N 1.292 -1.898 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.701 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.444 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.76 -24.96 12.84 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.676 2.251 . . . . 0.0 112.273 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -172.11 -178.21 42.19 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 24.5 t -116.75 -61.23 1.75 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -119.0 9.63 11.92 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 122.657 1.218 . . . . 0.0 108.312 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.17 19.93 4.01 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.365 -1.743 . . . . 0.0 110.691 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.29 -35.52 36.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.745 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . 0.475 ' O ' ' HB2' ' A' ' 326' ' ' ARG . 17.7 m95 -56.6 -60.4 3.59 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 124.024 0.93 . . . . 0.0 110.913 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.85 -41.32 95.79 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.488 0.492 . . . . 0.0 111.657 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.4 mt -68.06 -42.88 85.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 123.095 0.558 . . . . 0.0 111.545 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.6 -36.24 60.36 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 322' ' ' TRP . 14.3 tpt85 -63.94 -41.15 97.7 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.364 0.666 . . . . 0.0 111.345 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.76 -4.59 59.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.547 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -87.92 150.3 47.51 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.59 150.24 82.9 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.817 1.678 . . . . 0.0 111.273 176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.1 -29.31 3.93 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.644 3.563 . . . . 0.0 115.96 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 50.5 m -85.41 -2.06 57.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -93.44 -22.26 19.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -44.08 -52.51 7.13 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.86 1.264 . . . . 0.0 112.905 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -57.0 -53.0 63.03 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.433 0.693 . . . . 0.0 111.858 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -57.87 -50.37 73.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.983 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.67 -40.43 89.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.892 -175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.94 -57.72 11.56 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.623 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -68.89 -23.02 64.15 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -64.14 -44.8 91.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.92 0.39 . . . . 0.0 110.082 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -91.13 -8.4 48.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 89.13 32.5 10.56 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.442 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 17.6 t -94.52 122.8 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.338 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 9.3 p -97.82 -22.57 16.31 Favored 'General case' 0 C--N 1.276 -2.618 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.934 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -83.89 63.23 7.43 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.714 0.768 . . . . 0.0 110.297 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 27.6 tp -75.56 -47.16 27.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.286 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -65.79 -26.14 67.56 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 351' ' ' ARG . . . -61.86 -34.25 88.13 Favored Glycine 0 N--CA 1.423 -2.17 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.829 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 53.9 tpp -68.08 -38.75 82.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.077 0.465 . . . . 0.0 110.157 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.95 -34.25 77.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.058 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -63.0 -45.5 92.12 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 347' ' ' GLY . 83.8 mtt180 -61.18 -46.12 91.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.854 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.64 -49.88 75.89 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.728 0.811 . . . . 0.0 111.016 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.91 -15.72 60.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.071 0.462 . . . . 0.0 110.787 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -97.68 25.85 25.62 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.759 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 23.6 mmt -87.25 -19.09 28.82 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -62.48 137.55 58.28 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.235 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -99.11 170.5 8.65 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.508 ' OD2' ' HG2' ' A' ' 360' ' ' LYS . 35.9 t70 -133.51 136.47 45.08 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -109.48 92.88 4.23 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.561 ' HE3' ' HA ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -101.74 -93.67 0.3 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.25 175.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.441 ' HG3' ' H ' ' A' ' 362' ' ' SER . 18.0 tptp 59.77 -170.45 0.14 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.978 0.911 . . . . 0.0 108.623 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.441 ' H ' ' HG3' ' A' ' 361' ' ' LYS . 44.8 t 63.39 30.23 15.5 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 121.489 0.661 . . . . 0.0 109.914 176.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 75.0 p -72.54 -32.24 65.93 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.402 -172.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -97.53 4.93 50.22 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.17 0.509 . . . . 0.0 110.776 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -117.0 117.6 30.11 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.689 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -85.08 -21.93 29.15 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 120.826 0.346 . . . . 0.0 110.36 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . 0.426 ' HB2' ' HE2' ' A' ' 367' ' ' LYS . 23.6 ttmm -159.67 127.38 4.77 Favored 'General case' 0 N--CA 1.391 -3.383 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 35.6 mtmm -110.75 177.35 4.7 Favored 'General case' 0 C--N 1.253 -3.615 0 O-C-N 124.28 0.987 . . . . 0.0 108.357 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.424 HD13 HG22 ' A' ' 445' ' ' THR . 86.4 mt -71.98 141.94 49.37 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.144 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.67 158.66 67.02 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.202 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -44.8 -39.81 14.09 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 123.451 2.767 . . . . 0.0 113.809 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -156.11 162.53 40.24 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -137.97 149.2 45.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -133.38 137.34 45.79 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.42 143.78 33.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 46.7 m -79.43 141.99 36.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -57.28 125.59 23.48 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 122.957 0.503 . . . . 0.0 110.402 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 96.47 -9.97 66.96 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.917 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -96.71 170.75 8.98 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.149 0.499 . . . . 0.0 110.791 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 6.9 mtpm? -101.08 161.05 13.88 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.729 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 18.2 tt -154.98 133.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 121.201 0.524 . . . . 0.0 110.665 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -99.99 127.47 46.2 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.546 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 420' ' ' THR . 70.3 mt -105.77 109.37 21.3 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 87.7 m -107.19 126.01 51.85 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.13 149.25 33.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 418' ' ' LYS . 41.5 mt-10 -114.43 135.55 53.98 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 54.1 mt -104.04 165.44 11.05 Favored 'General case' 0 C--N 1.261 -3.263 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.03 -29.84 49.61 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.164 0.507 . . . . 0.0 109.929 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -112.01 146.94 37.0 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.181 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -78.9 -22.44 45.92 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -112.5 26.23 10.74 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.236 0.541 . . . . 0.0 111.398 -173.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -113.37 137.54 51.36 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -122.31 154.45 37.6 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.893 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.61 153.53 7.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.33 0.586 . . . . 0.0 111.491 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -103.43 133.37 48.6 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.453 ' CB ' HD12 ' A' ' 403' ' ' ILE . 44.8 m95 -101.51 139.06 37.68 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 434' ' ' TYR . 10.3 mp -121.13 143.61 49.01 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.644 ' HG3' HG12 ' A' ' 403' ' ' ILE . 22.5 mtmm -103.83 108.61 20.0 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.7 p30 50.95 16.81 0.37 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 124.966 1.306 . . . . 0.0 113.998 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.15 -5.96 17.52 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.643 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -102.04 124.85 48.37 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -64.13 118.39 8.48 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.932 0.396 . . . . 0.0 111.987 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.644 HG12 ' HG3' ' A' ' 398' ' ' LYS . 41.0 mt -66.33 122.0 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.248 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -102.1 157.34 16.95 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.557 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 48.0 ttm -71.54 94.6 1.31 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.0 t -89.92 102.22 14.92 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 58.68 -114.38 5.92 Favored Glycine 0 N--CA 1.437 -1.251 0 O-C-N 124.086 0.866 . . . . 0.0 112.141 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 26.4 m -119.3 17.12 13.1 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.05 -0.575 . . . . 0.0 109.735 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -76.34 -46.39 27.76 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.864 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.557 ' O ' ' HG3' ' A' ' 405' ' ' MET . 93.4 m-85 -111.62 108.44 17.93 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.89 0.376 . . . . 0.0 110.292 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 49.6 mt -107.91 113.75 44.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -87.23 105.1 16.99 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.409 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.99 138.61 41.87 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.638 0.732 . . . . 0.0 111.365 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 13.1 p -118.38 122.81 43.73 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.089 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.79 89.89 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.03 -123.83 15.69 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.41 -6.36 55.02 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.317 0.58 . . . . 0.0 110.027 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.407 ' HG3' ' HG2' ' A' ' 386' ' ' GLU . 31.2 ttpt -88.85 125.26 34.84 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . 0.444 ' HD3' ' HA ' ' A' ' 419' ' ' ARG . 2.5 tpp180 -113.2 137.3 51.67 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 76.9 m -142.11 122.94 14.38 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.367 0.603 . . . . 0.0 112.162 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 410' ' ' TYR . 63.9 tp -91.19 114.32 26.82 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 43.7 m -93.97 108.08 19.92 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 50.7 mt -92.84 130.62 41.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . 0.5 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 16.5 m -106.58 132.19 52.87 Favored 'General case' 0 N--CA 1.406 -2.656 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.832 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.438 HE21 ' HB3' ' A' ' 425' ' ' GLN 0.321 2.0 pt20 46.64 76.5 0.1 Allowed 'General case' 0 C--O 1.238 0.467 0 O-C-N 125.16 1.537 . . . . 0.0 114.575 177.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 60.5 m -70.28 128.39 36.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.968 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.0 m -112.9 -174.16 2.4 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.64 -19.79 62.78 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.89 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -72.55 -24.72 61.17 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.182 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.38 -21.57 42.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.13 95.54 0.41 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.412 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.95 171.51 18.58 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.2 132.74 34.24 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . 0.59 ' HA ' ' O ' ' A' ' 397' ' ' LEU . 38.7 m-85 -104.81 145.57 30.19 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.1 OUTLIER -129.62 123.28 30.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 7.8 p -94.38 118.28 31.39 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 13.0 t -111.53 121.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.28 160.06 6.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -67.37 112.29 4.71 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 117.764 -2.16 . . . . 0.0 110.242 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 107.52 -35.41 5.03 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 112.391 -0.283 . . . . 0.0 112.391 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.408 ' OE1' ' HG3' ' A' ' 361' ' ' LYS . 23.3 mm-40 -120.03 127.82 52.95 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 122.428 -0.454 . . . . 0.0 110.612 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -130.85 128.93 41.63 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.7 t -120.31 138.05 53.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 434' ' ' TYR . 12.7 p -116.43 148.11 41.03 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 123.412 0.445 . . . . 0.0 111.013 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.424 HG22 HD13 ' A' ' 369' ' ' LEU . 12.6 t -140.54 150.92 44.3 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -101.73 119.28 38.54 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 24.4 tp -95.98 137.22 35.35 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -118.35 115.74 25.31 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.52 122.17 41.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -93.73 106.63 18.59 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.724 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--N 1.292 -1.896 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.274 179.284 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.479 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.2 148.92 92.34 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.131 1.887 . . . . 0.0 109.817 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -84.0 45.19 3.44 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.864 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 3.1 p -77.3 0.42 22.24 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 123.264 0.626 . . . . 0.0 112.616 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 43.5 mp0 -78.91 -24.36 44.16 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 69.31 -19.12 0.18 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.476 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 7.2 p -51.33 -34.4 14.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 123.873 0.869 . . . . 0.0 112.209 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -55.91 -47.71 76.98 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.872 0.869 . . . . 0.0 110.92 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 11.6 pt-20 -85.85 -38.12 18.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.69 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.79 -50.47 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.311 0.1 . . . . 0.0 111.167 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.39 -32.0 70.75 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -57.87 -39.14 77.09 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.846 0.858 . . . . 0.0 112.199 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 23.2 pt20 -104.88 2.38 29.86 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.173 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -77.12 160.77 75.25 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.529 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.84 135.51 48.61 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.276 1.984 . . . . 0.0 111.029 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -65.96 -4.83 10.85 Favored 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 123.759 2.972 . . . . 0.0 114.772 -173.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 24.5 p -90.25 -16.7 28.85 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.208 0.528 . . . . 0.0 111.192 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.403 ' O ' HG13 ' A' ' 336' ' ' ILE . 29.3 mm-40 -106.92 -0.72 22.98 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.54 -172.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -55.73 -42.24 75.06 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.07 -44.14 97.33 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.528 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -59.36 -53.53 57.18 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.697 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 332' ' ' GLU . 48.5 mt -59.04 -44.06 90.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 O-C-N 123.792 0.683 . . . . 0.0 110.613 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.66 -60.79 3.28 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.126 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -67.12 -22.85 65.78 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -66.39 -45.62 79.4 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 123.2 0.6 . . . . 0.0 110.205 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . 0.476 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 80.8 m-85 -88.83 -20.19 24.98 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 112.63 14.09 10.79 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 119.532 -1.318 . . . . 0.0 112.551 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.37 97.14 6.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.2 m -65.06 -42.67 93.99 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.693 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -115.99 95.9 5.32 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.706 0.765 . . . . 0.0 111.409 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.647 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.6 pt? -71.31 -28.27 63.99 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.104 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -65.74 -46.0 80.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.681 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -68.31 -23.02 74.94 Favored Glycine 0 C--O 1.239 0.448 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . 0.539 ' O ' ' HG2' ' A' ' 351' ' ' ARG . 25.2 ttt -67.18 -54.64 19.32 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 350' ' ' LYS . 4.4 pp -70.06 -29.54 66.57 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.276 0.56 . . . . 0.0 111.09 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.433 ' N ' HD12 ' A' ' 349' ' ' LEU . 84.8 tttt -57.85 -46.4 84.83 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.514 1.126 . . . . 0.0 110.512 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 348' ' ' MET . 15.2 ptp180 -72.07 -22.0 61.43 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.713 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.67 -21.44 55.41 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -62.72 -53.74 49.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.76 -4.18 70.12 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.415 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 44.2 ttm -89.79 -45.25 9.42 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 122.939 0.495 . . . . 0.0 110.053 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -79.76 -79.07 0.15 Allowed 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.681 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -176.98 75.25 0.02 OUTLIER 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.218 0.532 . . . . 0.0 110.792 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 360' ' ' LYS . 34.5 t70 -121.25 11.5 10.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 123.228 1.489 . . . . 0.0 109.14 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -88.72 93.11 9.46 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 358' ' ' ASP . 3.7 mppt? -81.84 -62.21 1.7 Allowed 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.534 -176.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.433 ' HB3' ' H ' ' A' ' 362' ' ' SER . 14.1 mptt 54.72 -158.76 0.19 Allowed 'General case' 0 C--O 1.241 0.655 0 O-C-N 124.156 0.91 . . . . 0.0 110.537 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.433 ' H ' ' HB3' ' A' ' 361' ' ' LYS . 16.2 m 67.11 19.56 10.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.665 0.745 . . . . 0.0 109.456 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.6 t -104.62 -16.61 14.95 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.363 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -86.14 -3.34 58.94 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.204 1.002 . . . . 0.0 108.558 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.47 ' CD1' ' HB3' ' A' ' 441' ' ' GLU . 0.3 OUTLIER -91.98 126.45 37.07 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 114.226 -1.352 . . . . 0.0 107.899 173.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -93.25 -18.09 22.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.48 0.657 . . . . 0.0 110.023 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -157.24 126.08 5.8 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.728 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 37.4 mtmm -106.86 176.58 5.12 Favored 'General case' 0 C--N 1.276 -2.596 0 O-C-N 123.791 0.682 . . . . 0.0 109.841 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.528 HD11 ' SG ' ' A' ' 436' ' ' CYS . 72.3 mt -74.51 147.54 41.75 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.23 159.06 82.34 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.61 -35.85 38.86 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.277 2.651 . . . . 0.0 112.997 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -156.35 160.72 39.95 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -133.82 148.76 51.35 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -128.25 144.69 51.15 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.8 149.24 15.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 m -88.66 154.02 20.64 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.01 121.43 11.82 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.167 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 90.63 4.37 70.26 Favored Glycine 0 C--N 1.303 -1.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.16 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -98.78 176.9 5.46 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 122.434 -0.451 . . . . 0.0 110.767 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -110.42 143.13 41.17 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.044 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.464 HG22 ' SG ' ' A' ' 426' ' ' CYS . 10.0 tp -130.99 143.04 42.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -121.19 121.9 38.8 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 66.7 mt -100.17 113.33 25.91 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 26.9 m -112.14 125.21 53.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.311 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.99 157.54 40.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.502 ' HG2' ' HG2' ' A' ' 418' ' ' LYS . 46.5 mt-10 -124.11 137.32 54.58 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.535 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 86.7 mt -98.8 138.13 36.39 Favored 'General case' 0 C--N 1.267 -3.007 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.64 -38.56 58.8 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -106.95 99.8 9.34 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.626 -1.625 . . . . 0.0 106.917 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 417' ' ' ALA . 20.3 p80 -73.9 -16.64 61.1 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 120.817 0.341 . . . . 0.0 111.712 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -87.28 3.97 44.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.177 0.513 . . . . 0.0 110.528 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -107.67 96.18 6.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.434 ' HG2' ' NH2' ' A' ' 419' ' ' ARG . 35.0 mt-10 -75.27 159.81 31.08 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 8.6 p -118.11 157.95 19.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 113.485 -1.688 . . . . 0.0 109.668 -173.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -132.15 161.22 33.87 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.46 ' CB ' HD12 ' A' ' 403' ' ' ILE . 38.7 m95 -114.14 144.62 42.87 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.7 mp -122.74 136.41 54.86 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.53 ' HG2' HG12 ' A' ' 403' ' ' ILE . 8.2 mmtp -93.17 108.62 20.19 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.479 173.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.8 p30 53.03 12.92 0.32 Allowed 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 125.024 1.33 . . . . 0.0 114.078 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 108.44 9.72 26.72 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.007 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -90.77 -98.89 0.11 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 173.21 137.53 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.53 HG12 ' HG2' ' A' ' 398' ' ' LYS . 48.4 mt -97.75 120.8 47.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 120.831 0.348 . . . . 0.0 110.401 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -91.77 130.99 37.45 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 58.1 ttp -62.21 103.73 0.41 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.8 m -106.16 120.31 41.5 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.265 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 48.62 -118.89 5.21 Favored Glycine 0 C--N 1.334 0.42 0 O-C-N 125.027 1.454 . . . . 0.0 115.278 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.6 m -112.14 7.57 19.65 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.468 0.651 . . . . 0.0 109.623 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 424' ' ' SER . 82.6 tttt -83.3 -49.5 9.32 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.658 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -109.74 129.05 55.65 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.93 118.16 51.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -87.91 105.87 17.72 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -112.76 113.09 25.03 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.166 0.508 . . . . 0.0 111.73 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 37.4 t -98.22 119.42 36.86 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.84 95.42 3.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 71.32 -107.83 2.3 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.535 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -101.6 -13.11 17.97 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.073 0.463 . . . . 0.0 109.846 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.502 ' HG2' ' HG2' ' A' ' 386' ' ' GLU . 60.4 mtpt -74.86 137.61 41.92 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 121.601 0.715 . . . . 0.0 111.695 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . 0.434 ' NH2' ' HG2' ' A' ' 393' ' ' GLU . 21.8 mmt180 -122.3 112.74 18.5 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 173.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 6.8 m -116.64 122.01 43.34 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.449 ' HB2' ' CE2' ' A' ' 396' ' ' TRP . 53.5 tp -96.23 111.0 23.2 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 67.4 m -92.36 109.5 20.88 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 56.4 mt -101.95 122.15 53.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 409' ' ' LYS . 18.3 m -108.42 141.08 40.8 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 64.84 58.32 0.97 Allowed 'General case' 0 C--O 1.254 1.303 0 C-N-CA 124.427 1.091 . . . . 0.0 111.782 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . 0.464 ' SG ' HG22 ' A' ' 381' ' ' ILE . 85.2 m -66.06 131.47 46.28 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.497 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . 0.491 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 5.5 m -126.0 177.62 6.24 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 98.8 mt -67.3 -30.7 70.63 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 118.19 0.45 . . . . 0.0 111.633 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.98 -9.11 59.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.759 0.79 . . . . 0.0 110.298 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . 0.491 ' HB3' ' H ' ' A' ' 427' ' ' SER . 18.7 t70 -97.23 -13.94 21.72 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -71.24 114.52 9.39 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.123 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -156.34 172.97 17.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.776 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.67 126.78 33.67 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -106.91 145.27 32.41 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 120.995 0.426 . . . . 0.0 110.864 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.13 143.44 24.15 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.551 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' A' ' 369' ' ' LEU . 59.0 m -98.26 131.87 44.23 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 56.7 t -116.04 107.98 24.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.284 0.564 . . . . 0.0 111.771 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 58.6 t -116.91 160.82 16.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 170.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -68.27 109.56 2.97 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 117.21 -2.424 . . . . 0.0 111.891 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 99.97 -36.21 4.26 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 125.861 1.696 . . . . 0.0 108.966 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 438' ' ' VAL . 6.4 mp0 -90.25 96.18 10.55 Favored 'General case' 0 N--CA 1.395 -3.196 0 C-N-CA 124.887 1.275 . . . . 0.0 112.341 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 37.9 ttmt -121.59 118.04 28.24 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 174.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 51.6 t -115.31 133.69 55.8 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 10.8 p -112.22 147.59 35.89 Favored 'General case' 0 N--CA 1.432 -1.33 0 O-C-N 123.565 0.541 . . . . 0.0 111.143 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.515 HG22 HD13 ' A' ' 369' ' ' LEU . 14.5 t -144.88 151.25 38.42 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -112.24 117.68 33.19 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 118.805 -1.158 . . . . 0.0 109.624 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 58.4 tp -88.0 136.54 32.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -118.52 113.5 21.39 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.13 117.26 33.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -94.06 109.32 21.09 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-O 121.386 0.612 . . . . 0.0 111.309 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.809 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.484 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.52 -3.98 11.49 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.413 2.076 . . . . 0.0 112.068 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 153.62 -163.02 30.62 Favored Glycine 0 N--CA 1.417 -2.578 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 4.4 p -81.83 -11.17 59.08 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.964 0.888 . . . . 0.0 111.053 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -132.98 151.28 52.08 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -100.11 19.49 16.29 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-O 121.601 0.715 . . . . 0.0 111.149 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.463 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 5.3 p -54.57 -39.43 45.91 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.495 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -52.26 -57.26 10.25 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 124.202 1.001 . . . . 0.0 111.334 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -72.24 -35.43 68.83 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.765 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.44 -52.79 53.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.015 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.19 -34.81 73.4 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.005 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -58.89 -40.86 85.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.694 0.398 . . . . 0.0 110.986 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -93.54 2.02 56.55 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.437 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -88.89 158.2 47.75 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.362 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.93 161.63 40.9 Favored 'Trans proline' 0 CA--C 1.555 1.555 0 C-N-CA 122.539 2.159 . . . . 0.0 111.194 173.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.61 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 10.9 Cg_endo -55.35 -35.8 92.43 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.68 2.92 . . . . 0.0 114.861 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 14.8 m -72.72 -8.58 56.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.428 0.632 . . . . 0.0 112.412 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.504 ' HB3' HD11 ' A' ' 336' ' ' ILE . 12.0 mm-40 -97.31 -22.88 16.4 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.859 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.61 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 23.3 m-30 -55.14 -50.08 70.16 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -174.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.71 -18.99 62.12 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.29 0.567 . . . . 0.0 111.207 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -82.82 -57.36 3.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.504 HD11 ' HB3' ' A' ' 332' ' ' GLU . 69.4 mt -58.29 -39.41 73.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.495 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.11 -59.57 4.89 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.472 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -68.48 -23.48 64.58 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -68.2 -36.74 80.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.07 0.462 . . . . 0.0 110.537 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . 0.463 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 85.7 m-85 -97.12 -17.35 20.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 107.15 20.78 8.46 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.93 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 15.0 t -95.41 129.67 45.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 34.2 p -94.66 -49.72 5.5 Favored 'General case' 0 C--N 1.277 -2.581 0 C-N-CA 119.435 -0.906 . . . . 0.0 112.351 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.11 69.21 3.19 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -171.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 0.0 OUTLIER -74.46 -26.12 59.84 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -68.28 -32.06 71.96 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -70.91 -36.86 65.27 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 27.3 ttt -65.09 -41.83 94.61 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 114.905 -0.647 . . . . 0.0 109.88 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 93.9 mt -68.7 -40.9 79.81 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.129 0.49 . . . . 0.0 110.527 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 353' ' ' LYS . 86.5 tttt -53.65 -46.24 70.5 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.43 1.092 . . . . 0.0 110.306 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -83.12 -21.03 33.74 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.507 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 355' ' ' MET . 51.6 tp -65.97 -25.98 67.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.554 0.692 . . . . 0.0 111.281 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 350' ' ' LYS . 54.6 mtmt -72.34 -20.09 61.53 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.908 0.861 . . . . 0.0 109.821 177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -118.62 27.3 7.28 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.529 ' HB2' ' HA ' ' A' ' 352' ' ' LEU . 46.8 tpp -66.65 -54.31 24.56 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -133.76 -69.2 0.55 Allowed 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.244 -1.344 . . . . 0.0 107.385 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -171.35 105.66 0.23 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 120.825 0.345 . . . . 0.0 111.026 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -123.33 148.48 45.96 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.48 63.65 1.1 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 360' ' ' LYS . 41.3 mmtm -124.52 15.67 8.87 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 171.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -85.6 173.54 10.09 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 110.984 -2.826 . . . . 0.0 111.321 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 49.7 m 68.3 40.52 2.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -172.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.8 t -86.53 -30.2 22.12 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.082 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.453 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -102.34 -19.97 14.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.7 0.762 . . . . 0.0 109.712 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -100.14 137.02 39.15 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.318 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -99.26 -16.37 18.53 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.4 OUTLIER -162.74 115.96 1.66 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 178.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.62 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 15.0 mtpp -88.51 169.41 11.77 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.422 HD13 HG22 ' A' ' 445' ' ' THR . 87.9 mt -64.22 140.37 58.86 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -60.18 147.88 79.94 Favored Pre-proline 0 C--N 1.318 -0.788 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -43.96 -47.49 10.09 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.616 2.877 . . . . 0.0 114.15 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -151.14 142.69 23.56 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.121 0.486 . . . . 0.0 111.435 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -122.14 156.59 33.33 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -142.28 134.06 27.0 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.64 156.91 20.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 15.1 m -79.76 157.23 27.16 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 2.0 tmmm? -77.34 135.56 38.38 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.56 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 86.82 5.65 80.89 Favored Glycine 0 CA--C 1.494 -1.247 0 CA-C-O 121.372 0.429 . . . . 0.0 112.097 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -99.14 -170.67 1.95 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -114.84 139.36 49.81 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.1 tp -121.88 128.74 75.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -102.37 103.58 14.01 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.78 0.8 . . . . 0.0 112.319 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 65.4 mt -91.2 114.95 27.61 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.1 m -123.56 130.59 52.9 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.473 -169.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.438 HG11 ' SG ' ' A' ' 436' ' ' CYS . 14.7 m -127.96 154.09 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.054 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -120.88 142.43 49.68 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 49.6 mt -98.62 142.27 30.41 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.47 -35.18 54.02 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -125.07 142.57 51.41 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -74.48 -16.98 60.83 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.429 0.633 . . . . 0.0 110.775 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.37 11.78 22.65 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.948 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -104.2 88.76 3.07 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -78.35 147.99 33.94 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 11.8 p -106.62 157.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.761 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.477 ' HA ' ' HE3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER -125.79 150.72 47.56 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 175.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.436 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 3.2 m-90 -121.94 123.85 42.66 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.7 mp -129.81 144.71 51.44 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 118.438 0.563 . . . . 0.0 110.689 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -123.21 121.04 34.93 Favored 'General case' 0 N--CA 1.404 -2.769 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.9 p30 49.73 17.03 0.23 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.531 1.532 . . . . 0.0 114.183 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.08 -4.35 23.9 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.624 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -108.28 123.0 48.12 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 35.7 tt0 -61.45 122.63 15.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.927 0.394 . . . . 0.0 110.908 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 42.7 mt -73.78 114.6 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.972 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -99.03 147.36 25.1 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 171.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.612 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 0.0 OUTLIER -77.28 126.14 30.45 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.255 -176.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 15.0 m -109.68 88.57 2.78 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 61.22 -109.76 2.66 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.0 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 45.2 t -109.78 4.02 21.36 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 122.808 -0.231 . . . . 0.0 110.809 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 409' ' ' LYS . 12.2 tmtt? -79.45 -34.28 41.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.612 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 91.2 m-85 -126.63 117.35 22.59 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 52.8 mt -118.3 113.8 43.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.428 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.505 ' CD1' HD13 ' A' ' 421' ' ' LEU . 23.6 m-85 -87.97 109.48 19.84 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -108.05 106.31 16.47 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 50.5 m -92.28 106.28 18.31 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.84 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 58.3 mt -113.71 92.82 2.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.33 -110.45 3.42 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.572 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.68 -2.23 35.94 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.007 0.432 . . . . 0.0 110.562 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -101.85 133.85 45.97 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.512 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -111.18 110.47 21.0 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 17.4 m -108.59 118.14 36.01 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.554 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.505 HD13 ' CD1' ' A' ' 412' ' ' PHE . 22.6 tp -98.25 107.96 20.54 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 39.2 m -93.61 100.38 12.64 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.9 mt -83.97 115.66 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 14.9 m -100.33 134.81 42.73 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 69.19 54.15 0.44 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.541 1.136 . . . . 0.0 111.002 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 1.9 p -62.38 123.94 19.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.222 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . 0.426 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 9.2 m -114.27 169.53 8.96 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -173.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.33 -37.92 77.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.168 0.509 . . . . 0.0 111.815 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -84.29 1.24 45.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.751 0.786 . . . . 0.0 110.223 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 427' ' ' SER . 28.4 t70 -106.34 -17.59 14.24 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.824 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.5 125.33 17.64 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.849 174.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.47 169.11 23.68 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.994 0.426 . . . . 0.0 111.191 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -86.39 133.64 33.77 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 170.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -114.7 137.87 51.39 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.04 140.33 52.09 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 20.8 p -115.84 113.98 24.1 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 173.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 47.0 t -113.47 118.46 58.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.028 0.442 . . . . 0.0 111.863 -174.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 97.0 t -114.17 161.69 12.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.24 113.06 5.52 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.758 -1.211 . . . . 0.0 111.831 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 100.67 -35.41 4.86 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.085 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 31.1 mm-40 -128.26 135.98 50.39 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 120.693 0.282 . . . . 0.0 110.889 -173.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -141.94 177.64 8.06 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 53.1 t -160.27 142.33 12.89 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 3.8 p -121.15 131.27 54.15 Favored 'General case' 0 N--CA 1.425 -1.681 0 O-C-N 123.69 0.619 . . . . 0.0 110.197 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.422 HG22 HD13 ' A' ' 369' ' ' LEU . 14.9 t -121.61 150.71 41.3 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.72 111.12 18.7 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.21 0.529 . . . . 0.0 110.212 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 61.0 tp -90.62 140.77 29.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.596 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -115.18 108.38 16.53 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 42.3 t -90.4 109.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 376' ' ' SER . 37.8 ttpt -111.82 127.19 55.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.29 -1.984 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.367 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.048 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.69 -35.21 95.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.95 2.433 . . . . 0.0 112.527 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -91.15 119.37 5.65 Favored Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.782 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 19.2 m -88.25 80.03 7.66 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.385 0.612 . . . . 0.0 110.104 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -120.35 19.56 12.07 Favored 'General case' 0 C--O 1.208 -1.114 0 CA-C-O 121.269 0.557 . . . . 0.0 110.715 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.56 9.74 8.77 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.631 0.729 . . . . 0.0 110.229 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.528 HG11 HG21 ' A' ' 342' ' ' VAL . 6.5 p -50.84 -37.23 16.04 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.587 0 C-N-CA 125.721 1.608 . . . . 0.0 113.608 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -61.79 -56.68 16.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.663 0.744 . . . . 0.0 110.732 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 13.2 pt-20 -71.96 -21.61 61.56 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.017 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.5 mt -74.29 -46.36 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.387 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.97 -40.2 84.06 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 122.905 0.482 . . . . 0.0 110.325 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . 0.416 ' NH2' ' HG ' ' A' ' 352' ' ' LEU . 20.1 tpp180 -55.54 -36.83 67.19 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.194 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 20.9 pt20 -100.79 5.76 43.63 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.163 0.506 . . . . 0.0 111.511 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -106.62 152.83 40.86 Favored Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.587 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -62.65 138.51 70.17 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.416 2.077 . . . . 0.0 111.886 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.7 -22.38 64.26 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.484 2.789 . . . . 0.0 112.468 -174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 2.8 p -74.59 -14.22 60.75 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.165 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -111.49 4.49 18.87 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.355 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -49.12 -41.12 34.99 Favored 'General case' 0 C--O 1.208 -1.082 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.9 -54.21 49.17 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.511 0.507 . . . . 0.0 111.584 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -61.1 -44.97 96.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.845 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 38.6 mt -68.35 -42.49 84.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.264 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -60.84 -54.32 46.55 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.593 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -61.84 -32.28 72.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -61.01 -39.86 91.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.828 0.347 . . . . 0.0 110.495 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -91.75 1.35 57.22 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 86.81 23.46 42.04 Favored Glycine 0 CA--C 1.505 -0.569 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.646 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.528 HG21 HG11 ' A' ' 321' ' ' VAL . 19.0 t -107.3 134.35 49.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.8 p -110.78 -15.35 13.83 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-O 120.981 0.42 . . . . 0.0 110.651 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -95.35 45.68 1.1 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.852 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -29.21 68.13 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.449 0.642 . . . . 0.0 110.924 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -65.03 -27.47 68.83 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.27 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -69.42 -30.58 71.22 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 114.416 -1.266 . . . . 0.0 111.9 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 25.5 ttt -62.78 -43.8 97.84 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.926 0.393 . . . . 0.0 110.707 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -71.19 -38.94 72.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.335 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -58.3 -58.46 8.39 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.067 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 355' ' ' MET . 17.4 ptp180 -58.41 -35.54 72.21 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.416 ' HG ' ' NH2' ' A' ' 326' ' ' ARG . 4.2 mm? -71.02 -21.16 62.31 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -80.36 -34.05 36.8 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -70.3 -29.82 69.88 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.841 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' A' ' 351' ' ' ARG . 25.1 ptp -128.39 93.09 3.56 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.509 0.671 . . . . 0.0 110.142 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 359' ' ' GLU . 72.2 mtm180 -73.73 74.08 1.55 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -70.86 135.85 48.3 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 73.83 -55.37 0.67 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.582 1.153 . . . . 0.0 111.184 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 356' ' ' ARG . 56.2 mm-40 -59.19 -22.21 60.66 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 125.941 1.696 . . . . 0.0 112.347 -176.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.481 ' HD3' ' N ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -60.48 -26.6 66.92 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 178.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.481 ' N ' ' HD3' ' A' ' 360' ' ' LYS . 14.5 tppt? -113.87 30.67 7.08 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 123.204 1.478 . . . . 0.0 107.956 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 5.2 m -144.43 43.46 1.4 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 6.2 t -94.37 -27.3 16.14 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.228 -175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -103.98 0.35 29.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 122.0 0.905 . . . . 0.0 109.598 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.81 137.76 50.66 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.415 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -103.21 -19.4 14.51 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.827 0.346 . . . . 0.0 110.104 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -156.46 125.54 6.04 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.438 ' HE2' ' SG ' ' A' ' 443' ' ' CYS . 60.6 mtpt -112.16 172.32 6.98 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.625 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 96.0 mt -72.6 117.81 14.74 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 175.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -63.65 142.17 97.98 Favored Pre-proline 0 C--N 1.314 -0.953 0 O-C-N 124.033 0.833 . . . . 0.0 108.882 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -47.72 -35.3 23.17 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 123.326 2.684 . . . . 0.0 113.129 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -127.46 128.0 45.0 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.493 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 44.9 m-85 -128.81 147.38 50.79 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -134.09 145.14 49.07 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.3 p -150.75 159.06 4.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.401 ' HB2' ' CG ' ' A' ' 379' ' ' HIS . 13.9 m -89.16 156.48 18.77 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -67.19 123.36 20.09 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.43 5.09 67.52 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . 0.401 ' CG ' ' HB2' ' A' ' 376' ' ' SER . 12.4 m170 -101.69 164.95 11.48 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.331 -0.434 . . . . 0.0 110.378 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -102.36 136.85 41.44 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.504 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.58 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.9 tt -136.35 154.69 33.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.418 ' CB ' ' HA ' ' A' ' 422' ' ' THR . 18.4 ptt180 -134.76 126.09 28.24 Favored 'General case' 0 N--CA 1.413 -2.316 0 C-N-CA 119.175 -1.01 . . . . 0.0 112.031 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.401 ' HB3' HD21 ' A' ' 369' ' ' LEU . 3.0 mm? -78.9 109.79 13.51 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 113.892 -1.504 . . . . 0.0 109.0 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.461 ' CG2' ' HD2' ' A' ' 418' ' ' LYS . 23.5 m -105.46 124.27 49.27 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.869 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.49 158.44 42.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -130.51 132.76 45.79 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 79.6 mt -96.61 159.79 14.74 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.49 -41.35 76.23 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -101.37 147.27 26.52 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.284 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.472 ' CD2' ' HB2' ' A' ' 417' ' ' ALA . 11.1 m170 -80.84 -24.28 38.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.27 25.6 1.16 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.448 1.499 . . . . 0.0 110.819 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -131.84 153.99 49.61 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -175.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -124.64 172.15 9.48 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 123.226 0.329 . . . . 0.0 110.629 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.38 144.25 37.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.081 0.467 . . . . 0.0 110.61 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -103.27 129.4 50.25 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.798 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.663 ' HB3' HD12 ' A' ' 403' ' ' ILE . 34.4 m95 -110.28 128.27 55.44 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.955 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.4 139.73 50.94 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -109.2 125.56 52.36 Favored 'General case' 0 N--CA 1.407 -2.61 0 C-N-CA 118.224 -1.39 . . . . 0.0 108.906 171.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 27.3 p30 50.89 21.68 1.01 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 126.628 1.971 . . . . 0.0 114.296 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.67 12.35 56.99 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.52 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -96.14 -91.58 0.23 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 176.02 139.85 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.663 HD12 ' HB3' ' A' ' 396' ' ' TRP . 9.4 mt -111.51 106.15 20.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 167.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -115.2 146.46 41.39 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 51.8 ttm -55.93 104.83 0.15 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.431 0.634 . . . . 0.0 111.195 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.0 t -117.3 110.14 17.71 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 51.42 -117.34 5.6 Favored Glycine 0 C--N 1.33 0.211 0 O-C-N 124.147 0.904 . . . . 0.0 113.35 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.9 p -114.46 8.7 16.58 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.671 0.748 . . . . 0.0 110.44 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -72.74 -40.71 65.85 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.052 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -129.33 113.91 15.56 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 64.2 mt -112.88 116.92 53.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.772 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -86.61 109.55 19.23 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.765 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.03 108.13 19.1 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 20.6 m -103.16 104.91 15.1 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.135 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.5 mm -123.65 103.91 13.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 66.63 -113.39 5.63 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.472 ' HB2' ' CD2' ' A' ' 390' ' ' HIS . . . -99.51 -12.97 19.69 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.381 0.61 . . . . 0.0 109.601 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.461 ' HD2' ' CG2' ' A' ' 384' ' ' THR . 7.8 ttpm? -86.96 136.35 32.96 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.34 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -122.33 126.44 48.07 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 16.3 m -127.51 125.63 40.76 Favored 'General case' 0 C--N 1.274 -2.698 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.48 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.456 HD21 HG21 ' A' ' 403' ' ' ILE . 50.3 tp -100.1 103.93 15.46 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.492 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 70.0 m -89.97 116.84 28.32 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.023 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 48.8 mt -107.54 118.63 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.0 m -89.97 144.59 25.79 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 57.19 62.72 2.11 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 123.979 0.912 . . . . 0.0 112.401 174.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . 0.58 ' SG ' HG22 ' A' ' 381' ' ' ILE . 82.8 m -69.56 118.18 12.11 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . 0.533 ' H ' ' HB3' ' A' ' 430' ' ' ASP . 14.1 m -111.05 171.79 7.26 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.55 -35.12 78.44 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.079 0.466 . . . . 0.0 110.367 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.42 -7.74 56.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.789 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . 0.533 ' HB3' ' H ' ' A' ' 427' ' ' SER . 29.5 t70 -105.34 -9.32 17.67 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.618 0.723 . . . . 0.0 109.711 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.71 112.28 2.19 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.625 -1.17 . . . . 0.0 107.872 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -153.59 168.2 26.98 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.068 0.461 . . . . 0.0 111.283 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.53 131.5 34.36 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -114.97 132.17 56.67 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 396' ' ' TRP . 0.6 OUTLIER -112.08 136.93 50.82 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 16.9 p -106.07 106.21 16.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.49 124.03 53.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.246 0.546 . . . . 0.0 111.513 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.91 152.06 36.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -70.08 113.33 4.89 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 118.689 -1.719 . . . . 0.0 110.901 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 109.23 -36.31 4.41 Favored Glycine 0 N--CA 1.418 -2.558 0 C-N-CA 123.306 0.479 . . . . 0.0 111.928 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.514 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 6.3 mm-40 -130.21 126.32 37.1 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -136.4 146.84 46.89 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.438 ' SG ' ' HE2' ' A' ' 368' ' ' LYS . 8.9 t -144.9 160.24 41.63 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 7.6 p -142.92 133.2 24.63 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.329 0.393 . . . . 0.0 110.583 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 8.6 t -109.36 150.18 28.41 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -111.57 110.68 21.22 Favored 'General case' 0 N--CA 1.406 -2.668 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.45 145.49 31.9 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -119.13 107.6 13.66 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 56.7 t -91.18 110.41 22.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -102.15 127.81 48.91 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.437 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.412 -2.344 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 176.539 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.688 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.88 -41.94 57.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.096 2.53 . . . . 0.0 112.074 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 90.87 17.04 53.28 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.447 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 36.8 p -100.65 -178.36 3.76 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 321' ' ' VAL . 3.7 mp0 -103.7 -73.61 0.66 Allowed 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 67.69 -14.2 0.22 Allowed 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 125.917 1.687 . . . . 0.0 112.589 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.48 ' H ' ' C ' ' A' ' 319' ' ' GLU . 14.2 p -55.52 -28.22 22.39 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.651 0 C-N-CA 124.942 1.297 . . . . 0.0 111.911 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -57.32 -56.56 20.23 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 123.093 0.557 . . . . 0.0 110.614 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.42 -32.77 58.69 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.366 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.2 mt -71.46 -45.57 67.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.938 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 9.6 tt -73.28 -29.41 62.71 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -61.78 -42.72 99.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.445 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -89.16 -0.59 57.57 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.984 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -94.58 154.87 40.02 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.815 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.93 141.47 44.65 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.031 1.821 . . . . 0.0 111.279 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.85 -20.76 53.8 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.815 3.01 . . . . 0.0 114.049 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 5.6 m -66.71 -27.96 68.06 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.471 ' HG3' HD11 ' A' ' 336' ' ' ILE . 7.9 pt-20 -110.57 11.84 22.86 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -52.94 -37.73 61.23 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.415 ' HA ' HD22 ' A' ' 345' ' ' LEU . 40.1 tt0 -63.81 -47.43 80.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.608 0.242 . . . . 0.0 110.99 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -62.61 -42.59 99.67 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.543 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.471 HD11 ' HG3' ' A' ' 332' ' ' GLU . 74.1 mt -61.63 -44.99 99.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.158 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.89 -54.01 51.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.13 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -69.19 -23.11 63.87 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -69.79 -44.4 70.16 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.221 0.534 . . . . 0.0 109.987 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -88.47 1.23 55.22 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 72.49 35.64 59.5 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.151 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.404 HG21 HG11 ' A' ' 321' ' ' VAL . 8.2 t -103.56 111.53 33.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.1 p -84.01 -20.66 32.4 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-O 122.341 1.067 . . . . 0.0 110.15 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.46 44.18 1.19 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.149 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 334' ' ' GLU . 33.6 tp -73.59 -37.1 65.56 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 172.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -54.93 -46.03 74.87 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 112.485 -2.143 . . . . 0.0 111.029 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -77.2 -32.63 47.6 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.577 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . 0.479 ' O ' ' HB2' ' A' ' 352' ' ' LEU . 14.6 tpt -62.6 -44.15 97.04 Favored 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 122.252 0.221 . . . . 0.0 110.977 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 85.0 mt -69.24 -39.47 78.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.379 0.609 . . . . 0.0 110.221 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.56 -50.33 74.19 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.778 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -77.0 -22.39 53.18 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.234 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 348' ' ' MET . 1.4 tm? -62.22 -38.21 88.28 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -75.51 -44.11 45.45 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.643 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -90.89 29.66 6.75 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.405 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 54.8 tpp -77.47 23.59 0.21 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.122 0.969 . . . . 0.0 113.013 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -80.65 -12.46 59.49 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 120.73 -1.231 . . . . 0.0 110.503 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.34 165.65 30.42 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -135.54 168.22 19.64 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -80.59 -12.2 59.54 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.546 0.689 . . . . 0.0 109.309 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -98.39 92.83 5.87 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.98 146.91 28.03 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 57.6 p 56.77 57.75 4.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.099 1.428 . . . . 0.0 109.45 -171.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.6 t -119.01 -21.95 7.47 Favored 'General case' 0 N--CA 1.411 -2.393 0 CA-C-N 112.67 -2.059 . . . . 0.0 108.243 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.544 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -100.31 -33.29 10.46 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -89.08 123.15 33.1 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.512 173.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -87.44 -25.18 23.89 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 367' ' ' LYS . 36.9 ttmt -164.29 118.79 1.45 Allowed 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.484 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 51.3 mtmt -91.26 170.59 9.87 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 123.403 0.439 . . . . 0.0 110.452 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.635 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 76.1 mt -60.12 143.81 51.34 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 123.896 0.748 . . . . 0.0 111.582 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 373' ' ' TYR . 35.7 mm-40 -64.75 149.1 96.5 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.856 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.04 -52.37 9.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.858 2.372 . . . . 0.0 112.812 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -142.23 144.43 33.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.012 0.434 . . . . 0.0 111.666 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 370' ' ' GLU . 56.3 m-85 -123.76 163.23 21.58 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -134.06 142.84 47.72 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.5 p -144.82 157.68 14.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 48.8 m -97.23 150.28 21.09 Favored 'General case' 0 N--CA 1.412 -2.332 0 C-N-CA 120.414 -0.515 . . . . 0.0 109.688 174.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.06 128.79 37.83 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.264 0.626 . . . . 0.0 111.207 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 83.81 15.66 69.82 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.659 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -118.31 176.3 5.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.3 mtpt -102.83 146.13 28.73 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.18 0.3 . . . . 0.0 110.392 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.489 HG22 ' SG ' ' A' ' 426' ' ' CYS . 10.7 tp -135.65 156.62 38.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 30.5 ptt180 -142.64 124.43 15.09 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.422 0.63 . . . . 0.0 111.587 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -94.71 126.2 39.86 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.391 -1.277 . . . . 0.0 107.924 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 68.0 m -108.63 138.91 44.18 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 11.8 m -141.43 159.67 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 C-N-CA 124.111 0.964 . . . . 0.0 108.93 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 85.9 mt-10 -130.04 136.92 49.91 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.33 148.74 23.85 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -84.47 10.03 11.9 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.456 0.646 . . . . 0.0 110.422 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -157.58 135.97 11.17 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -67.12 -24.25 65.91 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.145 0.497 . . . . 0.0 111.664 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -107.05 26.27 10.34 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.18 0.99 . . . . 0.0 110.915 -173.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -98.61 122.27 41.61 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -93.16 137.56 32.38 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 19.4 m -106.29 154.22 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.97 174.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 15.3 tptm -123.6 157.42 33.78 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 175.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.498 ' O ' HD12 ' A' ' 397' ' ' LEU . 4.4 m-90 -118.95 126.05 50.85 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 123.338 0.399 . . . . 0.0 109.969 -168.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 396' ' ' TRP . 6.5 mp -135.89 144.26 45.46 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -123.57 121.96 36.94 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 27.9 p30 46.71 22.31 0.18 Allowed 'General case' 0 N--CA 1.504 2.272 0 C-N-CA 125.614 1.566 . . . . 0.0 114.891 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 107.69 -0.21 34.33 Favored Glycine 0 C--O 1.224 -0.517 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.998 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -111.17 129.96 55.78 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -65.71 122.31 16.99 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-O 121.2 0.524 . . . . 0.0 111.035 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.434 ' HB ' ' CB ' ' A' ' 396' ' ' TRP . 57.7 mt -80.15 123.51 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -128.21 154.21 46.07 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.41 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 66.7 mtm -70.55 93.6 0.92 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.11 0.481 . . . . 0.0 111.507 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 39.8 m -92.79 100.53 12.99 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 71.77 -129.25 15.9 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.8 m -112.68 14.88 20.08 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -65.77 -42.81 90.41 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 94.0 m-85 -123.9 127.73 48.43 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 50.5 mm -118.0 117.35 54.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -86.79 108.12 18.58 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.302 0.572 . . . . 0.0 109.546 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -97.45 123.85 41.44 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.842 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 35.7 t -118.8 111.98 19.13 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 70.1 mt -124.76 84.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.716 0.769 . . . . 0.0 109.247 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 72.12 -109.89 2.99 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -99.17 -20.28 16.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.904 0.383 . . . . 0.0 110.182 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 386' ' ' GLU . 22.0 ptmt -88.36 133.1 34.18 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.782 0.801 . . . . 0.0 110.27 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.29 139.45 53.78 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . 0.402 ' CG2' ' HB2' ' A' ' 382' ' ' ARG . 74.1 m -134.26 130.36 36.99 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-O 121.148 0.499 . . . . 0.0 110.884 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 382' ' ' ARG . 37.8 tp -95.64 109.39 21.66 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.0 m -97.53 118.87 35.01 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.51 124.68 55.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 7.1 m -101.71 132.28 47.51 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 63.91 70.27 0.52 Allowed 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 124.235 0.959 . . . . 0.0 110.919 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . 0.489 ' SG ' HG22 ' A' ' 381' ' ' ILE . 73.5 m -68.23 123.74 21.56 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.67 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 45.3 t -106.23 155.23 19.69 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.46 -27.13 69.07 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.129 0.572 . . . . 0.0 110.475 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -87.22 1.08 54.24 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.264 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -114.15 1.98 14.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.32 111.75 3.16 Favored 'General case' 0 C--O 1.255 1.362 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.789 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -161.71 171.4 17.98 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.576 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -87.68 130.89 34.65 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -111.26 138.66 47.45 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 444' ' ' SER . 0.4 OUTLIER -120.52 141.6 50.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.411 ' SG ' HD11 ' A' ' 369' ' ' LEU . 73.7 m -109.13 111.38 22.97 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 168.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.93 119.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.281 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 47.6 t -110.85 159.82 10.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 169.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.15 113.93 6.34 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 119.269 -1.443 . . . . 0.0 111.52 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 89.04 -24.27 14.0 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 121.081 0.267 . . . . 0.0 112.824 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.544 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 4.9 mm-40 -118.29 109.89 16.86 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.479 0.712 . . . . 0.0 109.107 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -136.26 149.55 48.54 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 34.2 t -148.2 139.53 23.47 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 435' ' ' GLN . 9.3 m -112.31 151.07 30.14 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 14.6 t -129.15 144.64 51.28 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -110.63 109.81 20.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 121.752 0.787 . . . . 0.0 109.108 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -93.72 129.52 40.03 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.993 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -107.82 115.4 30.07 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.377 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 38.2 t -90.08 125.58 42.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 376' ' ' SER . 12.0 pttp -116.11 146.83 41.92 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 C--N 1.259 -3.327 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 174.844 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.732 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.32 -37.01 42.47 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.692 2.261 . . . . 0.0 111.264 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -62.88 98.03 0.2 Allowed Glycine 0 N--CA 1.434 -1.495 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.889 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 7.4 m -119.78 22.15 11.69 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.48 10.13 4.39 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.635 ' HA ' ' NE1' ' A' ' 322' ' ' TRP . 1.1 m-20 -78.77 46.21 0.65 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 112.644 -2.071 . . . . 0.0 112.424 -175.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 340' ' ' TYR . 7.4 p -56.25 -38.65 55.65 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.192 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.802 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . 0.635 ' NE1' ' HA ' ' A' ' 320' ' ' ASP . 0.0 OUTLIER -45.79 -52.04 11.79 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.616 ' HG2' ' HB3' ' A' ' 320' ' ' ASP . 8.4 pt-20 -85.48 -38.42 18.63 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.422 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 87.1 mt -65.46 -40.45 88.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.632 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.2 tt -75.76 -33.06 60.19 Favored 'General case' 0 C--O 1.202 -1.429 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -69.06 -36.47 77.7 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -85.39 -7.55 58.89 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.173 0.511 . . . . 0.0 111.329 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -84.52 161.39 54.09 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.316 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.14 135.48 51.08 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.922 2.415 . . . . 0.0 111.469 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.53 -34.61 90.32 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 124.048 3.165 . . . . 0.0 115.568 -171.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 19.5 t -83.7 -1.9 55.06 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.682 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -102.82 -4.24 25.19 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.869 0.366 . . . . 0.0 110.07 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -52.38 -42.07 63.68 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -64.5 -38.59 91.56 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.468 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -66.37 -46.3 77.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 109.485 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 62.5 mt -60.06 -37.61 73.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.288 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.75 -62.45 1.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.582 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -62.19 -32.96 73.67 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -59.72 -41.2 90.32 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.806 0.842 . . . . 0.0 111.564 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . 0.425 ' CB ' ' HB ' ' A' ' 321' ' ' VAL . 95.6 m-85 -97.25 10.71 38.78 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.177 0.513 . . . . 0.0 111.962 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 86.72 15.93 62.57 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.577 174.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 4.2 t -94.12 105.57 17.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.3 p -84.23 -14.95 48.59 Favored 'General case' 0 C--N 1.267 -2.98 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -133.27 95.46 3.53 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.5 pt? -76.31 -21.71 55.88 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.18 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -54.97 -50.07 69.85 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.562 0.745 . . . . 0.0 110.828 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -79.25 -29.48 49.91 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.413 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -60.79 -47.62 85.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 86.5 mt -63.4 -40.42 97.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.201 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -56.64 -51.13 69.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.375 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -20.94 56.01 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 355' ' ' MET . 30.5 tp -81.85 -31.44 31.61 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -75.4 -37.21 60.62 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -91.2 36.98 3.47 Favored Glycine 0 N--CA 1.417 -2.612 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.112 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.532 ' HB2' ' O ' ' A' ' 352' ' ' LEU . 43.7 ttm -54.94 -34.39 63.16 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 125.312 1.445 . . . . 0.0 111.5 -176.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -127.18 28.15 5.79 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.696 0.76 . . . . 0.0 110.325 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -104.18 155.84 18.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.651 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -96.25 151.87 19.1 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -76.36 -70.12 0.47 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp 41.18 85.14 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 125.123 1.369 . . . . 0.0 113.185 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -132.42 41.3 3.22 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.345 -174.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 14.9 m 72.11 71.08 0.15 Allowed 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -171.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 61.0 m -85.23 -44.26 13.05 Favored 'General case' 0 N--CA 1.392 -3.334 0 CA-C-N 112.449 -2.16 . . . . 0.0 112.727 -172.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.602 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -93.32 -10.73 34.41 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.036 0.922 . . . . 0.0 109.494 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -100.11 127.65 46.32 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.707 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -95.39 -17.67 21.37 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -165.5 126.12 1.87 Allowed 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.592 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 33.4 mtmm -102.34 -179.49 4.0 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 65.7 mt -74.3 147.12 42.58 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.98 137.61 89.81 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -55.64 -35.81 93.59 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.497 2.132 . . . . 0.0 112.465 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -128.36 134.09 48.78 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.998 0.428 . . . . 0.0 112.025 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -133.12 155.41 49.31 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.989 0.916 . . . . 0.0 109.298 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -134.64 147.67 50.22 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.19 154.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 10.1 t -96.13 150.66 20.26 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.523 ' HD2' ' HG2' ' A' ' 451' ' ' GLU . 83.4 tttt -61.42 120.81 11.2 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 123.169 0.587 . . . . 0.0 110.978 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 97.83 -4.56 61.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.5 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -98.27 175.04 6.21 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.659 0.266 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -104.77 150.45 24.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.994 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.434 HG22 ' SG ' ' A' ' 426' ' ' CYS . 16.2 tt -141.19 136.84 33.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 120.953 0.406 . . . . 0.0 110.126 174.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -107.9 123.68 48.98 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.375 0.607 . . . . 0.0 109.896 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 68.1 mt -101.81 114.18 28.03 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 67.3 m -109.31 127.91 54.67 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -172.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 20.3 m -132.39 160.67 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.5 135.19 46.87 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.438 HD11 ' CG1' ' A' ' 394' ' ' VAL . 3.1 mm? -99.57 155.92 17.33 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.23 -7.93 56.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.513 0.673 . . . . 0.0 110.506 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 392' ' ' ALA . 13.1 t70 -129.53 140.37 51.26 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -75.52 -24.47 56.78 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -115.3 25.77 10.6 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.624 0.726 . . . . 0.0 111.638 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 389' ' ' ASP . . . -97.72 133.39 42.32 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 175.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -104.72 160.18 15.18 Favored 'General case' 0 N--CA 1.41 -2.432 0 C-N-CA 118.44 -1.304 . . . . 0.0 111.479 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.438 ' CG1' HD11 ' A' ' 387' ' ' LEU . 7.6 m -109.78 154.08 11.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.614 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -105.62 116.89 32.71 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.47 ' O ' ' HA ' ' A' ' 402' ' ' GLU . 1.2 m-90 -92.3 120.2 32.62 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.94 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.4 mp -125.9 140.36 52.7 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 118.466 0.575 . . . . 0.0 110.576 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -118.29 116.77 27.44 Favored 'General case' 0 N--CA 1.405 -2.699 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 172.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.9 p30 52.41 18.16 0.89 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.444 1.497 . . . . 0.0 113.816 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.56 -4.71 23.06 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.303 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -110.22 128.68 55.63 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 396' ' ' TRP . 35.1 tt0 -62.32 121.34 12.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 0.0 110.078 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 396' ' ' TRP . 58.4 mt -66.51 124.6 22.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.163 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -108.61 153.0 24.02 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.943 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 50.9 ttm -71.02 105.15 3.21 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 33.6 t -104.39 98.54 8.31 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 57.84 -114.42 5.66 Favored Glycine 0 C--N 1.329 0.173 0 O-C-N 123.485 0.491 . . . . 0.0 112.488 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . 0.441 ' HA ' HD11 ' A' ' 411' ' ' ILE . 23.0 m -114.72 10.81 16.7 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.569 0.699 . . . . 0.0 109.837 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -77.08 -45.34 27.37 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.526 ' O ' ' HG3' ' A' ' 405' ' ' MET . 65.8 m-85 -122.66 109.27 14.05 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.441 HD11 ' HA ' ' A' ' 408' ' ' SER . 48.3 mm -115.2 119.68 62.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 120.981 0.419 . . . . 0.0 110.909 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.522 ' CE2' HD13 ' A' ' 421' ' ' LEU . 24.6 m-85 -87.24 108.49 18.96 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -97.99 108.46 21.17 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 22.9 m -100.37 104.67 16.11 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.7 mt -121.19 83.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 66.93 -119.14 11.4 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.562 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -79.75 -23.67 42.08 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -74.81 125.27 28.42 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.73 0.776 . . . . 0.0 111.45 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 419' ' ' ARG . 1.9 tpp180 -114.98 111.68 21.51 Favored 'General case' 0 N--CA 1.399 -3.018 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 170.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 63.5 m -119.82 120.57 36.89 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.368 0.604 . . . . 0.0 111.498 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.522 HD13 ' CE2' ' A' ' 412' ' ' PHE . 36.2 tp -91.81 115.6 28.19 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 45.4 m -98.2 110.34 22.94 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.3 mt -97.54 123.65 50.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 33.9 m -104.33 136.7 43.43 Favored 'General case' 0 N--CA 1.403 -2.781 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 59.38 64.78 1.28 Allowed 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 124.673 1.233 . . . . 0.0 111.49 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . 0.434 ' SG ' HG22 ' A' ' 381' ' ' ILE . 58.6 m -67.33 134.75 52.14 Favored 'General case' 0 C--N 1.298 -1.63 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.941 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 20.1 m -125.57 -177.96 4.08 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 84.6 mt -79.79 -21.91 43.75 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.918 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.43 73.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.443 0.639 . . . . 0.0 109.774 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.77 -0.37 57.26 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.141 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.69 108.13 1.62 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -149.0 165.07 32.73 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.012 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.87 115.84 23.75 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -104.01 152.09 22.45 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.36 150.72 35.27 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.078 175.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 77.0 m -116.09 118.6 33.33 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 38.6 t -106.31 132.94 52.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 67.4 t -128.15 161.41 36.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -61.45 112.36 4.68 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 118.989 -1.577 . . . . 0.0 111.865 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 96.29 -35.18 4.5 Favored Glycine 0 N--CA 1.421 -2.345 0 CA-C-N 114.768 -0.716 . . . . 0.0 112.82 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.602 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 9.8 mm-40 -120.08 132.88 55.6 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.928 0.364 . . . . 0.0 110.388 -174.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -137.81 166.97 22.69 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.0 t -150.51 133.76 16.26 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 6.0 p -108.89 146.98 32.87 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 123.542 0.526 . . . . 0.0 110.378 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 11.3 t -129.66 149.7 51.3 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -116.36 113.28 22.7 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 68.4 tp -91.85 146.1 24.02 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.303 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -123.31 108.17 12.46 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.04 117.01 32.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 376' ' ' SER . 38.7 ttpt -105.79 119.98 40.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.581 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.523 ' HG2' ' HD2' ' A' ' 377' ' ' LYS . 26.4 mt-10 . . . . . 0 C--N 1.328 -0.338 0 O-C-N 123.695 0.622 . . . . 0.0 110.872 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.76 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.34 -34.25 67.39 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.961 2.441 . . . . 0.0 112.499 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 82.84 -88.59 1.48 Allowed Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 38.4 t -157.7 82.52 0.88 Allowed 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.07 -63.79 1.26 Allowed 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 56.52 4.9 0.17 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.398 1.479 . . . . 0.0 113.586 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.476 HG21 HG21 ' A' ' 342' ' ' VAL . 12.3 p -60.34 -35.16 60.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 123.761 0.825 . . . . 0.0 111.549 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -47.18 -51.89 17.18 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 124.983 1.313 . . . . 0.0 110.245 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 9.8 pt-20 -85.36 -48.49 8.99 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.76 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.74 -50.73 78.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 C-N-CA 122.798 0.439 . . . . 0.0 112.063 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.4 HD13 ' HB ' ' A' ' 336' ' ' ILE . 47.3 tp -74.02 -20.97 60.15 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.822 0.344 . . . . 0.0 110.928 -175.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -77.68 -42.99 32.65 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.22 0.533 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 4.1 pt20 -88.35 -20.96 24.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.139 -175.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -70.66 146.45 93.65 Favored Pre-proline 0 C--N 1.31 -1.129 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.46 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.78 155.1 61.61 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.017 1.812 . . . . 0.0 110.625 175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.48 -22.05 20.35 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.255 3.304 . . . . 0.0 113.989 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 6.4 m -72.71 -21.62 61.01 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.202 0.525 . . . . 0.0 111.527 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.519 ' HB3' HD11 ' A' ' 336' ' ' ILE . 7.7 mm-40 -88.82 -20.89 24.1 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.928 -177.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -51.44 -53.47 36.64 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -173.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -56.07 -33.01 64.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -80.66 -59.82 2.54 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.773 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' A' ' 332' ' ' GLU . 79.8 mt -55.58 -49.63 72.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.124 -174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 345' ' ' LEU . . . -58.97 -57.65 12.15 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.426 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -67.8 -26.63 66.18 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -66.33 -40.37 89.86 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -94.03 -7.95 41.24 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 98.71 16.42 31.34 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.635 -1.269 . . . . 0.0 112.958 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.476 HG21 HG21 ' A' ' 321' ' ' VAL . 10.5 t -94.05 97.27 6.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 5.2 m -72.35 -39.4 68.14 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.941 -172.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.582 ' OD1' ' HA3' ' A' ' 347' ' ' GLY . 13.7 p-10 -101.54 88.89 3.55 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 122.537 1.161 . . . . 0.0 110.725 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 346' ' ' ARG . 4.5 pp -71.36 -35.09 71.0 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.462 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . 0.482 ' N ' HD12 ' A' ' 345' ' ' LEU . 22.5 ttm180 -77.14 -16.84 58.99 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.582 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -64.15 -21.27 65.86 Favored Glycine 0 N--CA 1.42 -2.397 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.565 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . 0.504 ' O ' HD23 ' A' ' 352' ' ' LEU . 40.6 ttm -60.09 -45.22 93.66 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.55 -36.48 73.68 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.419 ' HE2' ' HA2' ' A' ' 347' ' ' GLY . 36.2 ttpt -57.12 -56.92 15.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.265 1.026 . . . . 0.0 110.704 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -56.6 -33.02 65.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.471 0.708 . . . . 0.0 112.456 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 348' ' ' MET . 4.5 mm? -81.64 -32.41 31.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.28 0.562 . . . . 0.0 111.083 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -66.49 -39.81 88.93 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.0 0.24 39.22 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.518 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 26.2 mmt -75.7 -57.28 3.98 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.93 0.365 . . . . 0.0 110.28 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -170.54 35.24 0.02 OUTLIER 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -66.46 -43.26 85.99 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.941 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -154.87 170.4 21.75 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -117.81 -83.97 0.64 Allowed 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 118.21 0.459 . . . . 0.0 110.087 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 53.34 -161.27 0.12 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.123 0.89 . . . . 0.0 110.063 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt 67.43 -74.16 0.07 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.016 0.927 . . . . 0.0 112.945 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.478 ' HA ' ' OE1' ' A' ' 441' ' ' GLU . 45.0 p 171.4 91.1 0.0 OUTLIER 'General case' 0 C--O 1.248 0.986 0 C-N-CA 126.15 1.78 . . . . 0.0 106.928 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 75.2 p -120.79 -57.19 1.9 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.973 0.416 . . . . 0.0 110.072 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.569 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -83.2 -24.34 32.46 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.56 ' CD2' ' HB3' ' A' ' 441' ' ' GLU . 7.2 m-85 -94.23 132.94 38.27 Favored 'General case' 0 N--CA 1.406 -2.659 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.557 175.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -98.01 -17.09 19.35 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -161.54 119.44 2.31 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -99.33 159.58 14.9 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 79.6 mt -61.7 133.61 55.78 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 123.363 0.415 . . . . 0.0 111.367 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.41 137.67 68.77 Favored Pre-proline 0 C--O 1.215 -0.743 0 O-C-N 124.584 1.178 . . . . 0.0 108.341 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.93 -27.24 52.95 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.71 2.273 . . . . 0.0 113.424 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -134.65 138.97 44.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.412 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 36.0 m-85 -136.93 143.88 43.15 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -128.94 142.12 51.04 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.46 155.82 20.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 16.2 m -88.06 151.89 22.42 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -72.76 116.49 13.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.282 0.563 . . . . 0.0 110.096 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.29 43.76 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -116.9 156.12 27.91 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.329 -0.936 . . . . 0.0 109.637 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -92.49 141.51 28.43 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.694 0.798 . . . . 0.0 112.121 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.58 HG22 ' SG ' ' A' ' 426' ' ' CYS . 15.6 tt -139.05 146.93 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -123.87 128.95 50.22 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 122.218 1.009 . . . . 0.0 112.084 175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 420' ' ' THR . 17.8 mt -99.82 125.89 45.82 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.19 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 31.9 m -116.66 130.08 56.53 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.71 160.15 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 418' ' ' LYS . 64.3 mt-10 -129.89 138.57 51.0 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 88.8 mt -101.6 139.0 37.85 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.114 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -84.6 -25.88 28.31 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -106.48 122.06 45.53 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.307 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 417' ' ' ALA . 22.7 m-70 -80.95 -7.58 59.55 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.756 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -91.37 11.57 23.32 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -129.79 158.63 38.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -130.14 164.75 23.77 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 29.1 m -106.73 134.84 47.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.492 0.663 . . . . 0.0 111.491 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -103.5 129.17 50.62 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.678 ' HB3' HD12 ' A' ' 403' ' ' ILE . 50.1 m95 -103.68 130.03 51.09 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 434' ' ' TYR . 8.2 mp -116.76 139.53 50.47 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.647 ' HG2' HG12 ' A' ' 403' ' ' ILE . 32.8 mmtp -90.81 107.4 19.16 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 11.1 p30 48.66 12.59 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.9 4.07 15.08 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.657 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -89.38 -96.38 0.1 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 122.57 0.348 . . . . 0.0 110.353 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 175.05 139.43 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.678 HD12 ' HB3' ' A' ' 396' ' ' TRP . 47.4 mt -94.48 114.85 31.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 172.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -96.6 139.85 32.08 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 87.8 mtp -71.82 89.8 1.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.746 0.308 . . . . 0.0 110.541 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 50.9 m -79.32 98.39 6.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.81 -119.01 16.4 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.059 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 32.8 t -111.27 16.98 20.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -76.24 -47.94 22.09 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -106.82 108.68 20.31 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.19 113.2 36.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -87.08 107.21 18.34 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.912 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -105.55 107.88 19.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 50.0 m -104.97 110.56 22.99 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.31 79.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.84 -110.9 3.76 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.95 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.429 ' HB2' ' CE1' ' A' ' 390' ' ' HIS . . . -83.47 -27.68 29.3 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.759 0.314 . . . . 0.0 110.414 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.43 ' HB3' ' HG2' ' A' ' 386' ' ' GLU . 10.9 ptmm? -95.32 116.69 29.11 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 122.116 0.96 . . . . 0.0 111.394 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -108.4 139.15 43.54 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.361 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 61.6 m -136.15 130.13 32.8 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-O 121.256 0.551 . . . . 0.0 111.524 -173.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 39.8 tp -103.8 115.85 31.23 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 38.7 m -102.04 115.08 29.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 50.4 mt -100.98 119.95 49.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 2.9 m -90.53 131.96 35.96 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.222 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 58.12 67.32 0.97 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.015 0.926 . . . . 0.0 111.93 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . 0.58 ' SG ' HG22 ' A' ' 381' ' ' ILE . 64.5 m -68.48 115.17 7.58 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . 0.411 ' O ' HG21 ' A' ' 449' ' ' VAL . 79.6 p -101.44 -176.63 3.2 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.05 -22.25 63.09 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.28 0.562 . . . . 0.0 109.837 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.94 -8.54 58.26 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.376 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -99.26 -3.45 34.14 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.189 -0.319 . . . . 0.0 110.399 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.79 95.54 2.92 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -152.15 166.13 32.64 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.25 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.99 129.43 34.8 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 397' ' ' LEU . 20.3 m-85 -104.67 145.33 30.48 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.595 ' N ' HE21 ' A' ' 435' ' ' GLN . 0.0 OUTLIER -129.14 127.34 41.21 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 7.6 p -96.33 109.15 21.72 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.1 t -105.29 126.12 60.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-O 121.231 0.539 . . . . 0.0 111.377 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 60.0 t -129.15 161.39 38.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -66.79 113.6 5.77 Favored Glycine 0 C--N 1.315 -0.599 0 C-N-CA 119.082 -1.532 . . . . 0.0 111.104 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 98.6 -26.33 24.37 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.569 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 3.1 mm-40 -126.48 136.08 52.16 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 18.6 ptpt -147.9 160.67 42.54 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 16.9 t -155.82 134.37 11.73 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.457 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 5.5 p -106.47 126.38 52.18 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.336 0.588 . . . . 0.0 110.7 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.7 t -112.57 146.37 38.68 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.98 114.39 27.67 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.293 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.35 121.87 33.46 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.667 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -104.87 118.91 37.72 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.166 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 427' ' ' SER . 57.3 t -90.14 120.55 39.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 376' ' ' SER . 0.1 OUTLIER -113.7 119.98 39.27 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--N 1.308 -1.229 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.366 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.487 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.72 163.82 34.97 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.374 2.049 . . . . 0.0 112.708 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -171.57 141.06 6.17 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 31.7 m -147.01 -25.68 0.4 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.139 0.495 . . . . 0.0 110.559 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 321' ' ' VAL . 28.9 mm-40 -107.43 178.35 4.57 Favored 'General case' 0 CA--C 1.489 -1.377 0 C-N-CA 123.133 0.573 . . . . 0.0 110.757 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 75.81 -26.78 0.19 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.96 1.304 . . . . 0.0 112.051 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.561 ' HB ' ' CG ' ' A' ' 340' ' ' TYR . 4.3 p -47.44 -37.15 4.84 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 C-N-CA 125.102 1.361 . . . . 0.0 112.365 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -57.59 -47.17 82.86 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.639 0.776 . . . . 0.0 110.762 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.9 -35.12 20.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.826 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.03 -49.54 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.795 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.32 -34.19 75.67 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.488 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -58.12 -40.37 81.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.281 0.562 . . . . 0.0 110.701 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -93.07 -4.13 52.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.331 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -89.02 153.84 49.38 Favored Pre-proline 0 C--N 1.301 -1.525 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.711 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . 0.412 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 23.6 Cg_endo -61.19 143.99 98.75 Favored 'Trans proline' 0 CA--C 1.55 1.321 0 C-N-CA 122.946 2.431 . . . . 0.0 112.763 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.481 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 10.7 Cg_endo -54.89 -34.57 86.31 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 124.216 3.277 . . . . 0.0 115.572 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 44.0 m -77.82 -5.56 51.25 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.412 ' CG ' ' HG2' ' A' ' 329' ' ' PRO . 15.0 mm-40 -99.67 -13.33 19.39 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.818 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.481 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 18.4 m-30 -47.86 -47.52 31.55 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -174.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.441 ' HA ' HD22 ' A' ' 345' ' ' LEU . 37.4 tt0 -68.18 -35.64 78.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.8 0.333 . . . . 0.0 111.295 -174.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -71.79 -42.88 66.58 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.818 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 59.1 mt -64.78 -38.66 83.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.464 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.09 51.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.033 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -68.9 -24.63 64.33 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.36 -39.83 94.43 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.007 0.523 . . . . 0.0 109.958 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . 0.561 ' CG ' ' HB ' ' A' ' 321' ' ' VAL . 82.5 m-85 -95.59 -4.7 44.1 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.194 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 83.38 26.52 43.11 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.498 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.32 116.96 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 3.0 p -94.52 -5.97 44.82 Favored 'General case' 0 C--N 1.268 -2.94 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.808 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.47 44.42 0.8 Allowed 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 123.46 0.704 . . . . 0.0 111.314 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 334' ' ' GLU . 24.4 tp -75.95 -64.82 1.0 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.779 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 350' ' ' LYS . 29.5 mmt180 -66.2 -31.41 72.23 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.492 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -70.67 -39.79 66.62 Favored Glycine 0 N--CA 1.442 -0.926 0 O-C-N 123.547 0.529 . . . . 0.0 112.075 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 26.6 ttt -71.19 -48.5 51.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.89 -31.27 72.11 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.705 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 346' ' ' ARG . 42.7 tttm -52.72 -44.89 66.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.949 0.88 . . . . 0.0 109.132 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.526 ' O ' ' HB3' ' A' ' 355' ' ' MET . 53.0 mtm180 -72.06 -36.93 69.72 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.824 -1.535 . . . . 0.0 112.472 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.58 -27.36 31.59 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.647 0.737 . . . . 0.0 112.703 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -86.79 -54.36 4.41 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.447 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -97.15 65.66 0.92 Allowed Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.526 ' HB3' ' O ' ' A' ' 351' ' ' ARG . 23.0 ptt? -114.58 7.05 15.98 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.138 -0.531 . . . . 0.0 110.04 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -159.26 -39.4 0.06 Allowed 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -78.37 85.0 4.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 12.5 t70 179.53 125.87 0.07 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 169.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -95.13 17.71 13.6 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.421 0.629 . . . . 0.0 111.004 -177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.416 ' HE3' ' HG2' ' A' ' 441' ' ' GLU 0.302 42.4 mtmt 48.84 -104.64 0.13 Allowed 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 174.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.617 ' HG3' ' H ' ' A' ' 362' ' ' SER . 38.2 pttt -177.28 -79.17 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 O-C-N 123.19 0.306 . . . . 0.0 111.046 -175.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.617 ' H ' ' HG3' ' A' ' 361' ' ' LYS . 70.3 m -178.91 76.96 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 128.168 2.587 . . . . 0.0 105.66 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.4 t -130.13 -31.76 1.87 Allowed 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.421 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.671 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -87.65 -27.54 22.4 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -87.13 114.37 23.69 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.66 170.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -89.44 -17.24 29.11 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.061 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 367' ' ' LYS . 0.0 OUTLIER -164.61 120.53 1.49 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 176.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -97.04 173.3 7.34 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.834 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.465 HD13 HG22 ' A' ' 445' ' ' THR . 91.2 mt -71.07 142.16 50.85 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.876 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -62.04 129.93 92.34 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -43.39 -33.32 4.02 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.86 3.04 . . . . 0.0 114.819 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -146.56 120.66 9.46 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 122.068 -0.395 . . . . 0.0 111.239 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.565 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 59.0 m-85 -101.35 156.08 17.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -127.91 138.35 52.63 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.972 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.93 152.69 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.552 ' HB2' ' CD2' ' A' ' 379' ' ' HIS . 12.0 m -86.62 146.48 26.31 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 1.4 tmmm? -63.1 125.75 25.07 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.277 0.56 . . . . 0.0 110.006 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.475 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 98.89 -3.56 58.8 Favored Glycine 0 C--N 1.304 -1.206 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.623 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' A' ' 376' ' ' SER . 27.7 m-70 -95.63 169.37 10.07 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 120.889 0.376 . . . . 0.0 111.935 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -108.1 126.75 53.12 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.524 HG22 ' SG ' ' A' ' 426' ' ' CYS . 14.9 tt -128.6 158.34 40.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 41.9 mtt-85 -125.89 142.7 51.39 Favored 'General case' 0 CA--C 1.491 -1.318 0 CA-C-O 121.663 0.744 . . . . 0.0 110.589 -177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.31 107.47 18.48 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.8 m -105.31 126.28 51.92 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.272 -174.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 7.6 m -127.91 157.17 40.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 123.855 0.862 . . . . 0.0 109.374 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -120.36 136.61 54.65 Favored 'General case' 0 CA--C 1.474 -1.946 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 392' ' ' ALA . 92.0 mt -107.88 141.33 39.65 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.19 71.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.142 0.496 . . . . 0.0 110.355 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -117.98 138.04 52.45 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -63.53 -32.57 74.07 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 123.293 0.637 . . . . 0.0 112.693 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.82 25.78 11.4 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.395 0.617 . . . . 0.0 111.879 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . 0.533 ' O ' HD13 ' A' ' 387' ' ' LEU . . . -91.69 106.53 18.55 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 104.276 -2.491 . . . . 0.0 104.276 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -78.67 143.87 35.88 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.638 -172.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 4.1 m -105.98 148.3 10.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -111.22 130.07 55.76 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.46 ' HB3' HD12 ' A' ' 403' ' ' ILE . 8.2 m-90 -101.21 121.77 42.45 Favored 'General case' 0 C--N 1.26 -3.292 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.911 -173.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 402' ' ' GLU . 6.2 mp -129.19 125.53 37.19 Favored 'General case' 0 CA--C 1.482 -1.671 0 CA-C-N 117.635 0.198 . . . . 0.0 111.4 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.436 ' HB3' HG12 ' A' ' 403' ' ' ILE . 28.8 pttt -103.94 128.14 51.46 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 47.61 22.76 0.34 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.415 1.486 . . . . 0.0 114.24 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.16 8.05 56.86 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.379 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -92.32 -92.63 0.15 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 397' ' ' LEU . 52.7 tt0 172.69 138.53 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 396' ' ' TRP . 55.4 mt -92.0 102.29 13.41 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -99.23 126.02 44.95 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.854 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.454 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 18.3 ptt? -63.95 95.17 0.11 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 122.119 0.962 . . . . 0.0 112.257 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . 0.42 ' H ' ' HD2' ' A' ' 410' ' ' TYR . 14.8 m -83.67 93.32 7.88 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.946 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 64.22 -128.26 36.22 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.568 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 8.9 p -97.69 5.53 49.19 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 120.921 0.391 . . . . 0.0 111.599 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -71.79 -32.31 67.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.74 0.305 . . . . 0.0 111.636 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.454 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 69.5 m-85 -123.44 112.5 17.6 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 39.6 mm -108.87 116.58 52.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.8 m-85 -87.03 105.54 17.23 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -106.49 108.56 20.13 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.478 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 27.8 t -90.54 105.38 17.78 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.0 mm -104.04 87.46 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.94 -98.6 0.64 Allowed Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -120.11 -5.01 10.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.358 0.599 . . . . 0.0 109.443 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -95.23 99.69 11.61 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -92.7 132.14 37.17 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.227 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 22.5 m -125.28 129.81 50.76 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.531 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.532 HD13 ' CE2' ' A' ' 412' ' ' PHE . 22.2 tp -100.82 111.51 23.75 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 58.8 m -94.34 108.78 20.66 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.601 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 56.1 mt -96.92 116.93 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 15.1 m -90.84 136.47 33.05 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.054 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 55.72 68.63 0.84 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.0 1.72 . . . . 0.0 111.117 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . 0.524 ' SG ' HG22 ' A' ' 381' ' ' ILE . 61.7 m -68.87 113.2 6.08 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 11.0 m -103.65 -170.75 1.83 Allowed 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 89.9 mt -71.12 -23.88 62.18 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.269 0.557 . . . . 0.0 110.513 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -76.08 -15.04 60.18 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.235 0.541 . . . . 0.0 110.1 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -97.6 7.84 45.73 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.764 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.63 100.23 11.31 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -157.02 172.33 18.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.201 0.524 . . . . 0.0 111.609 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -90.51 118.08 29.7 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -107.39 131.81 53.85 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.839 -0.538 . . . . 0.0 110.252 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.496 ' HG3' ' OG ' ' A' ' 444' ' ' SER . 2.0 mp0 -122.95 146.71 47.36 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 123.345 0.658 . . . . 0.0 110.388 -175.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 78.8 m -123.28 113.26 18.64 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.14 133.94 53.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.951 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 49.2 t -125.56 161.85 29.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -57.56 112.73 3.94 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 118.955 -1.593 . . . . 0.0 111.577 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 85.36 -35.28 3.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.553 0.597 . . . . 0.0 112.714 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.671 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 7.9 mm-40 -99.53 126.24 45.44 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 123.601 0.761 . . . . 0.0 110.938 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -142.22 163.67 32.22 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.754 0.312 . . . . 0.0 111.401 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 25.6 p -160.34 150.04 17.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.496 ' OG ' ' HG3' ' A' ' 435' ' ' GLN . 3.4 m -137.08 146.72 45.49 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.565 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 9.0 t -129.94 132.2 46.25 Favored 'General case' 0 N--CA 1.399 -2.978 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.677 172.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.81 110.58 21.49 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 60.5 tp -84.72 119.59 25.44 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -95.79 108.21 20.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 64.0 t -94.79 109.13 21.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -100.17 117.49 34.52 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.216 0.531 . . . . 0.0 111.082 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.288 -2.071 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.539 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.645 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.517 ' CB ' ' HA ' ' A' ' 320' ' ' ASP . 34.1 Cg_exo -67.64 -175.81 0.8 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.911 2.407 . . . . 0.0 112.467 176.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -125.02 69.82 0.48 Allowed Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.016 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 17.4 m 77.23 -12.31 1.08 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.234 1.414 . . . . 0.0 113.719 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.8 -48.16 5.86 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.517 ' HA ' ' CB ' ' A' ' 316' ' ' PRO . 2.0 m-20 65.92 11.93 8.04 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 171.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.73 -32.6 31.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 C-N-CA 123.156 0.582 . . . . 0.0 112.444 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -59.32 -46.18 89.3 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 124.698 1.199 . . . . 0.0 110.873 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.22 -32.37 22.66 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.862 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.6 mt -63.23 -45.57 98.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.637 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 333' ' ' TYR . 39.8 mt -61.74 -43.42 98.88 Favored 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.681 0.613 . . . . 0.0 110.466 177.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -55.73 -42.03 74.74 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.248 0.619 . . . . 0.0 111.777 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -81.78 -10.37 59.36 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.59 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -100.6 146.81 32.68 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -63.37 138.21 64.67 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 121.589 1.526 . . . . 0.0 110.12 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.51 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 4.9 Cg_endo -48.12 -28.98 11.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.046 3.164 . . . . 0.0 114.85 -176.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 44.2 p -64.15 -25.32 68.03 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 121.362 0.601 . . . . 0.0 112.323 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 336' ' ' ILE . 7.2 mm-40 -86.44 -14.51 43.05 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.467 -175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 3.8 m-85 -49.11 -44.62 42.47 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -57.97 -31.0 66.47 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.807 0.692 . . . . 0.0 110.607 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 339' ' ' GLN . 42.3 ttp180 -86.3 -51.68 6.1 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.338 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 332' ' ' GLU . 44.5 mt -60.38 -46.64 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.442 0.697 . . . . 0.0 111.692 -173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 342' ' ' VAL . . . -51.66 -52.38 48.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 123.912 0.885 . . . . 0.0 111.843 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -65.42 -21.72 66.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 335' ' ' ARG . 57.4 mt-30 -71.5 -34.9 70.54 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.519 0.676 . . . . 0.0 109.376 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -97.69 -12.78 21.98 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.154 -174.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 101.1 18.04 20.89 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.706 -1.235 . . . . 0.0 112.357 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.423 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 17.5 t -92.75 84.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.4 m -63.57 -42.29 98.34 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.572 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -99.87 76.18 1.94 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.602 1.192 . . . . 0.0 111.412 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.633 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.0 OUTLIER -75.22 -16.77 60.45 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.372 175.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . 0.496 ' H ' ' HD2' ' A' ' 346' ' ' ARG . 1.8 mpt_? -69.31 -42.3 75.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 350' ' ' LYS . . . -67.9 -34.91 83.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.86 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 16.0 tpt -59.99 -43.38 95.2 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 96.4 mt -59.62 -43.96 93.62 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.066 0.46 . . . . 0.0 109.902 176.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.494 ' HG2' ' NH2' ' A' ' 356' ' ' ARG . 29.9 ttmt -56.73 -48.62 77.37 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.762 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 355' ' ' MET . 79.4 mtp180 -74.52 -21.21 59.66 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.068 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -82.04 -38.51 24.86 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -78.61 -47.98 16.04 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.987 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -104.68 83.27 0.38 Allowed Glycine 1 N--CA 1.396 -4.02 0 N-CA-C 104.464 -3.454 . . . . 0.0 104.464 172.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 351' ' ' ARG . 65.8 mtt -46.82 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.482 -1.639 0 O-C-N 125.888 1.581 . . . . 0.0 113.768 -172.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.494 ' NH2' ' HG2' ' A' ' 350' ' ' LYS . 76.1 mtm180 -123.19 78.63 1.59 Allowed 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 112.953 -1.931 . . . . 0.0 112.848 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -126.07 -165.58 1.45 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 172.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 47.38 34.85 3.51 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.797 1.239 . . . . 0.0 113.744 173.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.16 22.74 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.106 0.955 . . . . 0.0 112.013 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.21 22.94 1.95 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.364 172.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -73.85 -50.96 17.9 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.011 175.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 48.5 p 176.49 106.13 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.574 1.15 . . . . 0.0 109.24 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 7.4 p -139.49 -49.03 0.48 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.894 0.878 . . . . 0.0 110.023 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -89.77 -31.53 17.37 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 122.033 0.92 . . . . 0.0 108.91 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -87.93 140.81 29.12 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.336 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -96.92 -23.55 16.27 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -159.31 134.54 8.3 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' A' ' 443' ' ' CYS . 94.7 mttt -111.26 173.08 6.51 Favored 'General case' 0 C--N 1.283 -2.299 0 O-C-N 123.821 0.7 . . . . 0.0 111.56 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.56 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 87.6 mt -68.89 141.47 55.04 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.886 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -64.84 143.72 98.83 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -44.74 -38.91 13.17 Favored 'Trans proline' 0 C--O 1.257 1.454 0 C-N-CA 123.354 2.702 . . . . 0.0 113.593 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -145.09 158.75 43.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.565 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.418 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 42.6 m-85 -138.54 154.52 48.75 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -138.03 135.97 36.42 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.439 HG21 ' HB ' ' A' ' 381' ' ' ILE . 11.1 p -140.64 155.69 22.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.437 ' HB2' ' CD2' ' A' ' 379' ' ' HIS . 32.2 m -92.34 144.89 24.93 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.402 ' HB3' ' NZ ' ' A' ' 377' ' ' LYS . 3.0 ttpm? -57.18 128.75 38.56 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 123.699 0.8 . . . . 0.0 110.622 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.84 8.73 63.27 Favored Glycine 0 C--N 1.317 -0.486 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.367 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . 0.437 ' CD2' ' HB2' ' A' ' 376' ' ' SER . 56.3 m-70 -112.06 -179.58 3.73 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 122.453 -0.439 . . . . 0.0 110.472 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -98.35 143.81 28.42 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.439 ' HB ' HG21 ' A' ' 375' ' ' VAL . 7.6 tp -138.15 139.23 42.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 20.6 ptt180 -134.32 122.91 23.32 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 122.157 0.98 . . . . 0.0 113.302 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.411 ' HB3' ' CD2' ' A' ' 369' ' ' LEU . 2.1 mm? -88.5 129.12 35.53 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.293 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 34.4 m -120.76 122.62 40.77 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -173.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.26 155.32 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.966 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -126.31 140.53 52.45 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.486 HD11 HG13 ' A' ' 394' ' ' VAL . 5.5 mp -101.49 158.94 15.7 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.2 -24.56 57.82 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.449 0.642 . . . . 0.0 109.624 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -108.37 137.44 46.32 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -80.97 -28.11 35.73 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.908 0.385 . . . . 0.0 111.357 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -99.88 17.29 21.23 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.546 -174.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -116.25 148.55 40.36 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -115.43 174.14 6.16 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.403 0.621 . . . . 0.0 110.609 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.486 HG13 HD11 ' A' ' 387' ' ' LEU . 9.2 m -106.68 164.74 4.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.162 176.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 436' ' ' CYS . 8.1 tptp -109.23 146.14 34.71 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 175.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -115.76 111.32 20.36 Favored 'General case' 0 C--N 1.281 -2.398 0 O-C-N 123.171 0.294 . . . . 0.0 110.549 -171.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.3 mp -122.34 141.91 51.05 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.048 0.452 . . . . 0.0 111.23 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -120.87 122.56 40.52 Favored 'General case' 0 N--CA 1.406 -2.645 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.1 p30 53.82 12.37 0.41 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 126.183 1.793 . . . . 0.0 113.563 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.62 11.29 29.14 Favored Glycine 0 C--O 1.22 -0.75 0 C-N-CA 121.245 -0.502 . . . . 0.0 111.964 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -118.64 120.68 38.15 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -61.19 125.93 25.51 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 56.5 mt -65.85 132.72 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.625 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -96.97 122.29 39.79 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 27.0 ttt -68.81 93.39 0.54 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.38 0.61 . . . . 0.0 112.543 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 409' ' ' LYS . 42.7 t -82.54 128.27 34.14 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 172.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -34.82 -70.74 0.16 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 6.4 p -101.62 18.54 20.05 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.517 0.675 . . . . 0.0 112.329 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 406' ' ' SER . 17.2 tppt? -104.65 -57.79 1.98 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.31 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -113.31 108.13 16.82 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 57.1 mt -108.67 114.6 47.2 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.715 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.1 m-85 -85.78 107.53 17.67 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.719 0.771 . . . . 0.0 108.924 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.2 113.13 26.37 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 16.6 m -104.45 124.63 49.59 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.2 mp -122.12 76.61 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.199 0 CA-C-O 121.546 0.689 . . . . 0.0 109.428 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 74.76 -86.04 0.76 Allowed Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.294 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -109.45 -19.17 13.35 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.341 0.591 . . . . 0.0 109.508 177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.546 ' HE2' ' OG1' ' A' ' 420' ' ' THR . 82.6 tttt -86.29 118.93 26.05 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.779 -176.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -104.95 118.52 36.73 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . 0.546 ' OG1' ' HE2' ' A' ' 418' ' ' LYS . 8.3 m -114.59 124.49 51.99 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.527 HD13 ' CE2' ' A' ' 412' ' ' PHE . 20.4 tp -101.29 103.85 14.85 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 27.8 m -99.76 111.12 23.47 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.108 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 45.2 mt -89.3 121.38 39.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 177.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 18.6 m -106.94 128.71 54.57 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 63.17 67.7 0.66 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.711 -1.131 . . . . 0.0 107.979 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 48.1 t -74.1 123.78 25.07 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 91.4 p -105.25 -176.72 3.16 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 97.0 mt -74.33 -25.68 59.69 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -76.09 -12.17 60.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.227 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -92.16 -21.55 20.34 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.786 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -50.76 119.62 4.03 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.421 1.076 . . . . 0.0 110.601 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -169.77 165.01 9.98 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 123.573 0.546 . . . . 0.0 109.548 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.67 124.42 32.18 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -106.44 141.7 37.31 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -175.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.71 140.76 34.94 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 121.341 0.591 . . . . 0.0 111.735 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 395' ' ' LYS . 63.8 m -105.38 128.77 53.68 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.93 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 55.2 t -115.74 134.63 58.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.243 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.459 ' CG2' HG12 ' A' ' 394' ' ' VAL . 97.1 t -131.57 160.94 42.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.1 114.0 6.46 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 119.148 -1.501 . . . . 0.0 110.365 175.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.76 -35.11 5.15 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-O 119.39 -0.672 . . . . 0.0 113.348 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -139.53 173.15 11.84 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 122.636 1.208 . . . . 0.0 113.997 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -149.92 166.96 28.02 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.67 -1.604 . . . . 0.0 106.933 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.424 ' HB3' ' HD3' ' A' ' 368' ' ' LYS . 27.5 p -154.4 133.28 12.3 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 172.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 5.0 m -118.04 143.23 46.6 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.301 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 13.5 t -125.59 150.79 47.21 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -110.48 110.72 21.58 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 68.1 tp -90.47 129.7 36.62 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -106.77 107.9 19.14 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.77 119.28 37.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -98.28 126.59 43.83 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--N 1.311 -1.098 0 C-N-CA 123.957 0.903 . . . . 0.0 110.119 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.369 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.05 -45.88 11.64 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.01 2.474 . . . . 0.0 111.571 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -99.94 -49.84 1.44 Allowed Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 68.4 m -80.01 95.59 6.2 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 121.445 0.64 . . . . 0.0 112.203 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.33 6.26 10.68 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.836 0.826 . . . . 0.0 109.606 173.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -86.04 31.06 0.64 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.397 1.079 . . . . 0.0 111.631 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.46 -29.63 47.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.441 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -53.32 -54.51 35.37 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.471 0.708 . . . . 0.0 111.375 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.03 -38.18 53.37 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.297 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 67.9 mt -64.12 -50.64 76.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.252 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.43 -28.79 64.23 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -64.06 -43.73 94.59 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.944 0.402 . . . . 0.0 110.836 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -91.26 -0.56 57.7 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.101 0.477 . . . . 0.0 112.015 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -91.16 152.29 43.9 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.849 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . 0.405 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 9.4 Cg_endo -58.15 148.33 78.64 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.704 2.269 . . . . 0.0 112.23 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 26.7 Cg_endo -60.85 -21.96 72.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.496 2.797 . . . . 0.0 114.139 -173.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 5.1 m -85.54 -4.01 59.03 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.116 0.484 . . . . 0.0 111.873 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 336' ' ' ILE . 48.9 mm-40 -99.49 -14.93 18.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.935 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.454 ' HB3' HD11 ' A' ' 345' ' ' LEU . 15.6 m-30 -44.15 -55.12 5.01 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -173.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -65.65 -38.22 88.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.243 0.545 . . . . 0.0 111.179 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.03 -42.48 84.8 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.659 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 332' ' ' GLU . 74.2 mt -65.04 -44.5 95.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -55.65 -58.51 7.52 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.315 0.646 . . . . 0.0 111.395 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -67.75 -23.34 65.23 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -68.01 -42.3 80.89 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.777 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -89.4 -15.51 33.08 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.193 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 100.2 34.63 4.75 Favored Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.3 t -112.21 118.24 57.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 43.4 p -97.75 -13.94 21.12 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-O 122.015 0.912 . . . . 0.0 109.21 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -82.39 47.09 1.11 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.754 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 333' ' ' TYR . 36.0 tp -59.75 -53.13 61.55 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.732 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -67.7 -30.61 70.16 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.301 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -68.04 -38.76 88.81 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 28.0 ttt -71.88 -42.52 66.72 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 345' ' ' LEU . 8.6 mp -61.38 -39.01 89.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.152 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -53.72 -43.87 69.4 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.864 0.727 . . . . 0.0 110.057 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 355' ' ' MET . 93.1 mtt180 -64.15 -45.74 87.12 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.39 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 355' ' ' MET . 7.7 mp -71.91 -21.59 61.61 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . 0.635 ' HE2' ' O ' ' A' ' 359' ' ' GLU . 0.0 OUTLIER -63.47 -34.71 78.36 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 173.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -84.74 -24.05 47.43 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.344 176.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 352' ' ' LEU . 24.0 mmt -74.06 -32.75 63.43 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.882 0.372 . . . . 0.0 111.431 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -93.9 -83.95 0.32 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . 0.488 ' HD2' ' OD2' ' A' ' 358' ' ' ASP . 19.5 ttm180 166.22 -82.77 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.468 1.107 . . . . 0.0 109.821 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.488 ' OD2' ' HD2' ' A' ' 357' ' ' ARG . 3.0 p30 -112.29 2.92 16.77 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.263 -173.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.635 ' O ' ' HE2' ' A' ' 353' ' ' LYS . 1.2 tm-20 -58.66 103.13 0.14 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -128.59 170.34 13.34 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-O 122.975 1.369 . . . . 0.0 112.962 -175.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -146.23 155.87 42.99 Favored 'General case' 0 C--N 1.267 -3.021 1 N-CA-C 99.456 -4.275 . . . . 0.0 99.456 169.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.611 ' OG ' ' HB2' ' A' ' 365' ' ' PHE . 10.3 t -70.56 112.23 6.66 Favored 'General case' 0 N--CA 1.384 -3.757 0 CA-C-O 122.137 0.97 . . . . 0.0 108.668 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 7.2 t -129.52 -21.41 3.15 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.092 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.747 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -85.26 -13.33 50.12 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.611 ' HB2' ' OG ' ' A' ' 362' ' ' SER . 0.5 OUTLIER -90.16 117.84 29.23 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 170.027 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -77.17 -29.64 54.55 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.406 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -151.42 115.96 5.12 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.434 ' HD2' ' HB3' ' A' ' 362' ' ' SER . 49.1 mtpt -98.51 160.28 14.39 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 76.5 mt -70.17 144.85 51.85 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.49 151.14 96.61 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -37.96 -45.48 1.96 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 124.397 3.398 . . . . 0.0 114.022 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -148.38 153.74 38.99 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.665 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 447' ' ' LEU . 74.9 m-85 -134.19 146.03 49.77 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -124.01 147.07 48.1 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.37 155.96 18.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' A' ' 379' ' ' HIS . 15.0 m -87.16 151.65 23.01 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.527 ' CB ' ' HA ' ' A' ' 451' ' ' GLU . 0.0 OUTLIER -70.13 115.33 9.21 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 120.85 0.357 . . . . 0.0 110.105 -178.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 100.49 -6.06 57.39 Favored Glycine 0 CA--C 1.496 -1.11 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 376' ' ' SER . 16.3 t60 -96.11 152.9 18.11 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -96.18 143.46 27.27 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.944 0.402 . . . . 0.0 111.772 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.65 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.9 tp -121.97 129.69 75.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -109.98 112.53 24.61 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.32 0.581 . . . . 0.0 110.304 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 79.8 mt -93.96 139.11 31.32 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 64.3 m -134.55 113.38 11.72 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.686 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.86 145.39 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 22.2 mt-10 -121.54 137.69 54.62 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.497 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 82.5 mt -95.57 144.81 25.72 Favored 'General case' 0 C--N 1.276 -2.613 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -83.84 -21.56 32.01 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.0 121.23 44.04 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.915 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -75.36 -27.12 59.03 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.265 0.555 . . . . 0.0 110.689 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -90.06 18.91 5.35 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.866 0.866 . . . . 0.0 111.304 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -113.55 142.43 45.96 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -110.5 165.99 11.36 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.82 144.31 38.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.256 0.551 . . . . 0.0 110.745 -176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -108.37 143.75 36.87 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.545 ' HB3' HD12 ' A' ' 403' ' ' ILE . 10.2 m-90 -113.21 119.08 36.53 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.596 -174.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 6.9 mp -126.79 138.83 53.41 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -120.36 121.37 38.44 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 22.4 p30 51.22 12.72 0.14 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 126.393 1.877 . . . . 0.0 114.551 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.93 8.24 22.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.197 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -120.07 138.74 53.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.03 126.65 28.05 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 120.753 0.311 . . . . 0.0 110.57 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 396' ' ' TRP . 34.5 mt -72.58 102.07 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -76.26 137.75 40.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 51.0 ttp -73.27 100.01 3.02 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . 0.432 ' H ' ' HD1' ' A' ' 410' ' ' TYR . 43.8 t -101.75 119.19 38.39 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.257 -174.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 49.64 -132.21 26.75 Favored Glycine 0 C--N 1.338 0.641 0 O-C-N 124.748 1.28 . . . . 0.0 113.959 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 24.8 t -104.79 11.95 33.24 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . 0.477 ' HD3' ' OD2' ' A' ' 430' ' ' ASP . 33.1 ttmt -75.74 -61.12 2.03 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.952 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.5 ' O ' ' HG3' ' A' ' 405' ' ' MET . 82.0 m-85 -94.78 117.27 29.87 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.2 mt -121.43 113.53 39.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.524 ' CE1' HD13 ' A' ' 421' ' ' LEU . 24.3 m-85 -86.99 112.3 21.69 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 420' ' ' THR . 41.7 mt-10 -107.7 107.04 17.65 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 32.0 t -99.22 114.68 27.61 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 123.592 0.757 . . . . 0.0 108.991 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.614 ' HB ' ' CG ' ' A' ' 418' ' ' LYS . 41.9 mm -115.26 79.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 67.25 -83.46 0.13 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.376 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -100.9 -31.95 10.89 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.575 0.35 . . . . 0.0 110.767 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.614 ' CG ' ' HB ' ' A' ' 415' ' ' ILE . 1.5 ptpp? -84.49 140.4 31.5 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 121.715 0.769 . . . . 0.0 111.744 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -124.18 100.77 6.87 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 413' ' ' GLU . 31.4 m -98.73 134.42 41.66 Favored 'General case' 0 C--N 1.259 -3.345 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.427 -174.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.524 HD13 ' CE1' ' A' ' 412' ' ' PHE . 33.2 tp -117.0 106.81 13.81 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.359 0.6 . . . . 0.0 109.426 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 36.3 m -97.33 109.67 22.38 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.0 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.6 mt -97.72 110.01 24.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.1 m -95.82 141.47 29.24 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 61.89 52.56 3.37 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.904 0.752 . . . . 0.0 110.479 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . 0.65 ' SG ' HG22 ' A' ' 381' ' ' ILE . 13.5 m -65.19 113.19 3.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 12.0 m -108.4 -167.69 1.26 Allowed 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.14 -20.77 60.85 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 121.703 -0.623 . . . . 0.0 111.006 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -78.83 -4.51 49.91 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.405 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . 0.477 ' OD2' ' HD3' ' A' ' 409' ' ' LYS . 18.1 m-20 -110.7 7.91 22.4 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.959 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.94 96.67 9.44 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -151.27 162.63 40.56 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.932 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.75 122.66 30.15 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . 0.524 ' HD2' HD11 ' A' ' 403' ' ' ILE . 93.5 m-85 -106.55 140.58 39.21 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 120.827 0.346 . . . . 0.0 110.131 -175.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.33 137.78 30.78 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.227 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 65.5 m -103.95 128.57 51.48 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.95 130.67 73.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.366 0.603 . . . . 0.0 111.556 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 441' ' ' GLU . 63.7 t -124.7 161.58 27.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 174.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -61.26 112.97 5.2 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 118.513 -1.804 . . . . 0.0 111.534 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 94.38 -35.3 4.26 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.632 -0.284 . . . . 0.0 112.547 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.747 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 9.1 mm-40 -105.96 138.98 41.21 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 122.467 -0.431 . . . . 0.0 110.681 -173.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.79 163.92 35.94 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 171.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 13.8 p -151.28 133.49 15.27 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 12.1 p -119.62 132.17 55.64 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 123.654 0.596 . . . . 0.0 110.707 -175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.431 ' OG1' ' HD2' ' A' ' 373' ' ' TYR . 14.6 t -124.07 147.9 47.52 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -106.04 111.02 23.47 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 373' ' ' TYR . 3.3 tm? -93.14 125.69 37.86 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -113.25 124.97 53.75 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.817 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.6 t -97.53 122.25 48.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -106.16 117.06 33.04 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 377' ' ' LYS . 2.6 mp0 . . . . . 0 C--O 1.256 1.417 0 C-N-CA 125.234 1.413 . . . . 0.0 113.929 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.473 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.37 113.19 2.8 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.405 2.07 . . . . 0.0 111.808 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 131.9 -140.33 11.71 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.521 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 15.6 t -129.26 31.1 4.9 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 62.92 76.42 0.37 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -108.43 -8.83 15.5 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.689 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.55 -37.67 39.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.717 -1.128 . . . . 0.0 113.36 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -56.3 -46.45 79.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -85.05 -29.6 24.8 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.288 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.01 -48.29 86.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.324 0.39 . . . . 0.0 110.392 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 62.9 mt -59.42 -41.23 89.07 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.119 0.485 . . . . 0.0 110.236 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -58.62 -30.01 66.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.237 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -112.9 7.14 18.19 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.26 0.552 . . . . 0.0 111.187 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -100.67 150.82 37.32 Favored Pre-proline 0 C--N 1.306 -1.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.695 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . 0.457 ' HG2' ' HG2' ' A' ' 332' ' ' GLU . 19.2 Cg_endo -66.43 142.84 67.26 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.433 2.089 . . . . 0.0 111.389 175.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.476 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 18.5 Cg_endo -58.52 -21.38 54.17 Favored 'Trans proline' 0 N--CA 1.481 0.747 0 C-N-CA 123.813 3.008 . . . . 0.0 114.205 -176.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 36.1 p -74.34 -17.16 60.87 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.047 0.451 . . . . 0.0 112.16 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.457 ' HG2' ' HG2' ' A' ' 329' ' ' PRO . 19.9 mm-40 -103.97 -2.88 25.43 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.494 -175.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 20.8 m-30 -56.89 -40.23 75.85 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -174.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.27 -30.16 70.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.989 0.423 . . . . 0.0 111.121 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -72.56 -57.72 3.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.0 -40.32 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.845 1.258 . . . . 0.0 111.792 -173.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -58.54 -60.1 4.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.639 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -67.8 -22.97 65.15 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.028 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -64.44 -34.2 77.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.384 0.674 . . . . 0.0 109.515 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -110.25 13.23 23.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 76.48 29.61 57.8 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.806 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 12.2 t -108.75 118.73 56.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 17.6 p -94.79 -14.19 24.91 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-O 122.115 0.96 . . . . 0.0 109.928 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -92.52 49.16 1.45 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.478 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.7 pt? -73.04 -26.2 61.21 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.499 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -70.75 -24.21 62.57 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -64.76 -31.48 81.06 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.764 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 24.2 ttt -66.83 -45.51 78.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.81 -35.44 80.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.1 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -57.84 -32.35 67.54 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.935 0.894 . . . . 0.0 111.133 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 355' ' ' MET . 36.5 mmt180 -61.72 -42.15 98.57 Favored 'General case' 0 C--O 1.21 -0.987 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.93 -27.63 33.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.573 0.701 . . . . 0.0 110.217 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -63.8 -37.87 89.0 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.961 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -95.97 1.14 62.93 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.371 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 351' ' ' ARG . 43.8 tpp -88.0 60.82 6.03 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 122.629 -0.336 . . . . 0.0 110.764 -175.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 52.4 -29.11 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 118.697 2.851 . . . . 0.0 118.697 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -73.64 -35.66 65.32 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 118.509 0.595 . . . . 0.0 111.338 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.65 120.52 31.78 Favored 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.348 -171.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.37 112.58 24.35 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.403 ' HE2' ' CD ' ' A' ' 441' ' ' GLU . 3.2 mppt? -92.3 -79.8 0.38 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.121 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -178.74 -51.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 O-C-N 123.615 0.572 . . . . 0.0 110.714 -176.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 5.8 p -176.6 71.97 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.133 0.973 . . . . 0.0 110.059 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 38.2 p -103.32 -54.74 2.54 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.51 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.78 -13.02 61.22 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 122.063 0.935 . . . . 0.0 109.438 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.434 ' CG ' ' HG2' ' A' ' 368' ' ' LYS . 5.4 m-85 -107.09 120.48 42.21 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.38 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -79.77 -27.11 40.47 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.76 0.79 . . . . 0.0 109.169 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -157.01 118.23 3.7 Favored 'General case' 0 N--CA 1.403 -2.815 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.434 ' HG2' ' CG ' ' A' ' 365' ' ' PHE . 42.2 mtmt -94.89 178.42 5.57 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.445 HD11 ' SG ' ' A' ' 436' ' ' CYS . 82.5 mt -67.51 144.35 55.71 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 175.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.21 136.77 93.9 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -43.72 -34.81 5.99 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.059 3.173 . . . . 0.0 114.543 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -144.78 143.66 30.78 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.113 0.482 . . . . 0.0 112.234 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.413 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 63.2 m-85 -137.3 143.28 42.04 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.233 1.013 . . . . 0.0 109.315 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -122.27 138.98 54.31 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 9.0 p -134.76 149.39 29.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.1 m -82.2 147.7 28.84 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 378' ' ' GLY . 1.6 tmmm? -64.6 127.11 30.15 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.312 0.577 . . . . 0.0 110.031 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.501 ' N ' ' HD2' ' A' ' 377' ' ' LYS . . . 95.01 -7.13 69.7 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.382 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -93.08 168.33 11.19 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.757 0.313 . . . . 0.0 111.402 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 44.6 mtmt -98.12 157.61 16.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 17.8 tt -145.73 128.58 9.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-O 121.576 0.703 . . . . 0.0 109.924 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -103.19 114.99 29.73 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.913 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 76.3 mt -98.0 141.07 31.41 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 35.2 m -139.81 138.49 35.86 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.416 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.0 143.16 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -116.87 126.02 52.39 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.412 ' O ' ' HB1' ' A' ' 417' ' ' ALA . 84.3 mt -91.64 139.86 30.28 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.457 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -71.73 -42.59 67.1 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.95 103.57 16.08 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.631 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -73.18 -21.83 60.6 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.181 -177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.15 26.98 3.03 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.735 1.255 . . . . 0.0 109.748 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -124.06 162.53 23.31 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.06 166.49 19.16 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.693 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 6.7 m -117.02 167.72 9.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.609 0.718 . . . . 0.0 111.91 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.498 ' HA ' ' HE2' ' A' ' 395' ' ' LYS . 8.9 mmpt? -112.81 140.16 47.83 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.403 ' HB3' HD12 ' A' ' 403' ' ' ILE . 11.6 m-90 -112.38 113.56 25.82 Favored 'General case' 0 C--N 1.278 -2.523 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 10.0 mp -124.59 137.4 54.39 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.751 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 119.04 30.15 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 171.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.2 p30 56.05 18.11 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 126.725 2.01 . . . . 0.0 112.249 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.5 1.98 47.06 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.093 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -106.24 133.72 50.5 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.18 123.46 20.35 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.439 0.638 . . . . 0.0 111.312 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 396' ' ' TRP . 69.6 mt -66.34 109.75 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.48 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -85.96 135.76 33.53 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 28.0 ttt -73.3 94.77 2.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.155 0.503 . . . . 0.0 110.155 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.0 p -89.04 94.4 9.93 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.05 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.17 -106.6 0.95 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.54 -0.754 . . . . 0.0 113.563 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 19.2 t -122.14 12.36 10.31 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . 0.457 ' HD2' ' CD2' ' A' ' 410' ' ' TYR . 6.2 tmtm? -74.31 -56.88 4.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.536 ' O ' ' HG3' ' A' ' 405' ' ' MET . 79.8 m-85 -107.23 113.44 26.85 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 176.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.68 113.9 45.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.097 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.401 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.0 m-85 -87.05 106.0 17.55 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 420' ' ' THR . 45.3 mt-10 -98.37 107.6 20.1 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 11.4 t -96.59 111.33 23.51 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.499 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 33.4 mm -115.1 82.02 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -174.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.91 -88.89 0.23 Allowed Glycine 0 C--O 1.236 0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 112.816 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 387' ' ' LEU . . . -101.2 -29.28 12.19 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 121.203 0.525 . . . . 0.0 110.665 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 14.9 ptmt -94.76 127.41 40.74 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 122.143 0.973 . . . . 0.0 113.473 -171.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -100.21 105.81 17.43 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 413' ' ' GLU . 27.9 m -100.06 120.24 39.54 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.693 -174.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.401 HD13 ' CE2' ' A' ' 412' ' ' PHE . 45.8 tp -104.49 106.8 17.44 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.169 0.509 . . . . 0.0 110.312 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 58.5 m -95.8 111.63 23.55 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 38.3 mt -99.06 120.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 15.6 m -97.46 130.19 44.58 Favored 'General case' 0 N--CA 1.407 -2.614 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 63.32 74.68 0.42 Allowed 'General case' 0 C--O 1.243 0.751 0 O-C-N 124.168 0.918 . . . . 0.0 113.427 172.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 81.8 m -80.93 121.04 25.51 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.666 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 29.4 p -101.07 -177.26 3.4 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.56 -19.95 62.84 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.964 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -86.24 -11.65 51.79 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.73 177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -99.24 2.89 46.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.804 1.288 . . . . 0.0 108.39 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -77.54 116.91 18.49 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.46 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 447' ' ' LEU . . . -161.66 172.53 16.12 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -84.74 130.55 34.68 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -112.05 132.17 54.98 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.555 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.531 ' N ' HE21 ' A' ' 435' ' ' GLN . 0.0 OUTLIER -126.66 142.16 51.63 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.19 -174.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.445 ' SG ' HD11 ' A' ' 369' ' ' LEU . 71.7 m -123.87 120.85 33.77 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 172.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 395' ' ' LYS . 40.7 t -115.94 128.76 73.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.932 -174.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.49 161.11 19.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 170.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -64.63 112.32 4.91 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.178 -1.487 . . . . 0.0 111.614 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 96.59 -35.11 4.57 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 115.344 -0.428 . . . . 0.0 112.143 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.403 ' CD ' ' HE2' ' A' ' 360' ' ' LYS . 6.0 mm-40 -116.09 124.63 50.89 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -174.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.01 167.54 21.88 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.702 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 41.7 t -151.79 147.2 26.38 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 80.1 p -125.92 116.59 21.73 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 9.0 t -94.93 138.92 32.04 Favored 'General case' 0 N--CA 1.401 -2.899 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -88.36 110.0 20.44 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 432' ' ' ALA . 3.4 tm? -99.47 121.79 41.65 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -116.62 114.24 23.81 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.646 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.63 119.62 39.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -109.35 130.28 55.5 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.407 -2.612 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.506 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 316' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.445 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 315' ' ' GLY . 28.1 Cg_exo -66.89 -33.68 32.57 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.615 2.21 . . . . 0.0 111.827 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -96.05 175.63 32.46 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 26.1 m -82.81 114.48 21.17 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.968 0.414 . . . . 0.0 111.658 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 321' ' ' VAL . 12.1 pt-20 -98.94 14.15 30.1 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -71.17 25.18 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 126.696 1.998 . . . . 0.0 112.831 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' A' ' 319' ' ' GLU . 10.7 p -61.32 -33.62 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 C-N-CA 123.628 0.771 . . . . 0.0 109.492 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . 0.404 ' HA ' ' CE ' ' A' ' 348' ' ' MET . 43.7 p-90 -52.97 -47.97 67.77 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 123.213 0.605 . . . . 0.0 112.085 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.64 -40.26 16.4 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 79.2 mt -63.22 -45.21 99.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 120.715 0.293 . . . . 0.0 111.439 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 9.3 tt -73.21 -31.09 63.96 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.389 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -70.36 -27.12 64.08 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 121.198 0.523 . . . . 0.0 111.22 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -97.82 -1.81 42.36 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.235 0.54 . . . . 0.0 110.988 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.88 148.24 35.28 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.84 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.6 146.49 92.64 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 122.328 2.019 . . . . 0.0 112.659 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.415 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 10.8 Cg_endo -52.76 -24.1 22.46 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 124.201 3.268 . . . . 0.0 115.922 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 9.0 m -76.61 -12.93 60.09 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.498 0.666 . . . . 0.0 111.644 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.409 ' O ' HG13 ' A' ' 336' ' ' ILE . 7.1 mm-40 -94.61 -15.74 23.79 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.405 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 9.5 m-30 -48.98 -49.3 41.41 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 -171.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -65.78 -31.51 72.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.157 0.503 . . . . 0.0 111.52 -174.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -69.14 -53.54 19.6 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 332' ' ' GLU . 62.6 mt -59.36 -49.86 81.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.887 -175.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -56.4 -62.06 1.98 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.933 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -62.62 -23.17 66.92 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -70.74 -39.96 73.01 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 122.782 0.433 . . . . 0.0 110.842 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -91.08 1.26 57.22 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.011 0.434 . . . . 0.0 112.078 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 87.87 25.7 31.37 Favored Glycine 0 C--N 1.311 -0.808 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.718 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.2 t -104.81 117.17 49.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 73.9 p -95.46 -30.54 13.82 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 117.685 -1.606 . . . . 0.0 111.599 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -95.39 84.65 4.06 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.54 -30.54 59.76 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.431 0.634 . . . . 0.0 110.589 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -73.35 -40.55 64.33 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -67.49 -17.97 69.27 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.379 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . 0.597 ' O ' ' HG2' ' A' ' 351' ' ' ARG . 24.1 ttt -79.7 -56.25 4.42 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 122.887 0.475 . . . . 0.0 109.987 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.09 -20.19 66.35 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 353' ' ' LYS . 22.6 pttp -65.94 -30.22 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.077 0.465 . . . . 0.0 111.395 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 348' ' ' MET . 24.8 ptt180 -79.65 -22.75 43.14 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.23 -21.67 56.12 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 122.371 1.081 . . . . 0.0 108.492 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 356' ' ' ARG . 11.8 tppt? -72.26 -30.23 64.66 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.905 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -93.89 -16.17 46.04 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.192 -0.913 . . . . 0.0 114.715 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -19.89 60.94 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 117.742 0.771 . . . . 0.0 112.271 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 353' ' ' LYS . 21.5 ptt180 -82.57 -27.69 31.41 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.086 0.47 . . . . 0.0 111.806 -177.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . 0.25 0.0 OUTLIER -86.38 148.41 25.59 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -169.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -122.45 131.15 53.73 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.362 -172.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -140.76 117.51 10.99 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 170.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 360' ' ' LYS . 29.6 mmtp -113.99 130.99 56.5 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.614 0.721 . . . . 0.0 112.165 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -57.3 -16.87 9.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.911 1.685 . . . . 0.0 113.248 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 12.2 m 69.82 57.04 0.32 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.356 1.063 . . . . 0.0 109.253 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 14.6 t -95.48 -38.12 10.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.165 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.473 ' H ' ' HG3' ' A' ' 441' ' ' GLU . . . -88.78 -12.95 40.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.716 0.769 . . . . 0.0 109.635 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -109.74 117.57 34.24 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.522 177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -82.87 -18.86 38.8 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -160.08 116.47 2.45 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -94.69 172.76 7.98 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 96.8 mt -71.63 139.26 49.22 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 174.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -56.71 146.53 56.47 Favored Pre-proline 0 C--N 1.316 -0.864 0 O-C-N 123.926 0.766 . . . . 0.0 108.998 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.09 -33.01 41.62 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 123.025 2.484 . . . . 0.0 112.986 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -147.76 144.37 28.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.846 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.549 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 51.9 m-85 -129.8 159.07 37.68 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -136.72 141.9 43.07 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.75 147.3 25.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 25.2 m -84.16 144.5 28.96 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.424 ' HD3' ' HG2' ' A' ' 451' ' ' GLU . 26.7 ttpp -60.26 128.15 35.32 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.741 0.416 . . . . 0.0 110.949 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 90.7 8.84 65.07 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.883 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -111.07 175.2 5.51 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -99.57 136.51 39.39 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.649 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.2 tp -121.36 139.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.478 ' CZ ' HG21 ' A' ' 420' ' ' THR . 35.5 ttt85 -131.74 116.66 17.58 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.187 0.994 . . . . 0.0 111.581 -173.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.08 130.4 48.66 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.974 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 21.7 m -127.61 126.11 41.46 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.415 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 5.1 m -122.04 144.2 32.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.813 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.414 ' HG2' ' HG3' ' A' ' 418' ' ' LYS . 48.0 mt-10 -111.91 119.25 37.89 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 86.0 mt -88.11 145.65 25.83 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.515 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -72.09 -24.26 61.47 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.058 0.456 . . . . 0.0 110.183 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -123.33 135.5 54.22 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.426 ' CD2' ' HB2' ' A' ' 417' ' ' ALA . 11.7 m-70 -70.86 -23.25 62.28 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.87 19.39 17.99 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.223 0.535 . . . . 0.0 110.86 -172.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -96.59 132.64 42.0 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -98.71 156.12 17.0 Favored 'General case' 0 C--N 1.267 -2.99 0 C-N-CA 118.541 -1.263 . . . . 0.0 111.96 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 2.8 m -115.53 152.23 17.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.225 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -115.0 139.35 49.92 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 403' ' ' ILE . 5.8 m-90 -110.9 125.16 53.36 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -173.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 8.3 mp -127.47 136.23 51.5 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 117.832 0.287 . . . . 0.0 110.859 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.432 ' HB3' HD11 ' A' ' 403' ' ' ILE . 0.0 OUTLIER -111.61 115.63 29.46 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.277 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . 0.259 28.6 p30 50.88 13.71 0.15 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 126.814 2.046 . . . . 0.0 114.961 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 123.17 -7.11 9.27 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.366 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -107.51 134.15 50.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.88 120.74 16.9 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.193 0.521 . . . . 0.0 111.109 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 398' ' ' LYS . 43.1 mt -78.87 111.97 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.915 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.6 151.14 20.84 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 61.7 ttp -62.46 102.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 409' ' ' LYS . 27.4 t -100.78 95.91 6.96 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 55.29 -137.7 44.48 Favored Glycine 0 N--CA 1.442 -0.947 0 O-C-N 124.114 0.884 . . . . 0.0 113.04 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.3 p -95.44 8.56 42.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.385 0.612 . . . . 0.0 110.607 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 423' ' ' ILE . 2.5 tppp? -72.5 -47.72 46.29 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 175.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.486 ' O ' ' HG3' ' A' ' 405' ' ' MET . 41.1 m-85 -119.43 108.63 14.8 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 57.6 mt -108.66 112.8 41.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 CA-C-O 120.987 0.423 . . . . 0.0 109.955 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.503 ' CD2' HD13 ' A' ' 421' ' ' LEU . 22.7 m-85 -87.08 109.37 19.38 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.468 175.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -108.68 108.72 19.68 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 70.3 m -100.16 110.38 22.66 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.352 0.596 . . . . 0.0 111.172 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 36.1 mt -104.06 74.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.11 -107.05 1.71 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.404 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.426 ' HB2' ' CD2' ' A' ' 390' ' ' HIS . . . -89.93 -25.64 20.83 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.664 0.386 . . . . 0.0 110.396 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.414 ' HG3' ' HG2' ' A' ' 386' ' ' GLU . 31.1 ttpt -88.39 98.47 11.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -100.7 130.23 46.71 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-O 121.317 0.579 . . . . 0.0 109.722 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . 0.478 HG21 ' CZ ' ' A' ' 382' ' ' ARG . 16.8 m -123.0 145.77 48.21 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.553 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.503 HD13 ' CD2' ' A' ' 412' ' ' PHE . 23.2 tp -118.56 112.63 20.13 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.353 174.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 33.9 m -102.07 109.87 21.69 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 409' ' ' LYS . 33.0 mt -98.4 121.69 49.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.4 m -101.24 145.02 29.39 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.227 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 58.53 47.61 13.16 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.397 1.079 . . . . 0.0 110.836 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.64 122.86 16.9 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 11.2 m -116.63 -177.95 3.31 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.21 -29.55 69.89 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -81.76 -2.8 52.0 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -103.22 -7.05 21.5 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.2 113.84 1.54 Allowed 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.841 173.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -168.79 163.05 11.8 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.914 -177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.39 129.25 34.85 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -104.61 134.31 47.99 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' A' ' 444' ' ' SER . 0.0 OUTLIER -123.87 130.0 51.9 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.406 -178.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 443' ' ' CYS . 81.4 m -107.89 111.84 24.17 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 171.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.31 128.22 53.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.756 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.12 161.3 29.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -59.96 112.93 4.84 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.278 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 93.15 -36.29 3.77 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 124.223 0.916 . . . . 0.0 112.441 175.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 364' ' ' ALA . 12.6 mm-40 -116.61 134.99 54.18 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 120.732 0.301 . . . . 0.0 110.403 -173.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -134.61 162.35 32.54 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 436' ' ' CYS . 23.3 p -136.19 144.49 44.97 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 173.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.478 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 5.0 p -139.66 112.83 8.2 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 123.23 0.332 . . . . 0.0 111.348 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.549 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 9.9 t -104.13 141.54 36.06 Favored 'General case' 0 N--CA 1.41 -2.446 0 C-N-CA 120.239 -0.584 . . . . 0.0 109.78 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -102.63 110.53 22.49 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -89.11 143.71 26.65 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.924 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -118.73 128.65 54.69 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.51 115.93 45.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.51 ' HA ' ' HE3' ' A' ' 450' ' ' LYS . 1.1 tpmt? -105.4 115.67 30.65 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.424 ' HG2' ' HD3' ' A' ' 377' ' ' LYS . 36.0 mt-10 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.708 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.706 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.92 132.62 25.1 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 122.457 2.105 . . . . 0.0 113.2 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -101.92 -178.65 27.93 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 57.8 m -161.53 -66.13 0.06 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.574 0.749 . . . . 0.0 109.285 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.72 -45.65 5.18 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.089 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 62.49 12.67 5.57 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.481 1.112 . . . . 0.0 113.769 172.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.2 -34.63 27.68 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 C-N-CA 123.238 0.615 . . . . 0.0 112.0 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -51.8 -55.25 20.97 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 124.808 1.243 . . . . 0.0 109.987 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.9 -35.57 22.07 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.843 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.75 -49.26 78.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 O-C-N 122.96 0.163 . . . . 0.0 111.375 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.4 tt -71.84 -32.71 67.8 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.994 0.426 . . . . 0.0 110.035 -177.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -64.18 -33.24 75.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.48 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -96.31 0.62 51.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.416 0.627 . . . . 0.0 110.314 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -90.44 151.93 44.85 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.72 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.39 140.65 95.35 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.701 2.267 . . . . 0.0 111.596 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.472 ' HA ' ' CD2' ' A' ' 333' ' ' TYR . 14.0 Cg_endo -55.8 -23.03 39.8 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.796 2.997 . . . . 0.0 115.072 -174.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 34.1 p -75.78 -21.57 57.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.273 0.559 . . . . 0.0 111.932 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -93.84 -8.28 40.87 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.511 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.472 ' CD2' ' HA ' ' A' ' 330' ' ' PRO . 4.2 m-30 -43.66 -54.86 4.72 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.505 1.122 . . . . 0.0 113.856 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.86 -49.1 79.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 339' ' ' GLN . 11.2 ttp180 -60.73 -40.27 91.71 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.305 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 34.1 mt -73.6 -37.8 50.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.173 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -61.85 -58.55 7.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.178 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -66.84 -23.03 65.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.43 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 335' ' ' ARG . 7.9 tp-100 -59.14 -43.63 92.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.267 0.627 . . . . 0.0 109.624 176.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.59 4.92 43.78 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 88.58 18.22 55.32 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.219 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 24.5 t -91.87 101.04 12.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 4.3 m -82.33 -40.18 21.8 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.078 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -99.69 87.75 3.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.961 0.886 . . . . 0.0 109.631 175.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.4 pt? -75.59 -36.23 60.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.101 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -63.21 -38.76 92.44 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.926 -173.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -73.42 -22.1 78.95 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.745 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 56.1 ttp -73.81 -45.79 49.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.3 -32.96 73.77 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.944 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -56.04 -46.77 78.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.278 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -67.42 -41.46 84.81 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.997 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.48 -21.08 66.6 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -63.81 -42.35 97.69 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.46 -44.01 14.16 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.162 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 48.8 mtm -84.19 84.19 7.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.635 0.731 . . . . 0.0 109.905 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -73.64 -17.36 61.17 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.554 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . 0.407 ' HD3' ' C ' ' A' ' 357' ' ' ARG . 0.0 OUTLIER 74.88 92.25 0.08 Allowed 'General case' 0 C--O 1.248 1.019 0 C-N-CA 125.392 1.477 . . . . 0.0 108.176 -175.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -121.36 121.85 38.53 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.72 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -82.57 -30.84 29.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.569 ' HE2' ' O ' ' A' ' 440' ' ' GLY . 0.0 OUTLIER -77.41 153.84 33.25 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.554 172.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -156.26 47.1 0.46 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.093 -167.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . 0.286 56.0 p 63.42 73.77 0.44 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.737 1.256 . . . . 0.0 110.233 -175.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 15.4 t -127.02 -18.06 4.71 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.173 -1.83 . . . . 0.0 109.277 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -99.33 -35.77 9.83 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -105.64 128.74 53.81 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.94 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . 0.484 HE21 ' HB3' ' A' ' 386' ' ' GLU . 24.3 mt-30 -83.27 -43.74 15.72 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 6.0 mmpt? -137.68 124.07 20.7 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 442' ' ' LYS . 56.7 mtpt -98.46 168.29 10.29 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.215 -175.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 84.5 mt -62.03 141.31 58.15 Favored 'General case' 0 C--O 1.255 1.343 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -63.16 149.11 91.69 Favored Pre-proline 0 C--N 1.302 -1.461 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.629 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.1 -35.29 25.69 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 123.393 2.729 . . . . 0.0 113.259 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -153.34 152.5 31.17 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -133.35 158.29 43.36 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -135.71 136.94 41.26 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.07 156.19 24.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 8.4 t -93.15 151.27 19.94 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -64.15 119.12 9.6 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.851 0.357 . . . . 0.0 110.777 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 99.76 -1.49 56.78 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -91.79 -177.73 4.84 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.176 0.513 . . . . 0.0 110.836 177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.0 mtpt -119.34 130.39 55.34 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.617 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.0 tp -120.84 130.01 75.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.417 0.627 . . . . 0.0 110.245 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 74.3 mtt180 -101.76 110.09 22.0 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.078 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 78.4 mt -95.65 117.83 31.21 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 16.1 m -122.95 144.36 49.29 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.943 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 9.5 m -140.72 143.24 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.484 ' HB3' HE21 ' A' ' 366' ' ' GLN . 5.9 mp0 -108.94 119.55 39.88 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.473 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 81.6 mt -85.64 143.3 28.49 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.79 -44.6 27.03 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.41 114.87 22.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.325 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -79.4 -21.53 45.53 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.018 0.437 . . . . 0.0 111.415 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -94.09 26.9 3.04 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.739 0.78 . . . . 0.0 111.59 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -128.47 161.46 29.46 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.27 176.88 7.58 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 12.1 m -116.6 164.45 12.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 120.939 0.399 . . . . 0.0 110.728 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -119.0 135.42 54.63 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -106.93 123.61 48.43 Favored 'General case' 0 C--N 1.283 -2.311 0 O-C-N 123.867 0.729 . . . . 0.0 109.979 -169.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.2 mp -131.6 144.12 50.83 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.773 -0.579 . . . . 0.0 111.425 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.427 ' HB3' HD11 ' A' ' 403' ' ' ILE . 23.0 pttp -126.18 125.42 42.42 Favored 'General case' 0 N--CA 1.405 -2.701 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 169.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 24.6 p30 54.25 17.03 1.36 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.812 1.645 . . . . 0.0 113.009 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.44 4.66 46.54 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.891 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -109.03 124.15 50.27 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.6 111.28 1.76 Allowed 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 398' ' ' LYS . 19.3 mt -75.6 148.75 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 O-C-N 124.302 1.001 . . . . 0.0 108.415 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -139.94 173.85 11.11 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 48.6 ttm -66.96 101.57 0.86 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.9 m -97.71 97.48 9.05 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 62.97 -127.47 38.57 Favored Glycine 0 N--CA 1.434 -1.47 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.35 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.8 p -106.07 12.16 30.66 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.092 0.472 . . . . 0.0 110.623 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -78.76 -60.71 2.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.085 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.431 ' O ' ' HG3' ' A' ' 405' ' ' MET . 95.5 m-85 -96.55 107.62 20.06 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 49.7 mm -106.16 112.53 39.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 CA-C-O 121.178 0.513 . . . . 0.0 110.01 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' A' ' 421' ' ' LEU . 23.0 m-85 -86.79 115.87 24.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -110.5 108.33 18.29 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 19.3 m -98.41 111.63 23.91 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 39.4 mm -112.31 87.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.74 2.21 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -92.82 -27.0 17.43 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.453 0.168 . . . . 0.0 110.948 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 21.8 ptmt -83.96 141.73 31.02 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.565 0.698 . . . . 0.0 111.929 -175.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -115.22 120.9 41.24 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.115 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 53.0 m -112.67 122.38 47.5 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.526 HD13 ' CE2' ' A' ' 412' ' ' PHE . 21.4 tp -102.41 110.16 22.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 31.3 m -95.46 102.0 13.77 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.7 mt -86.78 112.67 23.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 13.3 m -96.36 139.83 31.92 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.718 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 61.27 57.92 2.3 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 124.905 1.282 . . . . 0.0 110.087 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 381' ' ' ILE . 25.5 m -64.48 120.9 13.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.093 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 82.1 p -94.89 178.55 5.53 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.25 -19.38 61.71 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -79.89 -2.17 42.45 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.669 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -103.3 8.04 38.3 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.542 0.687 . . . . 0.0 109.507 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -80.21 94.76 6.11 Favored 'General case' 0 C--O 1.256 1.415 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -145.24 170.21 16.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.466 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -89.53 120.71 31.07 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 398' ' ' LYS . 89.5 m-85 -107.43 138.66 43.23 Favored 'General case' 0 C--N 1.286 -2.196 0 O-C-N 122.276 -0.265 . . . . 0.0 111.166 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 0.1 OUTLIER -134.4 133.98 41.15 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.841 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 443' ' ' CYS . 85.7 m -108.13 114.12 27.78 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 169.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 44.6 t -109.84 132.54 57.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.481 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 73.9 t -125.9 160.74 32.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 173.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -66.26 113.24 5.55 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 119.054 -1.546 . . . . 0.0 111.888 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . 0.569 ' O ' ' HE2' ' A' ' 360' ' ' LYS . . . 107.89 -36.67 4.24 Favored Glycine 0 N--CA 1.424 -2.109 0 CA-C-N 115.088 -0.556 . . . . 0.0 112.507 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -134.99 152.58 51.86 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 117.988 0.894 . . . . 0.0 110.849 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.502 ' O ' ' HE3' ' A' ' 368' ' ' LYS . 20.0 ptpt -141.95 178.26 7.63 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 436' ' ' CYS . 5.9 p -148.0 134.3 19.52 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 8.0 p -121.32 129.36 53.05 Favored 'General case' 0 C--N 1.288 -2.077 0 O-C-N 123.798 0.686 . . . . 0.0 110.538 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 15.1 t -128.53 150.11 50.32 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -111.96 111.16 21.89 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 62.0 tp -90.83 130.01 36.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.08 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -109.83 110.59 21.62 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.0 120.67 45.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 376' ' ' SER . 20.0 ttpp -116.05 131.42 56.95 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.973 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.529 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.63 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -67.19 -25.79 42.91 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.548 2.166 . . . . 0.0 112.946 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -96.17 -156.35 31.22 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 35.6 m -140.2 -43.9 0.42 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 117.309 0.555 . . . . 0.0 111.989 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -115.06 5.75 15.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.585 1.183 . . . . 0.0 107.824 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.54 24.96 0.19 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.487 1.515 . . . . 0.0 112.662 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.85 -34.1 47.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 122.563 0.345 . . . . 0.0 110.723 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -53.53 -47.41 69.98 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.561 1.144 . . . . 0.0 111.186 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 8.6 pt-20 -85.81 -42.09 14.47 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.897 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.34 -50.47 80.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 122.671 0.388 . . . . 0.0 111.532 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.94 -27.88 64.08 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.352 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -60.63 -49.78 76.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.432 0.634 . . . . 0.0 111.78 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.468 ' H ' ' HG2' ' A' ' 327' ' ' GLN . 19.3 pt20 -94.46 0.82 55.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.785 -174.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -81.82 153.61 70.18 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.257 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.53 143.31 94.85 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 122.157 1.904 . . . . 0.0 110.988 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HA ' ' CE2' ' A' ' 333' ' ' TYR . 28.3 Cg_endo -60.27 -24.29 76.88 Favored 'Trans proline' 0 N--CA 1.473 0.299 0 C-N-CA 123.764 2.976 . . . . 0.0 113.992 -172.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.1 m -79.81 -8.81 59.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 120.989 0.423 . . . . 0.0 111.583 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 336' ' ' ILE . 20.5 mm-40 -94.66 -19.3 20.56 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.207 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 330' ' ' PRO . 14.2 m-30 -44.24 -50.33 8.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.03 -55.76 30.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.673 0.608 . . . . 0.0 111.765 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -65.44 -41.02 93.94 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.043 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 332' ' ' GLU . 77.6 mt -59.25 -45.81 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.69 -58.83 6.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.847 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -62.11 -30.71 71.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.17 -36.54 84.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.767 0.317 . . . . 0.0 111.117 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -93.21 4.49 53.91 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 84.11 12.87 75.65 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.983 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 19.0 t -89.94 90.22 3.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -45.68 93.21 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.128 -174.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -110.98 100.79 9.43 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.757 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 345' ' ' LEU . 0.8 OUTLIER -75.93 -21.2 57.31 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.411 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -61.54 -44.63 96.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.856 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -63.53 -34.56 90.28 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 25.7 ttt -70.17 -48.39 57.5 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.041 0.448 . . . . 0.0 109.924 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 353' ' ' LYS . 97.5 mt -65.01 -33.62 76.48 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.292 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -59.91 -46.32 89.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.874 0.845 . . . . 0.0 108.949 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -72.43 -40.3 67.19 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.122 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 12.0 tp -70.83 -21.03 62.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.666 0.746 . . . . 0.0 110.192 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 349' ' ' LEU . 35.9 ttmt -64.83 -14.01 57.85 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 124.335 1.054 . . . . 0.0 110.964 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -96.26 8.69 67.18 Favored Glycine 0 C--N 1.3 -1.462 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.837 176.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 26.4 mmt -87.33 23.65 1.81 Allowed 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.123 -0.633 . . . . 0.0 111.936 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 47.95 36.74 6.53 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.298 1.439 . . . . 0.0 113.538 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -119.69 -37.21 3.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.449 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -102.34 73.48 1.34 Allowed 'General case' 0 C--O 1.254 1.299 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -96.96 104.78 16.82 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.886 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -66.51 -39.87 88.89 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.088 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.505 ' HE3' ' OE1' ' A' ' 441' ' ' GLU . 15.6 ptmt -102.6 -39.8 6.92 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 2.9 m -75.62 72.35 2.57 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.887 0.851 . . . . 0.0 109.836 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 77.2 p -111.24 -45.55 3.4 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.401 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.03 68.1 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.393 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -86.99 135.43 33.28 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.861 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . 0.505 ' HB3' ' CB ' ' A' ' 386' ' ' GLU . 0.0 OUTLIER -89.03 -37.68 14.98 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 177.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -157.02 135.68 11.55 Favored 'General case' 0 CA--C 1.465 -2.31 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 9.9 mtmp? -98.09 175.06 6.24 Favored 'General case' 0 C--N 1.268 -2.963 0 O-C-N 124.298 0.999 . . . . 0.0 109.756 -175.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.521 HD11 ' SG ' ' A' ' 436' ' ' CYS . 34.6 mt -61.08 155.7 19.78 Favored 'General case' 0 C--O 1.249 1.031 0 O-C-N 124.066 0.854 . . . . 0.0 111.523 178.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.48 149.32 91.05 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 170.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.81 -37.19 76.3 Favored 'Trans proline' 0 C--O 1.245 0.826 0 C-N-CA 122.592 2.194 . . . . 0.0 113.293 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -143.8 153.15 42.09 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.638 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -135.2 163.24 30.4 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -138.05 145.34 41.66 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 381' ' ' ILE . 13.3 p -148.33 155.25 9.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.471 ' HB2' ' CG ' ' A' ' 379' ' ' HIS . 49.8 m -90.96 146.86 23.52 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.46 ' HB3' ' NZ ' ' A' ' 377' ' ' LYS . 1.7 ttpm? -63.47 121.04 12.85 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.7 0.32 57.77 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.703 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . 0.471 ' CG ' ' HB2' ' A' ' 376' ' ' SER . 12.5 m170 -103.78 171.08 7.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 120.827 0.346 . . . . 0.0 111.309 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 56.0 mtpt -101.44 143.32 31.6 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 382' ' ' ARG . 0.1 OUTLIER -135.92 138.57 47.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.476 ' N ' HD13 ' A' ' 381' ' ' ILE . 55.0 mtt180 -114.62 117.35 30.63 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.377 0.608 . . . . 0.0 112.244 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 420' ' ' THR . 29.7 mt -96.53 128.81 43.81 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 28.7 m -123.74 134.57 53.66 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 14.2 m -141.97 162.82 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 C-N-CA 124.211 1.004 . . . . 0.0 108.629 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.505 ' CB ' ' HB3' ' A' ' 366' ' ' GLN . 37.8 mt-10 -123.33 138.89 54.51 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 46.2 mt -105.67 146.65 29.46 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.82 -5.72 54.15 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.386 0.613 . . . . 0.0 111.242 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 392' ' ' ALA . 21.5 t70 -135.58 138.39 42.92 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -75.54 -22.76 56.79 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.379 0.672 . . . . 0.0 112.002 -174.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -109.6 23.16 14.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 122.763 1.268 . . . . 0.0 109.29 -174.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 389' ' ' ASP . . . -101.21 139.31 37.07 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -177.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -103.25 140.75 36.97 Favored 'General case' 0 N--CA 1.393 -3.313 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.93 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.408 ' CG1' ' HG2' ' A' ' 419' ' ' ARG . 6.0 p -120.04 134.1 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.405 0 CA-C-N 113.848 -1.524 . . . . 0.0 107.556 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -111.3 146.13 37.58 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 421' ' ' LEU . 24.4 m95 -106.19 126.75 52.6 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 7.7 mp -114.34 131.44 56.54 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -98.83 110.54 23.12 Favored 'General case' 0 N--CA 1.407 -2.588 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.751 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.0 p30 56.11 2.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 127.637 2.375 . . . . 0.0 114.121 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 131.91 -5.98 5.44 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -103.33 127.89 50.56 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.74 118.86 6.66 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 123.016 0.526 . . . . 0.0 112.036 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.431 HD12 ' CB ' ' A' ' 396' ' ' TRP . 54.0 mt -79.48 114.26 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 170.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -104.28 141.26 36.61 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.563 ' HA ' ' HB2' ' A' ' 410' ' ' TYR . 27.1 ptt? -70.11 109.81 4.8 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.228 -176.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 13.3 m -103.05 102.48 12.51 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.214 -175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 52.1 -124.12 23.61 Favored Glycine 0 N--CA 1.445 -0.727 0 O-C-N 124.451 1.094 . . . . 0.0 114.639 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 16.1 m -91.46 -5.76 53.77 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.435 -0.382 . . . . 0.0 111.518 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -78.33 -53.5 7.22 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.585 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 90.9 m-85 -110.97 121.5 45.52 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 46.2 mt -121.7 119.64 59.39 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.71 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 405' ' ' MET . 3.1 m-30 -88.02 106.02 17.86 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -106.69 133.67 51.0 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 9.6 t -118.73 121.7 40.73 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.585 ' O ' ' HG2' ' A' ' 418' ' ' LYS . 65.4 mt -118.84 94.94 3.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 69.78 -98.63 0.62 Allowed Glycine 0 C--N 1.305 -1.142 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -121.37 3.57 10.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.062 0.458 . . . . 0.0 110.166 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 415' ' ' ILE . 21.2 ptmt -104.9 136.6 44.08 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . 0.408 ' HG2' ' CG1' ' A' ' 394' ' ' VAL . 9.7 tpp85 -110.71 139.07 46.31 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 29.9 m -131.22 125.31 32.58 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.507 ' HB2' ' CE2' ' A' ' 396' ' ' TRP . 50.6 tp -97.83 117.68 32.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 54.3 m -103.62 106.96 17.62 Favored 'General case' 0 N--CA 1.41 -2.428 0 O-C-N 123.906 0.754 . . . . 0.0 108.967 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 52.6 mt -98.87 125.16 52.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 44.7 m -104.59 128.8 52.7 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 66.06 66.98 0.48 Allowed 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 124.552 1.158 . . . . 0.0 110.689 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.07 122.38 17.27 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.634 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 9.2 m -105.58 -177.87 3.49 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 451' ' ' GLU . 71.8 mt -68.01 -28.69 67.63 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.976 0.417 . . . . 0.0 110.57 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -75.32 -6.27 49.04 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.344 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -101.17 -11.08 19.83 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.14 106.83 2.53 Favored 'General case' 0 C--O 1.25 1.083 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -160.38 165.57 30.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.533 -176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.53 129.23 34.87 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -104.97 135.35 46.48 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 1.8 mp0 -121.54 123.91 43.11 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 442' ' ' LYS . 91.9 m -84.45 117.05 23.41 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.25 112.73 37.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.84 160.86 14.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.03 112.88 5.35 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 119.134 -1.507 . . . . 0.0 110.749 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.39 -36.21 4.5 Favored Glycine 0 N--CA 1.405 -3.4 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.109 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.505 ' OE1' ' HE3' ' A' ' 361' ' ' LYS . 70.8 mm-40 -137.41 170.17 16.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -173.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 22.2 ptmt -147.02 162.73 38.19 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.574 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 53.2 t -149.48 135.85 19.18 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.416 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 15.3 p -103.73 142.58 34.1 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 123.739 0.649 . . . . 0.0 111.353 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.429 ' CG2' HD13 ' A' ' 369' ' ' LEU . 15.1 t -131.16 150.2 52.25 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.81 112.46 19.26 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.076 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 36.4 tp -85.16 142.8 29.22 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.831 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -116.01 109.75 17.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.5 t -91.96 118.08 36.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 176.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -103.65 121.99 44.09 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.519 ' HG3' HD21 ' A' ' 428' ' ' LEU . 1.8 mp0 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.62 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.723 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.87 149.37 61.3 Favored 'Trans proline' 0 C--O 1.251 1.145 0 C-N-CA 123.411 2.74 . . . . 0.0 111.988 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 85.62 42.64 6.79 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.1 t -123.9 110.13 14.46 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 321' ' ' VAL . 22.1 mp0 -76.82 -39.9 49.76 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 72.74 -23.38 0.21 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 125.307 1.443 . . . . 0.0 113.061 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.425 ' H ' ' C ' ' A' ' 319' ' ' GLU . 15.0 p -49.95 -29.02 4.85 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.027 0 C-N-CA 125.124 1.37 . . . . 0.0 112.357 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -57.92 -55.39 35.51 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.43 0.692 . . . . 0.0 110.737 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.29 -20.64 43.91 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.163 0.506 . . . . 0.0 110.708 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 321' ' ' VAL . 76.2 mt -72.36 -50.28 36.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.703 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.26 -34.8 78.45 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.303 0.573 . . . . 0.0 110.268 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -54.92 -39.8 69.18 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.854 1.262 . . . . 0.0 112.434 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -103.54 -1.72 27.9 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.278 0.561 . . . . 0.0 110.129 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -80.94 149.22 66.47 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.824 -174.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . 0.422 ' HG2' ' HG3' ' A' ' 332' ' ' GLU . 21.5 Cg_endo -65.47 144.42 79.46 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.325 2.016 . . . . 0.0 110.066 173.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.78 -22.84 69.33 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.868 2.379 . . . . 0.0 113.384 -174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 1.5 m -78.87 -8.53 58.92 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.422 ' HG3' ' HG2' ' A' ' 329' ' ' PRO . 5.4 mm-40 -111.38 2.38 17.55 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 121.099 -0.241 . . . . 0.0 111.183 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -47.85 -52.36 19.41 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.429 ' O ' ' HD2' ' A' ' 338' ' ' PHE . 39.7 tt0 -60.29 -44.43 95.37 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.654 0.596 . . . . 0.0 111.312 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -59.99 -54.18 49.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.265 0.555 . . . . 0.0 109.994 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 51.5 mt -64.88 -41.23 91.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.886 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 342' ' ' VAL . . . -60.47 -55.43 33.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.993 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.429 ' HD2' ' O ' ' A' ' 334' ' ' GLU . 77.2 m-85 -68.7 -24.08 64.45 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -68.11 -40.6 82.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.552 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -93.65 -7.9 42.53 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 95.25 33.8 6.39 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.188 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.426 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 8.3 t -116.57 106.35 20.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 72.0 p -91.28 -18.26 24.65 Favored 'General case' 0 C--N 1.265 -3.078 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.816 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -96.57 45.89 1.06 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.978 -177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -30.29 70.69 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.082 0.468 . . . . 0.0 110.799 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -67.99 -29.27 68.25 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.502 ' O ' ' HG3' ' A' ' 351' ' ' ARG . . . -72.48 -37.43 58.49 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.909 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 27.4 ttt -63.25 -42.02 99.13 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.5 -42.49 87.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.685 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -55.96 -47.56 77.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.234 1.014 . . . . 0.0 110.331 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 347' ' ' GLY . 74.3 mtp180 -62.6 -43.81 97.87 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.969 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.76 -47.75 84.88 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.146 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.47 -8.92 57.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.964 0.411 . . . . 0.0 111.076 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -95.96 -1.2 61.56 Favored Glycine 0 N--CA 1.434 -1.458 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.737 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 25.8 mmt -77.97 -70.64 0.47 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -93.11 111.77 23.5 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.025 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.75 135.73 5.77 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -100.66 85.24 2.88 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 122.634 1.207 . . . . 0.0 111.137 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.85 111.5 18.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.622 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.455 ' HB3' ' H ' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -134.09 141.52 47.18 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.538 178.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' A' ' 363' ' ' THR . 22.9 mtpp -125.02 -21.63 4.63 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.388 -174.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 16.3 m 63.21 65.62 0.76 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.589 1.956 . . . . 0.0 111.292 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 361' ' ' LYS . 9.8 t -139.09 -30.71 0.73 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.845 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -91.24 -11.06 39.31 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.726 0.774 . . . . 0.0 109.422 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.46 127.72 48.0 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -89.64 -32.06 17.25 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.485 0.659 . . . . 0.0 109.314 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.5 OUTLIER -148.83 116.07 6.12 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.355 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -91.17 163.9 14.1 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.607 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 59.6 mt -64.84 144.6 57.15 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 123.837 0.71 . . . . 0.0 109.272 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -67.45 146.42 98.69 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -45.89 -43.05 19.98 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 123.597 2.865 . . . . 0.0 113.821 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -148.9 155.06 40.33 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.068 0.461 . . . . 0.0 111.002 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -137.81 158.65 43.91 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -129.22 142.63 50.8 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 12.8 p -140.64 151.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 450' ' ' LYS . 43.3 m -81.45 145.09 30.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -62.4 117.54 6.29 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.691 0.282 . . . . 0.0 111.163 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 98.09 5.13 57.41 Favored Glycine 0 CA--C 1.499 -0.914 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -104.96 163.25 12.67 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.47 148.17 24.52 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.439 HG22 ' SG ' ' A' ' 426' ' ' CYS . 15.9 tt -150.55 149.25 14.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 1.2 ptp180 -127.37 137.16 52.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.446 0.641 . . . . 0.0 112.325 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.07 153.97 20.78 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 50.7 m -139.68 138.23 35.86 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.692 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.13 144.02 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 35.1 mt-10 -121.28 137.19 54.8 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.429 HD12 ' NH1' ' A' ' 419' ' ' ARG . 96.4 mt -96.67 157.13 16.04 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.472 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -86.46 -15.25 40.77 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -127.93 142.72 51.18 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -80.67 -23.35 39.68 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -106.03 21.94 16.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.307 0.575 . . . . 0.0 110.545 -174.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -99.39 159.16 15.21 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -121.79 145.81 47.69 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 118.585 -1.246 . . . . 0.0 112.983 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.424 HG12 HG22 ' A' ' 438' ' ' VAL . 11.7 m -109.94 158.85 9.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.314 175.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.3 tptm -132.35 133.46 44.01 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -101.03 127.41 47.55 Favored 'General case' 0 C--N 1.275 -2.634 0 O-C-N 124.458 1.099 . . . . 0.0 108.527 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 402' ' ' GLU . 10.1 mt -137.64 146.02 43.39 Favored 'General case' 0 CA--C 1.458 -2.559 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 433' ' ' ALA . 22.5 pttp -126.58 132.82 51.21 Favored 'General case' 0 N--CA 1.399 -3.002 0 C-N-CA 118.772 -1.171 . . . . 0.0 109.652 174.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.6 p30 48.41 27.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 126.438 1.895 . . . . 0.0 114.451 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.06 23.35 30.05 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.865 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -114.18 -96.22 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.559 0.219 . . . . 0.0 111.317 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . 0.708 ' HA ' HD23 ' A' ' 397' ' ' LEU . 43.6 tt0 176.92 135.97 0.06 Allowed 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 58.1 mt -91.07 128.67 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.997 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -99.43 138.5 36.44 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.462 ' HB2' ' CE1' ' A' ' 412' ' ' PHE . 60.1 ttp -79.62 80.9 5.96 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 t -88.81 111.33 21.9 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.363 -171.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 54.06 -125.12 32.44 Favored Glycine 0 N--CA 1.446 -0.698 0 O-C-N 124.331 1.019 . . . . 0.0 113.443 176.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . 0.55 ' HA ' HD11 ' A' ' 411' ' ' ILE . 15.3 m -106.74 3.85 27.04 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.719 0.771 . . . . 0.0 108.927 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -75.2 -41.8 57.04 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.399 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.433 ' HB2' ' HA ' ' A' ' 405' ' ' MET . 99.4 m-85 -119.27 117.98 30.03 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 408' ' ' SER . 43.9 mm -114.96 114.82 47.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.482 ' CE2' HD13 ' A' ' 421' ' ' LEU . 22.3 m-30 -87.42 109.96 19.94 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -105.01 108.57 20.16 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 78.6 p -99.69 121.6 41.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.235 0.541 . . . . 0.0 109.65 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.435 ' HB ' ' HG3' ' A' ' 418' ' ' LYS . 43.5 mm -123.64 85.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.94 -90.39 0.13 Allowed Glycine 0 C--N 1.321 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 113.825 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -102.36 -28.16 12.41 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.817 0.342 . . . . 0.0 110.332 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 386' ' ' GLU . 21.2 ptmt -93.8 134.8 35.76 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.754 0.788 . . . . 0.0 112.44 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . 0.429 ' NH1' HD12 ' A' ' 387' ' ' LEU . 10.8 mpt_? -110.86 124.36 51.92 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 28.6 m -115.89 122.26 44.8 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.482 HD13 ' CE2' ' A' ' 412' ' ' PHE . 20.2 tp -103.61 109.02 20.54 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.0 m -100.02 110.75 23.06 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.403 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 49.8 mt -96.95 141.18 16.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 31.8 m -120.72 135.89 55.01 Favored 'General case' 0 N--CA 1.388 -3.561 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 59.31 58.47 3.01 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 124.783 1.302 . . . . 0.0 111.332 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 381' ' ' ILE . 60.7 m -63.6 113.46 3.35 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.347 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.7 m -100.37 -176.84 3.33 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.19 -23.77 63.96 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.125 0.488 . . . . 0.0 111.184 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -77.29 -5.65 50.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.048 0.452 . . . . 0.0 110.867 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -98.21 -5.7 32.79 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.073 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.82 88.7 1.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -146.7 162.49 38.39 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.166 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 398' ' ' LYS . . . -85.42 129.35 34.83 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -108.26 132.47 53.64 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.6 144.93 41.26 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.49 ' SG ' HD11 ' A' ' 369' ' ' LEU . 79.1 m -122.84 103.08 8.4 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.578 HG22 ' HG3' ' A' ' 442' ' ' LYS . 14.8 t -104.77 136.92 36.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.14 -174.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 441' ' ' GLU . 29.9 t -122.17 161.14 23.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 174.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -74.41 109.73 2.88 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 115.423 -3.275 . . . . 0.0 110.176 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 104.61 4.34 43.04 Favored Glycine 0 N--CA 1.42 -2.367 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 438' ' ' VAL . 4.5 tp10 -151.53 143.27 23.71 Favored 'General case' 0 N--CA 1.396 -3.14 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -176.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.578 ' HG3' HG22 ' A' ' 437' ' ' VAL . 26.9 ttpt -148.93 152.77 36.96 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.04 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 28.4 p -150.11 144.18 25.55 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 170.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 22.6 m -133.62 140.52 47.16 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 13.3 t -122.45 148.16 45.46 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.14 111.03 20.4 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 51.6 tp -84.36 134.3 34.49 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.98 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -107.89 115.09 29.5 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.27 108.38 19.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 376' ' ' SER . 3.8 tmmm? -100.21 117.82 35.24 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -176.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--N 1.303 -1.423 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.604 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.285 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.25 103.48 1.29 Allowed 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.409 2.073 . . . . 0.0 110.068 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -131.05 -115.65 1.74 Allowed Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.6 p -96.81 -28.48 14.24 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.629 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.608 ' HB3' HG12 ' A' ' 321' ' ' VAL . 1.4 mp0 68.33 -52.69 0.54 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 125.509 1.524 . . . . 0.0 111.814 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 70.61 -20.6 0.2 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 125.839 1.656 . . . . 0.0 112.848 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . 0.608 HG12 ' HB3' ' A' ' 319' ' ' GLU . 13.3 p -50.52 -44.04 24.13 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.814 0 C-N-CA 125.257 1.423 . . . . 0.0 111.442 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -59.33 -42.8 92.31 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.73 -38.28 18.43 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.8 mt -65.61 -45.83 91.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 120.74 0.305 . . . . 0.0 110.36 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.9 tt -68.23 -32.63 72.96 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.208 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -63.95 -34.63 78.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.103 0.561 . . . . 0.0 110.728 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -94.5 1.59 55.71 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.764 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.78 155.41 36.59 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.751 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . 0.449 ' HG2' ' CG ' ' A' ' 332' ' ' GLU . 15.6 Cg_endo -60.31 142.78 98.96 Favored 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 122.665 2.244 . . . . 0.0 112.422 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.27 -26.98 72.99 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.21 3.273 . . . . 0.0 114.753 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 41.7 m -83.55 -1.19 53.23 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.11 0.481 . . . . 0.0 112.231 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.449 ' CG ' ' HG2' ' A' ' 329' ' ' PRO . 63.0 mm-40 -100.39 -11.29 20.37 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -45.84 -49.07 15.68 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . 0.41 ' HA ' HD22 ' A' ' 345' ' ' LEU . 45.4 tt0 -72.83 -34.59 66.92 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.97 0.414 . . . . 0.0 110.805 -175.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -65.51 -44.32 87.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 332' ' ' GLU . 66.2 mt -67.08 -43.57 88.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.155 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.19 -54.26 48.81 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.454 0.471 . . . . 0.0 110.653 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 334' ' ' GLU . 75.3 m-85 -69.81 -23.09 63.27 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -66.88 -36.21 81.79 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.09 0.471 . . . . 0.0 109.981 175.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -100.96 2.58 40.83 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 83.61 22.31 56.32 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.649 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 16.9 t -98.47 123.09 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 28.7 p -100.62 -28.55 12.8 Favored 'General case' 0 C--N 1.27 -2.863 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.999 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -90.6 56.57 3.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.715 0.769 . . . . 0.0 111.74 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 334' ' ' GLU . 31.8 tp -58.2 -52.97 63.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.469 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.27 -26.49 68.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.729 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -65.37 -37.02 93.4 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 26.8 ttt -67.9 -50.85 53.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.27 -30.83 71.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.55 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -57.59 -56.77 17.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.913 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -72.48 -23.7 61.07 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.042 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.03 -28.67 64.56 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 120.992 0.425 . . . . 0.0 111.341 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -86.95 -20.72 26.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.677 0.751 . . . . 0.0 109.944 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -104.73 34.59 5.67 Favored Glycine 0 C--N 1.301 -1.391 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.663 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 69.6 mtm -68.09 3.91 1.43 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -81.65 -16.82 50.17 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.631 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -103.17 -177.8 3.48 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -139.8 105.2 5.07 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.295 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -22.97 11.46 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.516 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 71.23 173.38 0.31 Allowed 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.11 1.364 . . . . 0.0 112.583 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -58.19 -30.83 66.74 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.067 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.525 ' CB ' ' HZ3' ' A' ' 368' ' ' LYS . 47.9 m 68.18 64.73 0.35 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 122.775 1.274 . . . . 0.0 110.934 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.5 t -129.17 -15.11 4.24 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.172 -1.831 . . . . 0.0 108.569 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -90.43 -38.2 13.44 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 368' ' ' LYS . 11.9 m-85 -86.92 146.89 26.0 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 169.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -102.38 -15.67 16.46 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -168.5 125.04 1.01 Allowed 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.534 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 62.0 mttp -100.35 169.27 9.23 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 123.452 0.47 . . . . 0.0 110.16 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 70.3 mt -64.14 143.11 58.12 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.548 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -68.25 146.76 98.15 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -45.7 -43.44 18.68 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.817 3.011 . . . . 0.0 113.837 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -149.05 137.42 20.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.327 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.413 ' HD2' ' OG1' ' A' ' 445' ' ' THR . 78.8 m-85 -118.78 159.61 23.4 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.88 127.08 28.15 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.486 HG21 ' HB ' ' A' ' 381' ' ' ILE . 14.0 p -133.4 160.87 42.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 14.1 m -95.66 142.84 27.5 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.403 ' HE2' ' OE2' ' A' ' 451' ' ' GLU . 0.4 OUTLIER -64.26 127.3 30.85 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.984 0.421 . . . . 0.0 110.099 -176.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 95.43 1.78 62.17 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.972 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -100.97 172.37 7.07 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.917 0.389 . . . . 0.0 110.887 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 26.5 mtpp -97.85 134.75 40.57 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.486 ' HB ' HG21 ' A' ' 375' ' ' VAL . 6.7 tp -130.31 135.99 59.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 421' ' ' LEU . 26.8 ptt180 -127.58 128.74 46.11 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.406 0.622 . . . . 0.0 112.591 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 420' ' ' THR . 1.1 mm? -105.98 138.89 41.4 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.462 -1.244 . . . . 0.0 107.793 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 51.5 m -119.04 128.41 54.33 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.803 0.335 . . . . 0.0 111.794 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 13.5 m -126.41 145.08 34.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -118.33 136.83 53.49 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.607 HD23 ' HD3' ' A' ' 419' ' ' ARG . 3.9 mm? -95.59 152.37 18.49 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.066 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.74 -33.41 58.14 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -101.31 154.54 18.69 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -77.37 -40.34 44.18 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -174.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -103.34 7.39 38.23 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.788 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . 0.579 ' O ' ' HG ' ' A' ' 387' ' ' LEU . . . -84.14 132.63 34.67 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 175.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.95 177.31 7.2 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.034 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 438' ' ' VAL . 15.8 m -112.44 164.38 8.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.466 -175.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -107.92 148.76 29.2 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.42 ' CB ' ' HB ' ' A' ' 403' ' ' ILE . 9.5 m-90 -110.22 113.01 25.34 Favored 'General case' 0 C--N 1.274 -2.699 0 O-C-N 124.144 0.902 . . . . 0.0 109.587 -171.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 401' ' ' GLN . 7.8 mp -126.35 134.26 51.12 Favored 'General case' 0 CA--C 1.48 -1.727 0 CA-C-O 120.675 0.274 . . . . 0.0 111.217 178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -113.95 132.76 55.84 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 46.95 24.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.89 14.79 64.24 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.43 ' O ' ' HG ' ' A' ' 397' ' ' LEU . 24.7 tp60 -94.61 -116.29 0.1 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -174.62 128.45 0.33 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 173.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.42 ' HB ' ' CB ' ' A' ' 396' ' ' TRP . 68.4 mt -81.56 101.9 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -82.23 127.68 33.43 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.69 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -66.22 102.47 0.84 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.7 m -110.92 110.0 20.4 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.877 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 52.32 -119.16 8.64 Favored Glycine 0 N--CA 1.444 -0.801 0 O-C-N 124.408 1.067 . . . . 0.0 114.048 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 18.7 m -108.23 5.74 26.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.205 0.526 . . . . 0.0 110.669 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.04 -41.01 59.98 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.835 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -117.4 109.75 17.17 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.323 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 43.5 mm -108.12 114.88 47.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.497 ' CE1' HD13 ' A' ' 421' ' ' LEU . 23.0 m-85 -87.85 105.96 17.77 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -98.02 108.65 21.41 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.444 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 12.6 p -103.4 105.08 15.26 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.575 0.702 . . . . 0.0 109.85 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 51.2 mt -112.75 83.75 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 76.83 -111.6 3.31 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -97.56 -14.01 21.3 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.135 0.493 . . . . 0.0 109.923 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -78.43 119.34 21.6 Favored 'General case' 0 N--CA 1.429 -1.522 0 C-N-CA 124.047 0.939 . . . . 0.0 111.023 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . 0.607 ' HD3' HD23 ' A' ' 387' ' ' LEU . 9.9 mpt_? -111.37 113.85 26.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 383' ' ' LEU . 99.0 m -115.06 116.17 28.0 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.577 0.703 . . . . 0.0 110.593 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 382' ' ' ARG . 26.3 tp -91.0 115.5 28.06 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.106 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.2 m -103.85 112.23 25.11 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 56.8 mt -100.26 118.13 46.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 11.3 m -96.91 138.93 33.7 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 63.15 47.65 4.05 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 124.019 0.824 . . . . 0.0 110.599 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 44.4 t -57.92 118.6 5.54 Favored 'General case' 0 C--O 1.249 1.068 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 16.1 m -107.89 -177.81 3.44 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -175.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 86.4 mt -69.78 -23.11 63.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.03 0.443 . . . . 0.0 110.604 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -74.39 -5.02 39.96 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.582 0.706 . . . . 0.0 110.27 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -110.88 -9.57 14.45 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.922 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.1 98.68 0.6 Allowed 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 170.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -164.78 173.67 11.53 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.575 -169.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.4 132.05 34.29 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 444' ' ' SER . 23.7 m-85 -111.42 132.06 54.73 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.1 134.4 55.03 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.447 ' SG ' HD11 ' A' ' 369' ' ' LEU . 73.4 m -109.45 113.07 25.57 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 11.0 t -105.34 125.24 60.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.732 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 394' ' ' VAL . 39.4 t -116.62 160.92 15.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -69.73 113.2 4.89 Favored Glycine 0 N--CA 1.419 -2.435 0 C-N-CA 118.316 -1.897 . . . . 0.0 109.39 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.22 -35.75 4.79 Favored Glycine 0 N--CA 1.425 -2.046 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.937 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' A' ' 362' ' ' SER . 86.7 mt-10 -135.81 158.0 45.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.576 1.188 . . . . 0.0 111.596 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -148.73 173.19 13.49 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 35.0 t -159.96 142.74 13.64 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 170.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 434' ' ' TYR . 12.3 p -122.1 130.94 53.69 Favored 'General case' 0 N--CA 1.418 -2.072 0 O-C-N 123.801 0.688 . . . . 0.0 110.09 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 10.7 t -107.02 142.3 36.86 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -98.58 110.02 22.69 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 38.7 tp -89.22 138.83 31.08 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.898 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -115.19 111.23 20.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.17 119.07 45.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 450' ' ' LYS . 0.0 OUTLIER -100.23 134.59 42.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.225 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . 0.403 ' OE2' ' HE2' ' A' ' 377' ' ' LYS . 44.9 tt0 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.643 ' N ' ' HG ' ' A' ' 318' ' ' SER . . . . . . . . 0 CA--C 1.503 -0.688 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -63.3 111.49 1.46 Allowed 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.157 1.905 . . . . 0.0 109.924 174.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 107.4 13.24 21.38 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . 0.643 ' HG ' ' N ' ' A' ' 315' ' ' GLY . 10.1 m -125.32 0.37 7.71 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.128 0.49 . . . . 0.0 109.985 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.11 165.67 10.92 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -175.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 72.78 -4.88 2.01 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.616 1.166 . . . . 0.0 112.985 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.82 -33.08 33.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 C-N-CA 123.511 0.724 . . . . 0.0 111.272 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -54.02 -46.46 71.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.907 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -86.13 -38.11 18.08 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 120.216 -0.593 . . . . 0.0 111.702 177.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.01 -54.91 28.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 O-C-N 123.223 0.327 . . . . 0.0 111.613 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.15 -21.29 65.83 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.652 0.739 . . . . 0.0 110.148 -175.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -72.8 -37.53 67.53 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.075 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -94.03 -23.99 17.8 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.634 0.73 . . . . 0.0 110.431 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.34 89.51 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.763 -176.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . 0.406 ' HG2' ' HG2' ' A' ' 332' ' ' GLU . 24.5 Cg_endo -63.85 137.55 58.75 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.509 2.139 . . . . 0.0 112.649 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.638 ' HA ' ' CZ ' ' A' ' 333' ' ' TYR . 8.9 Cg_endo -52.23 -29.44 37.89 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.302 3.335 . . . . 0.0 115.555 -175.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 11.8 p -70.86 -23.84 62.39 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' ' 336' ' ' ILE . 22.1 mm-40 -95.27 -4.51 45.55 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -171.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.638 ' CZ ' ' HA ' ' A' ' 330' ' ' PRO . 21.5 m-30 -46.12 -48.59 17.2 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -173.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.04 -29.46 68.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.061 0.458 . . . . 0.0 111.42 -175.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -76.01 -47.29 25.42 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 332' ' ' GLU . 60.7 mt -58.45 -44.12 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.117 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -57.85 -58.52 8.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.305 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -68.69 -23.51 64.39 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -71.13 -35.68 71.83 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.16 0.584 . . . . 0.0 110.03 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -100.9 5.35 43.28 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 79.89 38.53 19.37 Favored Glycine 0 C--N 1.31 -0.912 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.699 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 9.9 t -114.82 119.14 60.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 23.6 p -99.1 -14.55 19.35 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-O 121.556 0.693 . . . . 0.0 110.751 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.79 45.43 0.97 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.327 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.617 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 1.3 pt? -68.33 -36.12 78.79 Favored 'General case' 0 C--O 1.197 -1.67 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.986 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -71.9 -24.4 61.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.183 0.516 . . . . 0.0 111.113 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.589 ' O ' ' HG2' ' A' ' 350' ' ' LYS . . . -77.11 -28.79 57.8 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 174.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 26.6 ttt -78.67 -41.76 30.38 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.271 0.557 . . . . 0.0 109.583 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 345' ' ' LEU . 81.4 mt -64.92 -35.12 80.13 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.844 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 347' ' ' GLY . 25.2 pttm -61.21 -27.26 68.31 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.215 0.531 . . . . 0.0 111.232 -177.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -62.47 -50.11 72.74 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.896 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.09 -32.87 30.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.413 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -68.63 -38.29 80.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.104 0.478 . . . . 0.0 110.217 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -102.4 26.82 22.87 Favored Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 35.0 tpp -85.15 -60.64 1.98 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.85 0.357 . . . . 0.0 111.083 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -91.42 -13.29 32.62 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.842 0.829 . . . . 0.0 110.678 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . 0.406 ' C ' ' HD3' ' A' ' 357' ' ' ARG . 1.7 tmt_? -70.94 94.93 1.11 Allowed 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 172.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -156.15 -48.81 0.08 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -66.68 -19.72 65.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.825 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 71.59 -84.82 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.871 1.268 . . . . 0.0 108.149 -172.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt 46.74 -87.22 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.263 1.425 . . . . 0.0 113.107 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 54.3 p -170.48 78.62 0.08 Allowed 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 16.7 p -111.69 -30.47 7.32 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.471 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -105.64 -13.47 15.57 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -110.32 136.02 50.15 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.198 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -98.02 -19.78 17.8 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.389 0.614 . . . . 0.0 110.016 175.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -158.5 122.35 3.98 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.721 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 45.4 mtpt -106.69 172.33 6.87 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 80.9 mt -75.04 132.67 41.48 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.02 127.97 88.56 Favored Pre-proline 0 CA--C 1.5 -0.973 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.64 -32.18 53.32 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.279 1.986 . . . . 0.0 112.438 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -110.57 110.97 21.89 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.467 ' HD1' ' OG1' ' A' ' 445' ' ' THR . 13.9 m-85 -118.43 151.07 38.49 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 171.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -144.87 143.54 30.64 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 10.6 p -150.63 154.89 8.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.546 ' HB2' ' CD2' ' A' ' 379' ' ' HIS . 16.1 m -85.55 157.19 20.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . 0.526 ' HG3' ' HA ' ' A' ' 427' ' ' SER . 35.6 ttpt -71.98 135.35 46.38 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.782 0.325 . . . . 0.0 111.071 -177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 85.86 15.58 65.1 Favored Glycine 0 C--N 1.318 -0.469 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.8 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . 0.546 ' CD2' ' HB2' ' A' ' 376' ' ' SER . 31.5 m-70 -105.35 -177.53 3.39 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.984 0.421 . . . . 0.0 110.317 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -114.63 138.46 50.64 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.95 130.71 73.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 CA-C-O 120.904 0.383 . . . . 0.0 109.98 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -108.27 103.62 12.83 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.161 0.505 . . . . 0.0 110.475 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.26 113.11 20.88 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 19.9 m -110.35 130.86 55.47 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.149 -171.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.7 151.34 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 123.55 0.74 . . . . 0.0 109.69 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.486 ' HG2' ' HB3' ' A' ' 418' ' ' LYS . 50.0 mt-10 -118.55 131.61 56.22 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.457 HD22 HG21 ' A' ' 438' ' ' VAL . 26.1 mt -100.91 148.94 24.41 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -81.84 3.87 24.42 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.088 0.471 . . . . 0.0 111.782 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -142.43 136.84 29.89 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -80.42 -21.87 41.76 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.564 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -102.58 4.51 38.49 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.153 0.978 . . . . 0.0 110.042 -173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -100.21 134.84 42.56 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.96 175.89 5.24 Favored 'General case' 0 C--N 1.28 -2.449 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.847 -174.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 4.8 p -131.36 141.32 46.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 120.967 0.413 . . . . 0.0 111.082 -172.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -114.02 135.85 53.55 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 175.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.683 ' HB3' HD12 ' A' ' 403' ' ' ILE . 68.4 m95 -104.35 134.35 47.7 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.913 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 8.3 mp -119.85 125.75 49.29 Favored 'General case' 0 CA--C 1.475 -1.909 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.031 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -102.62 127.38 49.75 Favored 'General case' 0 N--CA 1.416 -2.147 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.702 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 20.9 p30 54.95 15.38 1.14 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 127.125 2.17 . . . . 0.0 113.498 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.2 19.37 42.59 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.251 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -98.13 -89.29 0.3 Allowed 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 169.63 145.9 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.695 HD11 ' HD1' ' A' ' 434' ' ' TYR . 30.3 mt -99.24 108.04 21.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -95.96 134.01 39.48 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.159 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -65.74 104.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.461 0.475 . . . . 0.0 110.674 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 30.6 t -117.44 120.76 39.11 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 50.84 -122.42 13.59 Favored Glycine 0 C--N 1.336 0.579 0 O-C-N 124.25 0.969 . . . . 0.0 113.574 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 23.8 m -116.72 19.6 14.42 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -76.5 -44.6 34.53 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.01 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -122.47 108.53 13.28 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.951 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' A' ' 422' ' ' THR . 3.7 mp -105.24 114.89 45.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -88.09 104.82 17.03 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.442 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -99.37 119.14 37.47 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 13.1 t -115.26 108.18 16.24 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 66.0 mt -113.95 82.75 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.345 -174.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 68.21 -104.17 1.14 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.144 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -94.26 -21.89 18.74 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 122.409 0.284 . . . . 0.0 110.851 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 386' ' ' GLU . 21.5 ptmt -101.45 137.08 40.25 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.713 0.768 . . . . 0.0 111.47 -175.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -118.47 139.06 52.01 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.022 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 34.4 m -134.37 117.24 16.12 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-O 121.483 0.659 . . . . 0.0 110.503 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . . . . . . . . . 57.1 tp -91.2 113.45 25.71 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.415 ' HB ' ' HB ' ' A' ' 411' ' ' ILE . 29.1 m -97.59 106.72 19.08 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.73 116.4 33.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 14.7 m -96.5 146.09 25.11 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.001 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 58.26 50.4 9.77 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.189 1.396 . . . . 0.0 110.15 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . . . . . . . . . 8.0 p -60.46 112.96 2.17 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.73 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . 0.526 ' HA ' ' HG3' ' A' ' 377' ' ' LYS . 17.7 m -109.98 -170.46 1.65 Allowed 'General case' 0 N--CA 1.406 -2.629 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.08 -21.06 62.28 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 118.964 0.802 . . . . 0.0 111.736 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -73.24 -14.31 61.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.375 0.607 . . . . 0.0 110.077 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -98.34 9.08 43.88 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.78 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.5 107.64 17.54 Favored 'General case' 0 C--O 1.252 1.22 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -155.44 165.01 37.93 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 120.99 0.424 . . . . 0.0 110.556 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -86.59 115.35 24.01 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 172.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . 0.695 ' HD1' HD11 ' A' ' 403' ' ' ILE . 98.5 m-85 -104.87 133.05 50.33 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 121.019 0.438 . . . . 0.0 110.578 -175.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 2.0 mp0 -128.08 134.29 49.14 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 443' ' ' CYS . 3.7 p -100.89 118.36 36.79 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.65 123.29 58.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.457 HG21 HD22 ' A' ' 387' ' ' LEU . 92.9 t -131.44 160.68 42.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.18 114.61 7.05 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.031 -1.081 . . . . 0.0 111.059 175.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.83 -36.49 4.32 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-O 119.31 -0.717 . . . . 0.0 113.7 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -139.16 -179.75 6.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.728 1.251 . . . . 0.0 114.228 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 443' ' ' CYS . 33.0 ttmt -149.24 157.12 43.09 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 368' ' ' LYS . 42.4 t -143.63 134.43 25.24 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 171.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.42 ' HB3' ' HG3' ' A' ' 435' ' ' GLN . 12.2 p -110.15 142.77 41.2 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 123.573 0.545 . . . . 0.0 110.917 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.467 ' OG1' ' HD1' ' A' ' 373' ' ' TYR . 8.8 t -137.87 147.59 44.6 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.23 111.13 23.37 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 64.5 tp -88.82 111.3 21.86 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -93.13 107.87 19.58 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 48.8 t -92.22 114.23 28.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -107.2 124.13 49.29 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.427 -1.577 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.836 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.08 103.13 1.7 Allowed 'Trans proline' 0 C--O 1.251 1.14 0 C-N-CA 122.621 2.214 . . . . 0.0 110.807 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -131.04 10.54 5.65 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.321 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 28.7 m -135.55 27.58 3.37 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.725 0.774 . . . . 0.0 109.543 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.38 -45.63 10.38 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.502 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 72.68 1.0 3.84 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.681 1.592 . . . . 0.0 111.902 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.89 -36.31 49.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 123.438 0.695 . . . . 0.0 111.675 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' TRP . . . . . . . . . . . . . 31.9 p-90 -58.22 -41.63 84.5 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 123.182 0.593 . . . . 0.0 111.653 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -86.6 -45.97 10.55 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 80.1 mt -58.2 -52.44 58.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 8.0 tt -66.43 -33.54 75.94 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-O 121.501 0.667 . . . . 0.0 109.617 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -64.47 -32.89 74.71 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 124.524 1.129 . . . . 0.0 111.446 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -96.97 -11.08 25.03 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.331 0.586 . . . . 0.0 110.845 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -83.84 161.77 54.68 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.412 -174.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.52 142.25 58.49 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.68 2.254 . . . . 0.0 110.829 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.98 -16.69 56.31 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 123.784 2.989 . . . . 0.0 114.199 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' SER . . . . . . . . . . . . . 8.4 m -77.54 -17.07 58.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.719 0.295 . . . . 0.0 111.765 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -104.43 1.13 29.72 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' TYR . . . . . 0.404 ' HB3' ' CD1' ' A' ' 345' ' ' LEU . 8.8 m-30 -53.4 -42.54 67.07 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -174.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.8 -27.87 55.4 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.395 -177.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 -63.62 -54.44 35.83 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 34.0 mt -64.01 -43.41 97.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.751 -176.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -59.47 -59.99 4.56 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.2 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.26 -22.78 66.32 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -65.67 -42.56 91.16 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.235 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -97.95 7.04 46.99 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 90.07 13.72 60.13 Favored Glycine 0 CA--C 1.499 -0.912 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.904 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 18.0 t -94.54 99.43 9.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.3 m -76.39 -38.75 55.25 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.082 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -110.09 94.21 4.9 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.643 0.735 . . . . 0.0 109.873 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.615 ' H ' HD23 ' A' ' 345' ' ' LEU . 1.8 pt? -75.65 -29.8 59.22 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.356 -178.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -63.86 -38.65 91.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.479 -174.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -66.13 -34.79 89.3 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.79 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' MET . . . . . . . . . . . . . 60.9 ttp -70.46 -43.3 70.12 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 353' ' ' LYS . 94.3 mt -62.1 -40.46 95.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.493 177.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -65.86 -33.4 75.75 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.854 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -70.21 -42.24 72.59 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.256 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.26 -42.16 69.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 349' ' ' LEU . 18.6 ptpt -77.06 -16.92 59.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.867 0.841 . . . . 0.0 109.224 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -83.83 0.76 89.4 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.005 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 25.5 mmt -71.7 -10.9 60.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 122.068 0.937 . . . . 0.0 108.762 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -78.3 16.95 0.69 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.123 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 358' ' ' ASP . 7.6 ppt_? -66.7 -19.68 65.81 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.517 0.675 . . . . 0.0 109.961 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.439 ' O ' ' HD2' ' A' ' 357' ' ' ARG . 8.4 t70 67.04 -154.71 0.22 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.551 171.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 63.8 66.51 0.66 Allowed 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.514 1.126 . . . . 0.0 109.836 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -100.82 176.84 5.15 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.667 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.62 32.48 22.21 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 123.09 1.424 . . . . 0.0 107.556 -176.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 15.6 m -158.39 45.69 0.32 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.034 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 8.8 t -101.51 -37.36 8.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.335 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.511 ' HB3' ' HG3' ' A' ' 441' ' ' GLU . . . -86.39 -27.06 24.44 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.869 0.842 . . . . 0.0 109.482 177.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -89.65 127.63 35.95 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.23 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -90.54 -28.37 18.55 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 367' ' ' LYS . 0.4 OUTLIER -149.46 115.4 5.68 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 177.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.428 ' HB3' ' SG ' ' A' ' 443' ' ' CYS . 57.9 mtpt -89.85 162.09 15.65 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 175.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 445' ' ' THR . 74.5 mt -64.57 138.65 58.52 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -61.83 145.0 92.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.76 -24.09 44.8 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.6 2.2 . . . . 0.0 113.437 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -142.68 135.6 28.2 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.87 0.367 . . . . 0.0 111.668 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -135.69 146.79 48.12 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -131.05 136.04 48.1 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.47 146.41 31.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 15.5 m -82.79 142.37 31.62 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -57.38 115.84 2.96 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 122.958 0.503 . . . . 0.0 111.248 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 108.03 -18.51 33.81 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.504 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -82.25 179.98 7.61 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.114 0.483 . . . . 0.0 110.925 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 424' ' ' SER . 54.3 mtpt -108.76 140.07 42.69 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.574 HG22 ' SG ' ' A' ' 426' ' ' CYS . 9.6 tp -127.12 133.25 68.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 176.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -105.87 112.6 25.72 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.918 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 80.2 mt -94.51 110.65 22.44 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 45.0 m -108.32 128.89 55.14 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.65 143.45 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 172.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 418' ' ' LYS . 18.0 mt-10 -120.13 138.37 53.62 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.41 HD12 ' NH1' ' A' ' 419' ' ' ARG . 95.5 mt -100.19 152.35 20.37 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -85.24 -14.63 46.14 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.403 0.621 . . . . 0.0 110.081 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 392' ' ' ALA . 10.6 t70 -117.84 141.47 48.39 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -79.99 -26.84 39.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.795 0.331 . . . . 0.0 111.718 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -108.04 25.61 11.38 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.632 1.206 . . . . 0.0 109.896 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 389' ' ' ASP . . . -96.75 154.97 16.98 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.15 149.23 51.95 Favored 'General case' 0 C--N 1.274 -2.7 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.116 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . . . . . . . . . 5.3 m -105.92 135.79 42.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.056 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.1 tptm -103.74 136.69 42.97 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 173.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' TRP . . . . . 0.544 ' HB3' HD12 ' A' ' 403' ' ' ILE . 4.8 m-90 -103.23 118.53 36.99 Favored 'General case' 0 C--N 1.264 -3.148 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.981 -170.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . . . . . . . . . 9.7 mp -128.75 130.21 46.77 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 120.966 0.412 . . . . 0.0 111.757 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -109.22 128.06 54.75 Favored 'General case' 0 N--CA 1.412 -2.363 0 C-N-CA 118.886 -1.126 . . . . 0.0 108.894 170.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 9.5 p30 49.57 23.86 1.03 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.698 1.599 . . . . 0.0 113.295 -176.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.34 4.96 60.74 Favored Glycine 0 CA--C 1.494 -1.227 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.737 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -90.12 -92.26 0.13 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.501 0.191 . . . . 0.0 110.6 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 171.77 133.69 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.544 HD12 ' HB3' ' A' ' 396' ' ' TRP . 15.0 mt -94.71 124.84 47.36 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 173.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -123.76 145.17 49.22 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.996 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 410' ' ' TYR . 27.3 ttt -64.91 94.26 0.13 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.677 0.791 . . . . 0.0 111.32 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.6 t -93.5 101.08 13.26 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 59.23 -128.8 48.21 Favored Glycine 0 N--CA 1.446 -0.659 0 O-C-N 123.915 0.759 . . . . 0.0 112.191 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.7 m -105.24 18.16 22.78 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.395 0.617 . . . . 0.0 109.599 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 424' ' ' SER . 86.5 tttt -83.03 -59.76 2.38 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.359 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' TYR . . . . . 0.533 ' O ' ' HG3' ' A' ' 405' ' ' MET . 75.9 m-85 -96.44 108.12 20.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.76 115.13 48.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.189 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 421' ' ' LEU . 25.4 m-85 -87.41 106.02 17.67 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.8 108.76 21.53 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 29.8 t -95.64 122.8 38.79 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.498 ' HB ' ' CG ' ' A' ' 418' ' ' LYS . 58.3 mt -129.08 85.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 65.75 -98.03 0.33 Allowed Glycine 0 C--N 1.314 -0.674 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.491 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -92.26 -28.96 16.66 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.849 0.357 . . . . 0.0 110.57 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' LYS . . . . . 0.498 ' CG ' ' HB ' ' A' ' 415' ' ' ILE . 23.2 ptmt -92.55 146.72 23.45 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 121.896 0.855 . . . . 0.0 112.143 -175.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' ARG . . . . . 0.41 ' NH1' HD12 ' A' ' 387' ' ' LEU . 11.4 mpt_? -125.25 125.07 42.99 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 173.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . . . . . . . . . 34.7 m -121.18 126.61 50.11 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 120.925 0.393 . . . . 0.0 110.279 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' LEU . . . . . 0.56 HD13 ' CE2' ' A' ' 412' ' ' PHE . 33.4 tp -98.15 108.44 21.15 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.7 m -94.83 105.23 17.15 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.718 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 380' ' ' LYS . 52.4 mt -90.06 115.7 30.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 380' ' ' LYS . 19.5 m -102.25 128.67 48.69 Favored 'General case' 0 N--CA 1.406 -2.635 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 69.97 59.93 0.27 Allowed 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 124.343 1.027 . . . . 0.0 110.148 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 381' ' ' ILE . 27.8 m -66.23 113.72 4.78 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.268 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 14.5 m -106.43 -166.37 1.18 Allowed 'General case' 0 N--CA 1.404 -2.762 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 54.5 mt -77.84 -22.48 49.86 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.315 -174.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -73.03 -6.41 45.34 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-O 121.64 0.733 . . . . 0.0 110.277 176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -103.69 2.71 33.45 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.077 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -87.36 100.04 12.43 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . -154.58 167.19 30.95 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.78 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' ALA . . . . . . . . . . . . . . . -85.66 122.9 30.42 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 170.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' TYR . . . . . 0.534 ' HD2' HD11 ' A' ' 403' ' ' ILE . 94.8 m-85 -108.04 132.25 53.74 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 120.754 0.311 . . . . 0.0 110.468 -176.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 443' ' ' CYS . 2.1 mp0 -121.86 126.08 47.9 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.098 0.475 . . . . 0.0 110.668 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 10.7 p -95.48 113.95 25.67 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.4 123.91 65.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.747 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.48 162.69 32.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.5 113.09 5.55 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 118.448 -1.834 . . . . 0.0 110.727 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' GLY . . . . . . . . . . . . . . . 108.26 -35.23 5.1 Favored Glycine 0 N--CA 1.429 -1.818 0 CA-C-O 119.661 -0.522 . . . . 0.0 113.524 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.511 ' HG3' ' HB3' ' A' ' 364' ' ' ALA . 3.3 mm-40 -130.84 154.2 48.29 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 117.944 0.872 . . . . 0.0 110.75 -173.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -148.58 154.65 40.05 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 435' ' ' GLN . 13.6 t -147.74 139.45 23.95 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.419 ' HB3' ' OE1' ' A' ' 435' ' ' GLN . 3.4 m -115.78 118.99 34.56 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.739 0.649 . . . . 0.0 109.465 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 369' ' ' LEU . 11.0 t -105.92 146.23 30.26 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -101.59 110.29 22.25 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' LEU . . . . . . . . . . . . . 66.6 tp -96.2 118.04 31.97 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -101.76 117.73 35.48 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.68 113.13 30.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -95.09 119.29 33.34 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.831 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.958 . . . . . . . . 0 0 . 1 stop_ save_